data_2jv0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jv0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.354 0 CA-C-O 121.177 0.513 . . . . 1.0 110.112 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.2 m 151.52 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.465 -1.243 . . . . 1.0 107.845 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.38 157.44 17.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.234 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 150.54 43.95 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 121.644 0.735 . . . . 1.0 112.587 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.568 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.12 -35.47 25.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.08 -0.963 . . . . 1.0 110.204 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.29 -9.79 58.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.931 -1.031 . . . . 1.0 111.382 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -31.76 22.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.62 0.97 . . . . 1.0 113.62 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.15 142.91 65.48 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 35.3 Cg_exo -48.44 122.78 8.23 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.431 1.421 . . . . 1.0 110.677 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 37.7 tt0 -48.35 -25.42 1.58 Allowed 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 113.303 0.853 . . . . 1.0 113.303 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.737 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.2 OUTLIER -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.164 0.802 . . . . 1.0 113.164 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 98' ' ' TRP . 6.8 t -76.97 -49.7 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.727 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -71.23 -19.58 62.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.711 0.767 . . . . 1.0 109.934 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.83 -27.37 68.83 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 -176.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.33 42.58 1.91 Allowed Glycine 0 N--CA 1.47 0.942 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' PRO . 18.5 mt -76.77 155.47 83.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' O ' ' O ' ' A' ' 26' ' ' LEU . 23.9 Cg_exo -36.25 -112.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 124.537 3.491 . . . . 1.0 113.516 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.92 -57.61 3.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.755 -1.578 . . . . 1.0 107.6 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 12.0 pt-20 -172.89 37.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 2.4 t -45.69 171.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 113.412 -1.722 . . . . 1.0 107.785 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.534 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -141.67 154.1 45.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -91.83 134.67 34.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 118.894 -1.122 . . . . 1.0 109.874 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.7 m-85 -133.95 144.56 52.15 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 42' ' ' ILE . 3.1 Cg_exo -48.32 142.46 16.85 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 CA-C-N 119.715 0.934 . . . . 1.0 114.031 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -61.69 52.43 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-O 123.087 1.423 . . . . 1.0 110.892 -178.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 34' ' ' PRO . . . -56.84 -5.36 0.23 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.017 -1.901 . . . . 1.0 108.272 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.648 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -82.55 -50.37 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 113.689 -1.596 . . . . 1.0 111.83 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.605 ' C ' ' H ' ' A' ' 40' ' ' THR . 44.8 t0 -156.04 -66.72 0.11 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.536 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 41' ' ' ARG . 8.1 mmpp? -58.72 3.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.22 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.605 ' H ' ' C ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER 35.73 14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 35' ' ' SER . 49.2 mtp85 -107.3 -116.46 0.26 Allowed 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 105.356 -2.09 . . . . 1.0 105.356 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.752 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 9.5 mm -102.19 134.03 44.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 120.09 1.314 . . . . 1.0 111.318 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.23 159.79 23.19 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 p -102.84 131.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.234 0.54 . . . . 1.0 111.627 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.452 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 13.5 m95 -130.33 154.46 47.62 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.711 1.004 . . . . 1.0 113.711 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.83 131.39 45.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.456 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 31' ' ' ARG . 76.3 p -124.96 -15.19 6.47 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.769 1.271 . . . . 1.0 108.57 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.611 ' CD ' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.65 168.89 9.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.843 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.07 152.38 27.86 Favored 'Trans proline' 0 C--N 1.293 -2.356 0 C-N-CA 122.425 2.083 . . . . 1.0 112.415 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.85 144.28 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.871 -1.059 . . . . 1.0 111.229 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' CD2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -116.4 154.37 30.4 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.925 -1.488 . . . . 1.0 110.828 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.508 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.97 125.76 25.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.8 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.28 0.76 55.78 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -53.25 152.54 4.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 119.382 -0.927 . . . . 1.0 109.218 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.64 107.61 12.59 Favored 'General case' 0 N--CA 1.424 -1.757 0 O-C-N 124.714 1.259 . . . . 1.0 109.198 176.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 10.9 m-30 -119.78 124.46 46.22 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.302 1.048 . . . . 1.0 109.323 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.69 -148.84 20.74 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.223 -1.808 . . . . 1.0 109.753 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 9.5 Cg_endo -80.41 152.57 83.53 Favored 'Cis proline' 0 N--CA 1.49 1.304 0 CA-C-N 119.821 1.811 . . . . 1.0 112.681 0.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.461 ' CE1' HG21 ' A' ' 60' ' ' VAL . 9.2 t80 -65.12 115.89 5.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.513 -1.221 . . . . 1.0 111.733 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.589 HG21 ' H ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -21.68 -63.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.565 178.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.589 ' H ' HG21 ' A' ' 60' ' ' VAL . . . 51.29 104.82 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.354 -0.839 . . . . 1.0 112.945 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -94.18 144.11 25.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.529 -1.656 . . . . 1.0 106.529 177.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -92.02 114.6 27.18 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.949 -1.1 . . . . 1.0 113.025 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.594 ' HZ1' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -142.99 169.94 16.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.139 -1.391 . . . . 1.0 109.056 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.415 ' HD2' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.91 152.98 27.81 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.123 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 4.1 ttm180 -56.31 -24.49 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.756 -0.59 . . . . 1.0 110.706 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.218 0.532 . . . . 1.0 110.055 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.71 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 120.98 0.419 . . . . 1.0 111.731 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.582 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -161.18 163.58 31.08 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.454 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -100.62 125.32 47.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.148 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.12 139.06 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.85 -0.613 . . . . 1.0 112.152 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 11.5 t80 -79.46 126.13 30.45 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.573 0.701 . . . . 1.0 111.601 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 82' ' ' ASN . 7.0 m-85 -99.3 131.36 25.25 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.523 -1.217 . . . . 1.0 112.032 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.19 13.86 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.01 1.807 . . . . 1.0 109.367 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 80' ' ' TYR . 46.2 m-80 -124.35 -9.78 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.681 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.69 -1.16 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.57 -158.89 15.64 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 120.481 -0.866 . . . . 1.0 113.074 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.534 ' O ' ' SD ' ' A' ' 86' ' ' MET . 67.4 m95 -71.34 120.44 16.93 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.0 mmm -125.96 164.68 20.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.328 0.862 . . . . 1.0 113.328 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -111.5 132.81 54.23 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' MET . 5.5 mt -107.42 109.76 29.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 118.734 -0.651 . . . . 1.0 111.43 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.594 ' CB ' ' HZ1' ' A' ' 64' ' ' LYS . 21.4 t0 -133.14 130.97 39.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.269 0.94 . . . . 1.0 112.818 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -136.09 97.58 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.441 ' HG1' HH11 ' A' ' 100' ' ' ARG . 0.1 OUTLIER -130.78 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.734 -0.786 . . . . 1.0 110.756 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.423 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -153.84 159.05 32.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.096 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.49 -38.91 13.49 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.567 1.511 . . . . 1.0 111.234 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -77.08 -42.58 37.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.561 -1.199 . . . . 1.0 113.896 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -9.91 16.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.123 -0.231 . . . . 1.0 110.915 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.423 ' CA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.48 123.63 6.11 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.575 ' H ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -71.88 -151.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.163 0.506 . . . . 1.0 110.774 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.453 ' N ' HG11 ' A' ' 22' ' ' VAL . 44.0 p-90 -76.06 -31.16 58.65 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.644 -0.707 . . . . 1.0 111.655 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.408 ' HB2' HD22 ' A' ' 97' ' ' ASN . 0.3 OUTLIER -57.0 -27.85 61.91 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.602 ' NE ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -67.18 -15.44 63.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.573 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -93.92 2.91 56.04 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.3 t -78.27 128.61 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.213 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 136' ' ' LEU . 15.9 p-10 -87.42 -143.75 0.12 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.909 -0.716 . . . . 1.0 111.495 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.41 ' CE3' ' C ' ' A' ' 103' ' ' ASN . 6.6 m-90 -127.05 160.3 31.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.498 0.555 . . . . 1.0 112.498 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.78 -134.62 0.31 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.639 1.348 . . . . 1.0 114.639 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 t -154.21 -51.81 0.09 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.706 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 109' ' ' GLU . 38.9 m -165.26 65.4 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.231 0.826 . . . . 1.0 113.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.09 -12.62 0.01 OUTLIER Glycine 0 CA--C 1.534 1.224 0 N-CA-C 114.324 0.49 . . . . 1.0 114.324 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.618 ' H ' ' C ' ' A' ' 107' ' ' SER . 12.6 pt-20 -81.19 -26.59 35.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.494 0.647 . . . . 1.0 111.592 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 137' ' ' LEU . 6.0 pt-20 -122.21 -24.39 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.783 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.866 HE21 ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -53.81 132.34 41.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 177.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.67 ' OD1' ' N ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -112.68 -21.02 11.45 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.317 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.524 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 4.2 mm? -125.61 143.49 51.0 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.859 -0.737 . . . . 1.0 110.661 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CE2' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -128.7 131.32 23.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 119.463 -0.895 . . . . 1.0 112.191 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.11 128.34 22.11 Favored 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 124.058 3.172 . . . . 1.0 115.017 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.5 tp -140.43 132.74 28.29 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.817 -0.552 . . . . 1.0 110.103 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.446 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 6.8 mm-40 -105.58 115.58 30.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.907 -0.717 . . . . 1.0 110.029 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 pt -139.9 129.61 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.066 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 49.4 46.52 23.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.255 0.55 . . . . 1.0 110.489 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 56.11 32.92 21.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.208 -0.597 . . . . 1.0 109.904 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.06 141.73 42.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.321 -0.854 . . . . 1.0 109.006 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.446 ' CD1' ' CD ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -102.53 113.0 37.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.079 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.572 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 3.1 m-85 -101.04 155.62 17.88 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.774 ' CA ' ' HZ2' ' A' ' 125' ' ' LYS . 1.4 m-30 -119.02 125.24 48.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.623 -2.362 . . . . 1.0 104.623 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.774 ' HZ2' ' CA ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -125.81 155.58 40.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.091 -175.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.67 ' O ' ' N ' ' A' ' 53' ' ' GLY . 15.1 p -105.71 117.1 33.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.477 ' CD1' HE22 ' A' ' 111' ' ' GLN . 0.3 OUTLIER -81.35 -9.43 59.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.844 0.715 . . . . 1.0 109.952 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.597 ' HZ3' ' CA ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -150.42 141.48 14.8 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 120.452 -0.499 . . . . 1.0 111.947 -178.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -55.75 140.38 84.56 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.133 1.889 . . . . 1.0 111.733 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.52 136.33 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.8 37.88 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.3 105.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.35 2.034 . . . . 1.0 113.048 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 133.53 0.18 4.11 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 109.977 -1.249 . . . . 1.0 109.977 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.14 137.81 35.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.63 -0.785 . . . . 1.0 109.21 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.651 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.2 pm0 -73.02 138.77 46.17 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.903 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.463 ' O ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 mp -79.35 127.01 31.55 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.262 -1.384 . . . . 1.0 107.262 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.67 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -141.04 159.07 43.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.603 -176.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.03 172.5 7.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 113.611 0.967 . . . . 1.0 113.611 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.466 ' HE1' ' HB2' ' A' ' 111' ' ' GLN . 36.3 p-90 . . . . . 0 C--O 1.212 -0.884 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.924 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mm . . . . . 0 N--CA 1.423 -1.803 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.34 -48.97 59.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.13 81.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.216 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.272 178.793 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 111.61 0.226 . . . . 1.0 111.61 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -120.4 -41.8 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.096 0.474 . . . . 1.0 110.057 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.29 161.49 23.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 1.0 108.811 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -122.16 155.11 36.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 1.0 111.851 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.424 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.56 -34.7 18.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.52 -15.88 59.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.604 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 14' ' ' THR . 20.8 tp10 -79.16 -41.39 28.58 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.78 154.15 59.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 119.43 -0.908 . . . . 1.0 108.904 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.585 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 24.6 Cg_exo -56.14 130.39 39.95 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 120.982 1.121 . . . . 1.0 109.56 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.418 ' O ' ' CD ' ' A' ' 24' ' ' ARG . 24.5 tt0 -50.86 -35.46 32.73 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -75.63 -22.68 56.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.36 -51.81 18.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 CA-C-N 119.966 1.257 . . . . 1.0 112.087 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.721 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 1.6 pt? -70.9 -24.82 62.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.293 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.439 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -61.49 -19.56 62.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.509 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.63 33.64 6.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.875 -0.679 . . . . 1.0 112.338 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 27' ' ' PRO . 36.3 mt -77.41 154.29 81.76 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 117.68 0.74 . . . . 1.0 110.609 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' A' ' 26' ' ' LEU . 10.7 Cg_exo -34.0 -109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.383 2.722 . . . . 1.0 114.003 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.687 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -74.55 -58.82 3.05 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.624 177.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.687 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 5.1 pt-20 -170.24 47.36 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.455 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 54.2 t -57.95 162.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 114.787 -1.097 . . . . 1.0 108.268 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -134.1 158.25 44.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.247 0.546 . . . . 1.0 110.616 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.44 144.64 26.24 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.4 101.75 3.77 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.083 -0.647 . . . . 1.0 112.436 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 35' ' ' SER . 63.1 Cg_endo -82.69 150.01 14.45 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.23 2.62 . . . . 1.0 111.613 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 24.2 p 102.72 -60.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.168 0.918 . . . . 1.0 111.882 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -50.77 -54.63 21.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.629 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -101.09 -51.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 118.739 0.699 . . . . 1.0 111.434 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -89.39 82.0 6.53 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.292 0.568 . . . . 1.0 109.591 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -32.38 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.457 -1.247 . . . . 1.0 109.423 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.2 t -143.28 55.38 1.36 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.76 179.1 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.503 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -99.45 128.68 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.221 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.36 152.5 17.02 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.224 -1.551 . . . . 1.0 109.224 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 p -105.71 127.24 60.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.456 ' CZ3' ' CD ' ' A' ' 135' ' ' GLU . 21.7 m95 -126.59 146.55 50.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.281 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.666 ' O ' ' HA2' ' A' ' 133' ' ' GLY . . . -65.57 146.64 54.59 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.51 ' CA ' ' O ' ' A' ' 132' ' ' PRO . 34.6 p -117.76 -15.56 10.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.66 0.663 . . . . 1.0 109.662 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -119.33 158.42 48.76 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.321 -178.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 7.8 Cg_endo -62.08 124.52 14.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.377 2.052 . . . . 1.0 110.216 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 130' ' ' ILE . 3.4 mp -99.5 147.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.744 0.783 . . . . 1.0 110.282 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.61 148.03 34.19 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.829 -1.532 . . . . 1.0 109.471 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.552 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 4.1 ttpt -59.51 126.49 27.83 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.18 4.53 47.42 Favored Glycine 0 N--CA 1.467 0.747 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.668 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 126' ' ' THR . 19.7 ttmt -89.48 139.58 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -106.53 145.7 31.53 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 175.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -120.5 124.83 46.35 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.545 -1.207 . . . . 1.0 109.735 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.29 -133.83 4.16 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 113.23 -1.805 . . . . 1.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 123' ' ' TYR . 78.6 Cg_endo -74.64 148.25 91.35 Favored 'Cis proline' 0 N--CA 1.502 1.991 0 CA-C-N 120.027 1.914 . . . . 1.0 113.308 0.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' O ' ' C ' ' A' ' 60' ' ' VAL . 68.5 t80 -56.26 116.75 3.23 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.934 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.524 ' C ' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -16.38 -67.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 124.024 0.827 . . . . 1.0 112.622 178.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' N ' ' CD2' ' A' ' 59' ' ' PHE . . . 97.83 62.01 0.9 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.271 -1.132 . . . . 1.0 110.271 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' ASP . 19.7 t0 -88.45 133.55 34.09 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 106.181 -1.785 . . . . 1.0 106.181 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.54 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -104.25 113.19 26.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -176.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' CYS . 1.7 ptpt -133.03 166.91 21.3 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.316 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HZ1' ' H ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -76.9 139.36 40.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 176.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.93 -23.63 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.736 0.303 . . . . 1.0 111.204 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.109 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.507 ' HE2' ' H ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -138.99 144.6 38.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.35 -1.75 . . . . 1.0 109.786 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.75 123.03 47.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.076 -0.65 . . . . 1.0 111.717 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -143.18 133.8 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.79 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 2.3 t80 -89.8 126.38 35.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 82' ' ' ASN . 6.8 m-85 -92.31 105.7 15.15 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 113.516 -1.675 . . . . 1.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.77 -14.24 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.009 1.806 . . . . 1.0 109.604 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.554 ' H ' ' C ' ' A' ' 80' ' ' TYR . 71.2 m-80 -81.72 -99.12 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.138 -1.392 . . . . 1.0 110.361 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 84' ' ' GLY . 0.4 OUTLIER -66.43 -41.93 88.47 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.374 1.25 . . . . 1.0 114.374 -176.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.41 ' H ' ' HG ' ' A' ' 83' ' ' LEU . . . 144.68 -176.1 23.99 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 120.03 -1.081 . . . . 1.0 110.485 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.404 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 14.5 m95 -54.27 120.62 6.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.779 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 78' ' ' VAL . 51.4 tpp -129.37 160.92 31.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.399 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -117.85 145.42 44.6 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.934 0.873 . . . . 1.0 109.656 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 52.1 mt -93.09 159.1 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.892 -1.504 . . . . 1.0 108.492 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.688 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -128.99 123.99 33.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.425 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.512 ' CB ' ' HE1' ' A' ' 76' ' ' TRP . . . -133.54 136.36 44.95 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 105.251 -2.129 . . . . 1.0 105.251 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 166.52 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 120.573 1.533 . . . . 1.0 111.112 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.579 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -126.23 148.89 65.25 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.454 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 62.8 Cg_endo -66.11 -34.68 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.757 2.305 . . . . 1.0 111.849 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -71.91 -10.23 59.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.223 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.757 ' CB ' HH12 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.88 -16.01 35.14 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.695 ' N ' ' NH1' ' A' ' 100' ' ' ARG . . . -173.81 -92.49 0.08 OUTLIER Glycine 0 C--N 1.348 1.201 0 C-N-CA 120.136 -1.031 . . . . 1.0 114.05 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.575 ' H ' ' HD3' ' A' ' 100' ' ' ARG . 5.2 p30 -146.58 -149.34 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.48 0.657 . . . . 1.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.547 ' CD1' ' OD1' ' A' ' 97' ' ' ASN . 35.2 p-90 -80.39 -24.5 39.68 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 115.163 1.542 . . . . 1.0 115.163 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.461 ' CD2' ' CD2' ' A' ' 124' ' ' TYR . 3.0 mp -53.5 -27.59 26.23 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.592 -0.843 . . . . 1.0 111.181 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.757 HH12 ' CB ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.65 -30.33 52.07 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 177.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.503 ' CE1' ' CG2' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -64.58 -17.57 64.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.16 117.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.041 -0.982 . . . . 1.0 110.786 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.579 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 14.5 m-20 -77.5 138.69 39.36 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 105.883 -1.895 . . . . 1.0 105.883 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.533 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 16.2 p90 -94.68 122.56 37.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.825 0.822 . . . . 1.0 111.955 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 26.96 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.04 -1.436 . . . . 1.0 114.77 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 105' ' ' ALA . 52.5 t -29.54 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER 174.01 11.29 0.0 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-N 114.721 -1.127 . . . . 1.0 111.03 174.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.58 19.69 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.83 -42.18 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.035 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -118.32 -33.11 4.46 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.038 1.125 . . . . 1.0 114.038 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 110' ' ' GLU . 4.9 mt-30 16.18 101.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.472 0.545 . . . . 1.0 112.472 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.585 ' CA ' ' HZ2' ' A' ' 128' ' ' LYS . 18.0 p-10 -128.12 37.5 4.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.812 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 1.4 tp -153.32 173.63 15.36 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.152 -0.619 . . . . 1.0 110.698 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 115' ' ' PRO . 9.3 t80 -132.23 147.67 66.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 119.553 -0.26 . . . . 1.0 111.638 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.495 ' N ' ' CD1' ' A' ' 114' ' ' PHE . 23.2 Cg_endo -100.04 96.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.502 2.134 . . . . 1.0 113.483 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 123' ' ' TYR . 8.1 tp -117.41 135.93 53.54 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -109.24 117.19 33.45 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.977 0.798 . . . . 1.0 111.128 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -137.43 136.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.087 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 49.73 38.41 15.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.432 0.634 . . . . 1.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 63.4 13.3 6.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.019 179.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -110.0 154.89 22.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.082 -1.417 . . . . 1.0 107.86 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 31.5 mm -109.8 115.2 49.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 121.802 0.81 . . . . 1.0 111.888 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.46 ' CG ' ' CD1' ' A' ' 118' ' ' ILE . 3.6 m-85 -100.44 141.08 33.79 Favored 'General case' 0 CA--C 1.481 -1.694 0 O-C-N 121.234 -0.916 . . . . 1.0 109.27 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 18.3 m-30 -102.73 117.25 34.23 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.29 -2.115 . . . . 1.0 105.29 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -104.37 135.44 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.687 1.242 . . . . 1.0 110.636 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 53' ' ' GLY . 33.0 p -106.4 112.98 26.23 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.131 0.491 . . . . 1.0 110.696 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.621 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -76.64 -6.11 50.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.546 -1.206 . . . . 1.0 111.996 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.585 ' HZ2' ' CA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -143.2 158.29 58.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.097 -0.641 . . . . 1.0 112.598 -175.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -72.25 145.3 43.38 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 N-CA-C 104.722 -2.838 . . . . 1.0 104.722 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 50' ' ' ILE . 59.7 mt -123.5 142.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -174.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.56 128.49 88.37 Favored Pre-proline 0 C--N 1.34 0.193 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.798 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.5 Cg_exo -35.1 -27.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.655 2.236 . . . . 1.0 116.684 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 46' ' ' ALA . . . -125.6 37.04 2.61 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 120.308 1.413 . . . . 1.0 110.511 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 135' ' ' GLU . 4.6 tt0 -95.23 162.38 13.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.907 0.385 . . . . 1.0 111.371 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.492 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 1.6 pm0 -80.85 140.3 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.358 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.529 ' HA ' HD22 ' A' ' 112' ' ' ASN . 4.9 mt -95.17 121.77 37.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.603 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -128.01 153.13 47.11 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.607 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 15.7 t -124.12 159.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.257 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.607 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 116.16 1.911 . . . . 1.0 116.16 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.838 0 CA-C-O 119.777 -0.154 . . . . 1.0 110.855 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -65.06 -46.84 79.56 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 116.457 -2.097 . . . . 1.0 108.244 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.15 25.8 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 115.46 1.652 . . . . 1.0 115.46 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.174 0 CA-C-N 120.603 1.547 . . . . 1.0 111.596 -178.48 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.774 0.321 . . . . 1.0 111.162 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.37 -55.82 2.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -104.69 153.94 20.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 17' ' ' GLU . 4.3 m -121.74 156.36 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 1.0 111.676 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.19 -32.8 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.61 58.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.777 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' THR . 27.6 tp10 -82.2 -40.41 21.75 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 m -59.63 159.39 18.23 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.465 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.9 Cg_exo -66.8 133.12 30.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.128 1.219 . . . . 1.0 109.961 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 24' ' ' ARG . 18.6 tt0 -49.46 -38.01 28.13 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 123.749 0.656 . . . . 1.0 112.125 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 22' ' ' VAL . 4.4 p-80 -74.19 -23.25 59.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 1.5 t -75.89 -50.37 23.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 CA-C-N 119.805 1.184 . . . . 1.0 111.629 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.674 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 1.9 pt? -73.0 -26.02 61.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.648 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.95 -21.04 42.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.57 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.28 39.88 2.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.846 -0.692 . . . . 1.0 111.597 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.581 ' O ' ' O ' ' A' ' 27' ' ' PRO . 25.8 mt -85.17 153.52 59.65 Favored Pre-proline 0 N--CA 1.445 -0.702 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.229 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -34.6 -117.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 124.085 3.19 . . . . 1.0 114.166 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.628 ' CD ' ' N ' ' A' ' 29' ' ' GLU . 2.2 pp20? -72.98 -54.91 7.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 116.691 -2.004 . . . . 1.0 106.543 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 5.5 tt0 -174.64 57.75 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.275 1.036 . . . . 1.0 108.441 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.7 t -67.85 173.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.913 -1.04 . . . . 1.0 108.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.531 HH12 ' CG ' ' A' ' 29' ' ' GLU . 17.3 mtt85 -141.03 158.62 43.67 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.249 0.547 . . . . 1.0 110.013 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.53 147.43 25.35 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.92 101.74 3.65 Favored Pre-proline 0 C--N 1.314 -0.953 0 C-N-CA 119.672 -0.811 . . . . 1.0 112.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 44.5 Cg_endo -83.69 149.71 12.75 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 123.272 2.648 . . . . 1.0 111.95 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 4.2 t 99.75 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.183 0.927 . . . . 1.0 111.927 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.33 -53.65 27.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.921 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.07 -52.89 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.281 -0.567 . . . . 1.0 112.189 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -90.62 82.5 5.8 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 38' ' ' ASP . 7.7 mmpt? -28.28 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.343 -1.299 . . . . 1.0 110.07 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.597 ' N ' ' O ' ' A' ' 38' ' ' ASP . 16.4 p -143.22 54.09 1.36 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.2 168.21 8.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -92.27 131.24 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.824 -179.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.91 144.92 17.12 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.868 -1.693 . . . . 1.0 108.868 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -97.48 134.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 30' ' ' VAL . 10.6 m95 -129.04 147.65 50.92 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.146 -0.934 . . . . 1.0 110.83 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.634 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . -73.32 123.71 24.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.13 -1.028 . . . . 1.0 110.344 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.0 p -93.41 -15.42 25.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.687 0.756 . . . . 1.0 110.947 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.6 ' HZ1' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -107.49 170.72 5.3 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.247 -1.342 . . . . 1.0 111.133 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -81.68 131.88 7.46 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.232 1.955 . . . . 1.0 108.145 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.62 129.31 64.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 122.429 1.109 . . . . 1.0 111.908 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.537 ' C ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.83 147.96 22.83 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.515 -2.13 . . . . 1.0 107.755 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.537 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -59.65 123.72 17.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.38 2.48 47.57 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.626 -1.273 . . . . 1.0 113.253 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' THR . 9.7 ttmt -78.7 139.06 38.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 119.455 -0.898 . . . . 1.0 109.729 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -111.52 140.61 45.98 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 119.359 -0.936 . . . . 1.0 109.563 178.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 124' ' ' TYR . 37.2 m-85 -116.09 123.33 47.64 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.174 -1.83 . . . . 1.0 106.753 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.53 -164.33 30.36 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 113.778 -1.556 . . . . 1.0 110.201 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CB ' ' CE1' ' A' ' 123' ' ' TYR . 56.4 Cg_endo -98.22 137.66 3.4 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 CA-C-N 118.699 1.249 . . . . 1.0 111.638 -1.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 39.2 t80 -56.8 114.11 1.94 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 61' ' ' GLY . 9.7 p -44.69 -48.39 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.928 0.394 . . . . 1.0 111.109 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' N ' ' CG1' ' A' ' 60' ' ' VAL . . . 67.12 114.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 115.374 0.91 . . . . 1.0 115.374 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -99.75 134.43 42.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 175.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.54 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -92.2 112.11 23.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.162 1.171 . . . . 1.0 114.162 -176.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -145.07 166.31 25.74 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.983 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.431 ' HZ3' ' H ' ' A' ' 65' ' ' LYS . 2.7 mtmp? -76.86 133.82 39.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.606 0.717 . . . . 1.0 112.266 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -57.47 -21.37 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.846 -0.615 . . . . 1.0 112.643 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.029 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.507 ' C ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 CA-C-O 121.887 0.851 . . . . 1.0 112.886 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.752 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -141.43 134.67 29.43 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.038 -1.437 . . . . 1.0 110.108 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 86' ' ' MET . 8.7 tp10 -97.75 122.64 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.597 . . . . 1.0 111.099 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' MET . 2.8 t -142.44 132.25 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.942 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -87.22 123.92 32.75 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.417 -0.913 . . . . 1.0 111.833 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.679 ' C ' ' H ' ' A' ' 82' ' ' ASN . 3.0 m-85 -76.3 113.72 31.13 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.12 29.62 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.172 1.914 . . . . 1.0 110.566 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.679 ' H ' ' C ' ' A' ' 80' ' ' TYR . 62.0 m-80 -135.1 -90.7 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.294 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.0 -41.77 73.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.85 -174.99 26.48 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 119.743 -1.218 . . . . 1.0 110.614 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 11.9 m95 -55.11 121.14 8.12 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.823 -0.81 . . . . 1.0 112.177 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.506 ' O ' ' O ' ' A' ' 78' ' ' VAL . 33.7 tpp -128.63 160.72 31.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.289 0.477 . . . . 1.0 112.289 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -125.08 147.53 48.95 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.729 0.776 . . . . 1.0 109.199 175.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.488 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 6.3 mt -99.61 155.93 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 114.513 -1.221 . . . . 1.0 107.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.63 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.48 136.65 54.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.243 0.928 . . . . 1.0 113.155 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.55 ' HB1' ' HE1' ' A' ' 76' ' ' TRP . . . -134.95 136.22 42.09 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.753 ' H ' ' CG ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 169.88 -37.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.674 1.125 . . . . 1.0 111.401 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.861 ' H ' ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -120.76 146.31 43.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.787 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 59.0 Cg_endo -68.53 -36.79 14.23 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 123.246 2.631 . . . . 1.0 112.6 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -56.94 -10.68 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -89.54 -11.12 43.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' O ' ' OD1' ' A' ' 97' ' ' ASN . . . 96.56 160.84 32.25 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.819 HD22 ' N ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER 65.59 128.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 101' ' ' TYR . 47.0 p-90 -73.83 -21.31 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.133 -1.394 . . . . 1.0 109.63 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.781 ' N ' HD21 ' A' ' 97' ' ' ASN . 1.2 mp -50.12 -26.98 5.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.861 ' HE ' ' H ' ' A' ' 92' ' ' ASP . 6.5 ttt180 -74.68 -36.9 62.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.481 -1.69 . . . . 1.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.4 OUTLIER -68.05 -16.13 63.9 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.462 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.49 124.31 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.882 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.42 -174.69 5.41 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.55 -0.86 . . . . 1.0 109.06 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.4 ' HE3' ' N ' ' A' ' 104' ' ' TRP . 1.2 m-90 -94.79 154.62 17.19 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.39 0.614 . . . . 1.0 112.03 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.667 ' HB2' ' H ' ' A' ' 108' ' ' GLY . . . -31.34 -72.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.039 175.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 51.7 t 120.18 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.248 -2.13 . . . . 1.0 105.248 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 109' ' ' GLU . 2.6 t 178.32 29.16 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.33 -1.305 . . . . 1.0 111.934 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.667 ' H ' ' HB2' ' A' ' 105' ' ' ALA . . . 67.11 -10.81 0.77 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.132 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 107' ' ' SER . 10.3 mm-40 -74.32 -23.26 59.03 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.636 ' O ' ' O ' ' A' ' 111' ' ' GLN . 6.6 pt-20 -119.12 -0.32 11.1 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.636 ' O ' ' O ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -43.64 -150.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.64 ' ND2' ' O ' ' A' ' 135' ' ' GLU . 12.5 p30 144.03 27.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.271 -1.331 . . . . 1.0 112.293 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.631 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 7.3 mp -149.13 174.63 12.13 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.945 -0.472 . . . . 1.0 109.813 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -141.44 122.48 8.81 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.105 -0.638 . . . . 1.0 112.252 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.03 80.47 0.15 Allowed 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 121.456 1.438 . . . . 1.0 114.546 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.7 tp -90.23 133.66 34.78 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.245 -0.284 . . . . 1.0 110.731 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -108.68 120.39 42.34 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.799 0.687 . . . . 1.0 111.898 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -136.5 135.04 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.166 -0.924 . . . . 1.0 111.634 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' ILE . 2.6 m-80 35.24 57.28 0.82 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.642 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 8.2 mtp180 57.88 21.13 7.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.3 0.572 . . . . 1.0 111.664 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -125.0 149.81 47.35 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 41.4 mm -118.93 100.84 10.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.068 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.524 ' CE1' ' CB ' ' A' ' 58' ' ' PRO . 8.3 m-30 -97.33 158.9 15.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 121.762 0.791 . . . . 1.0 110.849 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 56' ' ' PHE . 13.7 m-30 -106.28 129.11 54.37 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.933 -1.485 . . . . 1.0 108.668 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -117.53 136.62 53.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 113.407 -1.724 . . . . 1.0 109.026 -177.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 53' ' ' GLY . 29.8 p -104.18 106.37 16.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.362 -0.935 . . . . 1.0 110.629 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.603 ' N ' ' HE2' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -73.57 -7.98 54.1 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 112.829 -1.987 . . . . 1.0 111.449 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.606 ' NZ ' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -133.63 148.74 69.82 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.803 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -74.15 140.97 28.72 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 105.983 -2.353 . . . . 1.0 105.983 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.76 138.55 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 118.852 0.751 . . . . 1.0 112.255 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.573 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -75.35 134.54 73.41 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.31 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . 46.2 Cg_exo -54.41 116.43 3.07 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 122.155 1.904 . . . . 1.0 113.02 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . 121.61 4.21 9.84 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.949 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -83.02 147.97 27.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.498 -1.351 . . . . 1.0 114.5 -178.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.64 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 2.0 pm0 -75.5 108.09 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.823 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 137' ' ' LEU . 21.7 mt -71.73 114.87 10.28 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.496 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 2.2 mp -135.11 160.8 37.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.451 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 26.3 t -118.29 152.52 20.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 O-C-N 123.69 0.618 . . . . 1.0 111.984 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.534 ' O ' ' CD1' ' A' ' 139' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.542 0 O-C-N 124.959 1.412 . . . . 1.0 113.059 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.513 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -68.45 -49.12 62.22 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.253 -1.379 . . . . 1.0 107.824 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.3 -57.29 13.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.028 -1.896 . . . . 1.0 114.34 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.455 0 CA-C-N 120.189 1.359 . . . . 1.0 110.827 -178.741 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.582 ' H ' ' CG ' ' A' ' 34' ' ' PRO . . . . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 1.3 m -177.57 -25.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.6 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -72.37 0.36 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 119.195 -1.002 . . . . 1.0 113.271 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.498 ' OG1' ' CG ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -142.01 -179.69 6.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.253 -1.794 . . . . 1.0 110.102 174.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 2.4 tt -73.66 -62.79 1.37 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 172.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.463 ' O ' ' CD1' ' A' ' 42' ' ' ILE . . . -89.64 -58.45 2.52 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.768 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 1.1 tm-20 89.57 -155.08 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.098 -2.186 . . . . 1.0 105.098 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.768 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER 51.34 152.39 0.04 OUTLIER Pre-proline 0 C--N 1.268 -2.947 0 O-C-N 125.766 1.916 . . . . 1.0 111.021 -178.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.54 140.16 12.35 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.895 2.396 . . . . 1.0 111.477 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 26.1 tt0 -50.5 -53.05 32.93 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.156 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -60.83 -22.55 64.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 2.2 t -79.28 -49.13 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.329 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 1.0 111.769 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -63.42 -16.89 61.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.68 28.17 15.55 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.012 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 27' ' ' PRO . 39.8 mt -76.96 156.03 82.53 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 112.364 0.505 . . . . 1.0 112.364 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -32.93 -123.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 125.087 3.858 . . . . 1.0 114.033 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' CD ' ' N ' ' A' ' 29' ' ' GLU . 2.2 pp20? -72.76 -51.43 19.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.425 -1.694 . . . . 1.0 106.425 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 tt0 -175.69 60.72 0.02 OUTLIER 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.638 0.733 . . . . 1.0 109.507 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 3.4 t -74.15 176.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 8.5 mtt180 -141.91 162.33 35.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.437 0.637 . . . . 1.0 110.881 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -96.81 121.84 39.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -119.76 109.53 37.82 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.87 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.582 ' CG ' ' H ' ' A' ' 11' ' ' ALA . 11.7 Cg_endo -84.5 150.32 11.66 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.529 2.819 . . . . 1.0 114.714 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 9.3 p 95.03 -50.87 0.01 OUTLIER 'General case' 0 C--N 1.344 0.333 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.721 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.538 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -48.08 -54.74 12.15 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.631 -0.713 . . . . 1.0 112.704 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 ' H ' ' A' ' 39' ' ' LYS . 2.5 p -90.74 -40.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.76 1.164 . . . . 1.0 110.824 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 67.43 9.94 7.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 178.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.502 ' CE ' ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -43.79 -27.84 0.37 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 177.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.477 ' N ' ' C ' ' A' ' 38' ' ' ASP . 8.7 m -170.27 -58.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.584 -1.189 . . . . 1.0 111.451 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.37 -96.74 0.09 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.502 ' O ' ' CE ' ' A' ' 39' ' ' LYS . 2.9 tt -98.34 140.9 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 113.795 1.035 . . . . 1.0 113.795 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -120.17 165.23 13.66 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.37 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -103.31 123.74 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.212 0.529 . . . . 1.0 110.313 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.538 ' CZ2' ' CB ' ' A' ' 36' ' ' ALA . 20.9 m95 -127.9 149.04 50.48 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.116 -0.947 . . . . 1.0 112.231 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.757 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -63.37 126.04 26.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.644 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 66.1 p -102.21 -22.22 14.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.504 1.145 . . . . 1.0 108.136 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HZ2' ' HZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -105.74 172.49 3.94 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.231 -2.259 . . . . 1.0 112.458 -175.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -87.74 125.53 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.897 2.398 . . . . 1.0 109.525 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.412 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 3.6 mp -98.84 145.94 9.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.481 0.657 . . . . 1.0 110.383 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.14 148.01 33.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.181 -1.372 . . . . 1.0 108.561 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.549 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 5.0 ttpt -60.05 126.55 27.97 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.136 0.421 . . . . 1.0 112.136 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.16 4.9 47.29 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 119.32 -1.419 . . . . 1.0 114.133 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 126' ' ' THR . 2.3 ttmt -89.16 142.47 27.62 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.45 -0.9 . . . . 1.0 113.289 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.2 OUTLIER -103.81 138.01 41.02 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.876 -0.787 . . . . 1.0 108.876 175.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' HZ ' ' HZ2' ' A' ' 48' ' ' LYS . 36.2 m-85 -119.47 125.34 48.67 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.787 1.28 . . . . 1.0 111.443 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.09 -110.98 1.28 Allowed Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 111.905 -2.407 . . . . 1.0 109.182 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' CB ' ' CE1' ' A' ' 123' ' ' TYR . 83.6 Cg_endo -72.95 177.22 37.53 Favored 'Cis proline' 0 N--CA 1.503 2.08 0 CA-C-N 119.76 1.78 . . . . 1.0 112.107 -0.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CZ ' ' CB ' ' A' ' 90' ' ' ALA . 19.4 t80 -68.61 112.2 5.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.716 0.77 . . . . 1.0 111.234 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 97' ' ' ASN . 1.3 p -33.18 -54.84 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.934 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 59' ' ' PHE . . . 75.64 108.97 0.11 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-O 121.389 0.438 . . . . 1.0 113.933 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -99.54 131.09 45.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.422 -2.066 . . . . 1.0 105.422 175.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.549 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -93.47 112.85 24.85 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.86 1.43 . . . . 1.0 114.86 -175.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -148.34 166.34 28.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.3 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.755 ' HZ3' ' H ' ' A' ' 65' ' ' LYS . 1.4 mtmp? -77.26 135.44 38.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.227 0.537 . . . . 1.0 111.531 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.411 HH11 ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.62 -23.37 50.75 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.657 0.614 . . . . 1.0 112.657 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.887 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.549 ' C ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.022 0 CA-C-O 121.649 0.738 . . . . 1.0 111.884 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.73 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -147.75 140.55 24.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.628 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.4 124.59 47.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.365 0.603 . . . . 1.0 111.762 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 86' ' ' MET . 2.2 t -144.75 130.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -88.28 124.88 34.32 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.659 ' CZ ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 m-85 -77.55 113.19 29.7 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.632 -1.622 . . . . 1.0 112.856 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -53.68 -2.46 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.014 1.809 . . . . 1.0 110.326 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 80' ' ' TYR . 53.2 m-80 -102.98 -96.08 0.3 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.976 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.84 -40.22 91.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.88 1.437 . . . . 1.0 114.88 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 147.71 -173.54 27.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 119.772 -1.204 . . . . 1.0 110.32 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -55.16 122.14 10.37 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.88 -0.777 . . . . 1.0 111.454 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.497 ' O ' ' O ' ' A' ' 78' ' ' VAL . 5.8 tpp -127.61 157.2 40.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.354 0.501 . . . . 1.0 112.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -120.12 145.36 46.98 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.962 0.887 . . . . 1.0 110.179 176.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.512 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 19.7 mt -97.07 156.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.847 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.93 134.02 46.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.483 ' CB ' ' CZ ' ' A' ' 59' ' ' PHE . . . -132.83 138.17 46.98 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.082 -2.192 . . . . 1.0 105.082 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.469 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 164.88 -31.43 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.868 1.213 . . . . 1.0 111.383 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.29 148.05 59.59 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.537 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 31.5 Cg_exo -55.28 -44.61 47.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.368 1.379 . . . . 1.0 112.481 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.69 -9.32 58.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.746 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -12.59 56.5 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.05 -107.54 0.22 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 119.507 -1.33 . . . . 1.0 113.217 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -150.23 -156.1 0.69 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.447 -178.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.44 ' O ' ' N ' ' A' ' 101' ' ' TYR . 23.2 p-90 -70.91 -25.57 62.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HB2' HD22 ' A' ' 97' ' ' ASN . 0.3 OUTLIER -53.46 -27.41 24.81 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.487 ' C ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.39 -30.67 53.74 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.554 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.2 m-85 -66.97 -18.54 65.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.32 0.581 . . . . 1.0 109.774 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.92 116.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.08 -0.964 . . . . 1.0 110.396 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.67 140.79 46.33 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.131 -2.174 . . . . 1.0 105.131 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.531 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 15.8 p90 -92.07 118.73 31.08 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.937 -1.105 . . . . 1.0 110.696 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 12.61 78.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 113.953 -1.476 . . . . 1.0 114.81 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.498 ' C ' ' O ' ' A' ' 105' ' ' ALA . 0.1 OUTLIER -19.5 -40.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 125.197 1.56 . . . . 1.0 110.031 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -168.38 7.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.739 176.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.96 22.48 23.01 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.717 -0.953 . . . . 1.0 110.717 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.425 ' CD ' ' SG ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -77.79 -37.8 48.04 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.297 -0.561 . . . . 1.0 110.118 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.534 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -119.41 -31.91 4.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.981 1.104 . . . . 1.0 113.981 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.534 ' C ' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 14.25 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 123.416 0.448 . . . . 1.0 111.609 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.54 HD22 ' HA ' ' A' ' 136' ' ' LEU . 34.0 p-10 -128.06 32.97 4.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.573 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER -152.96 172.49 16.73 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.3 OUTLIER -148.26 124.15 5.26 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 119.351 -0.94 . . . . 1.0 112.702 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.451 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.8 Cg_endo -74.71 109.82 2.99 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 120.64 0.893 . . . . 1.0 113.313 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 23.2 tp -117.42 140.8 49.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.698 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.97 121.34 45.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.794 0.664 . . . . 1.0 112.794 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -135.54 135.66 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.875 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 118' ' ' ILE . 8.0 m-80 35.94 62.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.373 0.509 . . . . 1.0 112.373 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.659 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 7.2 mtp180 55.93 11.89 0.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.984 0.365 . . . . 1.0 111.984 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -122.92 146.16 47.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mm -107.41 117.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 121.112 0.482 . . . . 1.0 110.566 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CD1' ' CG1' ' A' ' 118' ' ' ILE . 3.0 m-85 -101.14 143.44 31.24 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 15.6 m-30 -102.03 114.72 29.08 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 104.139 -2.541 . . . . 1.0 104.139 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 7.7 ttmt -105.51 141.2 37.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.379 1.05 . . . . 1.0 109.344 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 53' ' ' GLY . 18.6 p -106.87 110.88 23.16 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.401 0.62 . . . . 1.0 110.068 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.608 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -72.41 -4.66 31.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.67 -1.604 . . . . 1.0 111.239 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.465 ' HZ1' ' CA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -145.72 161.14 41.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 120.234 -0.586 . . . . 1.0 112.311 -177.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -75.5 144.42 28.64 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 N-CA-C 105.911 -2.38 . . . . 1.0 105.911 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.412 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 5.2 mt -126.19 135.71 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.719 0.691 . . . . 1.0 110.532 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.53 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.7 134.26 95.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.224 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -59.87 117.98 4.8 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 CA-C-N 120.006 1.038 . . . . 1.0 110.415 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.757 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.28 5.82 14.27 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.824 -1.311 . . . . 1.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.574 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -89.21 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.3 pm0 -78.59 118.84 21.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.268 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.54 ' HA ' HD22 ' A' ' 112' ' ' ASN . 2.8 mt -80.3 116.8 20.57 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.573 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 1.7 mp -129.3 156.17 44.43 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 108.688 -0.856 . . . . 1.0 108.688 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.531 ' H ' ' HA ' ' A' ' 104' ' ' TRP . 5.0 t -122.09 157.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.963 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.536 ' O ' ' CD1' ' A' ' 139' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.204 -1.339 0 N-CA-C 114.985 1.476 . . . . 1.0 114.985 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.563 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.563 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -56.34 -52.43 64.6 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 117.615 -1.634 . . . . 1.0 108.213 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.76 -62.32 1.82 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.775 -1.557 . . . . 1.0 113.4 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.311 0 CA-C-N 120.12 1.327 . . . . 1.0 111.652 -177.761 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 34' ' ' PRO . . . . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 1.2 m 178.22 -27.65 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.354 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.38 -73.63 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.712 0.767 . . . . 1.0 112.412 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.431 ' HB ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.36 175.81 9.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.135 -1.393 . . . . 1.0 110.632 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 3.0 tt -77.19 -62.88 1.51 Allowed 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 172.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 42' ' ' ILE . . . -86.34 -59.39 2.3 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.745 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 9.1 tt0 92.48 -171.48 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 105.415 -2.069 . . . . 1.0 105.415 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.745 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 58.49 151.83 0.08 OUTLIER Pre-proline 0 C--N 1.245 -3.97 0 CA-C-N 112.034 -2.348 . . . . 1.0 108.792 -178.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.92 138.87 6.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 123.429 2.752 . . . . 1.0 111.886 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 27.9 tt0 -50.27 -51.82 41.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-N 114.932 -1.031 . . . . 1.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -63.2 -24.36 67.84 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.36 -50.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 118.631 -1.228 . . . . 1.0 110.211 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.95 -29.28 65.25 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.132 -0.485 . . . . 1.0 112.245 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.89 -15.98 15.29 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.235 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.42 20.81 31.88 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.936 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 98' ' ' TRP 0.251 17.9 mt -69.19 139.63 90.13 Favored Pre-proline 0 CA--C 1.489 -1.381 0 CA-C-N 118.384 1.092 . . . . 1.0 109.99 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.605 ' C ' ' H ' ' A' ' 29' ' ' GLU . 5.9 Cg_exo -61.11 148.43 92.88 Favored 'Trans proline' 0 C--N 1.281 -3.026 0 N-CA-C 107.159 -1.9 . . . . 1.0 107.159 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -49.17 -15.27 0.11 Allowed 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.567 1.175 . . . . 1.0 110.275 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' H ' ' C ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.15 19.47 5.8 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 112.596 -2.093 . . . . 1.0 112.707 -178.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 ' C ' ' CG2' ' A' ' 47' ' ' THR . 1.8 t -145.38 151.73 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 118.655 -1.218 . . . . 1.0 112.483 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -147.39 159.09 44.09 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.863 -1.971 . . . . 1.0 106.737 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.92 140.81 38.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -148.47 115.35 3.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.641 0.608 . . . . 1.0 112.641 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.9 Cg_endo -85.98 127.62 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.319 2.012 . . . . 1.0 111.123 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 152.55 -71.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.739 0.65 . . . . 1.0 110.831 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.18 -53.25 36.59 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.771 -0.772 . . . . 1.0 113.025 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -53.24 -52.17 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.369 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' A' ' 40' ' ' THR . 6.4 p-10 -171.34 55.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? 53.82 -9.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.63 ' H ' ' C ' ' A' ' 38' ' ' ASP . 12.3 p -135.42 -90.4 0.31 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.301 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 40' ' ' THR . 4.5 mtt85 -29.43 133.27 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.641 0.588 . . . . 1.0 111.09 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -78.84 133.86 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.94 153.41 17.16 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.3 -1.12 . . . . 1.0 110.3 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.14 127.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.621 0.724 . . . . 1.0 109.212 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.571 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 4.8 m95 -130.88 149.92 52.28 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 114.469 -1.241 . . . . 1.0 111.507 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.32 138.24 51.31 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.572 -1.251 . . . . 1.0 111.03 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.439 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -112.62 -28.25 7.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.364 -178.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.14 159.71 38.45 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 119.167 -1.013 . . . . 1.0 111.32 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 Cg_endo -57.21 132.27 50.16 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.812 2.341 . . . . 1.0 111.469 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.15 144.22 19.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.047 -0.979 . . . . 1.0 108.613 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.536 ' C ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -113.59 149.23 34.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -64.69 135.47 55.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.757 0.789 . . . . 1.0 111.951 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.7 2.93 49.83 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 119.356 -1.402 . . . . 1.0 113.078 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.19 139.73 31.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.162 -1.015 . . . . 1.0 113.475 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.99 139.89 35.01 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 120.16 -0.616 . . . . 1.0 109.534 176.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 29' ' ' GLU . 37.1 m-85 -121.89 127.81 50.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 122.852 1.31 . . . . 1.0 110.917 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.11 -106.55 0.59 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 111.526 -2.579 . . . . 1.0 110.251 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 88.8 Cg_endo -83.52 170.46 53.19 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 CA-C-N 119.507 1.654 . . . . 1.0 111.994 -0.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.567 ' CE1' ' NH2' ' A' ' 100' ' ' ARG . 27.7 t80 -59.14 109.75 0.92 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.957 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 p -45.99 -50.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.719 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' CA ' HH22 ' A' ' 100' ' ' ARG . . . 72.31 111.18 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.359 -0.448 . . . . 1.0 114.038 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t0 -99.7 132.54 44.98 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.601 ' HZ2' ' CB ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -91.22 110.21 21.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 -177.091 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -146.47 166.91 24.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.641 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HZ1' ' H ' ' A' ' 65' ' ' LYS . 2.1 mtmp? -80.38 132.85 35.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.597 0.713 . . . . 1.0 112.08 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 67' ' ' SER . 2.7 ptm180 -50.19 -24.68 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 1.0 111.28 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.509 ' C ' ' O ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.638 0 O-C-N 123.981 0.801 . . . . 1.0 111.907 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.502 ' C ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.506 -0.728 0 N-CA-C 114.006 1.113 . . . . 1.0 114.006 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.747 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -138.7 125.35 20.78 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.735 -1.575 . . . . 1.0 109.815 -177.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -97.37 123.25 41.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.448 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.0 139.43 22.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.224 -1.353 . . . . 1.0 109.297 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -83.62 129.28 34.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.65 ' CE2' ' NE ' ' A' ' 120' ' ' ARG . 15.5 m-85 -103.52 117.23 60.5 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.693 -1.14 . . . . 1.0 113.74 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -69.9 4.11 2.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.541 1.494 . . . . 1.0 109.774 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.72 ' ND2' HH12 ' A' ' 120' ' ' ARG . 62.8 m-20 -102.11 -2.84 28.58 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.911 -1.04 . . . . 1.0 111.112 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.9 0.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' TYR . . . 99.19 -164.46 20.36 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 18.8 m95 -60.86 120.18 9.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.759 -0.776 . . . . 1.0 111.019 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 1.4 tpp -130.82 165.62 22.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.185 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.605 ' N ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -120.72 144.48 48.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.045 0.926 . . . . 1.0 110.477 176.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.506 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 61.1 mt -97.7 156.01 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.44 136.57 54.68 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.273 0.942 . . . . 1.0 112.765 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.584 ' CB ' ' HE1' ' A' ' 76' ' ' TRP . . . -134.32 139.82 45.93 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.607 ' H ' ' CB ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER 167.16 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 120.086 1.312 . . . . 1.0 111.269 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.425 ' OD1' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.62 152.37 62.92 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.692 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.85 -37.67 19.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.543 2.162 . . . . 1.0 111.086 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.16 -14.17 62.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.51 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.67 -10.78 50.3 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.92 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 119.761 -1.209 . . . . 1.0 113.854 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.528 ' C ' HD21 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -148.26 -163.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.942 0.401 . . . . 1.0 111.783 -177.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.586 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 30.0 p-90 -71.3 -26.8 63.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.472 ' CD2' ' CD2' ' A' ' 124' ' ' TYR . 2.1 mp -55.03 -28.14 49.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.98 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.607 ' CB ' ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -77.09 -45.27 27.57 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.684 -0.806 . . . . 1.0 111.989 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 98' ' ' TRP . 11.7 p90 -77.54 1.83 18.26 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 118.335 -1.346 . . . . 1.0 110.82 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.82 119.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 129.28 39.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.52 -1.289 . . . . 1.0 107.52 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.498 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 22.4 p90 -93.42 123.53 36.79 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.883 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.695 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 22.49 76.92 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.065 -1.425 . . . . 1.0 114.094 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.549 ' C ' ' O ' ' A' ' 105' ' ' ALA . 2.2 t -23.99 -38.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.787 1.304 . . . . 1.0 108.165 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -177.98 15.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.3 -1.318 . . . . 1.0 109.716 174.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.17 36.28 7.69 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 114.891 -1.049 . . . . 1.0 110.658 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -78.91 -44.41 22.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.047 -0.661 . . . . 1.0 109.891 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.527 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -120.46 -28.33 5.0 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.601 -0.714 . . . . 1.0 112.337 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.53 ' OE1' ' C ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER 22.66 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.937 0.773 . . . . 1.0 110.188 -178.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.528 ' C ' ' HZ3' ' A' ' 128' ' ' LYS . 41.1 p-10 -128.28 37.89 4.08 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.606 ' N ' ' NZ ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -154.34 173.44 16.18 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -178.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -147.09 123.02 5.46 Favored Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 119.598 -0.841 . . . . 1.0 111.623 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -67.23 92.52 0.34 Allowed 'Trans proline' 0 N--CA 1.482 0.798 0 CA-C-N 119.276 0.777 . . . . 1.0 112.281 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 31.4 tp -93.07 130.29 38.74 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.98 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.49 116.23 31.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 1.0 110.726 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 121' ' ' ALA . 2.0 pt -138.39 135.89 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.481 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' ILE . 60.0 m-20 40.35 56.85 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.236 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.72 HH12 ' ND2' ' A' ' 82' ' ' ASN . 5.8 mtp180 58.12 12.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 111.84 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -117.25 150.25 39.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.673 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 26.3 mm -110.52 104.18 16.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.418 0 C-N-CA 120.5 -0.48 . . . . 1.0 109.877 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 116' ' ' LEU . 3.5 m-85 -92.77 149.96 20.96 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 120.799 -1.188 . . . . 1.0 110.36 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 15.5 m-30 -102.12 111.34 23.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 104.817 -2.29 . . . . 1.0 104.817 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 139.33 40.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 124.691 1.245 . . . . 1.0 109.095 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' GLY . 6.4 p -107.24 111.26 23.57 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.684 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -77.27 0.89 20.37 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.681 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.606 ' NZ ' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -144.02 140.84 17.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.943 -176.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.98 140.77 61.68 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 N-CA-C 105.589 -2.504 . . . . 1.0 105.589 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.451 ' CG2' ' CG ' ' A' ' 134' ' ' GLU . 24.2 mt -118.89 134.7 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.89 0.768 . . . . 1.0 112.249 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.437 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -72.82 120.81 82.86 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.08 122.45 6.33 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.934 1.756 . . . . 1.0 112.233 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 130.59 -2.92 5.74 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.576 -0.821 . . . . 1.0 114.06 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.684 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -103.81 167.17 9.95 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.111 0.958 . . . . 1.0 112.76 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.3 pm0 -80.5 139.24 36.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.778 -1.555 . . . . 1.0 111.027 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.502 ' HA ' HD22 ' A' ' 112' ' ' ASN . 9.2 mt -88.55 118.14 28.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.566 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 2.1 mp -121.57 150.68 41.32 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.047 0.451 . . . . 1.0 110.292 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.622 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 17.5 t -118.94 153.27 21.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.166 -0.925 . . . . 1.0 110.12 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.622 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 O-C-N 124.429 1.081 . . . . 1.0 113.634 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.175 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.55 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -71.62 -47.21 56.11 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.388 -1.325 . . . . 1.0 109.097 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.99 -57.06 12.4 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.629 -1.623 . . . . 1.0 113.235 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.344 0 CA-C-N 120.298 1.408 . . . . 1.0 111.94 -178.413 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 121.01 0.433 . . . . 1.0 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -124.2 -78.29 0.6 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.55 -151.56 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.459 ' OG1' ' OE2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -125.49 155.33 40.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.937 0.875 . . . . 1.0 112.269 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.586 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -51.55 -32.39 28.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.085 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.52 -15.71 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.36 -0.836 . . . . 1.0 112.608 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' OE2' ' OG1' ' A' ' 14' ' ' THR . 2.8 mt-10 -91.48 -25.36 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.677 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.75 141.53 17.77 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.364 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.637 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 22.5 Cg_exo -51.0 141.85 35.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.61 2.206 . . . . 1.0 112.558 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.425 ' CG ' ' NE ' ' A' ' 24' ' ' ARG . 47.8 tt0 -63.45 -31.73 72.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 113.43 0.9 . . . . 1.0 113.43 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 93' ' ' PRO . 4.6 p-80 -74.56 -26.54 60.01 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.789 1.403 . . . . 1.0 114.789 -176.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 4.4 m -78.87 -47.27 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.47 1.032 . . . . 1.0 111.953 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.675 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.17 -22.02 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 122.676 1.227 . . . . 1.0 109.392 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.425 ' NE ' ' CG ' ' A' ' 20' ' ' GLU . 1.2 mpt_? -63.74 -43.63 95.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.952 -1.931 . . . . 1.0 113.066 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.21 33.95 6.11 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.502 -0.856 . . . . 1.0 112.933 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 mt -68.49 153.52 95.6 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.668 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.51 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 71.9 Cg_exo -47.37 -106.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 124.287 3.324 . . . . 1.0 115.653 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -74.16 -58.89 3.0 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER -174.76 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 177.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.464 HG21 ' HZ3' ' A' ' 48' ' ' LYS . 50.5 t -48.04 178.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.65 -1.159 . . . . 1.0 108.588 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.416 ' H ' HG11 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -147.88 159.04 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.7 mm? -94.96 121.04 36.16 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.1 -0.64 . . . . 1.0 110.683 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -132.48 139.84 36.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.003 -0.999 . . . . 1.0 111.057 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.2 Cg_endo -80.41 153.18 20.83 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.957 2.438 . . . . 1.0 112.484 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 44.2 t 124.16 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.69 1.196 . . . . 1.0 110.958 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.552 ' O ' ' CG ' ' A' ' 103' ' ' ASN . . . -89.79 12.83 16.01 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.892 1.329 . . . . 1.0 108.057 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.568 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 3.6 p -93.1 -52.41 9.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 113.306 -1.77 . . . . 1.0 115.062 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 26.6 t0 126.26 46.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.85 ' H ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 31.86 40.91 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.543 179.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 38' ' ' ASP . 18.4 p -133.56 -16.95 2.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.925 -1.034 . . . . 1.0 111.467 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 9.1 ttm-85 179.81 -166.03 0.07 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.784 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.02 155.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.887 0.375 . . . . 1.0 110.817 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -114.66 166.14 12.13 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -105.41 126.61 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.752 0.776 . . . . 1.0 111.313 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 16.1 m95 -126.9 142.38 51.56 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.376 -0.829 . . . . 1.0 113.226 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -69.19 133.51 48.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.305 -1.316 . . . . 1.0 110.304 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 56.0 p -130.34 12.68 5.52 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.868 -1.531 . . . . 1.0 106.868 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.487 ' NZ ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -133.09 170.32 11.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 112.593 -2.094 . . . . 1.0 110.908 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -89.59 141.99 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.289 2.659 . . . . 1.0 111.338 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.487 HD13 ' NZ ' ' A' ' 48' ' ' LYS . 45.2 mt -134.3 146.94 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 114.871 -1.059 . . . . 1.0 112.046 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.583 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.03 168.69 9.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.0 177.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -65.79 122.83 18.21 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.48 -0.488 . . . . 1.0 111.589 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.926 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.09 7.74 49.24 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.066 -1.064 . . . . 1.0 113.803 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.5 ttmt -75.51 133.16 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 116.787 -1.965 . . . . 1.0 113.852 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -85.8 121.21 28.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 1.0 113.397 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.51 ' CD1' ' HB3' ' A' ' 27' ' ' PRO . 20.9 m-85 -121.17 142.77 49.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.309 1.226 . . . . 1.0 114.309 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.29 -100.49 1.65 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.013 -1.903 . . . . 1.0 110.59 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.25 167.9 78.8 Favored 'Cis proline' 0 N--CA 1.499 1.814 0 CA-C-N 119.342 1.571 . . . . 1.0 112.049 -0.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 60' ' ' VAL . 19.4 t80 -54.85 108.99 0.45 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 95' ' ' LYS . 3.7 p -37.05 -53.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 52.74 119.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.883 -0.675 . . . . 1.0 113.917 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.85 143.28 33.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 111.47 22.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.388 0.613 . . . . 1.0 110.921 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CD ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.92 178.84 6.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 1.0 111.79 -176.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' N ' ' HE2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -50.88 167.76 0.07 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.084 -0.962 . . . . 1.0 111.703 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.21 -51.55 24.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.266 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.277 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.531 ' O ' ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -163.95 163.61 23.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.777 -0.769 . . . . 1.0 113.034 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 5.4 pt-20 -100.97 123.24 44.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.093 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.2 124.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -78.06 124.15 27.69 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.639 ' C ' ' H ' ' A' ' 82' ' ' ASN . 23.2 m-85 -103.5 101.65 24.83 Favored Pre-proline 0 N--CA 1.448 -0.571 0 O-C-N 124.522 1.138 . . . . 1.0 112.889 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -65.35 22.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 121.423 1.415 . . . . 1.0 110.611 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.639 ' H ' ' C ' ' A' ' 80' ' ' TYR . 83.0 m-20 -118.38 -2.3 11.12 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.837 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -178.1 6.48 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 102.91 174.94 26.71 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 113.844 0.298 . . . . 1.0 113.844 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.518 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.1 m95 -59.1 120.31 8.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.816 0.447 . . . . 1.0 111.656 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.518 ' SD ' ' C ' ' A' ' 85' ' ' TRP . 26.7 mmm -125.46 167.86 14.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.039 1.125 . . . . 1.0 114.039 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.67 138.23 50.94 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 105.604 -1.999 . . . . 1.0 105.604 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 75' ' ' MET . 72.2 mt -103.79 101.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -128.96 127.96 42.75 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.268 0.556 . . . . 1.0 111.283 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.75 92.5 2.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.476 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.13 -5.97 21.51 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.419 -0.912 . . . . 1.0 112.811 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.645 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -86.79 120.55 71.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.605 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 52.6 Cg_exo -47.83 -26.98 7.75 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.114 1.876 . . . . 1.0 113.934 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.6 -44.24 82.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.638 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.82 3.26 15.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.619 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.789 ' O ' ' ND2' ' A' ' 97' ' ' ASN . . . -97.54 -2.94 58.63 Favored Glycine 0 C--O 1.219 -0.795 0 CA-C-N 115.39 -0.823 . . . . 1.0 113.019 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.789 ' ND2' ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER 42.57 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.19 0.495 . . . . 1.0 110.109 -177.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 101' ' ' TYR . 67.6 p-90 -70.58 -24.55 62.79 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.591 ' HB2' HD22 ' A' ' 97' ' ' ASN . 5.2 mp -55.36 -23.6 25.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.078 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.48 ' NE ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -68.26 -13.81 62.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 176.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.3 m-85 -96.93 -10.62 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.475 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.7 t -66.95 118.5 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.872 -0.731 . . . . 1.0 110.03 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.77 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -80.57 -164.39 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.55 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.474 ' N ' ' CE3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -121.9 154.6 36.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.505 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.768 ' H ' HE22 ' A' ' 111' ' ' GLN . . . -134.89 -176.72 4.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.421 0.629 . . . . 1.0 112.016 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.505 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.43 -54.15 2.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.596 -178.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -103.16 175.22 5.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 111.379 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.1 -36.88 34.08 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -54.59 -25.39 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 1.0 110.401 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.505 ' OE2' ' SG ' ' A' ' 106' ' ' CYS . 8.3 pt-20 -107.64 -24.01 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.435 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.872 ' NE2' ' O ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -103.09 103.82 13.92 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.22 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.498 ' HA ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -114.45 34.25 4.84 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -177.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 137' ' ' LEU . 5.3 mp -144.42 149.25 35.76 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.606 -0.838 . . . . 1.0 111.77 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -150.67 127.16 5.21 Favored Pre-proline 0 N--CA 1.47 0.528 0 C-N-CA 120.287 -0.565 . . . . 1.0 112.395 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 51.6 Cg_exo -60.5 133.55 49.53 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.087 1.858 . . . . 1.0 113.797 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -134.98 136.16 41.98 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.35 120.87 41.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.07 0.462 . . . . 1.0 111.757 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -129.61 114.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 56.7 42.67 26.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.614 ' HE ' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 65.89 15.1 9.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.974 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.75 124.64 49.91 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.66 120.74 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.597 0.713 . . . . 1.0 112.238 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 116' ' ' LEU . 7.7 m-85 -112.07 153.68 26.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.796 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -112.86 126.51 55.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.45 152.69 43.02 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.558 -0.857 . . . . 1.0 112.525 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.926 ' O ' ' N ' ' A' ' 53' ' ' GLY . 7.3 p -106.68 106.24 16.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.082 -1.417 . . . . 1.0 109.83 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' N ' ' HE3' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -69.89 -0.46 7.35 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.927 0.767 . . . . 1.0 111.594 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.945 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -148.28 126.95 6.1 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.173 -176.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.63 148.48 2.34 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.951 2.434 . . . . 1.0 112.547 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.89 135.87 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.524 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -78.27 115.29 49.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -40.78 117.87 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.458 2.105 . . . . 1.0 113.282 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.62 6.19 13.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.522 -0.599 . . . . 1.0 112.566 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 131' ' ' ALA . 2.4 pt-20 -104.92 166.98 10.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.938 0.869 . . . . 1.0 112.269 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.42 ' OE1' ' OD1' ' A' ' 103' ' ' ASN . 5.4 pt-20 -81.09 136.59 35.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.306 -1.315 . . . . 1.0 111.74 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.48 128.05 34.92 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.919 -1.037 . . . . 1.0 109.955 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.517 ' CD2' ' OD1' ' A' ' 103' ' ' ASN . 4.9 mp -142.65 157.98 44.12 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.993 0.517 . . . . 1.0 111.71 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.605 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.66 146.26 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 178.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.872 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.192 -1.973 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 121.222 0.534 . . . . 1.0 111.968 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -51.54 -33.03 30.32 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.647 -0.706 . . . . 1.0 112.523 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.19 45.44 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.23 -0.588 . . . . 1.0 111.537 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.89 179.556 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.33 0.586 . . . . 1.0 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -140.49 -58.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.2 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.06 160.06 0.53 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.06 151.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.737 0.779 . . . . 1.0 112.748 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -55.56 -36.87 67.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.985 -1.007 . . . . 1.0 109.487 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -15.79 60.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.754 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -23.3 33.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.997 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 144.59 89.08 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.15 148.64 6.9 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.101 2.534 . . . . 1.0 113.228 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 30.0 tt0 -60.72 -42.03 96.46 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.617 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 7.8 p-80 -73.4 -29.32 62.52 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.258 1.577 . . . . 1.0 115.258 -176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 m -75.36 -47.16 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 119.909 1.231 . . . . 1.0 110.652 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' H ' HD21 ' A' ' 23' ' ' LEU . 1.6 pt? -67.5 -25.33 65.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.815 0.817 . . . . 1.0 110.321 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -71.07 -36.04 72.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.078 -1.419 . . . . 1.0 112.813 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.1 31.24 7.11 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.74 -0.743 . . . . 1.0 111.617 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 30' ' ' VAL . 10.3 mt -72.68 120.89 83.21 Favored Pre-proline 0 CA--C 1.5 -0.952 0 C-N-CA 119.651 -0.82 . . . . 1.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.85 168.39 7.21 Favored 'Trans proline' 0 C--N 1.296 -2.227 0 CA-C-N 120.085 1.066 . . . . 1.0 109.438 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.433 ' O ' ' OG1' ' A' ' 47' ' ' THR . 3.7 pt-20 -59.02 -8.89 1.59 Allowed 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 112.491 -2.141 . . . . 1.0 115.386 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.769 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -112.51 11.95 19.87 Favored 'General case' 0 CA--C 1.458 -2.586 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.973 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.487 ' CG2' ' C ' ' A' ' 29' ' ' GLU . 2.3 t -137.1 117.06 16.22 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 C-N-CA 117.38 -1.728 . . . . 1.0 113.95 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' NE ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.67 142.02 49.85 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.144 -1.428 . . . . 1.0 107.144 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' GLY . 4.2 mm? -90.07 116.93 28.47 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.175 1.352 . . . . 1.0 111.548 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -139.73 141.34 27.53 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.725 -1.125 . . . . 1.0 110.942 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 35' ' ' SER . 53.2 Cg_endo -76.16 159.04 37.46 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.863 3.042 . . . . 1.0 113.804 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.82 ' C ' ' H ' ' A' ' 37' ' ' VAL . 13.4 m 110.4 -85.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.814 1.246 . . . . 1.0 108.575 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' ASN . . . -55.54 12.17 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.896 0.855 . . . . 1.0 111.822 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.82 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -95.51 -53.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.864 -1.517 . . . . 1.0 112.555 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.1 m-20 143.65 42.14 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.323 1.014 . . . . 1.0 109.187 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.0 23.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.309 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 38' ' ' ASP . 9.7 t -122.76 -4.48 8.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.064 0.764 . . . . 1.0 113.064 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.632 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.33 -162.95 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 mm -79.08 156.21 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.956 0.408 . . . . 1.0 110.904 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -124.88 165.12 18.14 Favored Glycine 0 C--O 1.196 -2.26 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.99 135.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 117.605 0.702 . . . . 1.0 110.937 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 15.6 m95 -130.65 149.96 52.06 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.993 -1.003 . . . . 1.0 113.69 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.769 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.15 128.98 38.15 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.345 -1.298 . . . . 1.0 113.428 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 28' ' ' GLU . 81.5 p -115.8 -20.91 9.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.058 -0.974 . . . . 1.0 111.085 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' CD ' ' C ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.57 168.22 10.58 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.298 178.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.14 121.99 6.87 Favored 'Trans proline' 0 CA--C 1.498 -1.314 0 C-N-CA 121.915 1.743 . . . . 1.0 111.666 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.61 143.02 14.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 112.858 -1.974 . . . . 1.0 109.581 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.534 ' C ' ' CD1' ' A' ' 51' ' ' LEU . 4.0 pp -109.01 164.27 12.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.79 -1.096 . . . . 1.0 109.294 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' O ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.34 122.74 21.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.01 0.91 . . . . 1.0 111.111 177.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.896 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.13 10.07 40.47 Favored Glycine 0 C--N 1.303 -1.304 0 C-N-CA 120.022 -1.085 . . . . 1.0 114.029 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -89.19 130.85 35.54 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.328 -1.749 . . . . 1.0 114.624 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 4.4 mtmm -85.9 124.54 32.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.857 -1.52 . . . . 1.0 111.473 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CD2' ' OE1' ' A' ' 29' ' ' GLU . 47.5 m-85 -121.65 149.71 42.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.9 -102.37 1.56 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.215 -1.357 . . . . 1.0 111.507 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.15 165.14 64.22 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 119.753 1.776 . . . . 1.0 113.036 0.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -54.39 110.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.849 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.52 ' CG1' ' HE ' ' A' ' 100' ' ' ARG . 2.9 p -35.42 -56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.446 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 51.28 116.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.558 -0.829 . . . . 1.0 114.799 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 21.4 t0 -103.49 146.69 28.14 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.549 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 3.2 mtmp? -89.29 113.64 24.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.443 -0.903 . . . . 1.0 112.202 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.628 ' CE ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -136.04 166.29 23.7 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.328 -0.851 . . . . 1.0 111.345 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.628 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -81.25 131.24 35.28 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.517 0.562 . . . . 1.0 112.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -40.64 -24.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 65' ' ' LYS . 27.5 m . . . . . 0 C--N 1.317 -0.822 0 C-N-CA 119.461 -0.895 . . . . 1.0 108.714 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.626 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.471 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -164.49 164.23 21.9 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.493 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.73 122.78 41.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.17 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.42 119.45 13.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 3.0 t80 -78.19 125.03 28.76 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 113.41 0.893 . . . . 1.0 113.41 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 82' ' ' ASN . 25.0 m-85 -103.22 97.8 10.71 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 114.698 -1.137 . . . . 1.0 112.172 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.31 -11.33 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.247 1.298 . . . . 1.0 109.785 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.55 ' H ' ' C ' ' A' ' 80' ' ' TYR . 77.3 m-20 -76.53 -3.42 37.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.424 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.505 ' CD1' ' SD ' ' A' ' 86' ' ' MET . 2.5 pp -178.29 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.497 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 146.82 173.24 17.87 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.132 -1.032 . . . . 1.0 112.523 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.502 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.9 m95 -58.53 120.25 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.646 -0.277 . . . . 1.0 111.547 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.505 ' SD ' ' CD1' ' A' ' 83' ' ' LEU . 20.3 mmm -127.25 163.87 22.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.996 1.109 . . . . 1.0 113.996 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.4 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.24 139.78 46.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.354 -2.091 . . . . 1.0 105.354 172.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 75' ' ' MET . 66.4 mt -107.58 103.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 118.219 -0.895 . . . . 1.0 109.7 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -130.29 130.77 44.94 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.207 0.912 . . . . 1.0 112.362 -178.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . . . -142.72 113.04 7.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.201 -0.909 . . . . 1.0 109.72 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -132.68 26.93 4.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.979 0.809 . . . . 1.0 110.139 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.713 ' N ' HH11 ' A' ' 100' ' ' ARG . 2.6 m-20 -117.15 81.62 13.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.818 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.617 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 58.6 Cg_exo -48.48 -12.67 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.084 2.523 . . . . 1.0 112.629 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HA ' ' HE2' ' A' ' 21' ' ' HIS . 2.7 mt-10 -79.1 -28.52 43.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.365 0.602 . . . . 1.0 109.691 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 17.89 15.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 1.0 112.779 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -141.02 -121.65 1.79 Allowed Glycine 0 N--CA 1.461 0.336 0 C-N-CA 119.422 -1.371 . . . . 1.0 114.78 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.527 ' C ' HD21 ' A' ' 97' ' ' ASN . 0.2 OUTLIER -139.18 -177.96 5.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.533 -0.834 . . . . 1.0 110.489 -178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -68.31 -21.66 64.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 99' ' ' LEU . 4.4 mp -56.88 -28.41 61.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.713 HH11 ' N ' ' A' ' 92' ' ' ASP . 32.0 mtt180 -62.57 -12.52 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.355 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -104.77 -3.35 23.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.643 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.407 ' O ' ' CZ3' ' A' ' 104' ' ' TRP . 18.5 t -66.14 135.03 29.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.893 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 104' ' ' TRP . 4.0 t-20 -102.63 -174.13 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 120.696 -0.402 . . . . 1.0 110.204 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.673 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.53 157.06 36.25 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.99 -158.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.515 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.53 -22.98 11.38 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.518 -1.219 . . . . 1.0 111.934 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -171.68 137.38 1.02 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 111' ' ' GLN . . . -31.74 -32.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.735 -0.666 . . . . 1.0 113.717 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' SER . 2.1 mt-10 -53.92 -26.76 26.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 117.816 0.808 . . . . 1.0 110.337 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.515 ' OE2' ' SG ' ' A' ' 106' ' ' CYS . 11.0 pt-20 -116.94 -24.34 7.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.07 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.48 ' OE1' ' O ' ' A' ' 139' ' ' TRP . 2.5 tm0? -93.76 143.98 25.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.11 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -153.9 40.32 0.49 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.845 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.5 HD11 ' N ' ' A' ' 137' ' ' LEU . 4.8 mp -143.79 143.21 31.25 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.08 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.582 ' N ' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -148.73 128.76 6.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.349 -179.04 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.475 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.5 Cg_exo -63.19 121.73 9.67 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.385 2.057 . . . . 1.0 112.284 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.2 tp -117.14 128.74 55.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -98.02 116.64 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.684 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.3 118.95 51.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.51 31.98 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 79' ' ' TYR . 11.3 mmp_? 67.67 18.22 9.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.53 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.39 125.35 50.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 76' ' ' TRP . 5.6 mm -85.33 120.79 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.009 -0.677 . . . . 1.0 112.659 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.89 162.32 15.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.909 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.1 m-30 -112.28 118.2 34.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 114' ' ' PHE . 1.9 mttt -110.81 145.91 37.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.695 0.998 . . . . 1.0 113.695 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 53' ' ' GLY . 3.1 p -106.64 111.33 23.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.701 -1.591 . . . . 1.0 109.448 176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.543 HD11 ' H ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.94 -4.35 46.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.951 0.782 . . . . 1.0 110.076 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.507 ' HZ1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -139.45 147.36 52.15 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.371 177.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.83 146.08 77.0 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.288 1.325 . . . . 1.0 111.833 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.7 136.44 50.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.336 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.559 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -79.58 121.06 82.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.16 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -41.98 112.28 0.23 Allowed 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 123.111 2.541 . . . . 1.0 115.044 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 119.16 8.03 9.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.001 -0.619 . . . . 1.0 112.768 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.559 ' OE2' ' N ' ' A' ' 131' ' ' ALA . 2.6 pt-20 -105.35 165.99 10.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 117.507 0.653 . . . . 1.0 111.115 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -80.01 133.91 36.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.769 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 6.4 mp -86.27 132.49 33.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.913 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 113' ' ' LEU . 4.7 mp -140.2 159.59 41.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.56 140.16 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.48 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 29.6 p90 . . . . . 0 CA--C 1.549 0.934 0 O-C-N 124.957 1.41 . . . . 1.0 114.322 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.245 0.545 . . . . 1.0 110.527 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.14 -30.96 62.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.237 -0.892 . . . . 1.0 112.275 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.48 -33.54 48.17 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.43 ' CB ' ' CE2' ' A' ' 114' ' ' PHE . . . . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 1.0 111.464 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.962 0.411 . . . . 1.0 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -139.13 -76.71 0.35 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.622 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -43.96 160.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.811 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -125.88 150.77 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.62 -0.718 . . . . 1.0 111.062 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.586 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -60.74 -27.75 68.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.357 0.599 . . . . 1.0 109.575 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.65 -23.38 63.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' O ' ' O ' ' A' ' 18' ' ' VAL . 1.6 mm-40 -88.84 -117.06 0.05 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.11 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.54 ' O ' ' O ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER 51.49 142.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 114.123 -1.399 . . . . 1.0 110.76 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.5 ' CD ' ' OH ' ' A' ' 101' ' ' TYR . 4.3 Cg_exo -55.64 134.64 65.19 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.14 1.226 . . . . 1.0 111.766 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' CD ' ' A' ' 24' ' ' ARG . 38.2 tt0 -53.23 -38.63 63.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.847 1.055 . . . . 1.0 113.847 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.684 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 10.1 p-80 -74.67 -34.25 62.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.467 1.654 . . . . 1.0 115.467 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 m -71.65 -47.83 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.279 0.945 . . . . 1.0 111.181 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 ' H ' HD21 ' A' ' 23' ' ' LEU . 1.7 pt? -68.15 -22.32 64.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.67 0.748 . . . . 1.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.49 -29.99 64.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.2 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.46 41.6 2.11 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 30' ' ' VAL . 46.7 mt -85.41 116.59 66.19 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 119.956 -0.698 . . . . 1.0 112.542 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 29' ' ' GLU . 18.7 Cg_endo -68.31 -139.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.682 0 C-N-CA 121.638 1.559 . . . . 1.0 112.856 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.678 ' HB2' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -30.52 -4.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 126.761 2.024 . . . . 1.0 115.648 -173.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' A' ' 27' ' ' PRO . 10.9 mt-10 129.55 5.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 126.437 1.895 . . . . 1.0 113.903 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.483 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 55.5 t -41.99 127.15 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.793 -1.094 . . . . 1.0 108.503 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' NE ' ' CG2' ' A' ' 47' ' ' THR . 0.1 OUTLIER -127.35 155.33 43.76 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.237 0.828 . . . . 1.0 113.237 -177.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -92.15 116.31 28.83 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.614 0.721 . . . . 1.0 111.863 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -129.87 141.4 41.73 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.601 -1.182 . . . . 1.0 110.907 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . 71.4 Cg_endo -72.58 155.56 54.59 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.742 2.294 . . . . 1.0 114.655 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.752 ' C ' ' H ' ' A' ' 37' ' ' VAL . 11.4 m 109.22 -76.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.324 -1.307 . . . . 1.0 108.179 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.484 ' O ' ' CG ' ' A' ' 103' ' ' ASN . . . -51.81 7.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.966 -1.016 . . . . 1.0 111.991 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.752 ' H ' ' C ' ' A' ' 35' ' ' SER . 2.1 p -103.44 -50.26 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 1.9 p30 158.86 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 36.58 76.0 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.698 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 1.4 t 152.04 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.475 1.11 . . . . 1.0 112.207 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 42' ' ' ILE . 3.3 tpt180 -172.21 -168.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.765 -0.774 . . . . 1.0 111.558 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.415 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -95.28 152.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 O-C-N 123.443 0.464 . . . . 1.0 109.933 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -130.87 165.85 22.8 Favored Glycine 0 C--O 1.209 -1.43 0 N-CA-C 108.162 -1.975 . . . . 1.0 108.162 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.455 ' CG2' ' CG1' ' A' ' 30' ' ' VAL . 13.6 p -101.05 139.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 117.97 0.885 . . . . 1.0 111.276 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 6.0 m95 -134.46 154.0 51.63 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.993 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -92.0 122.54 34.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.887 -1.506 . . . . 1.0 108.581 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 62.7 p -109.07 3.77 22.38 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.431 0.634 . . . . 1.0 110.644 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.678 ' HG2' ' HB2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -128.96 170.9 9.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.696 -1.138 . . . . 1.0 111.826 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' N ' ' HG3' ' A' ' 132' ' ' PRO . 5.3 Cg_endo -85.38 129.66 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.589 2.193 . . . . 1.0 111.921 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.494 HD11 ' HZ3' ' A' ' 48' ' ' LYS . 93.2 mt -120.32 147.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.853 -1.067 . . . . 1.0 111.667 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.698 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -107.01 163.23 13.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.567 -1.197 . . . . 1.0 110.871 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 127.68 33.84 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.017 0.913 . . . . 1.0 112.607 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.857 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.14 8.29 39.11 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 114.535 -1.211 . . . . 1.0 113.944 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.6 ttmm -93.32 131.04 38.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.671 -1.611 . . . . 1.0 115.115 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -96.18 133.73 40.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.415 -1.266 . . . . 1.0 113.532 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.94 149.72 41.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.404 -0.816 . . . . 1.0 112.416 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.67 -100.77 1.55 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.385 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 66.8 Cg_endo -77.26 166.63 81.64 Favored 'Cis proline' 0 N--CA 1.504 2.116 0 CA-C-N 119.195 1.498 . . . . 1.0 112.546 0.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' O ' ' C ' ' A' ' 60' ' ' VAL . 17.6 t80 -55.7 107.49 0.34 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.221 -0.592 . . . . 1.0 110.51 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' GLY . 3.5 p -30.85 -61.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 123.774 0.671 . . . . 1.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 49.16 117.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.302 -0.475 . . . . 1.0 113.678 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 51.6 t0 -101.79 148.38 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.604 ' NZ ' ' CD2' ' A' ' 83' ' ' LEU . 4.9 mtmt -89.14 112.91 24.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.521 0.677 . . . . 1.0 110.994 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.576 ' HE3' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -132.73 166.33 22.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.738 -1.119 . . . . 1.0 111.444 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.576 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -84.81 130.99 34.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.321 0.489 . . . . 1.0 112.321 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -43.31 -23.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.002 0.741 . . . . 1.0 113.002 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.542 0 C-N-CA 120.024 -0.671 . . . . 1.0 110.326 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.514 ' O ' ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 111.843 0.312 . . . . 1.0 111.843 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.514 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -165.73 164.34 18.92 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.076 -1.05 . . . . 1.0 112.641 175.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.63 122.14 45.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.898 0.856 . . . . 1.0 110.982 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.59 121.96 51.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 106.076 -1.824 . . . . 1.0 106.076 178.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -81.34 123.53 28.61 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.02 -1.072 . . . . 1.0 112.001 -177.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' C ' ' H ' ' A' ' 82' ' ' ASN . 9.9 m-85 -86.56 111.03 36.62 Favored Pre-proline 0 N--CA 1.438 -1.045 0 O-C-N 124.866 1.354 . . . . 1.0 112.531 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.62 -12.13 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.762 1.642 . . . . 1.0 109.518 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 80' ' ' TYR . 73.9 m-80 -85.62 -116.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.208 -1.36 . . . . 1.0 110.47 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.643 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -47.99 -34.92 10.02 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 139.43 -175.14 21.87 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.334 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.425 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 16.3 m95 -58.03 120.54 8.74 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.39 0.595 . . . . 1.0 111.704 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 7.2 mmm -130.46 169.25 15.77 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.99 140.77 50.45 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 113.991 -1.459 . . . . 1.0 107.784 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -106.1 103.01 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.195 -0.911 . . . . 1.0 108.598 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.81 129.32 36.37 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.962 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' CB ' ' HZ2' ' A' ' 95' ' ' LYS . . . -141.41 91.7 2.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.953 -0.699 . . . . 1.0 112.159 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.579 ' HA ' HH11 ' A' ' 100' ' ' ARG . 0.1 OUTLIER -103.31 14.0 32.53 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.456 -0.897 . . . . 1.0 109.873 178.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.17 113.27 62.87 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.245 -0.889 . . . . 1.0 108.936 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.684 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 24.6 Cg_endo -69.58 -22.62 32.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.26 1.973 . . . . 1.0 112.097 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -56.6 -42.44 78.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.372 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -114.0 -5.51 13.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.854 0.359 . . . . 1.0 110.77 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -89.0 -144.28 10.33 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.516 -1.325 . . . . 1.0 113.432 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.66 -173.38 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.833 -0.684 . . . . 1.0 109.616 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -68.58 -19.29 64.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.885 -0.143 . . . . 1.0 111.163 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.12 -30.31 64.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.728 -0.789 . . . . 1.0 108.958 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 91' ' ' THR . 3.2 mtp85 -58.76 -11.26 2.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.85 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.5 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 10.7 m-85 -100.96 6.77 43.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.209 0.528 . . . . 1.0 110.405 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -81.11 129.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.642 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.597 HD22 ' CD1' ' A' ' 137' ' ' LEU . 0.5 OUTLIER -102.42 -137.85 0.34 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.13 -0.941 . . . . 1.0 111.22 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.539 ' N ' ' CG ' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -132.41 160.39 36.53 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.396 -0.19 . . . . 1.0 110.78 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.472 ' CB ' ' NE2' ' A' ' 111' ' ' GLN . . . -95.0 -120.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.135 1.532 . . . . 1.0 115.135 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.2 t -174.68 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.419 -1.719 . . . . 1.0 107.678 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' GLY . 13.6 t -139.66 -179.02 5.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.84 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . . . -89.26 -5.69 72.35 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 121.325 -0.465 . . . . 1.0 112.682 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.66 -20.29 43.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 10.3 pt-20 -113.78 -19.93 11.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.764 0.793 . . . . 1.0 110.124 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.628 ' NE2' ' C ' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -81.75 157.17 24.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.213 -1.358 . . . . 1.0 108.457 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -173.22 37.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.903 0.859 . . . . 1.0 111.755 -176.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 137' ' ' LEU . 5.0 mp -141.13 141.5 34.17 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -144.04 123.3 7.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.142 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.507 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 50.5 Cg_exo -55.28 104.07 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.903 1.735 . . . . 1.0 110.709 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 123' ' ' TYR . 10.0 tp -109.49 118.44 36.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' OE1' ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -94.47 117.76 30.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.31 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.422 ' CD1' ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -127.41 118.22 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.372 -1.344 . . . . 1.0 107.372 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.01 31.73 20.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.41 -1.33 . . . . 1.0 107.41 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.715 ' HE ' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 72.2 18.83 4.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.887 -1.051 . . . . 1.0 110.941 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.417 -0.81 . . . . 1.0 108.903 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.69 120.26 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.9 0.857 . . . . 1.0 112.282 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 116' ' ' LEU . 6.0 m-85 -113.62 157.03 22.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.664 -1.607 . . . . 1.0 108.79 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 4.6 m-30 -115.72 104.84 12.08 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.687 -0.805 . . . . 1.0 111.237 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 114' ' ' PHE . 5.4 ttmm -102.63 150.77 23.1 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 114.331 1.234 . . . . 1.0 114.331 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.857 ' O ' ' N ' ' A' ' 53' ' ' GLY . 4.8 p -103.12 107.88 18.85 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.89 -1.959 . . . . 1.0 109.883 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.566 HD11 ' HZ2' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -73.69 0.29 13.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 177.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.566 ' HZ2' HD11 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -150.52 152.07 32.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.055 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.47 143.74 43.56 Favored 'Trans proline' 0 N--CA 1.516 2.803 0 C-N-CA 123.163 2.575 . . . . 1.0 114.379 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.437 ' CD1' ' CG ' ' A' ' 112' ' ' ASN . 0.8 OUTLIER -110.04 135.59 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.888 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.02 133.45 69.24 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.449 ' HG3' ' N ' ' A' ' 49' ' ' PRO . 86.9 Cg_exo -50.24 103.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 122.868 2.378 . . . . 1.0 116.513 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 129.15 12.06 2.68 Favored Glycine 0 N--CA 1.468 0.81 0 C-N-CA 120.372 -0.918 . . . . 1.0 113.789 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.451 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 2.9 pt-20 -109.41 166.47 10.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.881 0.841 . . . . 1.0 111.614 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.06 136.04 37.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.567 -1.197 . . . . 1.0 112.566 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 mt -82.84 116.03 21.98 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.147 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.597 ' CD1' HD22 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.16 159.25 30.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 122.95 0.5 . . . . 1.0 111.658 -178.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.628 ' C ' ' NE2' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -122.91 148.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 178.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.424 ' CB ' ' O ' ' A' ' 138' ' ' VAL . 2.7 m95 . . . . . 0 CA--C 1.478 -1.813 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.018 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 149' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 110.874 -0.047 . . . . 1.0 110.874 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.448 ' N ' HG21 ' A' ' 148' ' ' ILE . . . -54.38 -54.19 43.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.2 -31.35 52.76 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.0 -1.0 . . . . 1.0 109.012 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.401 ' CB ' ' CE2' ' A' ' 114' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.833 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.873 0.368 . . . . 1.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -128.7 -73.01 0.59 Allowed 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -44.51 154.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.345 -0.983 . . . . 1.0 108.345 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 151.4 41.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.437 0.637 . . . . 1.0 111.575 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -51.99 -32.67 34.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.137 -0.938 . . . . 1.0 109.03 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.59 60.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.728 -1.123 . . . . 1.0 111.948 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -24.94 22.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.511 -0.476 . . . . 1.0 112.146 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.73 144.85 64.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.8 Cg_exo -57.59 132.42 50.3 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.039 1.826 . . . . 1.0 113.077 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' CG ' ' HE ' ' A' ' 24' ' ' ARG . 34.3 tt0 -49.04 -31.79 8.32 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.782 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -74.18 -34.32 63.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 23' ' ' LEU . 14.5 m -75.88 -46.08 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.774 -177.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.01 -21.01 65.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.515 -0.874 . . . . 1.0 109.646 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HE ' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.0 -38.91 69.55 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.294 -1.321 . . . . 1.0 111.947 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.57 36.43 4.35 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.681 -0.771 . . . . 1.0 112.318 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.5 mt -90.09 129.3 46.42 Favored Pre-proline 0 CA--C 1.503 -0.861 0 C-N-CA 119.728 -0.789 . . . . 1.0 111.823 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.02 167.48 15.9 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 N-CA-C 108.63 -1.334 . . . . 1.0 108.63 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.431 ' O ' ' OG1' ' A' ' 47' ' ' THR . 2.7 pt-20 -57.09 -10.2 1.11 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.94 -1.482 . . . . 1.0 114.521 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.899 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -109.23 18.67 20.27 Favored 'General case' 0 CA--C 1.449 -2.907 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.283 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.44 ' CG2' ' C ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -138.47 123.35 22.51 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 C-N-CA 117.268 -1.773 . . . . 1.0 114.115 -175.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -130.47 151.79 50.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.228 -1.805 . . . . 1.0 107.685 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.11 124.87 42.86 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.175 -0.61 . . . . 1.0 109.881 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.44 133.48 9.57 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.353 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 35' ' ' SER . 5.9 Cg_endo -85.21 149.86 10.58 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.168 1.912 . . . . 1.0 108.389 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.4 m 152.33 -73.31 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.82 -61.29 2.3 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.575 -1.25 . . . . 1.0 108.895 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.8 p -60.94 -51.75 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.94 -0.392 . . . . 1.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.8 OUTLIER 59.52 -40.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.592 0.96 . . . . 1.0 113.592 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 40' ' ' THR . 25.6 mttm -30.4 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.172 0.295 . . . . 1.0 111.663 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 153.41 22.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.038 0.836 . . . . 1.0 111.654 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.402 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 17.0 mtp180 -140.54 163.0 34.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.796 -0.762 . . . . 1.0 111.932 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 149.15 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.397 0.618 . . . . 1.0 110.88 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.78 13.63 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.87 127.25 59.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 22.5 m95 -126.65 144.69 50.83 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.899 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.72 134.31 49.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.997 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 28' ' ' GLU . 68.4 p -119.11 -21.71 7.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.08 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.614 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -117.84 165.99 14.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.439 179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -77.79 125.31 7.34 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 123.04 2.493 . . . . 1.0 111.772 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.1 149.58 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 113.394 -1.73 . . . . 1.0 112.801 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.708 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.87 164.64 12.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.828 -1.533 . . . . 1.0 110.261 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.619 ' H ' ' CE ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -68.71 128.03 35.18 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.103 178.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 1.003 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.57 8.22 38.03 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 119.066 -0.852 . . . . 1.0 114.455 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 1.9 ttmt -82.24 130.87 35.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 117.278 -1.769 . . . . 1.0 115.308 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -88.98 120.18 30.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.682 -1.599 . . . . 1.0 113.13 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.606 ' CG ' ' OE2' ' A' ' 29' ' ' GLU . 55.0 m-85 -119.75 150.02 41.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.483 0.658 . . . . 1.0 112.714 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.25 -102.29 2.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 113.706 -1.588 . . . . 1.0 110.151 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.79 170.45 69.42 Favored 'Cis proline' 0 N--CA 1.499 1.816 0 CA-C-N 119.355 1.578 . . . . 1.0 112.414 -1.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.628 ' CD1' ' NH2' ' A' ' 100' ' ' ARG . 38.5 t80 -54.46 107.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.785 -0.766 . . . . 1.0 109.056 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG12 ' NH2' ' A' ' 100' ' ' ARG . 5.6 p -42.74 -49.51 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.967 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 45.0 121.32 0.0 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.621 0.608 . . . . 1.0 114.621 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.87 145.93 28.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HZ3' ' CD1' ' A' ' 83' ' ' LEU . 1.1 mtmp? -89.51 113.92 25.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.056 0.455 . . . . 1.0 111.679 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.493 ' CE ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -142.76 169.88 16.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.631 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -80.65 133.61 35.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.374 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 67' ' ' SER . 30.8 ttp85 -45.53 -21.34 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.783 1.031 . . . . 1.0 113.783 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.969 0.414 . . . . 1.0 110.939 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.727 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -162.79 163.85 26.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 118.999 -1.08 . . . . 1.0 113.091 175.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -103.37 122.73 45.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.89 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.17 122.67 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.932 -1.507 . . . . 1.0 106.932 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.5 t80 -80.67 125.66 30.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.635 ' C ' ' H ' ' A' ' 82' ' ' ASN . 20.2 m-85 -103.05 104.2 38.72 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 114.897 -1.047 . . . . 1.0 113.059 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -62.87 10.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.388 1.392 . . . . 1.0 110.811 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.635 ' H ' ' C ' ' A' ' 80' ' ' TYR . 76.3 m-20 -97.39 2.41 50.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.094 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 83' ' ' LEU . 1.1 pt? -178.23 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.015 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 150.09 179.67 26.09 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.439 ' C ' ' SD ' ' A' ' 86' ' ' MET . 18.2 m95 -58.15 122.37 12.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 19.1 mmm -127.28 167.39 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.483 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -117.75 138.04 52.3 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.265 -1.754 . . . . 1.0 106.265 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.67 102.28 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -131.18 128.18 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.119 0.485 . . . . 1.0 111.33 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.73 92.47 2.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.219 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -111.1 13.31 21.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.366 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 94' ' ' GLU . 1.1 m-20 -108.84 99.6 35.43 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.938 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.434 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 50.6 Cg_exo -51.2 -14.78 1.74 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.628 2.218 . . . . 1.0 111.45 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 92' ' ' ASP . 5.9 mm-40 -63.92 -43.84 94.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.646 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' CD ' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -116.28 -8.48 11.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.785 -179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 97' ' ' ASN . . . -95.48 -143.1 13.77 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.125 -1.036 . . . . 1.0 113.05 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.619 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 24.6 m-20 -137.18 -166.21 1.88 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.999 0.428 . . . . 1.0 110.475 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.407 ' O ' ' N ' ' A' ' 101' ' ' TYR . 58.6 p-90 -70.4 -22.13 62.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.797 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.416 HD13 ' H ' ' A' ' 99' ' ' LEU . 5.9 mp -54.13 -24.22 17.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.741 ' H ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -61.7 -10.28 8.26 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 12.8 m-85 -107.24 -11.81 15.5 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.232 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.88 117.66 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.101 -1.04 . . . . 1.0 109.878 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -152.02 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' N ' ' CE3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -124.5 165.25 18.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.372 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 138' ' ' VAL . . . -108.84 -131.83 0.32 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.44 -31.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' A' ' 110' ' ' GLU . 4.0 m -143.78 175.7 9.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.695 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.95 -23.25 76.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 -22.37 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 107' ' ' SER . 4.0 pt-20 -109.15 -25.86 10.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.127 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' CD ' ' O ' ' A' ' 111' ' ' GLN . 0.6 OUTLIER -86.93 102.21 14.14 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.515 ' HA ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -104.09 0.32 29.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -140.51 144.75 36.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -142.82 132.51 12.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.736 1.754 . . . . 1.0 115.736 -176.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.6 122.36 3.93 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.122 3.215 . . . . 1.0 114.722 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 123' ' ' TYR . 1.9 tp -132.2 128.05 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -97.49 118.73 34.63 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.947 -0.701 . . . . 1.0 110.856 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.423 HG23 HD12 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -129.36 114.95 33.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.088 -1.078 . . . . 1.0 108.088 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.4 39.21 25.52 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.622 ' HE ' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 67.05 17.56 10.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.004 -0.998 . . . . 1.0 110.658 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.69 123.82 49.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.394 -0.821 . . . . 1.0 108.974 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -82.25 126.98 40.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 116' ' ' LEU . 6.0 m-85 -122.01 155.13 36.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.799 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -111.68 124.22 51.88 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -128.76 152.82 48.01 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 1.003 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.8 p -102.04 139.73 37.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.111 -1.858 . . . . 1.0 110.789 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.708 ' H ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -107.18 -4.44 18.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.182 -1.372 . . . . 1.0 109.024 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.921 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.45 131.83 11.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 114.937 -1.028 . . . . 1.0 110.435 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 145.64 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.601 1.534 . . . . 1.0 111.51 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mt -108.39 134.48 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' H ' ' CD ' ' A' ' 134' ' ' GLU . . . -77.15 115.77 51.67 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -38.68 113.12 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 123.004 2.469 . . . . 1.0 114.243 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 118.32 6.43 12.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.915 -0.659 . . . . 1.0 113.251 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' ALA . 4.5 pt-20 -100.41 164.43 11.92 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.419 1.11 . . . . 1.0 111.429 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HB3' ' CZ3' ' A' ' 45' ' ' TRP . 5.9 pt-20 -78.62 133.24 37.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.075 -0.966 . . . . 1.0 111.345 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 5.9 mp -86.36 122.4 30.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.326 -0.852 . . . . 1.0 108.941 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -130.71 158.16 40.83 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 139' ' ' TRP . 4.1 t -114.83 146.13 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.586 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.817 0 O-C-N 125.83 1.956 . . . . 1.0 113.228 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.17 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.077 -0.965 . . . . 1.0 111.684 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.39 -34.27 47.24 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 1.0 111.206 177.439 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.519 -0.233 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 20.5 m -175.27 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.202 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 2.9 mm-40 -57.8 166.23 1.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 1.0 111.453 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -127.42 148.88 50.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.038 -0.983 . . . . 1.0 110.593 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.665 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -58.39 -36.2 73.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.9 -18.73 55.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.271 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 14' ' ' THR . 4.6 tp10 -80.28 -46.65 15.82 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.626 -0.716 . . . . 1.0 112.383 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -41.17 158.36 0.18 Allowed Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 120.173 -0.611 . . . . 1.0 109.574 -178.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.38 118.75 3.49 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.505 2.136 . . . . 1.0 112.093 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -51.43 -43.24 61.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.459 1.281 . . . . 1.0 114.459 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.594 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 4.7 p80 -62.1 -29.41 70.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.095 0.474 . . . . 1.0 111.302 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.529 HG13 ' N ' ' A' ' 98' ' ' TRP . 73.2 t -72.93 -48.72 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.305 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.69 -25.88 62.28 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.175 0.988 . . . . 1.0 110.779 176.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -34.36 58.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.433 -1.712 . . . . 1.0 109.612 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.84 17.62 17.59 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.194 -0.762 . . . . 1.0 111.194 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.548 HD11 ' CD2' ' A' ' 98' ' ' TRP . 45.2 tp -79.41 122.98 84.57 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 117.081 0.441 . . . . 1.0 110.735 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 26' ' ' LEU . 35.4 Cg_exo -35.23 137.26 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.286 1.324 . . . . 1.0 110.954 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.504 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 18.5 pt-20 -53.32 -31.91 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.777 -1.556 . . . . 1.0 109.373 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 1.5 pm0 -85.4 18.26 2.78 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 113.538 -1.664 . . . . 1.0 112.496 -176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.527 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 87.0 t -136.15 143.64 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 C-N-CA 118.726 -1.189 . . . . 1.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -144.0 155.36 43.99 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.192 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -102.68 148.02 26.11 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.673 0.749 . . . . 1.0 111.753 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.421 ' CG ' HD11 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -156.75 119.78 2.24 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 113.86 -1.518 . . . . 1.0 111.834 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 35' ' ' SER . 19.0 Cg_endo -80.69 152.02 19.53 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.899 1.732 . . . . 1.0 111.062 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 4.3 p 87.76 -27.04 0.07 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.964 0.888 . . . . 1.0 108.799 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.465 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -53.89 -62.53 1.59 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.89 -52.32 62.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.563 -0.29 . . . . 1.0 111.586 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 2.2 m-20 162.12 63.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.621 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.488 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.0 OUTLIER 30.63 36.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.917 -1.038 . . . . 1.0 109.365 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 91.1 m -91.96 -24.3 19.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.558 -1.655 . . . . 1.0 110.094 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 161.55 -157.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.229 -1.397 . . . . 1.0 107.229 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.19 137.55 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.863 -1.532 . . . . 1.0 106.863 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.57 155.35 19.5 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 109.032 -1.627 . . . . 1.0 109.032 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 2.0 m -100.91 136.5 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.166 0.984 . . . . 1.0 110.52 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.531 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 18.9 m95 -129.97 154.25 47.56 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.477 -1.692 . . . . 1.0 110.37 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.642 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -70.88 144.18 50.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.242 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.65 -26.54 2.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.389 -0.525 . . . . 1.0 110.381 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HE3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -120.44 158.77 50.38 Favored Pre-proline 0 C--N 1.341 0.215 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.96 124.73 16.62 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.424 2.083 . . . . 1.0 112.379 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 50' ' ' ILE . 3.9 mt -112.18 131.27 64.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.584 -1.189 . . . . 1.0 108.425 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.672 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.42 146.11 36.44 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 122.26 1.029 . . . . 1.0 111.314 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -50.69 133.63 25.59 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 113.324 -1.762 . . . . 1.0 107.532 177.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.77 2.06 52.57 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.612 -1.28 . . . . 1.0 115.447 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 26.6 ttpt -96.29 140.72 30.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.913 1.357 . . . . 1.0 112.594 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.21 135.59 40.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.947 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 34.3 m-85 -115.72 126.67 54.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.216 0.531 . . . . 1.0 112.093 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.69 -132.04 7.32 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 119.362 -0.688 . . . . 1.0 112.983 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -80.62 171.97 58.26 Favored 'Cis proline' 0 N--CA 1.511 2.551 0 CA-C-N 120.03 1.915 . . . . 1.0 114.305 3.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.759 ' CD2' ' ND2' ' A' ' 97' ' ' ASN . 1.6 t80 -72.44 122.15 20.78 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.672 0.748 . . . . 1.0 109.531 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.733 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 63.8 t -102.9 138.65 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.169 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.39 -171.23 26.03 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.48 138.83 37.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.907 0.384 . . . . 1.0 110.499 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.84 117.28 29.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.636 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -140.4 164.81 29.11 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.297 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.661 ' H ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.19 145.16 33.8 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.653 0.264 . . . . 1.0 110.764 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -50.27 -44.5 53.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 110.161 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.432 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.955 0.407 . . . . 1.0 110.826 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.66 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -135.3 166.89 22.09 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.446 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -126.43 128.03 46.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.764 0.316 . . . . 1.0 110.744 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.56 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -141.77 141.51 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.294 0.568 . . . . 1.0 112.405 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 15.9 t80 -91.19 125.29 35.92 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.855 0.687 . . . . 1.0 112.855 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 7.1 m-85 -102.22 145.56 30.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.841 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.62 3.22 5.59 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.72 1.614 . . . . 1.0 109.706 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -125.41 -68.77 0.82 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.412 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.491 ' CD2' ' CD2' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -74.41 -23.38 58.94 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.102 -178.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.39 -152.65 25.58 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 108.78 -1.728 . . . . 1.0 108.78 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -63.42 119.22 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.39 -0.924 . . . . 1.0 110.119 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.7 ppp? -129.46 169.15 15.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.838 -1.073 . . . . 1.0 108.951 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' LYS . 26.2 m -121.02 144.79 48.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.36 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 mt -98.58 146.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 106.8 -1.555 . . . . 1.0 106.8 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 139.5 50.22 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.078 0.77 . . . . 1.0 113.078 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.66 140.62 50.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.615 -1.624 . . . . 1.0 106.615 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 p -151.63 15.7 0.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.987 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.26 141.83 0.13 Allowed Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.815 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.81 -18.18 32.25 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.263 1.975 . . . . 1.0 112.597 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -78.04 -6.19 53.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.826 0.822 . . . . 1.0 109.277 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 9.77 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.375 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 97' ' ' ASN . . . 94.26 156.16 32.13 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.759 ' ND2' ' CD2' ' A' ' 59' ' ' PHE . 17.2 t30 84.07 110.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.579 ' O ' ' CD1' ' A' ' 101' ' ' TYR . 70.0 p-90 -71.31 -25.53 62.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.187 0.518 . . . . 1.0 109.759 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.491 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 1.7 mt -60.08 -24.46 64.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.636 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' NE ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -68.29 -11.1 58.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 119.107 -0.473 . . . . 1.0 111.234 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 98' ' ' TRP . 0.1 OUTLIER -120.14 5.87 10.79 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.613 -0.835 . . . . 1.0 113.173 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.65 119.0 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.291 -0.564 . . . . 1.0 110.825 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -80.98 114.75 20.07 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.531 ' CD1' ' O ' ' A' ' 105' ' ' ALA . 4.9 p90 -88.03 159.09 18.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 104' ' ' TRP . . . -38.72 159.55 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 113.772 -1.558 . . . . 1.0 113.45 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.27 -4.4 21.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.134 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.64 -30.6 0.09 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.561 -0.456 . . . . 1.0 111.974 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.67 -29.37 6.64 Favored Glycine 0 C--N 1.321 -0.28 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.24 -19.46 5.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -112.76 -24.37 9.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.483 -0.78 . . . . 1.0 111.389 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.645 ' CD ' ' O ' ' A' ' 139' ' ' TRP . 1.1 tp-100 -48.2 139.12 8.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.101 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.633 ' C ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -124.98 6.73 7.97 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 119.154 -0.451 . . . . 1.0 112.106 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.672 ' N ' ' HZ3' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -154.96 174.56 14.99 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 118.263 0.483 . . . . 1.0 110.084 176.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 113' ' ' LEU . 1.6 p90 -139.62 145.6 44.15 Favored Pre-proline 0 C--N 1.346 0.425 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -82.38 138.2 9.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.754 2.303 . . . . 1.0 113.892 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' TYR . 0.7 OUTLIER -139.52 134.5 32.32 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.894 179.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.451 ' H ' HD22 ' A' ' 116' ' ' LEU . 40.4 mt-10 -89.25 123.71 33.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.223 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 121' ' ' ALA . 15.3 mt -139.6 129.49 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 46.14 43.01 10.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.114 -0.634 . . . . 1.0 110.012 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? 62.87 17.51 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.904 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -121.99 128.71 51.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -88.93 116.46 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.692 -0.803 . . . . 1.0 112.676 -177.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.461 ' HB2' ' HZ3' ' A' ' 125' ' ' LYS . 13.7 m-85 -108.06 156.67 19.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.157 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 5.4 m-30 -112.89 125.78 54.75 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 107.575 -1.268 . . . . 1.0 107.575 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 114' ' ' PHE . 2.0 mptt -116.53 139.23 50.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -131.82 125.59 32.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.676 -0.678 . . . . 1.0 112.453 178.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -98.96 21.42 11.65 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 119.911 -0.716 . . . . 1.0 109.592 175.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.672 ' HZ3' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -124.53 119.51 25.99 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.23 97.78 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.963 0 CA-C-N 120.628 1.26 . . . . 1.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.62 136.42 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.447 -176.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.54 132.8 51.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.302 0.852 . . . . 1.0 113.302 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.04 103.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.163 1.908 . . . . 1.0 111.675 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 124.82 -7.22 8.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.062 -0.589 . . . . 1.0 113.164 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 135' ' ' GLU . 1.4 pp20? -87.7 154.14 20.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.942 0.871 . . . . 1.0 111.026 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.454 ' O ' ' OE2' ' A' ' 134' ' ' GLU . 1.6 pm0 -73.71 125.08 27.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.233 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.9 mp -78.39 124.85 28.57 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.665 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 4.2 mp -123.56 146.1 48.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-O 118.982 -0.532 . . . . 1.0 112.18 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.536 ' CA ' ' OE1' ' A' ' 111' ' ' GLN . 9.4 t -104.46 132.96 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.645 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.394 0 C-N-CA 125.19 1.396 . . . . 1.0 110.869 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.485 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.09 -34.82 64.1 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.548 -0.861 . . . . 1.0 109.744 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.25 -66.6 0.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.603 -0.839 . . . . 1.0 110.765 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 117.834 -1.546 . . . . 1.0 110.868 -174.714 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 120.97 0.415 . . . . 1.0 109.949 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 88.1 m -169.93 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 34' ' ' PRO . 1.7 mt-10 -50.93 165.54 0.11 Allowed 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.539 0.685 . . . . 1.0 110.735 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -126.72 153.81 44.98 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.913 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -52.31 -31.89 35.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.95 -17.77 56.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.073 -1.422 . . . . 1.0 110.131 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.62 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.8 tp10 -77.97 -47.92 17.45 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.292 0.849 . . . . 1.0 113.292 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.85 147.8 4.3 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' CD ' ' OH ' ' A' ' 101' ' ' TYR . 5.2 Cg_exo -52.39 130.52 36.38 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.199 1.266 . . . . 1.0 111.898 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 4.4 tt0 -52.15 -34.94 46.99 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 114.564 -1.198 . . . . 1.0 113.011 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.724 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -79.27 -35.26 41.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.573 0.953 . . . . 1.0 113.573 -177.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.52 -31.2 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -71.81 -41.57 68.08 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.753 -2.021 . . . . 1.0 110.831 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -81.54 -20.02 40.89 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.164 0.585 . . . . 1.0 112.279 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.75 -26.98 36.31 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 110.148 -1.181 . . . . 1.0 110.148 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.624 ' HB3' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -63.76 144.13 97.97 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 117.907 -1.517 . . . . 1.0 111.564 -178.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.04 151.68 8.5 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 120.988 1.125 . . . . 1.0 111.871 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt-20 -52.84 -31.08 37.24 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.985 -1.461 . . . . 1.0 110.407 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -87.93 20.53 3.06 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 115.017 -0.992 . . . . 1.0 111.181 -178.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.412 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 21.4 t -135.29 137.03 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 C-N-CA 119.52 -0.872 . . . . 1.0 110.879 -177.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.544 ' NH1' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER -146.26 159.45 43.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.1 mm? -104.57 141.08 37.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.16 120.82 3.31 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.772 -0.632 . . . . 1.0 111.654 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.488 ' N ' HG13 ' A' ' 42' ' ' ILE . 9.8 Cg_endo -82.1 151.69 16.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.693 1.596 . . . . 1.0 111.689 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.429 ' HB3' ' N ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 78.06 15.6 1.43 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.46 -1.682 . . . . 1.0 106.46 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.413 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.55 -64.53 1.13 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.62 -29.77 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 78.44 -11.79 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.18 -0.918 . . . . 1.0 112.636 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 40' ' ' THR . 1.3 pttp -49.92 -12.19 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.587 ' H ' ' C ' ' A' ' 38' ' ' ASP . 4.9 m 98.84 64.41 0.0 OUTLIER 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.77 1.294 . . . . 1.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.403 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER 171.99 -165.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.196 -0.911 . . . . 1.0 108.951 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 34' ' ' PRO . 2.4 tt -101.62 144.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.58 163.02 22.78 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 109.316 -1.513 . . . . 1.0 109.316 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -99.66 136.24 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 CA-C-O 121.263 0.554 . . . . 1.0 109.724 -178.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.504 ' CZ3' ' CB ' ' A' ' 135' ' ' GLU . 28.6 m95 -129.29 151.84 49.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.881 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -68.57 144.67 54.47 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.085 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.544 ' CG2' ' NH1' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -126.44 -29.64 2.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.538 -178.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -124.5 159.99 55.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.13 123.95 13.73 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.195 1.93 . . . . 1.0 112.937 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.04 131.52 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.145 -1.389 . . . . 1.0 107.544 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.686 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -109.72 155.24 21.8 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.925 0.869 . . . . 1.0 111.034 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -63.42 133.76 54.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.03 -1.441 . . . . 1.0 109.027 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.72 1.94 55.26 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.503 -1.332 . . . . 1.0 115.107 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 15.3 ttpt -90.1 134.34 34.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.167 -1.013 . . . . 1.0 112.485 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.08 130.43 36.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.14 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 5.5 m-85 -115.36 127.37 55.36 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.728 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.17 -146.97 17.59 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -79.87 166.51 77.01 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 CA-C-N 119.583 1.692 . . . . 1.0 115.118 0.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -83.17 111.83 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.246 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.803 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.8 t -43.24 -61.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.401 -2.181 . . . . 1.0 114.079 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 32.35 106.34 0.0 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-O 121.469 0.483 . . . . 1.0 112.931 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -72.81 143.13 47.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.531 ' NZ ' ' HH ' ' A' ' 80' ' ' TYR . 1.7 mptp? -92.62 117.67 30.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.587 0.708 . . . . 1.0 112.79 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HZ3' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -141.91 167.89 21.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.677 -1.147 . . . . 1.0 111.213 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 135.86 37.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.1 0.476 . . . . 1.0 110.435 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -48.07 -24.39 1.08 Allowed 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.964 -0.46 . . . . 1.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.342 . . . . 1.0 111.403 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.997 0.427 . . . . 1.0 111.504 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.678 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -128.58 165.35 20.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.845 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.88 132.04 53.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.749 0.277 . . . . 1.0 111.749 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.567 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -146.73 141.33 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.512 0.672 . . . . 1.0 112.798 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -83.51 124.94 31.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.286 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 82' ' ' ASN . 4.4 m-85 -102.95 120.09 53.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.28 -12.86 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 N-CA-C 109.208 -1.112 . . . . 1.0 109.208 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.554 ' H ' ' C ' ' A' ' 80' ' ' TYR . 1.1 m-80 -101.16 -86.96 0.4 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.78 -1.1 . . . . 1.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' H ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 119.794 -0.762 . . . . 1.0 110.842 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . 89.46 -139.77 15.32 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.905 -1.678 . . . . 1.0 108.905 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.1 118.58 12.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.47 -0.892 . . . . 1.0 110.378 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.567 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -128.9 170.15 13.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.139 178.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.9 m -115.01 142.47 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.439 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.513 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 16.9 mt -96.22 152.08 3.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.563 ' CB ' ' HZ3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -129.39 136.16 49.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.312 0.577 . . . . 1.0 112.312 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 91' ' ' THR . . . -133.39 142.23 48.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 161.28 7.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 96' ' ' GLY . 5.4 p30 -117.07 62.79 3.08 Favored Pre-proline 0 C--O 1.22 -0.499 0 CA-C-N 114.565 -1.198 . . . . 1.0 109.433 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -45.68 -13.86 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.566 2.178 . . . . 1.0 112.143 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.535 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -78.2 -42.93 29.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.094 0.949 . . . . 1.0 110.065 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -11.71 12.67 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.134 -1.393 . . . . 1.0 110.143 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.803 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -63.29 -62.36 5.46 Favored Glycine 0 C--O 1.18 -3.269 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.768 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.576 HD21 ' C ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 138.09 150.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.638 0.775 . . . . 1.0 109.621 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.624 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 56.0 p-90 -56.68 -22.72 36.8 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.7 mt -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.491 -0.884 . . . . 1.0 109.524 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.536 ' H ' HD21 ' A' ' 97' ' ' ASN . 0.2 OUTLIER -75.91 -9.93 59.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 177.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 98' ' ' TRP . 12.3 m-85 -90.33 -9.76 46.59 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.6 131.16 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 114.651 -1.159 . . . . 1.0 111.438 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.01 -158.86 0.7 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.109 -1.405 . . . . 1.0 110.033 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.484 ' C ' ' CD1' ' A' ' 104' ' ' TRP . 24.5 p90 -136.72 164.26 28.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.524 -1.216 . . . . 1.0 112.058 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.457 ' CB ' ' HE1' ' A' ' 139' ' ' TRP . . . -87.2 140.24 29.74 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.261 0.837 . . . . 1.0 113.261 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -76.0 -13.29 60.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 177.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -142.66 132.04 23.56 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.707 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -46.97 -17.17 0.27 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' C ' ' A' ' 107' ' ' SER . 10.7 mm-40 -77.41 -32.88 55.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.861 0.362 . . . . 1.0 110.44 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 107' ' ' SER . 25.4 tp10 -88.69 -22.88 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.321 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.886 HE22 ' N ' ' A' ' 139' ' ' TRP . 3.8 tp60 -59.42 142.47 52.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.51 0.671 . . . . 1.0 109.392 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 135' ' ' GLU . 33.2 p30 -144.3 14.19 1.62 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.6 -1.182 . . . . 1.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.714 ' N ' ' HZ2' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -148.54 166.88 26.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.444 -0.503 . . . . 1.0 110.243 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -152.45 130.76 6.27 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 119.093 -1.043 . . . . 1.0 112.552 178.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.44 139.59 20.82 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.241 1.96 . . . . 1.0 113.96 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.542 HD21 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -142.4 138.76 31.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.517 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.542 ' H ' HD21 ' A' ' 116' ' ' LEU . 3.7 tm-20 -92.16 119.26 31.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.4 mt -138.11 130.05 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 120.629 -0.428 . . . . 1.0 111.162 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.2 50.63 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.311 0.577 . . . . 1.0 111.473 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HG3' ' CE1' ' A' ' 80' ' ' TYR . 1.3 tpp180 65.55 1.64 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.51 -0.476 . . . . 1.0 112.034 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.4 158.06 27.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.276 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.411 HD13 ' CD2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -107.69 110.78 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 C-N-CA 119.785 -0.766 . . . . 1.0 112.011 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -101.53 152.58 20.61 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.976 -1.011 . . . . 1.0 108.761 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.572 ' C ' ' HZ1' ' A' ' 125' ' ' LYS . 10.6 m-30 -113.86 127.26 55.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.734 ' HZ1' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -118.14 142.62 47.24 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 1.0 112.103 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -130.22 120.21 24.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.346 -1.297 . . . . 1.0 111.605 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.513 ' H ' ' CD2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -96.41 27.92 3.56 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.523 177.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.714 ' HZ2' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -129.0 123.36 21.8 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.04 94.99 0.41 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 CA-C-N 120.736 1.299 . . . . 1.0 109.14 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mt -71.45 136.05 26.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.465 0.65 . . . . 1.0 109.311 -176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.83 132.67 63.67 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.995 -1.002 . . . . 1.0 113.282 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.53 104.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.923 1.749 . . . . 1.0 111.781 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.06 -7.81 8.1 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.418 ' OE2' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -87.6 150.95 23.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.559 . . . . 1.0 111.485 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 0.6 OUTLIER -79.73 136.96 36.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.773 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 5.4 mp -89.53 136.66 32.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 1.9 mm? -123.44 135.39 54.07 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.529 0.937 . . . . 1.0 113.529 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 104' ' ' TRP . 1.7 t -104.79 131.81 52.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.03 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.886 ' N ' HE22 ' A' ' 111' ' ' GLN . 6.8 p-90 . . . . . 0 N--CA 1.499 1.996 0 C-N-CA 125.502 1.521 . . . . 1.0 109.886 176.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.213 -0.858 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.558 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -75.87 -49.61 17.41 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.292 1.044 . . . . 1.0 109.431 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.04 -65.74 0.53 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.11 -1.859 . . . . 1.0 109.055 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.702 0 C-N-CA 118.103 -1.439 . . . . 1.0 111.209 -175.627 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.558 ' CG2' ' N ' ' A' ' 13' ' ' GLU . 81.6 m -174.83 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 12' ' ' THR . 4.6 mm-40 53.8 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.57 ' HB ' ' H ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -140.2 176.32 8.86 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.0 174.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.488 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 2.5 tt -58.12 -56.73 18.25 Favored 'General case' 0 CA--C 1.47 -2.128 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 175.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.621 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . -80.87 -54.55 5.49 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 111.853 -2.431 . . . . 1.0 106.911 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 1.1 tt0 160.24 -21.37 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 115.777 1.769 . . . . 1.0 115.777 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.279 1.1 m -145.17 -178.66 0.81 Allowed Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 120.457 1.481 . . . . 1.0 111.709 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.506 ' O ' HD11 ' A' ' 23' ' ' LEU . 4.2 Cg_exo -38.4 151.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.362 2.708 . . . . 1.0 111.113 173.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.477 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 13.7 tt0 -67.75 -34.26 76.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 115.778 1.77 . . . . 1.0 115.778 -176.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -73.63 -25.22 60.2 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -68.6 -51.37 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.769 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.6 ' H ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.05 -24.76 66.02 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.08 0.943 . . . . 1.0 110.617 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.727 -1.579 . . . . 1.0 108.801 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.41 3.98 47.3 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.951 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' CD2' ' CG ' ' A' ' 98' ' ' TRP . 11.6 mt -62.6 158.51 49.88 Favored Pre-proline 0 CA--C 1.491 -1.309 0 CA-C-N 118.311 1.055 . . . . 1.0 110.256 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.66 145.36 51.73 Favored 'Trans proline' 0 C--N 1.29 -2.552 0 N-CA-C 107.338 -1.832 . . . . 1.0 107.338 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' O ' ' CE ' ' A' ' 48' ' ' LYS . 19.7 pt-20 -49.01 -30.23 5.86 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.333 1.063 . . . . 1.0 110.944 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 1.4 pm0 -87.39 25.63 1.38 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.002 -1.454 . . . . 1.0 112.463 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -143.33 148.91 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.977 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.436 ' HB3' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER -158.34 155.36 28.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.007 -1.906 . . . . 1.0 106.407 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -128.73 151.05 49.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.439 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -156.93 142.57 12.69 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 124.209 0.943 . . . . 1.0 113.481 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 45.8 Cg_endo -86.83 150.16 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.699 2.266 . . . . 1.0 109.634 174.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.2 m 85.76 15.75 0.14 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.264 -1.384 . . . . 1.0 107.264 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 45' ' ' TRP . . . -90.84 -61.11 1.74 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.69 -1.967 . . . . 1.0 105.69 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -51.55 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.263 -1.335 . . . . 1.0 112.946 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 40' ' ' THR . 27.8 t70 179.56 46.76 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER 30.11 39.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.17 0.986 . . . . 1.0 110.187 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.6 m -127.11 -56.23 1.34 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.714 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -120.08 157.53 28.75 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.228 -2.26 . . . . 1.0 107.324 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.6 HG12 ' OE1' ' A' ' 17' ' ' GLU . 10.3 tt -103.64 146.39 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 118.706 -0.664 . . . . 1.0 109.934 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 17' ' ' GLU . . . -140.46 173.04 23.27 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 119.275 -1.44 . . . . 1.0 114.08 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.75 131.39 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 36' ' ' ALA . 27.0 m95 -125.88 146.91 49.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -71.4 144.0 49.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.538 -0.756 . . . . 1.0 112.201 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 45.1 p -119.76 -30.0 4.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.103 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -119.19 158.66 47.84 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.39 123.05 12.86 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 121.873 1.715 . . . . 1.0 111.593 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.19 133.43 48.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.648 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.9 157.35 19.96 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.29 1.043 . . . . 1.0 111.757 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.77 130.05 42.06 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.464 -1.698 . . . . 1.0 108.938 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.78 3.39 49.37 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 119.607 -1.282 . . . . 1.0 115.797 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 24.7 ttpt -92.48 143.7 26.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 1.267 . . . . 1.0 113.063 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.6 41.77 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.751 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 20.9 m-85 -115.78 129.11 56.32 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.884 -1.053 . . . . 1.0 108.206 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 132.95 -149.42 19.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.19 -1.005 . . . . 1.0 112.461 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 70.0 Cg_endo -89.17 153.03 30.93 Favored 'Cis proline' 0 N--CA 1.51 2.497 0 CA-C-N 119.214 1.507 . . . . 1.0 115.206 0.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.47 ' CE2' ' NE1' ' A' ' 76' ' ' TRP . 3.9 t80 -58.01 112.88 1.65 Allowed 'General case' 0 CA--C 1.495 -1.142 0 CA-C-O 122.08 0.943 . . . . 1.0 111.905 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.703 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -86.25 134.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.781 -1.554 . . . . 1.0 108.033 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.52 147.84 17.25 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.84 -1.704 . . . . 1.0 108.84 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -69.15 142.12 54.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.456 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.4 mptt -92.38 115.75 28.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.31 0.576 . . . . 1.0 111.883 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -142.59 167.56 21.81 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.649 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.574 ' H ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.98 149.04 34.16 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.28 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -48.56 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 1.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.322 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.705 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.868 0.366 . . . . 1.0 110.119 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.616 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -134.02 166.79 21.92 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.165 -0.679 . . . . 1.0 109.165 -178.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -133.48 125.58 29.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.186 0.517 . . . . 1.0 110.576 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.54 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.39 139.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.544 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.548 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 49.7 t80 -87.15 129.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.644 0.735 . . . . 1.0 111.228 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.435 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 4.7 m-85 -105.73 140.42 21.18 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.956 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.56 17.04 0.98 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.849 1.7 . . . . 1.0 110.83 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.548 HD22 ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -149.07 -31.46 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.92 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.548 ' CD1' HD22 ' A' ' 82' ' ' ASN . 0.2 OUTLIER -106.09 -16.61 14.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.962 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.31 -165.3 53.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -62.84 121.28 13.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.549 -0.86 . . . . 1.0 109.881 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.3 ppp? -130.96 168.66 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.14 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' LYS . 54.4 m -123.84 144.64 49.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.933 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.8 mt -99.93 146.14 9.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 7.4 p-10 -133.61 119.29 19.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.349 0.977 . . . . 1.0 112.012 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.0 90.99 2.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.71 0.85 28.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.618 1.099 . . . . 1.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -128.89 131.55 23.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.819 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 96' ' ' GLY . 65.9 Cg_exo -48.97 -28.78 14.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.845 1.697 . . . . 1.0 113.728 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.22 -18.69 45.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.313 1.054 . . . . 1.0 108.428 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -88.63 18.19 4.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.123 -1.853 . . . . 1.0 109.473 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' PRO . . . -174.36 166.09 37.89 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.96 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.712 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -71.6 175.3 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.293 -1.002 . . . . 1.0 108.293 177.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.627 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 25.9 p-90 -56.44 -22.01 29.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.908 -0.717 . . . . 1.0 112.732 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 19.2 mt -53.71 -28.05 31.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 177.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -74.88 -12.9 60.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.949 -0.569 . . . . 1.0 112.006 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 98' ' ' TRP . 15.9 p90 -123.56 4.15 8.97 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 119.696 -0.802 . . . . 1.0 110.694 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 2.7 p -71.71 116.45 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.475 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 1.7 m-20 -85.22 143.36 28.8 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.311 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 33.7 p90 -111.58 162.9 14.66 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.835 0.826 . . . . 1.0 112.945 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 111' ' ' GLN . . . -50.9 -179.15 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.132 -1.395 . . . . 1.0 112.336 -177.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -75.09 -20.4 59.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.669 178.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 106' ' ' CYS . 1.5 p 151.91 71.17 0.0 OUTLIER 'General case' 0 C--N 1.347 0.464 0 O-C-N 123.857 0.723 . . . . 1.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.784 ' H ' ' NE2' ' A' ' 111' ' ' GLN . . . 72.72 13.96 78.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.559 -0.616 . . . . 1.0 111.559 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.57 -44.08 19.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.012 -0.675 . . . . 1.0 111.36 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -120.19 -30.59 4.6 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.605 -0.438 . . . . 1.0 111.863 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.784 ' NE2' ' H ' ' A' ' 108' ' ' GLY . 1.5 mt-30 -24.92 139.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.889 0.876 . . . . 1.0 113.083 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.565 ' C ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.15 19.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 1.0 110.134 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.687 ' N ' ' HZ2' ' A' ' 128' ' ' LYS . 2.1 tp -153.12 149.3 27.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.69 -0.672 . . . . 1.0 109.698 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 125' ' ' LYS . 3.9 p90 -126.31 150.12 69.18 Favored Pre-proline 0 C--N 1.366 1.305 0 N-CA-C 114.616 1.339 . . . . 1.0 114.616 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -88.68 141.37 4.56 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 123.007 2.472 . . . . 1.0 114.073 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.414 HD21 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -141.81 139.74 32.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.847 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' H ' HD21 ' A' ' 116' ' ' LEU . 7.5 mt-10 -98.41 120.43 38.82 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.567 -0.288 . . . . 1.0 110.677 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -136.75 126.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 120.827 0.346 . . . . 1.0 110.637 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 121' ' ' ALA . 1.1 m-80 52.64 47.92 23.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.177 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 1.8 mmt-85 62.97 5.96 2.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.126 0.489 . . . . 1.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASN . . . -107.07 156.8 18.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 1.0 108.785 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -115.82 103.97 16.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.911 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.51 ' C ' ' HZ1' ' A' ' 125' ' ' LYS . 13.4 m-85 -100.1 148.82 24.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -113.16 114.08 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.661 ' HZ3' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -107.13 142.57 36.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.124 1.157 . . . . 1.0 114.124 -178.065 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -129.84 132.43 46.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.423 -1.262 . . . . 1.0 112.491 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -106.38 26.04 10.35 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.7 0.682 . . . . 1.0 109.536 175.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.687 ' HZ2' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -127.66 117.01 21.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.03 97.87 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 CA-C-N 120.465 1.202 . . . . 1.0 110.635 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mt -70.36 136.8 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.27 1.033 . . . . 1.0 109.561 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.13 132.67 76.33 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 113.96 -1.473 . . . . 1.0 114.188 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -50.13 97.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.67 1.58 . . . . 1.0 110.737 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.68 -4.28 8.06 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.786 -0.525 . . . . 1.0 111.786 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -87.48 151.65 22.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.4 pm0 -77.21 129.08 35.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.919 0.39 . . . . 1.0 110.085 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 5.5 mp -81.33 142.21 33.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 135' ' ' GLU . 6.8 mp -139.86 155.25 47.31 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.59 131.81 60.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 CA-C-N 114.93 -1.032 . . . . 1.0 113.228 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.707 ' CG ' ' NE2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.5 0.667 . . . . 1.0 112.662 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.057 0 N-CA-C 106.874 -1.528 . . . . 1.0 106.874 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.464 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -73.87 -35.77 64.76 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.952 -0.699 . . . . 1.0 110.203 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.03 -66.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.046 -1.061 . . . . 1.0 110.233 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 119.129 -1.028 . . . . 1.0 110.153 -175.234 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 13' ' ' GLU . . . . . . . . 0 CA--C 1.522 -0.113 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 14' ' ' THR . 0.4 OUTLIER 73.44 -39.8 0.45 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.579 179.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' ALA . 1.4 mm-40 28.23 -87.09 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -136.78 172.18 13.4 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.663 174.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 6.3 tt -73.04 -59.91 2.48 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.823 -1.151 . . . . 1.0 108.336 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -78.35 -59.57 2.73 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-N 113.216 -1.811 . . . . 1.0 108.407 -176.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.674 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -145.77 -102.58 0.1 Allowed 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 118.565 -1.254 . . . . 1.0 114.289 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.674 ' H ' ' CG ' ' A' ' 17' ' ' GLU 0.284 0.2 OUTLIER 179.38 -80.42 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 116.974 -1.489 . . . . 1.0 111.601 -177.456 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 4.4 Cg_exo -74.19 147.01 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 CA-C-N 124.875 2.777 . . . . 1.0 111.404 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.499 ' CD ' HH12 ' A' ' 24' ' ' ARG . 37.4 tt0 -67.73 -50.26 58.29 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.338 1.066 . . . . 1.0 110.404 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.569 ' NE2' ' O ' ' A' ' 94' ' ' GLU . 28.7 p80 -56.36 -24.85 46.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.884 -1.053 . . . . 1.0 113.408 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 26' ' ' LEU . 2.0 m -64.09 -45.0 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 121.284 1.857 . . . . 1.0 106.362 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' H ' HG22 ' A' ' 22' ' ' VAL . 6.5 mp -54.71 -28.67 49.7 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.596 0.712 . . . . 1.0 110.405 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.499 HH12 ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.05 -20.84 60.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.519 -1.219 . . . . 1.0 108.616 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . -114.7 -12.68 10.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.309 -1.314 . . . . 1.0 113.063 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.62 ' O ' ' O ' ' A' ' 27' ' ' PRO . 16.8 mt -60.19 150.21 72.31 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-N 118.988 1.394 . . . . 1.0 110.589 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 26' ' ' LEU . 75.9 Cg_exo -42.56 -128.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.666 2.911 . . . . 1.0 113.184 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 49' ' ' PRO . 4.2 mt-10 -68.77 -50.75 47.85 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.776 -1.57 . . . . 1.0 106.796 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' H ' ' HE2' ' A' ' 48' ' ' LYS . 12.5 tt0 -126.18 -77.71 0.59 Allowed 'General case' 0 C--N 1.363 1.17 0 C-N-CA 120.157 -0.617 . . . . 1.0 111.489 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 31' ' ' ARG 0.365 4.9 t 59.43 152.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 C-N-CA 127.881 2.472 . . . . 1.0 116.265 -176.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.408 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -147.79 160.61 42.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.173 -2.285 . . . . 1.0 110.948 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 16' ' ' ALA . 3.5 mm? -117.75 120.41 37.88 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 174.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 15' ' ' LEU . 1.1 t80 -129.43 122.56 20.94 Favored Pre-proline 0 N--CA 1.485 1.299 0 O-C-N 121.193 -0.942 . . . . 1.0 112.633 -176.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 4.3 Cg_exo -79.22 130.4 9.2 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.804 2.336 . . . . 1.0 112.897 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.3 t 87.8 30.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.667 -2.06 . . . . 1.0 107.286 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' CB ' ' CE2' ' A' ' 45' ' ' TRP . . . -94.57 -54.12 3.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.4 -49.85 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 113.614 -1.63 . . . . 1.0 111.993 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 169.28 -50.91 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.3 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.548 -1.205 . . . . 1.0 107.909 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 20.7 m -102.83 -34.73 8.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 40' ' ' THR . 7.7 mtm-85 155.06 -159.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.7 -1.593 . . . . 1.0 106.7 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.474 HG13 ' C ' ' A' ' 33' ' ' PHE . 9.5 tt -84.07 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 118.915 0.779 . . . . 1.0 111.315 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 32' ' ' LEU . . . -106.75 166.72 13.66 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.28 120.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 118.134 0.967 . . . . 1.0 111.426 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 4.9 m95 -127.51 143.79 51.14 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.258 -0.883 . . . . 1.0 110.173 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -84.7 123.84 30.83 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.2 -1.0 . . . . 1.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -21.76 19.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.37 0.605 . . . . 1.0 109.409 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -107.87 167.89 8.68 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 114.728 -1.124 . . . . 1.0 110.963 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 5.9 Cg_exo -76.09 144.34 26.69 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.65 2.233 . . . . 1.0 111.158 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.412 HD11 ' HZ2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -118.73 144.09 27.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.91 -178.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.663 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.98 146.31 39.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.92 0.866 . . . . 1.0 110.742 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.65 140.14 58.47 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.323 -1.308 . . . . 1.0 111.822 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.79 3.92 58.07 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 119.409 -1.377 . . . . 1.0 115.302 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' CG ' ' N ' ' A' ' 55' ' ' LYS . 30.0 ttpt -106.22 146.27 30.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 118.92 -1.112 . . . . 1.0 113.968 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -97.39 140.71 31.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.791 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.59 131.03 56.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.052 -1.462 . . . . 1.0 107.052 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.64 -150.45 21.11 Favored Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -84.83 170.7 46.88 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 119.671 1.735 . . . . 1.0 113.457 0.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.672 ' CD1' ' ND2' ' A' ' 97' ' ' ASN . 36.9 t80 -73.72 122.31 22.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.622 0.725 . . . . 1.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.562 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -44.37 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.886 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 37.12 109.14 0.0 OUTLIER Glycine 0 C--N 1.333 0.399 0 CA-C-O 121.711 0.617 . . . . 1.0 113.244 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t70 -85.78 134.96 33.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 1.5 mptt -90.59 116.33 28.41 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.517 0.675 . . . . 1.0 112.124 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 75' ' ' MET . 0.1 OUTLIER -124.05 158.08 33.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.626 -1.17 . . . . 1.0 110.98 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.63 135.53 34.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -53.27 -31.04 41.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.783 -0.573 . . . . 1.0 110.394 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.838 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.653 0.74 . . . . 1.0 112.584 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.629 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -123.11 164.28 18.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.525 -1.216 . . . . 1.0 110.512 -178.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -122.69 122.21 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.181 0.515 . . . . 1.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.96 139.93 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.406 -0.816 . . . . 1.0 111.83 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.516 ' O ' ' CZ ' ' A' ' 120' ' ' ARG . 4.4 t80 -92.67 135.84 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.875 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -117.12 146.05 37.17 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -70.19 44.46 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 N-CA-C 108.225 -1.49 . . . . 1.0 108.225 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 80' ' ' TYR . 1.5 t30 -148.21 -85.77 0.1 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.212 -1.358 . . . . 1.0 110.297 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.575 ' N ' ' CG ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -80.48 -8.99 59.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.33 -1.305 . . . . 1.0 112.322 -176.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' O ' ' CD1' ' A' ' 83' ' ' LEU . . . 81.65 -145.81 25.31 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -78.68 118.13 20.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.721 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -129.96 173.38 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.744 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.586 ' N ' ' SD ' ' A' ' 86' ' ' MET . 67.8 m -117.96 141.41 48.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.152 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.4 150.66 3.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 N-CA-C 108.05 -1.093 . . . . 1.0 108.05 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -133.66 136.69 44.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.827 1.047 . . . . 1.0 113.827 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -133.23 139.93 47.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 90' ' ' ALA . 30.2 p -158.61 -13.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.487 0.585 . . . . 1.0 110.033 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.03 106.31 3.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.75 -22.09 9.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.132 1.888 . . . . 1.0 114.353 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.569 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 5.9 pt-20 -83.18 -8.39 59.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.904 0.859 . . . . 1.0 110.215 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 11.65 35.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.343 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.442 ' O ' ' ND1' ' A' ' 21' ' ' HIS . . . -165.44 -95.07 0.1 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 119.073 -1.537 . . . . 1.0 114.012 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.672 ' ND2' ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -146.18 173.35 12.29 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.596 ' CG ' HD23 ' A' ' 26' ' ' LEU . 30.6 p-90 -70.86 -19.95 62.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -50.18 -24.11 2.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.747 HH22 HD22 ' A' ' 103' ' ' ASN . 3.1 tpm_? -84.57 -23.16 29.78 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 120.146 -0.621 . . . . 1.0 110.749 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -72.57 -7.35 49.69 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.299 1.047 . . . . 1.0 109.479 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 3.4 t -82.48 119.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.249 -1.796 . . . . 1.0 111.041 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.747 HD22 HH22 ' A' ' 100' ' ' ARG . 38.4 m-20 -156.15 71.68 0.73 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.661 0.664 . . . . 1.0 111.464 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.794 ' HE1' ' N ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -141.88 176.69 8.73 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.089 0.956 . . . . 1.0 111.497 -177.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 107' ' ' SER . . . 26.53 52.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.43 1.081 . . . . 1.0 109.995 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -48.56 -14.53 0.06 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.613 ' H ' ' C ' ' A' ' 105' ' ' ALA . 20.0 p -174.98 18.06 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.35 -1.295 . . . . 1.0 110.561 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.67 ' N ' ' HE1' ' A' ' 139' ' ' TRP . . . -85.2 131.26 10.33 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.06 -12.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.26 5.52 4.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 113.698 0.999 . . . . 1.0 113.698 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.566 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.4 pp0? -54.48 140.23 35.04 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.673 1.36 . . . . 1.0 114.673 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.921 ' ND2' ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -117.58 -5.22 11.19 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.333 -1.758 . . . . 1.0 111.663 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 114' ' ' PHE . 0.3 OUTLIER -155.8 165.47 36.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 119.441 -0.314 . . . . 1.0 110.931 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -133.11 138.03 30.77 Favored Pre-proline 0 C--N 1.357 0.933 0 N-CA-C 113.869 1.062 . . . . 1.0 113.869 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.78 146.02 10.37 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.422 2.748 . . . . 1.0 113.648 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.534 HD22 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -144.66 146.54 32.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.293 178.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.534 ' H ' HD22 ' A' ' 116' ' ' LEU . 1.2 tt0 -97.38 119.06 35.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 121' ' ' ALA . 7.7 mt -137.39 132.21 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.929 -177.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 121' ' ' ALA . 30.2 m-20 50.14 57.95 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.485 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.516 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 9.8 mmp_? 57.21 -0.8 0.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.494 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' H ' ' C ' ' A' ' 119' ' ' ASN . . . -123.21 155.62 36.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.248 -0.278 . . . . 1.0 110.248 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CE2' ' A' ' 76' ' ' TRP . 1.0 OUTLIER -103.8 113.94 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.35 149.32 24.16 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 3.1 m-30 -112.97 126.93 56.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.338 -1.356 . . . . 1.0 107.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.83 ' HZ1' ' N ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -122.5 140.43 52.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -128.73 134.47 48.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 1.0 109.708 178.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.493 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -105.87 16.78 24.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.103 176.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.587 ' NZ ' ' C ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -125.16 127.01 25.13 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.22 98.79 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 121.33 1.511 . . . . 1.0 111.068 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CD1' ' OD1' ' A' ' 112' ' ' ASN . 55.6 mt -67.81 134.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.273 1.035 . . . . 1.0 109.594 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.663 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.01 139.32 97.75 Favored Pre-proline 0 C--O 1.212 -0.872 0 CA-C-N 113.929 -1.487 . . . . 1.0 114.086 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.52 115.44 4.29 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.556 2.171 . . . . 1.0 111.692 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 109.65 0.95 30.73 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.914 -0.474 . . . . 1.0 111.914 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.702 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -97.75 173.27 7.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.84 0.829 . . . . 1.0 112.353 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' CG ' ' CD1' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -85.81 141.42 29.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.211 -1.358 . . . . 1.0 108.359 176.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.582 ' O ' ' CZ2' ' A' ' 104' ' ' TRP . 5.4 mp -89.9 136.88 32.78 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.218 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.921 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 6.8 mp -121.6 142.84 49.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.757 0.789 . . . . 1.0 112.104 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.794 ' N ' ' HE1' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -119.97 137.12 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 114.034 -1.439 . . . . 1.0 110.014 -176.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.67 ' HE1' ' N ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--O 1.204 -1.295 0 N-CA-C 106.388 -1.708 . . . . 1.0 106.388 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.05 -50.4 34.35 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.123 -1.831 . . . . 1.0 109.191 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.87 -65.59 0.68 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.285 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.296 0 CA-C-N 120.846 1.657 . . . . 1.0 112.374 -176.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.191 0.52 . . . . 1.0 110.192 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.3 m 149.54 -68.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.251 -1.341 . . . . 1.0 108.212 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -45.8 138.71 4.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.556 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -121.37 153.45 37.78 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 121.554 0.692 . . . . 1.0 112.321 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -47.39 -36.0 9.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.465 -178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.96 44.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.581 -1.191 . . . . 1.0 109.802 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -97.47 -38.1 9.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.034 -0.984 . . . . 1.0 113.617 -177.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.49 147.11 95.87 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.688 -1.967 . . . . 1.0 105.688 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.1 118.61 3.28 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.621 1.548 . . . . 1.0 112.042 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.15 -42.39 60.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.973 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -64.08 -23.65 67.4 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.949 -0.7 . . . . 1.0 111.703 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 98' ' ' TRP . 14.9 t -80.17 -45.33 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 119.009 0.822 . . . . 1.0 111.247 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -25.7 66.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.951 0.881 . . . . 1.0 108.993 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -61.27 -19.18 61.43 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.592 -1.186 . . . . 1.0 111.913 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.8 39.67 2.82 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.246 -0.502 . . . . 1.0 112.054 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.542 HD23 ' CG ' ' A' ' 98' ' ' TRP . 32.7 mt -80.04 154.48 75.09 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' O ' ' O ' ' A' ' 26' ' ' LEU . 86.0 Cg_exo -44.23 -120.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.966 3.111 . . . . 1.0 114.138 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.18 -55.11 11.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.65 -2.352 . . . . 1.0 104.65 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 30' ' ' VAL . 7.6 tp10 -133.95 -72.59 0.49 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 96.4 t 52.28 163.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.989 0.9 . . . . 1.0 110.953 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.504 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 3.2 ttt85 -161.44 163.16 30.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.92 -1.491 . . . . 1.0 107.006 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.1 mm? -94.45 155.07 17.13 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.544 -1.262 . . . . 1.0 110.098 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.72 111.67 2.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' O ' ' OG ' ' A' ' 35' ' ' SER . 13.0 Cg_endo -88.31 154.18 6.71 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.691 2.927 . . . . 1.0 111.926 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 34' ' ' PRO . 1.8 p 50.84 40.3 24.42 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.98 -46.4 6.53 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.282 -2.235 . . . . 1.0 106.899 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -96.3 -4.06 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 114.16 -1.382 . . . . 1.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t70 98.24 -11.32 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.982 0.802 . . . . 1.0 111.54 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' HZ2' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.24 -35.84 66.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.874 -0.73 . . . . 1.0 109.326 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 92.11 -11.22 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.526 0.936 . . . . 1.0 113.526 177.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.626 ' CB ' ' HZ2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -77.22 162.45 27.37 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.455 ' CG2' ' HB3' ' A' ' 32' ' ' LEU . 4.2 mm -74.48 124.73 32.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 120.485 1.493 . . . . 1.0 112.097 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.77 174.19 16.86 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.698 -1.761 . . . . 1.0 108.698 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.83 125.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.94 0.4 . . . . 1.0 109.94 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.661 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 30.2 m95 -126.92 149.43 49.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.618 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.55 133.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.959 -1.019 . . . . 1.0 108.859 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.8 p -115.93 -15.73 11.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.241 -1.392 . . . . 1.0 107.241 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -116.2 171.69 4.47 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 112.847 -1.979 . . . . 1.0 109.59 -178.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.46 153.71 13.84 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 123.264 2.643 . . . . 1.0 111.982 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 4.1 mp -132.11 150.84 34.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.728 -1.124 . . . . 1.0 111.354 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -120.55 165.09 15.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 1.0 111.71 178.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.9 129.62 40.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.093 177.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.708 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.33 -0.71 60.13 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 119.854 -1.165 . . . . 1.0 113.375 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.633 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.7 tptt -57.09 157.96 5.51 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.732 -1.187 . . . . 1.0 110.284 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.633 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.7 ttmt -123.76 109.3 13.5 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.46 -1.245 . . . . 1.0 108.403 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 11.6 m-30 -119.58 125.12 48.04 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.02 -153.49 24.83 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.08 -1.418 . . . . 1.0 110.573 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -82.66 150.83 71.6 Favored 'Cis proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.35 1.575 . . . . 1.0 113.604 0.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' VAL . 17.6 t80 -62.94 118.92 8.46 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.759 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.556 HG21 ' H ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -27.03 -65.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.345 -1.752 . . . . 1.0 111.495 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 60' ' ' VAL . . . 53.89 104.55 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.827 -0.701 . . . . 1.0 113.482 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.01 149.8 20.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 176.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.541 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -93.53 116.36 28.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -146.87 167.22 24.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.016 -178.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.706 ' H ' ' NZ ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -65.94 153.05 43.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.652 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 6.2 ttm-85 -66.09 -45.33 81.6 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.499 -0.751 . . . . 1.0 111.932 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 121.008 0.432 . . . . 1.0 110.151 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.7 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.599 0 CA-C-O 121.788 0.804 . . . . 1.0 111.732 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.603 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -160.59 162.3 32.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.244 -1.344 . . . . 1.0 112.618 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 77' ' ' GLU . 1.3 pm0 -100.93 121.88 42.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.959 0.885 . . . . 1.0 111.355 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.583 ' CG1' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.24 135.85 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 114.747 -1.115 . . . . 1.0 108.986 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.512 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.9 t80 -87.0 124.37 33.12 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.511 -0.875 . . . . 1.0 111.329 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.555 ' C ' ' H ' ' A' ' 82' ' ' ASN . 5.0 m-85 -92.19 135.53 26.89 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 114.195 -1.366 . . . . 1.0 110.466 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.34 7.69 1.74 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.771 1.647 . . . . 1.0 108.869 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 80' ' ' TYR . 70.5 m-80 -110.27 -90.72 0.47 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.256 -1.338 . . . . 1.0 111.48 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.677 ' H ' ' CD2' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -79.64 -7.08 58.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.36 -157.32 15.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 120.393 -0.908 . . . . 1.0 112.717 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.525 ' O ' ' SD ' ' A' ' 86' ' ' MET . 25.4 m95 -66.08 121.16 14.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.609 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.525 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 38.1 mmm -124.85 150.8 46.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.377 0.88 . . . . 1.0 113.377 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.652 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -106.97 131.36 54.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' MET . 17.0 mt -106.16 105.34 18.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.572 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 23.5 t0 -130.83 127.57 38.88 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.287 0.949 . . . . 1.0 112.085 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -132.82 96.45 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.192 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.573 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 29.3 p -129.55 75.42 1.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.726 0.694 . . . . 1.0 110.617 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.686 ' N ' ' HE ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -162.85 160.82 19.36 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.338 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -67.26 -38.93 14.14 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.15 1.9 . . . . 1.0 112.418 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -77.87 -44.46 27.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -11.42 16.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 1.0 112.076 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . -110.77 111.46 3.02 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.487 -0.863 . . . . 1.0 112.04 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.578 ' C ' HD21 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -61.95 -157.92 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.919 0.39 . . . . 1.0 110.466 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.542 ' CG ' HD23 ' A' ' 26' ' ' LEU . 43.0 p-90 -72.75 -35.49 67.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.318 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.457 ' HB2' HD22 ' A' ' 97' ' ' ASN . 0.4 OUTLIER -54.8 -26.5 35.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.365 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.686 ' HE ' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -72.29 -20.5 61.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.917 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.87 -10.68 57.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.758 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.49 141.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.561 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.627 ' ND2' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -101.22 -155.18 0.5 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.088 -0.645 . . . . 1.0 112.234 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.432 ' C ' ' HB3' ' A' ' 137' ' ' LEU . 2.6 m-90 -112.79 144.12 42.87 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.466 -0.788 . . . . 1.0 111.813 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 106' ' ' CYS . . . -79.06 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER 159.23 -16.05 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.768 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -136.54 -81.56 0.39 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.197 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 163.69 -52.0 0.3 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -24.62 65.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.677 ' O ' ' O ' ' A' ' 111' ' ' GLN . 2.5 pt-20 -92.13 -22.98 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.995 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.715 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -51.24 -134.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.715 ' H ' ' CG ' ' A' ' 111' ' ' GLN . 0.8 OUTLIER 158.51 -33.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.572 -0.705 . . . . 1.0 109.488 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 4.2 mm? -129.55 148.26 51.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.807 -0.757 . . . . 1.0 112.055 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -134.06 130.63 20.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 115.105 -0.952 . . . . 1.0 112.498 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 76' ' ' TRP . 78.6 Cg_exo -51.23 130.22 31.53 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 123.894 3.063 . . . . 1.0 115.899 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.478 HD21 ' HZ2' ' A' ' 125' ' ' LYS . 56.2 tp -142.17 137.24 30.7 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 176.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 4.7 mm-40 -108.06 114.95 29.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.403 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.9 pt -139.09 127.82 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.536 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.59 47.5 23.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 1.0 110.909 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.583 ' HE ' ' CG1' ' A' ' 78' ' ' VAL . 1.9 mmp_? 54.43 30.56 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.82 148.98 47.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.026 -1.101 . . . . 1.0 108.026 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.498 ' CD1' ' CD ' ' A' ' 117' ' ' GLU . 1.6 mm -110.42 114.24 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.745 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.443 ' HB3' ' NZ ' ' A' ' 125' ' ' LYS . 4.6 m-85 -102.22 157.53 16.83 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.175 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -116.66 130.73 56.91 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 105.522 -2.029 . . . . 1.0 105.522 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.545 ' HZ3' ' CG ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -125.95 153.96 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.967 -177.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.708 ' O ' ' N ' ' A' ' 53' ' ' GLY . 27.7 p -100.76 118.51 37.01 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.231 -0.588 . . . . 1.0 112.471 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.646 ' N ' ' HZ3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -82.77 -21.38 34.66 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 124.224 0.953 . . . . 1.0 109.559 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.804 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -139.8 137.97 19.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.724 0.268 . . . . 1.0 111.724 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.88 144.2 45.58 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.628 1.552 . . . . 1.0 110.732 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.402 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -122.13 137.06 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -75.08 134.18 74.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.15 -0.477 . . . . 1.0 112.112 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.06 108.99 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 CA-C-N 119.808 0.967 . . . . 1.0 110.534 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 122.03 7.65 7.73 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 2.3 mm-40 -105.53 117.61 34.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.137 0.494 . . . . 1.0 111.187 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.661 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -46.06 146.71 1.21 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.772 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.604 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 7.2 mp -91.08 132.67 35.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.096 -0.956 . . . . 1.0 108.488 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.711 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -136.62 161.81 34.86 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.751 0.786 . . . . 1.0 112.071 -178.28 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.475 ' CA ' ' OE1' ' A' ' 111' ' ' GLN . 3.1 m -146.13 170.87 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.778 -1.101 . . . . 1.0 111.337 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.655 ' CD1' ' NE2' ' A' ' 111' ' ' GLN . 44.5 p-90 . . . . . 0 C--N 1.307 -1.239 0 CA-C-N 113.585 -1.643 . . . . 1.0 108.41 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 N--CA 1.428 -1.546 0 CA-C-O 120.678 0.275 . . . . 1.0 110.662 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 -48.83 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.71 74.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 1.0 111.968 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.01 0 C-N-CA 119.48 -0.888 . . . . 1.0 111.451 179.403 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 89.9 m 122.36 103.62 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 125.204 1.565 . . . . 1.0 107.623 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.464 ' CB ' ' OE2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER 66.25 161.07 0.14 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.106 -1.406 . . . . 1.0 108.824 -177.476 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.547 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -121.29 156.17 33.1 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 120.458 0.171 . . . . 1.0 111.074 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -43.9 -30.21 0.66 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.219 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.41 59.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.61 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -73.14 -44.65 59.84 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.787 1.032 . . . . 1.0 113.787 -176.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.496 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -56.2 149.77 34.83 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.973 -1.862 . . . . 1.0 105.973 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -47.37 143.23 11.52 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 120.884 1.056 . . . . 1.0 110.874 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 14.8 tt0 -60.81 -49.9 75.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.511 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.484 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 8.2 p80 -61.76 -26.07 67.85 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 98' ' ' TRP . 22.6 t -79.78 -49.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 118.656 0.662 . . . . 1.0 111.656 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -67.89 -25.5 65.54 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.795 0.807 . . . . 1.0 109.449 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 8.6 mmm180 -59.74 -19.23 48.89 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.181 -1.372 . . . . 1.0 112.019 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.84 35.88 4.38 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.149 -0.548 . . . . 1.0 111.979 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.4 mt -82.03 123.12 80.08 Favored Pre-proline 0 CA--C 1.514 -0.419 0 CA-C-O 119.477 -0.297 . . . . 1.0 111.11 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 14.2 Cg_exo -55.41 156.72 16.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 119.748 0.946 . . . . 1.0 110.236 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.18 -13.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 115.172 1.545 . . . . 1.0 115.172 -174.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.641 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 6.2 pm0 -114.19 15.73 18.14 Favored 'General case' 0 CA--C 1.463 -2.386 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.16 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.513 ' CG2' ' OE2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -126.82 125.78 67.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 114.605 1.335 . . . . 1.0 114.605 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -141.6 153.44 44.79 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 113.36 -1.745 . . . . 1.0 107.17 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.82 143.69 26.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 118.84 -1.144 . . . . 1.0 109.958 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.47 110.06 3.64 Favored Pre-proline 0 N--CA 1.444 -0.732 0 N-CA-C 113.253 0.834 . . . . 1.0 113.253 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . 15.5 Cg_endo -84.87 152.58 11.31 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.883 2.389 . . . . 1.0 111.24 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.9 p 86.46 -38.49 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -49.3 -57.88 6.05 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.516 -1.22 . . . . 1.0 107.847 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 3.9 m -57.27 -50.05 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.869 -0.732 . . . . 1.0 110.232 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 1.7 m-20 156.9 70.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.448 0.468 . . . . 1.0 110.591 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER 35.67 29.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.387 0.613 . . . . 1.0 109.811 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 m -90.88 -33.56 15.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.086 -0.961 . . . . 1.0 112.62 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 42' ' ' ILE . 4.7 ptm180 162.61 -163.98 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.525 ' O ' ' NE ' ' A' ' 41' ' ' ARG . 2.7 mm -84.37 135.56 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 118.156 0.434 . . . . 1.0 110.386 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.73 155.14 18.92 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.545 -1.022 . . . . 1.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.41 131.53 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.51 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 12.0 m95 -132.26 155.21 48.72 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 -176.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.06 120.41 14.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.553 ' H ' ' C ' ' A' ' 29' ' ' GLU . 1.4 p -102.83 -20.81 14.16 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' CD ' ' C ' ' A' ' 48' ' ' LYS 0.252 0.0 OUTLIER -129.29 170.71 10.19 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.827 178.056 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -80.42 125.35 5.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.123 1.882 . . . . 1.0 114.097 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 51' ' ' LEU . 3.7 mp -99.66 150.78 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.809 -1.541 . . . . 1.0 110.659 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.537 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.17 164.03 13.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.674 177.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.507 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -66.61 124.18 22.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.813 -0.554 . . . . 1.0 110.385 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 99.75 1.28 56.34 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 119.924 -1.132 . . . . 1.0 113.087 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 2.2 tptt -52.32 159.47 0.97 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 117.625 -1.63 . . . . 1.0 108.356 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.704 ' HG2' ' HZ1' ' A' ' 125' ' ' LYS . 8.8 ttmt -121.48 103.16 8.73 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.315 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.587 ' CE2' ' OE2' ' A' ' 29' ' ' GLU . 13.4 m-85 -116.36 126.44 53.49 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 106.473 -1.677 . . . . 1.0 106.473 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.17 -164.75 35.63 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 109.876 -1.289 . . . . 1.0 109.876 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -89.68 138.44 13.22 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 CA-C-N 119.094 1.447 . . . . 1.0 112.884 -0.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' O ' ' C ' ' A' ' 60' ' ' VAL . 10.2 t80 -59.13 114.82 2.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.675 0.75 . . . . 1.0 110.509 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -21.51 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.209 -1.814 . . . . 1.0 111.393 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 45.76 105.49 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.586 -0.734 . . . . 1.0 113.349 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ASP . 13.7 t70 -93.52 147.28 23.12 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -92.8 115.08 27.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.122 0.963 . . . . 1.0 113.149 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -139.85 170.3 16.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.619 -1.628 . . . . 1.0 110.708 -177.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.608 ' H ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.48 145.91 31.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 121.126 -0.23 . . . . 1.0 111.384 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -50.85 -23.9 3.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.782 -0.574 . . . . 1.0 111.986 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 66' ' ' ARG . 29.0 t . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.234 0.54 . . . . 1.0 110.136 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.56 ' C ' ' CG ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.513 0 CA-C-O 121.125 0.488 . . . . 1.0 111.75 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.56 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -157.13 162.81 39.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.031 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.27 122.98 44.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.08 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' CG1' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -134.56 136.59 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.139 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 t80 -85.41 124.56 32.15 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.512 0.672 . . . . 1.0 112.182 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.567 ' C ' ' H ' ' A' ' 82' ' ' ASN . 27.3 m-85 -100.69 125.37 39.07 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.637 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.71 8.57 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 108.305 -1.46 . . . . 1.0 108.305 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 80' ' ' TYR . 74.5 m-20 -109.44 -10.14 14.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.0 -1.455 . . . . 1.0 111.27 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -168.65 1.85 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.709 1.374 . . . . 1.0 114.709 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.59 -160.78 14.27 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 120.608 -0.806 . . . . 1.0 112.912 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.553 ' O ' ' SD ' ' A' ' 86' ' ' MET . 27.5 m95 -76.5 121.06 22.59 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.553 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.8 mmm -127.54 163.63 23.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.131 1.53 . . . . 1.0 115.131 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.03 134.07 53.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.157 -1.383 . . . . 1.0 108.175 177.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' MET . 9.2 mt -106.61 111.5 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 118.481 -0.771 . . . . 1.0 109.816 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -134.42 130.94 37.56 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.04 104.8 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 91' ' ' THR . 0.6 OUTLIER -136.79 49.3 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.994 -0.682 . . . . 1.0 109.202 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.62 162.39 36.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.094 -0.957 . . . . 1.0 109.955 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HA ' HH21 ' A' ' 100' ' ' ARG . 3.0 Cg_exo -69.62 -38.73 7.7 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.307 2.005 . . . . 1.0 112.688 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -78.16 -42.38 31.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 -11.26 20.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.661 0.267 . . . . 1.0 111.529 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.35 -166.76 26.63 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.545 ' N ' HD21 ' A' ' 97' ' ' ASN . 0.0 OUTLIER -145.36 -153.8 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.239 0.542 . . . . 1.0 111.072 178.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.416 ' N ' HG12 ' A' ' 22' ' ' VAL . 14.4 p-90 -72.34 -29.61 63.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.949 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -30.85 71.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.457 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.581 ' NH2' ' OH ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 119.926 -0.71 . . . . 1.0 109.937 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.581 ' OH ' ' NH2' ' A' ' 100' ' ' ARG . 7.8 m-85 -92.96 0.44 57.4 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.69 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.99 126.11 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.142 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -72.7 -157.48 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.605 0.595 . . . . 1.0 112.605 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 137' ' ' LEU . 4.1 m-90 -112.41 158.72 19.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.468 -0.787 . . . . 1.0 111.046 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.653 ' O ' ' N ' ' A' ' 107' ' ' SER . . . -100.56 -14.62 18.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 116.086 1.884 . . . . 1.0 116.086 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 107' ' ' SER . 49.7 t 32.62 23.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.406 0.548 . . . . 1.0 112.422 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.3 OUTLIER 159.4 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.641 0.258 . . . . 1.0 110.663 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.645 ' O ' ' NE2' ' A' ' 111' ' ' GLN . . . -85.25 2.21 88.26 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.197 -0.525 . . . . 1.0 111.907 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -86.59 -22.85 26.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.003 0.371 . . . . 1.0 112.003 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 111' ' ' GLN . 8.4 pt-20 -115.93 -27.55 6.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.401 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.787 ' N ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER -44.13 110.13 0.19 Allowed 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.762 ' OD1' ' N ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -88.28 -5.31 58.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -140.55 172.1 13.2 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 124.014 0.821 . . . . 1.0 112.723 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.593 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -148.71 132.07 8.28 Favored Pre-proline 0 N--CA 1.433 -1.287 0 C-N-CA 119.488 -0.885 . . . . 1.0 111.029 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 139' ' ' TRP . 80.6 Cg_exo -55.55 116.39 3.12 Favored 'Trans proline' 0 N--CA 1.509 2.406 0 C-N-CA 123.4 2.733 . . . . 1.0 113.99 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.6 tp -120.39 121.74 39.23 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.048 0.452 . . . . 1.0 111.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -102.84 114.26 28.38 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.505 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.3 pt -139.61 134.41 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.437 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.64 38.69 30.39 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.039 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.456 ' HE ' ' CG1' ' A' ' 78' ' ' VAL . 1.2 mmp_? 58.33 32.34 21.96 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.179 0.514 . . . . 1.0 110.452 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.37 155.22 50.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.434 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 122' ' ' ILE . 15.0 mm -96.22 125.85 48.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.989 0.423 . . . . 1.0 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.411 ' HB3' ' CE ' ' A' ' 125' ' ' LYS . 0.5 OUTLIER -124.05 150.64 44.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.277 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.764 ' O ' ' NZ ' ' A' ' 125' ' ' LYS . 1.8 m-30 -118.64 118.76 32.53 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.761 0.315 . . . . 1.0 110.486 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.764 ' NZ ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -115.33 155.29 27.59 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.319 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.64 ' O ' ' N ' ' A' ' 53' ' ' GLY . 10.7 p -106.69 109.86 21.89 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.843 1.339 . . . . 1.0 110.487 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.452 ' N ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -76.18 -8.38 56.9 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.33 1.019 . . . . 1.0 112.091 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.775 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -151.02 135.73 9.94 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 119.923 -0.711 . . . . 1.0 110.929 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.19 129.02 31.42 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.497 1.465 . . . . 1.0 111.65 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.5 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.054 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.439 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -84.18 132.92 46.32 Favored Pre-proline 0 C--O 1.219 -0.541 0 C-N-CA 120.162 -0.615 . . . . 1.0 109.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -45.42 104.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.907 1.738 . . . . 1.0 114.032 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 139.57 0.5 2.05 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 120.254 -0.974 . . . . 1.0 113.382 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.485 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -102.71 138.74 39.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.306 0.574 . . . . 1.0 110.145 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.51 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -61.29 130.97 48.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.763 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 11.0 mp -75.6 129.54 37.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.721 -0.791 . . . . 1.0 109.134 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.762 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -141.97 159.4 42.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.44 172.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.399 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.588 ' HE1' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.624 0 CA-C-O 121.961 0.886 . . . . 1.0 111.036 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mm . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.41 70.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.79 -38.25 90.34 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.438 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.792 0 C-N-CA 120.184 -0.607 . . . . 1.0 110.631 178.769 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.644 0 CA-C-O 121.699 0.761 . . . . 1.0 110.379 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER 171.67 -53.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.979 -1.464 . . . . 1.0 109.198 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -126.44 162.1 26.38 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.707 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -119.61 161.46 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.614 0.721 . . . . 1.0 111.416 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.16 -39.49 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.614 -178.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.21 -9.4 58.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.391 0.615 . . . . 1.0 110.696 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.707 ' CB ' ' H ' ' A' ' 14' ' ' THR . 17.3 tp10 -89.32 -45.24 9.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -48.26 149.88 2.47 Favored Pre-proline 0 C--N 1.342 0.242 0 N-CA-C 105.168 -2.16 . . . . 1.0 105.168 177.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' CB ' ' CE1' ' A' ' 21' ' ' HIS . 14.5 Cg_exo -46.77 137.41 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 CA-C-N 120.371 1.168 . . . . 1.0 111.531 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 3.2 tt0 -59.27 -52.01 67.51 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.021 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.417 ' CE1' ' CB ' ' A' ' 19' ' ' PRO . 6.7 p80 -57.13 -28.89 63.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.991 0.737 . . . . 1.0 112.991 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 98' ' ' TRP . 23.7 t -79.28 -49.65 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.368 0.531 . . . . 1.0 110.379 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.01 -26.92 62.41 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.364 0.602 . . . . 1.0 111.253 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 10.6 mmm180 -57.87 -25.51 60.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.124 -0.944 . . . . 1.0 112.372 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.25 48.27 0.95 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.604 HD23 ' CG ' ' A' ' 98' ' ' TRP . 11.7 mt -96.83 131.24 28.33 Favored Pre-proline 0 CA--C 1.511 -0.529 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.557 ' C ' ' H ' ' A' ' 29' ' ' GLU . 2.9 Cg_exo -61.86 143.61 95.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 N-CA-C 109.912 -0.842 . . . . 1.0 109.912 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -52.43 -10.04 0.13 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.947 -177.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.85 ' N ' ' HZ1' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -84.33 12.14 7.22 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 178.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.509 ' CG2' ' OE1' ' A' ' 29' ' ' GLU . 10.8 t -140.1 131.78 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.492 0 N-CA-C 118.227 2.677 . . . . 1.0 118.227 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -134.99 141.37 46.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 110.95 -2.841 . . . . 1.0 103.567 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -91.28 153.1 20.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 117.759 -1.576 . . . . 1.0 109.856 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.416 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 1.3 m-85 -154.53 110.41 2.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 12.5 Cg_endo -87.89 151.25 7.21 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.104 2.536 . . . . 1.0 112.105 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 35' ' ' SER . 2.3 p 55.46 44.11 27.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.19 -43.9 8.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.11 -1.404 . . . . 1.0 107.218 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.578 ' CG2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -104.19 -0.65 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 113.938 -1.483 . . . . 1.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 7.0 t70 96.7 3.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.154 0.909 . . . . 1.0 110.693 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.42 -37.27 44.25 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.512 ' N ' ' CD ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER 84.12 -9.96 0.93 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.741 0.651 . . . . 1.0 112.714 177.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.637 ' H ' ' HG2' ' A' ' 39' ' ' LYS . 18.9 ttm180 -77.59 157.03 30.48 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 176.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mm -77.66 127.1 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 120.599 1.545 . . . . 1.0 109.482 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.36 -176.35 19.38 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.53 130.04 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.652 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 52.5 m95 -130.57 151.16 51.34 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -66.05 132.0 47.52 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.684 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -26.07 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.85 ' HZ1' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.58 156.25 41.71 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 177.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' CD ' ' HG2' ' A' ' 48' ' ' LYS . 8.1 Cg_exo -73.97 128.35 12.24 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 CA-C-N 121.975 1.741 . . . . 1.0 112.885 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.01 146.47 8.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.77 -1.559 . . . . 1.0 112.821 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.525 HD11 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.76 151.96 32.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.019 -1.901 . . . . 1.0 110.23 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.511 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.25 125.8 25.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.018 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.29 -0.87 53.98 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.451 -1.059 . . . . 1.0 110.451 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.9 tptt -54.42 152.29 6.72 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.817 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 2.9 ttmt -122.51 108.56 13.3 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.857 0.723 . . . . 1.0 109.738 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' ' CD ' ' A' ' 29' ' ' GLU . 18.9 m-85 -116.93 123.11 46.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.865 -1.531 . . . . 1.0 106.865 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.82 -157.15 27.57 Favored Glycine 0 C--N 1.31 -0.911 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -86.21 150.37 44.9 Favored 'Cis proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.356 1.578 . . . . 1.0 113.201 0.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CE2' ' CA ' ' A' ' 61' ' ' GLY . 7.2 t80 -64.04 120.35 11.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.404 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -27.05 -65.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.829 -1.532 . . . . 1.0 111.432 178.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' CA ' ' CE2' ' A' ' 59' ' ' PHE . . . 48.78 107.64 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.572 -0.74 . . . . 1.0 113.162 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -94.4 149.46 21.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 176.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -90.52 114.1 26.22 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.177 -1.009 . . . . 1.0 112.165 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.661 ' HZ3' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -148.28 171.08 16.54 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.628 -1.169 . . . . 1.0 110.672 -176.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 135.1 37.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.102 0.477 . . . . 1.0 111.48 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 9.7 ptt85 -57.95 -24.15 56.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.275 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.756 -0.377 . . . . 1.0 111.188 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 121.543 0.687 . . . . 1.0 111.657 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.564 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -159.73 163.4 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.91 -1.041 . . . . 1.0 111.962 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 3.6 pt-20 -98.02 122.49 41.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.894 0.854 . . . . 1.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -126.78 131.01 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 115.219 -0.9 . . . . 1.0 109.194 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -89.79 121.69 32.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.848 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 82' ' ' ASN . 13.7 m-85 -86.48 108.05 16.21 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 114.607 -1.179 . . . . 1.0 110.047 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.29 48.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.206 1.937 . . . . 1.0 109.955 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.652 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -151.85 -84.0 0.08 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.237 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.652 ' N ' ' CG ' ' A' ' 82' ' ' ASN . 4.1 pp -78.05 -42.33 32.66 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.442 ' N ' ' CD1' ' A' ' 83' ' ' LEU . . . 151.22 -170.8 30.88 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.563 -1.303 . . . . 1.0 112.356 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.573 ' O ' ' SD ' ' A' ' 86' ' ' MET . 11.8 m95 -70.43 122.5 19.74 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 117.155 0.478 . . . . 1.0 110.322 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.573 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 42.1 mmm -126.91 160.2 31.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -113.35 134.2 54.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.563 -1.199 . . . . 1.0 108.144 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' MET . 7.0 mt -107.64 108.52 25.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 118.668 -0.682 . . . . 1.0 111.943 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.661 ' N ' ' HZ3' ' A' ' 64' ' ' LYS . 28.9 t0 -133.78 131.93 39.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.619 1.1 . . . . 1.0 113.521 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -136.22 91.47 2.68 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.549 ' HG1' HH12 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -114.91 49.63 1.03 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.862 0.839 . . . . 1.0 110.122 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.438 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -144.15 152.26 54.01 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.987 177.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.36 -44.33 4.88 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.282 1.321 . . . . 1.0 112.72 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.48 -45.09 69.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.732 -1.122 . . . . 1.0 113.562 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -11.3 33.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.832 0.349 . . . . 1.0 110.65 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.68 -158.42 15.97 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -145.01 -153.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 1.0 110.007 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.604 ' CG ' HD23 ' A' ' 26' ' ' LEU . 45.6 p-90 -74.59 -34.89 62.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.855 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.401 ' HB2' HD22 ' A' ' 97' ' ' ASN . 0.5 OUTLIER -54.9 -29.22 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.056 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.549 HH12 ' HG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -66.27 -15.08 62.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.9 OUTLIER -94.86 0.58 54.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.831 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 t -70.46 132.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 119.936 -0.706 . . . . 1.0 110.174 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -79.26 -153.84 0.08 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.209 -0.596 . . . . 1.0 111.878 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.27 159.35 33.34 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.714 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.492 ' HB1' HE21 ' A' ' 111' ' ' GLN . . . -139.27 174.73 10.21 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.427 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -47.87 2.87 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.784 ' O ' ' N ' ' A' ' 109' ' ' GLU . 20.3 m -148.9 132.0 16.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.68 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' C ' ' OE1' ' A' ' 111' ' ' GLN . . . -19.52 -4.29 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 118.456 2.142 . . . . 1.0 118.456 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.784 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.5 mt-10 -82.03 -24.43 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 119.236 1.518 . . . . 1.0 113.693 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 111' ' ' GLN . 13.4 pt-20 -124.18 -17.14 6.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.767 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 6.5 mp0 -45.7 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.954 1.408 . . . . 1.0 109.886 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.577 HD22 ' CD1' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 163.21 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.961 -1.018 . . . . 1.0 111.852 177.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mp -137.92 164.19 29.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.205 -0.998 . . . . 1.0 112.177 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -143.7 130.32 10.34 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 119.013 -1.075 . . . . 1.0 113.566 -178.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.42 131.04 31.1 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.676 2.917 . . . . 1.0 113.625 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.469 HD21 ' HZ1' ' A' ' 125' ' ' LYS . 34.2 tp -141.34 130.66 23.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.127 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.461 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 6.2 mm-40 -102.83 114.85 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.436 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.2 pt -139.16 123.76 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.851 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.2 42.41 25.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.354 0.597 . . . . 1.0 110.668 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.594 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 5.2 mmt-85 56.74 32.46 21.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.49 144.04 49.18 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.461 ' CD1' ' CD ' ' A' ' 117' ' ' GLU . 4.1 mm -103.07 116.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.567 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 125' ' ' LYS . 3.5 m-85 -109.04 158.25 17.91 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -116.85 132.14 56.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -127.64 146.33 50.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.488 -177.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 53' ' ' GLY . 13.1 p -100.72 111.45 23.68 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.935 0.772 . . . . 1.0 111.483 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.517 ' N ' ' HZ1' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.96 -5.58 59.2 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 123.926 0.766 . . . . 1.0 111.88 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.866 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.74 122.62 7.23 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.458 0.572 . . . . 1.0 109.986 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -44.17 138.59 6.76 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.521 1.481 . . . . 1.0 111.21 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.13 134.61 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.96 132.59 60.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.02 -0.672 . . . . 1.0 109.931 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.07 104.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.21 1.273 . . . . 1.0 111.906 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 131.87 2.91 4.19 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.035 -0.602 . . . . 1.0 112.834 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -105.56 115.54 30.42 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.218 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.652 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -47.18 139.73 5.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.889 0.852 . . . . 1.0 111.359 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.509 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 8.6 mp -78.34 128.79 34.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.708 -1.133 . . . . 1.0 109.072 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.577 ' CD1' HD22 ' A' ' 112' ' ' ASN . 0.0 OUTLIER -142.58 161.34 38.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.569 0.699 . . . . 1.0 110.706 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.31 177.38 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.885 . . . . 1.0 111.968 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.674 ' HE1' ' CG ' ' A' ' 111' ' ' GLN . 9.2 p-90 . . . . . 0 CA--C 1.509 -0.622 0 C-N-CA 119.806 -0.758 . . . . 1.0 113.034 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 N--CA 1.429 -1.49 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.83 -52.15 33.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.7 77.42 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.817 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.204 -1.329 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.674 178.261 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.482 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' -1' ' ' GLY . 1.2 p 75.39 -46.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.791 0.329 . . . . 1.0 110.553 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -101.19 82.21 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.596 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.08 -6.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -52.8 179.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.558 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -104.71 151.06 24.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -74.08 128.74 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.616 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -57.33 140.13 50.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.95 152.9 80.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.358 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.24 155.39 70.09 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.511 2.141 . . . . 1.0 112.133 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.43 158.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.642 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.73 106.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.783 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . -129.86 -76.54 0.54 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.112 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.2 m 151.52 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.465 -1.243 . . . . 1.0 107.845 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.38 157.44 17.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.234 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 150.54 43.95 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 121.644 0.735 . . . . 1.0 112.587 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.568 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.12 -35.47 25.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.08 -0.963 . . . . 1.0 110.204 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.29 -9.79 58.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.931 -1.031 . . . . 1.0 111.382 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -31.76 22.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.62 0.97 . . . . 1.0 113.62 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.15 142.91 65.48 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 35.3 Cg_exo -48.44 122.78 8.23 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.431 1.421 . . . . 1.0 110.677 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 37.7 tt0 -48.35 -25.42 1.58 Allowed 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 113.303 0.853 . . . . 1.0 113.303 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.737 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.2 OUTLIER -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.164 0.802 . . . . 1.0 113.164 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 98' ' ' TRP . 6.8 t -76.97 -49.7 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.727 ' H ' ' CD2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -71.23 -19.58 62.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.711 0.767 . . . . 1.0 109.934 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.83 -27.37 68.83 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 -176.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.33 42.58 1.91 Allowed Glycine 0 N--CA 1.47 0.942 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' PRO . 18.5 mt -76.77 155.47 83.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' O ' ' O ' ' A' ' 26' ' ' LEU . 23.9 Cg_exo -36.25 -112.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 124.537 3.491 . . . . 1.0 113.516 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.92 -57.61 3.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.755 -1.578 . . . . 1.0 107.6 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 12.0 pt-20 -172.89 37.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 2.4 t -45.69 171.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 113.412 -1.722 . . . . 1.0 107.785 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.534 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -141.67 154.1 45.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' A' ' 32' ' ' LEU . 3.9 mm? -91.83 134.67 34.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 118.894 -1.122 . . . . 1.0 109.874 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.7 m-85 -133.95 144.56 52.15 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 42' ' ' ILE . 3.1 Cg_exo -48.32 142.46 16.85 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 CA-C-N 119.715 0.934 . . . . 1.0 114.031 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -61.69 52.43 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-O 123.087 1.423 . . . . 1.0 110.892 -178.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 34' ' ' PRO . . . -56.84 -5.36 0.23 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.017 -1.901 . . . . 1.0 108.272 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.648 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -82.55 -50.37 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 113.689 -1.596 . . . . 1.0 111.83 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.605 ' C ' ' H ' ' A' ' 40' ' ' THR . 44.8 t0 -156.04 -66.72 0.11 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.536 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 41' ' ' ARG . 8.1 mmpp? -58.72 3.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.22 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.605 ' H ' ' C ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER 35.73 14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 35' ' ' SER . 49.2 mtp85 -107.3 -116.46 0.26 Allowed 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 105.356 -2.09 . . . . 1.0 105.356 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.752 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 9.5 mm -102.19 134.03 44.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 120.09 1.314 . . . . 1.0 111.318 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.23 159.79 23.19 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 p -102.84 131.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.234 0.54 . . . . 1.0 111.627 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 13.5 m95 -130.33 154.46 47.62 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.711 1.004 . . . . 1.0 113.711 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.83 131.39 45.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.456 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 31' ' ' ARG . 76.3 p -124.96 -15.19 6.47 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.769 1.271 . . . . 1.0 108.57 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.611 ' CD ' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.65 168.89 9.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.843 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.07 152.38 27.86 Favored 'Trans proline' 0 C--N 1.293 -2.356 0 C-N-CA 122.425 2.083 . . . . 1.0 112.415 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.85 144.28 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.871 -1.059 . . . . 1.0 111.229 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' CD2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -116.4 154.37 30.4 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.925 -1.488 . . . . 1.0 110.828 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.97 125.76 25.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.8 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.28 0.76 55.78 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -53.25 152.54 4.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 119.382 -0.927 . . . . 1.0 109.218 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.64 107.61 12.59 Favored 'General case' 0 N--CA 1.424 -1.757 0 O-C-N 124.714 1.259 . . . . 1.0 109.198 176.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 10.9 m-30 -119.78 124.46 46.22 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.302 1.048 . . . . 1.0 109.323 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.69 -148.84 20.74 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.223 -1.808 . . . . 1.0 109.753 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 9.5 Cg_endo -80.41 152.57 83.53 Favored 'Cis proline' 0 N--CA 1.49 1.304 0 CA-C-N 119.821 1.811 . . . . 1.0 112.681 0.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 9.2 t80 -65.12 115.89 5.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.513 -1.221 . . . . 1.0 111.733 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.589 HG21 ' H ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -21.68 -63.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.565 178.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.589 ' H ' HG21 ' A' ' 60' ' ' VAL . . . 51.29 104.82 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.354 -0.839 . . . . 1.0 112.945 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -94.18 144.11 25.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.529 -1.656 . . . . 1.0 106.529 177.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -92.02 114.6 27.18 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.949 -1.1 . . . . 1.0 113.025 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.594 ' HZ1' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -142.99 169.94 16.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.139 -1.391 . . . . 1.0 109.056 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.415 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.91 152.98 27.81 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.123 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 4.1 ttm180 -56.31 -24.49 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.756 -0.59 . . . . 1.0 110.706 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 t -38.08 -27.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.218 0.532 . . . . 1.0 110.055 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' ARG . 11.2 mt-30 -91.29 -150.35 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.276 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.1 t 58.72 153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-O 121.1 0.476 . . . . 1.0 111.431 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -179.16 89.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.089 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 66.56 64.11 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.024 0.44 . . . . 1.0 109.912 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 23.5 t-20 -137.17 -171.7 3.02 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.36 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.674 ' C ' ' H ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -134.3 -48.5 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 118.835 0.743 . . . . 1.0 110.915 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -62.09 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.751 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.71 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -140.31 140.66 35.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.98 0.419 . . . . 1.0 111.731 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.582 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -161.18 163.58 31.08 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.454 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -100.62 125.32 47.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.148 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.12 139.06 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.85 -0.613 . . . . 1.0 112.152 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 11.5 t80 -79.46 126.13 30.45 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.573 0.701 . . . . 1.0 111.601 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 82' ' ' ASN . 7.0 m-85 -99.3 131.36 25.25 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.523 -1.217 . . . . 1.0 112.032 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.19 13.86 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.01 1.807 . . . . 1.0 109.367 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 80' ' ' TYR . 46.2 m-80 -124.35 -9.78 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.681 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.69 -1.16 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.57 -158.89 15.64 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 120.481 -0.866 . . . . 1.0 113.074 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.534 ' O ' ' SD ' ' A' ' 86' ' ' MET . 67.4 m95 -71.34 120.44 16.93 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.0 mmm -125.96 164.68 20.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.328 0.862 . . . . 1.0 113.328 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -111.5 132.81 54.23 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' MET . 5.5 mt -107.42 109.76 29.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 118.734 -0.651 . . . . 1.0 111.43 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.594 ' CB ' ' HZ1' ' A' ' 64' ' ' LYS . 21.4 t0 -133.14 130.97 39.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.269 0.94 . . . . 1.0 112.818 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -136.09 97.58 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.441 ' HG1' HH11 ' A' ' 100' ' ' ARG . 0.1 OUTLIER -130.78 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.734 -0.786 . . . . 1.0 110.756 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.423 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -153.84 159.05 32.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.096 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.49 -38.91 13.49 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.567 1.511 . . . . 1.0 111.234 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -77.08 -42.58 37.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.561 -1.199 . . . . 1.0 113.896 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -9.91 16.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.123 -0.231 . . . . 1.0 110.915 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.423 ' CA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.48 123.63 6.11 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.575 ' H ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -71.88 -151.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.163 0.506 . . . . 1.0 110.774 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.453 ' N ' HG11 ' A' ' 22' ' ' VAL . 44.0 p-90 -76.06 -31.16 58.65 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.644 -0.707 . . . . 1.0 111.655 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.408 ' HB2' HD22 ' A' ' 97' ' ' ASN . 0.3 OUTLIER -57.0 -27.85 61.91 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.602 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -67.18 -15.44 63.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.573 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -93.92 2.91 56.04 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.3 t -78.27 128.61 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.213 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 136' ' ' LEU . 15.9 p-10 -87.42 -143.75 0.12 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.909 -0.716 . . . . 1.0 111.495 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.424 ' CZ2' ' CG2' ' A' ' 73' ' ' VAL . 6.6 m-90 -127.05 160.3 31.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.498 0.555 . . . . 1.0 112.498 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.78 -134.62 0.31 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.639 1.348 . . . . 1.0 114.639 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 t -154.21 -51.81 0.09 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.706 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 109' ' ' GLU . 38.9 m -165.26 65.4 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.231 0.826 . . . . 1.0 113.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.09 -12.62 0.01 OUTLIER Glycine 0 CA--C 1.534 1.224 0 N-CA-C 114.324 0.49 . . . . 1.0 114.324 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.618 ' H ' ' C ' ' A' ' 107' ' ' SER . 12.6 pt-20 -81.19 -26.59 35.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.494 0.647 . . . . 1.0 111.592 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 137' ' ' LEU . 6.0 pt-20 -122.21 -24.39 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.783 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.866 HE21 ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -53.81 132.34 41.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 177.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.67 ' OD1' ' N ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -112.68 -21.02 11.45 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.317 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.524 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 4.2 mm? -125.61 143.49 51.0 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.859 -0.737 . . . . 1.0 110.661 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CE2' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -128.7 131.32 23.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 119.463 -0.895 . . . . 1.0 112.191 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.11 128.34 22.11 Favored 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 124.058 3.172 . . . . 1.0 115.017 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.5 tp -140.43 132.74 28.29 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.817 -0.552 . . . . 1.0 110.103 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.446 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 6.8 mm-40 -105.58 115.58 30.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.907 -0.717 . . . . 1.0 110.029 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 pt -139.9 129.61 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.066 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 49.4 46.52 23.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.255 0.55 . . . . 1.0 110.489 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 56.11 32.92 21.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.208 -0.597 . . . . 1.0 109.904 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.06 141.73 42.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.321 -0.854 . . . . 1.0 109.006 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.446 ' CD1' ' CD ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -102.53 113.0 37.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.079 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.572 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 3.1 m-85 -101.04 155.62 17.88 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.774 ' CA ' ' HZ2' ' A' ' 125' ' ' LYS . 1.4 m-30 -119.02 125.24 48.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.623 -2.362 . . . . 1.0 104.623 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.774 ' HZ2' ' CA ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -125.81 155.58 40.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.091 -175.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.67 ' O ' ' N ' ' A' ' 53' ' ' GLY . 15.1 p -105.71 117.1 33.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.477 ' CD1' HE22 ' A' ' 111' ' ' GLN . 0.3 OUTLIER -81.35 -9.43 59.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.844 0.715 . . . . 1.0 109.952 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.597 ' HZ3' ' CA ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -150.42 141.48 14.8 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 120.452 -0.499 . . . . 1.0 111.947 -178.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -55.75 140.38 84.56 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.133 1.889 . . . . 1.0 111.733 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.52 136.33 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.8 37.88 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.3 105.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.35 2.034 . . . . 1.0 113.048 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 133.53 0.18 4.11 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 109.977 -1.249 . . . . 1.0 109.977 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.14 137.81 35.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.63 -0.785 . . . . 1.0 109.21 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.2 pm0 -73.02 138.77 46.17 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.903 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.463 ' O ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 mp -79.35 127.01 31.55 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.262 -1.384 . . . . 1.0 107.262 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.67 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -141.04 159.07 43.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.603 -176.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.03 172.5 7.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 113.611 0.967 . . . . 1.0 113.611 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.689 ' CZ2' ' CE1' ' A' ' 140' ' ' TYR . 36.3 p-90 171.87 -164.7 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.924 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.805 ' CD1' ' ND2' ' A' ' 145' ' ' ASN . 52.8 m-85 108.08 48.23 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 O-C-N 125.419 1.7 . . . . 1.0 108.395 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.559 ' OD1' ' C ' ' A' ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.559 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 3.0 mt-10 -33.74 -89.32 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -108.93 56.55 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.052 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.805 ' ND2' ' CD1' ' A' ' 140' ' ' TYR . 3.9 p30 -68.97 167.27 21.12 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.435 ' O ' ' CB ' ' A' ' 150' ' ' ALA . 9.6 Cg_endo -82.02 -11.79 10.99 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.79 1.66 . . . . 1.0 112.244 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.603 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -70.15 -31.49 69.01 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.614 -1.995 . . . . 1.0 105.614 175.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.629 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.4 mm -78.47 -54.23 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.117 -1.401 . . . . 1.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.34 -48.97 59.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 146' ' ' PRO . . . -58.42 -48.13 81.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.473 ' O ' ' CD ' ' A' ' 155' ' ' GLU . . . -73.01 -26.87 61.48 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.272 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 148' ' ' ILE . 35.3 mt -65.0 -44.39 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.526 ' CG ' HH21 ' A' ' 156' ' ' ARG . 1.7 tt0 -53.48 -53.99 43.46 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.913 -0.715 . . . . 1.0 111.442 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 1.5 pm0 -57.11 -37.16 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.414 -0.914 . . . . 1.0 112.788 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' O ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -74.16 -56.62 4.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.554 -0.859 . . . . 1.0 110.835 179.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.526 HH21 ' CG ' ' A' ' 153' ' ' GLU . 3.2 ppt_? -67.82 -43.67 79.05 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.361 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -58.26 -41.58 84.58 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.863 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 160' ' ' ARG . 51.1 m -74.29 -24.13 59.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 1.0 111.03 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.81 8.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.612 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 158' ' ' SER . 8.4 mmm180 -124.65 -82.96 0.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.495 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.022 -0.989 . . . . 1.0 110.527 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 t -146.57 -63.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 1.0 110.573 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -178.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.603 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.43 91.1 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.569 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -152.04 -165.04 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.567 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.68 69.7 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.56 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 114.04 4.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.637 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 m -73.44 -67.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.57 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 41.02 79.22 0.33 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.44 -172.59 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.208 2.605 . . . . 1.0 112.314 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' ALA . 1.3 m -61.11 -174.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.345 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 48.33 96.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.115 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.8 -62.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -120.4 -41.8 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.096 0.474 . . . . 1.0 110.057 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.29 161.49 23.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 1.0 108.811 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -122.16 155.11 36.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 1.0 111.851 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.56 -34.7 18.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.52 -15.88 59.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.604 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 14' ' ' THR . 20.8 tp10 -79.16 -41.39 28.58 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.78 154.15 59.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 119.43 -0.908 . . . . 1.0 108.904 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.585 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 24.6 Cg_exo -56.14 130.39 39.95 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 120.982 1.121 . . . . 1.0 109.56 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.418 ' O ' ' CD ' ' A' ' 24' ' ' ARG . 24.5 tt0 -50.86 -35.46 32.73 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -75.63 -22.68 56.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.36 -51.81 18.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 CA-C-N 119.966 1.257 . . . . 1.0 112.087 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.721 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 1.6 pt? -70.9 -24.82 62.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.293 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.439 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -61.49 -19.56 62.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.509 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.63 33.64 6.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.875 -0.679 . . . . 1.0 112.338 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 27' ' ' PRO . 36.3 mt -77.41 154.29 81.76 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 117.68 0.74 . . . . 1.0 110.609 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' A' ' 26' ' ' LEU . 10.7 Cg_exo -34.0 -109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.383 2.722 . . . . 1.0 114.003 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.687 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -74.55 -58.82 3.05 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.624 177.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.687 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 5.1 pt-20 -170.24 47.36 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.455 ' CG1' ' O ' ' A' ' 45' ' ' TRP . 54.2 t -57.95 162.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 114.787 -1.097 . . . . 1.0 108.268 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -134.1 158.25 44.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.247 0.546 . . . . 1.0 110.616 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.44 144.64 26.24 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.4 101.75 3.77 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.083 -0.647 . . . . 1.0 112.436 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 35' ' ' SER . 63.1 Cg_endo -82.69 150.01 14.45 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.23 2.62 . . . . 1.0 111.613 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 24.2 p 102.72 -60.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.168 0.918 . . . . 1.0 111.882 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -50.77 -54.63 21.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.629 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -101.09 -51.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 118.739 0.699 . . . . 1.0 111.434 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -89.39 82.0 6.53 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.292 0.568 . . . . 1.0 109.591 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -32.38 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.457 -1.247 . . . . 1.0 109.423 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.2 t -143.28 55.38 1.36 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.76 179.1 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.503 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -99.45 128.68 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.221 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.36 152.5 17.02 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.224 -1.551 . . . . 1.0 109.224 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 p -105.71 127.24 60.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.456 ' CZ3' ' CD ' ' A' ' 135' ' ' GLU . 21.7 m95 -126.59 146.55 50.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.281 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.666 ' O ' ' HA2' ' A' ' 133' ' ' GLY . . . -65.57 146.64 54.59 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.51 ' CA ' ' O ' ' A' ' 132' ' ' PRO . 34.6 p -117.76 -15.56 10.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.66 0.663 . . . . 1.0 109.662 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -119.33 158.42 48.76 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.321 -178.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 7.8 Cg_endo -62.08 124.52 14.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.377 2.052 . . . . 1.0 110.216 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 130' ' ' ILE . 3.4 mp -99.5 147.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.744 0.783 . . . . 1.0 110.282 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.61 148.03 34.19 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.829 -1.532 . . . . 1.0 109.471 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.552 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 4.1 ttpt -59.51 126.49 27.83 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.18 4.53 47.42 Favored Glycine 0 N--CA 1.467 0.747 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.668 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 126' ' ' THR . 19.7 ttmt -89.48 139.58 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -106.53 145.7 31.53 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 175.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -120.5 124.83 46.35 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.545 -1.207 . . . . 1.0 109.735 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.29 -133.83 4.16 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 113.23 -1.805 . . . . 1.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 123' ' ' TYR . 78.6 Cg_endo -74.64 148.25 91.35 Favored 'Cis proline' 0 N--CA 1.502 1.991 0 CA-C-N 120.027 1.914 . . . . 1.0 113.308 0.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' O ' ' C ' ' A' ' 60' ' ' VAL . 68.5 t80 -56.26 116.75 3.23 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.934 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.524 ' C ' ' O ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -16.38 -67.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 124.024 0.827 . . . . 1.0 112.622 178.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' N ' ' CD2' ' A' ' 59' ' ' PHE . . . 97.83 62.01 0.9 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.271 -1.132 . . . . 1.0 110.271 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' ASP . 19.7 t0 -88.45 133.55 34.09 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 106.181 -1.785 . . . . 1.0 106.181 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.54 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -104.25 113.19 26.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -176.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' CYS . 1.7 ptpt -133.03 166.91 21.3 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.316 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.531 ' NZ ' ' OE1' ' A' ' 68' ' ' GLN . 0.2 OUTLIER -76.9 139.36 40.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 176.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.93 -23.63 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.736 0.303 . . . . 1.0 111.204 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -78.48 135.93 37.48 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.109 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.531 ' OE1' ' NZ ' ' A' ' 65' ' ' LYS . 2.6 pt20 103.2 -8.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.369 1.043 . . . . 1.0 111.943 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.79 117.56 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.031 0.444 . . . . 1.0 110.46 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -110.22 -131.22 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.14 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.68 -135.54 1.47 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.002 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.454 ' O ' ' CE ' ' A' ' 75' ' ' MET . 7.8 m120 -128.04 -78.14 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.84 0.681 . . . . 1.0 112.84 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.09 2.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.441 -0.504 . . . . 1.0 112.237 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 90' ' ' ALA . 2.5 m-85 -48.66 -53.48 18.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.135 0.791 . . . . 1.0 113.135 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.507 ' HE2' ' H ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -122.77 162.57 21.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 -174.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -138.99 144.6 38.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.35 -1.75 . . . . 1.0 109.786 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.75 123.03 47.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.076 -0.65 . . . . 1.0 111.717 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -143.18 133.8 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.79 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 2.3 t80 -89.8 126.38 35.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 82' ' ' ASN . 6.8 m-85 -92.31 105.7 15.15 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 113.516 -1.675 . . . . 1.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.77 -14.24 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.009 1.806 . . . . 1.0 109.604 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.554 ' H ' ' C ' ' A' ' 80' ' ' TYR . 71.2 m-80 -81.72 -99.12 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.138 -1.392 . . . . 1.0 110.361 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 84' ' ' GLY . 0.4 OUTLIER -66.43 -41.93 88.47 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.374 1.25 . . . . 1.0 114.374 -176.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' H ' ' HG ' ' A' ' 83' ' ' LEU . . . 144.68 -176.1 23.99 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 120.03 -1.081 . . . . 1.0 110.485 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.404 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 14.5 m95 -54.27 120.62 6.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.779 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 78' ' ' VAL . 51.4 tpp -129.37 160.92 31.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.399 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -117.85 145.42 44.6 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.934 0.873 . . . . 1.0 109.656 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 52.1 mt -93.09 159.1 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.892 -1.504 . . . . 1.0 108.492 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.688 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -128.99 123.99 33.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.425 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 74' ' ' TYR . . . -133.54 136.36 44.95 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 105.251 -2.129 . . . . 1.0 105.251 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 166.52 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 120.573 1.533 . . . . 1.0 111.112 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.579 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -126.23 148.89 65.25 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.454 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 62.8 Cg_endo -66.11 -34.68 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.757 2.305 . . . . 1.0 111.849 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -71.91 -10.23 59.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.223 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.757 ' CB ' HH12 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.88 -16.01 35.14 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.695 ' N ' ' NH1' ' A' ' 100' ' ' ARG . . . -173.81 -92.49 0.08 OUTLIER Glycine 0 C--N 1.348 1.201 0 C-N-CA 120.136 -1.031 . . . . 1.0 114.05 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.575 ' H ' ' HD3' ' A' ' 100' ' ' ARG . 5.2 p30 -146.58 -149.34 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.48 0.657 . . . . 1.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.547 ' CD1' ' OD1' ' A' ' 97' ' ' ASN . 35.2 p-90 -80.39 -24.5 39.68 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 115.163 1.542 . . . . 1.0 115.163 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.461 ' CD2' ' CD2' ' A' ' 124' ' ' TYR . 3.0 mp -53.5 -27.59 26.23 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.592 -0.843 . . . . 1.0 111.181 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.757 HH12 ' CB ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.65 -30.33 52.07 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 177.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.503 ' CE1' ' CG2' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -64.58 -17.57 64.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.16 117.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.041 -0.982 . . . . 1.0 110.786 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.579 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 14.5 m-20 -77.5 138.69 39.36 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 105.883 -1.895 . . . . 1.0 105.883 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.533 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 16.2 p90 -94.68 122.56 37.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.825 0.822 . . . . 1.0 111.955 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 26.96 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.04 -1.436 . . . . 1.0 114.77 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 105' ' ' ALA . 52.5 t -29.54 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER 174.01 11.29 0.0 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-N 114.721 -1.127 . . . . 1.0 111.03 174.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.58 19.69 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.83 -42.18 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.035 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -118.32 -33.11 4.46 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.038 1.125 . . . . 1.0 114.038 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 110' ' ' GLU . 4.9 mt-30 16.18 101.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.472 0.545 . . . . 1.0 112.472 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.585 ' CA ' ' HZ2' ' A' ' 128' ' ' LYS . 18.0 p-10 -128.12 37.5 4.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.812 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 1.4 tp -153.32 173.63 15.36 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.152 -0.619 . . . . 1.0 110.698 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 115' ' ' PRO . 9.3 t80 -132.23 147.67 66.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 119.553 -0.26 . . . . 1.0 111.638 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.495 ' N ' ' CD1' ' A' ' 114' ' ' PHE . 23.2 Cg_endo -100.04 96.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.502 2.134 . . . . 1.0 113.483 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 123' ' ' TYR . 8.1 tp -117.41 135.93 53.54 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -109.24 117.19 33.45 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.977 0.798 . . . . 1.0 111.128 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -137.43 136.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.087 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 49.73 38.41 15.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.432 0.634 . . . . 1.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 63.4 13.3 6.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.019 179.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -110.0 154.89 22.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.082 -1.417 . . . . 1.0 107.86 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 31.5 mm -109.8 115.2 49.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 121.802 0.81 . . . . 1.0 111.888 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.46 ' CG ' ' CD1' ' A' ' 118' ' ' ILE . 3.6 m-85 -100.44 141.08 33.79 Favored 'General case' 0 CA--C 1.481 -1.694 0 O-C-N 121.234 -0.916 . . . . 1.0 109.27 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 18.3 m-30 -102.73 117.25 34.23 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.29 -2.115 . . . . 1.0 105.29 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -104.37 135.44 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.687 1.242 . . . . 1.0 110.636 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 53' ' ' GLY . 33.0 p -106.4 112.98 26.23 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.131 0.491 . . . . 1.0 110.696 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.621 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -76.64 -6.11 50.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.546 -1.206 . . . . 1.0 111.996 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' HZ2' ' CA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -143.2 158.29 58.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.097 -0.641 . . . . 1.0 112.598 -175.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -72.25 145.3 43.38 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 N-CA-C 104.722 -2.838 . . . . 1.0 104.722 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 50' ' ' ILE . 59.7 mt -123.5 142.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -174.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.56 128.49 88.37 Favored Pre-proline 0 C--N 1.34 0.193 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.798 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.5 Cg_exo -35.1 -27.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.655 2.236 . . . . 1.0 116.684 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.666 ' HA2' ' O ' ' A' ' 46' ' ' ALA . . . -125.6 37.04 2.61 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 120.308 1.413 . . . . 1.0 110.511 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 135' ' ' GLU . 4.6 tt0 -95.23 162.38 13.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.907 0.385 . . . . 1.0 111.371 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.492 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 1.6 pm0 -80.85 140.3 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.358 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.529 ' HA ' HD22 ' A' ' 112' ' ' ASN . 4.9 mt -95.17 121.77 37.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.603 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -128.01 153.13 47.11 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.607 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 15.7 t -124.12 159.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.257 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.684 ' CG ' ' N ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER 59.37 -176.22 0.09 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.16 1.911 . . . . 1.0 116.16 175.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.684 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 71.3 t80 -153.1 -174.9 5.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.016 -1.447 . . . . 1.0 109.904 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.681 ' N ' ' CG ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.329 0 N-CA-C 111.647 -0.581 . . . . 1.0 111.647 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.491 ' N ' ' HB3' ' A' ' 140' ' ' TYR . 2.1 pt-20 -171.39 -98.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.179 -0.609 . . . . 1.0 112.226 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.461 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 2.2 t70 72.52 -36.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.574 ' ND2' ' CD1' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -73.59 147.81 87.31 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 119.721 -0.792 . . . . 1.0 110.098 -179.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.517 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 0.3 OUTLIER -34.05 -89.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.229 2.62 . . . . 1.0 116.527 -178.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 151' ' ' ALA . 9.8 tp10 -55.52 -48.21 75.03 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -46.31 -53.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.471 -1.24 . . . . 1.0 110.855 -175.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -65.06 -46.84 79.56 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 116.457 -2.097 . . . . 1.0 108.244 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.15 25.8 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 115.46 1.652 . . . . 1.0 115.46 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -73.1 -37.37 66.74 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.603 1.547 . . . . 1.0 111.596 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.527 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 84.3 mt -55.46 -44.01 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 157' ' ' ALA . 1.2 tt0 -59.87 -55.47 33.71 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 123.51 0.506 . . . . 1.0 111.917 -177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.01 -38.67 91.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 118.067 0.394 . . . . 1.0 111.629 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -73.1 -48.62 34.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.401 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -76.54 -28.73 56.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.309 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -52.5 -50.6 62.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.532 -0.867 . . . . 1.0 108.911 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.39 -23.82 4.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.9 19.21 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.653 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -120.31 60.03 0.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.17 -5.15 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 1.0 110.559 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' H ' ' C ' ' A' ' -1' ' ' GLY . 0.3 OUTLIER -75.35 149.56 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.54 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -93.89 117.95 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.58 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 4' ' ' ASN . 9.9 tt0 -87.3 -23.99 24.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.562 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER 58.64 115.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.572 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 p -129.92 -168.87 2.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.495 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -94.59 125.22 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.536 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -121.24 157.44 55.77 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.44 141.16 38.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.533 2.155 . . . . 1.0 112.179 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 10' ' ' ALA . 23.0 m -91.51 47.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . -43.17 167.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.757 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.64 -66.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.162 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.37 -55.82 2.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -104.69 153.94 20.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 17' ' ' GLU . 4.3 m -121.74 156.36 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 1.0 111.676 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.19 -32.8 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.61 58.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.777 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' THR . 27.6 tp10 -82.2 -40.41 21.75 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 m -59.63 159.39 18.23 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.465 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.9 Cg_exo -66.8 133.12 30.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.128 1.219 . . . . 1.0 109.961 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 24' ' ' ARG . 18.6 tt0 -49.46 -38.01 28.13 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 123.749 0.656 . . . . 1.0 112.125 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 22' ' ' VAL . 4.4 p-80 -74.19 -23.25 59.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 1.5 t -75.89 -50.37 23.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 CA-C-N 119.805 1.184 . . . . 1.0 111.629 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.674 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 1.9 pt? -73.0 -26.02 61.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.648 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.95 -21.04 42.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.57 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.28 39.88 2.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.846 -0.692 . . . . 1.0 111.597 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.581 ' O ' ' O ' ' A' ' 27' ' ' PRO . 25.8 mt -85.17 153.52 59.65 Favored Pre-proline 0 N--CA 1.445 -0.702 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.229 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -34.6 -117.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 124.085 3.19 . . . . 1.0 114.166 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.628 ' CD ' ' N ' ' A' ' 29' ' ' GLU . 2.2 pp20? -72.98 -54.91 7.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 116.691 -2.004 . . . . 1.0 106.543 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 5.5 tt0 -174.64 57.75 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.275 1.036 . . . . 1.0 108.441 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.7 t -67.85 173.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.913 -1.04 . . . . 1.0 108.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.531 HH12 ' CG ' ' A' ' 29' ' ' GLU . 17.3 mtt85 -141.03 158.62 43.67 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.249 0.547 . . . . 1.0 110.013 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.53 147.43 25.35 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.92 101.74 3.65 Favored Pre-proline 0 C--N 1.314 -0.953 0 C-N-CA 119.672 -0.811 . . . . 1.0 112.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 44.5 Cg_endo -83.69 149.71 12.75 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 123.272 2.648 . . . . 1.0 111.95 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 4.2 t 99.75 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.183 0.927 . . . . 1.0 111.927 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.33 -53.65 27.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.921 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.07 -52.89 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.281 -0.567 . . . . 1.0 112.189 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -90.62 82.5 5.8 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 38' ' ' ASP . 7.7 mmpt? -28.28 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.343 -1.299 . . . . 1.0 110.07 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.597 ' N ' ' O ' ' A' ' 38' ' ' ASP . 16.4 p -143.22 54.09 1.36 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.2 168.21 8.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -92.27 131.24 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.824 -179.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.91 144.92 17.12 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.868 -1.693 . . . . 1.0 108.868 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -97.48 134.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.651 ' O ' HG13 ' A' ' 30' ' ' VAL . 10.6 m95 -129.04 147.65 50.92 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.146 -0.934 . . . . 1.0 110.83 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.634 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . -73.32 123.71 24.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.13 -1.028 . . . . 1.0 110.344 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.0 p -93.41 -15.42 25.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.687 0.756 . . . . 1.0 110.947 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.6 ' HZ1' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -107.49 170.72 5.3 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.247 -1.342 . . . . 1.0 111.133 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -81.68 131.88 7.46 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.232 1.955 . . . . 1.0 108.145 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.62 129.31 64.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 122.429 1.109 . . . . 1.0 111.908 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.537 ' C ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.83 147.96 22.83 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.515 -2.13 . . . . 1.0 107.755 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.537 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -59.65 123.72 17.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.38 2.48 47.57 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.626 -1.273 . . . . 1.0 113.253 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' THR . 9.7 ttmt -78.7 139.06 38.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 119.455 -0.898 . . . . 1.0 109.729 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -111.52 140.61 45.98 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 119.359 -0.936 . . . . 1.0 109.563 178.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 124' ' ' TYR . 37.2 m-85 -116.09 123.33 47.64 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.174 -1.83 . . . . 1.0 106.753 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.53 -164.33 30.36 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 113.778 -1.556 . . . . 1.0 110.201 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CB ' ' CE1' ' A' ' 123' ' ' TYR . 56.4 Cg_endo -98.22 137.66 3.4 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 CA-C-N 118.699 1.249 . . . . 1.0 111.638 -1.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 39.2 t80 -56.8 114.11 1.94 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 61' ' ' GLY . 9.7 p -44.69 -48.39 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.928 0.394 . . . . 1.0 111.109 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' N ' ' CG1' ' A' ' 60' ' ' VAL . . . 67.12 114.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 115.374 0.91 . . . . 1.0 115.374 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -99.75 134.43 42.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 175.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.54 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -92.2 112.11 23.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.162 1.171 . . . . 1.0 114.162 -176.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -145.07 166.31 25.74 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.983 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' O ' ' OE1' ' A' ' 68' ' ' GLN . 2.7 mtmp? -76.86 133.82 39.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.606 0.717 . . . . 1.0 112.266 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.725 ' O ' ' N ' ' A' ' 68' ' ' GLN . 10.2 ttt180 -57.47 -21.37 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.846 -0.615 . . . . 1.0 112.643 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 t -52.89 55.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.725 ' N ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER 161.62 -126.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.502 ' C ' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER 16.84 77.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.224 0.61 . . . . 1.0 111.969 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' VAL . 8.0 mttt 26.66 -137.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.446 -0.797 . . . . 1.0 112.599 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -162.69 28.03 0.1 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 0.1 OUTLIER -123.11 -76.64 0.59 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.855 178.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 104' ' ' TRP . 1.1 t -118.25 -30.95 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 90' ' ' ALA . 40.4 m-85 -39.92 -31.81 0.13 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.554 0.692 . . . . 1.0 111.312 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.507 ' C ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -147.77 166.23 28.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.886 -176.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.752 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -141.43 134.67 29.43 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.038 -1.437 . . . . 1.0 110.108 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 86' ' ' MET . 8.7 tp10 -97.75 122.64 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.597 . . . . 1.0 111.099 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' MET . 2.8 t -142.44 132.25 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.942 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -87.22 123.92 32.75 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.417 -0.913 . . . . 1.0 111.833 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.679 ' C ' ' H ' ' A' ' 82' ' ' ASN . 3.0 m-85 -76.3 113.72 31.13 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.12 29.62 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.172 1.914 . . . . 1.0 110.566 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.679 ' H ' ' C ' ' A' ' 80' ' ' TYR . 62.0 m-80 -135.1 -90.7 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.294 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.0 -41.77 73.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.85 -174.99 26.48 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 119.743 -1.218 . . . . 1.0 110.614 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 11.9 m95 -55.11 121.14 8.12 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.823 -0.81 . . . . 1.0 112.177 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.506 ' O ' ' O ' ' A' ' 78' ' ' VAL . 33.7 tpp -128.63 160.72 31.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.289 0.477 . . . . 1.0 112.289 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -125.08 147.53 48.95 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.729 0.776 . . . . 1.0 109.199 175.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.488 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 6.3 mt -99.61 155.93 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 114.513 -1.221 . . . . 1.0 107.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.63 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.48 136.65 54.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.243 0.928 . . . . 1.0 113.155 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 74' ' ' TYR . . . -134.95 136.22 42.09 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.753 ' H ' ' CG ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 169.88 -37.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.674 1.125 . . . . 1.0 111.401 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.861 ' H ' ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -120.76 146.31 43.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.787 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 59.0 Cg_endo -68.53 -36.79 14.23 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 123.246 2.631 . . . . 1.0 112.6 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -56.94 -10.68 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -89.54 -11.12 43.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' O ' ' OD1' ' A' ' 97' ' ' ASN . . . 96.56 160.84 32.25 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.819 HD22 ' N ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER 65.59 128.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 101' ' ' TYR . 47.0 p-90 -73.83 -21.31 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.133 -1.394 . . . . 1.0 109.63 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.781 ' N ' HD21 ' A' ' 97' ' ' ASN . 1.2 mp -50.12 -26.98 5.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.861 ' HE ' ' H ' ' A' ' 92' ' ' ASP . 6.5 ttt180 -74.68 -36.9 62.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.481 -1.69 . . . . 1.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.4 OUTLIER -68.05 -16.13 63.9 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.462 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.49 124.31 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.882 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.42 -174.69 5.41 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.55 -0.86 . . . . 1.0 109.06 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.481 ' CZ2' ' CE1' ' A' ' 74' ' ' TYR . 1.2 m-90 -94.79 154.62 17.19 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.39 0.614 . . . . 1.0 112.03 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.667 ' HB2' ' H ' ' A' ' 108' ' ' GLY . . . -31.34 -72.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.039 175.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 51.7 t 120.18 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.248 -2.13 . . . . 1.0 105.248 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 109' ' ' GLU . 2.6 t 178.32 29.16 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.33 -1.305 . . . . 1.0 111.934 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.667 ' H ' ' HB2' ' A' ' 105' ' ' ALA . . . 67.11 -10.81 0.77 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.132 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 107' ' ' SER . 10.3 mm-40 -74.32 -23.26 59.03 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.636 ' O ' ' O ' ' A' ' 111' ' ' GLN . 6.6 pt-20 -119.12 -0.32 11.1 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.636 ' O ' ' O ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -43.64 -150.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.64 ' ND2' ' O ' ' A' ' 135' ' ' GLU . 12.5 p30 144.03 27.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.271 -1.331 . . . . 1.0 112.293 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.631 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 7.3 mp -149.13 174.63 12.13 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.945 -0.472 . . . . 1.0 109.813 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CD2' ' OE2' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -141.44 122.48 8.81 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.105 -0.638 . . . . 1.0 112.252 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.03 80.47 0.15 Allowed 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 121.456 1.438 . . . . 1.0 114.546 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.7 tp -90.23 133.66 34.78 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.245 -0.284 . . . . 1.0 110.731 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -108.68 120.39 42.34 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.799 0.687 . . . . 1.0 111.898 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -136.5 135.04 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.166 -0.924 . . . . 1.0 111.634 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' ILE . 2.6 m-80 35.24 57.28 0.82 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.642 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 8.2 mtp180 57.88 21.13 7.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.3 0.572 . . . . 1.0 111.664 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -125.0 149.81 47.35 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 41.4 mm -118.93 100.84 10.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.068 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.524 ' CE1' ' CB ' ' A' ' 58' ' ' PRO . 8.3 m-30 -97.33 158.9 15.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 121.762 0.791 . . . . 1.0 110.849 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 56' ' ' PHE . 13.7 m-30 -106.28 129.11 54.37 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.933 -1.485 . . . . 1.0 108.668 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -117.53 136.62 53.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 113.407 -1.724 . . . . 1.0 109.026 -177.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 53' ' ' GLY . 29.8 p -104.18 106.37 16.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.362 -0.935 . . . . 1.0 110.629 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.603 ' N ' ' HE2' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -73.57 -7.98 54.1 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 112.829 -1.987 . . . . 1.0 111.449 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.606 ' NZ ' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -133.63 148.74 69.82 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.803 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -74.15 140.97 28.72 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 105.983 -2.353 . . . . 1.0 105.983 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.76 138.55 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 118.852 0.751 . . . . 1.0 112.255 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.573 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -75.35 134.54 73.41 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.31 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . 46.2 Cg_exo -54.41 116.43 3.07 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 122.155 1.904 . . . . 1.0 113.02 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . 121.61 4.21 9.84 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.949 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -83.02 147.97 27.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.498 -1.351 . . . . 1.0 114.5 -178.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.64 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 2.0 pm0 -75.5 108.09 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.823 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 137' ' ' LEU . 21.7 mt -71.73 114.87 10.28 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.496 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 2.2 mp -135.11 160.8 37.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.451 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 26.3 t -118.29 152.52 20.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 O-C-N 123.69 0.618 . . . . 1.0 111.984 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.534 ' O ' ' CD1' ' A' ' 139' ' ' TRP . 0.0 OUTLIER 69.52 137.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.959 1.412 . . . . 1.0 113.059 176.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.562 ' CE1' ' O ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER -87.02 171.49 10.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.775 -1.102 . . . . 1.0 112.16 -178.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.49 ' C ' ' O ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.248 -1.541 . . . . 1.0 109.248 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 149' ' ' ALA . 64.7 mt-10 61.71 37.11 16.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.235 -0.982 . . . . 1.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.65 -2.53 54.27 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.407 0.521 . . . . 1.0 112.407 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.532 ' C ' ' ND2' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -68.03 151.71 96.99 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.513 -1.291 . . . . 1.0 107.513 179.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.531 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 8.1 Cg_exo -41.32 -85.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.851 1.701 . . . . 1.0 116.442 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.538 ' OE2' ' CD2' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -57.03 -45.82 82.83 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.685 0.755 . . . . 1.0 109.049 -177.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.5 OUTLIER -47.49 -50.43 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.688 -175.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.513 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -68.45 -49.12 62.22 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.253 -1.379 . . . . 1.0 107.824 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.3 -57.29 13.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.028 -1.896 . . . . 1.0 114.34 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -68.17 -36.29 79.38 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 120.189 1.359 . . . . 1.0 110.827 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 156' ' ' ARG . 32.2 mt -52.78 -41.92 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.159 -1.423 . . . . 1.0 107.159 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 1.2 mt-10 -61.82 -52.5 63.92 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.077 -0.965 . . . . 1.0 109.955 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -58.67 -50.4 74.0 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 120.848 0.356 . . . . 1.0 110.684 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.7 OUTLIER -70.97 -50.66 31.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.033 -179.143 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -78.72 -53.25 7.34 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.086 -1.046 . . . . 1.0 110.563 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 159' ' ' ALA . . . -70.38 -50.27 40.54 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.936 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 154' ' ' GLU . 0.1 OUTLIER 31.84 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.841 0.713 . . . . 1.0 111.409 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.604 ' N ' ' O ' ' A' ' 157' ' ' ALA . . . -100.65 -120.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.595 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.545 ' N ' ' CD ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER 31.29 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.231 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.502 ' HG ' ' C ' ' A' ' 160' ' ' ARG . 1.8 m . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.536 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.57 -1.412 . . . . 1.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.3 t -162.49 -167.12 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 1.0 110.568 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mtm -99.8 54.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.563 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -140.41 112.86 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.579 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.15 -41.84 10.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.533 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t30 54.37 -161.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -160.81 48.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.497 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.4 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 19.8 m -148.93 -64.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 6' ' ' THR . 2.6 mp0 47.75 86.27 0.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.798 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.85 178.41 3.22 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.955 2.436 . . . . 1.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ALA . 33.1 m -53.63 171.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 50.6 104.7 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.436 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.582 ' H ' ' CG ' ' A' ' 34' ' ' PRO . . . -68.35 -43.91 76.43 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.678 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 1.3 m -177.57 -25.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.6 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -72.37 0.36 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 119.195 -1.002 . . . . 1.0 113.271 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.498 ' OG1' ' CG ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -142.01 -179.69 6.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.253 -1.794 . . . . 1.0 110.102 174.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 2.4 tt -73.66 -62.79 1.37 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 172.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.463 ' O ' ' CD1' ' A' ' 42' ' ' ILE . . . -89.64 -58.45 2.52 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.768 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 1.1 tm-20 89.57 -155.08 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.098 -2.186 . . . . 1.0 105.098 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.768 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER 51.34 152.39 0.04 OUTLIER Pre-proline 0 C--N 1.268 -2.947 0 O-C-N 125.766 1.916 . . . . 1.0 111.021 -178.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.54 140.16 12.35 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.895 2.396 . . . . 1.0 111.477 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 26.1 tt0 -50.5 -53.05 32.93 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.156 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -60.83 -22.55 64.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 2.2 t -79.28 -49.13 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.329 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 1.0 111.769 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -63.42 -16.89 61.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.68 28.17 15.55 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.012 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 27' ' ' PRO . 39.8 mt -76.96 156.03 82.53 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 112.364 0.505 . . . . 1.0 112.364 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -32.93 -123.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 125.087 3.858 . . . . 1.0 114.033 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' CD ' ' N ' ' A' ' 29' ' ' GLU . 2.2 pp20? -72.76 -51.43 19.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.425 -1.694 . . . . 1.0 106.425 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 tt0 -175.69 60.72 0.02 OUTLIER 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.638 0.733 . . . . 1.0 109.507 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 3.4 t -74.15 176.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 8.5 mtt180 -141.91 162.33 35.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.437 0.637 . . . . 1.0 110.881 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -96.81 121.84 39.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -119.76 109.53 37.82 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.87 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.582 ' CG ' ' H ' ' A' ' 11' ' ' ALA . 11.7 Cg_endo -84.5 150.32 11.66 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.529 2.819 . . . . 1.0 114.714 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 9.3 p 95.03 -50.87 0.01 OUTLIER 'General case' 0 C--N 1.344 0.333 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.721 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.538 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -48.08 -54.74 12.15 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.631 -0.713 . . . . 1.0 112.704 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 ' H ' ' A' ' 39' ' ' LYS . 2.5 p -90.74 -40.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.76 1.164 . . . . 1.0 110.824 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 67.43 9.94 7.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 178.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.502 ' CE ' ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -43.79 -27.84 0.37 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 177.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.477 ' N ' ' C ' ' A' ' 38' ' ' ASP . 8.7 m -170.27 -58.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.584 -1.189 . . . . 1.0 111.451 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.37 -96.74 0.09 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.502 ' O ' ' CE ' ' A' ' 39' ' ' LYS . 2.9 tt -98.34 140.9 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 113.795 1.035 . . . . 1.0 113.795 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -120.17 165.23 13.66 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.37 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -103.31 123.74 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.212 0.529 . . . . 1.0 110.313 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.538 ' CZ2' ' CB ' ' A' ' 36' ' ' ALA . 20.9 m95 -127.9 149.04 50.48 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.116 -0.947 . . . . 1.0 112.231 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.757 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -63.37 126.04 26.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.644 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 66.1 p -102.21 -22.22 14.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.504 1.145 . . . . 1.0 108.136 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HZ2' ' HZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -105.74 172.49 3.94 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.231 -2.259 . . . . 1.0 112.458 -175.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -87.74 125.53 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.897 2.398 . . . . 1.0 109.525 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.412 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 3.6 mp -98.84 145.94 9.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.481 0.657 . . . . 1.0 110.383 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.14 148.01 33.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.181 -1.372 . . . . 1.0 108.561 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.549 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 5.0 ttpt -60.05 126.55 27.97 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.136 0.421 . . . . 1.0 112.136 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.16 4.9 47.29 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 119.32 -1.419 . . . . 1.0 114.133 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 126' ' ' THR . 2.3 ttmt -89.16 142.47 27.62 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.45 -0.9 . . . . 1.0 113.289 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.2 OUTLIER -103.81 138.01 41.02 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.876 -0.787 . . . . 1.0 108.876 175.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' HZ ' ' HZ2' ' A' ' 48' ' ' LYS . 36.2 m-85 -119.47 125.34 48.67 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.787 1.28 . . . . 1.0 111.443 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.09 -110.98 1.28 Allowed Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 111.905 -2.407 . . . . 1.0 109.182 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' CB ' ' CE1' ' A' ' 123' ' ' TYR . 83.6 Cg_endo -72.95 177.22 37.53 Favored 'Cis proline' 0 N--CA 1.503 2.08 0 CA-C-N 119.76 1.78 . . . . 1.0 112.107 -0.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CZ ' ' CB ' ' A' ' 90' ' ' ALA . 19.4 t80 -68.61 112.2 5.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.716 0.77 . . . . 1.0 111.234 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 97' ' ' ASN . 1.3 p -33.18 -54.84 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.934 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' HA2' ' CE2' ' A' ' 59' ' ' PHE . . . 75.64 108.97 0.11 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-O 121.389 0.438 . . . . 1.0 113.933 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -99.54 131.09 45.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.422 -2.066 . . . . 1.0 105.422 175.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.549 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -93.47 112.85 24.85 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.86 1.43 . . . . 1.0 114.86 -175.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -148.34 166.34 28.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.3 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.755 ' HZ3' ' H ' ' A' ' 65' ' ' LYS . 1.4 mtmp? -77.26 135.44 38.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.227 0.537 . . . . 1.0 111.531 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -57.62 -23.37 50.75 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.657 0.614 . . . . 1.0 112.657 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.441 ' OG ' ' OE1' ' A' ' 68' ' ' GLN . 5.0 p -59.63 38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -173.87 7.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.86 135.93 29.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 18.2 pttp -150.31 -141.98 0.12 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.201 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 70' ' ' LYS . 9.3 t30 76.98 -138.91 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -101.95 -83.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.298 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 1.1 t -102.92 104.96 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 119.891 -0.724 . . . . 1.0 111.715 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 12.1 m-85 -162.95 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.824 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.549 ' C ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -143.51 162.39 35.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.649 0.738 . . . . 1.0 111.884 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.73 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -147.75 140.55 24.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.628 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.4 124.59 47.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.365 0.603 . . . . 1.0 111.762 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 86' ' ' MET . 2.2 t -144.75 130.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -88.28 124.88 34.32 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.659 ' CZ ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 m-85 -77.55 113.19 29.7 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.632 -1.622 . . . . 1.0 112.856 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -53.68 -2.46 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.014 1.809 . . . . 1.0 110.326 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 80' ' ' TYR . 53.2 m-80 -102.98 -96.08 0.3 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.976 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.84 -40.22 91.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.88 1.437 . . . . 1.0 114.88 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 147.71 -173.54 27.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 119.772 -1.204 . . . . 1.0 110.32 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -55.16 122.14 10.37 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.88 -0.777 . . . . 1.0 111.454 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.497 ' O ' ' O ' ' A' ' 78' ' ' VAL . 5.8 tpp -127.61 157.2 40.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.354 0.501 . . . . 1.0 112.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -120.12 145.36 46.98 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.962 0.887 . . . . 1.0 110.179 176.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.512 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 19.7 mt -97.07 156.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.847 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.93 134.02 46.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.483 ' CB ' ' CZ ' ' A' ' 59' ' ' PHE . . . -132.83 138.17 46.98 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.082 -2.192 . . . . 1.0 105.082 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.469 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 164.88 -31.43 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.868 1.213 . . . . 1.0 111.383 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.29 148.05 59.59 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.537 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 31.5 Cg_exo -55.28 -44.61 47.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.368 1.379 . . . . 1.0 112.481 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.69 -9.32 58.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.746 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -12.59 56.5 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.05 -107.54 0.22 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 119.507 -1.33 . . . . 1.0 113.217 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -150.23 -156.1 0.69 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.447 -178.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.44 ' O ' ' N ' ' A' ' 101' ' ' TYR . 23.2 p-90 -70.91 -25.57 62.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HB2' HD22 ' A' ' 97' ' ' ASN . 0.3 OUTLIER -53.46 -27.41 24.81 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.487 ' C ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.39 -30.67 53.74 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.554 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.2 m-85 -66.97 -18.54 65.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.32 0.581 . . . . 1.0 109.774 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.92 116.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.08 -0.964 . . . . 1.0 110.396 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.67 140.79 46.33 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.131 -2.174 . . . . 1.0 105.131 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.531 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 15.8 p90 -92.07 118.73 31.08 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.937 -1.105 . . . . 1.0 110.696 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 12.61 78.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 113.953 -1.476 . . . . 1.0 114.81 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.498 ' C ' ' O ' ' A' ' 105' ' ' ALA . 0.1 OUTLIER -19.5 -40.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 125.197 1.56 . . . . 1.0 110.031 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -168.38 7.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.739 176.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.96 22.48 23.01 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.717 -0.953 . . . . 1.0 110.717 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.425 ' CD ' ' SG ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -77.79 -37.8 48.04 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.297 -0.561 . . . . 1.0 110.118 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.534 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -119.41 -31.91 4.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.981 1.104 . . . . 1.0 113.981 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.534 ' C ' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 14.25 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 123.416 0.448 . . . . 1.0 111.609 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.54 HD22 ' HA ' ' A' ' 136' ' ' LEU . 34.0 p-10 -128.06 32.97 4.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.573 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER -152.96 172.49 16.73 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.3 OUTLIER -148.26 124.15 5.26 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 119.351 -0.94 . . . . 1.0 112.702 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.8 Cg_endo -74.71 109.82 2.99 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 120.64 0.893 . . . . 1.0 113.313 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 23.2 tp -117.42 140.8 49.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.698 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.97 121.34 45.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.794 0.664 . . . . 1.0 112.794 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -135.54 135.66 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.875 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 118' ' ' ILE . 8.0 m-80 35.94 62.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.373 0.509 . . . . 1.0 112.373 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.659 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 7.2 mtp180 55.93 11.89 0.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.984 0.365 . . . . 1.0 111.984 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -122.92 146.16 47.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.0 mm -107.41 117.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 121.112 0.482 . . . . 1.0 110.566 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CD1' ' CG1' ' A' ' 118' ' ' ILE . 3.0 m-85 -101.14 143.44 31.24 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 15.6 m-30 -102.03 114.72 29.08 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 104.139 -2.541 . . . . 1.0 104.139 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 7.7 ttmt -105.51 141.2 37.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.379 1.05 . . . . 1.0 109.344 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 53' ' ' GLY . 18.6 p -106.87 110.88 23.16 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.401 0.62 . . . . 1.0 110.068 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.608 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -72.41 -4.66 31.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.67 -1.604 . . . . 1.0 111.239 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.465 ' HZ1' ' CA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -145.72 161.14 41.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 120.234 -0.586 . . . . 1.0 112.311 -177.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -75.5 144.42 28.64 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 N-CA-C 105.911 -2.38 . . . . 1.0 105.911 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.412 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 5.2 mt -126.19 135.71 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.719 0.691 . . . . 1.0 110.532 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.53 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.7 134.26 95.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.224 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -59.87 117.98 4.8 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 CA-C-N 120.006 1.038 . . . . 1.0 110.415 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.757 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.28 5.82 14.27 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.824 -1.311 . . . . 1.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.574 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -89.21 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.3 pm0 -78.59 118.84 21.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.268 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.54 ' HA ' HD22 ' A' ' 112' ' ' ASN . 2.8 mt -80.3 116.8 20.57 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.573 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 1.7 mp -129.3 156.17 44.43 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 108.688 -0.856 . . . . 1.0 108.688 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.531 ' H ' ' HA ' ' A' ' 104' ' ' TRP . 5.0 t -122.09 157.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.963 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.578 ' CZ2' ' C ' ' A' ' 141' ' ' IAS . 0.0 OUTLIER 63.03 150.69 0.03 OUTLIER 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 114.985 1.476 . . . . 1.0 114.985 176.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 139' ' ' TRP . 31.4 t80 -108.61 -172.5 2.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.37 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.578 ' C ' ' CZ2' ' A' ' 139' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.262 0 N-CA-C 110.653 -0.979 . . . . 1.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.636 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 0.1 OUTLIER -145.93 -100.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.723 178.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.636 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 4.9 t70 72.04 -37.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.541 ' ND2' ' N ' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -71.77 150.66 93.2 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.541 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 14.9 Cg_exo -42.7 -84.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.204 0 N-CA-C 117.15 1.942 . . . . 1.0 117.15 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 151' ' ' ALA . 8.5 tp10 -58.36 -46.78 85.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.391 0.615 . . . . 1.0 109.692 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.563 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.3 OUTLIER -46.12 -53.25 2.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.534 -1.212 . . . . 1.0 109.883 -173.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.563 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -56.34 -52.43 64.6 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 117.615 -1.634 . . . . 1.0 108.213 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.76 -62.32 1.82 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.775 -1.557 . . . . 1.0 113.4 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -63.55 -36.58 84.27 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.12 1.327 . . . . 1.0 111.652 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 156' ' ' ARG . 64.2 mt -53.45 -47.54 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 1.8 tt0 -60.76 -53.05 62.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.2 -0.909 . . . . 1.0 110.206 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -57.2 -52.71 64.21 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.027 0.441 . . . . 1.0 111.324 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 3.1 tm-20 -70.17 -49.41 50.67 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.839 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -74.65 -27.27 60.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.108 -0.637 . . . . 1.0 111.029 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -49.41 -34.6 16.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 118.871 -1.131 . . . . 1.0 108.217 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.82 -27.71 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.845 -1.071 . . . . 1.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -156.55 119.26 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.626 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -137.39 117.38 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.907 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.616 179.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.521 -1.432 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 29.7 m -150.44 7.7 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 1.0 110.554 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 61.74 117.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.499 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -50.14 124.78 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.598 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 7.1 tt0 -75.26 -63.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.614 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 3' ' ' GLN . 0.7 OUTLIER 176.71 -178.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.578 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.73 147.69 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.422 ' N ' ' OE2' ' A' ' 7' ' ' GLU . 6.2 m 55.03 98.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.342 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.422 ' OE2' ' N ' ' A' ' 6' ' ' THR . 4.1 mp0 -126.11 85.98 58.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.98 -175.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.483 2.122 . . . . 1.0 111.798 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -49.6 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.221 0.534 . . . . 1.0 110.891 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.95 145.24 36.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.711 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 34' ' ' PRO . . . -82.75 -44.12 15.97 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 1.2 m 178.22 -27.65 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.354 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.38 -73.63 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.712 0.767 . . . . 1.0 112.412 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.431 ' HB ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.36 175.81 9.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.135 -1.393 . . . . 1.0 110.632 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 3.0 tt -77.19 -62.88 1.51 Allowed 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 172.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 42' ' ' ILE . . . -86.34 -59.39 2.3 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.745 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 9.1 tt0 92.48 -171.48 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 105.415 -2.069 . . . . 1.0 105.415 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.745 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 58.49 151.83 0.08 OUTLIER Pre-proline 0 C--N 1.245 -3.97 0 CA-C-N 112.034 -2.348 . . . . 1.0 108.792 -178.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.92 138.87 6.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 123.429 2.752 . . . . 1.0 111.886 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 27.9 tt0 -50.27 -51.82 41.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-N 114.932 -1.031 . . . . 1.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -63.2 -24.36 67.84 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.36 -50.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 118.631 -1.228 . . . . 1.0 110.211 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.95 -29.28 65.25 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.132 -0.485 . . . . 1.0 112.245 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.89 -15.98 15.29 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.235 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.42 20.81 31.88 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.936 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 98' ' ' TRP 0.251 17.9 mt -69.19 139.63 90.13 Favored Pre-proline 0 CA--C 1.489 -1.381 0 CA-C-N 118.384 1.092 . . . . 1.0 109.99 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.605 ' C ' ' H ' ' A' ' 29' ' ' GLU . 5.9 Cg_exo -61.11 148.43 92.88 Favored 'Trans proline' 0 C--N 1.281 -3.026 0 N-CA-C 107.159 -1.9 . . . . 1.0 107.159 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -49.17 -15.27 0.11 Allowed 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.567 1.175 . . . . 1.0 110.275 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' H ' ' C ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.15 19.47 5.8 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 112.596 -2.093 . . . . 1.0 112.707 -178.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 ' C ' ' CG2' ' A' ' 47' ' ' THR . 1.8 t -145.38 151.73 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 118.655 -1.218 . . . . 1.0 112.483 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -147.39 159.09 44.09 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.863 -1.971 . . . . 1.0 106.737 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.92 140.81 38.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -148.47 115.35 3.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.641 0.608 . . . . 1.0 112.641 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.9 Cg_endo -85.98 127.62 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.319 2.012 . . . . 1.0 111.123 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 152.55 -71.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.739 0.65 . . . . 1.0 110.831 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.18 -53.25 36.59 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.771 -0.772 . . . . 1.0 113.025 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -53.24 -52.17 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.369 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' A' ' 40' ' ' THR . 6.4 p-10 -171.34 55.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? 53.82 -9.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.63 ' H ' ' C ' ' A' ' 38' ' ' ASP . 12.3 p -135.42 -90.4 0.31 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.301 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 40' ' ' THR . 4.5 mtt85 -29.43 133.27 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.641 0.588 . . . . 1.0 111.09 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -78.84 133.86 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.94 153.41 17.16 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.3 -1.12 . . . . 1.0 110.3 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.14 127.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.621 0.724 . . . . 1.0 109.212 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.571 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 4.8 m95 -130.88 149.92 52.28 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 114.469 -1.241 . . . . 1.0 111.507 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.32 138.24 51.31 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.572 -1.251 . . . . 1.0 111.03 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.439 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -112.62 -28.25 7.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.364 -178.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.14 159.71 38.45 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 119.167 -1.013 . . . . 1.0 111.32 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 Cg_endo -57.21 132.27 50.16 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.812 2.341 . . . . 1.0 111.469 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.15 144.22 19.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.047 -0.979 . . . . 1.0 108.613 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.536 ' C ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -113.59 149.23 34.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -64.69 135.47 55.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.757 0.789 . . . . 1.0 111.951 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.7 2.93 49.83 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 119.356 -1.402 . . . . 1.0 113.078 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.19 139.73 31.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.162 -1.015 . . . . 1.0 113.475 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.99 139.89 35.01 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 120.16 -0.616 . . . . 1.0 109.534 176.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 29' ' ' GLU . 37.1 m-85 -121.89 127.81 50.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 122.852 1.31 . . . . 1.0 110.917 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.11 -106.55 0.59 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 111.526 -2.579 . . . . 1.0 110.251 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 88.8 Cg_endo -83.52 170.46 53.19 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 CA-C-N 119.507 1.654 . . . . 1.0 111.994 -0.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.567 ' CE1' ' NH2' ' A' ' 100' ' ' ARG . 27.7 t80 -59.14 109.75 0.92 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.957 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 p -45.99 -50.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.719 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' CA ' HH22 ' A' ' 100' ' ' ARG . . . 72.31 111.18 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.359 -0.448 . . . . 1.0 114.038 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t0 -99.7 132.54 44.98 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.601 ' HZ2' ' CB ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -91.22 110.21 21.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 -177.091 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -146.47 166.91 24.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.641 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HZ1' ' H ' ' A' ' 65' ' ' LYS . 2.1 mtmp? -80.38 132.85 35.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.597 0.713 . . . . 1.0 112.08 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 67' ' ' SER . 2.7 ptm180 -50.19 -24.68 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 1.0 111.28 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.509 ' C ' ' O ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -18.75 -51.24 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.981 0.801 . . . . 1.0 111.907 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.532 ' O ' ' C ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -103.64 -115.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 68' ' ' GLN . 3.2 m 16.05 76.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.448 0 O-C-N 123.713 0.633 . . . . 1.0 111.438 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -114.02 113.34 24.64 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.279 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -174.36 -128.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.559 -0.746 . . . . 1.0 109.172 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -117.34 -57.57 2.13 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.075 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.42 1.4 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.054 0.454 . . . . 1.0 111.358 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.3 m-85 -53.61 -34.75 59.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.502 ' C ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -148.16 165.85 29.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.006 1.113 . . . . 1.0 114.006 -175.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.747 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -138.7 125.35 20.78 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.735 -1.575 . . . . 1.0 109.815 -177.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -97.37 123.25 41.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.448 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.0 139.43 22.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.224 -1.353 . . . . 1.0 109.297 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -83.62 129.28 34.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.65 ' CE2' ' NE ' ' A' ' 120' ' ' ARG . 15.5 m-85 -103.52 117.23 60.5 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.693 -1.14 . . . . 1.0 113.74 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -69.9 4.11 2.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.541 1.494 . . . . 1.0 109.774 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.72 ' ND2' HH12 ' A' ' 120' ' ' ARG . 62.8 m-20 -102.11 -2.84 28.58 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.911 -1.04 . . . . 1.0 111.112 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.9 0.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' TYR . . . 99.19 -164.46 20.36 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 18.8 m95 -60.86 120.18 9.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.759 -0.776 . . . . 1.0 111.019 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 1.4 tpp -130.82 165.62 22.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.185 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.605 ' N ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -120.72 144.48 48.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.045 0.926 . . . . 1.0 110.477 176.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.506 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 61.1 mt -97.7 156.01 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.44 136.57 54.68 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.273 0.942 . . . . 1.0 112.765 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.584 ' CB ' ' HE1' ' A' ' 76' ' ' TRP . . . -134.32 139.82 45.93 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.607 ' H ' ' CB ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER 167.16 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 120.086 1.312 . . . . 1.0 111.269 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.425 ' OD1' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.62 152.37 62.92 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.692 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.85 -37.67 19.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.543 2.162 . . . . 1.0 111.086 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.16 -14.17 62.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.51 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.67 -10.78 50.3 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.92 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 119.761 -1.209 . . . . 1.0 113.854 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.528 ' C ' HD21 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -148.26 -163.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.942 0.401 . . . . 1.0 111.783 -177.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.586 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 30.0 p-90 -71.3 -26.8 63.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.472 ' CD2' ' CD2' ' A' ' 124' ' ' TYR . 2.1 mp -55.03 -28.14 49.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.98 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.607 ' CB ' ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -77.09 -45.27 27.57 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.684 -0.806 . . . . 1.0 111.989 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 98' ' ' TRP . 11.7 p90 -77.54 1.83 18.26 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 118.335 -1.346 . . . . 1.0 110.82 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.82 119.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 129.28 39.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.52 -1.289 . . . . 1.0 107.52 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.498 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 22.4 p90 -93.42 123.53 36.79 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.883 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.695 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 22.49 76.92 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.065 -1.425 . . . . 1.0 114.094 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.549 ' C ' ' O ' ' A' ' 105' ' ' ALA . 2.2 t -23.99 -38.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.787 1.304 . . . . 1.0 108.165 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -177.98 15.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.3 -1.318 . . . . 1.0 109.716 174.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.17 36.28 7.69 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 114.891 -1.049 . . . . 1.0 110.658 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -78.91 -44.41 22.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.047 -0.661 . . . . 1.0 109.891 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.527 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -120.46 -28.33 5.0 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.601 -0.714 . . . . 1.0 112.337 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' OE1' ' C ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER 22.66 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.937 0.773 . . . . 1.0 110.188 -178.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.528 ' C ' ' HZ3' ' A' ' 128' ' ' LYS . 41.1 p-10 -128.28 37.89 4.08 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.606 ' N ' ' NZ ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -154.34 173.44 16.18 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -178.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -147.09 123.02 5.46 Favored Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 119.598 -0.841 . . . . 1.0 111.623 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -67.23 92.52 0.34 Allowed 'Trans proline' 0 N--CA 1.482 0.798 0 CA-C-N 119.276 0.777 . . . . 1.0 112.281 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 31.4 tp -93.07 130.29 38.74 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.98 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.49 116.23 31.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 1.0 110.726 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 121' ' ' ALA . 2.0 pt -138.39 135.89 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.481 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' ILE . 60.0 m-20 40.35 56.85 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.236 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.72 HH12 ' ND2' ' A' ' 82' ' ' ASN . 5.8 mtp180 58.12 12.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 111.84 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -117.25 150.25 39.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.673 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 26.3 mm -110.52 104.18 16.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.418 0 C-N-CA 120.5 -0.48 . . . . 1.0 109.877 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 116' ' ' LEU . 3.5 m-85 -92.77 149.96 20.96 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 120.799 -1.188 . . . . 1.0 110.36 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 15.5 m-30 -102.12 111.34 23.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 104.817 -2.29 . . . . 1.0 104.817 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 139.33 40.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 124.691 1.245 . . . . 1.0 109.095 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' GLY . 6.4 p -107.24 111.26 23.57 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.684 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -77.27 0.89 20.37 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.681 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.606 ' NZ ' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -144.02 140.84 17.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.943 -176.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.98 140.77 61.68 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 N-CA-C 105.589 -2.504 . . . . 1.0 105.589 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.451 ' CG2' ' CG ' ' A' ' 134' ' ' GLU . 24.2 mt -118.89 134.7 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.89 0.768 . . . . 1.0 112.249 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.437 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -72.82 120.81 82.86 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.08 122.45 6.33 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.934 1.756 . . . . 1.0 112.233 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 130.59 -2.92 5.74 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.576 -0.821 . . . . 1.0 114.06 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.684 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -103.81 167.17 9.95 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.111 0.958 . . . . 1.0 112.76 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.3 pm0 -80.5 139.24 36.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.778 -1.555 . . . . 1.0 111.027 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' HA ' HD22 ' A' ' 112' ' ' ASN . 9.2 mt -88.55 118.14 28.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.566 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 2.1 mp -121.57 150.68 41.32 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.047 0.451 . . . . 1.0 110.292 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.622 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 17.5 t -118.94 153.27 21.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.166 -0.925 . . . . 1.0 110.12 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.622 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER 59.33 168.29 0.06 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.429 1.081 . . . . 1.0 113.634 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 141' ' ' IAS . 55.1 t80 -114.51 168.33 9.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.678 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.576 ' N ' ' CG ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 143' ' ' GLU . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.443 ' N ' ' HB3' ' A' ' 140' ' ' TYR . 10.3 pt-20 38.01 103.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 1.0 112.377 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.401 ' CB ' ' CD2' ' A' ' 140' ' ' TYR . 11.0 t70 -139.38 -33.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.061 -0.972 . . . . 1.0 112.063 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.53 ' C ' ' ND2' ' A' ' 145' ' ' ASN . 0.2 OUTLIER -67.91 151.33 97.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.501 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 5.4 Cg_exo -40.69 -85.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.151 0 N-CA-C 117.496 2.075 . . . . 1.0 117.496 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.555 ' OE1' ' N ' ' A' ' 151' ' ' ALA . 5.6 tp10 -58.12 -42.26 85.36 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.0 OUTLIER -45.91 -50.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.943 -1.481 . . . . 1.0 109.455 -174.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.55 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -71.62 -47.21 56.11 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.388 -1.325 . . . . 1.0 109.097 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.99 -57.06 12.4 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.629 -1.623 . . . . 1.0 113.235 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.555 ' N ' ' OE1' ' A' ' 147' ' ' GLU . . . -72.5 -35.21 68.08 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 120.298 1.408 . . . . 1.0 111.94 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 148' ' ' ILE . 55.5 mt -51.95 -48.3 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 106.813 -1.551 . . . . 1.0 106.813 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 2.3 mt-10 -60.92 -52.91 63.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.469 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -56.86 -53.24 60.22 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.976 -0.289 . . . . 1.0 111.7 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.539 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -74.12 -48.67 27.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.81 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -70.84 -28.04 64.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.953 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -49.92 -44.59 50.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.74 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.48 -35.71 30.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.83 -154.91 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.42 ' HE ' ' HE ' ' A' ' 156' ' ' ARG . 13.4 mmt180 57.8 50.93 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.607 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.668 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.8 t 43.54 32.25 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 1.0 110.57 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmt 52.77 173.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' ASN . 1.7 p30 -154.04 22.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -78.11 19.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.506 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -80.03 -14.44 58.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.637 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.84 138.36 15.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.7 m -50.97 117.98 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.56 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -75.15 153.59 86.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.202 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.18 169.69 18.84 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.269 1.979 . . . . 1.0 112.061 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.46 110.15 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.679 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.77 131.66 31.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.247 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.11 -172.35 2.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.01 0.433 . . . . 1.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -124.2 -78.29 0.6 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.55 -151.56 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 ' OG1' ' OE2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -125.49 155.33 40.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.937 0.875 . . . . 1.0 112.269 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.586 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -51.55 -32.39 28.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.085 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.52 -15.71 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.36 -0.836 . . . . 1.0 112.608 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' OE2' ' OG1' ' A' ' 14' ' ' THR . 2.8 mt-10 -91.48 -25.36 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.677 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.75 141.53 17.77 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.364 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.637 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 22.5 Cg_exo -51.0 141.85 35.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.61 2.206 . . . . 1.0 112.558 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.425 ' CG ' ' NE ' ' A' ' 24' ' ' ARG . 47.8 tt0 -63.45 -31.73 72.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 113.43 0.9 . . . . 1.0 113.43 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 93' ' ' PRO . 4.6 p-80 -74.56 -26.54 60.01 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.789 1.403 . . . . 1.0 114.789 -176.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 4.4 m -78.87 -47.27 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.47 1.032 . . . . 1.0 111.953 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.675 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.17 -22.02 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 122.676 1.227 . . . . 1.0 109.392 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.425 ' NE ' ' CG ' ' A' ' 20' ' ' GLU . 1.2 mpt_? -63.74 -43.63 95.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.952 -1.931 . . . . 1.0 113.066 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.21 33.95 6.11 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.502 -0.856 . . . . 1.0 112.933 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 mt -68.49 153.52 95.6 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.668 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.51 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 71.9 Cg_exo -47.37 -106.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 124.287 3.324 . . . . 1.0 115.653 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -74.16 -58.89 3.0 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER -174.76 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 177.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.464 HG21 ' HZ3' ' A' ' 48' ' ' LYS . 50.5 t -48.04 178.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.65 -1.159 . . . . 1.0 108.588 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.416 ' H ' HG11 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -147.88 159.04 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.7 mm? -94.96 121.04 36.16 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.1 -0.64 . . . . 1.0 110.683 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -132.48 139.84 36.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.003 -0.999 . . . . 1.0 111.057 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.2 Cg_endo -80.41 153.18 20.83 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.957 2.438 . . . . 1.0 112.484 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 44.2 t 124.16 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.69 1.196 . . . . 1.0 110.958 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.552 ' O ' ' CG ' ' A' ' 103' ' ' ASN . . . -89.79 12.83 16.01 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.892 1.329 . . . . 1.0 108.057 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.568 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 3.6 p -93.1 -52.41 9.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 113.306 -1.77 . . . . 1.0 115.062 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.568 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 26.6 t0 126.26 46.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.85 ' H ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 31.86 40.91 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.543 179.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 38' ' ' ASP . 18.4 p -133.56 -16.95 2.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.925 -1.034 . . . . 1.0 111.467 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 9.1 ttm-85 179.81 -166.03 0.07 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.784 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.02 155.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.887 0.375 . . . . 1.0 110.817 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -114.66 166.14 12.13 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -105.41 126.61 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.752 0.776 . . . . 1.0 111.313 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 16.1 m95 -126.9 142.38 51.56 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.376 -0.829 . . . . 1.0 113.226 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -69.19 133.51 48.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.305 -1.316 . . . . 1.0 110.304 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 56.0 p -130.34 12.68 5.52 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.868 -1.531 . . . . 1.0 106.868 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.487 ' NZ ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -133.09 170.32 11.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 112.593 -2.094 . . . . 1.0 110.908 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -89.59 141.99 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.289 2.659 . . . . 1.0 111.338 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.487 HD13 ' NZ ' ' A' ' 48' ' ' LYS . 45.2 mt -134.3 146.94 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 114.871 -1.059 . . . . 1.0 112.046 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.583 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.03 168.69 9.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.0 177.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -65.79 122.83 18.21 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.48 -0.488 . . . . 1.0 111.589 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.926 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.09 7.74 49.24 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.066 -1.064 . . . . 1.0 113.803 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.5 ttmt -75.51 133.16 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 116.787 -1.965 . . . . 1.0 113.852 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -85.8 121.21 28.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 1.0 113.397 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.51 ' CD1' ' HB3' ' A' ' 27' ' ' PRO . 20.9 m-85 -121.17 142.77 49.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.309 1.226 . . . . 1.0 114.309 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.29 -100.49 1.65 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.013 -1.903 . . . . 1.0 110.59 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.25 167.9 78.8 Favored 'Cis proline' 0 N--CA 1.499 1.814 0 CA-C-N 119.342 1.571 . . . . 1.0 112.049 -0.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.46 ' CZ ' ' O ' ' A' ' 74' ' ' TYR . 19.4 t80 -54.85 108.99 0.45 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 95' ' ' LYS . 3.7 p -37.05 -53.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 52.74 119.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.883 -0.675 . . . . 1.0 113.917 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.85 143.28 33.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 111.47 22.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.388 0.613 . . . . 1.0 110.921 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CD ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.92 178.84 6.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 1.0 111.79 -176.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' N ' ' HE2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -50.88 167.76 0.07 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.084 -0.962 . . . . 1.0 111.703 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.21 -51.55 24.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.67 123.05 48.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.277 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.462 ' CB ' ' NZ ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER 176.94 -20.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.675 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.548 ' CG1' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -109.12 -61.71 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.514 0.197 . . . . 1.0 111.404 -178.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 72' ' ' ASN . 44.5 mttp 62.67 -123.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.581 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.426 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 1.6 t30 -42.12 89.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 39.9 t-20 -171.63 -169.21 0.67 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.036 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.671 ' O ' ' CZ3' ' A' ' 76' ' ' TRP . 0.2 OUTLIER -137.95 -56.8 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.529 -0.468 . . . . 1.0 112.064 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' O ' ' CZ ' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -60.68 37.39 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.291 0.37 . . . . 1.0 111.625 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.627 ' N ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -135.19 141.56 45.9 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.671 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -163.95 163.61 23.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.777 -0.769 . . . . 1.0 113.034 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 5.4 pt-20 -100.97 123.24 44.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.093 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.2 124.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -78.06 124.15 27.69 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.639 ' C ' ' H ' ' A' ' 82' ' ' ASN . 23.2 m-85 -103.5 101.65 24.83 Favored Pre-proline 0 N--CA 1.448 -0.571 0 O-C-N 124.522 1.138 . . . . 1.0 112.889 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -65.35 22.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 121.423 1.415 . . . . 1.0 110.611 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.639 ' H ' ' C ' ' A' ' 80' ' ' TYR . 83.0 m-20 -118.38 -2.3 11.12 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.837 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -178.1 6.48 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 102.91 174.94 26.71 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 113.844 0.298 . . . . 1.0 113.844 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.518 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.1 m95 -59.1 120.31 8.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.816 0.447 . . . . 1.0 111.656 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.518 ' SD ' ' C ' ' A' ' 85' ' ' TRP . 26.7 mmm -125.46 167.86 14.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.039 1.125 . . . . 1.0 114.039 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.67 138.23 50.94 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 105.604 -1.999 . . . . 1.0 105.604 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 75' ' ' MET . 72.2 mt -103.79 101.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -128.96 127.96 42.75 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.268 0.556 . . . . 1.0 111.283 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.75 92.5 2.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.476 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.13 -5.97 21.51 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.419 -0.912 . . . . 1.0 112.811 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.645 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -86.79 120.55 71.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.605 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 52.6 Cg_exo -47.83 -26.98 7.75 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.114 1.876 . . . . 1.0 113.934 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.6 -44.24 82.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.638 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.82 3.26 15.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.619 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.789 ' O ' ' ND2' ' A' ' 97' ' ' ASN . . . -97.54 -2.94 58.63 Favored Glycine 0 C--O 1.219 -0.795 0 CA-C-N 115.39 -0.823 . . . . 1.0 113.019 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.789 ' ND2' ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER 42.57 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.19 0.495 . . . . 1.0 110.109 -177.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 101' ' ' TYR . 67.6 p-90 -70.58 -24.55 62.79 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.591 ' HB2' HD22 ' A' ' 97' ' ' ASN . 5.2 mp -55.36 -23.6 25.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.078 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' NE ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -68.26 -13.81 62.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 176.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.3 m-85 -96.93 -10.62 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.475 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.7 t -66.95 118.5 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.872 -0.731 . . . . 1.0 110.03 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.77 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -80.57 -164.39 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.55 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.655 ' HE1' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -121.9 154.6 36.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.505 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.768 ' H ' HE22 ' A' ' 111' ' ' GLN . . . -134.89 -176.72 4.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.421 0.629 . . . . 1.0 112.016 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -105.43 -54.15 2.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.596 -178.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -103.16 175.22 5.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 111.379 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.1 -36.88 34.08 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -54.59 -25.39 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 1.0 110.401 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.505 ' OE2' ' SG ' ' A' ' 106' ' ' CYS . 8.3 pt-20 -107.64 -24.01 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.435 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.872 ' NE2' ' O ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -103.09 103.82 13.92 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.22 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.498 ' HA ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -114.45 34.25 4.84 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -177.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 137' ' ' LEU . 5.3 mp -144.42 149.25 35.76 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.606 -0.838 . . . . 1.0 111.77 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -150.67 127.16 5.21 Favored Pre-proline 0 N--CA 1.47 0.528 0 C-N-CA 120.287 -0.565 . . . . 1.0 112.395 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 51.6 Cg_exo -60.5 133.55 49.53 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.087 1.858 . . . . 1.0 113.797 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -134.98 136.16 41.98 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.35 120.87 41.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.07 0.462 . . . . 1.0 111.757 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -129.61 114.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 56.7 42.67 26.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.614 ' HE ' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 65.89 15.1 9.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.974 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.75 124.64 49.91 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.66 120.74 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.597 0.713 . . . . 1.0 112.238 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 116' ' ' LEU . 7.7 m-85 -112.07 153.68 26.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.796 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -112.86 126.51 55.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.45 152.69 43.02 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.558 -0.857 . . . . 1.0 112.525 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.926 ' O ' ' N ' ' A' ' 53' ' ' GLY . 7.3 p -106.68 106.24 16.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.082 -1.417 . . . . 1.0 109.83 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' N ' ' HE3' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -69.89 -0.46 7.35 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.927 0.767 . . . . 1.0 111.594 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.945 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -148.28 126.95 6.1 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.173 -176.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.63 148.48 2.34 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.951 2.434 . . . . 1.0 112.547 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.89 135.87 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.524 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -78.27 115.29 49.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -40.78 117.87 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.458 2.105 . . . . 1.0 113.282 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.62 6.19 13.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.522 -0.599 . . . . 1.0 112.566 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 131' ' ' ALA . 2.4 pt-20 -104.92 166.98 10.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.938 0.869 . . . . 1.0 112.269 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.42 ' OE1' ' OD1' ' A' ' 103' ' ' ASN . 5.4 pt-20 -81.09 136.59 35.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.306 -1.315 . . . . 1.0 111.74 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.48 128.05 34.92 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.919 -1.037 . . . . 1.0 109.955 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.517 ' CD2' ' OD1' ' A' ' 103' ' ' ASN . 4.9 mp -142.65 157.98 44.12 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.993 0.517 . . . . 1.0 111.71 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.605 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.66 146.26 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 178.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.872 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 0.3 OUTLIER 23.41 -123.88 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.973 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.647 ' CD1' ' O ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -163.56 -14.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.618 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.993 ' O ' ' N ' ' A' ' 145' ' ' ASN . 2.0 tm-20 -62.86 -74.54 0.09 Allowed 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.251 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -36.16 52.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.211 0.944 . . . . 1.0 111.86 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.993 ' N ' ' O ' ' A' ' 143' ' ' GLU . 16.4 t30 -117.57 164.14 20.77 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 114.616 -1.174 . . . . 1.0 109.659 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 63.6 Cg_endo -96.38 -24.83 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.235 1.957 . . . . 1.0 112.203 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.523 ' O ' ' CD2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.459 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 93.3 mt -65.5 -53.18 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.222 0.534 . . . . 1.0 111.968 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -51.54 -33.03 30.32 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.647 -0.706 . . . . 1.0 112.523 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.19 45.44 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.23 -0.588 . . . . 1.0 111.537 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.53 -39.98 36.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.89 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.406 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 20.1 mt -53.33 -52.61 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 106.445 -1.687 . . . . 1.0 106.445 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -56.39 -28.04 58.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.056 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.6 OUTLIER -70.47 -49.4 48.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.006 -1.078 . . . . 1.0 111.345 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 10.7 tp10 -79.39 -50.14 11.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -64.07 -39.71 94.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.423 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . -63.57 -23.27 67.31 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 m -92.81 34.41 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.276 -0.875 . . . . 1.0 110.201 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -143.15 40.15 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.986 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -115.42 -38.98 3.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.464 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.623 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.448 ' H3 ' ' H ' ' A' ' 0' ' ' SER . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.448 ' H ' ' H3 ' ' A' ' -1' ' ' GLY . 11.0 m -52.04 -75.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 1.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.92 171.9 13.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.592 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 44.26 51.64 7.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.502 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 3' ' ' GLN . 1.5 tm0? -97.49 55.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.586 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.649 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.7 OUTLIER 45.32 18.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.549 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 3' ' ' GLN . 3.8 m -92.07 90.04 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.539 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.5 m 58.74 114.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.596 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -131.71 85.46 51.68 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -50.59 174.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.432 2.088 . . . . 1.0 112.052 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.4 141.06 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.324 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 54.52 172.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.416 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.74 -137.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.33 0.586 . . . . 1.0 110.804 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -140.49 -58.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.2 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.06 160.06 0.53 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.06 151.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.737 0.779 . . . . 1.0 112.748 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -55.56 -36.87 67.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.985 -1.007 . . . . 1.0 109.487 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -15.79 60.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.754 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -23.3 33.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.997 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 144.59 89.08 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.15 148.64 6.9 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.101 2.534 . . . . 1.0 113.228 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 30.0 tt0 -60.72 -42.03 96.46 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.617 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 7.8 p-80 -73.4 -29.32 62.52 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.258 1.577 . . . . 1.0 115.258 -176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 m -75.36 -47.16 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 119.909 1.231 . . . . 1.0 110.652 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' H ' HD21 ' A' ' 23' ' ' LEU . 1.6 pt? -67.5 -25.33 65.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.815 0.817 . . . . 1.0 110.321 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -71.07 -36.04 72.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.078 -1.419 . . . . 1.0 112.813 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.1 31.24 7.11 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.74 -0.743 . . . . 1.0 111.617 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 30' ' ' VAL . 10.3 mt -72.68 120.89 83.21 Favored Pre-proline 0 CA--C 1.5 -0.952 0 C-N-CA 119.651 -0.82 . . . . 1.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.85 168.39 7.21 Favored 'Trans proline' 0 C--N 1.296 -2.227 0 CA-C-N 120.085 1.066 . . . . 1.0 109.438 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.433 ' O ' ' OG1' ' A' ' 47' ' ' THR . 3.7 pt-20 -59.02 -8.89 1.59 Allowed 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 112.491 -2.141 . . . . 1.0 115.386 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.769 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -112.51 11.95 19.87 Favored 'General case' 0 CA--C 1.458 -2.586 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.973 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.487 ' CG2' ' C ' ' A' ' 29' ' ' GLU . 2.3 t -137.1 117.06 16.22 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 C-N-CA 117.38 -1.728 . . . . 1.0 113.95 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' NE ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.67 142.02 49.85 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.144 -1.428 . . . . 1.0 107.144 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 43' ' ' GLY . 4.2 mm? -90.07 116.93 28.47 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.175 1.352 . . . . 1.0 111.548 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -139.73 141.34 27.53 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.725 -1.125 . . . . 1.0 110.942 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 35' ' ' SER . 53.2 Cg_endo -76.16 159.04 37.46 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.863 3.042 . . . . 1.0 113.804 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.82 ' C ' ' H ' ' A' ' 37' ' ' VAL . 13.4 m 110.4 -85.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.814 1.246 . . . . 1.0 108.575 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' ASN . . . -55.54 12.17 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.896 0.855 . . . . 1.0 111.822 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.82 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -95.51 -53.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.864 -1.517 . . . . 1.0 112.555 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.1 m-20 143.65 42.14 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.323 1.014 . . . . 1.0 109.187 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.0 23.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.309 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 38' ' ' ASP . 9.7 t -122.76 -4.48 8.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.064 0.764 . . . . 1.0 113.064 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.632 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.33 -162.95 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 mm -79.08 156.21 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.956 0.408 . . . . 1.0 110.904 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -124.88 165.12 18.14 Favored Glycine 0 C--O 1.196 -2.26 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.99 135.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 117.605 0.702 . . . . 1.0 110.937 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 15.6 m95 -130.65 149.96 52.06 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.993 -1.003 . . . . 1.0 113.69 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.769 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.15 128.98 38.15 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.345 -1.298 . . . . 1.0 113.428 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 28' ' ' GLU . 81.5 p -115.8 -20.91 9.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.058 -0.974 . . . . 1.0 111.085 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' CD ' ' C ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.57 168.22 10.58 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.298 178.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.14 121.99 6.87 Favored 'Trans proline' 0 CA--C 1.498 -1.314 0 C-N-CA 121.915 1.743 . . . . 1.0 111.666 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.61 143.02 14.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 112.858 -1.974 . . . . 1.0 109.581 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.534 ' C ' ' CD1' ' A' ' 51' ' ' LEU . 4.0 pp -109.01 164.27 12.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.79 -1.096 . . . . 1.0 109.294 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' O ' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.34 122.74 21.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.01 0.91 . . . . 1.0 111.111 177.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.896 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.13 10.07 40.47 Favored Glycine 0 C--N 1.303 -1.304 0 C-N-CA 120.022 -1.085 . . . . 1.0 114.029 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -89.19 130.85 35.54 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.328 -1.749 . . . . 1.0 114.624 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 4.4 mtmm -85.9 124.54 32.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.857 -1.52 . . . . 1.0 111.473 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CD2' ' OE1' ' A' ' 29' ' ' GLU . 47.5 m-85 -121.65 149.71 42.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.9 -102.37 1.56 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.215 -1.357 . . . . 1.0 111.507 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.15 165.14 64.22 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 119.753 1.776 . . . . 1.0 113.036 0.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.484 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 20.4 t80 -54.39 110.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.849 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.52 ' CG1' ' HE ' ' A' ' 100' ' ' ARG . 2.9 p -35.42 -56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.446 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 51.28 116.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.558 -0.829 . . . . 1.0 114.799 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 21.4 t0 -103.49 146.69 28.14 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.549 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 3.2 mtmp? -89.29 113.64 24.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.443 -0.903 . . . . 1.0 112.202 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.628 ' CE ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -136.04 166.29 23.7 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.328 -0.851 . . . . 1.0 111.345 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.628 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -81.25 131.24 35.28 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.517 0.562 . . . . 1.0 112.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -40.64 -24.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.507 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 27.5 m -76.92 60.97 1.87 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.461 -0.895 . . . . 1.0 108.714 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.559 ' CB ' ' HZ1' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -167.0 -7.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.163 1.171 . . . . 1.0 114.163 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -110.51 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 119.063 0.847 . . . . 1.0 111.36 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 69' ' ' VAL . 0.4 OUTLIER 88.76 -80.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.833 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -102.94 92.83 4.73 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 18.8 t-20 -170.59 172.56 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.107 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.669 ' C ' ' H ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -122.43 -52.31 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 114.38 1.252 . . . . 1.0 114.38 -178.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.823 ' C ' ' SD ' ' A' ' 75' ' ' MET . 0.2 OUTLIER -63.54 34.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 -176.493 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.823 ' SD ' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -126.45 139.32 53.34 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -177.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.641 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -164.49 164.23 21.9 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.493 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.73 122.78 41.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.17 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.42 119.45 13.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 3.0 t80 -78.19 125.03 28.76 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 113.41 0.893 . . . . 1.0 113.41 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 82' ' ' ASN . 25.0 m-85 -103.22 97.8 10.71 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 114.698 -1.137 . . . . 1.0 112.172 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.31 -11.33 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.247 1.298 . . . . 1.0 109.785 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.55 ' H ' ' C ' ' A' ' 80' ' ' TYR . 77.3 m-20 -76.53 -3.42 37.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.424 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.505 ' CD1' ' SD ' ' A' ' 86' ' ' MET . 2.5 pp -178.29 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.497 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 146.82 173.24 17.87 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.132 -1.032 . . . . 1.0 112.523 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.502 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.9 m95 -58.53 120.25 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.646 -0.277 . . . . 1.0 111.547 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.505 ' SD ' ' CD1' ' A' ' 83' ' ' LEU . 20.3 mmm -127.25 163.87 22.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.996 1.109 . . . . 1.0 113.996 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.4 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.24 139.78 46.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.354 -2.091 . . . . 1.0 105.354 172.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 75' ' ' MET . 66.4 mt -107.58 103.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 118.219 -0.895 . . . . 1.0 109.7 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -130.29 130.77 44.94 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.207 0.912 . . . . 1.0 112.362 -178.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' HB3' ' NH2' ' A' ' 100' ' ' ARG . . . -142.72 113.04 7.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.201 -0.909 . . . . 1.0 109.72 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -132.68 26.93 4.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.979 0.809 . . . . 1.0 110.139 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.713 ' N ' HH11 ' A' ' 100' ' ' ARG . 2.6 m-20 -117.15 81.62 13.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.818 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.617 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 58.6 Cg_exo -48.48 -12.67 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.084 2.523 . . . . 1.0 112.629 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HA ' ' HE2' ' A' ' 21' ' ' HIS . 2.7 mt-10 -79.1 -28.52 43.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.365 0.602 . . . . 1.0 109.691 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 17.89 15.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 1.0 112.779 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -141.02 -121.65 1.79 Allowed Glycine 0 N--CA 1.461 0.336 0 C-N-CA 119.422 -1.371 . . . . 1.0 114.78 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.527 ' C ' HD21 ' A' ' 97' ' ' ASN . 0.2 OUTLIER -139.18 -177.96 5.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.533 -0.834 . . . . 1.0 110.489 -178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -68.31 -21.66 64.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 99' ' ' LEU . 4.4 mp -56.88 -28.41 61.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.713 HH11 ' N ' ' A' ' 92' ' ' ASP . 32.0 mtt180 -62.57 -12.52 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.355 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -104.77 -3.35 23.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.643 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.407 ' O ' ' CZ3' ' A' ' 104' ' ' TRP . 18.5 t -66.14 135.03 29.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.893 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 104' ' ' TRP . 4.0 t-20 -102.63 -174.13 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 120.696 -0.402 . . . . 1.0 110.204 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.673 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.53 157.06 36.25 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 140' ' ' TYR . . . -118.99 -158.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.515 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.53 -22.98 11.38 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.518 -1.219 . . . . 1.0 111.934 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -171.68 137.38 1.02 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 111' ' ' GLN . . . -31.74 -32.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.735 -0.666 . . . . 1.0 113.717 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' SER . 2.1 mt-10 -53.92 -26.76 26.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 117.816 0.808 . . . . 1.0 110.337 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.515 ' OE2' ' SG ' ' A' ' 106' ' ' CYS . 11.0 pt-20 -116.94 -24.34 7.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.07 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.48 ' OE1' ' O ' ' A' ' 139' ' ' TRP . 2.5 tm0? -93.76 143.98 25.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.11 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -153.9 40.32 0.49 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.845 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.5 HD11 ' N ' ' A' ' 137' ' ' LEU . 4.8 mp -143.79 143.21 31.25 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.08 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.582 ' N ' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -148.73 128.76 6.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.349 -179.04 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.5 Cg_exo -63.19 121.73 9.67 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.385 2.057 . . . . 1.0 112.284 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.2 tp -117.14 128.74 55.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -98.02 116.64 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.684 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.3 118.95 51.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.51 31.98 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 79' ' ' TYR . 11.3 mmp_? 67.67 18.22 9.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.53 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.39 125.35 50.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 76' ' ' TRP . 5.6 mm -85.33 120.79 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.009 -0.677 . . . . 1.0 112.659 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -112.89 162.32 15.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.909 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.1 m-30 -112.28 118.2 34.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 114' ' ' PHE . 1.9 mttt -110.81 145.91 37.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.695 0.998 . . . . 1.0 113.695 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 53' ' ' GLY . 3.1 p -106.64 111.33 23.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.701 -1.591 . . . . 1.0 109.448 176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.543 HD11 ' H ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.94 -4.35 46.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.951 0.782 . . . . 1.0 110.076 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.507 ' HZ1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -139.45 147.36 52.15 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.371 177.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.83 146.08 77.0 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.288 1.325 . . . . 1.0 111.833 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.7 136.44 50.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.336 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.559 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -79.58 121.06 82.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.16 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -41.98 112.28 0.23 Allowed 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 123.111 2.541 . . . . 1.0 115.044 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 119.16 8.03 9.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.001 -0.619 . . . . 1.0 112.768 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.559 ' OE2' ' N ' ' A' ' 131' ' ' ALA . 2.6 pt-20 -105.35 165.99 10.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 117.507 0.653 . . . . 1.0 111.115 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -80.01 133.91 36.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.769 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 6.4 mp -86.27 132.49 33.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.913 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 113' ' ' LEU . 4.7 mp -140.2 159.59 41.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.703 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -108.56 140.16 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.759 ' CD1' ' N ' ' A' ' 140' ' ' TYR . 29.6 p90 33.96 -63.05 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 O-C-N 124.957 1.41 . . . . 1.0 114.322 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.759 ' N ' ' CD1' ' A' ' 139' ' ' TRP . 44.4 p90 155.5 -64.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.875 1.67 . . . . 1.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.723 ' N ' ' CD2' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 N-CA-C 111.453 -0.659 . . . . 1.0 111.453 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 1.066 ' O ' ' N ' ' A' ' 145' ' ' ASN . 4.2 tm-20 -66.61 -80.91 0.04 OUTLIER 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 0.8 OUTLIER -29.88 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.772 0.796 . . . . 1.0 111.506 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 1.066 ' N ' ' O ' ' A' ' 143' ' ' GLU . 30.2 t30 -111.15 162.85 19.07 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 114.32 -1.309 . . . . 1.0 108.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.431 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 73.3 Cg_endo -94.62 -20.27 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.767 1.644 . . . . 1.0 112.063 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.528 ' CG ' HD21 ' A' ' 145' ' ' ASN . 0.0 OUTLIER -74.14 -37.45 64.06 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.562 -1.273 . . . . 1.0 107.562 178.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 63.9 mt -75.02 -56.25 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.245 0.545 . . . . 1.0 110.527 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.14 -30.96 62.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.237 -0.892 . . . . 1.0 112.275 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.48 -33.54 48.17 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.43 ' CB ' ' CE2' ' A' ' 114' ' ' PHE . . . -75.55 -42.56 52.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 1.0 111.464 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.477 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 60.2 mt -54.24 -51.69 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.466 -1.309 . . . . 1.0 107.466 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -59.84 -29.71 68.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.783 0.677 . . . . 1.0 111.338 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.4 OUTLIER -71.08 -48.77 50.6 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.402 -0.919 . . . . 1.0 110.763 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.46 ' N ' ' HG2' ' A' ' 154' ' ' GLU . 15.9 tp10 -78.94 -49.83 12.15 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.477 ' CG ' ' O ' ' A' ' 152' ' ' ILE . 5.4 ppt_? -66.61 -40.53 88.85 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.836 0.68 . . . . 1.0 112.836 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . -64.66 -22.96 67.11 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 154' ' ' GLU . 3.0 m -93.9 19.04 9.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.522 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.43 32.44 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.337 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -110.7 -65.32 1.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.522 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.938 -1.029 . . . . 1.0 110.55 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.1 m 42.33 71.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 1.0 110.555 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mmt -101.77 135.21 43.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.566 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -156.66 52.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.27 -46.45 27.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.578 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -42.5 132.22 3.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.497 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 m -89.91 99.93 12.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 7' ' ' GLU . 3.1 t -70.03 -122.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.453 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.501 ' N ' ' OG1' ' A' ' 6' ' ' THR . 7.7 mt-10 -138.78 83.55 19.15 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -83.42 -172.91 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.978 2.452 . . . . 1.0 112.395 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.406 ' O ' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -69.85 -179.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.822 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 53.88 169.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.295 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.56 -144.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.962 0.411 . . . . 1.0 110.967 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -139.13 -76.71 0.35 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.622 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -43.96 160.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.811 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -125.88 150.77 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.62 -0.718 . . . . 1.0 111.062 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.586 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -60.74 -27.75 68.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.357 0.599 . . . . 1.0 109.575 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.65 -23.38 63.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' O ' ' O ' ' A' ' 18' ' ' VAL . 1.6 mm-40 -88.84 -117.06 0.05 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.11 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.54 ' O ' ' O ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER 51.49 142.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 114.123 -1.399 . . . . 1.0 110.76 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.5 ' CD ' ' OH ' ' A' ' 101' ' ' TYR . 4.3 Cg_exo -55.64 134.64 65.19 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.14 1.226 . . . . 1.0 111.766 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' O ' ' CD ' ' A' ' 24' ' ' ARG . 38.2 tt0 -53.23 -38.63 63.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.847 1.055 . . . . 1.0 113.847 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.684 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 10.1 p-80 -74.67 -34.25 62.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.467 1.654 . . . . 1.0 115.467 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 m -71.65 -47.83 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.279 0.945 . . . . 1.0 111.181 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 ' H ' HD21 ' A' ' 23' ' ' LEU . 1.7 pt? -68.15 -22.32 64.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.67 0.748 . . . . 1.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.49 -29.99 64.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.2 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.46 41.6 2.11 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 30' ' ' VAL . 46.7 mt -85.41 116.59 66.19 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 119.956 -0.698 . . . . 1.0 112.542 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 29' ' ' GLU . 18.7 Cg_endo -68.31 -139.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.682 0 C-N-CA 121.638 1.559 . . . . 1.0 112.856 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.678 ' HB2' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -30.52 -4.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 126.761 2.024 . . . . 1.0 115.648 -173.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' A' ' 27' ' ' PRO . 10.9 mt-10 129.55 5.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 126.437 1.895 . . . . 1.0 113.903 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.483 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 55.5 t -41.99 127.15 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.793 -1.094 . . . . 1.0 108.503 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' NE ' ' CG2' ' A' ' 47' ' ' THR . 0.1 OUTLIER -127.35 155.33 43.76 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.237 0.828 . . . . 1.0 113.237 -177.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -92.15 116.31 28.83 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.614 0.721 . . . . 1.0 111.863 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -129.87 141.4 41.73 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.601 -1.182 . . . . 1.0 110.907 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . 71.4 Cg_endo -72.58 155.56 54.59 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.742 2.294 . . . . 1.0 114.655 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.752 ' C ' ' H ' ' A' ' 37' ' ' VAL . 11.4 m 109.22 -76.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.324 -1.307 . . . . 1.0 108.179 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.484 ' O ' ' CG ' ' A' ' 103' ' ' ASN . . . -51.81 7.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.966 -1.016 . . . . 1.0 111.991 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.752 ' H ' ' C ' ' A' ' 35' ' ' SER . 2.1 p -103.44 -50.26 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 1.9 p30 158.86 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 36.58 76.0 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.698 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 1.4 t 152.04 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.475 1.11 . . . . 1.0 112.207 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 42' ' ' ILE . 3.3 tpt180 -172.21 -168.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.765 -0.774 . . . . 1.0 111.558 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.415 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -95.28 152.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 O-C-N 123.443 0.464 . . . . 1.0 109.933 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -130.87 165.85 22.8 Favored Glycine 0 C--O 1.209 -1.43 0 N-CA-C 108.162 -1.975 . . . . 1.0 108.162 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.455 ' CG2' ' CG1' ' A' ' 30' ' ' VAL . 13.6 p -101.05 139.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 117.97 0.885 . . . . 1.0 111.276 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 6.0 m95 -134.46 154.0 51.63 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.993 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -92.0 122.54 34.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.887 -1.506 . . . . 1.0 108.581 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 62.7 p -109.07 3.77 22.38 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.431 0.634 . . . . 1.0 110.644 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.678 ' HG2' ' HB2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -128.96 170.9 9.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.696 -1.138 . . . . 1.0 111.826 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' N ' ' HG3' ' A' ' 132' ' ' PRO . 5.3 Cg_endo -85.38 129.66 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.589 2.193 . . . . 1.0 111.921 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.494 HD11 ' HZ3' ' A' ' 48' ' ' LYS . 93.2 mt -120.32 147.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.853 -1.067 . . . . 1.0 111.667 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.698 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -107.01 163.23 13.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.567 -1.197 . . . . 1.0 110.871 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 127.68 33.84 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.017 0.913 . . . . 1.0 112.607 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.857 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.14 8.29 39.11 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 114.535 -1.211 . . . . 1.0 113.944 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.6 ttmm -93.32 131.04 38.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.671 -1.611 . . . . 1.0 115.115 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -96.18 133.73 40.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.415 -1.266 . . . . 1.0 113.532 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.94 149.72 41.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.404 -0.816 . . . . 1.0 112.416 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.67 -100.77 1.55 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.385 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 66.8 Cg_endo -77.26 166.63 81.64 Favored 'Cis proline' 0 N--CA 1.504 2.116 0 CA-C-N 119.195 1.498 . . . . 1.0 112.546 0.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' O ' ' C ' ' A' ' 60' ' ' VAL . 17.6 t80 -55.7 107.49 0.34 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.221 -0.592 . . . . 1.0 110.51 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' GLY . 3.5 p -30.85 -61.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 123.774 0.671 . . . . 1.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 49.16 117.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.302 -0.475 . . . . 1.0 113.678 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 51.6 t0 -101.79 148.38 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.604 ' NZ ' ' CD2' ' A' ' 83' ' ' LEU . 4.9 mtmt -89.14 112.91 24.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.521 0.677 . . . . 1.0 110.994 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.576 ' HE3' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -132.73 166.33 22.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.738 -1.119 . . . . 1.0 111.444 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.576 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -84.81 130.99 34.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.321 0.489 . . . . 1.0 112.321 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.531 ' C ' ' H ' ' A' ' 68' ' ' GLN . 14.2 ptt180 -43.31 -23.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.002 0.741 . . . . 1.0 113.002 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.12 -13.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.024 -0.671 . . . . 1.0 110.326 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 66' ' ' ARG . 19.5 mm100 -100.57 -152.77 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.998 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 68' ' ' GLN . 23.9 m 31.68 -167.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mttm 174.74 -58.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.189 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 72' ' ' ASN . 25.1 t-20 -111.31 -88.37 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.579 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER 36.61 -160.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.237 0.335 . . . . 1.0 111.009 178.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.606 ' O ' ' CZ3' ' A' ' 76' ' ' TRP . 0.2 OUTLIER -146.45 -50.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 120.115 -0.634 . . . . 1.0 111.186 -179.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -69.78 41.99 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.619 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.575 ' H ' ' C ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -128.31 139.06 52.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.843 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -165.73 164.34 18.92 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.076 -1.05 . . . . 1.0 112.641 175.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.63 122.14 45.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.898 0.856 . . . . 1.0 110.982 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.59 121.96 51.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 106.076 -1.824 . . . . 1.0 106.076 178.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -81.34 123.53 28.61 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.02 -1.072 . . . . 1.0 112.001 -177.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' C ' ' H ' ' A' ' 82' ' ' ASN . 9.9 m-85 -86.56 111.03 36.62 Favored Pre-proline 0 N--CA 1.438 -1.045 0 O-C-N 124.866 1.354 . . . . 1.0 112.531 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.62 -12.13 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.762 1.642 . . . . 1.0 109.518 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 80' ' ' TYR . 73.9 m-80 -85.62 -116.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.208 -1.36 . . . . 1.0 110.47 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.643 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -47.99 -34.92 10.02 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 139.43 -175.14 21.87 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.334 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.425 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 16.3 m95 -58.03 120.54 8.74 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.39 0.595 . . . . 1.0 111.704 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 7.2 mmm -130.46 169.25 15.77 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.99 140.77 50.45 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 113.991 -1.459 . . . . 1.0 107.784 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -106.1 103.01 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.195 -0.911 . . . . 1.0 108.598 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.81 129.32 36.37 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.962 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' CB ' ' HZ2' ' A' ' 95' ' ' LYS . . . -141.41 91.7 2.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.953 -0.699 . . . . 1.0 112.159 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.579 ' HA ' HH11 ' A' ' 100' ' ' ARG . 0.1 OUTLIER -103.31 14.0 32.53 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.456 -0.897 . . . . 1.0 109.873 178.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.17 113.27 62.87 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.245 -0.889 . . . . 1.0 108.936 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.684 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 24.6 Cg_endo -69.58 -22.62 32.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.26 1.973 . . . . 1.0 112.097 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -56.6 -42.44 78.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.372 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -114.0 -5.51 13.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.854 0.359 . . . . 1.0 110.77 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -89.0 -144.28 10.33 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.516 -1.325 . . . . 1.0 113.432 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.66 -173.38 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.833 -0.684 . . . . 1.0 109.616 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -68.58 -19.29 64.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.885 -0.143 . . . . 1.0 111.163 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.12 -30.31 64.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.728 -0.789 . . . . 1.0 108.958 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 91' ' ' THR . 3.2 mtp85 -58.76 -11.26 2.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.85 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.5 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 10.7 m-85 -100.96 6.77 43.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.209 0.528 . . . . 1.0 110.405 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -81.11 129.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.642 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.597 HD22 ' CD1' ' A' ' 137' ' ' LEU . 0.5 OUTLIER -102.42 -137.85 0.34 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.13 -0.941 . . . . 1.0 111.22 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.539 ' N ' ' CG ' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -132.41 160.39 36.53 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.396 -0.19 . . . . 1.0 110.78 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.472 ' CB ' ' NE2' ' A' ' 111' ' ' GLN . . . -95.0 -120.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.135 1.532 . . . . 1.0 115.135 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.2 t -174.68 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.419 -1.719 . . . . 1.0 107.678 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' GLY . 13.6 t -139.66 -179.02 5.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.84 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . . . -89.26 -5.69 72.35 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 121.325 -0.465 . . . . 1.0 112.682 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.66 -20.29 43.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 10.3 pt-20 -113.78 -19.93 11.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.764 0.793 . . . . 1.0 110.124 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.628 ' NE2' ' C ' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -81.75 157.17 24.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.213 -1.358 . . . . 1.0 108.457 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -173.22 37.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.903 0.859 . . . . 1.0 111.755 -176.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.533 ' O ' ' CE1' ' A' ' 140' ' ' TYR . 5.0 mp -141.13 141.5 34.17 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -144.04 123.3 7.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.142 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.507 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 50.5 Cg_exo -55.28 104.07 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.903 1.735 . . . . 1.0 110.709 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 123' ' ' TYR . 10.0 tp -109.49 118.44 36.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' OE1' ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -94.47 117.76 30.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.31 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.422 ' CD1' ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -127.41 118.22 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.372 -1.344 . . . . 1.0 107.372 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.01 31.73 20.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.41 -1.33 . . . . 1.0 107.41 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.715 ' HE ' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 72.2 18.83 4.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.887 -1.051 . . . . 1.0 110.941 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.417 -0.81 . . . . 1.0 108.903 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.69 120.26 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.9 0.857 . . . . 1.0 112.282 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 116' ' ' LEU . 6.0 m-85 -113.62 157.03 22.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.664 -1.607 . . . . 1.0 108.79 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 4.6 m-30 -115.72 104.84 12.08 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.687 -0.805 . . . . 1.0 111.237 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 114' ' ' PHE . 5.4 ttmm -102.63 150.77 23.1 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 114.331 1.234 . . . . 1.0 114.331 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.857 ' O ' ' N ' ' A' ' 53' ' ' GLY . 4.8 p -103.12 107.88 18.85 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.89 -1.959 . . . . 1.0 109.883 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.566 HD11 ' HZ2' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -73.69 0.29 13.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 177.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.566 ' HZ2' HD11 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -150.52 152.07 32.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.055 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.47 143.74 43.56 Favored 'Trans proline' 0 N--CA 1.516 2.803 0 C-N-CA 123.163 2.575 . . . . 1.0 114.379 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.437 ' CD1' ' CG ' ' A' ' 112' ' ' ASN . 0.8 OUTLIER -110.04 135.59 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.888 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.02 133.45 69.24 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.449 ' HG3' ' N ' ' A' ' 49' ' ' PRO . 86.9 Cg_exo -50.24 103.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 122.868 2.378 . . . . 1.0 116.513 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 129.15 12.06 2.68 Favored Glycine 0 N--CA 1.468 0.81 0 C-N-CA 120.372 -0.918 . . . . 1.0 113.789 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.451 ' H ' ' HG2' ' A' ' 134' ' ' GLU . 2.9 pt-20 -109.41 166.47 10.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.881 0.841 . . . . 1.0 111.614 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -79.06 136.04 37.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.567 -1.197 . . . . 1.0 112.566 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 mt -82.84 116.03 21.98 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.147 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.597 ' CD1' HD22 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.16 159.25 30.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 122.95 0.5 . . . . 1.0 111.658 -178.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.628 ' C ' ' NE2' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -122.91 148.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 178.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.829 ' C ' ' CD1' ' A' ' 140' ' ' TYR . 2.7 m95 140.37 -74.52 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.018 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.829 ' CD1' ' C ' ' A' ' 139' ' ' TRP . 15.9 p90 44.75 31.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 123.882 0.738 . . . . 1.0 111.75 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.584 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.492 ' O ' ' C ' ' A' ' 143' ' ' GLU . . . . . . . . 0 CA--C 1.532 1.141 0 N-CA-C 111.607 -0.597 . . . . 1.0 111.607 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 142' ' ' GLY . 0.4 OUTLIER -9.5 122.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.778 0.831 . . . . 1.0 112.546 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 143' ' ' GLU . 6.2 t0 89.33 -1.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.948 -1.478 . . . . 1.0 108.079 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.608 HD22 ' HB2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -71.71 144.68 88.73 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.347 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.416 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 28.3 Cg_endo -62.18 -20.33 69.61 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.13 1.887 . . . . 1.0 112.72 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.608 ' HB2' HD22 ' A' ' 145' ' ' ASN . 0.3 OUTLIER -77.2 -34.4 56.18 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 177.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -75.23 -54.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 113.933 -1.485 . . . . 1.0 110.874 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.448 ' N ' HG21 ' A' ' 148' ' ' ILE . . . -54.38 -54.19 43.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.2 -31.35 52.76 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.0 -1.0 . . . . 1.0 109.012 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.401 ' CB ' ' CE2' ' A' ' 114' ' ' PHE . . . -80.34 -45.16 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.833 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.467 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 30.2 mt -56.51 -49.37 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.587 -1.634 . . . . 1.0 106.587 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -60.82 -27.65 68.21 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.061 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.475 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -69.48 -50.71 42.82 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.094 -1.042 . . . . 1.0 111.192 -179.206 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.475 ' N ' ' HG2' ' A' ' 154' ' ' GLU . 8.6 tp10 -80.19 -50.52 10.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.467 ' CG ' ' O ' ' A' ' 152' ' ' ILE . 4.4 ppt_? -63.24 -41.12 99.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.455 ' O ' ' CZ ' ' A' ' 160' ' ' ARG . . . -64.12 -23.0 67.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.528 -0.916 . . . . 1.0 108.528 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 154' ' ' GLU . 11.0 m -89.67 15.04 10.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.199 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -136.32 39.85 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.16 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.455 ' CZ ' ' O ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -48.61 138.51 10.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.469 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.568 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.566 -1.414 . . . . 1.0 109.566 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.3 p 44.6 -90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.791 0.329 . . . . 1.0 110.565 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' -1' ' ' GLY . 0.1 OUTLIER -167.98 91.36 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.595 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -139.05 114.1 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.628 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -99.33 108.36 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.507 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -149.72 -66.68 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.594 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.686 ' HG1' ' H ' ' A' ' 6' ' ' THR . 15.0 t -145.4 -166.64 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.692 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.686 ' H ' ' HG1' ' A' ' 5' ' ' THR . 29.2 m -154.1 121.73 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.495 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -95.12 153.33 39.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.0 124.36 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.277 1.985 . . . . 1.0 112.002 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 p -84.17 107.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.634 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.05 60.72 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.509 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 38.18 -148.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -128.7 -73.01 0.59 Allowed 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -44.51 154.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.345 -0.983 . . . . 1.0 108.345 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 151.4 41.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.437 0.637 . . . . 1.0 111.575 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -51.99 -32.67 34.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.137 -0.938 . . . . 1.0 109.03 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.59 60.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.728 -1.123 . . . . 1.0 111.948 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -24.94 22.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.511 -0.476 . . . . 1.0 112.146 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.73 144.85 64.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.8 Cg_exo -57.59 132.42 50.3 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.039 1.826 . . . . 1.0 113.077 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' CG ' ' HE ' ' A' ' 24' ' ' ARG . 34.3 tt0 -49.04 -31.79 8.32 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.782 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -74.18 -34.32 63.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 23' ' ' LEU . 14.5 m -75.88 -46.08 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.774 -177.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CD2' ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.01 -21.01 65.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.515 -0.874 . . . . 1.0 109.646 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HE ' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.0 -38.91 69.55 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.294 -1.321 . . . . 1.0 111.947 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.57 36.43 4.35 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.681 -0.771 . . . . 1.0 112.318 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.5 mt -90.09 129.3 46.42 Favored Pre-proline 0 CA--C 1.503 -0.861 0 C-N-CA 119.728 -0.789 . . . . 1.0 111.823 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.02 167.48 15.9 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 N-CA-C 108.63 -1.334 . . . . 1.0 108.63 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.431 ' O ' ' OG1' ' A' ' 47' ' ' THR . 2.7 pt-20 -57.09 -10.2 1.11 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.94 -1.482 . . . . 1.0 114.521 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.899 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -109.23 18.67 20.27 Favored 'General case' 0 CA--C 1.449 -2.907 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.283 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.44 ' CG2' ' C ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -138.47 123.35 22.51 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 C-N-CA 117.268 -1.773 . . . . 1.0 114.115 -175.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -130.47 151.79 50.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.228 -1.805 . . . . 1.0 107.685 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.11 124.87 42.86 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.175 -0.61 . . . . 1.0 109.881 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.44 133.48 9.57 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.353 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 35' ' ' SER . 5.9 Cg_endo -85.21 149.86 10.58 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.168 1.912 . . . . 1.0 108.389 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.4 m 152.33 -73.31 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.82 -61.29 2.3 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.575 -1.25 . . . . 1.0 108.895 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.8 p -60.94 -51.75 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.94 -0.392 . . . . 1.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.8 OUTLIER 59.52 -40.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.592 0.96 . . . . 1.0 113.592 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 40' ' ' THR . 25.6 mttm -30.4 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.172 0.295 . . . . 1.0 111.663 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 153.41 22.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.038 0.836 . . . . 1.0 111.654 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 17.0 mtp180 -140.54 163.0 34.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.796 -0.762 . . . . 1.0 111.932 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 149.15 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.397 0.618 . . . . 1.0 110.88 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.78 13.63 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.87 127.25 59.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 22.5 m95 -126.65 144.69 50.83 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.899 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.72 134.31 49.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.997 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 28' ' ' GLU . 68.4 p -119.11 -21.71 7.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.08 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.614 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -117.84 165.99 14.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.439 179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -77.79 125.31 7.34 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 123.04 2.493 . . . . 1.0 111.772 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.1 149.58 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 113.394 -1.73 . . . . 1.0 112.801 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.708 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.87 164.64 12.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.828 -1.533 . . . . 1.0 110.261 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.619 ' H ' ' CE ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -68.71 128.03 35.18 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.103 178.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 1.003 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.57 8.22 38.03 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 119.066 -0.852 . . . . 1.0 114.455 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 1.9 ttmt -82.24 130.87 35.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 117.278 -1.769 . . . . 1.0 115.308 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -88.98 120.18 30.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.682 -1.599 . . . . 1.0 113.13 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.606 ' CG ' ' OE2' ' A' ' 29' ' ' GLU . 55.0 m-85 -119.75 150.02 41.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.483 0.658 . . . . 1.0 112.714 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.25 -102.29 2.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 113.706 -1.588 . . . . 1.0 110.151 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.79 170.45 69.42 Favored 'Cis proline' 0 N--CA 1.499 1.816 0 CA-C-N 119.355 1.578 . . . . 1.0 112.414 -1.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.628 ' CD1' ' NH2' ' A' ' 100' ' ' ARG . 38.5 t80 -54.46 107.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.785 -0.766 . . . . 1.0 109.056 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.525 HG12 ' NH2' ' A' ' 100' ' ' ARG . 5.6 p -42.74 -49.51 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.967 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 45.0 121.32 0.0 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.621 0.608 . . . . 1.0 114.621 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.87 145.93 28.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HZ3' ' CD1' ' A' ' 83' ' ' LEU . 1.1 mtmp? -89.51 113.92 25.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.056 0.455 . . . . 1.0 111.679 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' CE ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -142.76 169.88 16.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.631 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -80.65 133.61 35.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.374 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' O ' ' N ' ' A' ' 68' ' ' GLN . 30.8 ttp85 -45.53 -21.34 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.783 1.031 . . . . 1.0 113.783 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -35.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.969 0.414 . . . . 1.0 110.939 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 66' ' ' ARG . 59.5 mm-40 -95.7 -140.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.363 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 68' ' ' GLN . 15.7 m 38.87 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 121.521 0.676 . . . . 1.0 111.587 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -114.41 -29.5 6.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.707 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.69 31.7 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.214 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.506 ' CB ' ' SD ' ' A' ' 75' ' ' MET . 55.8 m-80 -89.69 -179.37 5.75 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.678 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -119.1 -55.58 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -177.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -66.36 46.84 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.259 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.727 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -129.78 139.58 51.24 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -162.79 163.85 26.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 118.999 -1.08 . . . . 1.0 113.091 175.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -103.37 122.73 45.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.89 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.17 122.67 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.932 -1.507 . . . . 1.0 106.932 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.5 t80 -80.67 125.66 30.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.635 ' C ' ' H ' ' A' ' 82' ' ' ASN . 20.2 m-85 -103.05 104.2 38.72 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 114.897 -1.047 . . . . 1.0 113.059 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -62.87 10.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.388 1.392 . . . . 1.0 110.811 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.635 ' H ' ' C ' ' A' ' 80' ' ' TYR . 76.3 m-20 -97.39 2.41 50.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.094 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 83' ' ' LEU . 1.1 pt? -178.23 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.015 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 150.09 179.67 26.09 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.439 ' C ' ' SD ' ' A' ' 86' ' ' MET . 18.2 m95 -58.15 122.37 12.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 19.1 mmm -127.28 167.39 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.483 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -117.75 138.04 52.3 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.265 -1.754 . . . . 1.0 106.265 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.67 102.28 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -131.18 128.18 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.119 0.485 . . . . 1.0 111.33 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.73 92.47 2.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.219 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -111.1 13.31 21.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.366 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 94' ' ' GLU . 1.1 m-20 -108.84 99.6 35.43 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.938 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.434 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 50.6 Cg_exo -51.2 -14.78 1.74 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.628 2.218 . . . . 1.0 111.45 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 92' ' ' ASP . 5.9 mm-40 -63.92 -43.84 94.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.646 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' CD ' ' C ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -116.28 -8.48 11.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.785 -179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.464 ' O ' ' OD1' ' A' ' 97' ' ' ASN . . . -95.48 -143.1 13.77 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.125 -1.036 . . . . 1.0 113.05 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.619 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 24.6 m-20 -137.18 -166.21 1.88 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.999 0.428 . . . . 1.0 110.475 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.407 ' O ' ' N ' ' A' ' 101' ' ' TYR . 58.6 p-90 -70.4 -22.13 62.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.797 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.43 ' O ' ' CE2' ' A' ' 74' ' ' TYR . 5.9 mp -54.13 -24.22 17.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.741 ' H ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -61.7 -10.28 8.26 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 12.8 m-85 -107.24 -11.81 15.5 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.232 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.88 117.66 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.101 -1.04 . . . . 1.0 109.878 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -152.02 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' N ' ' CE3' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -124.5 165.25 18.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.372 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 138' ' ' VAL . . . -108.84 -131.83 0.32 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.44 -31.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' A' ' 110' ' ' GLU . 4.0 m -143.78 175.7 9.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.695 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.95 -23.25 76.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 -22.37 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 107' ' ' SER . 4.0 pt-20 -109.15 -25.86 10.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.127 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' CD ' ' O ' ' A' ' 111' ' ' GLN . 0.6 OUTLIER -86.93 102.21 14.14 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.515 ' HA ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -104.09 0.32 29.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -140.51 144.75 36.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -142.82 132.51 12.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.736 1.754 . . . . 1.0 115.736 -176.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.6 122.36 3.93 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.122 3.215 . . . . 1.0 114.722 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 123' ' ' TYR . 1.9 tp -132.2 128.05 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -97.49 118.73 34.63 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.947 -0.701 . . . . 1.0 110.856 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.423 HG23 HD12 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -129.36 114.95 33.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.088 -1.078 . . . . 1.0 108.088 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.4 39.21 25.52 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.622 ' HE ' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 67.05 17.56 10.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.004 -0.998 . . . . 1.0 110.658 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.69 123.82 49.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.394 -0.821 . . . . 1.0 108.974 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -82.25 126.98 40.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 116' ' ' LEU . 6.0 m-85 -122.01 155.13 36.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.799 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -111.68 124.22 51.88 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -128.76 152.82 48.01 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 1.003 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.8 p -102.04 139.73 37.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.111 -1.858 . . . . 1.0 110.789 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.708 ' H ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -107.18 -4.44 18.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.182 -1.372 . . . . 1.0 109.024 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.921 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.45 131.83 11.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 114.937 -1.028 . . . . 1.0 110.435 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 145.64 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.601 1.534 . . . . 1.0 111.51 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mt -108.39 134.48 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' H ' ' CD ' ' A' ' 134' ' ' GLU . . . -77.15 115.77 51.67 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -38.68 113.12 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 123.004 2.469 . . . . 1.0 114.243 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 118.32 6.43 12.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.915 -0.659 . . . . 1.0 113.251 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' ALA . 4.5 pt-20 -100.41 164.43 11.92 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.419 1.11 . . . . 1.0 111.429 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HB3' ' CZ3' ' A' ' 45' ' ' TRP . 5.9 pt-20 -78.62 133.24 37.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.075 -0.966 . . . . 1.0 111.345 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 5.9 mp -86.36 122.4 30.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.326 -0.852 . . . . 1.0 108.941 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -130.71 158.16 40.83 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 139' ' ' TRP . 4.1 t -114.83 146.13 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.742 ' CG ' ' N ' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -15.32 -118.12 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 O-C-N 125.83 1.956 . . . . 1.0 113.228 177.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.742 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -124.87 18.63 8.56 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.36 1.615 . . . . 1.0 115.36 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.653 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.704 ' N ' ' HZ2' ' A' ' 139' ' ' TRP . . . . . . . . 0 CA--C 1.543 1.802 0 N-CA-C 111.826 -0.51 . . . . 1.0 111.826 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.916 ' O ' ' N ' ' A' ' 145' ' ' ASN . 1.7 tm-20 -177.77 -49.07 0.01 OUTLIER 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -18.97 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.033 1.494 . . . . 1.0 115.033 -178.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.916 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -119.48 166.94 13.2 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.159 0.584 . . . . 1.0 112.029 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.564 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 89.3 Cg_endo -98.56 -15.93 0.22 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 122.402 2.068 . . . . 1.0 112.934 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.799 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 0.6 OUTLIER -75.91 -36.97 59.23 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.471 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 1.4 mt -75.32 -55.97 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.758 -1.11 . . . . 1.0 109.757 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.17 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.077 -0.965 . . . . 1.0 111.684 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.39 -34.27 47.24 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.78 -33.19 52.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 1.0 111.206 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 148' ' ' ILE . 58.8 mt -52.92 -50.35 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 107.6 -1.259 . . . . 1.0 107.6 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 31.7 mt-10 -59.89 -36.62 77.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.427 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.473 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.6 OUTLIER -58.41 -46.48 86.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 119.528 -0.869 . . . . 1.0 111.566 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.545 ' CD ' ' HZ1' ' A' ' 125' ' ' LYS . 1.8 tp10 -79.15 -50.89 10.28 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.478 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 4.7 ppt_? -76.54 -46.8 24.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.955 0.724 . . . . 1.0 112.955 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.507 ' O ' ' NE ' ' A' ' 160' ' ' ARG . . . -61.76 -23.83 66.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.082 0.468 . . . . 1.0 109.944 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 154' ' ' GLU . 4.9 m -97.08 27.21 4.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.043 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -141.21 34.02 1.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.719 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -52.82 163.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.399 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.589 -1.405 . . . . 1.0 109.589 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.53 139.28 25.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.358 . . . . 1.0 110.579 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.68 105.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.588 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.94 90.48 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.596 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -46.96 131.68 12.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -59.15 177.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.489 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -155.31 57.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.542 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 m -88.56 104.88 17.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.511 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.16 154.85 94.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.296 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -39.32 159.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.396 2.064 . . . . 1.0 111.951 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -86.16 132.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.288 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 56.39 160.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.496 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -85.6 -35.83 20.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 20.5 m -175.27 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.202 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 34' ' ' PRO . 2.9 mm-40 -57.8 166.23 1.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 1.0 111.453 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -127.42 148.88 50.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.038 -0.983 . . . . 1.0 110.593 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.665 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -58.39 -36.2 73.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.9 -18.73 55.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.271 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 14' ' ' THR . 4.6 tp10 -80.28 -46.65 15.82 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.626 -0.716 . . . . 1.0 112.383 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -41.17 158.36 0.18 Allowed Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 120.173 -0.611 . . . . 1.0 109.574 -178.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.38 118.75 3.49 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.505 2.136 . . . . 1.0 112.093 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -51.43 -43.24 61.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.459 1.281 . . . . 1.0 114.459 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.594 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 4.7 p80 -62.1 -29.41 70.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.095 0.474 . . . . 1.0 111.302 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.529 HG13 ' N ' ' A' ' 98' ' ' TRP . 73.2 t -72.93 -48.72 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.305 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.69 -25.88 62.28 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.175 0.988 . . . . 1.0 110.779 176.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -34.36 58.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.433 -1.712 . . . . 1.0 109.612 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.84 17.62 17.59 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.194 -0.762 . . . . 1.0 111.194 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.548 HD11 ' CD2' ' A' ' 98' ' ' TRP . 45.2 tp -79.41 122.98 84.57 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 117.081 0.441 . . . . 1.0 110.735 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' C ' ' O ' ' A' ' 26' ' ' LEU . 35.4 Cg_exo -35.23 137.26 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.286 1.324 . . . . 1.0 110.954 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.504 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 18.5 pt-20 -53.32 -31.91 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.777 -1.556 . . . . 1.0 109.373 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 1.5 pm0 -85.4 18.26 2.78 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 113.538 -1.664 . . . . 1.0 112.496 -176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.527 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 87.0 t -136.15 143.64 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 C-N-CA 118.726 -1.189 . . . . 1.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -144.0 155.36 43.99 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.192 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -102.68 148.02 26.11 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.673 0.749 . . . . 1.0 111.753 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.421 ' CG ' HD11 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -156.75 119.78 2.24 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 113.86 -1.518 . . . . 1.0 111.834 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 35' ' ' SER . 19.0 Cg_endo -80.69 152.02 19.53 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.899 1.732 . . . . 1.0 111.062 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 4.3 p 87.76 -27.04 0.07 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.964 0.888 . . . . 1.0 108.799 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -53.89 -62.53 1.59 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.89 -52.32 62.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.563 -0.29 . . . . 1.0 111.586 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 2.2 m-20 162.12 63.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.621 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.488 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.0 OUTLIER 30.63 36.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.917 -1.038 . . . . 1.0 109.365 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 91.1 m -91.96 -24.3 19.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.558 -1.655 . . . . 1.0 110.094 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 161.55 -157.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.229 -1.397 . . . . 1.0 107.229 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.19 137.55 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.863 -1.532 . . . . 1.0 106.863 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.57 155.35 19.5 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 109.032 -1.627 . . . . 1.0 109.032 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 2.0 m -100.91 136.5 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.166 0.984 . . . . 1.0 110.52 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.531 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 18.9 m95 -129.97 154.25 47.56 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.477 -1.692 . . . . 1.0 110.37 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.642 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -70.88 144.18 50.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.242 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.65 -26.54 2.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.389 -0.525 . . . . 1.0 110.381 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HE3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -120.44 158.77 50.38 Favored Pre-proline 0 C--N 1.341 0.215 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.96 124.73 16.62 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.424 2.083 . . . . 1.0 112.379 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 50' ' ' ILE . 3.9 mt -112.18 131.27 64.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.584 -1.189 . . . . 1.0 108.425 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.672 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.42 146.11 36.44 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 122.26 1.029 . . . . 1.0 111.314 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -50.69 133.63 25.59 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 113.324 -1.762 . . . . 1.0 107.532 177.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.77 2.06 52.57 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.612 -1.28 . . . . 1.0 115.447 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 26.6 ttpt -96.29 140.72 30.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.913 1.357 . . . . 1.0 112.594 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.21 135.59 40.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.947 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 34.3 m-85 -115.72 126.67 54.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.216 0.531 . . . . 1.0 112.093 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.69 -132.04 7.32 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 119.362 -0.688 . . . . 1.0 112.983 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -80.62 171.97 58.26 Favored 'Cis proline' 0 N--CA 1.511 2.551 0 CA-C-N 120.03 1.915 . . . . 1.0 114.305 3.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.759 ' CD2' ' ND2' ' A' ' 97' ' ' ASN . 1.6 t80 -72.44 122.15 20.78 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.672 0.748 . . . . 1.0 109.531 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.733 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 63.8 t -102.9 138.65 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.169 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.39 -171.23 26.03 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.48 138.83 37.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.907 0.384 . . . . 1.0 110.499 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.84 117.28 29.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.636 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -140.4 164.81 29.11 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.297 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.661 ' H ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.19 145.16 33.8 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.653 0.264 . . . . 1.0 110.764 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -50.27 -44.5 53.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 110.161 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 p -70.26 70.39 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.432 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.0 -36.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.789 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 m -96.52 154.48 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.104 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -132.92 -90.62 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.48 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -69.94 48.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.253 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.571 HD22 ' CG2' ' A' ' 91' ' ' THR . 0.7 OUTLIER -118.25 -175.18 2.81 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.628 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 4.3 p -174.64 -9.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.56 . . . . 1.0 111.92 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 4.9 m-85 -92.37 43.18 1.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -118.03 156.47 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.826 -178.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.66 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -135.3 166.89 22.09 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.446 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -126.43 128.03 46.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.764 0.316 . . . . 1.0 110.744 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.56 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -141.77 141.51 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.294 0.568 . . . . 1.0 112.405 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 15.9 t80 -91.19 125.29 35.92 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.855 0.687 . . . . 1.0 112.855 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CD2' ' CD2' ' A' ' 83' ' ' LEU . 7.1 m-85 -102.22 145.56 30.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.841 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.62 3.22 5.59 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.72 1.614 . . . . 1.0 109.706 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -125.41 -68.77 0.82 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.412 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.491 ' CD2' ' CD2' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -74.41 -23.38 58.94 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.102 -178.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.39 -152.65 25.58 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 108.78 -1.728 . . . . 1.0 108.78 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -63.42 119.22 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.39 -0.924 . . . . 1.0 110.119 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.7 ppp? -129.46 169.15 15.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.838 -1.073 . . . . 1.0 108.951 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' LYS . 26.2 m -121.02 144.79 48.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.36 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 mt -98.58 146.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 106.8 -1.555 . . . . 1.0 106.8 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 139.5 50.22 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.078 0.77 . . . . 1.0 113.078 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.66 140.62 50.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.615 -1.624 . . . . 1.0 106.615 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.571 ' CG2' HD22 ' A' ' 72' ' ' ASN . 3.4 p -151.63 15.7 0.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.987 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.26 141.83 0.13 Allowed Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.815 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.81 -18.18 32.25 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.263 1.975 . . . . 1.0 112.597 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -78.04 -6.19 53.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.826 0.822 . . . . 1.0 109.277 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 9.77 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.375 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 97' ' ' ASN . . . 94.26 156.16 32.13 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.759 ' ND2' ' CD2' ' A' ' 59' ' ' PHE . 17.2 t30 84.07 110.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.579 ' O ' ' CD1' ' A' ' 101' ' ' TYR . 70.0 p-90 -71.31 -25.53 62.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.187 0.518 . . . . 1.0 109.759 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.491 ' HB2' ' ND2' ' A' ' 97' ' ' ASN . 1.7 mt -60.08 -24.46 64.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.636 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' NE ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -68.29 -11.1 58.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 119.107 -0.473 . . . . 1.0 111.234 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 98' ' ' TRP . 0.1 OUTLIER -120.14 5.87 10.79 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.613 -0.835 . . . . 1.0 113.173 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.65 119.0 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.291 -0.564 . . . . 1.0 110.825 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -80.98 114.75 20.07 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.531 ' CD1' ' O ' ' A' ' 105' ' ' ALA . 4.9 p90 -88.03 159.09 18.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 104' ' ' TRP . . . -38.72 159.55 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 113.772 -1.558 . . . . 1.0 113.45 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.27 -4.4 21.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.134 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.64 -30.6 0.09 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.561 -0.456 . . . . 1.0 111.974 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.67 -29.37 6.64 Favored Glycine 0 C--N 1.321 -0.28 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.24 -19.46 5.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -112.76 -24.37 9.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.483 -0.78 . . . . 1.0 111.389 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.645 ' CD ' ' O ' ' A' ' 139' ' ' TRP . 1.1 tp-100 -48.2 139.12 8.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.101 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.633 ' C ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -124.98 6.73 7.97 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 119.154 -0.451 . . . . 1.0 112.106 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.672 ' N ' ' HZ3' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -154.96 174.56 14.99 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 118.263 0.483 . . . . 1.0 110.084 176.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 113' ' ' LEU . 1.6 p90 -139.62 145.6 44.15 Favored Pre-proline 0 C--N 1.346 0.425 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -82.38 138.2 9.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.754 2.303 . . . . 1.0 113.892 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' TYR . 0.7 OUTLIER -139.52 134.5 32.32 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.894 179.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.451 ' H ' HD22 ' A' ' 116' ' ' LEU . 40.4 mt-10 -89.25 123.71 33.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.223 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 121' ' ' ALA . 15.3 mt -139.6 129.49 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 46.14 43.01 10.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.114 -0.634 . . . . 1.0 110.012 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? 62.87 17.51 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.904 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -121.99 128.71 51.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -88.93 116.46 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.692 -0.803 . . . . 1.0 112.676 -177.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.461 ' HB2' ' HZ3' ' A' ' 125' ' ' LYS . 13.7 m-85 -108.06 156.67 19.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.157 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 5.4 m-30 -112.89 125.78 54.75 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 107.575 -1.268 . . . . 1.0 107.575 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 114' ' ' PHE . 2.0 mptt -116.53 139.23 50.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -131.82 125.59 32.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.676 -0.678 . . . . 1.0 112.453 178.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.491 HD23 ' ND2' ' A' ' 145' ' ' ASN . 0.0 OUTLIER -98.96 21.42 11.65 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 119.911 -0.716 . . . . 1.0 109.592 175.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.672 ' HZ3' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -124.53 119.51 25.99 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.23 97.78 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.963 0 CA-C-N 120.628 1.26 . . . . 1.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.62 136.42 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.447 -176.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.54 132.8 51.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.302 0.852 . . . . 1.0 113.302 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.04 103.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.163 1.908 . . . . 1.0 111.675 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 124.82 -7.22 8.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.062 -0.589 . . . . 1.0 113.164 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 135' ' ' GLU . 1.4 pp20? -87.7 154.14 20.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.942 0.871 . . . . 1.0 111.026 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.454 ' O ' ' OE2' ' A' ' 134' ' ' GLU . 1.6 pm0 -73.71 125.08 27.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.233 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.9 mp -78.39 124.85 28.57 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.665 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 4.2 mp -123.56 146.1 48.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-O 118.982 -0.532 . . . . 1.0 112.18 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.536 ' CA ' ' OE1' ' A' ' 111' ' ' GLN . 9.4 t -104.46 132.96 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.645 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 92.36 142.27 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 125.19 1.396 . . . . 1.0 110.869 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 141' ' ' IAS . 8.1 t80 -118.62 163.37 16.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.825 1.417 . . . . 1.0 114.825 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.605 ' N ' ' CD1' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 140' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.396 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.488 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 2.6 mp0 53.82 88.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.853 -0.174 . . . . 1.0 110.946 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 144' ' ' ASP . 55.4 t0 -103.29 -41.44 6.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.663 2.098 . . . . 1.0 116.663 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.631 ' ND2' ' N ' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -66.07 156.28 84.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 119.933 -0.707 . . . . 1.0 112.817 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 150' ' ' ALA . 8.9 Cg_endo -48.13 -71.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.55 2.167 . . . . 1.0 110.131 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -55.52 -20.7 13.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.229 0.537 . . . . 1.0 110.169 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.631 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -74.44 -56.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 119.31 -0.956 . . . . 1.0 108.92 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' A' ' 153' ' ' GLU . . . -74.09 -34.82 64.1 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.548 -0.861 . . . . 1.0 109.744 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 146' ' ' PRO . . . -80.25 -66.6 0.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.603 -0.839 . . . . 1.0 110.765 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 147' ' ' GLU . . . -51.75 -29.54 19.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 117.834 -1.546 . . . . 1.0 110.868 -174.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.561 ' CD1' ' O ' ' A' ' 148' ' ' ILE . 55.9 mt -66.4 -53.12 39.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.405 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -68.09 -37.6 81.4 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.188 -0.915 . . . . 1.0 113.126 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.546 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 7.2 pt-20 -57.64 -50.12 74.2 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.889 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.546 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 26.8 tp10 -76.29 -50.1 15.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.382 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.482 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -77.57 -49.78 13.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.783 -179.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.482 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -63.84 -23.61 67.42 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.115 -0.634 . . . . 1.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.41 -35.18 0.25 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.243 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -129.45 136.07 49.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.954 0.407 . . . . 1.0 111.134 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -142.83 -49.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.577 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.593 -179.884 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 71.9 p -140.21 11.64 2.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.72 0.295 . . . . 1.0 110.544 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mmt -133.35 40.63 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.477 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -103.66 169.85 8.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.484 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.65 36.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.655 ' ND2' ' H ' ' A' ' 5' ' ' THR . 1.9 p-10 -169.36 -62.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.502 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.655 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 51.3 m 43.72 85.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -104.43 102.4 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.547 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.06 153.51 88.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.21 169.4 19.57 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.246 1.964 . . . . 1.0 112.248 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.404 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 47.7 t -144.7 50.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.56 176.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.498 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -80.99 -45.83 16.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.949 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 88.1 m -169.93 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 34' ' ' PRO . 1.7 mt-10 -50.93 165.54 0.11 Allowed 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.539 0.685 . . . . 1.0 110.735 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -126.72 153.81 44.98 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.913 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -52.31 -31.89 35.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.95 -17.77 56.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.073 -1.422 . . . . 1.0 110.131 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.62 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.8 tp10 -77.97 -47.92 17.45 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.292 0.849 . . . . 1.0 113.292 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.85 147.8 4.3 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' CD ' ' OH ' ' A' ' 101' ' ' TYR . 5.2 Cg_exo -52.39 130.52 36.38 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.199 1.266 . . . . 1.0 111.898 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 4.4 tt0 -52.15 -34.94 46.99 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 114.564 -1.198 . . . . 1.0 113.011 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.724 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -79.27 -35.26 41.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.573 0.953 . . . . 1.0 113.573 -177.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.52 -31.2 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -71.81 -41.57 68.08 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.753 -2.021 . . . . 1.0 110.831 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -81.54 -20.02 40.89 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.164 0.585 . . . . 1.0 112.279 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.75 -26.98 36.31 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 110.148 -1.181 . . . . 1.0 110.148 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.624 ' HB3' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -63.76 144.13 97.97 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 117.907 -1.517 . . . . 1.0 111.564 -178.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.04 151.68 8.5 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 120.988 1.125 . . . . 1.0 111.871 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt-20 -52.84 -31.08 37.24 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.985 -1.461 . . . . 1.0 110.407 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -87.93 20.53 3.06 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 115.017 -0.992 . . . . 1.0 111.181 -178.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 21.4 t -135.29 137.03 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 C-N-CA 119.52 -0.872 . . . . 1.0 110.879 -177.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.544 ' NH1' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER -146.26 159.45 43.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.1 mm? -104.57 141.08 37.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.16 120.82 3.31 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.772 -0.632 . . . . 1.0 111.654 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' N ' HG13 ' A' ' 42' ' ' ILE . 9.8 Cg_endo -82.1 151.69 16.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.693 1.596 . . . . 1.0 111.689 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.429 ' HB3' ' N ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 78.06 15.6 1.43 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.46 -1.682 . . . . 1.0 106.46 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.413 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.55 -64.53 1.13 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.62 -29.77 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 78.44 -11.79 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.18 -0.918 . . . . 1.0 112.636 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 40' ' ' THR . 1.3 pttp -49.92 -12.19 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.587 ' H ' ' C ' ' A' ' 38' ' ' ASP . 4.9 m 98.84 64.41 0.0 OUTLIER 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.77 1.294 . . . . 1.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.403 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER 171.99 -165.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.196 -0.911 . . . . 1.0 108.951 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 34' ' ' PRO . 2.4 tt -101.62 144.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.58 163.02 22.78 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 109.316 -1.513 . . . . 1.0 109.316 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -99.66 136.24 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 CA-C-O 121.263 0.554 . . . . 1.0 109.724 -178.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.504 ' CZ3' ' CB ' ' A' ' 135' ' ' GLU . 28.6 m95 -129.29 151.84 49.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.881 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -68.57 144.67 54.47 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.085 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.544 ' CG2' ' NH1' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -126.44 -29.64 2.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.538 -178.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -124.5 159.99 55.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.13 123.95 13.73 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.195 1.93 . . . . 1.0 112.937 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.04 131.52 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.145 -1.389 . . . . 1.0 107.544 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.686 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -109.72 155.24 21.8 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.925 0.869 . . . . 1.0 111.034 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -63.42 133.76 54.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.03 -1.441 . . . . 1.0 109.027 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.72 1.94 55.26 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.503 -1.332 . . . . 1.0 115.107 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 15.3 ttpt -90.1 134.34 34.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.167 -1.013 . . . . 1.0 112.485 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.08 130.43 36.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.14 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 5.5 m-85 -115.36 127.37 55.36 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.728 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.17 -146.97 17.59 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -79.87 166.51 77.01 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 CA-C-N 119.583 1.692 . . . . 1.0 115.118 0.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -83.17 111.83 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.246 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.803 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.8 t -43.24 -61.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.401 -2.181 . . . . 1.0 114.079 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 32.35 106.34 0.0 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-O 121.469 0.483 . . . . 1.0 112.931 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -72.81 143.13 47.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' NZ ' ' HH ' ' A' ' 80' ' ' TYR . 1.7 mptp? -92.62 117.67 30.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.587 0.708 . . . . 1.0 112.79 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HZ3' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -141.91 167.89 21.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.677 -1.147 . . . . 1.0 111.213 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 135.86 37.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.1 0.476 . . . . 1.0 110.435 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -48.07 -24.39 1.08 Allowed 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.964 -0.46 . . . . 1.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.68 -6.29 58.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.342 . . . . 1.0 111.403 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -70.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.674 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.606 ' CG2' ' H ' ' A' ' 70' ' ' LYS . 3.9 m -36.57 -93.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.606 ' H ' ' CG2' ' A' ' 69' ' ' VAL . 4.6 tttm 84.82 -4.75 0.96 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.866 0.365 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.85 52.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.104 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.598 HD22 ' CG2' ' A' ' 91' ' ' THR . 0.7 OUTLIER -154.66 -164.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.61 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 7.5 p -169.54 -8.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.486 -0.886 . . . . 1.0 112.939 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 8.8 m-85 -94.54 62.85 2.87 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.73 150.38 41.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.504 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.678 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -128.58 165.35 20.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.845 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.88 132.04 53.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.749 0.277 . . . . 1.0 111.749 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.567 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -146.73 141.33 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.512 0.672 . . . . 1.0 112.798 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -83.51 124.94 31.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.286 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 82' ' ' ASN . 4.4 m-85 -102.95 120.09 53.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.28 -12.86 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 N-CA-C 109.208 -1.112 . . . . 1.0 109.208 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.554 ' H ' ' C ' ' A' ' 80' ' ' TYR . 1.1 m-80 -101.16 -86.96 0.4 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.78 -1.1 . . . . 1.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' H ' ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 119.794 -0.762 . . . . 1.0 110.842 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . 89.46 -139.77 15.32 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.905 -1.678 . . . . 1.0 108.905 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.1 118.58 12.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.47 -0.892 . . . . 1.0 110.378 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.567 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -128.9 170.15 13.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.139 178.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.9 m -115.01 142.47 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.439 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.513 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 16.9 mt -96.22 152.08 3.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.563 ' CB ' ' HZ3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -129.39 136.16 49.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.312 0.577 . . . . 1.0 112.312 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 91' ' ' THR . . . -133.39 142.23 48.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.598 ' CG2' HD22 ' A' ' 72' ' ' ASN . 0.0 OUTLIER 161.28 7.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 96' ' ' GLY . 5.4 p30 -117.07 62.79 3.08 Favored Pre-proline 0 C--O 1.22 -0.499 0 CA-C-N 114.565 -1.198 . . . . 1.0 109.433 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -45.68 -13.86 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.566 2.178 . . . . 1.0 112.143 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.535 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -78.2 -42.93 29.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.094 0.949 . . . . 1.0 110.065 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -11.71 12.67 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.134 -1.393 . . . . 1.0 110.143 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.803 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -63.29 -62.36 5.46 Favored Glycine 0 C--O 1.18 -3.269 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.768 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.576 HD21 ' C ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 138.09 150.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.638 0.775 . . . . 1.0 109.621 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.624 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 56.0 p-90 -56.68 -22.72 36.8 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.7 mt -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.491 -0.884 . . . . 1.0 109.524 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.536 ' H ' HD21 ' A' ' 97' ' ' ASN . 0.2 OUTLIER -75.91 -9.93 59.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 177.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 98' ' ' TRP . 12.3 m-85 -90.33 -9.76 46.59 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.6 131.16 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 114.651 -1.159 . . . . 1.0 111.438 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.01 -158.86 0.7 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.109 -1.405 . . . . 1.0 110.033 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.484 ' C ' ' CD1' ' A' ' 104' ' ' TRP . 24.5 p90 -136.72 164.26 28.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.524 -1.216 . . . . 1.0 112.058 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' CB ' ' HE1' ' A' ' 139' ' ' TRP . . . -87.2 140.24 29.74 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.261 0.837 . . . . 1.0 113.261 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -76.0 -13.29 60.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 177.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -142.66 132.04 23.56 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.707 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -46.97 -17.17 0.27 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' C ' ' A' ' 107' ' ' SER . 10.7 mm-40 -77.41 -32.88 55.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.861 0.362 . . . . 1.0 110.44 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 107' ' ' SER . 25.4 tp10 -88.69 -22.88 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.321 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.886 HE22 ' N ' ' A' ' 139' ' ' TRP . 3.8 tp60 -59.42 142.47 52.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.51 0.671 . . . . 1.0 109.392 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 135' ' ' GLU . 33.2 p30 -144.3 14.19 1.62 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.6 -1.182 . . . . 1.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.714 ' N ' ' HZ2' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -148.54 166.88 26.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.444 -0.503 . . . . 1.0 110.243 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -152.45 130.76 6.27 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 119.093 -1.043 . . . . 1.0 112.552 178.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.44 139.59 20.82 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.241 1.96 . . . . 1.0 113.96 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.542 HD21 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -142.4 138.76 31.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.517 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.542 ' H ' HD21 ' A' ' 116' ' ' LEU . 3.7 tm-20 -92.16 119.26 31.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.4 mt -138.11 130.05 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 120.629 -0.428 . . . . 1.0 111.162 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.2 50.63 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.311 0.577 . . . . 1.0 111.473 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HG3' ' CE1' ' A' ' 80' ' ' TYR . 1.3 tpp180 65.55 1.64 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.51 -0.476 . . . . 1.0 112.034 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.4 158.06 27.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.276 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.411 HD13 ' CD2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -107.69 110.78 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 C-N-CA 119.785 -0.766 . . . . 1.0 112.011 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -101.53 152.58 20.61 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.976 -1.011 . . . . 1.0 108.761 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.572 ' C ' ' HZ1' ' A' ' 125' ' ' LYS . 10.6 m-30 -113.86 127.26 55.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.734 ' HZ1' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -118.14 142.62 47.24 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 1.0 112.103 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -130.22 120.21 24.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.346 -1.297 . . . . 1.0 111.605 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.513 ' H ' ' CD2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -96.41 27.92 3.56 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.523 177.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.714 ' HZ2' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -129.0 123.36 21.8 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.04 94.99 0.41 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 CA-C-N 120.736 1.299 . . . . 1.0 109.14 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mt -71.45 136.05 26.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.465 0.65 . . . . 1.0 109.311 -176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.83 132.67 63.67 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.995 -1.002 . . . . 1.0 113.282 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.53 104.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.923 1.749 . . . . 1.0 111.781 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.06 -7.81 8.1 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.418 ' OE2' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -87.6 150.95 23.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.559 . . . . 1.0 111.485 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 0.6 OUTLIER -79.73 136.96 36.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.773 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 5.4 mp -89.53 136.66 32.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 1.9 mm? -123.44 135.39 54.07 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.529 0.937 . . . . 1.0 113.529 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 104' ' ' TRP . 1.7 t -104.79 131.81 52.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.03 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.886 ' N ' HE22 ' A' ' 111' ' ' GLN . 6.8 p-90 142.27 -126.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.502 1.521 . . . . 1.0 109.886 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.683 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 0.1 OUTLIER 100.25 26.82 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.416 1.486 . . . . 1.0 109.681 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.517 ' OD1' ' C ' ' A' ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.471 1.025 0 N-CA-C 111.771 -0.532 . . . . 1.0 111.771 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 140' ' ' TYR . 3.7 tt0 32.77 52.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.264 0.554 . . . . 1.0 111.464 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -87.56 -35.3 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.296 -0.865 . . . . 1.0 111.596 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.597 ' HB3' ' HB ' ' A' ' 148' ' ' ILE . 9.5 t30 -66.83 172.1 3.77 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 114.054 -1.43 . . . . 1.0 110.279 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 150' ' ' ALA . 93.2 Cg_endo -93.2 -62.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.792 2.328 . . . . 1.0 110.092 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.444 ' H ' ' CG ' ' A' ' 146' ' ' PRO . 24.7 mt-10 -55.07 -22.56 16.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.724 0.774 . . . . 1.0 110.1 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -78.48 -55.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.454 178.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.558 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -75.87 -49.61 17.41 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.292 1.044 . . . . 1.0 109.431 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 146' ' ' PRO . . . -55.04 -65.74 0.53 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.11 -1.859 . . . . 1.0 109.055 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.47 62.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 118.103 -1.439 . . . . 1.0 111.209 -175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 63.8 mt -57.96 -53.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 117.576 -1.65 . . . . 1.0 108.601 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -66.87 -29.93 69.97 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.815 0.697 . . . . 1.0 111.893 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.508 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 2.8 pt-20 -67.42 -53.23 30.93 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.137 -1.025 . . . . 1.0 111.399 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.8 OUTLIER -82.28 -50.2 9.22 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.205 0.817 . . . . 1.0 113.205 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.525 ' HE ' ' C ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.07 -42.21 97.07 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 120.428 -0.509 . . . . 1.0 112.348 -178.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . -75.53 -23.37 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.245 -0.582 . . . . 1.0 111.233 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 157' ' ' ALA . 46.7 t -37.08 121.9 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.885 0.374 . . . . 1.0 110.976 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 66.69 88.35 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.72 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -139.08 92.49 2.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.479 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.578 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 6.1 t -158.28 71.22 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.21 105.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -143.71 -16.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.577 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.3 105.8 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.27 139.69 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.587 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -78.42 94.34 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.513 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 5' ' ' THR . 26.2 m -166.04 124.19 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.742 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 1.7 mp0 -121.59 99.71 44.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.207 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ALA . 2.9 Cg_exo -59.14 -177.65 0.12 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 121.524 1.483 . . . . 1.0 111.712 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.61 86.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.319 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . 173.17 154.35 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.505 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -75.07 -67.49 0.64 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.558 ' CG2' ' N ' ' A' ' 13' ' ' GLU . 81.6 m -174.83 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 12' ' ' THR . 4.6 mm-40 53.8 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.57 ' HB ' ' H ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -140.2 176.32 8.86 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.0 174.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.488 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 2.5 tt -58.12 -56.73 18.25 Favored 'General case' 0 CA--C 1.47 -2.128 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 175.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.621 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . -80.87 -54.55 5.49 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 111.853 -2.431 . . . . 1.0 106.911 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 1.1 tt0 160.24 -21.37 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 115.777 1.769 . . . . 1.0 115.777 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.279 1.1 m -145.17 -178.66 0.81 Allowed Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 120.457 1.481 . . . . 1.0 111.709 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' O ' HD11 ' A' ' 23' ' ' LEU . 4.2 Cg_exo -38.4 151.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.362 2.708 . . . . 1.0 111.113 173.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.477 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 13.7 tt0 -67.75 -34.26 76.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 115.778 1.77 . . . . 1.0 115.778 -176.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -73.63 -25.22 60.2 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -68.6 -51.37 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.769 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.6 ' H ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.05 -24.76 66.02 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.08 0.943 . . . . 1.0 110.617 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.727 -1.579 . . . . 1.0 108.801 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.41 3.98 47.3 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.951 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' CD2' ' CG ' ' A' ' 98' ' ' TRP . 11.6 mt -62.6 158.51 49.88 Favored Pre-proline 0 CA--C 1.491 -1.309 0 CA-C-N 118.311 1.055 . . . . 1.0 110.256 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.66 145.36 51.73 Favored 'Trans proline' 0 C--N 1.29 -2.552 0 N-CA-C 107.338 -1.832 . . . . 1.0 107.338 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' O ' ' CE ' ' A' ' 48' ' ' LYS . 19.7 pt-20 -49.01 -30.23 5.86 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.333 1.063 . . . . 1.0 110.944 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 1.4 pm0 -87.39 25.63 1.38 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.002 -1.454 . . . . 1.0 112.463 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 t -143.33 148.91 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.977 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.436 ' HB3' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER -158.34 155.36 28.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.007 -1.906 . . . . 1.0 106.407 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -128.73 151.05 49.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.439 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -156.93 142.57 12.69 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 124.209 0.943 . . . . 1.0 113.481 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 45.8 Cg_endo -86.83 150.16 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.699 2.266 . . . . 1.0 109.634 174.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.2 m 85.76 15.75 0.14 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.264 -1.384 . . . . 1.0 107.264 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 45' ' ' TRP . . . -90.84 -61.11 1.74 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.69 -1.967 . . . . 1.0 105.69 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -51.55 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.263 -1.335 . . . . 1.0 112.946 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 40' ' ' THR . 27.8 t70 179.56 46.76 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER 30.11 39.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.17 0.986 . . . . 1.0 110.187 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.6 m -127.11 -56.23 1.34 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.714 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -120.08 157.53 28.75 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.228 -2.26 . . . . 1.0 107.324 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.6 HG12 ' OE1' ' A' ' 17' ' ' GLU . 10.3 tt -103.64 146.39 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 118.706 -0.664 . . . . 1.0 109.934 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 17' ' ' GLU . . . -140.46 173.04 23.27 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 119.275 -1.44 . . . . 1.0 114.08 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.75 131.39 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 36' ' ' ALA . 27.0 m95 -125.88 146.91 49.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -71.4 144.0 49.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.538 -0.756 . . . . 1.0 112.201 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 45.1 p -119.76 -30.0 4.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.103 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -119.19 158.66 47.84 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.39 123.05 12.86 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 121.873 1.715 . . . . 1.0 111.593 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.19 133.43 48.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.648 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.9 157.35 19.96 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.29 1.043 . . . . 1.0 111.757 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.77 130.05 42.06 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.464 -1.698 . . . . 1.0 108.938 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.78 3.39 49.37 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 119.607 -1.282 . . . . 1.0 115.797 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 24.7 ttpt -92.48 143.7 26.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 1.267 . . . . 1.0 113.063 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.6 41.77 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.751 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 20.9 m-85 -115.78 129.11 56.32 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.884 -1.053 . . . . 1.0 108.206 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 132.95 -149.42 19.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.19 -1.005 . . . . 1.0 112.461 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 70.0 Cg_endo -89.17 153.03 30.93 Favored 'Cis proline' 0 N--CA 1.51 2.497 0 CA-C-N 119.214 1.507 . . . . 1.0 115.206 0.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.47 ' CE2' ' NE1' ' A' ' 76' ' ' TRP . 3.9 t80 -58.01 112.88 1.65 Allowed 'General case' 0 CA--C 1.495 -1.142 0 CA-C-O 122.08 0.943 . . . . 1.0 111.905 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.703 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -86.25 134.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.781 -1.554 . . . . 1.0 108.033 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.52 147.84 17.25 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.84 -1.704 . . . . 1.0 108.84 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -69.15 142.12 54.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.456 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.4 mptt -92.38 115.75 28.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.31 0.576 . . . . 1.0 111.883 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -142.59 167.56 21.81 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.649 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.574 ' H ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.98 149.04 34.16 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.28 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -61.26 -48.56 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 1.0 110.73 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 t -67.14 63.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.322 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 66' ' ' ARG . 1.9 mm-40 -157.51 -48.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.482 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -68.7 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.774 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' VAL . 16.5 tttm 83.29 157.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.055 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.74 17.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.98 0.419 . . . . 1.0 110.226 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.5 ' OD1' ' SD ' ' A' ' 75' ' ' MET . 0.4 OUTLIER -110.65 -165.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.023 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 75' ' ' MET . 2.0 p -173.58 -23.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 119.469 -0.892 . . . . 1.0 111.835 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' C ' ' SD ' ' A' ' 75' ' ' MET . 6.1 m-85 -76.38 35.96 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.705 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -117.35 152.6 34.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.119 -177.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.616 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -134.02 166.79 21.92 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.165 -0.679 . . . . 1.0 109.165 -178.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -133.48 125.58 29.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.186 0.517 . . . . 1.0 110.576 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.54 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.39 139.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.544 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.548 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 49.7 t80 -87.15 129.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.644 0.735 . . . . 1.0 111.228 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.435 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 4.7 m-85 -105.73 140.42 21.18 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.956 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.56 17.04 0.98 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.849 1.7 . . . . 1.0 110.83 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.548 HD22 ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -149.07 -31.46 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.92 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.548 ' CD1' HD22 ' A' ' 82' ' ' ASN . 0.2 OUTLIER -106.09 -16.61 14.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.962 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.31 -165.3 53.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -62.84 121.28 13.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.549 -0.86 . . . . 1.0 109.881 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.3 ppp? -130.96 168.66 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.14 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' LYS . 54.4 m -123.84 144.64 49.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.933 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.8 mt -99.93 146.14 9.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 7.4 p-10 -133.61 119.29 19.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.349 0.977 . . . . 1.0 112.012 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.0 90.99 2.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.71 0.85 28.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.618 1.099 . . . . 1.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -128.89 131.55 23.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.819 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 96' ' ' GLY . 65.9 Cg_exo -48.97 -28.78 14.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.845 1.697 . . . . 1.0 113.728 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.22 -18.69 45.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.313 1.054 . . . . 1.0 108.428 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -88.63 18.19 4.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.123 -1.853 . . . . 1.0 109.473 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' PRO . . . -174.36 166.09 37.89 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.96 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.712 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -71.6 175.3 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.293 -1.002 . . . . 1.0 108.293 177.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.627 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 25.9 p-90 -56.44 -22.01 29.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.908 -0.717 . . . . 1.0 112.732 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 19.2 mt -53.71 -28.05 31.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 177.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -74.88 -12.9 60.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.949 -0.569 . . . . 1.0 112.006 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 98' ' ' TRP . 15.9 p90 -123.56 4.15 8.97 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 119.696 -0.802 . . . . 1.0 110.694 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 2.7 p -71.71 116.45 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.475 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 1.7 m-20 -85.22 143.36 28.8 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.311 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 33.7 p90 -111.58 162.9 14.66 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.835 0.826 . . . . 1.0 112.945 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 111' ' ' GLN . . . -50.9 -179.15 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.132 -1.395 . . . . 1.0 112.336 -177.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -75.09 -20.4 59.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.669 178.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 106' ' ' CYS . 1.5 p 151.91 71.17 0.0 OUTLIER 'General case' 0 C--N 1.347 0.464 0 O-C-N 123.857 0.723 . . . . 1.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.784 ' H ' ' NE2' ' A' ' 111' ' ' GLN . . . 72.72 13.96 78.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.559 -0.616 . . . . 1.0 111.559 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.57 -44.08 19.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.012 -0.675 . . . . 1.0 111.36 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -120.19 -30.59 4.6 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.605 -0.438 . . . . 1.0 111.863 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.784 ' NE2' ' H ' ' A' ' 108' ' ' GLY . 1.5 mt-30 -24.92 139.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.889 0.876 . . . . 1.0 113.083 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.565 ' C ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.15 19.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 1.0 110.134 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.687 ' N ' ' HZ2' ' A' ' 128' ' ' LYS . 2.1 tp -153.12 149.3 27.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.69 -0.672 . . . . 1.0 109.698 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 125' ' ' LYS . 3.9 p90 -126.31 150.12 69.18 Favored Pre-proline 0 C--N 1.366 1.305 0 N-CA-C 114.616 1.339 . . . . 1.0 114.616 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -88.68 141.37 4.56 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 123.007 2.472 . . . . 1.0 114.073 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.414 HD21 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -141.81 139.74 32.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.847 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' H ' HD21 ' A' ' 116' ' ' LEU . 7.5 mt-10 -98.41 120.43 38.82 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.567 -0.288 . . . . 1.0 110.677 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -136.75 126.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 120.827 0.346 . . . . 1.0 110.637 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 121' ' ' ALA . 1.1 m-80 52.64 47.92 23.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.177 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 1.8 mmt-85 62.97 5.96 2.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.126 0.489 . . . . 1.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASN . . . -107.07 156.8 18.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 1.0 108.785 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -115.82 103.97 16.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.911 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.51 ' C ' ' HZ1' ' A' ' 125' ' ' LYS . 13.4 m-85 -100.1 148.82 24.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -113.16 114.08 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.661 ' HZ3' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -107.13 142.57 36.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.124 1.157 . . . . 1.0 114.124 -178.065 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -129.84 132.43 46.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.423 -1.262 . . . . 1.0 112.491 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.55 ' CD2' ' ND2' ' A' ' 145' ' ' ASN . 0.0 OUTLIER -106.38 26.04 10.35 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.7 0.682 . . . . 1.0 109.536 175.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.687 ' HZ2' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -127.66 117.01 21.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.03 97.87 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 CA-C-N 120.465 1.202 . . . . 1.0 110.635 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 mt -70.36 136.8 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.27 1.033 . . . . 1.0 109.561 -177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.13 132.67 76.33 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 113.96 -1.473 . . . . 1.0 114.188 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -50.13 97.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.67 1.58 . . . . 1.0 110.737 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.68 -4.28 8.06 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.786 -0.525 . . . . 1.0 111.786 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -87.48 151.65 22.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.4 pm0 -77.21 129.08 35.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.919 0.39 . . . . 1.0 110.085 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 5.5 mp -81.33 142.21 33.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 135' ' ' GLU . 6.8 mp -139.86 155.25 47.31 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.59 131.81 60.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 CA-C-N 114.93 -1.032 . . . . 1.0 113.228 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.707 ' CG ' ' NE2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 173.4 -167.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.5 0.667 . . . . 1.0 112.662 177.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.485 ' O ' ' C ' ' A' ' 141' ' ' IAS . 87.3 m-85 91.5 76.49 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 112.882 -1.963 . . . . 1.0 111.038 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.493 ' H ' ' N ' ' A' ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.493 ' N ' ' H ' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 110.802 -0.919 . . . . 1.0 110.802 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 58.96 104.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.26 0.552 . . . . 1.0 111.767 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.596 ' H ' HG23 ' A' ' 148' ' ' ILE . 25.1 t70 -124.55 -54.32 1.67 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.455 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.643 HD21 ' N ' ' A' ' 148' ' ' ILE . 0.3 OUTLIER -70.64 154.13 94.54 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 122.158 -0.339 . . . . 1.0 111.435 -178.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -49.38 -75.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 123.229 2.619 . . . . 1.0 111.977 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 151' ' ' ALA . 0.3 OUTLIER -54.9 -18.65 5.19 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.831 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.643 ' N ' HD21 ' A' ' 145' ' ' ASN . 0.0 OUTLIER -65.69 -54.33 28.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.874 -1.528 . . . . 1.0 106.874 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.464 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -73.87 -35.77 64.76 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.952 -0.699 . . . . 1.0 110.203 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.03 -66.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.046 -1.061 . . . . 1.0 110.233 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -48.5 -29.75 4.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.129 -1.028 . . . . 1.0 110.153 -175.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.582 ' CD1' ' O ' ' A' ' 148' ' ' ILE . 50.3 mt -65.04 -51.65 63.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 118.459 -1.296 . . . . 1.0 108.351 176.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -71.31 -37.52 71.8 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 114.94 -1.027 . . . . 1.0 113.1 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -57.27 -48.58 78.53 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.894 -177.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.495 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -74.06 -51.72 14.91 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.681 -0.407 . . . . 1.0 111.824 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.693 ' HE ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -76.84 -47.82 20.25 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.666 -0.814 . . . . 1.0 110.448 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.693 ' N ' ' HE ' ' A' ' 156' ' ' ARG . . . -78.42 -51.26 10.3 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.444 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER 39.38 -163.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.03 0.443 . . . . 1.0 110.949 179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.532 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . 42.99 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 158' ' ' SER . 15.0 mmt-85 42.26 32.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.25 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.683 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.7 p -143.81 -125.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.761 0.315 . . . . 1.0 110.6 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -168.26 97.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.54 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -156.86 98.97 1.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.499 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -101.38 106.16 17.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.621 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -172.31 -168.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.575 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 t -46.82 141.16 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.399 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 175.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.521 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -140.01 153.1 69.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.132 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.78 -173.1 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.073 1.849 . . . . 1.0 111.775 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ALA . 2.2 t -96.33 25.4 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 1.0 110.547 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 44.79 -174.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.003 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 13' ' ' GLU . . . -46.39 -35.44 5.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 14' ' ' THR . 0.4 OUTLIER 73.44 -39.8 0.45 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.579 179.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' ALA . 1.4 mm-40 28.23 -87.09 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -136.78 172.18 13.4 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.663 174.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 6.3 tt -73.04 -59.91 2.48 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.823 -1.151 . . . . 1.0 108.336 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 32' ' ' LEU . . . -78.35 -59.57 2.73 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-N 113.216 -1.811 . . . . 1.0 108.407 -176.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.674 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -145.77 -102.58 0.1 Allowed 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 118.565 -1.254 . . . . 1.0 114.289 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.674 ' H ' ' CG ' ' A' ' 17' ' ' GLU 0.284 0.2 OUTLIER 179.38 -80.42 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 116.974 -1.489 . . . . 1.0 111.601 -177.456 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 4.4 Cg_exo -74.19 147.01 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 CA-C-N 124.875 2.777 . . . . 1.0 111.404 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.499 ' CD ' HH12 ' A' ' 24' ' ' ARG . 37.4 tt0 -67.73 -50.26 58.29 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.338 1.066 . . . . 1.0 110.404 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.569 ' NE2' ' O ' ' A' ' 94' ' ' GLU . 28.7 p80 -56.36 -24.85 46.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.884 -1.053 . . . . 1.0 113.408 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 26' ' ' LEU . 2.0 m -64.09 -45.0 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 121.284 1.857 . . . . 1.0 106.362 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' H ' HG22 ' A' ' 22' ' ' VAL . 6.5 mp -54.71 -28.67 49.7 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.596 0.712 . . . . 1.0 110.405 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.499 HH12 ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.05 -20.84 60.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.519 -1.219 . . . . 1.0 108.616 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . -114.7 -12.68 10.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.309 -1.314 . . . . 1.0 113.063 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.62 ' O ' ' O ' ' A' ' 27' ' ' PRO . 16.8 mt -60.19 150.21 72.31 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-N 118.988 1.394 . . . . 1.0 110.589 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 26' ' ' LEU . 75.9 Cg_exo -42.56 -128.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.666 2.911 . . . . 1.0 113.184 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 49' ' ' PRO . 4.2 mt-10 -68.77 -50.75 47.85 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.776 -1.57 . . . . 1.0 106.796 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' H ' ' HE2' ' A' ' 48' ' ' LYS . 12.5 tt0 -126.18 -77.71 0.59 Allowed 'General case' 0 C--N 1.363 1.17 0 C-N-CA 120.157 -0.617 . . . . 1.0 111.489 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 31' ' ' ARG 0.365 4.9 t 59.43 152.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 C-N-CA 127.881 2.472 . . . . 1.0 116.265 -176.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.408 ' N ' HG13 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -147.79 160.61 42.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.173 -2.285 . . . . 1.0 110.948 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 16' ' ' ALA . 3.5 mm? -117.75 120.41 37.88 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 174.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 15' ' ' LEU . 1.1 t80 -129.43 122.56 20.94 Favored Pre-proline 0 N--CA 1.485 1.299 0 O-C-N 121.193 -0.942 . . . . 1.0 112.633 -176.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 4.3 Cg_exo -79.22 130.4 9.2 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.804 2.336 . . . . 1.0 112.897 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.3 t 87.8 30.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.667 -2.06 . . . . 1.0 107.286 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' CB ' ' CE2' ' A' ' 45' ' ' TRP . . . -94.57 -54.12 3.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.4 -49.85 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 113.614 -1.63 . . . . 1.0 111.993 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 169.28 -50.91 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.3 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.548 -1.205 . . . . 1.0 107.909 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 20.7 m -102.83 -34.73 8.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 40' ' ' THR . 7.7 mtm-85 155.06 -159.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.7 -1.593 . . . . 1.0 106.7 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.474 HG13 ' C ' ' A' ' 33' ' ' PHE . 9.5 tt -84.07 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 118.915 0.779 . . . . 1.0 111.315 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 32' ' ' LEU . . . -106.75 166.72 13.66 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.28 120.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 118.134 0.967 . . . . 1.0 111.426 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 4.9 m95 -127.51 143.79 51.14 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.258 -0.883 . . . . 1.0 110.173 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -84.7 123.84 30.83 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.2 -1.0 . . . . 1.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -21.76 19.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.37 0.605 . . . . 1.0 109.409 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -107.87 167.89 8.68 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 114.728 -1.124 . . . . 1.0 110.963 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 5.9 Cg_exo -76.09 144.34 26.69 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.65 2.233 . . . . 1.0 111.158 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.412 HD11 ' HZ2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -118.73 144.09 27.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.91 -178.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.663 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.98 146.31 39.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.92 0.866 . . . . 1.0 110.742 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.65 140.14 58.47 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.323 -1.308 . . . . 1.0 111.822 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.79 3.92 58.07 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 119.409 -1.377 . . . . 1.0 115.302 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' CG ' ' N ' ' A' ' 55' ' ' LYS . 30.0 ttpt -106.22 146.27 30.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 118.92 -1.112 . . . . 1.0 113.968 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -97.39 140.71 31.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.791 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.59 131.03 56.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.052 -1.462 . . . . 1.0 107.052 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.64 -150.45 21.11 Favored Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -84.83 170.7 46.88 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 119.671 1.735 . . . . 1.0 113.457 0.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.672 ' CD1' ' ND2' ' A' ' 97' ' ' ASN . 36.9 t80 -73.72 122.31 22.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.622 0.725 . . . . 1.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.562 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -44.37 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.886 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 37.12 109.14 0.0 OUTLIER Glycine 0 C--N 1.333 0.399 0 CA-C-O 121.711 0.617 . . . . 1.0 113.244 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t70 -85.78 134.96 33.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 1.5 mptt -90.59 116.33 28.41 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.517 0.675 . . . . 1.0 112.124 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 75' ' ' MET . 0.1 OUTLIER -124.05 158.08 33.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.626 -1.17 . . . . 1.0 110.98 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.63 135.53 34.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -53.27 -31.04 41.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.783 -0.573 . . . . 1.0 110.394 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -91.53 27.22 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.838 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 -68.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.743 0.782 . . . . 1.0 110.255 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.641 HG11 HD21 ' A' ' 72' ' ' ASN . 0.4 OUTLIER -73.85 170.44 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 114.402 -1.272 . . . . 1.0 111.259 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.503 ' CG ' ' H ' ' A' ' 71' ' ' ASN . 7.1 tttp -110.27 -128.71 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.108 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.503 ' H ' ' CG ' ' A' ' 70' ' ' LYS . 12.9 t-20 -36.87 -80.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.732 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.641 HD21 HG11 ' A' ' 69' ' ' VAL . 2.3 p30 49.28 -177.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.578 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.463 ' CG1' ' CE1' ' A' ' 74' ' ' TYR . 7.4 p -172.58 -13.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.03 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 3.0 m-85 -98.88 53.31 0.99 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.59 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -125.57 147.05 49.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.653 0.74 . . . . 1.0 112.584 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.629 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -123.11 164.28 18.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.525 -1.216 . . . . 1.0 110.512 -178.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -122.69 122.21 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.181 0.515 . . . . 1.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.96 139.93 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.406 -0.816 . . . . 1.0 111.83 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.516 ' O ' ' CZ ' ' A' ' 120' ' ' ARG . 4.4 t80 -92.67 135.84 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.875 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -117.12 146.05 37.17 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -70.19 44.46 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 N-CA-C 108.225 -1.49 . . . . 1.0 108.225 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 80' ' ' TYR . 1.5 t30 -148.21 -85.77 0.1 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.212 -1.358 . . . . 1.0 110.297 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.575 ' N ' ' CG ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -80.48 -8.99 59.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.33 -1.305 . . . . 1.0 112.322 -176.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' O ' ' CD1' ' A' ' 83' ' ' LEU . . . 81.65 -145.81 25.31 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -78.68 118.13 20.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.721 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -129.96 173.38 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.744 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.586 ' N ' ' SD ' ' A' ' 86' ' ' MET . 67.8 m -117.96 141.41 48.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.152 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.4 150.66 3.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 N-CA-C 108.05 -1.093 . . . . 1.0 108.05 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -133.66 136.69 44.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.827 1.047 . . . . 1.0 113.827 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -133.23 139.93 47.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 90' ' ' ALA . 30.2 p -158.61 -13.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.487 0.585 . . . . 1.0 110.033 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.03 106.31 3.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.75 -22.09 9.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.132 1.888 . . . . 1.0 114.353 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.569 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 5.9 pt-20 -83.18 -8.39 59.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.904 0.859 . . . . 1.0 110.215 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 11.65 35.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.343 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.442 ' O ' ' ND1' ' A' ' 21' ' ' HIS . . . -165.44 -95.07 0.1 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 119.073 -1.537 . . . . 1.0 114.012 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.672 ' ND2' ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -146.18 173.35 12.29 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.596 ' CG ' HD23 ' A' ' 26' ' ' LEU . 30.6 p-90 -70.86 -19.95 62.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -50.18 -24.11 2.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.747 HH22 HD22 ' A' ' 103' ' ' ASN . 3.1 tpm_? -84.57 -23.16 29.78 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 120.146 -0.621 . . . . 1.0 110.749 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -72.57 -7.35 49.69 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.299 1.047 . . . . 1.0 109.479 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 3.4 t -82.48 119.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.249 -1.796 . . . . 1.0 111.041 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.747 HD22 HH22 ' A' ' 100' ' ' ARG . 38.4 m-20 -156.15 71.68 0.73 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.661 0.664 . . . . 1.0 111.464 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.794 ' HE1' ' N ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -141.88 176.69 8.73 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.089 0.956 . . . . 1.0 111.497 -177.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 107' ' ' SER . . . 26.53 52.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.43 1.081 . . . . 1.0 109.995 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -48.56 -14.53 0.06 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.613 ' H ' ' C ' ' A' ' 105' ' ' ALA . 20.0 p -174.98 18.06 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.35 -1.295 . . . . 1.0 110.561 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.67 ' N ' ' HE1' ' A' ' 139' ' ' TRP . . . -85.2 131.26 10.33 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.06 -12.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.26 5.52 4.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 113.698 0.999 . . . . 1.0 113.698 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.566 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.4 pp0? -54.48 140.23 35.04 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.673 1.36 . . . . 1.0 114.673 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.921 ' ND2' ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -117.58 -5.22 11.19 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.333 -1.758 . . . . 1.0 111.663 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 114' ' ' PHE . 0.3 OUTLIER -155.8 165.47 36.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 119.441 -0.314 . . . . 1.0 110.931 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -133.11 138.03 30.77 Favored Pre-proline 0 C--N 1.357 0.933 0 N-CA-C 113.869 1.062 . . . . 1.0 113.869 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.78 146.02 10.37 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.422 2.748 . . . . 1.0 113.648 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.534 HD22 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -144.66 146.54 32.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.293 178.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.534 ' H ' HD22 ' A' ' 116' ' ' LEU . 1.2 tt0 -97.38 119.06 35.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 121' ' ' ALA . 7.7 mt -137.39 132.21 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.929 -177.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 121' ' ' ALA . 30.2 m-20 50.14 57.95 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.485 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.516 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 9.8 mmp_? 57.21 -0.8 0.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.494 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' H ' ' C ' ' A' ' 119' ' ' ASN . . . -123.21 155.62 36.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.248 -0.278 . . . . 1.0 110.248 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CE2' ' A' ' 76' ' ' TRP . 1.0 OUTLIER -103.8 113.94 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.35 149.32 24.16 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 3.1 m-30 -112.97 126.93 56.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.338 -1.356 . . . . 1.0 107.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.83 ' HZ1' ' N ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -122.5 140.43 52.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -128.73 134.47 48.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 1.0 109.708 178.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.493 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -105.87 16.78 24.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.103 176.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.587 ' NZ ' ' C ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -125.16 127.01 25.13 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.22 98.79 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 121.33 1.511 . . . . 1.0 111.068 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CD1' ' OD1' ' A' ' 112' ' ' ASN . 55.6 mt -67.81 134.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.273 1.035 . . . . 1.0 109.594 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.663 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.01 139.32 97.75 Favored Pre-proline 0 C--O 1.212 -0.872 0 CA-C-N 113.929 -1.487 . . . . 1.0 114.086 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.52 115.44 4.29 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.556 2.171 . . . . 1.0 111.692 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 109.65 0.95 30.73 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.914 -0.474 . . . . 1.0 111.914 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.702 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -97.75 173.27 7.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.84 0.829 . . . . 1.0 112.353 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' CG ' ' CD1' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -85.81 141.42 29.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.211 -1.358 . . . . 1.0 108.359 176.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.582 ' O ' ' CZ2' ' A' ' 104' ' ' TRP . 5.4 mp -89.9 136.88 32.78 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.218 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.921 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 6.8 mp -121.6 142.84 49.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.757 0.789 . . . . 1.0 112.104 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.794 ' N ' ' HE1' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -119.97 137.12 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 114.034 -1.439 . . . . 1.0 110.014 -176.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.67 ' HE1' ' N ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -137.65 134.82 35.9 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 -177.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 141' ' ' IAS . 0.1 OUTLIER -154.6 29.41 0.43 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.706 -1.588 . . . . 1.0 108.719 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.501 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.401 0 N-CA-C 112.282 -0.327 . . . . 1.0 112.282 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 144' ' ' ASP . 0.9 OUTLIER -166.53 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.264 -0.574 . . . . 1.0 111.511 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.629 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 12.2 t0 94.21 -43.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.83 0.706 . . . . 1.0 111.651 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.741 ' ND2' ' H ' ' A' ' 148' ' ' ILE . 0.3 OUTLIER -78.82 149.66 74.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.177 -177.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -55.61 -63.75 0.17 Allowed 'Trans proline' 0 N--CA 1.512 2.57 0 C-N-CA 123.141 2.561 . . . . 1.0 115.493 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.69 ' O ' ' N ' ' A' ' 151' ' ' ALA . 14.0 mm-40 -58.6 -49.07 78.82 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 120.973 0.416 . . . . 1.0 110.468 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.741 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 2.0 mt -47.48 -52.81 5.06 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 N-CA-C 106.388 -1.708 . . . . 1.0 106.388 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.431 ' O ' ' OE1' ' A' ' 153' ' ' GLU . . . -71.05 -50.4 34.35 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.123 -1.831 . . . . 1.0 109.191 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.87 -65.59 0.68 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.285 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.69 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -55.87 -34.22 65.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.846 1.657 . . . . 1.0 112.374 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 148' ' ' ILE . 48.5 mt -54.16 -47.26 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.198 -1.801 . . . . 1.0 108.24 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.518 ' HA ' ' HE ' ' A' ' 156' ' ' ARG . 0.3 OUTLIER -71.8 -38.57 70.22 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 124.057 0.848 . . . . 1.0 112.694 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.502 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 5.6 pt-20 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.597 -0.841 . . . . 1.0 112.978 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 4.7 tp10 -79.22 -51.51 9.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.518 ' HE ' ' HA ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -72.6 -50.34 26.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.225 -0.99 . . . . 1.0 112.201 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.508 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -53.79 -23.85 13.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 119.149 -1.02 . . . . 1.0 108.975 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.2 t -79.41 137.26 37.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.705 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 70.04 14.73 7.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.948 0.404 . . . . 1.0 110.209 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 161' ' ' SER . 2.2 tpt180 -85.99 103.62 14.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.509 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 160' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.499 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.28 -88.57 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 3' ' ' GLN . 4.7 tpp -142.72 126.02 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.598 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 4' ' ' ASN . 39.1 m-20 -65.91 72.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.574 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 1' ' ' MET . 3.2 tp-100 -71.77 12.18 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.599 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 2' ' ' ASP . 3.5 t30 -141.27 114.18 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.56 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.0 116.08 5.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m -41.68 104.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.557 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.9 pm0 -89.53 155.23 48.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.473 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.02 -166.73 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.714 2.276 . . . . 1.0 112.35 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 32.0 m -54.58 -171.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.499 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 9' ' ' VAL . . . 79.31 168.42 0.19 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.44 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . -87.81 -79.05 0.3 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.191 0.52 . . . . 1.0 110.192 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.3 m 149.54 -68.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.251 -1.341 . . . . 1.0 108.212 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -45.8 138.71 4.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.556 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -121.37 153.45 37.78 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 121.554 0.692 . . . . 1.0 112.321 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -47.39 -36.0 9.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.465 -178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.96 44.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.581 -1.191 . . . . 1.0 109.802 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -97.47 -38.1 9.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.034 -0.984 . . . . 1.0 113.617 -177.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.49 147.11 95.87 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.688 -1.967 . . . . 1.0 105.688 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.1 118.61 3.28 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.621 1.548 . . . . 1.0 112.042 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.15 -42.39 60.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.973 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -64.08 -23.65 67.4 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.949 -0.7 . . . . 1.0 111.703 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 98' ' ' TRP . 14.9 t -80.17 -45.33 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 119.009 0.822 . . . . 1.0 111.247 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -25.7 66.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.951 0.881 . . . . 1.0 108.993 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -61.27 -19.18 61.43 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.592 -1.186 . . . . 1.0 111.913 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.8 39.67 2.82 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.246 -0.502 . . . . 1.0 112.054 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.542 HD23 ' CG ' ' A' ' 98' ' ' TRP . 32.7 mt -80.04 154.48 75.09 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' O ' ' O ' ' A' ' 26' ' ' LEU . 86.0 Cg_exo -44.23 -120.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.966 3.111 . . . . 1.0 114.138 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.18 -55.11 11.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.65 -2.352 . . . . 1.0 104.65 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 30' ' ' VAL . 7.6 tp10 -133.95 -72.59 0.49 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 96.4 t 52.28 163.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.989 0.9 . . . . 1.0 110.953 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 3.2 ttt85 -161.44 163.16 30.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.92 -1.491 . . . . 1.0 107.006 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.1 mm? -94.45 155.07 17.13 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.544 -1.262 . . . . 1.0 110.098 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.72 111.67 2.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' O ' ' OG ' ' A' ' 35' ' ' SER . 13.0 Cg_endo -88.31 154.18 6.71 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.691 2.927 . . . . 1.0 111.926 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 34' ' ' PRO . 1.8 p 50.84 40.3 24.42 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.98 -46.4 6.53 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.282 -2.235 . . . . 1.0 106.899 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -96.3 -4.06 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 114.16 -1.382 . . . . 1.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t70 98.24 -11.32 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.982 0.802 . . . . 1.0 111.54 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.626 ' HZ2' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.24 -35.84 66.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.874 -0.73 . . . . 1.0 109.326 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 92.11 -11.22 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.526 0.936 . . . . 1.0 113.526 177.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.626 ' CB ' ' HZ2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -77.22 162.45 27.37 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.455 ' CG2' ' HB3' ' A' ' 32' ' ' LEU . 4.2 mm -74.48 124.73 32.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 120.485 1.493 . . . . 1.0 112.097 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.77 174.19 16.86 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.698 -1.761 . . . . 1.0 108.698 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.83 125.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.94 0.4 . . . . 1.0 109.94 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.661 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 30.2 m95 -126.92 149.43 49.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.618 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.55 133.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.959 -1.019 . . . . 1.0 108.859 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.8 p -115.93 -15.73 11.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.241 -1.392 . . . . 1.0 107.241 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -116.2 171.69 4.47 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 112.847 -1.979 . . . . 1.0 109.59 -178.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.46 153.71 13.84 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 123.264 2.643 . . . . 1.0 111.982 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 4.1 mp -132.11 150.84 34.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.728 -1.124 . . . . 1.0 111.354 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -120.55 165.09 15.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 1.0 111.71 178.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.9 129.62 40.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.093 177.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.708 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.33 -0.71 60.13 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 119.854 -1.165 . . . . 1.0 113.375 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.633 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.7 tptt -57.09 157.96 5.51 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.732 -1.187 . . . . 1.0 110.284 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.633 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.7 ttmt -123.76 109.3 13.5 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.46 -1.245 . . . . 1.0 108.403 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 11.6 m-30 -119.58 125.12 48.04 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.02 -153.49 24.83 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.08 -1.418 . . . . 1.0 110.573 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -82.66 150.83 71.6 Favored 'Cis proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.35 1.575 . . . . 1.0 113.604 0.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 17.6 t80 -62.94 118.92 8.46 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.759 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.556 HG21 ' H ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -27.03 -65.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.345 -1.752 . . . . 1.0 111.495 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 60' ' ' VAL . . . 53.89 104.55 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.827 -0.701 . . . . 1.0 113.482 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.01 149.8 20.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 176.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.541 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -93.53 116.36 28.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -146.87 167.22 24.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.016 -178.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.706 ' H ' ' NZ ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -65.94 153.05 43.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.652 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 6.2 ttm-85 -66.09 -45.33 81.6 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.499 -0.751 . . . . 1.0 111.932 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.7 p -65.87 46.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.008 0.432 . . . . 1.0 110.151 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 66' ' ' ARG . 9.4 mm100 -129.87 -28.97 2.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.333 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.14 158.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.882 0.372 . . . . 1.0 111.119 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 5.6 tttm -140.98 131.63 25.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 45.83 76.0 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.54 -169.24 1.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.992 -1.003 . . . . 1.0 113.394 -175.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.556 ' C ' ' H ' ' A' ' 75' ' ' MET . 25.0 t -150.48 -68.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.698 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.58 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -63.09 41.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.285 -178.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.7 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -149.49 148.23 29.15 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.788 0.804 . . . . 1.0 111.732 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.603 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -160.59 162.3 32.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.244 -1.344 . . . . 1.0 112.618 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 77' ' ' GLU . 1.3 pm0 -100.93 121.88 42.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.959 0.885 . . . . 1.0 111.355 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.583 ' CG1' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.24 135.85 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 114.747 -1.115 . . . . 1.0 108.986 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.512 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.9 t80 -87.0 124.37 33.12 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.511 -0.875 . . . . 1.0 111.329 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.555 ' C ' ' H ' ' A' ' 82' ' ' ASN . 5.0 m-85 -92.19 135.53 26.89 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 114.195 -1.366 . . . . 1.0 110.466 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.34 7.69 1.74 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.771 1.647 . . . . 1.0 108.869 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 80' ' ' TYR . 70.5 m-80 -110.27 -90.72 0.47 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.256 -1.338 . . . . 1.0 111.48 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.677 ' H ' ' CD2' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -79.64 -7.08 58.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.36 -157.32 15.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 120.393 -0.908 . . . . 1.0 112.717 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.525 ' O ' ' SD ' ' A' ' 86' ' ' MET . 25.4 m95 -66.08 121.16 14.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.609 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.525 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 38.1 mmm -124.85 150.8 46.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.377 0.88 . . . . 1.0 113.377 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.652 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -106.97 131.36 54.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' MET . 17.0 mt -106.16 105.34 18.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.572 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 23.5 t0 -130.83 127.57 38.88 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.287 0.949 . . . . 1.0 112.085 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -132.82 96.45 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.192 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.573 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 29.3 p -129.55 75.42 1.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.726 0.694 . . . . 1.0 110.617 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.686 ' N ' ' HE ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -162.85 160.82 19.36 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.338 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -67.26 -38.93 14.14 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.15 1.9 . . . . 1.0 112.418 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -77.87 -44.46 27.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -11.42 16.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 1.0 112.076 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . -110.77 111.46 3.02 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.487 -0.863 . . . . 1.0 112.04 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.578 ' C ' HD21 ' A' ' 97' ' ' ASN . 0.1 OUTLIER -61.95 -157.92 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.919 0.39 . . . . 1.0 110.466 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.542 ' CG ' HD23 ' A' ' 26' ' ' LEU . 43.0 p-90 -72.75 -35.49 67.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.318 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.457 ' HB2' HD22 ' A' ' 97' ' ' ASN . 0.4 OUTLIER -54.8 -26.5 35.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.365 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.686 ' HE ' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -72.29 -20.5 61.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.917 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.87 -10.68 57.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.758 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.436 ' O ' ' OH ' ' A' ' 74' ' ' TYR . 3.2 t -64.49 141.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.561 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.627 ' ND2' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -101.22 -155.18 0.5 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.088 -0.645 . . . . 1.0 112.234 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.492 ' NE1' ' CG2' ' A' ' 73' ' ' VAL . 2.6 m-90 -112.79 144.12 42.87 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.466 -0.788 . . . . 1.0 111.813 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 106' ' ' CYS . . . -79.06 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER 159.23 -16.05 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.768 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -136.54 -81.56 0.39 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.197 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 163.69 -52.0 0.3 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -24.62 65.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.677 ' O ' ' O ' ' A' ' 111' ' ' GLN . 2.5 pt-20 -92.13 -22.98 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.995 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.715 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -51.24 -134.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.715 ' H ' ' CG ' ' A' ' 111' ' ' GLN . 0.8 OUTLIER 158.51 -33.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.572 -0.705 . . . . 1.0 109.488 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 4.2 mm? -129.55 148.26 51.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.807 -0.757 . . . . 1.0 112.055 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -134.06 130.63 20.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 115.105 -0.952 . . . . 1.0 112.498 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 76' ' ' TRP . 78.6 Cg_exo -51.23 130.22 31.53 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 123.894 3.063 . . . . 1.0 115.899 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.478 HD21 ' HZ2' ' A' ' 125' ' ' LYS . 56.2 tp -142.17 137.24 30.7 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 176.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 4.7 mm-40 -108.06 114.95 29.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.403 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.9 pt -139.09 127.82 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.536 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.59 47.5 23.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 1.0 110.909 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.583 ' HE ' ' CG1' ' A' ' 78' ' ' VAL . 1.9 mmp_? 54.43 30.56 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.82 148.98 47.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.026 -1.101 . . . . 1.0 108.026 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.498 ' CD1' ' CD ' ' A' ' 117' ' ' GLU . 1.6 mm -110.42 114.24 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.745 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.443 ' HB3' ' NZ ' ' A' ' 125' ' ' LYS . 4.6 m-85 -102.22 157.53 16.83 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.175 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -116.66 130.73 56.91 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 105.522 -2.029 . . . . 1.0 105.522 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.545 ' HZ3' ' CG ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -125.95 153.96 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.967 -177.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.708 ' O ' ' N ' ' A' ' 53' ' ' GLY . 27.7 p -100.76 118.51 37.01 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.231 -0.588 . . . . 1.0 112.471 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.646 ' N ' ' HZ3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -82.77 -21.38 34.66 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 124.224 0.953 . . . . 1.0 109.559 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.804 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -139.8 137.97 19.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.724 0.268 . . . . 1.0 111.724 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.88 144.2 45.58 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.628 1.552 . . . . 1.0 110.732 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.402 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -122.13 137.06 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -75.08 134.18 74.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.15 -0.477 . . . . 1.0 112.112 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.06 108.99 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 CA-C-N 119.808 0.967 . . . . 1.0 110.534 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 122.03 7.65 7.73 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 2.3 mm-40 -105.53 117.61 34.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.137 0.494 . . . . 1.0 111.187 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.661 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -46.06 146.71 1.21 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.772 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.604 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 7.2 mp -91.08 132.67 35.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.096 -0.956 . . . . 1.0 108.488 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.711 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -136.62 161.81 34.86 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.751 0.786 . . . . 1.0 112.071 -178.28 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.475 ' CA ' ' OE1' ' A' ' 111' ' ' GLN . 3.1 m -146.13 170.87 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.778 -1.101 . . . . 1.0 111.337 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.655 ' CD1' ' NE2' ' A' ' 111' ' ' GLN . 44.5 p-90 170.77 -161.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.585 -1.643 . . . . 1.0 108.41 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.641 ' CD1' ' ND2' ' A' ' 145' ' ' ASN . 47.5 m-85 104.71 42.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.288 1.618 . . . . 1.0 107.657 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.561 ' OD1' ' N ' ' A' ' 143' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.559 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.561 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 53.6 mt-10 -31.37 -90.2 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 123.861 0.389 . . . . 1.0 110.124 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -108.29 56.49 0.63 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.879 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' ND2' ' CD1' ' A' ' 140' ' ' TYR . 3.1 p30 -68.96 167.08 22.03 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 150' ' ' ALA . 7.9 Cg_endo -81.04 -14.83 10.73 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.578 1.519 . . . . 1.0 111.311 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 1.1 mp0 -66.76 -32.68 74.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.745 -1.946 . . . . 1.0 105.745 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.618 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mm -79.04 -53.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.224 -1.353 . . . . 1.0 110.662 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 -48.83 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.428 ' O ' ' OE1' ' A' ' 154' ' ' GLU . . . -55.66 -48.71 74.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 1.0 111.968 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 155' ' ' GLU . . . -70.49 -28.89 65.33 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 119.48 -0.888 . . . . 1.0 111.451 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 148' ' ' ILE . 60.1 mt -66.88 -48.11 80.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 1.0 108.914 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 2.5 mt-10 -52.31 -51.91 55.99 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.67 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 1.2 pm0 -57.35 -38.97 74.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.057 -1.057 . . . . 1.0 112.268 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -77.83 -59.74 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 118.804 -1.158 . . . . 1.0 112.209 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.458 HH12 ' HZ2' ' A' ' 55' ' ' LYS . 12.4 mmm180 -70.76 -41.0 72.34 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.174 0.805 . . . . 1.0 113.174 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -65.65 -36.52 83.92 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 118.437 -1.305 . . . . 1.0 110.436 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 154' ' ' GLU . 12.5 m -77.93 -14.37 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.655 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.87 35.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.563 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -102.27 -73.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.685 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.94 -41.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 1.0 110.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.73 -165.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -160.0 53.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.514 ' H ' ' CD ' ' A' ' 3' ' ' GLN . 1.3 mp0 -41.22 128.81 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.644 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.65 ' ND2' ' H ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -100.24 -4.49 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.503 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.3 p -65.6 147.18 53.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.547 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 m -152.38 132.37 13.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -41.77 153.24 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.282 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.5 166.41 15.43 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.487 2.125 . . . . 1.0 111.981 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.44 -159.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.837 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.98 120.3 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.152 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . -161.12 -77.79 0.05 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.307 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 89.9 m 122.36 103.62 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 125.204 1.565 . . . . 1.0 107.623 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' CB ' ' OE2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER 66.25 161.07 0.14 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.106 -1.406 . . . . 1.0 108.824 -177.476 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.547 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -121.29 156.17 33.1 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 120.458 0.171 . . . . 1.0 111.074 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -43.9 -30.21 0.66 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.219 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.41 59.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.61 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -73.14 -44.65 59.84 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.787 1.032 . . . . 1.0 113.787 -176.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.496 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -56.2 149.77 34.83 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.973 -1.862 . . . . 1.0 105.973 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -47.37 143.23 11.52 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 120.884 1.056 . . . . 1.0 110.874 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 14.8 tt0 -60.81 -49.9 75.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.511 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.484 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 8.2 p80 -61.76 -26.07 67.85 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 98' ' ' TRP . 22.6 t -79.78 -49.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 118.656 0.662 . . . . 1.0 111.656 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -67.89 -25.5 65.54 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.795 0.807 . . . . 1.0 109.449 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 8.6 mmm180 -59.74 -19.23 48.89 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.181 -1.372 . . . . 1.0 112.019 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.84 35.88 4.38 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.149 -0.548 . . . . 1.0 111.979 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.4 mt -82.03 123.12 80.08 Favored Pre-proline 0 CA--C 1.514 -0.419 0 CA-C-O 119.477 -0.297 . . . . 1.0 111.11 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 14.2 Cg_exo -55.41 156.72 16.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 119.748 0.946 . . . . 1.0 110.236 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.18 -13.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 115.172 1.545 . . . . 1.0 115.172 -174.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.641 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 6.2 pm0 -114.19 15.73 18.14 Favored 'General case' 0 CA--C 1.463 -2.386 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.16 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.513 ' CG2' ' OE2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -126.82 125.78 67.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 114.605 1.335 . . . . 1.0 114.605 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -141.6 153.44 44.79 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 113.36 -1.745 . . . . 1.0 107.17 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.82 143.69 26.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 118.84 -1.144 . . . . 1.0 109.958 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.47 110.06 3.64 Favored Pre-proline 0 N--CA 1.444 -0.732 0 N-CA-C 113.253 0.834 . . . . 1.0 113.253 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . 15.5 Cg_endo -84.87 152.58 11.31 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.883 2.389 . . . . 1.0 111.24 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.9 p 86.46 -38.49 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -49.3 -57.88 6.05 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.516 -1.22 . . . . 1.0 107.847 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 3.9 m -57.27 -50.05 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.869 -0.732 . . . . 1.0 110.232 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 1.7 m-20 156.9 70.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.448 0.468 . . . . 1.0 110.591 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER 35.67 29.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.387 0.613 . . . . 1.0 109.811 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 m -90.88 -33.56 15.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.086 -0.961 . . . . 1.0 112.62 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 42' ' ' ILE . 4.7 ptm180 162.61 -163.98 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.525 ' O ' ' NE ' ' A' ' 41' ' ' ARG . 2.7 mm -84.37 135.56 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 118.156 0.434 . . . . 1.0 110.386 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.73 155.14 18.92 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.545 -1.022 . . . . 1.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.41 131.53 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.51 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 12.0 m95 -132.26 155.21 48.72 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 -176.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.06 120.41 14.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.553 ' H ' ' C ' ' A' ' 29' ' ' GLU . 1.4 p -102.83 -20.81 14.16 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' CD ' ' C ' ' A' ' 48' ' ' LYS 0.252 0.0 OUTLIER -129.29 170.71 10.19 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.827 178.056 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -80.42 125.35 5.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.123 1.882 . . . . 1.0 114.097 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 51' ' ' LEU . 3.7 mp -99.66 150.78 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.809 -1.541 . . . . 1.0 110.659 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.537 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.17 164.03 13.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.674 177.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -66.61 124.18 22.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.813 -0.554 . . . . 1.0 110.385 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 99.75 1.28 56.34 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 119.924 -1.132 . . . . 1.0 113.087 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 2.2 tptt -52.32 159.47 0.97 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 117.625 -1.63 . . . . 1.0 108.356 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.704 ' HG2' ' HZ1' ' A' ' 125' ' ' LYS . 8.8 ttmt -121.48 103.16 8.73 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.315 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.587 ' CE2' ' OE2' ' A' ' 29' ' ' GLU . 13.4 m-85 -116.36 126.44 53.49 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 106.473 -1.677 . . . . 1.0 106.473 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.17 -164.75 35.63 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 109.876 -1.289 . . . . 1.0 109.876 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -89.68 138.44 13.22 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 CA-C-N 119.094 1.447 . . . . 1.0 112.884 -0.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.608 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 10.2 t80 -59.13 114.82 2.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.675 0.75 . . . . 1.0 110.509 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -21.51 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.209 -1.814 . . . . 1.0 111.393 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 45.76 105.49 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.586 -0.734 . . . . 1.0 113.349 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ASP . 13.7 t70 -93.52 147.28 23.12 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -92.8 115.08 27.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.122 0.963 . . . . 1.0 113.149 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -139.85 170.3 16.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.619 -1.628 . . . . 1.0 110.708 -177.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.608 ' H ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.48 145.91 31.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 121.126 -0.23 . . . . 1.0 111.384 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -50.85 -23.9 3.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.782 -0.574 . . . . 1.0 111.986 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 66' ' ' ARG . 29.0 t -37.69 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.234 0.54 . . . . 1.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 66' ' ' ARG . 1.4 mt-30 -97.4 -142.07 0.29 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.534 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.5 ' CG2' ' NZ ' ' A' ' 64' ' ' LYS . 57.5 t 59.95 -95.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 117.858 0.299 . . . . 1.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 8.2 tptm 73.62 51.77 0.12 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.926 0.393 . . . . 1.0 110.609 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 70' ' ' LYS . 4.0 t30 78.01 113.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.377 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.25 -149.71 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.328 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.682 ' C ' ' H ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -137.87 -60.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-N 118.662 0.665 . . . . 1.0 111.519 -178.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.608 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -63.5 29.46 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.362 -0.835 . . . . 1.0 110.653 -178.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.682 ' H ' ' C ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -139.7 141.06 36.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.75 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.56 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -157.13 162.81 39.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.031 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.27 122.98 44.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.08 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' CG1' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -134.56 136.59 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.139 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 t80 -85.41 124.56 32.15 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.512 0.672 . . . . 1.0 112.182 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.567 ' C ' ' H ' ' A' ' 82' ' ' ASN . 27.3 m-85 -100.69 125.37 39.07 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.637 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.71 8.57 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 108.305 -1.46 . . . . 1.0 108.305 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 80' ' ' TYR . 74.5 m-20 -109.44 -10.14 14.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.0 -1.455 . . . . 1.0 111.27 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -168.65 1.85 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.709 1.374 . . . . 1.0 114.709 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.59 -160.78 14.27 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 120.608 -0.806 . . . . 1.0 112.912 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.553 ' O ' ' SD ' ' A' ' 86' ' ' MET . 27.5 m95 -76.5 121.06 22.59 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.553 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.8 mmm -127.54 163.63 23.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.131 1.53 . . . . 1.0 115.131 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.03 134.07 53.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.157 -1.383 . . . . 1.0 108.175 177.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' MET . 9.2 mt -106.61 111.5 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 118.481 -0.771 . . . . 1.0 109.816 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -134.42 130.94 37.56 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.04 104.8 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 91' ' ' THR . 0.6 OUTLIER -136.79 49.3 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.994 -0.682 . . . . 1.0 109.202 179.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.62 162.39 36.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.094 -0.957 . . . . 1.0 109.955 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HA ' HH21 ' A' ' 100' ' ' ARG . 3.0 Cg_exo -69.62 -38.73 7.7 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.307 2.005 . . . . 1.0 112.688 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -78.16 -42.38 31.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 -11.26 20.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.661 0.267 . . . . 1.0 111.529 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.35 -166.76 26.63 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.545 ' N ' HD21 ' A' ' 97' ' ' ASN . 0.0 OUTLIER -145.36 -153.8 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.239 0.542 . . . . 1.0 111.072 178.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.416 ' N ' HG12 ' A' ' 22' ' ' VAL . 14.4 p-90 -72.34 -29.61 63.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.949 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -30.85 71.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.457 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.581 ' NH2' ' OH ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 119.926 -0.71 . . . . 1.0 109.937 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.581 ' OH ' ' NH2' ' A' ' 100' ' ' ARG . 7.8 m-85 -92.96 0.44 57.4 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.69 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.99 126.11 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.142 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -72.7 -157.48 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.605 0.595 . . . . 1.0 112.605 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.607 ' CZ2' ' CG2' ' A' ' 73' ' ' VAL . 4.1 m-90 -112.41 158.72 19.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.468 -0.787 . . . . 1.0 111.046 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.653 ' O ' ' N ' ' A' ' 107' ' ' SER . . . -100.56 -14.62 18.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 116.086 1.884 . . . . 1.0 116.086 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 107' ' ' SER . 49.7 t 32.62 23.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.406 0.548 . . . . 1.0 112.422 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.3 OUTLIER 159.4 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.641 0.258 . . . . 1.0 110.663 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.645 ' O ' ' NE2' ' A' ' 111' ' ' GLN . . . -85.25 2.21 88.26 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.197 -0.525 . . . . 1.0 111.907 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -86.59 -22.85 26.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.003 0.371 . . . . 1.0 112.003 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 111' ' ' GLN . 8.4 pt-20 -115.93 -27.55 6.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.401 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.787 ' N ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER -44.13 110.13 0.19 Allowed 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.762 ' OD1' ' N ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -88.28 -5.31 58.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -140.55 172.1 13.2 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 124.014 0.821 . . . . 1.0 112.723 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.593 ' CD1' ' C ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -148.71 132.07 8.28 Favored Pre-proline 0 N--CA 1.433 -1.287 0 C-N-CA 119.488 -0.885 . . . . 1.0 111.029 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 139' ' ' TRP . 80.6 Cg_exo -55.55 116.39 3.12 Favored 'Trans proline' 0 N--CA 1.509 2.406 0 C-N-CA 123.4 2.733 . . . . 1.0 113.99 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.6 tp -120.39 121.74 39.23 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.048 0.452 . . . . 1.0 111.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -102.84 114.26 28.38 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.505 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.3 pt -139.61 134.41 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.437 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.64 38.69 30.39 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.039 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.456 ' HE ' ' CG1' ' A' ' 78' ' ' VAL . 1.2 mmp_? 58.33 32.34 21.96 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.179 0.514 . . . . 1.0 110.452 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.37 155.22 50.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.434 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 122' ' ' ILE . 15.0 mm -96.22 125.85 48.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.989 0.423 . . . . 1.0 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.411 ' HB3' ' CE ' ' A' ' 125' ' ' LYS . 0.5 OUTLIER -124.05 150.64 44.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.277 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.764 ' O ' ' NZ ' ' A' ' 125' ' ' LYS . 1.8 m-30 -118.64 118.76 32.53 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.761 0.315 . . . . 1.0 110.486 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.764 ' NZ ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -115.33 155.29 27.59 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.319 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.64 ' O ' ' N ' ' A' ' 53' ' ' GLY . 10.7 p -106.69 109.86 21.89 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.843 1.339 . . . . 1.0 110.487 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -76.18 -8.38 56.9 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.33 1.019 . . . . 1.0 112.091 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.775 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -151.02 135.73 9.94 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 119.923 -0.711 . . . . 1.0 110.929 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.19 129.02 31.42 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.497 1.465 . . . . 1.0 111.65 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.5 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.054 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.439 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -84.18 132.92 46.32 Favored Pre-proline 0 C--O 1.219 -0.541 0 C-N-CA 120.162 -0.615 . . . . 1.0 109.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -45.42 104.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.907 1.738 . . . . 1.0 114.032 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 139.57 0.5 2.05 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 120.254 -0.974 . . . . 1.0 113.382 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.485 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -102.71 138.74 39.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.306 0.574 . . . . 1.0 110.145 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.51 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -61.29 130.97 48.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.763 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 11.0 mp -75.6 129.54 37.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.721 -0.791 . . . . 1.0 109.134 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.762 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -141.97 159.4 42.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.44 172.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.399 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.588 ' HE1' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -101.3 -174.56 2.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.961 0.886 . . . . 1.0 111.036 178.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -87.38 -142.71 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.759 -1.564 . . . . 1.0 109.948 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.6 ' OD1' ' N ' ' A' ' 144' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 28.4 mt-10 57.35 20.54 5.98 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 1.5 m-20 89.35 69.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.847 -1.07 . . . . 1.0 109.852 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 0.1 OUTLIER -77.06 163.0 67.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.924 -1.035 . . . . 1.0 109.712 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.38 -20.82 69.89 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.604 1.536 . . . . 1.0 114.234 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 127' ' ' LEU . 0.5 OUTLIER -68.94 -37.67 79.01 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.538 -2.023 . . . . 1.0 105.538 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 152' ' ' ILE . 3.8 mm -74.55 -53.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.06 -1.427 . . . . 1.0 109.787 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.41 70.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.79 -38.25 90.34 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.438 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.27 68.64 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.184 -0.607 . . . . 1.0 110.631 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 148' ' ' ILE . 37.4 mt -61.21 -42.51 93.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 O-C-N 123.402 0.439 . . . . 1.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 3.3 tt0 -61.99 -55.67 26.95 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.793 -0.763 . . . . 1.0 111.967 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.61 -40.87 84.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.506 0.558 . . . . 1.0 112.506 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' A' ' 156' ' ' ARG . 1.7 pp20? -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.203 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -64.8 -40.59 95.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.318 . . . . 1.0 110.65 178.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -55.1 -49.68 71.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 160' ' ' ARG . 2.9 m -62.8 -32.15 73.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.844 -1.071 . . . . 1.0 111.03 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.445 ' CB ' ' NZ ' ' A' ' 55' ' ' LYS . . . -57.49 -5.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.256 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 158' ' ' SER . 9.3 mtm180 -107.43 -39.17 5.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.983 0.421 . . . . 1.0 110.48 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.566 179.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.6 m -71.21 -106.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 1.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.7 135.06 36.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.549 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -144.97 173.33 11.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.603 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.19 36.24 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' N ' ' OD2' ' A' ' 2' ' ' ASP . 0.6 OUTLIER 66.63 -176.19 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.558 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.471 ' H ' HD21 ' A' ' 4' ' ' ASN . 7.1 m -139.45 69.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.569 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -150.67 104.09 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.589 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 2.0 pm0 -90.35 157.75 44.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.394 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.61 -171.58 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.71 2.274 . . . . 1.0 112.222 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.02 -174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 68.11 171.19 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.401 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.46 -85.22 0.43 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.699 0.761 . . . . 1.0 110.379 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER 171.67 -53.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.979 -1.464 . . . . 1.0 109.198 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -126.44 162.1 26.38 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.707 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -119.61 161.46 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.614 0.721 . . . . 1.0 111.416 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.16 -39.49 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.614 -178.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.21 -9.4 58.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.391 0.615 . . . . 1.0 110.696 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.707 ' CB ' ' H ' ' A' ' 14' ' ' THR . 17.3 tp10 -89.32 -45.24 9.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -48.26 149.88 2.47 Favored Pre-proline 0 C--N 1.342 0.242 0 N-CA-C 105.168 -2.16 . . . . 1.0 105.168 177.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' CB ' ' CE1' ' A' ' 21' ' ' HIS . 14.5 Cg_exo -46.77 137.41 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 CA-C-N 120.371 1.168 . . . . 1.0 111.531 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 3.2 tt0 -59.27 -52.01 67.51 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.021 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.417 ' CE1' ' CB ' ' A' ' 19' ' ' PRO . 6.7 p80 -57.13 -28.89 63.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.991 0.737 . . . . 1.0 112.991 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 98' ' ' TRP . 23.7 t -79.28 -49.65 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.368 0.531 . . . . 1.0 110.379 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.01 -26.92 62.41 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.364 0.602 . . . . 1.0 111.253 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 10.6 mmm180 -57.87 -25.51 60.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.124 -0.944 . . . . 1.0 112.372 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.25 48.27 0.95 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.604 HD23 ' CG ' ' A' ' 98' ' ' TRP . 11.7 mt -96.83 131.24 28.33 Favored Pre-proline 0 CA--C 1.511 -0.529 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.557 ' C ' ' H ' ' A' ' 29' ' ' GLU . 2.9 Cg_exo -61.86 143.61 95.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 N-CA-C 109.912 -0.842 . . . . 1.0 109.912 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -52.43 -10.04 0.13 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.947 -177.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.85 ' N ' ' HZ1' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -84.33 12.14 7.22 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 178.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.509 ' CG2' ' OE1' ' A' ' 29' ' ' GLU . 10.8 t -140.1 131.78 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.492 0 N-CA-C 118.227 2.677 . . . . 1.0 118.227 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -134.99 141.37 46.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 110.95 -2.841 . . . . 1.0 103.567 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -91.28 153.1 20.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 117.759 -1.576 . . . . 1.0 109.856 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.416 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 1.3 m-85 -154.53 110.41 2.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 12.5 Cg_endo -87.89 151.25 7.21 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.104 2.536 . . . . 1.0 112.105 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 35' ' ' SER . 2.3 p 55.46 44.11 27.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.19 -43.9 8.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.11 -1.404 . . . . 1.0 107.218 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.578 ' CG2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -104.19 -0.65 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 113.938 -1.483 . . . . 1.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 7.0 t70 96.7 3.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.154 0.909 . . . . 1.0 110.693 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.42 -37.27 44.25 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.512 ' N ' ' CD ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER 84.12 -9.96 0.93 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.741 0.651 . . . . 1.0 112.714 177.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.637 ' H ' ' HG2' ' A' ' 39' ' ' LYS . 18.9 ttm180 -77.59 157.03 30.48 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 176.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mm -77.66 127.1 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 120.599 1.545 . . . . 1.0 109.482 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.36 -176.35 19.38 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.53 130.04 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.652 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 52.5 m95 -130.57 151.16 51.34 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -66.05 132.0 47.52 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.684 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -26.07 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.85 ' HZ1' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.58 156.25 41.71 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 177.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' CD ' ' HG2' ' A' ' 48' ' ' LYS . 8.1 Cg_exo -73.97 128.35 12.24 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 CA-C-N 121.975 1.741 . . . . 1.0 112.885 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.01 146.47 8.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.77 -1.559 . . . . 1.0 112.821 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.525 HD11 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.76 151.96 32.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.019 -1.901 . . . . 1.0 110.23 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.25 125.8 25.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.018 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.29 -0.87 53.98 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.451 -1.059 . . . . 1.0 110.451 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.9 tptt -54.42 152.29 6.72 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.817 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 2.9 ttmt -122.51 108.56 13.3 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.857 0.723 . . . . 1.0 109.738 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' ' CD ' ' A' ' 29' ' ' GLU . 18.9 m-85 -116.93 123.11 46.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.865 -1.531 . . . . 1.0 106.865 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.82 -157.15 27.57 Favored Glycine 0 C--N 1.31 -0.911 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -86.21 150.37 44.9 Favored 'Cis proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.356 1.578 . . . . 1.0 113.201 0.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.615 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 7.2 t80 -64.04 120.35 11.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.404 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -27.05 -65.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.829 -1.532 . . . . 1.0 111.432 178.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' CA ' ' CE2' ' A' ' 59' ' ' PHE . . . 48.78 107.64 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.572 -0.74 . . . . 1.0 113.162 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -94.4 149.46 21.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 176.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -90.52 114.1 26.22 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.177 -1.009 . . . . 1.0 112.165 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.661 ' HZ3' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -148.28 171.08 16.54 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.628 -1.169 . . . . 1.0 110.672 -176.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 135.1 37.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.102 0.477 . . . . 1.0 111.48 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.689 ' C ' ' H ' ' A' ' 68' ' ' GLN . 9.7 ptt85 -57.95 -24.15 56.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.275 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.51 21.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.756 -0.377 . . . . 1.0 111.188 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.689 ' H ' ' C ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.09 7.31 2.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.723 0.297 . . . . 1.0 111.676 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 70' ' ' LYS . 37.5 t -99.26 161.08 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 1.6 tttp -177.97 124.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.518 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 42.96 55.82 4.28 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' SD ' ' A' ' 75' ' ' MET . 5.4 t-20 -131.44 -178.37 4.82 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.493 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.678 ' C ' ' H ' ' A' ' 75' ' ' MET . 0.2 OUTLIER -138.36 -49.74 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 118.817 0.735 . . . . 1.0 111.411 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.615 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -62.69 36.45 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.503 -177.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.692 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -144.82 141.59 29.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.543 0.687 . . . . 1.0 111.657 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.564 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -159.73 163.4 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.91 -1.041 . . . . 1.0 111.962 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 3.6 pt-20 -98.02 122.49 41.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.894 0.854 . . . . 1.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -126.78 131.01 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 115.219 -0.9 . . . . 1.0 109.194 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -89.79 121.69 32.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.848 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 82' ' ' ASN . 13.7 m-85 -86.48 108.05 16.21 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 114.607 -1.179 . . . . 1.0 110.047 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.29 48.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.206 1.937 . . . . 1.0 109.955 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.652 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -151.85 -84.0 0.08 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.237 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.652 ' N ' ' CG ' ' A' ' 82' ' ' ASN . 4.1 pp -78.05 -42.33 32.66 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.442 ' N ' ' CD1' ' A' ' 83' ' ' LEU . . . 151.22 -170.8 30.88 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.563 -1.303 . . . . 1.0 112.356 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.573 ' O ' ' SD ' ' A' ' 86' ' ' MET . 11.8 m95 -70.43 122.5 19.74 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 117.155 0.478 . . . . 1.0 110.322 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.573 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 42.1 mmm -126.91 160.2 31.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -113.35 134.2 54.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.563 -1.199 . . . . 1.0 108.144 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' MET . 7.0 mt -107.64 108.52 25.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 118.668 -0.682 . . . . 1.0 111.943 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.661 ' N ' ' HZ3' ' A' ' 64' ' ' LYS . 28.9 t0 -133.78 131.93 39.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.619 1.1 . . . . 1.0 113.521 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -136.22 91.47 2.68 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.549 ' HG1' HH12 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -114.91 49.63 1.03 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.862 0.839 . . . . 1.0 110.122 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.438 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -144.15 152.26 54.01 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.987 177.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.36 -44.33 4.88 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.282 1.321 . . . . 1.0 112.72 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.48 -45.09 69.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.732 -1.122 . . . . 1.0 113.562 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -11.3 33.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.832 0.349 . . . . 1.0 110.65 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.68 -158.42 15.97 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -145.01 -153.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 1.0 110.007 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.604 ' CG ' HD23 ' A' ' 26' ' ' LEU . 45.6 p-90 -74.59 -34.89 62.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.855 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.401 ' HB2' HD22 ' A' ' 97' ' ' ASN . 0.5 OUTLIER -54.9 -29.22 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.056 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.549 HH12 ' HG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -66.27 -15.08 62.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.9 OUTLIER -94.86 0.58 54.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.831 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.8 t -70.46 132.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 119.936 -0.706 . . . . 1.0 110.174 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -79.26 -153.84 0.08 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.209 -0.596 . . . . 1.0 111.878 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.406 ' HE1' HG11 ' A' ' 73' ' ' VAL . 6.0 m-90 -126.27 159.35 33.34 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.714 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.492 ' HB1' HE21 ' A' ' 111' ' ' GLN . . . -139.27 174.73 10.21 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.427 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -47.87 2.87 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.784 ' O ' ' N ' ' A' ' 109' ' ' GLU . 20.3 m -148.9 132.0 16.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.68 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' C ' ' OE1' ' A' ' 111' ' ' GLN . . . -19.52 -4.29 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 118.456 2.142 . . . . 1.0 118.456 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.784 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.5 mt-10 -82.03 -24.43 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 119.236 1.518 . . . . 1.0 113.693 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 111' ' ' GLN . 13.4 pt-20 -124.18 -17.14 6.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.767 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 6.5 mp0 -45.7 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.954 1.408 . . . . 1.0 109.886 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.577 HD22 ' CD1' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 163.21 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.961 -1.018 . . . . 1.0 111.852 177.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mp -137.92 164.19 29.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.205 -0.998 . . . . 1.0 112.177 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -143.7 130.32 10.34 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 119.013 -1.075 . . . . 1.0 113.566 -178.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.42 131.04 31.1 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.676 2.917 . . . . 1.0 113.625 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.469 HD21 ' HZ1' ' A' ' 125' ' ' LYS . 34.2 tp -141.34 130.66 23.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.127 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.461 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 6.2 mm-40 -102.83 114.85 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.436 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.2 pt -139.16 123.76 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.851 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.2 42.41 25.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.354 0.597 . . . . 1.0 110.668 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.594 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 5.2 mmt-85 56.74 32.46 21.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.49 144.04 49.18 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.461 ' CD1' ' CD ' ' A' ' 117' ' ' GLU . 4.1 mm -103.07 116.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.567 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 125' ' ' LYS . 3.5 m-85 -109.04 158.25 17.91 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -116.85 132.14 56.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -127.64 146.33 50.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.488 -177.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 53' ' ' GLY . 13.1 p -100.72 111.45 23.68 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.935 0.772 . . . . 1.0 111.483 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.517 ' N ' ' HZ1' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.96 -5.58 59.2 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 123.926 0.766 . . . . 1.0 111.88 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.866 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.74 122.62 7.23 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.458 0.572 . . . . 1.0 109.986 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -44.17 138.59 6.76 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.521 1.481 . . . . 1.0 111.21 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.13 134.61 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.96 132.59 60.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.02 -0.672 . . . . 1.0 109.931 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.07 104.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.21 1.273 . . . . 1.0 111.906 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 131.87 2.91 4.19 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.035 -0.602 . . . . 1.0 112.834 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -105.56 115.54 30.42 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.218 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.652 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -47.18 139.73 5.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.889 0.852 . . . . 1.0 111.359 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.509 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 8.6 mp -78.34 128.79 34.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.708 -1.133 . . . . 1.0 109.072 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.577 ' CD1' HD22 ' A' ' 112' ' ' ASN . 0.0 OUTLIER -142.58 161.34 38.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.569 0.699 . . . . 1.0 110.706 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.31 177.38 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.885 . . . . 1.0 111.968 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.674 ' HE1' ' CG ' ' A' ' 111' ' ' GLN . 9.2 p-90 -158.09 -86.95 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 119.806 -0.758 . . . . 1.0 113.034 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.649 ' CE2' ' CE2' ' A' ' 139' ' ' TRP . 0.1 OUTLIER 24.47 59.14 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.141 0.901 . . . . 1.0 112.005 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' IAS . . . . . 0.576 ' OD1' ' N ' ' A' ' 143' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.516 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.469 0.874 0 CA-C-O 119.873 -0.404 . . . . 1.0 112.113 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.576 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 28.6 mt-10 -32.5 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -130.03 54.96 1.82 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.47 163.45 53.43 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.081 -0.963 . . . . 1.0 108.748 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 150' ' ' ALA . 10.5 Cg_exo -62.55 -20.2 69.99 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 120.929 1.086 . . . . 1.0 113.672 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.516 ' O ' ' CD2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -73.77 -34.08 64.53 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.726 -1.953 . . . . 1.0 105.726 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.623 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.5 mm -77.75 -50.63 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 113.866 -1.515 . . . . 1.0 109.699 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.83 -52.15 33.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 146' ' ' PRO . . . -56.58 -41.7 77.42 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.817 -176.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.512 ' O ' ' CD ' ' A' ' 155' ' ' GLU . . . -73.91 -31.19 62.98 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.674 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 148' ' ' ILE . 22.7 mt -62.47 -48.43 88.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 3.7 mt-10 -55.72 -52.28 64.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.345 -0.843 . . . . 1.0 113.071 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' O ' ' OG ' ' A' ' 158' ' ' SER . 0.8 OUTLIER -56.52 -49.64 74.15 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.75 -1.18 . . . . 1.0 112.543 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.512 ' CD ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -81.92 -58.71 2.86 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.457 -0.897 . . . . 1.0 112.171 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 152' ' ' ILE . 1.0 OUTLIER -55.65 -51.63 66.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.494 -0.775 . . . . 1.0 112.22 -179.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -58.78 -23.72 60.63 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 154' ' ' GLU . 48.9 m -96.26 0.01 50.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.346 -1.297 . . . . 1.0 110.509 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.04 38.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.494 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -125.95 -65.69 0.98 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.544 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.354 0 CA-C-O 121.177 0.513 . . . . 1.0 110.112 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.2 m 151.52 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.465 -1.243 . . . . 1.0 107.845 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.38 157.44 17.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.234 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 150.54 43.95 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 121.644 0.735 . . . . 1.0 112.587 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.813 ' N ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.12 -35.47 25.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.08 -0.963 . . . . 1.0 110.204 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.29 -9.79 58.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.931 -1.031 . . . . 1.0 111.382 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -31.76 22.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.62 0.97 . . . . 1.0 113.62 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 15' ' ' LEU . 1.5 p -56.15 142.91 65.48 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HB3' ' CE1' ' A' ' 21' ' ' HIS . 35.3 Cg_exo -48.44 122.78 8.23 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.431 1.421 . . . . 1.0 110.677 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.772 ' HA ' HD21 ' A' ' 23' ' ' LEU . 37.7 tt0 -48.35 -25.42 1.58 Allowed 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 113.303 0.853 . . . . 1.0 113.303 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.164 0.802 . . . . 1.0 113.164 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.756 HG22 ' HA ' ' A' ' 97' ' ' ASN . 6.8 t -76.97 -49.7 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.135 HD23 ' H ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -71.23 -19.58 62.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.711 0.767 . . . . 1.0 109.934 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.83 -27.37 68.83 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 -176.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.33 42.58 1.91 Allowed Glycine 0 N--CA 1.47 0.942 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' PRO . 18.5 mt -76.77 155.47 83.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' O ' ' O ' ' A' ' 26' ' ' LEU . 23.9 Cg_exo -36.25 -112.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 124.537 3.491 . . . . 1.0 113.516 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.92 -57.61 3.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.755 -1.578 . . . . 1.0 107.6 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 12.0 pt-20 -172.89 37.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 2.4 t -45.69 171.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 113.412 -1.722 . . . . 1.0 107.785 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.753 ' CB ' HG21 ' A' ' 47' ' ' THR . 0.0 OUTLIER -141.67 154.1 45.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -91.83 134.67 34.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 118.894 -1.122 . . . . 1.0 109.874 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.7 m-85 -133.95 144.56 52.15 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.866 ' HA ' ' HA ' ' A' ' 42' ' ' ILE . 3.1 Cg_exo -48.32 142.46 16.85 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 CA-C-N 119.715 0.934 . . . . 1.0 114.031 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.637 ' C ' ' H ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -61.69 52.43 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-O 123.087 1.423 . . . . 1.0 110.892 -178.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 34' ' ' PRO . . . -56.84 -5.36 0.23 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.017 -1.901 . . . . 1.0 108.272 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -82.55 -50.37 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 113.689 -1.596 . . . . 1.0 111.83 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 40' ' ' THR . 44.8 t0 -156.04 -66.72 0.11 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.536 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 41' ' ' ARG . 8.1 mmpp? -58.72 3.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.22 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER 35.73 14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 35' ' ' SER . 49.2 mtp85 -107.3 -116.46 0.26 Allowed 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 105.356 -2.09 . . . . 1.0 105.356 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.866 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 9.5 mm -102.19 134.03 44.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 120.09 1.314 . . . . 1.0 111.318 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.23 159.79 23.19 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.617 HG21 ' CE3' ' A' ' 98' ' ' TRP . 6.4 p -102.84 131.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.234 0.54 . . . . 1.0 111.627 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 13.5 m95 -130.33 154.46 47.62 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.711 1.004 . . . . 1.0 113.711 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.83 131.39 45.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.456 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.753 HG21 ' CB ' ' A' ' 31' ' ' ARG . 76.3 p -124.96 -15.19 6.47 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.769 1.271 . . . . 1.0 108.57 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.65 168.89 9.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.843 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.07 152.38 27.86 Favored 'Trans proline' 0 C--N 1.293 -2.356 0 C-N-CA 122.425 2.083 . . . . 1.0 112.415 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.481 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 3.3 mp -134.85 144.28 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.871 -1.059 . . . . 1.0 111.229 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.4 154.37 30.4 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.925 -1.488 . . . . 1.0 110.828 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.649 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.97 125.76 25.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.8 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.28 0.76 55.78 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -53.25 152.54 4.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 119.382 -0.927 . . . . 1.0 109.218 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.591 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.64 107.61 12.59 Favored 'General case' 0 N--CA 1.424 -1.757 0 O-C-N 124.714 1.259 . . . . 1.0 109.198 176.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 10.9 m-30 -119.78 124.46 46.22 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.302 1.048 . . . . 1.0 109.323 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.69 -148.84 20.74 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.223 -1.808 . . . . 1.0 109.753 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 9.5 Cg_endo -80.41 152.57 83.53 Favored 'Cis proline' 0 N--CA 1.49 1.304 0 CA-C-N 119.821 1.811 . . . . 1.0 112.681 0.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 60' ' ' VAL . 9.2 t80 -65.12 115.89 5.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.513 -1.221 . . . . 1.0 111.733 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.725 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -21.68 -63.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.565 178.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.725 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 51.29 104.82 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.354 -0.839 . . . . 1.0 112.945 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -94.18 144.11 25.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.529 -1.656 . . . . 1.0 106.529 177.001 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -92.02 114.6 27.18 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.949 -1.1 . . . . 1.0 113.025 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -142.99 169.94 16.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.139 -1.391 . . . . 1.0 109.056 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.91 152.98 27.81 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.123 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 4.1 ttm180 -56.31 -24.49 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.756 -0.59 . . . . 1.0 110.706 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.218 0.532 . . . . 1.0 110.055 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.71 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 120.98 0.419 . . . . 1.0 111.731 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.889 ' CE2' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -161.18 163.58 31.08 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.454 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -100.62 125.32 47.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.148 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.12 139.06 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.85 -0.613 . . . . 1.0 112.152 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 11.5 t80 -79.46 126.13 30.45 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.573 0.701 . . . . 1.0 111.601 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 82' ' ' ASN . 7.0 m-85 -99.3 131.36 25.25 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.523 -1.217 . . . . 1.0 112.032 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.19 13.86 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.01 1.807 . . . . 1.0 109.367 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 80' ' ' TYR . 46.2 m-80 -124.35 -9.78 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.681 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.69 -1.16 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.57 -158.89 15.64 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 120.481 -0.866 . . . . 1.0 113.074 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 67.4 m95 -71.34 120.44 16.93 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.0 mmm -125.96 164.68 20.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.328 0.862 . . . . 1.0 113.328 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -111.5 132.81 54.23 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 78' ' ' VAL . 5.5 mt -107.42 109.76 29.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 118.734 -0.651 . . . . 1.0 111.43 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.665 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 21.4 t0 -133.14 130.97 39.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.269 0.94 . . . . 1.0 112.818 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -136.09 97.58 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.628 HG22 ' OD1' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -130.78 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.734 -0.786 . . . . 1.0 110.756 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.423 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -153.84 159.05 32.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.096 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.49 -38.91 13.49 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.567 1.511 . . . . 1.0 111.234 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -77.08 -42.58 37.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.561 -1.199 . . . . 1.0 113.896 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -9.91 16.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.123 -0.231 . . . . 1.0 110.915 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.423 ' CA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.48 123.63 6.11 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.756 ' HA ' HG22 ' A' ' 22' ' ' VAL . 45.4 p-10 -71.88 -151.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.163 0.506 . . . . 1.0 110.774 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.635 ' N ' HG13 ' A' ' 22' ' ' VAL . 44.0 p-90 -76.06 -31.16 58.65 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.644 -0.707 . . . . 1.0 111.655 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.642 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -57.0 -27.85 61.91 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.602 ' NE ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -67.18 -15.44 63.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.573 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -93.92 2.91 56.04 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 99' ' ' LEU . 6.3 t -78.27 128.61 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.213 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.724 HD21 HD23 ' A' ' 137' ' ' LEU . 15.9 p-10 -87.42 -143.75 0.12 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.909 -0.716 . . . . 1.0 111.495 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.42 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 6.6 m-90 -127.05 160.3 31.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.498 0.555 . . . . 1.0 112.498 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.706 ' HB3' ' CD1' ' A' ' 139' ' ' TRP . . . -101.78 -134.62 0.31 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.639 1.348 . . . . 1.0 114.639 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 t -154.21 -51.81 0.09 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.706 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.595 ' C ' ' H ' ' A' ' 109' ' ' GLU . 38.9 m -165.26 65.4 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.231 0.826 . . . . 1.0 113.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.09 -12.62 0.01 OUTLIER Glycine 0 CA--C 1.534 1.224 0 N-CA-C 114.324 0.49 . . . . 1.0 114.324 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 107' ' ' SER . 12.6 pt-20 -81.19 -26.59 35.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.494 0.647 . . . . 1.0 111.592 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 137' ' ' LEU . 6.0 pt-20 -122.21 -24.39 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.783 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.697 HE22 ' HB3' ' A' ' 114' ' ' PHE . 1.6 tm0? -53.81 132.34 41.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.78 ' C ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.68 -21.02 11.45 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.317 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.78 HD22 ' C ' ' A' ' 112' ' ' ASN . 4.2 mm? -125.61 143.49 51.0 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.859 -0.737 . . . . 1.0 110.661 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -128.7 131.32 23.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 119.463 -0.895 . . . . 1.0 112.191 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.11 128.34 22.11 Favored 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 124.058 3.172 . . . . 1.0 115.017 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.5 tp -140.43 132.74 28.29 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.817 -0.552 . . . . 1.0 110.103 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.446 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 6.8 mm-40 -105.58 115.58 30.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.907 -0.717 . . . . 1.0 110.029 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 123' ' ' TYR . 4.8 pt -139.9 129.61 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.066 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 49.4 46.52 23.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.255 0.55 . . . . 1.0 110.489 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 56.11 32.92 21.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.208 -0.597 . . . . 1.0 109.904 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -137.06 141.73 42.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.321 -0.854 . . . . 1.0 109.006 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.889 HG21 ' CE2' ' A' ' 76' ' ' TRP . 0.8 OUTLIER -102.53 113.0 37.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.079 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.803 ' CD1' HD11 ' A' ' 118' ' ' ILE . 3.1 m-85 -101.04 155.62 17.88 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.874 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 1.4 m-30 -119.02 125.24 48.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.623 -2.362 . . . . 1.0 104.623 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.874 ' HZ2' ' C ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -125.81 155.58 40.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.091 -175.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 53' ' ' GLY . 15.1 p -105.71 117.1 33.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.3 OUTLIER -81.35 -9.43 59.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.844 0.715 . . . . 1.0 109.952 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.702 ' HZ2' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -150.42 141.48 14.8 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 120.452 -0.499 . . . . 1.0 111.947 -178.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -55.75 140.38 84.56 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.133 1.889 . . . . 1.0 111.733 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -121.52 136.33 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.8 37.88 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.3 105.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.35 2.034 . . . . 1.0 113.048 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 133.53 0.18 4.11 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 109.977 -1.249 . . . . 1.0 109.977 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.14 137.81 35.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.63 -0.785 . . . . 1.0 109.21 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.711 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.2 pm0 -73.02 138.77 46.17 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.903 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.463 ' O ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 mp -79.35 127.01 31.55 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.262 -1.384 . . . . 1.0 107.262 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.724 HD23 HD21 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -141.04 159.07 43.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.603 -176.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.735 HG11 ' CE2' ' A' ' 124' ' ' TYR . 26.8 m -143.03 172.5 7.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 113.611 0.967 . . . . 1.0 113.611 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.706 ' CD1' ' HB3' ' A' ' 105' ' ' ALA . 36.3 p-90 . . . . . 0 C--O 1.212 -0.884 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.924 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mm . . . . . 0 N--CA 1.423 -1.803 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.34 -48.97 59.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.13 81.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.468 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--O 1.206 -1.216 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.272 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 111.61 0.226 . . . . 1.0 111.61 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -120.4 -41.8 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.096 0.474 . . . . 1.0 110.057 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.29 161.49 23.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 1.0 108.811 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.581 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -122.16 155.11 36.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 1.0 111.851 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.56 -34.7 18.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.52 -15.88 59.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.604 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.581 ' CB ' ' H ' ' A' ' 14' ' ' THR . 20.8 tp10 -79.16 -41.39 28.58 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.74 HG23 HD22 ' A' ' 23' ' ' LEU . 27.7 m -60.78 154.15 59.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 119.43 -0.908 . . . . 1.0 108.904 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.585 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 24.6 Cg_exo -56.14 130.39 39.95 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 120.982 1.121 . . . . 1.0 109.56 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.535 ' HA ' HD21 ' A' ' 23' ' ' LEU . 24.5 tt0 -50.86 -35.46 32.73 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.585 ' CE1' HG23 ' A' ' 22' ' ' VAL . 19.3 p80 -75.63 -22.68 56.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 97' ' ' ASN . 2.2 t -76.36 -51.81 18.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 CA-C-N 119.966 1.257 . . . . 1.0 112.087 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.979 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.6 pt? -70.9 -24.82 62.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.293 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.418 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -61.49 -19.56 62.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.509 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.63 33.64 6.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.875 -0.679 . . . . 1.0 112.338 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.591 HD23 ' CG ' ' A' ' 98' ' ' TRP . 36.3 mt -77.41 154.29 81.76 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 117.68 0.74 . . . . 1.0 110.609 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' A' ' 26' ' ' LEU . 10.7 Cg_exo -34.0 -109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.383 2.722 . . . . 1.0 114.003 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.73 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -74.55 -58.82 3.05 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.624 177.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.73 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 5.1 pt-20 -170.24 47.36 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 45' ' ' TRP . 54.2 t -57.95 162.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 114.787 -1.097 . . . . 1.0 108.268 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -134.1 158.25 44.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.247 0.546 . . . . 1.0 110.616 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 32' ' ' LEU . 3.6 mm? -88.44 144.64 26.24 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.4 101.75 3.77 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.083 -0.647 . . . . 1.0 112.436 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 35' ' ' SER . 63.1 Cg_endo -82.69 150.01 14.45 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.23 2.62 . . . . 1.0 111.613 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 24.2 p 102.72 -60.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.168 0.918 . . . . 1.0 111.882 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.585 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.77 -54.63 21.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.629 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.519 HG13 ' CG ' ' A' ' 38' ' ' ASP . 1.9 p -101.09 -51.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 118.739 0.699 . . . . 1.0 111.434 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -89.39 82.0 6.53 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.292 0.568 . . . . 1.0 109.591 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -32.38 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.457 -1.247 . . . . 1.0 109.423 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.2 t -143.28 55.38 1.36 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.76 179.1 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.503 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -99.45 128.68 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.221 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.36 152.5 17.02 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.224 -1.551 . . . . 1.0 109.224 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.739 HG21 ' CE3' ' A' ' 98' ' ' TRP . 13.1 p -105.71 127.24 60.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.754 ' O ' HG13 ' A' ' 30' ' ' VAL . 21.7 m95 -126.59 146.55 50.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.281 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB1' HD11 ' A' ' 50' ' ' ILE . . . -65.57 146.64 54.59 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.51 ' CA ' ' O ' ' A' ' 132' ' ' PRO . 34.6 p -117.76 -15.56 10.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.66 0.663 . . . . 1.0 109.662 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.722 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -119.33 158.42 48.76 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.321 -178.445 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.505 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 7.8 Cg_endo -62.08 124.52 14.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.377 2.052 . . . . 1.0 110.216 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.748 HD11 ' HB1' ' A' ' 46' ' ' ALA . 3.4 mp -99.5 147.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.744 0.783 . . . . 1.0 110.282 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.07 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.61 148.03 34.19 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.829 -1.532 . . . . 1.0 109.471 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.07 ' N ' HD22 ' A' ' 51' ' ' LEU . 4.1 ttpt -59.51 126.49 27.83 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.18 4.53 47.42 Favored Glycine 0 N--CA 1.467 0.747 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.668 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 126' ' ' THR . 19.7 ttmt -89.48 139.58 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -106.53 145.7 31.53 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 175.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.62 ' CE2' HG21 ' A' ' 126' ' ' THR . 46.8 m-85 -120.5 124.83 46.35 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.545 -1.207 . . . . 1.0 109.735 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.29 -133.83 4.16 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 113.23 -1.805 . . . . 1.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 123' ' ' TYR . 78.6 Cg_endo -74.64 148.25 91.35 Favored 'Cis proline' 0 N--CA 1.502 1.991 0 CA-C-N 120.027 1.914 . . . . 1.0 113.308 0.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' O ' ' C ' ' A' ' 60' ' ' VAL . 68.5 t80 -56.26 116.75 3.23 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.934 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -16.38 -67.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 124.024 0.827 . . . . 1.0 112.622 178.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.622 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 97.83 62.01 0.9 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.271 -1.132 . . . . 1.0 110.271 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' ASP . 19.7 t0 -88.45 133.55 34.09 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 106.181 -1.785 . . . . 1.0 106.181 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -104.25 113.19 26.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -176.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' CYS . 1.7 ptpt -133.03 166.91 21.3 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.316 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.588 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -76.9 139.36 40.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 176.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.93 -23.63 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.736 0.303 . . . . 1.0 111.204 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.109 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.505 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.705 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -138.99 144.6 38.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.35 -1.75 . . . . 1.0 109.786 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.75 123.03 47.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.076 -0.65 . . . . 1.0 111.717 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -143.18 133.8 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.79 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 2.3 t80 -89.8 126.38 35.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ASN . 6.8 m-85 -92.31 105.7 15.15 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 113.516 -1.675 . . . . 1.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.77 -14.24 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.009 1.806 . . . . 1.0 109.604 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' TYR . 71.2 m-80 -81.72 -99.12 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.138 -1.392 . . . . 1.0 110.361 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -66.43 -41.93 88.47 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.374 1.25 . . . . 1.0 114.374 -176.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.1 23.99 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 120.03 -1.081 . . . . 1.0 110.485 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.429 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 14.5 m95 -54.27 120.62 6.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.779 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 78' ' ' VAL . 51.4 tpp -129.37 160.92 31.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.399 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -117.85 145.42 44.6 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.934 0.873 . . . . 1.0 109.656 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.484 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 52.1 mt -93.09 159.1 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.892 -1.504 . . . . 1.0 108.492 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.688 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -128.99 123.99 33.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.425 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.656 ' C ' HG22 ' A' ' 91' ' ' THR . . . -133.54 136.36 44.95 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 105.251 -2.129 . . . . 1.0 105.251 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.656 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 166.52 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 120.573 1.533 . . . . 1.0 111.112 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.579 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -126.23 148.89 65.25 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.454 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HB2' HG21 ' A' ' 22' ' ' VAL . 62.8 Cg_endo -66.11 -34.68 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.757 2.305 . . . . 1.0 111.849 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -71.91 -10.23 59.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.223 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.801 ' CB ' HH12 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.88 -16.01 35.14 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.695 ' N ' ' NH1' ' A' ' 100' ' ' ARG . . . -173.81 -92.49 0.08 OUTLIER Glycine 0 C--N 1.348 1.201 0 C-N-CA 120.136 -1.031 . . . . 1.0 114.05 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.739 ' HA ' HG22 ' A' ' 22' ' ' VAL . 5.2 p30 -146.58 -149.34 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.48 0.657 . . . . 1.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.739 ' CE3' HG21 ' A' ' 44' ' ' VAL . 35.2 p-90 -80.39 -24.5 39.68 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 115.163 1.542 . . . . 1.0 115.163 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.615 HD23 ' CE2' ' A' ' 124' ' ' TYR . 3.0 mp -53.5 -27.59 26.23 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.592 -0.843 . . . . 1.0 111.181 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.801 HH12 ' CB ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.65 -30.33 52.07 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 177.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.503 ' CE1' ' CG2' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -64.58 -17.57 64.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.427 HG22 HG11 ' A' ' 44' ' ' VAL . 98.1 t -63.16 117.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.041 -0.982 . . . . 1.0 110.786 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.579 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 14.5 m-20 -77.5 138.69 39.36 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 105.883 -1.895 . . . . 1.0 105.883 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.604 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 16.2 p90 -94.68 122.56 37.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.825 0.822 . . . . 1.0 111.955 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 26.96 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.04 -1.436 . . . . 1.0 114.77 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 105' ' ' ALA . 52.5 t -29.54 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER 174.01 11.29 0.0 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-N 114.721 -1.127 . . . . 1.0 111.03 174.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.58 19.69 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.83 -42.18 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.035 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -118.32 -33.11 4.46 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.038 1.125 . . . . 1.0 114.038 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 110' ' ' GLU . 4.9 mt-30 16.18 101.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.472 0.545 . . . . 1.0 112.472 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.794 HD22 HD13 ' A' ' 130' ' ' ILE . 18.0 p-10 -128.12 37.5 4.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.812 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 1.4 tp -153.32 173.63 15.36 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.152 -0.619 . . . . 1.0 110.698 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.735 ' CE2' ' HB3' ' A' ' 151' ' ' ALA . 9.3 t80 -132.23 147.67 66.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 119.553 -0.26 . . . . 1.0 111.638 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.495 ' N ' ' CD1' ' A' ' 114' ' ' PHE . 23.2 Cg_endo -100.04 96.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.502 2.134 . . . . 1.0 113.483 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 123' ' ' TYR . 8.1 tp -117.41 135.93 53.54 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -109.24 117.19 33.45 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.977 0.798 . . . . 1.0 111.128 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.954 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.8 OUTLIER -137.43 136.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.087 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 49.73 38.41 15.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.432 0.634 . . . . 1.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 63.4 13.3 6.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.019 179.256 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -110.0 154.89 22.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.082 -1.417 . . . . 1.0 107.86 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 31.5 mm -109.8 115.2 49.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 121.802 0.81 . . . . 1.0 111.888 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.954 ' CG ' HD11 ' A' ' 118' ' ' ILE . 3.6 m-85 -100.44 141.08 33.79 Favored 'General case' 0 CA--C 1.481 -1.694 0 O-C-N 121.234 -0.916 . . . . 1.0 109.27 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.615 ' CE2' HD23 ' A' ' 99' ' ' LEU . 18.3 m-30 -102.73 117.25 34.23 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.29 -2.115 . . . . 1.0 105.29 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -104.37 135.44 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.687 1.242 . . . . 1.0 110.636 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.62 HG21 ' CE2' ' A' ' 56' ' ' PHE . 33.0 p -106.4 112.98 26.23 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.131 0.491 . . . . 1.0 110.696 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -76.64 -6.11 50.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.546 -1.206 . . . . 1.0 111.996 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.59 ' HZ2' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -143.2 158.29 58.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.097 -0.641 . . . . 1.0 112.598 -175.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -72.25 145.3 43.38 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 N-CA-C 104.722 -2.838 . . . . 1.0 104.722 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.796 HG23 ' OE2' ' A' ' 134' ' ' GLU . 59.7 mt -123.5 142.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -174.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.56 128.49 88.37 Favored Pre-proline 0 C--N 1.34 0.193 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.798 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.5 Cg_exo -35.1 -27.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.655 2.236 . . . . 1.0 116.684 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.71 ' HA2' ' O ' ' A' ' 46' ' ' ALA . . . -125.6 37.04 2.61 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 120.308 1.413 . . . . 1.0 110.511 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.796 ' OE2' HG23 ' A' ' 130' ' ' ILE . 4.6 tt0 -95.23 162.38 13.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.907 0.385 . . . . 1.0 111.371 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.492 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 1.6 pm0 -80.85 140.3 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.358 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.535 ' HA ' HD21 ' A' ' 112' ' ' ASN . 4.9 mt -95.17 121.77 37.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.603 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -128.01 153.13 47.11 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.634 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 15.7 t -124.12 159.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.257 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 116.16 1.911 . . . . 1.0 116.16 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.838 0 CA-C-O 119.777 -0.154 . . . . 1.0 110.855 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -65.06 -46.84 79.56 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 116.457 -2.097 . . . . 1.0 108.244 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.15 25.8 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 115.46 1.652 . . . . 1.0 115.46 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB3' ' CE2' ' A' ' 114' ' ' PHE . . . . . . . . 0 C--N 1.34 0.174 0 CA-C-N 120.603 1.547 . . . . 1.0 111.596 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.774 0.321 . . . . 1.0 111.162 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.37 -55.82 2.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -104.69 153.94 20.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.212 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 17' ' ' GLU . 4.3 m -121.74 156.36 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 1.0 111.676 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.19 -32.8 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.61 58.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.777 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' THR . 27.6 tp10 -82.2 -40.41 21.75 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.741 HG23 HD22 ' A' ' 23' ' ' LEU . 28.7 m -59.63 159.39 18.23 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.465 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.9 Cg_exo -66.8 133.12 30.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.128 1.219 . . . . 1.0 109.961 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.551 ' HA ' HD21 ' A' ' 23' ' ' LEU . 18.6 tt0 -49.46 -38.01 28.13 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 123.749 0.656 . . . . 1.0 112.125 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.408 ' CE1' ' HB2' ' A' ' 19' ' ' PRO . 6.5 p80 -74.19 -23.25 59.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -75.89 -50.37 23.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 CA-C-N 119.805 1.184 . . . . 1.0 111.629 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.013 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.9 pt? -73.0 -26.02 61.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.648 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.95 -21.04 42.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.57 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.28 39.88 2.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.846 -0.692 . . . . 1.0 111.597 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.581 ' O ' ' O ' ' A' ' 27' ' ' PRO . 25.8 mt -85.17 153.52 59.65 Favored Pre-proline 0 N--CA 1.445 -0.702 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.229 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -34.6 -117.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 124.085 3.19 . . . . 1.0 114.166 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.694 ' HG2' ' HZ3' ' A' ' 48' ' ' LYS . 2.2 pp20? -72.98 -54.91 7.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 116.691 -2.004 . . . . 1.0 106.543 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 5.5 tt0 -174.64 57.75 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.275 1.036 . . . . 1.0 108.441 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.7 t -67.85 173.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.913 -1.04 . . . . 1.0 108.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.548 HH12 ' CG ' ' A' ' 29' ' ' GLU . 17.3 mtt85 -141.03 158.62 43.67 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.249 0.547 . . . . 1.0 110.013 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 32' ' ' LEU . 3.3 mm? -87.53 147.43 25.35 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.92 101.74 3.65 Favored Pre-proline 0 C--N 1.314 -0.953 0 C-N-CA 119.672 -0.811 . . . . 1.0 112.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 44.5 Cg_endo -83.69 149.71 12.75 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 123.272 2.648 . . . . 1.0 111.95 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 4.2 t 99.75 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.183 0.927 . . . . 1.0 111.927 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.33 -53.65 27.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.921 -175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 ' H ' ' A' ' 38' ' ' ASP . 2.4 p -102.07 -52.89 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.281 -0.567 . . . . 1.0 112.189 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -90.62 82.5 5.8 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 38' ' ' ASP . 7.7 mmpt? -28.28 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.343 -1.299 . . . . 1.0 110.07 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.597 ' N ' ' O ' ' A' ' 38' ' ' ASP . 16.4 p -143.22 54.09 1.36 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.2 168.21 8.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -92.27 131.24 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.824 -179.067 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.91 144.92 17.12 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.868 -1.693 . . . . 1.0 108.868 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.622 HG21 ' CE3' ' A' ' 98' ' ' TRP . 12.1 p -97.48 134.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.709 ' O ' HG13 ' A' ' 30' ' ' VAL . 10.6 m95 -129.04 147.65 50.92 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.146 -0.934 . . . . 1.0 110.83 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.973 ' HB3' ' CD ' ' A' ' 134' ' ' GLU . . . -73.32 123.71 24.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.13 -1.028 . . . . 1.0 110.344 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.0 p -93.41 -15.42 25.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.687 0.756 . . . . 1.0 110.947 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.694 ' HZ3' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -107.49 170.72 5.3 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.247 -1.342 . . . . 1.0 111.133 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.444 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 4.2 Cg_endo -81.68 131.88 7.46 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.232 1.955 . . . . 1.0 108.145 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 46' ' ' ALA . 4.3 mp -109.62 129.31 64.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 122.429 1.109 . . . . 1.0 111.908 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.053 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.83 147.96 22.83 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.515 -2.13 . . . . 1.0 107.755 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.053 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -59.65 123.72 17.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.38 2.48 47.57 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.626 -1.273 . . . . 1.0 113.253 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' THR . 9.7 ttmt -78.7 139.06 38.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 119.455 -0.898 . . . . 1.0 109.729 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.52 140.61 45.98 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 119.359 -0.936 . . . . 1.0 109.563 178.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.647 ' CE2' HG21 ' A' ' 126' ' ' THR . 37.2 m-85 -116.09 123.33 47.64 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.174 -1.83 . . . . 1.0 106.753 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . -176.53 -164.33 30.36 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 113.778 -1.556 . . . . 1.0 110.201 -176.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CB ' ' CE1' ' A' ' 123' ' ' TYR . 56.4 Cg_endo -98.22 137.66 3.4 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 CA-C-N 118.699 1.249 . . . . 1.0 111.638 -1.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 39.2 t80 -56.8 114.11 1.94 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.736 HG13 ' N ' ' A' ' 61' ' ' GLY . 9.7 p -44.69 -48.39 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.928 0.394 . . . . 1.0 111.109 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.736 ' N ' HG13 ' A' ' 60' ' ' VAL . . . 67.12 114.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 115.374 0.91 . . . . 1.0 115.374 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -99.75 134.43 42.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 175.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -92.2 112.11 23.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.162 1.171 . . . . 1.0 114.162 -176.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -145.07 166.31 25.74 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.983 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.586 ' HZ3' ' HB2' ' A' ' 65' ' ' LYS . 2.7 mtmp? -76.86 133.82 39.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.606 0.717 . . . . 1.0 112.266 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -57.47 -21.37 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.846 -0.615 . . . . 1.0 112.643 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.029 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.507 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 CA-C-O 121.887 0.851 . . . . 1.0 112.886 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.824 ' CE3' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -141.43 134.67 29.43 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.038 -1.437 . . . . 1.0 110.108 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 86' ' ' MET . 8.7 tp10 -97.75 122.64 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.597 . . . . 1.0 111.099 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' MET . 2.8 t -142.44 132.25 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.942 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -87.22 123.92 32.75 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.417 -0.913 . . . . 1.0 111.833 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.681 ' C ' ' H ' ' A' ' 82' ' ' ASN . 3.0 m-85 -76.3 113.72 31.13 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.12 29.62 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.172 1.914 . . . . 1.0 110.566 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.681 ' H ' ' C ' ' A' ' 80' ' ' TYR . 62.0 m-80 -135.1 -90.7 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.294 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.0 -41.77 73.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.85 -174.99 26.48 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 119.743 -1.218 . . . . 1.0 110.614 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 11.9 m95 -55.11 121.14 8.12 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.823 -0.81 . . . . 1.0 112.177 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.506 ' O ' ' O ' ' A' ' 78' ' ' VAL . 33.7 tpp -128.63 160.72 31.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.289 0.477 . . . . 1.0 112.289 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -125.08 147.53 48.95 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.729 0.776 . . . . 1.0 109.199 175.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 120' ' ' ARG . 6.3 mt -99.61 155.93 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 114.513 -1.221 . . . . 1.0 107.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.63 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.48 136.65 54.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.243 0.928 . . . . 1.0 113.155 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . . . -134.95 136.22 42.09 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.771 ' H ' ' CG ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 169.88 -37.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.674 1.125 . . . . 1.0 111.401 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.981 ' H ' ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -120.76 146.31 43.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.787 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 59.0 Cg_endo -68.53 -36.79 14.23 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 123.246 2.631 . . . . 1.0 112.6 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -56.94 -10.68 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -89.54 -11.12 43.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.706 ' O ' ' ND2' ' A' ' 97' ' ' ASN . . . 96.56 160.84 32.25 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.733 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 65.59 128.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.622 ' CE3' HG21 ' A' ' 44' ' ' VAL . 47.0 p-90 -73.83 -21.31 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.133 -1.394 . . . . 1.0 109.63 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.563 HD12 ' CE2' ' A' ' 98' ' ' TRP . 1.2 mp -50.12 -26.98 5.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.981 ' HE ' ' H ' ' A' ' 92' ' ' ASP . 6.5 ttt180 -74.68 -36.9 62.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.481 -1.69 . . . . 1.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.4 OUTLIER -68.05 -16.13 63.9 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.462 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.733 HG11 HG23 ' A' ' 138' ' ' VAL . 43.1 t -63.49 124.31 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.882 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -84.42 -174.69 5.41 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.55 -0.86 . . . . 1.0 109.06 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.407 ' HE3' ' N ' ' A' ' 104' ' ' TRP . 1.2 m-90 -94.79 154.62 17.19 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.39 0.614 . . . . 1.0 112.03 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.842 ' HB2' ' O ' ' A' ' 139' ' ' TRP . . . -31.34 -72.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.039 175.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 51.7 t 120.18 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.248 -2.13 . . . . 1.0 105.248 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 107' ' ' SER . 2.6 t 178.32 29.16 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.33 -1.305 . . . . 1.0 111.934 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.756 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . 67.11 -10.81 0.77 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.132 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 107' ' ' SER . 10.3 mm-40 -74.32 -23.26 59.03 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.636 ' O ' ' O ' ' A' ' 111' ' ' GLN . 6.6 pt-20 -119.12 -0.32 11.1 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.636 ' O ' ' O ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -43.64 -150.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.706 ' C ' HD12 ' A' ' 113' ' ' LEU . 12.5 p30 144.03 27.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.271 -1.331 . . . . 1.0 112.293 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 112' ' ' ASN . 7.3 mp -149.13 174.63 12.13 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.945 -0.472 . . . . 1.0 109.813 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.504 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -141.44 122.48 8.81 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.105 -0.638 . . . . 1.0 112.252 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.03 80.47 0.15 Allowed 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 121.456 1.438 . . . . 1.0 114.546 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.544 HD23 ' CD1' ' A' ' 118' ' ' ILE . 12.7 tp -90.23 133.66 34.78 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.245 -0.284 . . . . 1.0 110.731 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 tm-20 -108.68 120.39 42.34 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.799 0.687 . . . . 1.0 111.898 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.661 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -136.5 135.04 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.166 -0.924 . . . . 1.0 111.634 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' ILE . 2.6 m-80 35.24 57.28 0.82 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.642 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 8.2 mtp180 57.88 21.13 7.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.3 0.572 . . . . 1.0 111.664 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -125.0 149.81 47.35 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.824 HG21 ' CE3' ' A' ' 76' ' ' TRP . 41.4 mm -118.93 100.84 10.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.068 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.661 ' CG ' HD11 ' A' ' 118' ' ' ILE . 8.3 m-30 -97.33 158.9 15.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 121.762 0.791 . . . . 1.0 110.849 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.693 ' HB3' HD23 ' A' ' 113' ' ' LEU . 13.7 m-30 -106.28 129.11 54.37 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.933 -1.485 . . . . 1.0 108.668 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -117.53 136.62 53.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 113.407 -1.724 . . . . 1.0 109.026 -177.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.647 HG21 ' CE2' ' A' ' 56' ' ' PHE . 29.8 p -104.18 106.37 16.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.362 -0.935 . . . . 1.0 110.629 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -73.57 -7.98 54.1 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 112.829 -1.987 . . . . 1.0 111.449 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.632 ' HE2' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -133.63 148.74 69.82 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.803 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -74.15 140.97 28.72 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 105.983 -2.353 . . . . 1.0 105.983 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.422 HG22 ' HG3' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -127.76 138.55 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 118.852 0.751 . . . . 1.0 112.255 -175.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.573 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -75.35 134.54 73.41 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.31 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.53 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . 46.2 Cg_exo -54.41 116.43 3.07 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 122.155 1.904 . . . . 1.0 113.02 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . 121.61 4.21 9.84 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 1.052 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -83.02 147.97 27.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.498 -1.351 . . . . 1.0 114.5 -178.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.655 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 2.0 pm0 -75.5 108.09 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.823 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 137' ' ' LEU . 21.7 mt -71.73 114.87 10.28 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 136' ' ' LEU . 2.2 mp -135.11 160.8 37.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.733 HG23 HG11 ' A' ' 102' ' ' VAL . 26.3 t -118.29 152.52 20.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 O-C-N 123.69 0.618 . . . . 1.0 111.984 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.842 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.542 0 O-C-N 124.959 1.412 . . . . 1.0 113.059 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.513 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -68.45 -49.12 62.22 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.253 -1.379 . . . . 1.0 107.824 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.3 -57.29 13.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.028 -1.896 . . . . 1.0 114.34 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.455 0 CA-C-N 120.189 1.359 . . . . 1.0 110.827 -178.741 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -177.57 -25.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.6 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -72.37 0.36 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 119.195 -1.002 . . . . 1.0 113.271 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.498 ' OG1' ' CG ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -142.01 -179.69 6.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.253 -1.794 . . . . 1.0 110.102 174.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 15' ' ' LEU . 2.4 tt -73.66 -62.79 1.37 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 172.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 42' ' ' ILE . . . -89.64 -58.45 2.52 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.749 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 1.1 tm-20 89.57 -155.08 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.098 -2.186 . . . . 1.0 105.098 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.749 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER 51.34 152.39 0.04 OUTLIER Pre-proline 0 C--N 1.268 -2.947 0 O-C-N 125.766 1.916 . . . . 1.0 111.021 -178.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.54 140.16 12.35 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.895 2.396 . . . . 1.0 111.477 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -50.5 -53.05 32.93 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.156 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -60.83 -22.55 64.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 97' ' ' ASN . 2.2 t -79.28 -49.13 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.329 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 1.0 111.769 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -63.42 -16.89 61.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.68 28.17 15.55 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.012 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 27' ' ' PRO . 39.8 mt -76.96 156.03 82.53 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 112.364 0.505 . . . . 1.0 112.364 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -32.93 -123.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 125.087 3.858 . . . . 1.0 114.033 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' CD ' ' N ' ' A' ' 29' ' ' GLU . 2.2 pp20? -72.76 -51.43 19.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.425 -1.694 . . . . 1.0 106.425 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 tt0 -175.69 60.72 0.02 OUTLIER 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.638 0.733 . . . . 1.0 109.507 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 45' ' ' TRP . 3.4 t -74.15 176.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 8.5 mtt180 -141.91 162.33 35.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.437 0.637 . . . . 1.0 110.881 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -96.81 121.84 39.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -119.76 109.53 37.82 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.87 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 35' ' ' SER . 11.7 Cg_endo -84.5 150.32 11.66 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.529 2.819 . . . . 1.0 114.714 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 9.3 p 95.03 -50.87 0.01 OUTLIER 'General case' 0 C--N 1.344 0.333 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.721 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -48.08 -54.74 12.15 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.631 -0.713 . . . . 1.0 112.704 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.571 HG22 ' H ' ' A' ' 39' ' ' LYS . 2.5 p -90.74 -40.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.76 1.164 . . . . 1.0 110.824 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 67.43 9.94 7.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 178.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' H ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.79 -27.84 0.37 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 177.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.477 ' N ' ' C ' ' A' ' 38' ' ' ASP . 8.7 m -170.27 -58.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.584 -1.189 . . . . 1.0 111.451 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.37 -96.74 0.09 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 16' ' ' ALA . 2.9 tt -98.34 140.9 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 113.795 1.035 . . . . 1.0 113.795 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -120.17 165.23 13.66 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.37 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.758 HG21 ' CE3' ' A' ' 98' ' ' TRP . 12.6 p -103.31 123.74 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.212 0.529 . . . . 1.0 110.313 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 20.9 m95 -127.9 149.04 50.48 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.116 -0.947 . . . . 1.0 112.231 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.757 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -63.37 126.04 26.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.644 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -102.21 -22.22 14.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.504 1.145 . . . . 1.0 108.136 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HZ1' ' HZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -105.74 172.49 3.94 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.231 -2.259 . . . . 1.0 112.458 -175.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -87.74 125.53 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.897 2.398 . . . . 1.0 109.525 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.686 HD13 ' HB ' ' A' ' 130' ' ' ILE . 3.6 mp -98.84 145.94 9.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.481 0.657 . . . . 1.0 110.383 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.064 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.14 148.01 33.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.181 -1.372 . . . . 1.0 108.561 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.064 ' N ' HD22 ' A' ' 51' ' ' LEU . 5.0 ttpt -60.05 126.55 27.97 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.136 0.421 . . . . 1.0 112.136 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.16 4.9 47.29 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 119.32 -1.419 . . . . 1.0 114.133 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 126' ' ' THR . 2.3 ttmt -89.16 142.47 27.62 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.45 -0.9 . . . . 1.0 113.289 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -103.81 138.01 41.02 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.876 -0.787 . . . . 1.0 108.876 175.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 126' ' ' THR . 36.2 m-85 -119.47 125.34 48.67 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.787 1.28 . . . . 1.0 111.443 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.443 ' CA ' HD11 ' A' ' 99' ' ' LEU . . . 127.09 -110.98 1.28 Allowed Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 111.905 -2.407 . . . . 1.0 109.182 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HB3' ' CE1' ' A' ' 123' ' ' TYR . 83.6 Cg_endo -72.95 177.22 37.53 Favored 'Cis proline' 0 N--CA 1.503 2.08 0 CA-C-N 119.76 1.78 . . . . 1.0 112.107 -0.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.915 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 19.4 t80 -68.61 112.2 5.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.716 0.77 . . . . 1.0 111.234 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.672 HG13 ' H ' ' A' ' 61' ' ' GLY . 1.3 p -33.18 -54.84 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.934 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.672 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 75.64 108.97 0.11 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-O 121.389 0.438 . . . . 1.0 113.933 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -99.54 131.09 45.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.422 -2.066 . . . . 1.0 105.422 175.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.549 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -93.47 112.85 24.85 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.86 1.43 . . . . 1.0 114.86 -175.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -148.34 166.34 28.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.3 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.841 ' HZ2' ' H ' ' A' ' 65' ' ' LYS . 1.4 mtmp? -77.26 135.44 38.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.227 0.537 . . . . 1.0 111.531 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.443 HH11 ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.62 -23.37 50.75 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.657 0.614 . . . . 1.0 112.657 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.887 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.549 ' C ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.022 0 CA-C-O 121.649 0.738 . . . . 1.0 111.884 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.73 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -147.75 140.55 24.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.628 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.4 124.59 47.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.365 0.603 . . . . 1.0 111.762 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 120' ' ' ARG . 2.2 t -144.75 130.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -88.28 124.88 34.32 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.659 ' CZ ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 m-85 -77.55 113.19 29.7 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.632 -1.622 . . . . 1.0 112.856 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -53.68 -2.46 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.014 1.809 . . . . 1.0 110.326 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 80' ' ' TYR . 53.2 m-80 -102.98 -96.08 0.3 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.976 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 84' ' ' GLY . 0.8 OUTLIER -65.84 -40.22 91.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.88 1.437 . . . . 1.0 114.88 -176.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.4 ' N ' ' HG ' ' A' ' 83' ' ' LEU . . . 147.71 -173.54 27.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 119.772 -1.204 . . . . 1.0 110.32 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 12.0 m95 -55.16 122.14 10.37 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.88 -0.777 . . . . 1.0 111.454 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.497 ' O ' ' O ' ' A' ' 78' ' ' VAL . 5.8 tpp -127.61 157.2 40.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.354 0.501 . . . . 1.0 112.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -120.12 145.36 46.98 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.962 0.887 . . . . 1.0 110.179 176.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' O ' ' A' ' 120' ' ' ARG . 19.7 mt -97.07 156.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.847 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.93 134.02 46.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.915 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . . . -132.83 138.17 46.98 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.082 -2.192 . . . . 1.0 105.082 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 164.88 -31.43 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.868 1.213 . . . . 1.0 111.383 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.29 148.05 59.59 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.537 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 31.5 Cg_exo -55.28 -44.61 47.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.368 1.379 . . . . 1.0 112.481 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.69 -9.32 58.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.746 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -12.59 56.5 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' CA ' HG11 ' A' ' 60' ' ' VAL . . . -178.05 -107.54 0.22 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 119.507 -1.33 . . . . 1.0 113.217 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.691 ' HA ' HG22 ' A' ' 22' ' ' VAL . 44.3 p30 -150.23 -156.1 0.69 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.447 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.758 ' CE3' HG21 ' A' ' 44' ' ' VAL . 23.2 p-90 -70.91 -25.57 62.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.62 HD23 ' CD2' ' A' ' 124' ' ' TYR . 0.3 OUTLIER -53.46 -27.41 24.81 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.487 ' C ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.39 -30.67 53.74 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.554 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.2 m-85 -66.97 -18.54 65.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.32 0.581 . . . . 1.0 109.774 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 136' ' ' LEU . 6.3 t -63.92 116.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.08 -0.964 . . . . 1.0 110.396 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.67 140.79 46.33 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.131 -2.174 . . . . 1.0 105.131 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.637 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 15.8 p90 -92.07 118.73 31.08 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.937 -1.105 . . . . 1.0 110.696 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 12.61 78.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 113.953 -1.476 . . . . 1.0 114.81 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.498 ' C ' ' O ' ' A' ' 105' ' ' ALA . 0.1 OUTLIER -19.5 -40.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 125.197 1.56 . . . . 1.0 110.031 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -168.38 7.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.739 176.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.96 22.48 23.01 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.717 -0.953 . . . . 1.0 110.717 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.425 ' CD ' ' SG ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -77.79 -37.8 48.04 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.297 -0.561 . . . . 1.0 110.118 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.538 ' HG3' HD22 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -119.41 -31.91 4.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.981 1.104 . . . . 1.0 113.981 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.534 ' C ' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 14.25 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 123.416 0.448 . . . . 1.0 111.609 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.849 HD22 HG21 ' A' ' 130' ' ' ILE . 34.0 p-10 -128.06 32.97 4.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER -152.96 172.49 16.73 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.579 ' HB3' HD21 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -148.26 124.15 5.26 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 119.351 -0.94 . . . . 1.0 112.702 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.451 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.8 Cg_endo -74.71 109.82 2.99 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 120.64 0.893 . . . . 1.0 113.313 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 23.2 tp -117.42 140.8 49.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.698 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.97 121.34 45.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.794 0.664 . . . . 1.0 112.794 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -135.54 135.66 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.875 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 118' ' ' ILE . 8.0 m-80 35.94 62.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.373 0.509 . . . . 1.0 112.373 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.659 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 7.2 mtp180 55.93 11.89 0.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.984 0.365 . . . . 1.0 111.984 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -122.92 146.16 47.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 59' ' ' PHE . 4.0 mm -107.41 117.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 121.112 0.482 . . . . 1.0 110.566 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.61 ' HB2' HD11 ' A' ' 118' ' ' ILE . 3.0 m-85 -101.14 143.44 31.24 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.62 ' CD2' HD23 ' A' ' 99' ' ' LEU . 15.6 m-30 -102.03 114.72 29.08 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 104.139 -2.541 . . . . 1.0 104.139 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 7.7 ttmt -105.51 141.2 37.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.379 1.05 . . . . 1.0 109.344 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.509 HG21 ' CE2' ' A' ' 56' ' ' PHE . 18.6 p -106.87 110.88 23.16 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.401 0.62 . . . . 1.0 110.068 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -72.41 -4.66 31.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.67 -1.604 . . . . 1.0 111.239 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -145.72 161.14 41.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 120.234 -0.586 . . . . 1.0 112.311 -177.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -75.5 144.42 28.64 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 N-CA-C 105.911 -2.38 . . . . 1.0 105.911 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.849 HG21 HD22 ' A' ' 112' ' ' ASN . 5.2 mt -126.19 135.71 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.719 0.691 . . . . 1.0 110.532 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.53 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.7 134.26 95.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.224 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -59.87 117.98 4.8 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 CA-C-N 120.006 1.038 . . . . 1.0 110.415 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.757 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.28 5.82 14.27 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.824 -1.311 . . . . 1.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.574 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -89.21 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.3 pm0 -78.59 118.84 21.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.268 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 137' ' ' LEU . 2.8 mt -80.3 116.8 20.57 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 105' ' ' ALA . 1.7 mp -129.3 156.17 44.43 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 108.688 -0.856 . . . . 1.0 108.688 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.637 ' H ' ' HA ' ' A' ' 104' ' ' TRP . 5.0 t -122.09 157.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.963 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.543 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.204 -1.339 0 N-CA-C 114.985 1.476 . . . . 1.0 114.985 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.563 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.563 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -56.34 -52.43 64.6 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 117.615 -1.634 . . . . 1.0 108.213 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.76 -62.32 1.82 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.775 -1.557 . . . . 1.0 113.4 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.311 0 CA-C-N 120.12 1.327 . . . . 1.0 111.652 -177.761 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' N ' ' HG2' ' A' ' 34' ' ' PRO . . . . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m 178.22 -27.65 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.354 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.38 -73.63 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.712 0.767 . . . . 1.0 112.412 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.459 ' CB ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.36 175.81 9.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.135 -1.393 . . . . 1.0 110.632 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 15' ' ' LEU . 3.0 tt -77.19 -62.88 1.51 Allowed 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 172.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 42' ' ' ILE . . . -86.34 -59.39 2.3 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.77 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 9.1 tt0 92.48 -171.48 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 105.415 -2.069 . . . . 1.0 105.415 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.77 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 58.49 151.83 0.08 OUTLIER Pre-proline 0 C--N 1.245 -3.97 0 CA-C-N 112.034 -2.348 . . . . 1.0 108.792 -178.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.92 138.87 6.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 123.429 2.752 . . . . 1.0 111.886 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 27.9 tt0 -50.27 -51.82 41.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-N 114.932 -1.031 . . . . 1.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -63.2 -24.36 67.84 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 97' ' ' ASN . 3.4 t -76.36 -50.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 118.631 -1.228 . . . . 1.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.95 -29.28 65.25 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.132 -0.485 . . . . 1.0 112.245 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.89 -15.98 15.29 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.235 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.42 20.81 31.88 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.936 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 30' ' ' VAL 0.251 17.9 mt -69.19 139.63 90.13 Favored Pre-proline 0 CA--C 1.489 -1.381 0 CA-C-N 118.384 1.092 . . . . 1.0 109.99 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 29' ' ' GLU . 5.9 Cg_exo -61.11 148.43 92.88 Favored 'Trans proline' 0 C--N 1.281 -3.026 0 N-CA-C 107.159 -1.9 . . . . 1.0 107.159 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -49.17 -15.27 0.11 Allowed 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.567 1.175 . . . . 1.0 110.275 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -91.15 19.47 5.8 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 112.596 -2.093 . . . . 1.0 112.707 -178.211 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 26' ' ' LEU . 1.8 t -145.38 151.73 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 118.655 -1.218 . . . . 1.0 112.483 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -147.39 159.09 44.09 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.863 -1.971 . . . . 1.0 106.737 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.807 HD21 ' OH ' ' A' ' 101' ' ' TYR . 1.6 mm? -105.92 140.81 38.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m-85 -148.47 115.35 3.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.641 0.608 . . . . 1.0 112.641 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.9 Cg_endo -85.98 127.62 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.319 2.012 . . . . 1.0 111.123 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 152.55 -71.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.739 0.65 . . . . 1.0 110.831 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.667 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -51.18 -53.25 36.59 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.771 -0.772 . . . . 1.0 113.025 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -53.24 -52.17 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.369 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 40' ' ' THR . 6.4 p-10 -171.34 55.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? 53.82 -9.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.589 ' H ' ' C ' ' A' ' 38' ' ' ASP . 12.3 p -135.42 -90.4 0.31 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.301 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 40' ' ' THR . 4.5 mtt85 -29.43 133.27 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.641 0.588 . . . . 1.0 111.09 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -78.84 133.86 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.94 153.41 17.16 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.3 -1.12 . . . . 1.0 110.3 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -104.14 127.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.621 0.724 . . . . 1.0 109.212 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.667 ' CZ2' ' HB3' ' A' ' 36' ' ' ALA . 4.8 m95 -130.88 149.92 52.28 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 114.469 -1.241 . . . . 1.0 111.507 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.32 138.24 51.31 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.572 -1.251 . . . . 1.0 111.03 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.439 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -112.62 -28.25 7.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.364 -178.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.559 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -116.14 159.71 38.45 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 119.167 -1.013 . . . . 1.0 111.32 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 Cg_endo -57.21 132.27 50.16 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.812 2.341 . . . . 1.0 111.469 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 48' ' ' LYS . 3.4 mp -111.15 144.22 19.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.047 -0.979 . . . . 1.0 108.613 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.051 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.59 149.23 34.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.051 ' N ' HD22 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -64.69 135.47 55.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.757 0.789 . . . . 1.0 111.951 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.7 2.93 49.83 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 119.356 -1.402 . . . . 1.0 113.078 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.651 ' HE3' HD12 ' A' ' 51' ' ' LEU . 3.1 ttmt -96.19 139.73 31.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.162 -1.015 . . . . 1.0 113.475 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.99 139.89 35.01 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 120.16 -0.616 . . . . 1.0 109.534 176.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 126' ' ' THR . 37.1 m-85 -121.89 127.81 50.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 122.852 1.31 . . . . 1.0 110.917 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.409 ' CA ' HD11 ' A' ' 99' ' ' LEU . . . 135.11 -106.55 0.59 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 111.526 -2.579 . . . . 1.0 110.251 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 88.8 Cg_endo -83.52 170.46 53.19 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 CA-C-N 119.507 1.654 . . . . 1.0 111.994 -0.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.567 ' CE1' ' NH2' ' A' ' 100' ' ' ARG . 27.7 t80 -59.14 109.75 0.92 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.957 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG13 ' H ' ' A' ' 61' ' ' GLY . 3.0 p -45.99 -50.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.719 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.606 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 72.31 111.18 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.359 -0.448 . . . . 1.0 114.038 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t0 -99.7 132.54 44.98 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -91.22 110.21 21.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 -177.091 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -146.47 166.91 24.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.641 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.555 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 2.1 mtmp? -80.38 132.85 35.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.597 0.713 . . . . 1.0 112.08 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 67' ' ' SER . 2.7 ptm180 -50.19 -24.68 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 1.0 111.28 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.509 ' C ' ' O ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.638 0 O-C-N 123.981 0.801 . . . . 1.0 111.907 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.502 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.506 -0.728 0 N-CA-C 114.006 1.113 . . . . 1.0 114.006 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.747 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -138.7 125.35 20.78 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.735 -1.575 . . . . 1.0 109.815 -177.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -97.37 123.25 41.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.448 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.0 139.43 22.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.224 -1.353 . . . . 1.0 109.297 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -83.62 129.28 34.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.65 ' CE2' ' NE ' ' A' ' 120' ' ' ARG . 15.5 m-85 -103.52 117.23 60.5 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.693 -1.14 . . . . 1.0 113.74 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -69.9 4.11 2.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.541 1.494 . . . . 1.0 109.774 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 80' ' ' TYR . 15.7 m120 -102.11 -2.84 28.58 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.911 -1.04 . . . . 1.0 111.112 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.9 0.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 80' ' ' TYR . . . 99.19 -164.46 20.36 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 18.8 m95 -60.86 120.18 9.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.759 -0.776 . . . . 1.0 111.019 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 1.4 tpp -130.82 165.62 22.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.185 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.605 ' N ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -120.72 144.48 48.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.045 0.926 . . . . 1.0 110.477 176.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 120' ' ' ARG . 61.1 mt -97.7 156.01 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.44 136.57 54.68 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.273 0.942 . . . . 1.0 112.765 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' HE1' ' A' ' 76' ' ' TRP . . . -134.32 139.82 45.93 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.636 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 167.16 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 120.086 1.312 . . . . 1.0 111.269 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.62 152.37 62.92 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.692 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.443 ' HB2' HG21 ' A' ' 22' ' ' VAL . 51.7 Cg_endo -66.85 -37.67 19.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.543 2.162 . . . . 1.0 111.086 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.16 -14.17 62.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HB3' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.67 -10.78 50.3 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.452 ' HA3' HG11 ' A' ' 60' ' ' VAL . . . 174.92 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 119.761 -1.209 . . . . 1.0 113.854 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -148.26 -163.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.942 0.401 . . . . 1.0 111.783 -177.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.587 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 30.0 p-90 -71.3 -26.8 63.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.645 HD23 ' CD2' ' A' ' 124' ' ' TYR . 2.1 mp -55.03 -28.14 49.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.98 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.611 ' CB ' ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -77.09 -45.27 27.57 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.684 -0.806 . . . . 1.0 111.989 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.807 ' OH ' HD21 ' A' ' 32' ' ' LEU . 11.7 p90 -77.54 1.83 18.26 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 118.335 -1.346 . . . . 1.0 110.82 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.82 119.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 129.28 39.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.52 -1.289 . . . . 1.0 107.52 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.565 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 22.4 p90 -93.42 123.53 36.79 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.883 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.695 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 22.49 76.92 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.065 -1.425 . . . . 1.0 114.094 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.549 ' C ' ' O ' ' A' ' 105' ' ' ALA . 2.2 t -23.99 -38.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.787 1.304 . . . . 1.0 108.165 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -177.98 15.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.3 -1.318 . . . . 1.0 109.716 174.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 107' ' ' SER . . . 89.17 36.28 7.69 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 114.891 -1.049 . . . . 1.0 110.658 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -78.91 -44.41 22.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.047 -0.661 . . . . 1.0 109.891 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.547 ' HG3' HD22 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -120.46 -28.33 5.0 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.601 -0.714 . . . . 1.0 112.337 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.53 ' OE1' ' C ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER 22.66 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.937 0.773 . . . . 1.0 110.188 -178.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.531 HD21 ' HA ' ' A' ' 136' ' ' LEU . 41.1 p-10 -128.28 37.89 4.08 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 138' ' ' VAL . 1.0 OUTLIER -154.34 173.44 16.18 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -178.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.564 ' HB3' HD21 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -147.09 123.02 5.46 Favored Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 119.598 -0.841 . . . . 1.0 111.623 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HD3' ' H ' ' A' ' 139' ' ' TRP . 8.7 Cg_endo -67.23 92.52 0.34 Allowed 'Trans proline' 0 N--CA 1.482 0.798 0 CA-C-N 119.276 0.777 . . . . 1.0 112.281 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.576 HD22 ' HE3' ' A' ' 125' ' ' LYS . 31.4 tp -93.07 130.29 38.74 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.98 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.49 116.23 31.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 1.0 110.726 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.961 HD11 ' CG ' ' A' ' 123' ' ' TYR . 2.0 pt -138.39 135.89 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.481 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' ILE . 60.0 m-20 40.35 56.85 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.236 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.65 ' NE ' ' CE2' ' A' ' 80' ' ' TYR . 5.8 mtp180 58.12 12.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 111.84 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -117.25 150.25 39.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.673 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.723 HG21 ' CZ3' ' A' ' 76' ' ' TRP . 26.3 mm -110.52 104.18 16.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.418 0 C-N-CA 120.5 -0.48 . . . . 1.0 109.877 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.961 ' CG ' HD11 ' A' ' 118' ' ' ILE . 3.5 m-85 -92.77 149.96 20.96 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 120.799 -1.188 . . . . 1.0 110.36 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.645 ' CD2' HD23 ' A' ' 99' ' ' LEU . 15.5 m-30 -102.12 111.34 23.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 104.817 -2.29 . . . . 1.0 104.817 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.576 ' HE3' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -106.22 139.33 40.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 124.691 1.245 . . . . 1.0 109.095 -178.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.57 HG21 ' CE2' ' A' ' 56' ' ' PHE . 6.4 p -107.24 111.26 23.57 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.684 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -77.27 0.89 20.37 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.681 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.606 ' NZ ' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -144.02 140.84 17.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.943 -176.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 23.6 Cg_exo -65.98 140.77 61.68 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 N-CA-C 105.589 -2.504 . . . . 1.0 105.589 174.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.556 ' HB ' HD13 ' A' ' 50' ' ' ILE . 24.2 mt -118.89 134.7 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.89 0.768 . . . . 1.0 112.249 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.437 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -72.82 120.81 82.86 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.08 122.45 6.33 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.934 1.756 . . . . 1.0 112.233 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 130.59 -2.92 5.74 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.576 -0.821 . . . . 1.0 114.06 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.781 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -103.81 167.17 9.95 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.111 0.958 . . . . 1.0 112.76 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.3 pm0 -80.5 139.24 36.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.778 -1.555 . . . . 1.0 111.027 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.531 ' HA ' HD21 ' A' ' 112' ' ' ASN . 9.2 mt -88.55 118.14 28.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 105' ' ' ALA . 2.1 mp -121.57 150.68 41.32 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.047 0.451 . . . . 1.0 110.292 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.651 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 17.5 t -118.94 153.27 21.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.166 -0.925 . . . . 1.0 110.12 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.651 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 O-C-N 124.429 1.081 . . . . 1.0 113.634 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.647 HG13 HD11 ' A' ' 127' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.175 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.548 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -71.62 -47.21 56.11 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.388 -1.325 . . . . 1.0 109.097 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.99 -57.06 12.4 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.629 -1.623 . . . . 1.0 113.235 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.344 0 CA-C-N 120.298 1.408 . . . . 1.0 111.94 -178.413 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 121.01 0.433 . . . . 1.0 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.426 HG21 ' C ' ' A' ' 40' ' ' THR . 11.4 m -124.2 -78.29 0.6 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.55 -151.56 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.489 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -125.49 155.33 40.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.937 0.875 . . . . 1.0 112.269 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.657 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -51.55 -32.39 28.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.085 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.52 -15.71 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.36 -0.836 . . . . 1.0 112.608 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 14' ' ' THR . 2.8 mt-10 -91.48 -25.36 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.677 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.588 HG22 ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -50.75 141.53 17.77 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.364 -178.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.637 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 22.5 Cg_exo -51.0 141.85 35.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.61 2.206 . . . . 1.0 112.558 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.627 ' HA ' HD21 ' A' ' 23' ' ' LEU . 47.8 tt0 -63.45 -31.73 72.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 113.43 0.9 . . . . 1.0 113.43 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 93' ' ' PRO . 4.6 p-80 -74.56 -26.54 60.01 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.789 1.403 . . . . 1.0 114.789 -176.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.659 HG12 ' C ' ' A' ' 97' ' ' ASN . 4.4 m -78.87 -47.27 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.47 1.032 . . . . 1.0 111.953 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.029 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.17 -22.02 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 122.676 1.227 . . . . 1.0 109.392 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HE ' ' CG ' ' A' ' 20' ' ' GLU . 1.2 mpt_? -63.74 -43.63 95.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.952 -1.931 . . . . 1.0 113.066 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.21 33.95 6.11 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.502 -0.856 . . . . 1.0 112.933 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.651 HD22 ' HB ' ' A' ' 30' ' ' VAL . 35.8 mt -68.49 153.52 95.6 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.668 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.545 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 71.9 Cg_exo -47.37 -106.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 124.287 3.324 . . . . 1.0 115.653 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -74.16 -58.89 3.0 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER -174.76 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 177.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.651 ' HB ' HD22 ' A' ' 26' ' ' LEU . 50.5 t -48.04 178.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.65 -1.159 . . . . 1.0 108.588 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HB3' HG21 ' A' ' 47' ' ' THR . 0.7 OUTLIER -147.88 159.04 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.7 mm? -94.96 121.04 36.16 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.1 -0.64 . . . . 1.0 110.683 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -132.48 139.84 36.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.003 -0.999 . . . . 1.0 111.057 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.2 Cg_endo -80.41 153.18 20.83 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.957 2.438 . . . . 1.0 112.484 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.861 ' H ' HG12 ' A' ' 37' ' ' VAL . 44.2 t 124.16 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.69 1.196 . . . . 1.0 110.958 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.79 12.83 16.01 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.892 1.329 . . . . 1.0 108.057 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 41' ' ' ARG . 3.6 p -93.1 -52.41 9.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 113.306 -1.77 . . . . 1.0 115.062 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.834 ' O ' HG23 ' A' ' 40' ' ' THR . 26.6 t0 126.26 46.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.862 ' H ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 31.86 40.91 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.543 179.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 38' ' ' ASP . 18.4 p -133.56 -16.95 2.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.925 -1.034 . . . . 1.0 111.467 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.915 ' O ' HG11 ' A' ' 37' ' ' VAL . 9.1 ttm-85 179.81 -166.03 0.07 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.784 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -78.02 155.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.887 0.375 . . . . 1.0 110.817 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -114.66 166.14 12.13 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 136' ' ' LEU . 10.0 p -105.41 126.61 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.752 0.776 . . . . 1.0 111.313 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.629 ' O ' HG13 ' A' ' 30' ' ' VAL . 16.1 m95 -126.9 142.38 51.56 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.376 -0.829 . . . . 1.0 113.226 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -69.19 133.51 48.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.305 -1.316 . . . . 1.0 110.304 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.595 HG21 ' HB3' ' A' ' 31' ' ' ARG . 56.0 p -130.34 12.68 5.52 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.868 -1.531 . . . . 1.0 106.868 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.938 ' NZ ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -133.09 170.32 11.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 112.593 -2.094 . . . . 1.0 110.908 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -89.59 141.99 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.289 2.659 . . . . 1.0 111.338 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.938 HD11 ' NZ ' ' A' ' 48' ' ' LYS . 45.2 mt -134.3 146.94 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 114.871 -1.059 . . . . 1.0 112.046 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.718 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.03 168.69 9.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.0 177.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.553 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -65.79 122.83 18.21 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.48 -0.488 . . . . 1.0 111.589 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.926 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.09 7.74 49.24 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.066 -1.064 . . . . 1.0 113.803 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.5 ttmt -75.51 133.16 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 116.787 -1.965 . . . . 1.0 113.852 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -85.8 121.21 28.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 1.0 113.397 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 27' ' ' PRO . 20.9 m-85 -121.17 142.77 49.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.309 1.226 . . . . 1.0 114.309 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.29 -100.49 1.65 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.013 -1.903 . . . . 1.0 110.59 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 95.5 Cg_endo -76.25 167.9 78.8 Favored 'Cis proline' 0 N--CA 1.499 1.814 0 CA-C-N 119.342 1.571 . . . . 1.0 112.049 -0.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 19.4 t80 -54.85 108.99 0.45 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.901 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 3.7 p -37.05 -53.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.663 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 52.74 119.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.883 -0.675 . . . . 1.0 113.917 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.85 143.28 33.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -89.08 111.47 22.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.388 0.613 . . . . 1.0 110.921 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CD ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.92 178.84 6.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 1.0 111.79 -176.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -50.88 167.76 0.07 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.084 -0.962 . . . . 1.0 111.703 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.21 -51.55 24.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.266 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.277 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.531 ' O ' ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -163.95 163.61 23.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.777 -0.769 . . . . 1.0 113.034 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 5.4 pt-20 -100.97 123.24 44.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.093 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.2 124.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.411 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 4.1 t80 -78.06 124.15 27.69 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.632 ' C ' ' H ' ' A' ' 82' ' ' ASN . 23.2 m-85 -103.5 101.65 24.83 Favored Pre-proline 0 N--CA 1.448 -0.571 0 O-C-N 124.522 1.138 . . . . 1.0 112.889 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -65.35 22.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 121.423 1.415 . . . . 1.0 110.611 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.745 ' C ' HD13 ' A' ' 83' ' ' LEU . 83.0 m-20 -118.38 -2.3 11.12 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.837 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -178.1 6.48 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 102.91 174.94 26.71 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 113.844 0.298 . . . . 1.0 113.844 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.518 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.1 m95 -59.1 120.31 8.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.816 0.447 . . . . 1.0 111.656 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.518 ' SD ' ' C ' ' A' ' 85' ' ' TRP . 26.7 mmm -125.46 167.86 14.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.039 1.125 . . . . 1.0 114.039 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.419 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -114.67 138.23 50.94 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 105.604 -1.999 . . . . 1.0 105.604 172.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 78' ' ' VAL . 72.2 mt -103.79 101.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -128.96 127.96 42.75 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.268 0.556 . . . . 1.0 111.283 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -139.75 92.5 2.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.476 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.13 -5.97 21.51 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.419 -0.912 . . . . 1.0 112.811 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.645 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -86.79 120.55 71.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.605 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 52.6 Cg_exo -47.83 -26.98 7.75 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.114 1.876 . . . . 1.0 113.934 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.6 -44.24 82.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.638 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.724 ' O ' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.82 3.26 15.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.619 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . -97.54 -2.94 58.63 Favored Glycine 0 C--O 1.219 -0.795 0 CA-C-N 115.39 -0.823 . . . . 1.0 113.019 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.901 ' ND2' ' H ' ' A' ' 60' ' ' VAL . 28.9 p30 42.57 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.19 0.495 . . . . 1.0 110.109 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.466 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 67.6 p-90 -70.58 -24.55 62.79 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 99' ' ' LEU . 5.2 mp -55.36 -23.6 25.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.078 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.48 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -68.26 -13.81 62.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 176.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.3 m-85 -96.93 -10.62 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.475 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 99' ' ' LEU . 70.7 t -66.95 118.5 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.872 -0.731 . . . . 1.0 110.03 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.818 ' ND2' ' H ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -80.57 -164.39 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.55 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.615 ' O ' HD23 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -121.9 154.6 36.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.505 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.936 ' HB3' ' NE2' ' A' ' 111' ' ' GLN . . . -134.89 -176.72 4.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.421 0.629 . . . . 1.0 112.016 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.505 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.43 -54.15 2.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.596 -178.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -103.16 175.22 5.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 111.379 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.1 -36.88 34.08 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -54.59 -25.39 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 1.0 110.401 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 105' ' ' ALA . 8.3 pt-20 -107.64 -24.01 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.435 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.936 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -103.09 103.82 13.92 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.22 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.731 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -114.45 34.25 4.84 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -177.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 137' ' ' LEU . 5.3 mp -144.42 149.25 35.76 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.606 -0.838 . . . . 1.0 111.77 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.697 ' CD1' HG23 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -150.67 127.16 5.21 Favored Pre-proline 0 N--CA 1.47 0.528 0 C-N-CA 120.287 -0.565 . . . . 1.0 112.395 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 51.6 Cg_exo -60.5 133.55 49.53 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.087 1.858 . . . . 1.0 113.797 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -134.98 136.16 41.98 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.35 120.87 41.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.07 0.462 . . . . 1.0 111.757 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.862 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.1 OUTLIER -129.61 114.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 56.7 42.67 26.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.592 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 65.89 15.1 9.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.974 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -106.75 124.64 49.91 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.66 120.74 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.597 0.713 . . . . 1.0 112.238 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.862 ' CG ' HD11 ' A' ' 118' ' ' ILE . 7.7 m-85 -112.07 153.68 26.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.796 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -112.86 126.51 55.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.45 152.69 43.02 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.558 -0.857 . . . . 1.0 112.525 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.926 ' O ' ' N ' ' A' ' 53' ' ' GLY . 7.3 p -106.68 106.24 16.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.082 -1.417 . . . . 1.0 109.83 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -69.89 -0.46 7.35 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.927 0.767 . . . . 1.0 111.594 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 1.007 ' H ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -148.28 126.95 6.1 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.173 -176.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.63 148.48 2.34 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.951 2.434 . . . . 1.0 112.547 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -114.89 135.87 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.882 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -78.27 115.29 49.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -40.78 117.87 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.458 2.105 . . . . 1.0 113.282 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.62 6.19 13.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.522 -0.599 . . . . 1.0 112.566 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.882 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.4 pt-20 -104.92 166.98 10.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.938 0.869 . . . . 1.0 112.269 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' OE1' ' HB1' ' A' ' 36' ' ' ALA . 5.4 pt-20 -81.09 136.59 35.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.306 -1.315 . . . . 1.0 111.74 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 137' ' ' LEU . 1.2 mp -86.48 128.05 34.92 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.919 -1.037 . . . . 1.0 109.955 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.669 HD21 ' OD1' ' A' ' 103' ' ' ASN . 4.9 mp -142.65 157.98 44.12 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.993 0.517 . . . . 1.0 111.71 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.605 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.66 146.26 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 178.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.872 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.192 -1.973 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.697 HG23 ' CD1' ' A' ' 114' ' ' PHE . 93.3 mt . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 121.222 0.534 . . . . 1.0 111.968 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -51.54 -33.03 30.32 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.647 -0.706 . . . . 1.0 112.523 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.19 45.44 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.23 -0.588 . . . . 1.0 111.537 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.89 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.33 0.586 . . . . 1.0 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -140.49 -58.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.2 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.06 160.06 0.53 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -123.06 151.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.737 0.779 . . . . 1.0 112.748 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.71 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -55.56 -36.87 67.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.985 -1.007 . . . . 1.0 109.487 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -15.79 60.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.754 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -23.3 33.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.997 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.596 HG21 ' HG ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -60.66 144.59 89.08 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.644 ' O ' HD22 ' A' ' 23' ' ' LEU . 32.2 Cg_exo -48.15 148.64 6.9 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.101 2.534 . . . . 1.0 113.228 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' HD23 ' A' ' 23' ' ' LEU . 30.0 tt0 -60.72 -42.03 96.46 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.617 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 7.8 p-80 -73.4 -29.32 62.52 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.258 1.577 . . . . 1.0 115.258 -176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG12 ' C ' ' A' ' 97' ' ' ASN . 21.5 m -75.36 -47.16 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 119.909 1.231 . . . . 1.0 110.652 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 19' ' ' PRO . 1.6 pt? -67.5 -25.33 65.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.815 0.817 . . . . 1.0 110.321 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HE ' ' HG2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -71.07 -36.04 72.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.078 -1.419 . . . . 1.0 112.813 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.1 31.24 7.11 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.74 -0.743 . . . . 1.0 111.617 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 30' ' ' VAL . 10.3 mt -72.68 120.89 83.21 Favored Pre-proline 0 CA--C 1.5 -0.952 0 C-N-CA 119.651 -0.82 . . . . 1.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.85 168.39 7.21 Favored 'Trans proline' 0 C--N 1.296 -2.227 0 CA-C-N 120.085 1.066 . . . . 1.0 109.438 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 48' ' ' LYS . 3.7 pt-20 -59.02 -8.89 1.59 Allowed 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 112.491 -2.141 . . . . 1.0 115.386 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.822 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -112.51 11.95 19.87 Favored 'General case' 0 CA--C 1.458 -2.586 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.973 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.855 ' O ' HD13 ' A' ' 26' ' ' LEU . 2.3 t -137.1 117.06 16.22 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 C-N-CA 117.38 -1.728 . . . . 1.0 113.95 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' NE ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.67 142.02 49.85 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.144 -1.428 . . . . 1.0 107.144 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 26' ' ' LEU . 4.2 mm? -90.07 116.93 28.47 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.175 1.352 . . . . 1.0 111.548 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -139.73 141.34 27.53 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.725 -1.125 . . . . 1.0 110.942 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 35' ' ' SER . 53.2 Cg_endo -76.16 159.04 37.46 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.863 3.042 . . . . 1.0 113.804 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.75 ' C ' ' H ' ' A' ' 37' ' ' VAL . 13.4 m 110.4 -85.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.814 1.246 . . . . 1.0 108.575 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' ASN . . . -55.54 12.17 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.896 0.855 . . . . 1.0 111.822 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.75 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -95.51 -53.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.864 -1.517 . . . . 1.0 112.555 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.1 m-20 143.65 42.14 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.323 1.014 . . . . 1.0 109.187 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.0 23.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.309 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 38' ' ' ASP . 9.7 t -122.76 -4.48 8.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.064 0.764 . . . . 1.0 113.064 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.603 ' O ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.33 -162.95 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.568 HG21 ' HB3' ' A' ' 32' ' ' LEU . 1.4 mm -79.08 156.21 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.956 0.408 . . . . 1.0 110.904 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -124.88 165.12 18.14 Favored Glycine 0 C--O 1.196 -2.26 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -105.99 135.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 117.605 0.702 . . . . 1.0 110.937 -178.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 15.6 m95 -130.65 149.96 52.06 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.993 -1.003 . . . . 1.0 113.69 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.15 128.98 38.15 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.345 -1.298 . . . . 1.0 113.428 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 28' ' ' GLU . 81.5 p -115.8 -20.91 9.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.058 -0.974 . . . . 1.0 111.085 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' C ' ' CD ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.57 168.22 10.58 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.298 178.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.14 121.99 6.87 Favored 'Trans proline' 0 CA--C 1.498 -1.314 0 C-N-CA 121.915 1.743 . . . . 1.0 111.666 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.733 HD12 HG21 ' A' ' 130' ' ' ILE . 72.6 mt -100.61 143.02 14.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 112.858 -1.974 . . . . 1.0 109.581 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.791 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.0 pp -109.01 164.27 12.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.79 -1.096 . . . . 1.0 109.294 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.613 ' C ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.34 122.74 21.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.01 0.91 . . . . 1.0 111.111 177.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.896 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.13 10.07 40.47 Favored Glycine 0 C--N 1.303 -1.304 0 C-N-CA 120.022 -1.085 . . . . 1.0 114.029 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -89.19 130.85 35.54 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.328 -1.749 . . . . 1.0 114.624 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 4.4 mtmm -85.9 124.54 32.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.857 -1.52 . . . . 1.0 111.473 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CD2' ' OE1' ' A' ' 29' ' ' GLU . 47.5 m-85 -121.65 149.71 42.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.9 -102.37 1.56 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.215 -1.357 . . . . 1.0 111.507 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 50.7 Cg_endo -84.15 165.14 64.22 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 119.753 1.776 . . . . 1.0 113.036 0.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 20.4 t80 -54.39 110.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.849 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.628 HG11 ' HE ' ' A' ' 100' ' ' ARG . 2.9 p -35.42 -56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.446 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 51.28 116.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.558 -0.829 . . . . 1.0 114.799 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 21.4 t0 -103.49 146.69 28.14 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 63' ' ' LYS . 3.2 mtmp? -89.29 113.64 24.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.443 -0.903 . . . . 1.0 112.202 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.628 ' CE ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -136.04 166.29 23.7 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.328 -0.851 . . . . 1.0 111.345 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.628 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -81.25 131.24 35.28 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.517 0.562 . . . . 1.0 112.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -40.64 -24.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 65' ' ' LYS . 27.5 m . . . . . 0 C--N 1.317 -0.822 0 C-N-CA 119.461 -0.895 . . . . 1.0 108.714 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.471 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -164.49 164.23 21.9 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.493 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.73 122.78 41.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.17 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.42 119.45 13.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.445 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 3.0 t80 -78.19 125.03 28.76 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 113.41 0.893 . . . . 1.0 113.41 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ASN . 25.0 m-85 -103.22 97.8 10.71 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 114.698 -1.137 . . . . 1.0 112.172 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 79' ' ' TYR . 51.9 Cg_exo -51.31 -11.33 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.247 1.298 . . . . 1.0 109.785 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' TYR . 77.3 m-20 -76.53 -3.42 37.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.424 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 84' ' ' GLY . 2.5 pp -178.29 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.589 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 146.82 173.24 17.87 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.132 -1.032 . . . . 1.0 112.523 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.502 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.9 m95 -58.53 120.25 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.646 -0.277 . . . . 1.0 111.547 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.505 ' SD ' ' CD1' ' A' ' 83' ' ' LEU . 20.3 mmm -127.25 163.87 22.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.996 1.109 . . . . 1.0 113.996 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.432 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.24 139.78 46.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.354 -2.091 . . . . 1.0 105.354 172.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 75' ' ' MET . 66.4 mt -107.58 103.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 118.219 -0.895 . . . . 1.0 109.7 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -130.29 130.77 44.94 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.207 0.912 . . . . 1.0 112.362 -178.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.782 ' HB1' ' CZ ' ' A' ' 100' ' ' ARG . . . -142.72 113.04 7.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.201 -0.909 . . . . 1.0 109.72 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.496 ' O ' ' OG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -132.68 26.93 4.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.979 0.809 . . . . 1.0 110.139 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.729 ' N ' HH11 ' A' ' 100' ' ' ARG . 2.6 m-20 -117.15 81.62 13.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.818 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.617 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 58.6 Cg_exo -48.48 -12.67 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.084 2.523 . . . . 1.0 112.629 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HA ' ' HE2' ' A' ' 21' ' ' HIS . 2.7 mt-10 -79.1 -28.52 43.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.365 0.602 . . . . 1.0 109.691 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 17.89 15.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 1.0 112.779 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -141.02 -121.65 1.79 Allowed Glycine 0 N--CA 1.461 0.336 0 C-N-CA 119.422 -1.371 . . . . 1.0 114.78 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.569 ' C ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -139.18 -177.96 5.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.533 -0.834 . . . . 1.0 110.489 -178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.637 ' CE3' HG11 ' A' ' 30' ' ' VAL . 70.1 p-90 -68.31 -21.66 64.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 99' ' ' LEU . 4.4 mp -56.88 -28.41 61.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.782 ' CZ ' ' HB1' ' A' ' 90' ' ' ALA . 32.0 mtt180 -62.57 -12.52 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.355 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -104.77 -3.35 23.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.643 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.407 ' O ' ' CZ3' ' A' ' 104' ' ' TRP . 18.5 t -66.14 135.03 29.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.893 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.583 ' CG ' ' H ' ' A' ' 104' ' ' TRP . 62.5 t30 -102.63 -174.13 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 120.696 -0.402 . . . . 1.0 110.204 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.583 ' H ' ' CG ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.53 157.06 36.25 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.763 ' HB2' HD22 ' A' ' 137' ' ' LEU . . . -118.99 -158.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.513 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.53 -22.98 11.38 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.518 -1.219 . . . . 1.0 111.934 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -171.68 137.38 1.02 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 111' ' ' GLN . . . -31.74 -32.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.735 -0.666 . . . . 1.0 113.717 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' SER . 2.1 mt-10 -53.92 -26.76 26.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 117.816 0.808 . . . . 1.0 110.337 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.513 ' OE2' ' SG ' ' A' ' 106' ' ' CYS . 11.0 pt-20 -116.94 -24.34 7.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.07 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 105' ' ' ALA . 2.5 tm0? -93.76 143.98 25.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.11 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.649 ' O ' HG22 ' A' ' 126' ' ' THR . 0.1 OUTLIER -153.9 40.32 0.49 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.845 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.663 HD21 HD23 ' A' ' 136' ' ' LEU . 4.8 mp -143.79 143.21 31.25 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.08 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.695 ' CD1' HG23 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -148.73 128.76 6.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.349 -179.04 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.475 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.5 Cg_exo -63.19 121.73 9.67 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.385 2.057 . . . . 1.0 112.284 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 123' ' ' TYR . 9.2 tp -117.14 128.74 55.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -98.02 116.64 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.684 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.3 118.95 51.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.51 31.98 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 80' ' ' TYR . 11.3 mmp_? 67.67 18.22 9.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.53 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.39 125.35 50.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 76' ' ' TRP . 5.6 mm -85.33 120.79 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.009 -0.677 . . . . 1.0 112.659 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 116' ' ' LEU . 8.7 m-85 -112.89 162.32 15.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.909 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.1 m-30 -112.28 118.2 34.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 114' ' ' PHE . 1.9 mttt -110.81 145.91 37.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.695 0.998 . . . . 1.0 113.695 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 53' ' ' GLY . 3.1 p -106.64 111.33 23.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.701 -1.591 . . . . 1.0 109.448 176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.675 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.94 -4.35 46.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.951 0.782 . . . . 1.0 110.076 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.574 ' HZ1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -139.45 147.36 52.15 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.371 177.377 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.83 146.08 77.0 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.288 1.325 . . . . 1.0 111.833 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.733 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -113.7 136.44 50.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.336 -179.011 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.878 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -79.58 121.06 82.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.16 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -41.98 112.28 0.23 Allowed 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 123.111 2.541 . . . . 1.0 115.044 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 119.16 8.03 9.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.001 -0.619 . . . . 1.0 112.768 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.878 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.6 pt-20 -105.35 165.99 10.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 117.507 0.653 . . . . 1.0 111.115 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.493 ' OE1' HD11 ' A' ' 137' ' ' LEU . 4.6 pt-20 -80.01 133.91 36.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.769 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.88 ' C ' HD12 ' A' ' 137' ' ' LEU . 6.4 mp -86.27 132.49 33.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.913 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.88 HD12 ' C ' ' A' ' 136' ' ' LEU . 4.7 mp -140.2 159.59 41.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.434 ' C ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -108.56 140.16 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.501 ' N ' ' HG3' ' A' ' 111' ' ' GLN . 29.6 p90 . . . . . 0 CA--C 1.549 0.934 0 O-C-N 124.957 1.41 . . . . 1.0 114.322 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.695 HG23 ' CD1' ' A' ' 114' ' ' PHE . 63.9 mt . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.245 0.545 . . . . 1.0 110.527 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.14 -30.96 62.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.237 -0.892 . . . . 1.0 112.275 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.48 -33.54 48.17 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.507 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 1.0 111.464 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.962 0.411 . . . . 1.0 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -139.13 -76.71 0.35 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.622 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -43.96 160.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.811 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -125.88 150.77 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.62 -0.718 . . . . 1.0 111.062 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -60.74 -27.75 68.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.357 0.599 . . . . 1.0 109.575 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.65 -23.38 63.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' O ' ' O ' ' A' ' 18' ' ' VAL . 1.6 mm-40 -88.84 -117.06 0.05 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.11 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.609 HG23 HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER 51.49 142.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 114.123 -1.399 . . . . 1.0 110.76 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 18' ' ' VAL . 4.3 Cg_exo -55.64 134.64 65.19 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.14 1.226 . . . . 1.0 111.766 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HA ' HD21 ' A' ' 23' ' ' LEU . 38.2 tt0 -53.23 -38.63 63.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.847 1.055 . . . . 1.0 113.847 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.684 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 10.1 p-80 -74.67 -34.25 62.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.467 1.654 . . . . 1.0 115.467 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.669 HG12 ' C ' ' A' ' 97' ' ' ASN . 5.2 m -71.65 -47.83 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.279 0.945 . . . . 1.0 111.181 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 19' ' ' PRO . 1.7 pt? -68.15 -22.32 64.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.67 0.748 . . . . 1.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.49 -29.99 64.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.2 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.46 41.6 2.11 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 30' ' ' VAL . 46.7 mt -85.41 116.59 66.19 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 119.956 -0.698 . . . . 1.0 112.542 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 29' ' ' GLU . 18.7 Cg_endo -68.31 -139.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.682 0 C-N-CA 121.638 1.559 . . . . 1.0 112.856 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.821 ' HB2' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -30.52 -4.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 126.761 2.024 . . . . 1.0 115.648 -173.236 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' A' ' 27' ' ' PRO . 10.9 mt-10 129.55 5.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 126.437 1.895 . . . . 1.0 113.903 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.875 ' O ' HD22 ' A' ' 26' ' ' LEU . 55.5 t -41.99 127.15 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.793 -1.094 . . . . 1.0 108.503 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' NE ' ' CG2' ' A' ' 47' ' ' THR . 0.1 OUTLIER -127.35 155.33 43.76 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.237 0.828 . . . . 1.0 113.237 -177.085 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 32' ' ' LEU . 1.7 mm? -92.15 116.31 28.83 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.614 0.721 . . . . 1.0 111.863 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -129.87 141.4 41.73 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.601 -1.182 . . . . 1.0 110.907 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . 71.4 Cg_endo -72.58 155.56 54.59 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.742 2.294 . . . . 1.0 114.655 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.708 ' C ' ' H ' ' A' ' 37' ' ' VAL . 11.4 m 109.22 -76.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.324 -1.307 . . . . 1.0 108.179 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.531 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -51.81 7.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.966 -1.016 . . . . 1.0 111.991 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.708 ' H ' ' C ' ' A' ' 35' ' ' SER . 2.1 p -103.44 -50.26 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.772 ' O ' HG22 ' A' ' 40' ' ' THR . 1.9 p30 158.86 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' C ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER 36.58 76.0 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.698 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 38' ' ' ASP . 1.4 t 152.04 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.475 1.11 . . . . 1.0 112.207 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.708 ' O ' HG11 ' A' ' 37' ' ' VAL . 3.3 tpt180 -172.21 -168.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.765 -0.774 . . . . 1.0 111.558 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.609 HG13 HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -95.28 152.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 O-C-N 123.443 0.464 . . . . 1.0 109.933 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -130.87 165.85 22.8 Favored Glycine 0 C--O 1.209 -1.43 0 N-CA-C 108.162 -1.975 . . . . 1.0 108.162 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.848 HG21 ' CE3' ' A' ' 98' ' ' TRP . 13.6 p -101.05 139.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 117.97 0.885 . . . . 1.0 111.276 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.531 ' CZ2' ' HB2' ' A' ' 36' ' ' ALA . 6.0 m95 -134.46 154.0 51.63 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.993 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HB1' ' HZ3' ' A' ' 48' ' ' LYS . . . -92.0 122.54 34.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.887 -1.506 . . . . 1.0 108.581 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.461 ' CG2' ' NE ' ' A' ' 31' ' ' ARG . 62.7 p -109.07 3.77 22.38 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.431 0.634 . . . . 1.0 110.644 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.974 ' NZ ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -128.96 170.9 9.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.696 -1.138 . . . . 1.0 111.826 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' N ' ' HG3' ' A' ' 132' ' ' PRO . 5.3 Cg_endo -85.38 129.66 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.589 2.193 . . . . 1.0 111.921 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.974 HD11 ' NZ ' ' A' ' 48' ' ' LYS . 93.2 mt -120.32 147.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.853 -1.067 . . . . 1.0 111.667 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.816 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -107.01 163.23 13.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.567 -1.197 . . . . 1.0 110.871 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 127.68 33.84 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.017 0.913 . . . . 1.0 112.607 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.857 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.14 8.29 39.11 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 114.535 -1.211 . . . . 1.0 113.944 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.6 ttmm -93.32 131.04 38.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.671 -1.611 . . . . 1.0 115.115 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -96.18 133.73 40.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.415 -1.266 . . . . 1.0 113.532 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.94 149.72 41.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.404 -0.816 . . . . 1.0 112.416 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.67 -100.77 1.55 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.385 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 66.8 Cg_endo -77.26 166.63 81.64 Favored 'Cis proline' 0 N--CA 1.504 2.116 0 CA-C-N 119.195 1.498 . . . . 1.0 112.546 0.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CA ' HD22 ' A' ' 99' ' ' LEU . 17.6 t80 -55.7 107.49 0.34 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.221 -0.592 . . . . 1.0 110.51 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.755 HG13 ' H ' ' A' ' 61' ' ' GLY . 3.5 p -30.85 -61.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 123.774 0.671 . . . . 1.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.755 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 49.16 117.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.302 -0.475 . . . . 1.0 113.678 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 51.6 t0 -101.79 148.38 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.658 ' NZ ' HD21 ' A' ' 83' ' ' LEU . 4.9 mtmt -89.14 112.91 24.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.521 0.677 . . . . 1.0 110.994 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HE3' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -132.73 166.33 22.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.738 -1.119 . . . . 1.0 111.444 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.614 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -84.81 130.99 34.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.321 0.489 . . . . 1.0 112.321 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 14.2 ptt180 -43.31 -23.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.002 0.741 . . . . 1.0 113.002 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.542 0 C-N-CA 120.024 -0.671 . . . . 1.0 110.326 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.514 ' O ' ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 111.843 0.312 . . . . 1.0 111.843 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.514 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -165.73 164.34 18.92 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.076 -1.05 . . . . 1.0 112.641 175.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.63 122.14 45.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.898 0.856 . . . . 1.0 110.982 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.59 121.96 51.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 106.076 -1.824 . . . . 1.0 106.076 178.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -81.34 123.53 28.61 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.02 -1.072 . . . . 1.0 112.001 -177.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 82' ' ' ASN . 9.9 m-85 -86.56 111.03 36.62 Favored Pre-proline 0 N--CA 1.438 -1.045 0 O-C-N 124.866 1.354 . . . . 1.0 112.531 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.62 -12.13 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.762 1.642 . . . . 1.0 109.518 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 80' ' ' TYR . 73.9 m-80 -85.62 -116.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.208 -1.36 . . . . 1.0 110.47 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.948 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -47.99 -34.92 10.02 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 139.43 -175.14 21.87 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.334 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 16.3 m95 -58.03 120.54 8.74 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.39 0.595 . . . . 1.0 111.704 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 7.2 mmm -130.46 169.25 15.77 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.417 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -119.99 140.77 50.45 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 113.991 -1.459 . . . . 1.0 107.784 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -106.1 103.01 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.195 -0.911 . . . . 1.0 108.598 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.81 129.32 36.37 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.962 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.501 ' HB1' ' HZ3' ' A' ' 95' ' ' LYS . . . -141.41 91.7 2.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.953 -0.699 . . . . 1.0 112.159 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.565 ' HA ' HH11 ' A' ' 100' ' ' ARG . 0.1 OUTLIER -103.31 14.0 32.53 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.456 -0.897 . . . . 1.0 109.873 178.024 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.17 113.27 62.87 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.245 -0.889 . . . . 1.0 108.936 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.684 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 24.6 Cg_endo -69.58 -22.62 32.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.26 1.973 . . . . 1.0 112.097 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -56.6 -42.44 78.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.372 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HZ3' ' HB1' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -114.0 -5.51 13.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.854 0.359 . . . . 1.0 110.77 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.7 ' HA2' HG11 ' A' ' 60' ' ' VAL . . . -89.0 -144.28 10.33 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.516 -1.325 . . . . 1.0 113.432 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.669 ' C ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -146.66 -173.38 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.833 -0.684 . . . . 1.0 109.616 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.848 ' CE3' HG21 ' A' ' 44' ' ' VAL . 65.0 p-90 -68.58 -19.29 64.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.885 -0.143 . . . . 1.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 124' ' ' TYR . 6.3 mp -57.12 -30.31 64.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.728 -0.789 . . . . 1.0 108.958 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.565 HH11 ' HA ' ' A' ' 91' ' ' THR . 3.2 mtp85 -58.76 -11.26 2.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.85 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.5 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 10.7 m-85 -100.96 6.77 43.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.209 0.528 . . . . 1.0 110.405 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 99' ' ' LEU . 44.8 t -81.11 129.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.642 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.666 ' ND2' ' H ' ' A' ' 104' ' ' TRP . 3.1 p-10 -102.42 -137.85 0.34 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.13 -0.941 . . . . 1.0 111.22 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.666 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -132.41 160.39 36.53 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.396 -0.19 . . . . 1.0 110.78 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB3' ' NE2' ' A' ' 111' ' ' GLN . . . -95.0 -120.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.135 1.532 . . . . 1.0 115.135 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.2 t -174.68 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.419 -1.719 . . . . 1.0 107.678 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' GLY . 13.6 t -139.66 -179.02 5.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.84 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . . . -89.26 -5.69 72.35 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 121.325 -0.465 . . . . 1.0 112.682 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.66 -20.29 43.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 10.3 pt-20 -113.78 -19.93 11.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.764 0.793 . . . . 1.0 110.124 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 139' ' ' TRP . 0.9 OUTLIER -81.75 157.17 24.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.213 -1.358 . . . . 1.0 108.457 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.891 ' O ' HG22 ' A' ' 126' ' ' THR . 0.3 OUTLIER -173.22 37.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.903 0.859 . . . . 1.0 111.755 -176.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 137' ' ' LEU . 5.0 mp -141.13 141.5 34.17 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -144.04 123.3 7.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.142 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.507 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 50.5 Cg_exo -55.28 104.07 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.903 1.735 . . . . 1.0 110.709 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 123' ' ' TYR . 10.0 tp -109.49 118.44 36.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' OE1' ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -94.47 117.76 30.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.31 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.938 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -127.41 118.22 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.372 -1.344 . . . . 1.0 107.372 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.01 31.73 20.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.41 -1.33 . . . . 1.0 107.41 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.744 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 72.2 18.83 4.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.887 -1.051 . . . . 1.0 110.941 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.417 -0.81 . . . . 1.0 108.903 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.69 120.26 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.9 0.857 . . . . 1.0 112.282 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.938 ' CG ' HD11 ' A' ' 118' ' ' ILE . 6.0 m-85 -113.62 157.03 22.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.664 -1.607 . . . . 1.0 108.79 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.653 ' CD2' HD23 ' A' ' 99' ' ' LEU . 4.6 m-30 -115.72 104.84 12.08 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.687 -0.805 . . . . 1.0 111.237 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 114' ' ' PHE . 5.4 ttmm -102.63 150.77 23.1 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 114.331 1.234 . . . . 1.0 114.331 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 112' ' ' ASN . 4.8 p -103.12 107.88 18.85 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.89 -1.959 . . . . 1.0 109.883 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.767 ' HB2' ' HZ3' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -73.69 0.29 13.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 177.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.767 ' HZ3' ' HB2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -150.52 152.07 32.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.055 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.47 143.74 43.56 Favored 'Trans proline' 0 N--CA 1.516 2.803 0 C-N-CA 123.163 2.575 . . . . 1.0 114.379 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.851 HD11 ' OD1' ' A' ' 112' ' ' ASN . 0.8 OUTLIER -110.04 135.59 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.888 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.689 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -77.02 133.45 69.24 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HG3' ' N ' ' A' ' 49' ' ' PRO . 86.9 Cg_exo -50.24 103.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 122.868 2.378 . . . . 1.0 116.513 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 129.15 12.06 2.68 Favored Glycine 0 N--CA 1.468 0.81 0 C-N-CA 120.372 -0.918 . . . . 1.0 113.789 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.689 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.9 pt-20 -109.41 166.47 10.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.881 0.841 . . . . 1.0 111.614 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HB3' ' CE3' ' A' ' 45' ' ' TRP . 7.7 pt-20 -79.06 136.04 37.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.567 -1.197 . . . . 1.0 112.566 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.441 ' C ' HD13 ' A' ' 137' ' ' LEU . 1.3 mt -82.84 116.03 21.98 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.147 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -124.16 159.25 30.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 122.95 0.5 . . . . 1.0 111.658 -178.366 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.483 ' C ' ' OE1' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -122.91 148.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 178.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 2.7 m95 . . . . . 0 CA--C 1.478 -1.813 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.018 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 110.874 -0.047 . . . . 1.0 110.874 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.54 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -54.38 -54.19 43.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.2 -31.35 52.76 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.0 -1.0 . . . . 1.0 109.012 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.591 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.833 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.873 0.368 . . . . 1.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -128.7 -73.01 0.59 Allowed 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -44.51 154.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.345 -0.983 . . . . 1.0 108.345 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 151.4 41.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.437 0.637 . . . . 1.0 111.575 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.664 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -51.99 -32.67 34.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.137 -0.938 . . . . 1.0 109.03 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.59 60.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.728 -1.123 . . . . 1.0 111.948 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -24.94 22.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.511 -0.476 . . . . 1.0 112.146 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.552 ' CG1' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.73 144.85 64.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.8 Cg_exo -57.59 132.42 50.3 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.039 1.826 . . . . 1.0 113.077 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.668 ' HA ' HD21 ' A' ' 23' ' ' LEU . 34.3 tt0 -49.04 -31.79 8.32 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.842 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -74.18 -34.32 63.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.544 HG12 ' C ' ' A' ' 97' ' ' ASN . 14.5 m -75.88 -46.08 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.774 -177.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.973 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.01 -21.01 65.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.515 -0.874 . . . . 1.0 109.646 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HE ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.0 -38.91 69.55 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.294 -1.321 . . . . 1.0 111.947 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.57 36.43 4.35 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.681 -0.771 . . . . 1.0 112.318 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.849 HD13 ' O ' ' A' ' 30' ' ' VAL . 18.5 mt -90.09 129.3 46.42 Favored Pre-proline 0 CA--C 1.503 -0.861 0 C-N-CA 119.728 -0.789 . . . . 1.0 111.823 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.02 167.48 15.9 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 N-CA-C 108.63 -1.334 . . . . 1.0 108.63 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' C ' ' HG3' ' A' ' 48' ' ' LYS . 2.7 pt-20 -57.09 -10.2 1.11 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.94 -1.482 . . . . 1.0 114.521 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.957 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -109.23 18.67 20.27 Favored 'General case' 0 CA--C 1.449 -2.907 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.283 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.849 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -138.47 123.35 22.51 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 C-N-CA 117.268 -1.773 . . . . 1.0 114.115 -175.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' HB2' HG21 ' A' ' 47' ' ' THR . 3.3 ttp180 -130.47 151.79 50.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.228 -1.805 . . . . 1.0 107.685 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 26' ' ' LEU . 2.8 mm? -98.11 124.87 42.86 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.175 -0.61 . . . . 1.0 109.881 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.44 133.48 9.57 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.353 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 35' ' ' SER . 5.9 Cg_endo -85.21 149.86 10.58 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.168 1.912 . . . . 1.0 108.389 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.4 m 152.33 -73.31 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.459 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.82 -61.29 2.3 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.575 -1.25 . . . . 1.0 108.895 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 38' ' ' ASP . 4.8 p -60.94 -51.75 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.94 -0.392 . . . . 1.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.56 ' N ' HG13 ' A' ' 37' ' ' VAL . 0.8 OUTLIER 59.52 -40.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.592 0.96 . . . . 1.0 113.592 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.598 ' C ' HG22 ' A' ' 40' ' ' THR . 25.6 mttm -30.4 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.172 0.295 . . . . 1.0 111.663 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.598 HG22 ' C ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER 153.41 22.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.038 0.836 . . . . 1.0 111.654 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.402 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 17.0 mtp180 -140.54 163.0 34.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.796 -0.762 . . . . 1.0 111.932 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 149.15 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.397 0.618 . . . . 1.0 110.88 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.78 13.63 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.694 HG23 ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -104.87 127.25 59.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.459 ' CZ2' ' HB2' ' A' ' 36' ' ' ALA . 22.5 m95 -126.65 144.69 50.83 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.957 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.72 134.31 49.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.997 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 31' ' ' ARG . 68.4 p -119.11 -21.71 7.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.08 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.657 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -117.84 165.99 14.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.439 179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -77.79 125.31 7.34 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 123.04 2.493 . . . . 1.0 111.772 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.604 HD11 ' HB2' ' A' ' 29' ' ' GLU . 64.0 mt -113.1 149.58 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 113.394 -1.73 . . . . 1.0 112.801 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.833 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.87 164.64 12.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.828 -1.533 . . . . 1.0 110.261 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.695 ' H ' ' CE ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -68.71 128.03 35.18 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.103 178.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 1.003 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.57 8.22 38.03 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 119.066 -0.852 . . . . 1.0 114.455 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 1.9 ttmt -82.24 130.87 35.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 117.278 -1.769 . . . . 1.0 115.308 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -88.98 120.18 30.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.682 -1.599 . . . . 1.0 113.13 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.606 ' CG ' ' OE2' ' A' ' 29' ' ' GLU . 55.0 m-85 -119.75 150.02 41.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.483 0.658 . . . . 1.0 112.714 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.25 -102.29 2.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 113.706 -1.588 . . . . 1.0 110.151 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HB3' ' CE1' ' A' ' 123' ' ' TYR . 96.3 Cg_endo -78.79 170.45 69.42 Favored 'Cis proline' 0 N--CA 1.499 1.816 0 CA-C-N 119.355 1.578 . . . . 1.0 112.414 -1.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.628 ' CD1' ' NH2' ' A' ' 100' ' ' ARG . 38.5 t80 -54.46 107.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.785 -0.766 . . . . 1.0 109.056 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.732 HG12 ' NH2' ' A' ' 100' ' ' ARG . 5.6 p -42.74 -49.51 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.967 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 60' ' ' VAL . . . 45.0 121.32 0.0 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.621 0.608 . . . . 1.0 114.621 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.87 145.93 28.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' NZ ' HD11 ' A' ' 83' ' ' LEU . 1.1 mtmp? -89.51 113.92 25.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.056 0.455 . . . . 1.0 111.679 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.5 ' HG3' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -142.76 169.88 16.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.631 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -80.65 133.61 35.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.374 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 67' ' ' SER . 30.8 ttp85 -45.53 -21.34 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.783 1.031 . . . . 1.0 113.783 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.969 0.414 . . . . 1.0 110.939 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.727 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -162.79 163.85 26.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 118.999 -1.08 . . . . 1.0 113.091 175.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -103.37 122.73 45.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.89 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -137.17 122.67 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.932 -1.507 . . . . 1.0 106.932 179.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.5 t80 -80.67 125.66 30.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.653 ' OH ' HD11 ' A' ' 88' ' ' ILE . 20.2 m-85 -103.05 104.2 38.72 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 114.897 -1.047 . . . . 1.0 113.059 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -62.87 10.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.388 1.392 . . . . 1.0 110.811 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 80' ' ' TYR . 76.3 m-20 -97.39 2.41 50.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.094 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.721 ' N ' HD23 ' A' ' 83' ' ' LEU . 1.1 pt? -178.23 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.015 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 150.09 179.67 26.09 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.439 ' C ' ' SD ' ' A' ' 86' ' ' MET . 18.2 m95 -58.15 122.37 12.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 19.1 mmm -127.28 167.39 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -117.75 138.04 52.3 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.265 -1.754 . . . . 1.0 106.265 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.653 HD11 ' OH ' ' A' ' 80' ' ' TYR . 64.3 mt -104.67 102.28 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -131.18 128.18 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.119 0.485 . . . . 1.0 111.33 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HA ' ' HZ3' ' A' ' 95' ' ' LYS . . . -139.73 92.47 2.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.219 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -111.1 13.31 21.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.366 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.84 99.6 35.43 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.938 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.426 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 50.6 Cg_exo -51.2 -14.78 1.74 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.628 2.218 . . . . 1.0 111.45 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.92 -43.84 94.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.646 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.737 ' HZ3' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -116.28 -8.48 11.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.785 -179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.716 ' HA2' HG11 ' A' ' 60' ' ' VAL . . . -95.48 -143.1 13.77 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.125 -1.036 . . . . 1.0 113.05 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.619 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 24.6 m-20 -137.18 -166.21 1.88 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.999 0.428 . . . . 1.0 110.475 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.547 ' CZ3' HG21 ' A' ' 44' ' ' VAL . 58.6 p-90 -70.4 -22.13 62.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.797 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.581 HD12 ' H ' ' A' ' 99' ' ' LEU . 5.9 mp -54.13 -24.22 17.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.835 ' H ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -61.7 -10.28 8.26 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 12.8 m-85 -107.24 -11.81 15.5 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.232 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.517 ' CG1' HG23 ' A' ' 138' ' ' VAL . 55.3 t -62.88 117.66 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.101 -1.04 . . . . 1.0 109.878 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -152.02 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CE3' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -124.5 165.25 18.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.372 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HA ' HD23 ' A' ' 137' ' ' LEU . . . -108.84 -131.83 0.32 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.44 -31.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.47 ' H ' ' CG ' ' A' ' 110' ' ' GLU . 4.0 m -143.78 175.7 9.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.695 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.95 -23.25 76.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 -22.37 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.47 ' CG ' ' H ' ' A' ' 107' ' ' SER . 4.0 pt-20 -109.15 -25.86 10.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.127 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.6 OUTLIER -86.93 102.21 14.14 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.703 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -104.09 0.32 29.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -140.51 144.75 36.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -142.82 132.51 12.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.736 1.754 . . . . 1.0 115.736 -176.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.6 122.36 3.93 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.122 3.215 . . . . 1.0 114.722 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.745 HD13 ' HD2' ' A' ' 125' ' ' LYS . 1.9 tp -132.2 128.05 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -97.49 118.73 34.63 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.947 -0.701 . . . . 1.0 110.856 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.878 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -129.36 114.95 33.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.088 -1.078 . . . . 1.0 108.088 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 58.4 39.21 25.52 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.649 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 67.05 17.56 10.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.004 -0.998 . . . . 1.0 110.658 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -108.69 123.82 49.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.394 -0.821 . . . . 1.0 108.974 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -82.25 126.98 40.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.878 ' CG ' HD11 ' A' ' 118' ' ' ILE . 6.0 m-85 -122.01 155.13 36.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.799 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -111.68 124.22 51.88 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.745 ' HD2' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -128.76 152.82 48.01 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 1.003 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.8 p -102.04 139.73 37.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.111 -1.858 . . . . 1.0 110.789 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.783 ' H ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -107.18 -4.44 18.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.182 -1.372 . . . . 1.0 109.024 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.975 ' H ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.45 131.83 11.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 114.937 -1.028 . . . . 1.0 110.435 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 145.64 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.601 1.534 . . . . 1.0 111.51 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.73 HG23 ' CG ' ' A' ' 134' ' ' GLU . 1.8 mt -108.39 134.48 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.703 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -77.15 115.77 51.67 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -38.68 113.12 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 123.004 2.469 . . . . 1.0 114.243 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 118.32 6.43 12.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.915 -0.659 . . . . 1.0 113.251 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.73 ' CG ' HG23 ' A' ' 130' ' ' ILE . 4.5 pt-20 -100.41 164.43 11.92 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.419 1.11 . . . . 1.0 111.429 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 45' ' ' TRP . 5.9 pt-20 -78.62 133.24 37.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.075 -0.966 . . . . 1.0 111.345 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.882 HD21 ' OE1' ' A' ' 29' ' ' GLU . 5.9 mp -86.36 122.4 30.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.326 -0.852 . . . . 1.0 108.941 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.754 HD12 ' C ' ' A' ' 136' ' ' LEU . 6.6 mp -130.71 158.16 40.83 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 139' ' ' TRP . 4.1 t -114.83 146.13 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.586 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.817 0 O-C-N 125.83 1.956 . . . . 1.0 113.228 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 149' ' ' ALA . 1.4 mt . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -61.51 -52.17 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.077 -0.965 . . . . 1.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.39 -34.27 47.24 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 1.0 111.206 177.439 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . . . . . . . . 0 CA--C 1.519 -0.233 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 20.5 m -175.27 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.202 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' PRO . 2.9 mm-40 -57.8 166.23 1.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 1.0 111.453 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -127.42 148.88 50.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.038 -0.983 . . . . 1.0 110.593 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.946 HD12 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.39 -36.2 73.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.9 -18.73 55.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.271 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HB3' ' H ' ' A' ' 14' ' ' THR . 4.6 tp10 -80.28 -46.65 15.82 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.626 -0.716 . . . . 1.0 112.383 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -41.17 158.36 0.18 Allowed Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 120.173 -0.611 . . . . 1.0 109.574 -178.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' HD22 ' A' ' 23' ' ' LEU . 7.4 Cg_endo -48.38 118.75 3.49 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.505 2.136 . . . . 1.0 112.093 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 3.5 tt0 -51.43 -43.24 61.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.459 1.281 . . . . 1.0 114.459 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.629 ' CD2' HG23 ' A' ' 22' ' ' VAL . 8.9 p-80 -62.1 -29.41 70.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.095 0.474 . . . . 1.0 111.302 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.629 HG23 ' CD2' ' A' ' 21' ' ' HIS . 73.2 t -72.93 -48.72 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.305 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.899 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.69 -25.88 62.28 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.175 0.988 . . . . 1.0 110.779 176.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -53.77 -34.36 58.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.433 -1.712 . . . . 1.0 109.612 -176.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.84 17.62 17.59 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.194 -0.762 . . . . 1.0 111.194 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.789 HD12 ' HD2' ' A' ' 27' ' ' PRO . 45.2 tp -79.41 122.98 84.57 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 117.081 0.441 . . . . 1.0 110.735 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.789 ' HD2' HD12 ' A' ' 26' ' ' LEU . 35.4 Cg_exo -35.23 137.26 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.286 1.324 . . . . 1.0 110.954 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.543 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 18.5 pt-20 -53.32 -31.91 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.777 -1.556 . . . . 1.0 109.373 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.5 pm0 -85.4 18.26 2.78 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 113.538 -1.664 . . . . 1.0 112.496 -176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.768 ' CG1' HD11 ' A' ' 26' ' ' LEU . 87.0 t -136.15 143.64 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 C-N-CA 118.726 -1.189 . . . . 1.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -144.0 155.36 43.99 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.192 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.946 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -102.68 148.02 26.11 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.673 0.749 . . . . 1.0 111.753 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.75 119.78 2.24 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 113.86 -1.518 . . . . 1.0 111.834 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 19.0 Cg_endo -80.69 152.02 19.53 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.899 1.732 . . . . 1.0 111.062 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.584 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 4.3 p 87.76 -27.04 0.07 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.964 0.888 . . . . 1.0 108.799 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.713 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -53.89 -62.53 1.59 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.89 -52.32 62.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.563 -0.29 . . . . 1.0 111.586 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 2.2 m-20 162.12 63.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.621 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.0 OUTLIER 30.63 36.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.917 -1.038 . . . . 1.0 109.365 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 91.1 m -91.96 -24.3 19.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.558 -1.655 . . . . 1.0 110.094 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 161.55 -157.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.229 -1.397 . . . . 1.0 107.229 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.19 137.55 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.863 -1.532 . . . . 1.0 106.863 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.57 155.35 19.5 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 109.032 -1.627 . . . . 1.0 109.032 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 2.0 m -100.91 136.5 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.166 0.984 . . . . 1.0 110.52 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.713 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 18.9 m95 -129.97 154.25 47.56 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.477 -1.692 . . . . 1.0 110.37 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.642 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -70.88 144.18 50.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.242 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.65 -26.54 2.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.389 -0.525 . . . . 1.0 110.381 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -120.44 158.77 50.38 Favored Pre-proline 0 C--N 1.341 0.215 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.96 124.73 16.62 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.424 2.083 . . . . 1.0 112.379 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 130' ' ' ILE . 3.9 mt -112.18 131.27 64.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.584 -1.189 . . . . 1.0 108.425 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.944 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.42 146.11 36.44 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 122.26 1.029 . . . . 1.0 111.314 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -50.69 133.63 25.59 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 113.324 -1.762 . . . . 1.0 107.532 177.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.77 2.06 52.57 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.612 -1.28 . . . . 1.0 115.447 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 26.6 ttpt -96.29 140.72 30.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.913 1.357 . . . . 1.0 112.594 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.21 135.59 40.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.947 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 34.3 m-85 -115.72 126.67 54.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.216 0.531 . . . . 1.0 112.093 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.69 -132.04 7.32 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 119.362 -0.688 . . . . 1.0 112.983 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 37.3 Cg_endo -80.62 171.97 58.26 Favored 'Cis proline' 0 N--CA 1.511 2.551 0 CA-C-N 120.03 1.915 . . . . 1.0 114.305 3.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.759 ' CD2' ' ND2' ' A' ' 97' ' ' ASN . 1.6 t80 -72.44 122.15 20.78 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.672 0.748 . . . . 1.0 109.531 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.793 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 63.8 t -102.9 138.65 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.169 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.39 -171.23 26.03 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -100.48 138.83 37.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.907 0.384 . . . . 1.0 110.499 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.84 117.28 29.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.636 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -140.4 164.81 29.11 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.297 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.19 145.16 33.8 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.653 0.264 . . . . 1.0 110.764 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -50.27 -44.5 53.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 110.161 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.432 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.646 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.955 0.407 . . . . 1.0 110.826 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.66 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -135.3 166.89 22.09 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.446 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -126.43 128.03 46.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.764 0.316 . . . . 1.0 110.744 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.56 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -141.77 141.51 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.294 0.568 . . . . 1.0 112.405 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 15.9 t80 -91.19 125.29 35.92 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.855 0.687 . . . . 1.0 112.855 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CD2' HD23 ' A' ' 83' ' ' LEU . 7.1 m-85 -102.22 145.56 30.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.841 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.62 3.22 5.59 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.72 1.614 . . . . 1.0 109.706 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -125.41 -68.77 0.82 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.412 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.832 HD22 ' H ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -74.41 -23.38 58.94 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.102 -178.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.39 -152.65 25.58 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 108.78 -1.728 . . . . 1.0 108.78 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -63.42 119.22 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.39 -0.924 . . . . 1.0 110.119 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.7 ppp? -129.46 169.15 15.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.838 -1.073 . . . . 1.0 108.951 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' LYS . 26.2 m -121.02 144.79 48.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.36 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 mt -98.58 146.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 106.8 -1.555 . . . . 1.0 106.8 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.79 139.5 50.22 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.078 0.77 . . . . 1.0 113.078 -177.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.619 ' HB1' ' HD3' ' A' ' 100' ' ' ARG . . . -130.66 140.62 50.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.615 -1.624 . . . . 1.0 106.615 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 p -151.63 15.7 0.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.987 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.26 141.83 0.13 Allowed Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.815 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.488 ' O ' HG21 ' A' ' 22' ' ' VAL . 55.2 Cg_endo -70.81 -18.18 32.25 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.263 1.975 . . . . 1.0 112.597 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -78.04 -6.19 53.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.826 0.822 . . . . 1.0 109.277 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 9.77 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.375 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 97' ' ' ASN . . . 94.26 156.16 32.13 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.793 ' CG ' ' H ' ' A' ' 60' ' ' VAL . 17.2 t30 84.07 110.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.6 ' N ' HG13 ' A' ' 22' ' ' VAL . 70.0 p-90 -71.31 -25.53 62.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.187 0.518 . . . . 1.0 109.759 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 102' ' ' VAL . 1.7 mt -60.08 -24.46 64.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.636 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.619 ' HD3' ' HB1' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -68.29 -11.1 58.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 119.107 -0.473 . . . . 1.0 111.234 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 98' ' ' TRP . 0.1 OUTLIER -120.14 5.87 10.79 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.613 -0.835 . . . . 1.0 113.173 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 99' ' ' LEU . 8.8 p -78.65 119.0 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.291 -0.564 . . . . 1.0 110.825 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -80.98 114.75 20.07 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.62 ' HB2' ' H ' ' A' ' 138' ' ' VAL . 4.9 p90 -88.03 159.09 18.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 104' ' ' TRP . . . -38.72 159.55 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 113.772 -1.558 . . . . 1.0 113.45 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.27 -4.4 21.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.134 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.64 -30.6 0.09 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.561 -0.456 . . . . 1.0 111.974 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.67 -29.37 6.64 Favored Glycine 0 C--N 1.321 -0.28 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.24 -19.46 5.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.513 ' HG3' HD23 ' A' ' 137' ' ' LEU . 20.2 pt-20 -112.76 -24.37 9.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.483 -0.78 . . . . 1.0 111.389 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.645 ' CD ' ' O ' ' A' ' 139' ' ' TRP . 1.1 tp-100 -48.2 139.12 8.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.101 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.712 ' C ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -124.98 6.73 7.97 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 119.154 -0.451 . . . . 1.0 112.106 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.987 HD12 ' N ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -154.96 174.56 14.99 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 118.263 0.483 . . . . 1.0 110.084 176.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.987 ' N ' HD12 ' A' ' 113' ' ' LEU . 1.6 p90 -139.62 145.6 44.15 Favored Pre-proline 0 C--N 1.346 0.425 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 139' ' ' TRP . 70.5 Cg_endo -82.38 138.2 9.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.754 2.303 . . . . 1.0 113.892 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -139.52 134.5 32.32 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.894 179.157 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.766 ' N ' HD23 ' A' ' 116' ' ' LEU . 40.4 mt-10 -89.25 123.71 33.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.223 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 121' ' ' ALA . 15.3 mt -139.6 129.49 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 46.14 43.01 10.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.114 -0.634 . . . . 1.0 110.012 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? 62.87 17.51 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.904 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -121.99 128.71 51.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.445 HD13 ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -88.93 116.46 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.692 -0.803 . . . . 1.0 112.676 -177.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.52 ' HB2' ' HZ3' ' A' ' 125' ' ' LYS . 13.7 m-85 -108.06 156.67 19.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.157 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.591 ' HB3' HD13 ' A' ' 113' ' ' LEU . 5.4 m-30 -112.89 125.78 54.75 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 107.575 -1.268 . . . . 1.0 107.575 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' A' ' 114' ' ' PHE . 2.0 mptt -116.53 139.23 50.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -131.82 125.59 32.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.676 -0.678 . . . . 1.0 112.453 178.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.924 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -98.96 21.42 11.65 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 119.911 -0.716 . . . . 1.0 109.592 175.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.712 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -124.53 119.51 25.99 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.23 97.78 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.963 0 CA-C-N 120.628 1.26 . . . . 1.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.695 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -69.62 136.42 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.447 -176.273 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.54 132.8 51.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.302 0.852 . . . . 1.0 113.302 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.04 103.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.163 1.908 . . . . 1.0 111.675 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 124.82 -7.22 8.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.062 -0.589 . . . . 1.0 113.164 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 135' ' ' GLU . 1.4 pp20? -87.7 154.14 20.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.942 0.871 . . . . 1.0 111.026 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.454 ' O ' ' OE2' ' A' ' 134' ' ' GLU . 1.6 pm0 -73.71 125.08 27.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.233 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 137' ' ' LEU . 10.9 mp -78.39 124.85 28.57 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 4.2 mp -123.56 146.1 48.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-O 118.982 -0.532 . . . . 1.0 112.18 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.62 ' H ' ' HB2' ' A' ' 104' ' ' TRP . 9.4 t -104.46 132.96 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.645 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.394 0 C-N-CA 125.19 1.396 . . . . 1.0 110.869 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.676 HG12 HD21 ' A' ' 127' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.485 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.53 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -74.09 -34.82 64.1 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.548 -0.861 . . . . 1.0 109.744 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.25 -66.6 0.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.603 -0.839 . . . . 1.0 110.765 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 117.834 -1.546 . . . . 1.0 110.868 -174.714 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . . . . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 120.97 0.415 . . . . 1.0 109.949 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 88.1 m -169.93 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 34' ' ' PRO . 1.7 mt-10 -50.93 165.54 0.11 Allowed 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.539 0.685 . . . . 1.0 110.735 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.696 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -126.72 153.81 44.98 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.913 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.776 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -52.31 -31.89 35.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.95 -17.77 56.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.073 -1.422 . . . . 1.0 110.131 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.696 ' CB ' ' H ' ' A' ' 14' ' ' THR . 12.8 tp10 -77.97 -47.92 17.45 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.292 0.849 . . . . 1.0 113.292 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.68 HG23 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -48.85 147.8 4.3 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.68 ' HD2' HG23 ' A' ' 18' ' ' VAL . 5.2 Cg_exo -52.39 130.52 36.38 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.199 1.266 . . . . 1.0 111.898 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 4.4 tt0 -52.15 -34.94 46.99 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 114.564 -1.198 . . . . 1.0 113.011 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.734 ' CD2' ' O ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -79.27 -35.26 41.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.573 0.953 . . . . 1.0 113.573 -177.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.826 HG21 ' O ' ' A' ' 93' ' ' PRO . 1.6 t -79.52 -31.2 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.64 HD13 HG13 ' A' ' 18' ' ' VAL . 15.6 tp -71.81 -41.57 68.08 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.753 -2.021 . . . . 1.0 110.831 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -81.54 -20.02 40.89 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.164 0.585 . . . . 1.0 112.279 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.75 -26.98 36.31 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 110.148 -1.181 . . . . 1.0 110.148 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.689 ' HB3' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -63.76 144.13 97.97 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 117.907 -1.517 . . . . 1.0 111.564 -178.544 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 56' ' ' PHE . 50.8 Cg_exo -50.04 151.68 8.5 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 120.988 1.125 . . . . 1.0 111.871 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt-20 -52.84 -31.08 37.24 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.985 -1.461 . . . . 1.0 110.407 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.648 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -87.93 20.53 3.06 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 115.017 -0.992 . . . . 1.0 111.181 -178.366 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.643 HG12 HD22 ' A' ' 26' ' ' LEU . 21.4 t -135.29 137.03 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 C-N-CA 119.52 -0.872 . . . . 1.0 110.879 -177.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.544 ' NH1' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER -146.26 159.45 43.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.795 HD22 ' N ' ' A' ' 32' ' ' LEU . 1.1 mm? -104.57 141.08 37.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -152.16 120.82 3.31 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.772 -0.632 . . . . 1.0 111.654 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.564 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 9.8 Cg_endo -82.1 151.69 16.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.693 1.596 . . . . 1.0 111.689 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB3' ' N ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 78.06 15.6 1.43 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.46 -1.682 . . . . 1.0 106.46 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.654 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.55 -64.53 1.13 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.62 -29.77 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 78.44 -11.79 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.18 -0.918 . . . . 1.0 112.636 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 40' ' ' THR . 1.3 pttp -49.92 -12.19 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 4.9 m 98.84 64.41 0.0 OUTLIER 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.77 1.294 . . . . 1.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.418 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER 171.99 -165.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.196 -0.911 . . . . 1.0 108.951 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.531 HG13 ' N ' ' A' ' 34' ' ' PRO . 2.4 tt -101.62 144.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.58 163.02 22.78 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 109.316 -1.513 . . . . 1.0 109.316 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.565 HG23 HG13 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -99.66 136.24 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 CA-C-O 121.263 0.554 . . . . 1.0 109.724 -178.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 28.6 m95 -129.29 151.84 49.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.881 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.57 144.67 54.47 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.085 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.544 ' CG2' ' NH1' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -126.44 -29.64 2.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.538 -178.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -124.5 159.99 55.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.13 123.95 13.73 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.195 1.93 . . . . 1.0 112.937 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.564 ' C ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -111.04 131.52 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.145 -1.389 . . . . 1.0 107.544 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.003 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -109.72 155.24 21.8 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.925 0.869 . . . . 1.0 111.034 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -63.42 133.76 54.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.03 -1.441 . . . . 1.0 109.027 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.72 1.94 55.26 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.503 -1.332 . . . . 1.0 115.107 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 15.3 ttpt -90.1 134.34 34.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.167 -1.013 . . . . 1.0 112.485 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.08 130.43 36.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.14 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 5.5 m-85 -115.36 127.37 55.36 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.728 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.594 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 146.17 -146.97 17.59 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 5.1 Cg_endo -79.87 166.51 77.01 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 CA-C-N 119.583 1.692 . . . . 1.0 115.118 0.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.744 ' HA ' HD12 ' A' ' 99' ' ' LEU . 25.5 t80 -83.17 111.83 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.246 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.821 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.8 t -43.24 -61.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.401 -2.181 . . . . 1.0 114.079 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.52 ' N ' HG12 ' A' ' 60' ' ' VAL . . . 32.35 106.34 0.0 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-O 121.469 0.483 . . . . 1.0 112.931 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -72.81 143.13 47.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 1.7 mptp? -92.62 117.67 30.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.587 0.708 . . . . 1.0 112.79 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HZ3' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -141.91 167.89 21.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.677 -1.147 . . . . 1.0 111.213 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -78.95 135.86 37.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.1 0.476 . . . . 1.0 110.435 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -48.07 -24.39 1.08 Allowed 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.964 -0.46 . . . . 1.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.342 . . . . 1.0 111.403 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.405 ' HB3' ' HZ1' ' A' ' 64' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.997 0.427 . . . . 1.0 111.504 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.678 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -128.58 165.35 20.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.845 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.88 132.04 53.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.749 0.277 . . . . 1.0 111.749 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.567 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -146.73 141.33 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.512 0.672 . . . . 1.0 112.798 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -83.51 124.94 31.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.286 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.531 ' CE1' ' HG3' ' A' ' 120' ' ' ARG . 4.4 m-85 -102.95 120.09 53.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.28 -12.86 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 N-CA-C 109.208 -1.112 . . . . 1.0 109.208 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.529 ' N ' ' C ' ' A' ' 80' ' ' TYR . 1.1 m-80 -101.16 -86.96 0.4 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.78 -1.1 . . . . 1.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.913 HD22 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 119.794 -0.762 . . . . 1.0 110.842 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . 89.46 -139.77 15.32 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.905 -1.678 . . . . 1.0 108.905 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.1 118.58 12.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.47 -0.892 . . . . 1.0 110.378 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.567 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -128.9 170.15 13.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.139 178.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.9 m -115.01 142.47 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.439 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.513 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 16.9 mt -96.22 152.08 3.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.58 ' CB ' ' HZ3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -129.39 136.16 49.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.312 0.577 . . . . 1.0 112.312 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.612 ' C ' HG22 ' A' ' 91' ' ' THR . . . -133.39 142.23 48.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 161.28 7.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 96' ' ' GLY . 5.4 p30 -117.07 62.79 3.08 Favored Pre-proline 0 C--O 1.22 -0.499 0 CA-C-N 114.565 -1.198 . . . . 1.0 109.433 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.826 ' O ' HG21 ' A' ' 22' ' ' VAL . 6.0 Cg_exo -45.68 -13.86 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.566 2.178 . . . . 1.0 112.143 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.734 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -78.2 -42.93 29.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.094 0.949 . . . . 1.0 110.065 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -11.71 12.67 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.134 -1.393 . . . . 1.0 110.143 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.821 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -63.29 -62.36 5.46 Favored Glycine 0 C--O 1.18 -3.269 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.768 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.609 HD22 ' C ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 138.09 150.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.638 0.775 . . . . 1.0 109.621 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.689 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 56.0 p-90 -56.68 -22.72 36.8 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 59' ' ' PHE . 41.7 mt -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.491 -0.884 . . . . 1.0 109.524 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.602 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -75.91 -9.93 59.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 177.172 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 98' ' ' TRP . 12.3 m-85 -90.33 -9.76 46.59 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.6 131.16 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 114.651 -1.159 . . . . 1.0 111.438 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -97.01 -158.86 0.7 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.109 -1.405 . . . . 1.0 110.033 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 24.5 p90 -136.72 164.26 28.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.524 -1.216 . . . . 1.0 112.058 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.969 ' HB3' ' HE1' ' A' ' 139' ' ' TRP . . . -87.2 140.24 29.74 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.261 0.837 . . . . 1.0 113.261 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -76.0 -13.29 60.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 177.115 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -142.66 132.04 23.56 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.707 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -46.97 -17.17 0.27 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' C ' ' A' ' 107' ' ' SER . 10.7 mm-40 -77.41 -32.88 55.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.861 0.362 . . . . 1.0 110.44 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 137' ' ' LEU . 25.4 tp10 -88.69 -22.88 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.321 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.935 HE22 ' N ' ' A' ' 139' ' ' TRP . 3.8 tp60 -59.42 142.47 52.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.51 0.671 . . . . 1.0 109.392 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.599 ' HA ' ' HZ2' ' A' ' 128' ' ' LYS . 33.2 p30 -144.3 14.19 1.62 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.6 -1.182 . . . . 1.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -148.54 166.88 26.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.444 -0.503 . . . . 1.0 110.243 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -152.45 130.76 6.27 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 119.093 -1.043 . . . . 1.0 112.552 178.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.44 139.59 20.82 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.241 1.96 . . . . 1.0 113.96 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -142.4 138.76 31.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.517 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.713 ' H ' HD23 ' A' ' 116' ' ' LEU . 3.7 tm-20 -92.16 119.26 31.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 123' ' ' TYR . 23.4 mt -138.11 130.05 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 120.629 -0.428 . . . . 1.0 111.162 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.2 50.63 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.311 0.577 . . . . 1.0 111.473 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.531 ' HG3' ' CE1' ' A' ' 80' ' ' TYR . 1.3 tpp180 65.55 1.64 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.51 -0.476 . . . . 1.0 112.034 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.4 158.06 27.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.276 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -107.69 110.78 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 C-N-CA 119.785 -0.766 . . . . 1.0 112.011 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.3 m-85 -101.53 152.58 20.61 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.976 -1.011 . . . . 1.0 108.761 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.595 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 10.6 m-30 -113.86 127.26 55.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.616 ' N ' ' NZ ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -118.14 142.62 47.24 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 1.0 112.103 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.41 ' C ' HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -130.22 120.21 24.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.346 -1.297 . . . . 1.0 111.605 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.985 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -96.41 27.92 3.56 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.523 177.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HZ2' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -129.0 123.36 21.8 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.04 94.99 0.41 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 CA-C-N 120.736 1.299 . . . . 1.0 109.14 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 112' ' ' ASN . 1.3 mt -71.45 136.05 26.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.465 0.65 . . . . 1.0 109.311 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.83 132.67 63.67 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.995 -1.002 . . . . 1.0 113.282 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.53 104.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.923 1.749 . . . . 1.0 111.781 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.06 -7.81 8.1 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.6 150.95 23.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.559 . . . . 1.0 111.485 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 0.6 OUTLIER -79.73 136.96 36.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.773 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.4 mp -89.53 136.66 32.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 105' ' ' ALA . 1.9 mm? -123.44 135.39 54.07 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.529 0.937 . . . . 1.0 113.529 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 139' ' ' TRP . 1.7 t -104.79 131.81 52.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.03 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.969 ' HE1' ' HB3' ' A' ' 105' ' ' ALA . 6.8 p-90 . . . . . 0 N--CA 1.499 1.996 0 C-N-CA 125.502 1.521 . . . . 1.0 109.886 176.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.562 HG12 HD21 ' A' ' 127' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.213 -0.858 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.558 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -75.87 -49.61 17.41 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.292 1.044 . . . . 1.0 109.431 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.04 -65.74 0.53 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.11 -1.859 . . . . 1.0 109.055 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.702 0 C-N-CA 118.103 -1.439 . . . . 1.0 111.209 -175.627 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.742 HG22 ' N ' ' A' ' 13' ' ' GLU . 81.6 m -174.83 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.742 ' N ' HG22 ' A' ' 12' ' ' THR . 4.6 mm-40 53.8 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.672 ' HB ' ' H ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -140.2 176.32 8.86 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.0 174.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 16' ' ' ALA . 2.5 tt -58.12 -56.73 18.25 Favored 'General case' 0 CA--C 1.47 -2.128 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 175.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.691 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -80.87 -54.55 5.49 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 111.853 -2.431 . . . . 1.0 106.911 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.882 ' HG2' HG13 ' A' ' 18' ' ' VAL . 1.1 tt0 160.24 -21.37 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 115.777 1.769 . . . . 1.0 115.777 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.882 HG13 ' HG2' ' A' ' 17' ' ' GLU 0.279 1.1 m -145.17 -178.66 0.81 Allowed Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 120.457 1.481 . . . . 1.0 111.709 -175.072 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 4.2 Cg_exo -38.4 151.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.362 2.708 . . . . 1.0 111.113 173.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.704 ' HA ' HD11 ' A' ' 23' ' ' LEU . 13.7 tt0 -67.75 -34.26 76.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 115.778 1.77 . . . . 1.0 115.778 -176.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -73.63 -25.22 60.2 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -68.6 -51.37 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.769 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.84 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.05 -24.76 66.02 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.08 0.943 . . . . 1.0 110.617 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.727 -1.579 . . . . 1.0 108.801 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.41 3.98 47.3 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.951 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 32' ' ' LEU . 11.6 mt -62.6 158.51 49.88 Favored Pre-proline 0 CA--C 1.491 -1.309 0 CA-C-N 118.311 1.055 . . . . 1.0 110.256 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.66 145.36 51.73 Favored 'Trans proline' 0 C--N 1.29 -2.552 0 N-CA-C 107.338 -1.832 . . . . 1.0 107.338 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.434 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 19.7 pt-20 -49.01 -30.23 5.86 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.333 1.063 . . . . 1.0 110.944 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 1.4 pm0 -87.39 25.63 1.38 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.002 -1.454 . . . . 1.0 112.463 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 26' ' ' LEU . 11.2 t -143.33 148.91 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.977 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.922 ' C ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -158.34 155.36 28.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.007 -1.906 . . . . 1.0 106.407 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.042 ' H ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -128.73 151.05 49.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.439 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -156.93 142.57 12.69 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 124.209 0.943 . . . . 1.0 113.481 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 45.8 Cg_endo -86.83 150.16 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.699 2.266 . . . . 1.0 109.634 174.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.2 m 85.76 15.75 0.14 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.264 -1.384 . . . . 1.0 107.264 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.53 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -90.84 -61.11 1.74 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.69 -1.967 . . . . 1.0 105.69 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -67.46 -51.55 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.263 -1.335 . . . . 1.0 112.946 -178.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 40' ' ' THR . 27.8 t70 179.56 46.76 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER 30.11 39.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.17 0.986 . . . . 1.0 110.187 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.6 m -127.11 -56.23 1.34 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.714 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 37' ' ' VAL . 6.7 mtm180 -120.08 157.53 28.75 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.228 -2.26 . . . . 1.0 107.324 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.673 HG12 ' OE1' ' A' ' 17' ' ' GLU . 10.3 tt -103.64 146.39 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 118.706 -0.664 . . . . 1.0 109.934 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 17' ' ' GLU . . . -140.46 173.04 23.27 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 119.275 -1.44 . . . . 1.0 114.08 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.697 ' HB ' HD12 ' A' ' 32' ' ' LEU . 1.5 m -101.75 131.39 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.53 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 27.0 m95 -125.88 146.91 49.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -71.4 144.0 49.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.538 -0.756 . . . . 1.0 112.201 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.488 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 45.1 p -119.76 -30.0 4.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.103 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -119.19 158.66 47.84 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.39 123.05 12.86 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 121.873 1.715 . . . . 1.0 111.593 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.406 ' C ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -104.19 133.43 48.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.984 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.9 157.35 19.96 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.29 1.043 . . . . 1.0 111.757 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.77 130.05 42.06 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.464 -1.698 . . . . 1.0 108.938 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.78 3.39 49.37 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 119.607 -1.282 . . . . 1.0 115.797 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 24.7 ttpt -92.48 143.7 26.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 1.267 . . . . 1.0 113.063 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.6 41.77 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.751 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 20.9 m-85 -115.78 129.11 56.32 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.884 -1.053 . . . . 1.0 108.206 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.745 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 132.95 -149.42 19.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.19 -1.005 . . . . 1.0 112.461 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 70.0 Cg_endo -89.17 153.03 30.93 Favored 'Cis proline' 0 N--CA 1.51 2.497 0 CA-C-N 119.214 1.507 . . . . 1.0 115.206 0.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.808 ' CA ' HD12 ' A' ' 99' ' ' LEU . 3.9 t80 -58.01 112.88 1.65 Allowed 'General case' 0 CA--C 1.495 -1.142 0 CA-C-O 122.08 0.943 . . . . 1.0 111.905 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.759 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -86.25 134.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.781 -1.554 . . . . 1.0 108.033 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.52 147.84 17.25 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.84 -1.704 . . . . 1.0 108.84 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -69.15 142.12 54.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.456 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.4 mptt -92.38 115.75 28.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.31 0.576 . . . . 1.0 111.883 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -142.59 167.56 21.81 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.649 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.657 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.98 149.04 34.16 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.28 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -48.56 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 1.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.322 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.705 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.868 0.366 . . . . 1.0 110.119 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.616 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -134.02 166.79 21.92 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.165 -0.679 . . . . 1.0 109.165 -178.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -133.48 125.58 29.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.186 0.517 . . . . 1.0 110.576 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.54 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.39 139.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.544 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.548 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 49.7 t80 -87.15 129.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.644 0.735 . . . . 1.0 111.228 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.523 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 4.7 m-85 -105.73 140.42 21.18 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.956 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.56 17.04 0.98 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.849 1.7 . . . . 1.0 110.83 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.516 ' C ' ' ND2' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -149.07 -31.46 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.92 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.523 ' H ' ' HB3' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -106.09 -16.61 14.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.962 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.31 -165.3 53.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -62.84 121.28 13.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.549 -0.86 . . . . 1.0 109.881 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.3 ppp? -130.96 168.66 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.14 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' LYS . 54.4 m -123.84 144.64 49.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.933 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 59' ' ' PHE . 82.8 mt -99.93 146.14 9.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 7.4 p-10 -133.61 119.29 19.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.349 0.977 . . . . 1.0 112.012 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.408 ' HB3' ' HE ' ' A' ' 100' ' ' ARG . . . -143.0 90.99 2.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.71 0.85 28.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.618 1.099 . . . . 1.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -128.89 131.55 23.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.819 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 96' ' ' GLY . 65.9 Cg_exo -48.97 -28.78 14.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.845 1.697 . . . . 1.0 113.728 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.22 -18.69 45.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.313 1.054 . . . . 1.0 108.428 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -88.63 18.19 4.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.123 -1.853 . . . . 1.0 109.473 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' PRO . . . -174.36 166.09 37.89 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.96 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.773 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -71.6 175.3 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.293 -1.002 . . . . 1.0 108.293 177.291 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.656 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 25.9 p-90 -56.44 -22.01 29.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.908 -0.717 . . . . 1.0 112.732 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.808 HD12 ' CA ' ' A' ' 59' ' ' PHE . 19.2 mt -53.71 -28.05 31.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 177.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' NH2' ' HE1' ' A' ' 76' ' ' TRP . 13.6 tpp180 -74.88 -12.9 60.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.949 -0.569 . . . . 1.0 112.006 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.882 ' CD2' HG11 ' A' ' 18' ' ' VAL . 15.9 p90 -123.56 4.15 8.97 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 119.696 -0.802 . . . . 1.0 110.694 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 102' ' ' VAL . 2.7 p -71.71 116.45 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.517 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 1.7 m-20 -85.22 143.36 28.8 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.311 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.521 ' C ' HD23 ' A' ' 137' ' ' LEU . 33.7 p90 -111.58 162.9 14.66 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.835 0.826 . . . . 1.0 112.945 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.955 ' N ' HD23 ' A' ' 137' ' ' LEU . . . -50.9 -179.15 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.132 -1.395 . . . . 1.0 112.336 -177.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -75.09 -20.4 59.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.669 178.423 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 106' ' ' CYS . 1.5 p 151.91 71.17 0.0 OUTLIER 'General case' 0 C--N 1.347 0.464 0 O-C-N 123.857 0.723 . . . . 1.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.41 ' N ' ' OE1' ' A' ' 111' ' ' GLN . . . 72.72 13.96 78.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.559 -0.616 . . . . 1.0 111.559 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.57 -44.08 19.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.012 -0.675 . . . . 1.0 111.36 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.65 ' OE2' HD13 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -120.19 -30.59 4.6 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.605 -0.438 . . . . 1.0 111.863 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.8 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 3.4 mt-30 -24.92 139.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.889 0.876 . . . . 1.0 113.083 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.602 ' ND2' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -140.15 19.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 1.0 110.134 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.84 HD12 ' H ' ' A' ' 114' ' ' PHE . 2.1 tp -153.12 149.3 27.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.69 -0.672 . . . . 1.0 109.698 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.84 ' H ' HD12 ' A' ' 113' ' ' LEU . 3.9 p90 -126.31 150.12 69.18 Favored Pre-proline 0 C--N 1.366 1.305 0 N-CA-C 114.616 1.339 . . . . 1.0 114.616 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -88.68 141.37 4.56 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 123.007 2.472 . . . . 1.0 114.073 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.723 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -141.81 139.74 32.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.847 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.723 ' H ' HD23 ' A' ' 116' ' ' LEU . 7.5 mt-10 -98.41 120.43 38.82 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.567 -0.288 . . . . 1.0 110.677 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -136.75 126.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 120.827 0.346 . . . . 1.0 110.637 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 121' ' ' ALA . 3.5 m-20 52.64 47.92 23.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.177 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.586 ' H ' ' NH1' ' A' ' 120' ' ' ARG . 1.8 mmt-85 62.97 5.96 2.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.126 0.489 . . . . 1.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -107.07 156.8 18.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 1.0 108.785 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -115.82 103.97 16.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.911 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 116' ' ' LEU . 13.4 m-85 -100.1 148.82 24.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.747 ' HB3' HD11 ' A' ' 113' ' ' LEU . 13.5 m-30 -113.16 114.08 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.573 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -107.13 142.57 36.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.124 1.157 . . . . 1.0 114.124 -178.065 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.623 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -129.84 132.43 46.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.423 -1.262 . . . . 1.0 112.491 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -106.38 26.04 10.35 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.7 0.682 . . . . 1.0 109.536 175.216 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.601 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -127.66 117.01 21.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.03 97.87 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 CA-C-N 120.465 1.202 . . . . 1.0 110.635 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.54 HG23 ' CG ' ' A' ' 134' ' ' GLU . 1.6 mt -70.36 136.8 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.27 1.033 . . . . 1.0 109.561 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.13 132.67 76.33 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 113.96 -1.473 . . . . 1.0 114.188 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -50.13 97.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.67 1.58 . . . . 1.0 110.737 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.68 -4.28 8.06 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.786 -0.525 . . . . 1.0 111.786 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.602 ' OE2' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -87.48 151.65 22.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.4 pm0 -77.21 129.08 35.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.919 0.39 . . . . 1.0 110.085 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.863 ' C ' HD12 ' A' ' 137' ' ' LEU . 5.5 mp -81.33 142.21 33.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.955 HD23 ' N ' ' A' ' 105' ' ' ALA . 6.8 mp -139.86 155.25 47.31 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.52 HG21 ' CE2' ' A' ' 124' ' ' TYR . 2.4 t -110.59 131.81 60.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 CA-C-N 114.93 -1.032 . . . . 1.0 113.228 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.672 ' CD1' ' NE2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.5 0.667 . . . . 1.0 112.662 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.057 0 N-CA-C 106.874 -1.528 . . . . 1.0 106.874 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.537 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -73.87 -35.77 64.76 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.952 -0.699 . . . . 1.0 110.203 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.03 -66.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.046 -1.061 . . . . 1.0 110.233 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 119.129 -1.028 . . . . 1.0 110.153 -175.234 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 13' ' ' GLU . . . . . . . . 0 CA--C 1.522 -0.113 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 14' ' ' THR . 0.4 OUTLIER 73.44 -39.8 0.45 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.579 179.249 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 42' ' ' ILE . 1.4 mm-40 28.23 -87.09 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -136.78 172.18 13.4 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.663 174.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 15' ' ' LEU . 6.3 tt -73.04 -59.91 2.48 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.823 -1.151 . . . . 1.0 108.336 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -78.35 -59.57 2.73 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-N 113.216 -1.811 . . . . 1.0 108.407 -176.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.734 ' HG3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -145.77 -102.58 0.1 Allowed 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 118.565 -1.254 . . . . 1.0 114.289 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.745 HG13 ' HD3' ' A' ' 19' ' ' PRO 0.284 0.2 OUTLIER 179.38 -80.42 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 116.974 -1.489 . . . . 1.0 111.601 -177.456 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.745 ' HD3' HG13 ' A' ' 18' ' ' VAL . 4.4 Cg_exo -74.19 147.01 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 CA-C-N 124.875 2.777 . . . . 1.0 111.404 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.509 ' CD ' HH12 ' A' ' 24' ' ' ARG . 37.4 tt0 -67.73 -50.26 58.29 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.338 1.066 . . . . 1.0 110.404 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.569 ' NE2' ' O ' ' A' ' 94' ' ' GLU . 28.7 p80 -56.36 -24.85 46.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.884 -1.053 . . . . 1.0 113.408 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.795 HG23 HD12 ' A' ' 23' ' ' LEU . 2.0 m -64.09 -45.0 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 121.284 1.857 . . . . 1.0 106.362 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.795 HD12 HG23 ' A' ' 22' ' ' VAL . 6.5 mp -54.71 -28.67 49.7 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.596 0.712 . . . . 1.0 110.405 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.509 HH12 ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.05 -20.84 60.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.519 -1.219 . . . . 1.0 108.616 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . -114.7 -12.68 10.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.309 -1.314 . . . . 1.0 113.063 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.644 HD13 ' C ' ' A' ' 30' ' ' VAL . 16.8 mt -60.19 150.21 72.31 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-N 118.988 1.394 . . . . 1.0 110.589 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 26' ' ' LEU . 75.9 Cg_exo -42.56 -128.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.666 2.911 . . . . 1.0 113.184 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 48' ' ' LYS . 4.2 mt-10 -68.77 -50.75 47.85 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.776 -1.57 . . . . 1.0 106.796 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' H ' ' HE2' ' A' ' 48' ' ' LYS . 12.5 tt0 -126.18 -77.71 0.59 Allowed 'General case' 0 C--N 1.363 1.17 0 C-N-CA 120.157 -0.617 . . . . 1.0 111.489 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.644 ' C ' HD13 ' A' ' 26' ' ' LEU 0.365 4.9 t 59.43 152.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 C-N-CA 127.881 2.472 . . . . 1.0 116.265 -176.112 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' C ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.79 160.61 42.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.173 -2.285 . . . . 1.0 110.948 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 31' ' ' ARG . 3.5 mm? -117.75 120.41 37.88 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 174.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.54 ' C ' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -129.43 122.56 20.94 Favored Pre-proline 0 N--CA 1.485 1.299 0 O-C-N 121.193 -0.942 . . . . 1.0 112.633 -176.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 4.3 Cg_exo -79.22 130.4 9.2 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.804 2.336 . . . . 1.0 112.897 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.3 t 87.8 30.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.667 -2.06 . . . . 1.0 107.286 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -94.57 -54.12 3.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 38' ' ' ASP . 7.5 p -59.4 -49.85 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 113.614 -1.63 . . . . 1.0 111.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.558 ' N ' HG13 ' A' ' 37' ' ' VAL . 0.6 OUTLIER 169.28 -50.91 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.3 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.548 -1.205 . . . . 1.0 107.909 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.554 ' HB ' HG11 ' A' ' 37' ' ' VAL . 20.7 m -102.83 -34.73 8.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 40' ' ' THR . 7.7 mtm-85 155.06 -159.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.7 -1.593 . . . . 1.0 106.7 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 13' ' ' GLU . 9.5 tt -84.07 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 118.915 0.779 . . . . 1.0 111.315 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.558 ' C ' HD13 ' A' ' 32' ' ' LEU . . . -106.75 166.72 13.66 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -103.28 120.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 118.134 0.967 . . . . 1.0 111.426 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.651 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 4.9 m95 -127.51 143.79 51.14 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.258 -0.883 . . . . 1.0 110.173 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -84.7 123.84 30.83 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.2 -1.0 . . . . 1.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -21.76 19.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.37 0.605 . . . . 1.0 109.409 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.61 ' HZ2' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -107.87 167.89 8.68 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 114.728 -1.124 . . . . 1.0 110.963 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 5.9 Cg_exo -76.09 144.34 26.69 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.65 2.233 . . . . 1.0 111.158 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.61 HG12 ' HZ2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -118.73 144.09 27.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.91 -178.44 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.98 146.31 39.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.92 0.866 . . . . 1.0 110.742 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.65 140.14 58.47 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.323 -1.308 . . . . 1.0 111.822 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.79 3.92 58.07 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 119.409 -1.377 . . . . 1.0 115.302 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' CG ' ' N ' ' A' ' 55' ' ' LYS . 30.0 ttpt -106.22 146.27 30.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 118.92 -1.112 . . . . 1.0 113.968 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -97.39 140.71 31.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.791 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 126' ' ' THR . 3.0 m-85 -118.59 131.03 56.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.052 -1.462 . . . . 1.0 107.052 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.64 -150.45 21.11 Favored Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 21.6 Cg_endo -84.83 170.7 46.88 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 119.671 1.735 . . . . 1.0 113.457 0.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.823 ' HB2' HD12 ' A' ' 99' ' ' LEU . 36.9 t80 -73.72 122.31 22.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.622 0.725 . . . . 1.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -44.37 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.886 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 37.12 109.14 0.0 OUTLIER Glycine 0 C--N 1.333 0.399 0 CA-C-O 121.711 0.617 . . . . 1.0 113.244 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t70 -85.78 134.96 33.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 63' ' ' LYS . 1.5 mptt -90.59 116.33 28.41 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.517 0.675 . . . . 1.0 112.124 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HZ3' ' HB3' ' A' ' 87' ' ' CYS . 0.1 OUTLIER -124.05 158.08 33.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.626 -1.17 . . . . 1.0 110.98 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -83.63 135.53 34.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 177.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -53.27 -31.04 41.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.783 -0.573 . . . . 1.0 110.394 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.838 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.653 0.74 . . . . 1.0 112.584 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -123.11 164.28 18.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.525 -1.216 . . . . 1.0 110.512 -178.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -122.69 122.21 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.181 0.515 . . . . 1.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.96 139.93 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.406 -0.816 . . . . 1.0 111.83 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.516 ' O ' ' CZ ' ' A' ' 120' ' ' ARG . 4.4 t80 -92.67 135.84 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.875 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.61 ' CD1' HD11 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -117.12 146.05 37.17 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -70.19 44.46 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 N-CA-C 108.225 -1.49 . . . . 1.0 108.225 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.575 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 1.5 t30 -148.21 -85.77 0.1 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.212 -1.358 . . . . 1.0 110.297 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 84' ' ' GLY . 0.8 OUTLIER -80.48 -8.99 59.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.33 -1.305 . . . . 1.0 112.322 -176.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.74 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 81.65 -145.81 25.31 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -78.68 118.13 20.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.721 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -129.96 173.38 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.744 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.586 ' N ' ' SD ' ' A' ' 86' ' ' MET . 67.8 m -117.96 141.41 48.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.152 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.4 150.66 3.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 N-CA-C 108.05 -1.093 . . . . 1.0 108.05 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -133.66 136.69 44.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.827 1.047 . . . . 1.0 113.827 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 91' ' ' THR . . . -133.23 139.93 47.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 90' ' ' ALA . 30.2 p -158.61 -13.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.487 0.585 . . . . 1.0 110.033 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.03 106.31 3.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.75 -22.09 9.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.132 1.888 . . . . 1.0 114.353 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.569 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 5.9 pt-20 -83.18 -8.39 59.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.904 0.859 . . . . 1.0 110.215 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 11.65 35.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.343 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.442 ' O ' ' ND1' ' A' ' 21' ' ' HIS . . . -165.44 -95.07 0.1 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 119.073 -1.537 . . . . 1.0 114.012 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.672 ' ND2' ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -146.18 173.35 12.29 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 101' ' ' TYR . 30.6 p-90 -70.86 -19.95 62.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.823 HD12 ' HB2' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -50.18 -24.11 2.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.775 HH22 HD21 ' A' ' 103' ' ' ASN . 3.1 tpm_? -84.57 -23.16 29.78 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 120.146 -0.621 . . . . 1.0 110.749 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -72.57 -7.35 49.69 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.299 1.047 . . . . 1.0 109.479 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.718 HG22 ' CZ2' ' A' ' 104' ' ' TRP . 3.4 t -82.48 119.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.249 -1.796 . . . . 1.0 111.041 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.775 HD21 HH22 ' A' ' 100' ' ' ARG . 38.4 m-20 -156.15 71.68 0.73 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.661 0.664 . . . . 1.0 111.464 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.818 ' HE1' ' N ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -141.88 176.69 8.73 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.089 0.956 . . . . 1.0 111.497 -177.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.601 ' C ' ' N ' ' A' ' 107' ' ' SER . . . 26.53 52.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.43 1.081 . . . . 1.0 109.995 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -48.56 -14.53 0.06 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.593 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.601 ' N ' ' C ' ' A' ' 105' ' ' ALA . 20.0 p -174.98 18.06 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.35 -1.295 . . . . 1.0 110.561 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.704 ' N ' ' HE1' ' A' ' 139' ' ' TRP . . . -85.2 131.26 10.33 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.06 -12.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 4.3 pt-20 -74.26 5.52 4.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 113.698 0.999 . . . . 1.0 113.698 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.696 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.4 pp0? -54.48 140.23 35.04 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.673 1.36 . . . . 1.0 114.673 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.983 ' ND2' ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -117.58 -5.22 11.19 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.333 -1.758 . . . . 1.0 111.663 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 114' ' ' PHE . 0.3 OUTLIER -155.8 165.47 36.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 119.441 -0.314 . . . . 1.0 110.931 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 1.079 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -133.11 138.03 30.77 Favored Pre-proline 0 C--N 1.357 0.933 0 N-CA-C 113.869 1.062 . . . . 1.0 113.869 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.78 146.02 10.37 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.422 2.748 . . . . 1.0 113.648 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.822 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -144.66 146.54 32.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.293 178.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.822 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.2 tt0 -97.38 119.06 35.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 123' ' ' TYR . 7.7 mt -137.39 132.21 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.929 -177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 121' ' ' ALA . 30.2 m-20 50.14 57.95 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.485 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.516 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 9.8 mmp_? 57.21 -0.8 0.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.494 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 58' ' ' PRO . . . -123.21 155.62 36.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.248 -0.278 . . . . 1.0 110.248 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CE2' ' A' ' 76' ' ' TRP . 1.0 OUTLIER -103.8 113.94 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.602 ' HB2' HD12 ' A' ' 118' ' ' ILE . 5.0 m-85 -101.35 149.32 24.16 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.737 ' CE2' HG21 ' A' ' 138' ' ' VAL . 3.1 m-30 -112.97 126.93 56.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.338 -1.356 . . . . 1.0 107.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.946 ' H ' ' HZ2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -122.5 140.43 52.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.006 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.642 ' C ' HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -128.73 134.47 48.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 1.0 109.708 178.376 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.887 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -105.87 16.78 24.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.103 176.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.593 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -125.16 127.01 25.13 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.22 98.79 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 121.33 1.511 . . . . 1.0 111.068 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.531 HD13 ' OD1' ' A' ' 112' ' ' ASN . 55.6 mt -67.81 134.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.273 1.035 . . . . 1.0 109.594 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.663 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.01 139.32 97.75 Favored Pre-proline 0 C--O 1.212 -0.872 0 CA-C-N 113.929 -1.487 . . . . 1.0 114.086 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.52 115.44 4.29 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.556 2.171 . . . . 1.0 111.692 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 109.65 0.95 30.73 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.914 -0.474 . . . . 1.0 111.914 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.702 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -97.75 173.27 7.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.84 0.829 . . . . 1.0 112.353 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' CG ' ' CD1' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -85.81 141.42 29.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.211 -1.358 . . . . 1.0 108.359 176.369 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.711 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.4 mp -89.9 136.88 32.78 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.218 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.983 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 6.8 mp -121.6 142.84 49.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.757 0.789 . . . . 1.0 112.104 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.818 ' N ' ' HE1' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -119.97 137.12 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 114.034 -1.439 . . . . 1.0 110.014 -176.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.704 ' HE1' ' N ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--O 1.204 -1.295 0 N-CA-C 106.388 -1.708 . . . . 1.0 106.388 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.05 -50.4 34.35 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.123 -1.831 . . . . 1.0 109.191 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.87 -65.59 0.68 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.285 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.296 0 CA-C-N 120.846 1.657 . . . . 1.0 112.374 -176.898 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.696 ' HB2' ' OG ' ' A' ' 35' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.191 0.52 . . . . 1.0 110.192 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.3 m 149.54 -68.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.251 -1.341 . . . . 1.0 108.212 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.502 ' N ' HG22 ' A' ' 12' ' ' THR . 5.9 mm-40 -45.8 138.71 4.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.556 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -121.37 153.45 37.78 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 121.554 0.692 . . . . 1.0 112.321 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.982 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -47.39 -36.0 9.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.465 -178.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.96 44.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.581 -1.191 . . . . 1.0 109.802 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -97.47 -38.1 9.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.034 -0.984 . . . . 1.0 113.617 -177.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -63.49 147.11 95.87 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.688 -1.967 . . . . 1.0 105.688 178.232 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 18' ' ' VAL . 2.8 Cg_exo -48.1 118.61 3.28 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.621 1.548 . . . . 1.0 112.042 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.15 -42.39 60.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.973 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.425 ' CD2' ' H ' ' A' ' 21' ' ' HIS . 12.9 p80 -64.08 -23.65 67.4 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.949 -0.7 . . . . 1.0 111.703 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 97' ' ' ASN . 14.9 t -80.17 -45.33 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 119.009 0.822 . . . . 1.0 111.247 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.624 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -67.04 -25.7 66.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.951 0.881 . . . . 1.0 108.993 178.337 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -61.27 -19.18 61.43 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.592 -1.186 . . . . 1.0 111.913 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.8 39.67 2.82 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.246 -0.502 . . . . 1.0 112.054 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.661 HD22 ' CG1' ' A' ' 30' ' ' VAL . 32.7 mt -80.04 154.48 75.09 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG2' HG21 ' A' ' 30' ' ' VAL . 86.0 Cg_exo -44.23 -120.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.966 3.111 . . . . 1.0 114.138 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 7.8 mm-40 -69.18 -55.11 11.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.65 -2.352 . . . . 1.0 104.65 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 30' ' ' VAL . 7.6 tp10 -133.95 -72.59 0.49 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.661 ' CG1' HD22 ' A' ' 26' ' ' LEU . 96.4 t 52.28 163.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.989 0.9 . . . . 1.0 110.953 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB2' HG21 ' A' ' 47' ' ' THR . 3.2 ttt85 -161.44 163.16 30.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.92 -1.491 . . . . 1.0 107.006 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.654 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.1 mm? -94.45 155.07 17.13 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.544 -1.262 . . . . 1.0 110.098 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.72 111.67 2.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 35' ' ' SER . 13.0 Cg_endo -88.31 154.18 6.71 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.691 2.927 . . . . 1.0 111.926 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.696 ' OG ' ' HB2' ' A' ' 11' ' ' ALA . 1.8 p 50.84 40.3 24.42 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -95.98 -46.4 6.53 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.282 -2.235 . . . . 1.0 106.899 175.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -96.3 -4.06 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 114.16 -1.382 . . . . 1.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t70 98.24 -11.32 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.982 0.802 . . . . 1.0 111.54 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.726 ' HZ3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.24 -35.84 66.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.874 -0.73 . . . . 1.0 109.326 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 92.11 -11.22 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.526 0.936 . . . . 1.0 113.526 177.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.726 ' CB ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -77.22 162.45 27.37 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 32' ' ' LEU . 4.2 mm -74.48 124.73 32.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 120.485 1.493 . . . . 1.0 112.097 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.77 174.19 16.86 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.698 -1.761 . . . . 1.0 108.698 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG21 ' HE3' ' A' ' 98' ' ' TRP . 8.3 p -121.83 125.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.94 0.4 . . . . 1.0 109.94 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.661 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 30.2 m95 -126.92 149.43 49.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.618 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.55 133.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.959 -1.019 . . . . 1.0 108.859 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 31' ' ' ARG . 80.8 p -115.93 -15.73 11.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.241 -1.392 . . . . 1.0 107.241 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.595 ' CD ' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -116.2 171.69 4.47 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 112.847 -1.979 . . . . 1.0 109.59 -178.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.46 153.71 13.84 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 123.264 2.643 . . . . 1.0 111.982 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.495 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 4.1 mp -132.11 150.84 34.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.728 -1.124 . . . . 1.0 111.354 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.734 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.55 165.09 15.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 1.0 111.71 178.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.55 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.9 129.62 40.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.093 177.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.33 -0.71 60.13 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 119.854 -1.165 . . . . 1.0 113.375 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.671 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.7 tptt -57.09 157.96 5.51 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.732 -1.187 . . . . 1.0 110.284 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.7 ttmt -123.76 109.3 13.5 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.46 -1.245 . . . . 1.0 108.403 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 11.6 m-30 -119.58 125.12 48.04 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 58' ' ' PRO . . . 155.02 -153.49 24.83 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.08 -1.418 . . . . 1.0 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 10.2 Cg_endo -82.66 150.83 71.6 Favored 'Cis proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.35 1.575 . . . . 1.0 113.604 0.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.464 ' CE1' HG23 ' A' ' 60' ' ' VAL . 17.6 t80 -62.94 118.92 8.46 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.759 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -27.03 -65.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.345 -1.752 . . . . 1.0 111.495 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 53.89 104.55 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.827 -0.701 . . . . 1.0 113.482 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.01 149.8 20.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 176.412 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.541 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -93.53 116.36 28.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.299 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.719 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -146.87 167.22 24.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.016 -178.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.732 ' NZ ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -65.94 153.05 43.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.652 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 6.2 ttm-85 -66.09 -45.33 81.6 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.499 -0.751 . . . . 1.0 111.932 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 121.008 0.432 . . . . 1.0 110.151 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.7 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.599 0 CA-C-O 121.788 0.804 . . . . 1.0 111.732 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.918 ' CE2' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -160.59 162.3 32.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.244 -1.344 . . . . 1.0 112.618 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 1.3 pm0 -100.93 121.88 42.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.959 0.885 . . . . 1.0 111.355 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.623 ' CG1' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.24 135.85 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 114.747 -1.115 . . . . 1.0 108.986 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.9 t80 -87.0 124.37 33.12 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.511 -0.875 . . . . 1.0 111.329 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.543 ' C ' ' H ' ' A' ' 82' ' ' ASN . 5.0 m-85 -92.19 135.53 26.89 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 114.195 -1.366 . . . . 1.0 110.466 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.34 7.69 1.74 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.771 1.647 . . . . 1.0 108.869 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 80' ' ' TYR . 70.5 m-80 -110.27 -90.72 0.47 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.256 -1.338 . . . . 1.0 111.48 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.031 HD23 ' H ' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -79.64 -7.08 58.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.36 -157.32 15.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 120.393 -0.908 . . . . 1.0 112.717 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.4 m95 -66.08 121.16 14.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.609 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.525 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 38.1 mmm -124.85 150.8 46.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.377 0.88 . . . . 1.0 113.377 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.652 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -106.97 131.36 54.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 88' ' ' ILE . 17.0 mt -106.16 105.34 18.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.719 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 23.5 t0 -130.83 127.57 38.88 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.287 0.949 . . . . 1.0 112.085 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -132.82 96.45 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.192 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.628 HG23 ' OD1' ' A' ' 89' ' ' ASP . 29.3 p -129.55 75.42 1.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.726 0.694 . . . . 1.0 110.617 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.727 ' N ' ' HE ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -162.85 160.82 19.36 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.338 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -67.26 -38.93 14.14 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.15 1.9 . . . . 1.0 112.418 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -77.87 -44.46 27.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -11.42 16.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 1.0 112.076 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . -110.77 111.46 3.02 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.487 -0.863 . . . . 1.0 112.04 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.682 ' HA ' HG22 ' A' ' 22' ' ' VAL . 52.2 p30 -61.95 -157.92 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.919 0.39 . . . . 1.0 110.466 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.563 ' HE3' HG21 ' A' ' 44' ' ' VAL . 43.0 p-90 -72.75 -35.49 67.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.318 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -54.8 -26.5 35.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.365 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.727 ' HE ' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -72.29 -20.5 61.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.917 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.87 -10.68 57.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.758 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 99' ' ' LEU . 3.2 t -64.49 141.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.561 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -101.22 -155.18 0.5 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.088 -0.645 . . . . 1.0 112.234 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.47 ' C ' ' HB3' ' A' ' 137' ' ' LEU . 2.6 m-90 -112.79 144.12 42.87 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.466 -0.788 . . . . 1.0 111.813 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 139' ' ' TRP . . . -79.06 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER 159.23 -16.05 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.768 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -136.54 -81.56 0.39 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.197 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 163.69 -52.0 0.3 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -24.62 65.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.677 ' O ' ' O ' ' A' ' 111' ' ' GLN . 2.5 pt-20 -92.13 -22.98 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.995 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.688 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -51.24 -134.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.631 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 1.027 HD21 HD22 ' A' ' 137' ' ' LEU . 0.8 OUTLIER 158.51 -33.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.572 -0.705 . . . . 1.0 109.488 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 112' ' ' ASN . 4.2 mm? -129.55 148.26 51.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.807 -0.757 . . . . 1.0 112.055 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -134.06 130.63 20.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 115.105 -0.952 . . . . 1.0 112.498 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 76' ' ' TRP . 78.6 Cg_exo -51.23 130.22 31.53 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 123.894 3.063 . . . . 1.0 115.899 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.594 HD23 ' HZ1' ' A' ' 125' ' ' LYS . 56.2 tp -142.17 137.24 30.7 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 4.7 mm-40 -108.06 114.95 29.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.403 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.577 HD11 ' CD1' ' A' ' 123' ' ' TYR . 4.9 pt -139.09 127.82 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.536 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.59 47.5 23.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 1.0 110.909 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HE ' ' CG1' ' A' ' 78' ' ' VAL . 1.9 mmp_? 54.43 30.56 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -136.82 148.98 47.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.026 -1.101 . . . . 1.0 108.026 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.918 HG21 ' CE2' ' A' ' 76' ' ' TRP . 1.6 mm -110.42 114.24 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.745 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.577 ' CD1' HD11 ' A' ' 118' ' ' ILE . 4.6 m-85 -102.22 157.53 16.83 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.175 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.811 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.5 m-30 -116.66 130.73 56.91 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 105.522 -2.029 . . . . 1.0 105.522 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.594 ' HZ1' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -125.95 153.96 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.967 -177.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.689 ' O ' ' N ' ' A' ' 53' ' ' GLY . 27.7 p -100.76 118.51 37.01 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.231 -0.588 . . . . 1.0 112.471 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.67 HD23 ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -82.77 -21.38 34.66 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 124.224 0.953 . . . . 1.0 109.559 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.893 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -139.8 137.97 19.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.724 0.268 . . . . 1.0 111.724 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.88 144.2 45.58 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.628 1.552 . . . . 1.0 110.732 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.495 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -122.13 137.06 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.524 ' HB3' ' CG ' ' A' ' 134' ' ' GLU . . . -75.08 134.18 74.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.15 -0.477 . . . . 1.0 112.112 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.06 108.99 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 CA-C-N 119.808 0.967 . . . . 1.0 110.534 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 122.03 7.65 7.73 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 2.3 mm-40 -105.53 117.61 34.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.137 0.494 . . . . 1.0 111.187 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.661 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -46.06 146.71 1.21 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.772 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 137' ' ' LEU . 7.2 mp -91.08 132.67 35.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.096 -0.956 . . . . 1.0 108.488 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 1.027 HD22 HD21 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -136.62 161.81 34.86 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.751 0.786 . . . . 1.0 112.071 -178.28 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.811 HG11 ' CE2' ' A' ' 124' ' ' TYR . 3.1 m -146.13 170.87 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.778 -1.101 . . . . 1.0 111.337 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.655 ' CD1' ' NE2' ' A' ' 111' ' ' GLN . 44.5 p-90 . . . . . 0 C--N 1.307 -1.239 0 CA-C-N 113.585 -1.643 . . . . 1.0 108.41 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 N--CA 1.428 -1.546 0 CA-C-O 120.678 0.275 . . . . 1.0 110.662 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 -48.83 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.71 74.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 1.0 111.968 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.67 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--O 1.21 -1.01 0 C-N-CA 119.48 -0.888 . . . . 1.0 111.451 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 89.9 m 122.36 103.62 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 125.204 1.565 . . . . 1.0 107.623 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.511 ' HG3' HG22 ' A' ' 12' ' ' THR . 0.4 OUTLIER 66.25 161.07 0.14 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.106 -1.406 . . . . 1.0 108.824 -177.476 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.547 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -121.29 156.17 33.1 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 120.458 0.171 . . . . 1.0 111.074 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.738 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -43.9 -30.21 0.66 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.219 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.41 59.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.61 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -73.14 -44.65 59.84 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.787 1.032 . . . . 1.0 113.787 -176.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -56.2 149.77 34.83 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.973 -1.862 . . . . 1.0 105.973 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 18' ' ' VAL . 27.8 Cg_exo -47.37 143.23 11.52 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 120.884 1.056 . . . . 1.0 110.874 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 14.8 tt0 -60.81 -49.9 75.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.511 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.553 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 8.2 p80 -61.76 -26.07 67.85 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.624 HG13 ' C ' ' A' ' 97' ' ' ASN . 22.6 t -79.78 -49.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 118.656 0.662 . . . . 1.0 111.656 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.543 HD23 HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -67.89 -25.5 65.54 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.795 0.807 . . . . 1.0 109.449 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 8.6 mmm180 -59.74 -19.23 48.89 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.181 -1.372 . . . . 1.0 112.019 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.84 35.88 4.38 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.149 -0.548 . . . . 1.0 111.979 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 30' ' ' VAL . 16.4 mt -82.03 123.12 80.08 Favored Pre-proline 0 CA--C 1.514 -0.419 0 CA-C-O 119.477 -0.297 . . . . 1.0 111.11 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.509 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 14.2 Cg_exo -55.41 156.72 16.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 119.748 0.946 . . . . 1.0 110.236 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.423 ' C ' ' HG3' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -47.18 -13.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 115.172 1.545 . . . . 1.0 115.172 -174.266 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 6.2 pm0 -114.19 15.73 18.14 Favored 'General case' 0 CA--C 1.463 -2.386 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.16 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.714 HG12 HG22 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -126.82 125.78 67.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 114.605 1.335 . . . . 1.0 114.605 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.546 ' HB2' HG21 ' A' ' 47' ' ' THR . 6.6 tpm_? -141.6 153.44 44.79 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 113.36 -1.745 . . . . 1.0 107.17 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 15' ' ' LEU . 4.1 mm? -91.82 143.69 26.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 118.84 -1.144 . . . . 1.0 109.958 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.47 110.06 3.64 Favored Pre-proline 0 N--CA 1.444 -0.732 0 N-CA-C 113.253 0.834 . . . . 1.0 113.253 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . 15.5 Cg_endo -84.87 152.58 11.31 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.883 2.389 . . . . 1.0 111.24 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.9 p 86.46 -38.49 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.437 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -49.3 -57.88 6.05 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.516 -1.22 . . . . 1.0 107.847 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 3.9 m -57.27 -50.05 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.869 -0.732 . . . . 1.0 110.232 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 1.7 m-20 156.9 70.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.448 0.468 . . . . 1.0 110.591 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.1 OUTLIER 35.67 29.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.387 0.613 . . . . 1.0 109.811 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 m -90.88 -33.56 15.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.086 -0.961 . . . . 1.0 112.62 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 42' ' ' ILE . 4.7 ptm180 162.61 -163.98 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 HD12 ' A' ' 32' ' ' LEU . 2.7 mm -84.37 135.56 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 118.156 0.434 . . . . 1.0 110.386 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.73 155.14 18.92 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.545 -1.022 . . . . 1.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -102.41 131.53 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.51 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 12.0 m95 -132.26 155.21 48.72 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 -176.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.06 120.41 14.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.579 ' H ' ' C ' ' A' ' 29' ' ' GLU . 1.4 p -102.83 -20.81 14.16 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' CD ' ' C ' ' A' ' 48' ' ' LYS 0.252 0.0 OUTLIER -129.29 170.71 10.19 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.827 178.056 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -80.42 125.35 5.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.123 1.882 . . . . 1.0 114.097 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.652 HD11 ' HG3' ' A' ' 29' ' ' GLU . 3.7 mp -99.66 150.78 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.809 -1.541 . . . . 1.0 110.659 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.753 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.17 164.03 13.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.674 177.015 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -66.61 124.18 22.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.813 -0.554 . . . . 1.0 110.385 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 99.75 1.28 56.34 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 119.924 -1.132 . . . . 1.0 113.087 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 2.2 tptt -52.32 159.47 0.97 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 117.625 -1.63 . . . . 1.0 108.356 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.759 ' HG2' ' HZ2' ' A' ' 125' ' ' LYS . 8.8 ttmt -121.48 103.16 8.73 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.315 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.587 ' CE2' ' OE2' ' A' ' 29' ' ' GLU . 13.4 m-85 -116.36 126.44 53.49 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 106.473 -1.677 . . . . 1.0 106.473 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.17 -164.75 35.63 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 109.876 -1.289 . . . . 1.0 109.876 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 7.0 Cg_endo -89.68 138.44 13.22 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 CA-C-N 119.094 1.447 . . . . 1.0 112.884 -0.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.7 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 10.2 t80 -59.13 114.82 2.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.675 0.75 . . . . 1.0 110.509 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -21.51 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.209 -1.814 . . . . 1.0 111.393 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.615 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 45.76 105.49 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.586 -0.734 . . . . 1.0 113.349 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ASP . 13.7 t70 -93.52 147.28 23.12 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -92.8 115.08 27.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.122 0.963 . . . . 1.0 113.149 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -139.85 170.3 16.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.619 -1.628 . . . . 1.0 110.708 -177.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.698 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.48 145.91 31.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 121.126 -0.23 . . . . 1.0 111.384 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -50.85 -23.9 3.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.782 -0.574 . . . . 1.0 111.986 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 66' ' ' ARG . 29.0 t . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.234 0.54 . . . . 1.0 110.136 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.56 ' C ' ' CG ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.513 0 CA-C-O 121.125 0.488 . . . . 1.0 111.75 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.56 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -157.13 162.81 39.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.031 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.27 122.98 44.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.08 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.552 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -134.56 136.59 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.139 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 t80 -85.41 124.56 32.15 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.512 0.672 . . . . 1.0 112.182 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.805 ' OH ' HD11 ' A' ' 88' ' ' ILE . 27.3 m-85 -100.69 125.37 39.07 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.637 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.71 8.57 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 108.305 -1.46 . . . . 1.0 108.305 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 80' ' ' TYR . 74.5 m-20 -109.44 -10.14 14.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.0 -1.455 . . . . 1.0 111.27 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -168.65 1.85 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.709 1.374 . . . . 1.0 114.709 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.59 -160.78 14.27 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 120.608 -0.806 . . . . 1.0 112.912 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.553 ' O ' ' SD ' ' A' ' 86' ' ' MET . 27.5 m95 -76.5 121.06 22.59 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.553 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.8 mmm -127.54 163.63 23.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.131 1.53 . . . . 1.0 115.131 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.03 134.07 53.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.157 -1.383 . . . . 1.0 108.175 177.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.805 HD11 ' OH ' ' A' ' 80' ' ' TYR . 9.2 mt -106.61 111.5 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 118.481 -0.771 . . . . 1.0 109.816 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -134.42 130.94 37.56 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -139.04 104.8 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.79 49.3 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.994 -0.682 . . . . 1.0 109.202 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.62 162.39 36.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.094 -0.957 . . . . 1.0 109.955 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.62 -38.73 7.7 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.307 2.005 . . . . 1.0 112.688 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -78.16 -42.38 31.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 -11.26 20.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.661 0.267 . . . . 1.0 111.529 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 90' ' ' ALA . . . -102.35 -166.76 26.63 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.624 ' C ' HG13 ' A' ' 22' ' ' VAL . 44.1 p-10 -145.36 -153.8 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.239 0.542 . . . . 1.0 111.072 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.503 ' N ' HG13 ' A' ' 22' ' ' VAL . 14.4 p-90 -72.34 -29.61 63.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.949 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.721 HD23 ' CD2' ' A' ' 124' ' ' TYR . 0.3 OUTLIER -66.31 -30.85 71.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.457 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.581 ' NH2' ' OH ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 119.926 -0.71 . . . . 1.0 109.937 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.581 ' OH ' ' NH2' ' A' ' 100' ' ' ARG . 7.8 m-85 -92.96 0.44 57.4 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.69 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 99' ' ' LEU . 23.3 t -68.99 126.11 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -72.7 -157.48 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.605 0.595 . . . . 1.0 112.605 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.433 ' O ' ' HB3' ' A' ' 137' ' ' LEU . 4.1 m-90 -112.41 158.72 19.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.468 -0.787 . . . . 1.0 111.046 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.653 ' O ' ' N ' ' A' ' 107' ' ' SER . . . -100.56 -14.62 18.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 116.086 1.884 . . . . 1.0 116.086 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 107' ' ' SER . 49.7 t 32.62 23.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.406 0.548 . . . . 1.0 112.422 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.3 OUTLIER 159.4 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.641 0.258 . . . . 1.0 110.663 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' O ' ' OE1' ' A' ' 111' ' ' GLN . . . -85.25 2.21 88.26 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.197 -0.525 . . . . 1.0 111.907 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -86.59 -22.85 26.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.003 0.371 . . . . 1.0 112.003 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 111' ' ' GLN . 8.4 pt-20 -115.93 -27.55 6.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.401 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.775 HE21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -44.13 110.13 0.19 Allowed 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.762 ' OD1' ' N ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -88.28 -5.31 58.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.753 ' HB2' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -140.55 172.1 13.2 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 124.014 0.821 . . . . 1.0 112.723 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.593 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -148.71 132.07 8.28 Favored Pre-proline 0 N--CA 1.433 -1.287 0 C-N-CA 119.488 -0.885 . . . . 1.0 111.029 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 139' ' ' TRP . 80.6 Cg_exo -55.55 116.39 3.12 Favored 'Trans proline' 0 N--CA 1.509 2.406 0 C-N-CA 123.4 2.733 . . . . 1.0 113.99 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.6 tp -120.39 121.74 39.23 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.048 0.452 . . . . 1.0 111.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -102.84 114.26 28.38 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.505 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.557 HD11 ' CG ' ' A' ' 123' ' ' TYR . 2.3 pt -139.61 134.41 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.437 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.64 38.69 30.39 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.039 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.533 ' HE ' HG12 ' A' ' 78' ' ' VAL . 1.2 mmp_? 58.33 32.34 21.96 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.179 0.514 . . . . 1.0 110.452 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.37 155.22 50.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.434 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.52 HG21 ' NE1' ' A' ' 76' ' ' TRP . 15.0 mm -96.22 125.85 48.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.989 0.423 . . . . 1.0 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.557 ' CG ' HD11 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -124.05 150.64 44.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.277 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.817 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.8 m-30 -118.64 118.76 32.53 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.761 0.315 . . . . 1.0 110.486 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.764 ' NZ ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -115.33 155.29 27.59 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.319 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' GLY . 10.7 p -106.69 109.86 21.89 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.843 1.339 . . . . 1.0 110.487 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.775 HD13 HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER -76.18 -8.38 56.9 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.33 1.019 . . . . 1.0 112.091 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.836 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -151.02 135.73 9.94 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 119.923 -0.711 . . . . 1.0 110.929 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.19 129.02 31.42 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.497 1.465 . . . . 1.0 111.65 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.495 ' HB ' HD13 ' A' ' 50' ' ' ILE . 1.7 mt -106.5 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.054 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.521 ' HB3' ' OE2' ' A' ' 134' ' ' GLU . . . -84.18 132.92 46.32 Favored Pre-proline 0 C--O 1.219 -0.541 0 C-N-CA 120.162 -0.615 . . . . 1.0 109.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -45.42 104.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.907 1.738 . . . . 1.0 114.032 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 139.57 0.5 2.05 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 120.254 -0.974 . . . . 1.0 113.382 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -102.71 138.74 39.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.306 0.574 . . . . 1.0 110.145 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.51 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -61.29 130.97 48.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.763 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 11.0 mp -75.6 129.54 37.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.721 -0.791 . . . . 1.0 109.134 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.762 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -141.97 159.4 42.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.817 HG11 ' CE2' ' A' ' 124' ' ' TYR . 2.5 m -128.44 172.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.399 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.626 ' HE1' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.624 0 CA-C-O 121.961 0.886 . . . . 1.0 111.036 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mm . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.41 70.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.79 -38.25 90.34 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.438 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.564 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 N--CA 1.443 -0.792 0 C-N-CA 120.184 -0.607 . . . . 1.0 110.631 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.555 ' C ' HG22 ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.508 -0.644 0 CA-C-O 121.699 0.761 . . . . 1.0 110.379 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER 171.67 -53.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.979 -1.464 . . . . 1.0 109.198 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -126.44 162.1 26.38 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -119.61 161.46 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.614 0.721 . . . . 1.0 111.416 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.16 -39.49 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.614 -178.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.21 -9.4 58.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.391 0.615 . . . . 1.0 110.696 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.798 ' CB ' ' H ' ' A' ' 14' ' ' THR . 17.3 tp10 -89.32 -45.24 9.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.667 HG13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.26 149.88 2.47 Favored Pre-proline 0 C--N 1.342 0.242 0 N-CA-C 105.168 -2.16 . . . . 1.0 105.168 177.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.636 ' HD2' HG23 ' A' ' 18' ' ' VAL . 14.5 Cg_exo -46.77 137.41 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 CA-C-N 120.371 1.168 . . . . 1.0 111.531 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 3.2 tt0 -59.27 -52.01 67.51 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.021 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.516 ' ND1' HG23 ' A' ' 22' ' ' VAL . 6.7 p80 -57.13 -28.89 63.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.991 0.737 . . . . 1.0 112.991 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.763 HG22 ' HA ' ' A' ' 97' ' ' ASN . 23.7 t -79.28 -49.65 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.368 0.531 . . . . 1.0 110.379 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.667 ' CD2' HG13 ' A' ' 18' ' ' VAL . 1.1 pp -72.01 -26.92 62.41 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.364 0.602 . . . . 1.0 111.253 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 10.6 mmm180 -57.87 -25.51 60.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.124 -0.944 . . . . 1.0 112.372 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.25 48.27 0.95 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.878 HD22 HG11 ' A' ' 30' ' ' VAL . 11.7 mt -96.83 131.24 28.33 Favored Pre-proline 0 CA--C 1.511 -0.529 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 29' ' ' GLU . 2.9 Cg_exo -61.86 143.61 95.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 N-CA-C 109.912 -0.842 . . . . 1.0 109.912 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -52.43 -10.04 0.13 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.947 -177.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.908 ' N ' ' HZ2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -84.33 12.14 7.22 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 178.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.878 HG11 HD22 ' A' ' 26' ' ' LEU . 10.8 t -140.1 131.78 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.492 0 N-CA-C 118.227 2.677 . . . . 1.0 118.227 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -134.99 141.37 46.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 110.95 -2.841 . . . . 1.0 103.567 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.755 ' N ' HD22 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -91.28 153.1 20.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 117.759 -1.576 . . . . 1.0 109.856 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 1.3 m-85 -154.53 110.41 2.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HB3' HD13 ' A' ' 42' ' ' ILE . 12.5 Cg_endo -87.89 151.25 7.21 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.104 2.536 . . . . 1.0 112.105 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.436 ' N ' ' HA ' ' A' ' 40' ' ' THR . 2.3 p 55.46 44.11 27.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.19 -43.9 8.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.11 -1.404 . . . . 1.0 107.218 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.578 ' CG2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -104.19 -0.65 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 113.938 -1.483 . . . . 1.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 7.0 t70 96.7 3.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.154 0.909 . . . . 1.0 110.693 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HG2' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.42 -37.27 44.25 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER 84.12 -9.96 0.93 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.741 0.651 . . . . 1.0 112.714 177.315 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.759 ' H ' ' HG2' ' A' ' 39' ' ' LYS . 18.9 ttm180 -77.59 157.03 30.48 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 176.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 34' ' ' PRO . 5.0 mm -77.66 127.1 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 120.599 1.545 . . . . 1.0 109.482 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.36 -176.35 19.38 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.777 HG23 HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.53 130.04 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 178.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.652 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 52.5 m95 -130.57 151.16 51.34 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -66.05 132.0 47.52 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.684 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -26.07 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.908 ' HZ2' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.58 156.25 41.71 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 177.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' CD ' ' HG2' ' A' ' 48' ' ' LYS . 8.1 Cg_exo -73.97 128.35 12.24 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 CA-C-N 121.975 1.741 . . . . 1.0 112.885 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 48' ' ' LYS . 3.4 mp -99.01 146.47 8.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.77 -1.559 . . . . 1.0 112.821 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.76 151.96 32.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.019 -1.901 . . . . 1.0 110.23 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.622 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.25 125.8 25.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.018 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.29 -0.87 53.98 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.451 -1.059 . . . . 1.0 110.451 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.9 tptt -54.42 152.29 6.72 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.817 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 2.9 ttmt -122.51 108.56 13.3 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.857 0.723 . . . . 1.0 109.738 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' ' CD ' ' A' ' 29' ' ' GLU . 18.9 m-85 -116.93 123.11 46.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.865 -1.531 . . . . 1.0 106.865 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 155.82 -157.15 27.57 Favored Glycine 0 C--N 1.31 -0.911 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 10.5 Cg_endo -86.21 150.37 44.9 Favored 'Cis proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.356 1.578 . . . . 1.0 113.201 0.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.626 ' HA ' HD13 ' A' ' 99' ' ' LEU . 7.2 t80 -64.04 120.35 11.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.404 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -27.05 -65.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.829 -1.532 . . . . 1.0 111.432 178.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.675 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 48.78 107.64 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.572 -0.74 . . . . 1.0 113.162 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -94.4 149.46 21.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 176.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -90.52 114.1 26.22 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.177 -1.009 . . . . 1.0 112.165 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HZ2' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -148.28 171.08 16.54 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.628 -1.169 . . . . 1.0 110.672 -176.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 135.1 37.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.102 0.477 . . . . 1.0 111.48 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 9.7 ptt85 -57.95 -24.15 56.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.275 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.756 -0.377 . . . . 1.0 111.188 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 121.543 0.687 . . . . 1.0 111.657 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.881 ' NE1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -159.73 163.4 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.91 -1.041 . . . . 1.0 111.962 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 3.6 pt-20 -98.02 122.49 41.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.894 0.854 . . . . 1.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.731 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -126.78 131.01 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 115.219 -0.9 . . . . 1.0 109.194 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -89.79 121.69 32.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.848 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 82' ' ' ASN . 13.7 m-85 -86.48 108.05 16.21 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 114.607 -1.179 . . . . 1.0 110.047 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.29 48.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.206 1.937 . . . . 1.0 109.955 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.652 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -151.85 -84.0 0.08 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.237 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.779 HD12 ' N ' ' A' ' 84' ' ' GLY . 4.1 pp -78.05 -42.33 32.66 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.779 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 151.22 -170.8 30.88 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.563 -1.303 . . . . 1.0 112.356 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.573 ' O ' ' SD ' ' A' ' 86' ' ' MET . 11.8 m95 -70.43 122.5 19.74 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 117.155 0.478 . . . . 1.0 110.322 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.729 ' CG ' HD11 ' A' ' 83' ' ' LEU . 42.1 mmm -126.91 160.2 31.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -113.35 134.2 54.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.563 -1.199 . . . . 1.0 108.144 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.731 HD12 HG21 ' A' ' 78' ' ' VAL . 7.0 mt -107.64 108.52 25.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 118.668 -0.682 . . . . 1.0 111.943 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.66 ' N ' ' HZ2' ' A' ' 64' ' ' LYS . 28.9 t0 -133.78 131.93 39.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.619 1.1 . . . . 1.0 113.521 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -136.22 91.47 2.68 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.579 HG22 ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -114.91 49.63 1.03 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.862 0.839 . . . . 1.0 110.122 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.467 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -144.15 152.26 54.01 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.987 177.671 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.36 -44.33 4.88 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.282 1.321 . . . . 1.0 112.72 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.48 -45.09 69.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.732 -1.122 . . . . 1.0 113.562 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -11.3 33.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.832 0.349 . . . . 1.0 110.65 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA2' HG21 ' A' ' 60' ' ' VAL . . . -110.68 -158.42 15.97 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.763 ' HA ' HG22 ' A' ' 22' ' ' VAL . 37.9 p30 -145.01 -153.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 1.0 110.007 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.61 ' N ' HG13 ' A' ' 22' ' ' VAL . 45.6 p-90 -74.59 -34.89 62.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.855 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.626 HD13 ' HA ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -54.9 -29.22 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.056 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.486 ' NH1' ' C ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -66.27 -15.08 62.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 0.9 OUTLIER -94.86 0.58 54.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.831 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 99' ' ' LEU . 16.8 t -70.46 132.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 119.936 -0.706 . . . . 1.0 110.174 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -79.26 -153.84 0.08 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.209 -0.596 . . . . 1.0 111.878 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.27 159.35 33.34 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.714 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.657 ' HB2' ' HB2' ' A' ' 137' ' ' LEU . . . -139.27 174.73 10.21 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.427 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -47.87 2.87 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.784 ' O ' ' N ' ' A' ' 109' ' ' GLU . 20.3 m -148.9 132.0 16.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.68 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' C ' ' OE1' ' A' ' 111' ' ' GLN . . . -19.52 -4.29 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 118.456 2.142 . . . . 1.0 118.456 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.784 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.5 mt-10 -82.03 -24.43 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 119.236 1.518 . . . . 1.0 113.693 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 111' ' ' GLN . 13.4 pt-20 -124.18 -17.14 6.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.846 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 6.5 mp0 -45.7 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.954 1.408 . . . . 1.0 109.886 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.783 HD21 HD12 ' A' ' 137' ' ' LEU . 0.3 OUTLIER 163.21 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.961 -1.018 . . . . 1.0 111.852 177.212 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mp -137.92 164.19 29.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.205 -0.998 . . . . 1.0 112.177 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -143.7 130.32 10.34 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 119.013 -1.075 . . . . 1.0 113.566 -178.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.42 131.04 31.1 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.676 2.917 . . . . 1.0 113.625 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.538 HD23 ' HZ1' ' A' ' 125' ' ' LYS . 34.2 tp -141.34 130.66 23.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.127 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 78' ' ' VAL . 6.2 mm-40 -102.83 114.85 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.436 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 123' ' ' TYR . 3.2 pt -139.16 123.76 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.851 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.2 42.41 25.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.354 0.597 . . . . 1.0 110.668 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.594 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 5.2 mmt-85 56.74 32.46 21.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -133.49 144.04 49.18 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.881 HG21 ' NE1' ' A' ' 76' ' ' TRP . 4.1 mm -103.07 116.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.567 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.647 ' CD1' HD11 ' A' ' 118' ' ' ILE . 3.5 m-85 -109.04 158.25 17.91 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.4 m-30 -116.85 132.14 56.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -127.64 146.33 50.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.488 -177.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 112' ' ' ASN . 13.1 p -100.72 111.45 23.68 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.935 0.772 . . . . 1.0 111.483 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.702 HD12 ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.96 -5.58 59.2 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 123.926 0.766 . . . . 1.0 111.88 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.89 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.74 122.62 7.23 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.458 0.572 . . . . 1.0 109.986 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -44.17 138.59 6.76 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.521 1.481 . . . . 1.0 111.21 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.416 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -114.13 134.61 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.96 132.59 60.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.02 -0.672 . . . . 1.0 109.931 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.07 104.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.21 1.273 . . . . 1.0 111.906 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 131.87 2.91 4.19 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.035 -0.602 . . . . 1.0 112.834 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -105.56 115.54 30.42 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.218 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.652 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -47.18 139.73 5.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.889 0.852 . . . . 1.0 111.359 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.684 HD21 ' OE2' ' A' ' 29' ' ' GLU . 8.6 mp -78.34 128.79 34.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.708 -1.133 . . . . 1.0 109.072 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.783 HD12 HD21 ' A' ' 112' ' ' ASN . 0.0 OUTLIER -142.58 161.34 38.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.569 0.699 . . . . 1.0 110.706 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.508 HG11 ' CE2' ' A' ' 124' ' ' TYR . 27.9 m -146.31 177.38 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.885 . . . . 1.0 111.968 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.712 ' HE1' ' CG ' ' A' ' 111' ' ' GLN . 9.2 p-90 . . . . . 0 CA--C 1.509 -0.622 0 C-N-CA 119.806 -0.758 . . . . 1.0 113.034 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 N--CA 1.429 -1.49 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.83 -52.15 33.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.7 77.42 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.817 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.674 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--O 1.204 -1.329 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.674 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.482 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' -1' ' ' GLY . 1.2 p 75.39 -46.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.791 0.329 . . . . 1.0 110.553 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.495 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -101.19 82.21 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.596 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.08 -6.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -52.8 179.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.558 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -104.71 151.06 24.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -74.08 128.74 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.616 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -57.33 140.13 50.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.95 152.9 80.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.358 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.24 155.39 70.09 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.511 2.141 . . . . 1.0 112.133 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -143.43 158.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.642 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . 67.73 106.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . -129.86 -76.54 0.54 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.112 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.2 m 151.52 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.465 -1.243 . . . . 1.0 107.845 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.38 157.44 17.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.234 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 150.54 43.95 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 121.644 0.735 . . . . 1.0 112.587 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.12 -35.47 25.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.08 -0.963 . . . . 1.0 110.204 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.29 -9.79 58.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.931 -1.031 . . . . 1.0 111.382 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -31.76 22.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.62 0.97 . . . . 1.0 113.62 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 15' ' ' LEU . 1.5 p -56.15 142.91 65.48 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HB3' ' CE1' ' A' ' 21' ' ' HIS . 35.3 Cg_exo -48.44 122.78 8.23 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.431 1.421 . . . . 1.0 110.677 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.772 ' HA ' HD21 ' A' ' 23' ' ' LEU . 37.7 tt0 -48.35 -25.42 1.58 Allowed 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 113.303 0.853 . . . . 1.0 113.303 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.164 0.802 . . . . 1.0 113.164 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.756 HG22 ' HA ' ' A' ' 97' ' ' ASN . 6.8 t -76.97 -49.7 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.135 HD23 ' H ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -71.23 -19.58 62.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.711 0.767 . . . . 1.0 109.934 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.83 -27.37 68.83 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 -176.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.33 42.58 1.91 Allowed Glycine 0 N--CA 1.47 0.942 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' PRO . 18.5 mt -76.77 155.47 83.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' O ' ' O ' ' A' ' 26' ' ' LEU . 23.9 Cg_exo -36.25 -112.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 124.537 3.491 . . . . 1.0 113.516 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.92 -57.61 3.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.755 -1.578 . . . . 1.0 107.6 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 12.0 pt-20 -172.89 37.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 2.4 t -45.69 171.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 113.412 -1.722 . . . . 1.0 107.785 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.753 ' CB ' HG21 ' A' ' 47' ' ' THR . 0.0 OUTLIER -141.67 154.1 45.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.557 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.9 mm? -91.83 134.67 34.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 118.894 -1.122 . . . . 1.0 109.874 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.7 m-85 -133.95 144.56 52.15 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.866 ' HA ' ' HA ' ' A' ' 42' ' ' ILE . 3.1 Cg_exo -48.32 142.46 16.85 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 CA-C-N 119.715 0.934 . . . . 1.0 114.031 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.637 ' C ' ' H ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -61.69 52.43 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-O 123.087 1.423 . . . . 1.0 110.892 -178.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 34' ' ' PRO . . . -56.84 -5.36 0.23 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.017 -1.901 . . . . 1.0 108.272 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -82.55 -50.37 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 113.689 -1.596 . . . . 1.0 111.83 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 40' ' ' THR . 44.8 t0 -156.04 -66.72 0.11 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.536 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 41' ' ' ARG . 8.1 mmpp? -58.72 3.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.22 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER 35.73 14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 35' ' ' SER . 49.2 mtp85 -107.3 -116.46 0.26 Allowed 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 105.356 -2.09 . . . . 1.0 105.356 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.866 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 9.5 mm -102.19 134.03 44.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 120.09 1.314 . . . . 1.0 111.318 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.23 159.79 23.19 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.617 HG21 ' CE3' ' A' ' 98' ' ' TRP . 6.4 p -102.84 131.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.234 0.54 . . . . 1.0 111.627 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 13.5 m95 -130.33 154.46 47.62 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.711 1.004 . . . . 1.0 113.711 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.83 131.39 45.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.456 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.753 HG21 ' CB ' ' A' ' 31' ' ' ARG . 76.3 p -124.96 -15.19 6.47 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.769 1.271 . . . . 1.0 108.57 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.689 ' H ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.65 168.89 9.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.843 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.07 152.38 27.86 Favored 'Trans proline' 0 C--N 1.293 -2.356 0 C-N-CA 122.425 2.083 . . . . 1.0 112.415 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.481 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 3.3 mp -134.85 144.28 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.871 -1.059 . . . . 1.0 111.229 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.4 154.37 30.4 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.925 -1.488 . . . . 1.0 110.828 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.649 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.97 125.76 25.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.8 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.28 0.76 55.78 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -53.25 152.54 4.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 119.382 -0.927 . . . . 1.0 109.218 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.591 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.64 107.61 12.59 Favored 'General case' 0 N--CA 1.424 -1.757 0 O-C-N 124.714 1.259 . . . . 1.0 109.198 176.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 10.9 m-30 -119.78 124.46 46.22 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.302 1.048 . . . . 1.0 109.323 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.69 -148.84 20.74 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.223 -1.808 . . . . 1.0 109.753 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 9.5 Cg_endo -80.41 152.57 83.53 Favored 'Cis proline' 0 N--CA 1.49 1.304 0 CA-C-N 119.821 1.811 . . . . 1.0 112.681 0.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 9.2 t80 -65.12 115.89 5.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.513 -1.221 . . . . 1.0 111.733 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.725 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -21.68 -63.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.565 178.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.725 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 51.29 104.82 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.354 -0.839 . . . . 1.0 112.945 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -94.18 144.11 25.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.529 -1.656 . . . . 1.0 106.529 177.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -92.02 114.6 27.18 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.949 -1.1 . . . . 1.0 113.025 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -142.99 169.94 16.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.139 -1.391 . . . . 1.0 109.056 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.91 152.98 27.81 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.123 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 4.1 ttm180 -56.31 -24.49 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.756 -0.59 . . . . 1.0 110.706 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 t -38.08 -27.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.218 0.532 . . . . 1.0 110.055 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' ARG . 11.2 mt-30 -91.29 -150.35 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.276 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.538 HG22 ' OD2' ' A' ' 89' ' ' ASP . 59.1 t 58.72 153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-O 121.1 0.476 . . . . 1.0 111.431 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' N ' HG12 ' A' ' 69' ' ' VAL . 2.0 pttp -179.16 89.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.089 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 66.56 64.11 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.024 0.44 . . . . 1.0 109.912 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 23.5 t-20 -137.17 -171.7 3.02 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.36 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.85 HG22 ' CZ2' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -134.3 -48.5 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 118.835 0.743 . . . . 1.0 110.915 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -62.09 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.751 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.71 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -140.31 140.66 35.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.98 0.419 . . . . 1.0 111.731 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.889 ' CE2' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -161.18 163.58 31.08 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.454 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -100.62 125.32 47.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.148 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.12 139.06 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.85 -0.613 . . . . 1.0 112.152 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 11.5 t80 -79.46 126.13 30.45 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.573 0.701 . . . . 1.0 111.601 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 82' ' ' ASN . 7.0 m-85 -99.3 131.36 25.25 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.523 -1.217 . . . . 1.0 112.032 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.19 13.86 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.01 1.807 . . . . 1.0 109.367 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 80' ' ' TYR . 46.2 m-80 -124.35 -9.78 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.681 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.69 -1.16 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.57 -158.89 15.64 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 120.481 -0.866 . . . . 1.0 113.074 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 67.4 m95 -71.34 120.44 16.93 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.0 mmm -125.96 164.68 20.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.328 0.862 . . . . 1.0 113.328 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -111.5 132.81 54.23 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 78' ' ' VAL . 5.5 mt -107.42 109.76 29.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 118.734 -0.651 . . . . 1.0 111.43 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.665 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 21.4 t0 -133.14 130.97 39.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.269 0.94 . . . . 1.0 112.818 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -136.09 97.58 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.628 HG22 ' OD1' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -130.78 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.734 -0.786 . . . . 1.0 110.756 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.423 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -153.84 159.05 32.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.096 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.49 -38.91 13.49 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.567 1.511 . . . . 1.0 111.234 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -77.08 -42.58 37.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.561 -1.199 . . . . 1.0 113.896 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -9.91 16.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.123 -0.231 . . . . 1.0 110.915 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.423 ' CA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.48 123.63 6.11 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.756 ' HA ' HG22 ' A' ' 22' ' ' VAL . 45.4 p-10 -71.88 -151.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.163 0.506 . . . . 1.0 110.774 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.635 ' N ' HG13 ' A' ' 22' ' ' VAL . 44.0 p-90 -76.06 -31.16 58.65 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.644 -0.707 . . . . 1.0 111.655 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.642 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -57.0 -27.85 61.91 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.602 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -67.18 -15.44 63.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.573 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -93.92 2.91 56.04 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 99' ' ' LEU . 6.3 t -78.27 128.61 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.213 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.724 HD21 HD23 ' A' ' 137' ' ' LEU . 15.9 p-10 -87.42 -143.75 0.12 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.909 -0.716 . . . . 1.0 111.495 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.85 ' CZ2' HG22 ' A' ' 73' ' ' VAL . 6.6 m-90 -127.05 160.3 31.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.498 0.555 . . . . 1.0 112.498 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.706 ' HB3' ' CD1' ' A' ' 139' ' ' TRP . . . -101.78 -134.62 0.31 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.639 1.348 . . . . 1.0 114.639 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 t -154.21 -51.81 0.09 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.706 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.595 ' C ' ' H ' ' A' ' 109' ' ' GLU . 38.9 m -165.26 65.4 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.231 0.826 . . . . 1.0 113.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.09 -12.62 0.01 OUTLIER Glycine 0 CA--C 1.534 1.224 0 N-CA-C 114.324 0.49 . . . . 1.0 114.324 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 107' ' ' SER . 12.6 pt-20 -81.19 -26.59 35.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.494 0.647 . . . . 1.0 111.592 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 137' ' ' LEU . 6.0 pt-20 -122.21 -24.39 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.783 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.697 HE22 ' HB3' ' A' ' 114' ' ' PHE . 1.6 tm0? -53.81 132.34 41.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.78 ' C ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.68 -21.02 11.45 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.317 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.78 HD22 ' C ' ' A' ' 112' ' ' ASN . 4.2 mm? -125.61 143.49 51.0 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.859 -0.737 . . . . 1.0 110.661 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.697 ' HB3' HE22 ' A' ' 111' ' ' GLN . 0.3 OUTLIER -128.7 131.32 23.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 119.463 -0.895 . . . . 1.0 112.191 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.11 128.34 22.11 Favored 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 124.058 3.172 . . . . 1.0 115.017 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.747 HD13 HG12 ' A' ' 152' ' ' ILE . 56.5 tp -140.43 132.74 28.29 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.817 -0.552 . . . . 1.0 110.103 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.446 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 6.8 mm-40 -105.58 115.58 30.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.907 -0.717 . . . . 1.0 110.029 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 123' ' ' TYR . 4.8 pt -139.9 129.61 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.066 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 49.4 46.52 23.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.255 0.55 . . . . 1.0 110.489 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 56.11 32.92 21.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.208 -0.597 . . . . 1.0 109.904 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -137.06 141.73 42.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.321 -0.854 . . . . 1.0 109.006 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.889 HG21 ' CE2' ' A' ' 76' ' ' TRP . 0.8 OUTLIER -102.53 113.0 37.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.079 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.803 ' CD1' HD11 ' A' ' 118' ' ' ILE . 3.1 m-85 -101.04 155.62 17.88 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.874 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 1.4 m-30 -119.02 125.24 48.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.623 -2.362 . . . . 1.0 104.623 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.874 ' HZ2' ' C ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -125.81 155.58 40.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.091 -175.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 53' ' ' GLY . 15.1 p -105.71 117.1 33.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.3 OUTLIER -81.35 -9.43 59.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.844 0.715 . . . . 1.0 109.952 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.702 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -150.42 141.48 14.8 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 120.452 -0.499 . . . . 1.0 111.947 -178.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -55.75 140.38 84.56 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.133 1.889 . . . . 1.0 111.733 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -121.52 136.33 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.8 37.88 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.3 105.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.35 2.034 . . . . 1.0 113.048 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 133.53 0.18 4.11 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 109.977 -1.249 . . . . 1.0 109.977 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.14 137.81 35.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.63 -0.785 . . . . 1.0 109.21 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.711 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.2 pm0 -73.02 138.77 46.17 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.903 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.463 ' O ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 mp -79.35 127.01 31.55 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.262 -1.384 . . . . 1.0 107.262 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.724 HD23 HD21 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -141.04 159.07 43.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.603 -176.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.735 HG11 ' CE2' ' A' ' 124' ' ' TYR . 26.8 m -143.03 172.5 7.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 113.611 0.967 . . . . 1.0 113.611 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.706 ' CD1' ' HB3' ' A' ' 105' ' ' ALA . 36.3 p-90 171.87 -164.7 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.924 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.805 ' CD1' ' ND2' ' A' ' 145' ' ' ASN . 52.8 m-85 108.08 48.23 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 O-C-N 125.419 1.7 . . . . 1.0 108.395 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.559 ' OD1' ' C ' ' A' ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.559 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 3.0 mt-10 -33.74 -89.32 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -108.93 56.55 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.052 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.805 ' ND2' ' CD1' ' A' ' 140' ' ' TYR . 3.9 p30 -68.97 167.27 21.12 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 9.6 Cg_endo -82.02 -11.79 10.99 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.79 1.66 . . . . 1.0 112.244 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.603 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -70.15 -31.49 69.01 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.614 -1.995 . . . . 1.0 105.614 175.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.614 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.4 mm -78.47 -54.23 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.117 -1.401 . . . . 1.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.34 -48.97 59.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 146' ' ' PRO . . . -58.42 -48.13 81.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 154' ' ' GLU . . . -73.01 -26.87 61.48 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.272 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HD13 ' A' ' 116' ' ' LEU . 35.3 mt -65.0 -44.39 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.542 ' CG ' HH21 ' A' ' 156' ' ' ARG . 1.7 tt0 -53.48 -53.99 43.46 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.913 -0.715 . . . . 1.0 111.442 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 1.5 pm0 -57.11 -37.16 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.414 -0.914 . . . . 1.0 112.788 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -74.16 -56.62 4.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.554 -0.859 . . . . 1.0 110.835 179.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.542 HH21 ' CG ' ' A' ' 153' ' ' GLU . 3.2 ppt_? -67.82 -43.67 79.05 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.361 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -58.26 -41.58 84.58 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.863 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 160' ' ' ARG . 51.1 m -74.29 -24.13 59.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 1.0 111.03 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.81 8.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.612 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 158' ' ' SER . 8.4 mmm180 -124.65 -82.96 0.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.495 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.022 -0.989 . . . . 1.0 110.527 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 t -146.57 -63.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 1.0 110.573 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -178.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.603 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.43 91.1 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.569 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -152.04 -165.04 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.567 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -77.68 69.7 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.56 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 114.04 4.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.637 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 m -73.44 -67.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.57 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 41.02 79.22 0.33 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.44 -172.59 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.208 2.605 . . . . 1.0 112.314 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 10' ' ' ALA . 1.3 m -61.11 -174.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.345 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' N ' HG23 ' A' ' 9' ' ' VAL . . . 48.33 96.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.115 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.8 -62.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -120.4 -41.8 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.096 0.474 . . . . 1.0 110.057 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.29 161.49 23.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 1.0 108.811 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.581 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -122.16 155.11 36.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 1.0 111.851 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.56 -34.7 18.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.52 -15.88 59.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.604 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.581 ' CB ' ' H ' ' A' ' 14' ' ' THR . 20.8 tp10 -79.16 -41.39 28.58 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.74 HG23 HD22 ' A' ' 23' ' ' LEU . 27.7 m -60.78 154.15 59.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 119.43 -0.908 . . . . 1.0 108.904 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.585 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 24.6 Cg_exo -56.14 130.39 39.95 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 120.982 1.121 . . . . 1.0 109.56 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.535 ' HA ' HD21 ' A' ' 23' ' ' LEU . 24.5 tt0 -50.86 -35.46 32.73 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.585 ' CE1' HG23 ' A' ' 22' ' ' VAL . 19.3 p80 -75.63 -22.68 56.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 97' ' ' ASN . 2.2 t -76.36 -51.81 18.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 CA-C-N 119.966 1.257 . . . . 1.0 112.087 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.979 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.6 pt? -70.9 -24.82 62.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.293 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -61.49 -19.56 62.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.509 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.63 33.64 6.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.875 -0.679 . . . . 1.0 112.338 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.591 HD23 ' CG ' ' A' ' 98' ' ' TRP . 36.3 mt -77.41 154.29 81.76 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 117.68 0.74 . . . . 1.0 110.609 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' A' ' 26' ' ' LEU . 10.7 Cg_exo -34.0 -109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.383 2.722 . . . . 1.0 114.003 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.73 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -74.55 -58.82 3.05 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.624 177.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.73 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 5.1 pt-20 -170.24 47.36 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 45' ' ' TRP . 54.2 t -57.95 162.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 114.787 -1.097 . . . . 1.0 108.268 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -134.1 158.25 44.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.247 0.546 . . . . 1.0 110.616 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 32' ' ' LEU . 3.6 mm? -88.44 144.64 26.24 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.4 101.75 3.77 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.083 -0.647 . . . . 1.0 112.436 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 35' ' ' SER . 63.1 Cg_endo -82.69 150.01 14.45 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.23 2.62 . . . . 1.0 111.613 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 24.2 p 102.72 -60.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.168 0.918 . . . . 1.0 111.882 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.585 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.77 -54.63 21.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.629 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.519 HG13 ' CG ' ' A' ' 38' ' ' ASP . 1.9 p -101.09 -51.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 118.739 0.699 . . . . 1.0 111.434 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -89.39 82.0 6.53 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.292 0.568 . . . . 1.0 109.591 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -32.38 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.457 -1.247 . . . . 1.0 109.423 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.2 t -143.28 55.38 1.36 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.76 179.1 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.503 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -99.45 128.68 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.221 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.36 152.5 17.02 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.224 -1.551 . . . . 1.0 109.224 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.739 HG21 ' CE3' ' A' ' 98' ' ' TRP . 13.1 p -105.71 127.24 60.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.754 ' O ' HG13 ' A' ' 30' ' ' VAL . 21.7 m95 -126.59 146.55 50.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.281 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB1' HD11 ' A' ' 50' ' ' ILE . . . -65.57 146.64 54.59 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.51 ' CA ' ' O ' ' A' ' 132' ' ' PRO . 34.6 p -117.76 -15.56 10.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.66 0.663 . . . . 1.0 109.662 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.722 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -119.33 158.42 48.76 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.321 -178.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.505 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 7.8 Cg_endo -62.08 124.52 14.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.377 2.052 . . . . 1.0 110.216 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.748 HD11 ' HB1' ' A' ' 46' ' ' ALA . 3.4 mp -99.5 147.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.744 0.783 . . . . 1.0 110.282 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.07 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.61 148.03 34.19 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.829 -1.532 . . . . 1.0 109.471 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.07 ' N ' HD22 ' A' ' 51' ' ' LEU . 4.1 ttpt -59.51 126.49 27.83 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.18 4.53 47.42 Favored Glycine 0 N--CA 1.467 0.747 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.668 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 126' ' ' THR . 19.7 ttmt -89.48 139.58 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -106.53 145.7 31.53 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 175.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.62 ' CE2' HG21 ' A' ' 126' ' ' THR . 46.8 m-85 -120.5 124.83 46.35 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.545 -1.207 . . . . 1.0 109.735 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.29 -133.83 4.16 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 113.23 -1.805 . . . . 1.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 123' ' ' TYR . 78.6 Cg_endo -74.64 148.25 91.35 Favored 'Cis proline' 0 N--CA 1.502 1.991 0 CA-C-N 120.027 1.914 . . . . 1.0 113.308 0.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' O ' ' C ' ' A' ' 60' ' ' VAL . 68.5 t80 -56.26 116.75 3.23 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.934 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -16.38 -67.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 124.024 0.827 . . . . 1.0 112.622 178.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.622 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 97.83 62.01 0.9 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.271 -1.132 . . . . 1.0 110.271 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' ASP . 19.7 t0 -88.45 133.55 34.09 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 106.181 -1.785 . . . . 1.0 106.181 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -104.25 113.19 26.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -176.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' CYS . 1.7 ptpt -133.03 166.91 21.3 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.316 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.544 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -76.9 139.36 40.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 176.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.9 ptt180 -46.93 -23.63 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.736 0.303 . . . . 1.0 111.204 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -78.48 135.93 37.48 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.109 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.531 ' OE1' ' NZ ' ' A' ' 65' ' ' LYS . 2.6 pt20 103.2 -8.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.369 1.043 . . . . 1.0 111.943 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -117.79 117.56 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.031 0.444 . . . . 1.0 110.46 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -110.22 -131.22 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.14 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.468 ' ND2' ' CE1' ' A' ' 74' ' ' TYR . 8.3 t-20 53.68 -135.54 1.47 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.002 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.454 ' O ' ' CE ' ' A' ' 75' ' ' MET . 6.6 m-80 -128.04 -78.14 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.84 0.681 . . . . 1.0 112.84 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.422 HG22 ' CH2' ' A' ' 76' ' ' TRP . 0.3 OUTLIER -78.09 2.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.441 -0.504 . . . . 1.0 112.237 -177.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 90' ' ' ALA . 2.5 m-85 -48.66 -53.48 18.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.135 0.791 . . . . 1.0 113.135 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.505 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -122.77 162.57 21.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 -174.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.705 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -138.99 144.6 38.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.35 -1.75 . . . . 1.0 109.786 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.75 123.03 47.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.076 -0.65 . . . . 1.0 111.717 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -143.18 133.8 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.79 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 2.3 t80 -89.8 126.38 35.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ASN . 6.8 m-85 -92.31 105.7 15.15 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 113.516 -1.675 . . . . 1.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.77 -14.24 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.009 1.806 . . . . 1.0 109.604 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' TYR . 71.2 m-80 -81.72 -99.12 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.138 -1.392 . . . . 1.0 110.361 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -66.43 -41.93 88.47 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.374 1.25 . . . . 1.0 114.374 -176.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.1 23.99 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 120.03 -1.081 . . . . 1.0 110.485 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.429 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 14.5 m95 -54.27 120.62 6.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.779 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 78' ' ' VAL . 51.4 tpp -129.37 160.92 31.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.399 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -117.85 145.42 44.6 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.934 0.873 . . . . 1.0 109.656 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.484 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 52.1 mt -93.09 159.1 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.892 -1.504 . . . . 1.0 108.492 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.688 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -128.99 123.99 33.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.425 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.656 ' C ' HG22 ' A' ' 91' ' ' THR . . . -133.54 136.36 44.95 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 105.251 -2.129 . . . . 1.0 105.251 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.656 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 166.52 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 120.573 1.533 . . . . 1.0 111.112 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.579 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -126.23 148.89 65.25 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.454 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HB2' HG21 ' A' ' 22' ' ' VAL . 62.8 Cg_endo -66.11 -34.68 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.757 2.305 . . . . 1.0 111.849 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -71.91 -10.23 59.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.223 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.801 ' CB ' HH12 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.88 -16.01 35.14 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.695 ' N ' ' NH1' ' A' ' 100' ' ' ARG . . . -173.81 -92.49 0.08 OUTLIER Glycine 0 C--N 1.348 1.201 0 C-N-CA 120.136 -1.031 . . . . 1.0 114.05 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.739 ' HA ' HG22 ' A' ' 22' ' ' VAL . 5.2 p30 -146.58 -149.34 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.48 0.657 . . . . 1.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.739 ' CE3' HG21 ' A' ' 44' ' ' VAL . 35.2 p-90 -80.39 -24.5 39.68 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 115.163 1.542 . . . . 1.0 115.163 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.615 HD23 ' CE2' ' A' ' 124' ' ' TYR . 3.0 mp -53.5 -27.59 26.23 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.592 -0.843 . . . . 1.0 111.181 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.801 HH12 ' CB ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.65 -30.33 52.07 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 177.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.503 ' CE1' ' CG2' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -64.58 -17.57 64.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.427 HG22 HG11 ' A' ' 44' ' ' VAL . 98.1 t -63.16 117.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.041 -0.982 . . . . 1.0 110.786 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.579 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 14.5 m-20 -77.5 138.69 39.36 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 105.883 -1.895 . . . . 1.0 105.883 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.604 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 16.2 p90 -94.68 122.56 37.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.825 0.822 . . . . 1.0 111.955 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 26.96 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.04 -1.436 . . . . 1.0 114.77 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 105' ' ' ALA . 52.5 t -29.54 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER 174.01 11.29 0.0 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-N 114.721 -1.127 . . . . 1.0 111.03 174.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.58 19.69 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.83 -42.18 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.035 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -118.32 -33.11 4.46 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.038 1.125 . . . . 1.0 114.038 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 110' ' ' GLU . 4.9 mt-30 16.18 101.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.472 0.545 . . . . 1.0 112.472 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.794 HD22 HD13 ' A' ' 130' ' ' ILE . 18.0 p-10 -128.12 37.5 4.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.812 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 1.4 tp -153.32 173.63 15.36 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.152 -0.619 . . . . 1.0 110.698 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.735 ' CE2' ' HB3' ' A' ' 151' ' ' ALA . 9.3 t80 -132.23 147.67 66.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 119.553 -0.26 . . . . 1.0 111.638 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.495 ' N ' ' CD1' ' A' ' 114' ' ' PHE . 23.2 Cg_endo -100.04 96.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.502 2.134 . . . . 1.0 113.483 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 123' ' ' TYR . 8.1 tp -117.41 135.93 53.54 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -109.24 117.19 33.45 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.977 0.798 . . . . 1.0 111.128 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.954 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.8 OUTLIER -137.43 136.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.087 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 49.73 38.41 15.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.432 0.634 . . . . 1.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 63.4 13.3 6.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.019 179.256 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -110.0 154.89 22.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.082 -1.417 . . . . 1.0 107.86 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 31.5 mm -109.8 115.2 49.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 121.802 0.81 . . . . 1.0 111.888 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.954 ' CG ' HD11 ' A' ' 118' ' ' ILE . 3.6 m-85 -100.44 141.08 33.79 Favored 'General case' 0 CA--C 1.481 -1.694 0 O-C-N 121.234 -0.916 . . . . 1.0 109.27 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.615 ' CE2' HD23 ' A' ' 99' ' ' LEU . 18.3 m-30 -102.73 117.25 34.23 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.29 -2.115 . . . . 1.0 105.29 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -104.37 135.44 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.687 1.242 . . . . 1.0 110.636 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.62 HG21 ' CE2' ' A' ' 56' ' ' PHE . 33.0 p -106.4 112.98 26.23 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.131 0.491 . . . . 1.0 110.696 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.825 HD13 ' HB3' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -76.64 -6.11 50.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.546 -1.206 . . . . 1.0 111.996 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.59 ' HZ2' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -143.2 158.29 58.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.097 -0.641 . . . . 1.0 112.598 -175.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -72.25 145.3 43.38 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 N-CA-C 104.722 -2.838 . . . . 1.0 104.722 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.796 HG23 ' OE2' ' A' ' 134' ' ' GLU . 59.7 mt -123.5 142.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -174.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.56 128.49 88.37 Favored Pre-proline 0 C--N 1.34 0.193 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.798 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.5 Cg_exo -35.1 -27.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.655 2.236 . . . . 1.0 116.684 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.71 ' HA2' ' O ' ' A' ' 46' ' ' ALA . . . -125.6 37.04 2.61 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 120.308 1.413 . . . . 1.0 110.511 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.796 ' OE2' HG23 ' A' ' 130' ' ' ILE . 4.6 tt0 -95.23 162.38 13.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.907 0.385 . . . . 1.0 111.371 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.492 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 1.6 pm0 -80.85 140.3 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.358 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.535 ' HA ' HD21 ' A' ' 112' ' ' ASN . 4.9 mt -95.17 121.77 37.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.603 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -128.01 153.13 47.11 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.634 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 15.7 t -124.12 159.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.257 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.684 ' CG ' ' N ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER 59.37 -176.22 0.09 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.16 1.911 . . . . 1.0 116.16 175.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.684 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 71.3 t80 -153.1 -174.9 5.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.016 -1.447 . . . . 1.0 109.904 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.637 ' N ' ' CD2' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.329 0 N-CA-C 111.647 -0.581 . . . . 1.0 111.647 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.512 ' N ' ' HB3' ' A' ' 140' ' ' TYR . 2.1 pt-20 -171.39 -98.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.179 -0.609 . . . . 1.0 112.226 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.421 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 2.2 t70 72.52 -36.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.595 ' OD1' HD12 ' A' ' 127' ' ' LEU . 4.0 t-20 -73.59 147.81 87.31 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 119.721 -0.792 . . . . 1.0 110.098 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 145' ' ' ASN . 0.3 OUTLIER -34.05 -89.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.229 2.62 . . . . 1.0 116.527 -178.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.825 ' HB3' HD13 ' A' ' 127' ' ' LEU . 9.8 tp10 -55.52 -48.21 75.03 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.1 OUTLIER -46.31 -53.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.471 -1.24 . . . . 1.0 110.855 -175.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -65.06 -46.84 79.56 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 116.457 -2.097 . . . . 1.0 108.244 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.15 25.8 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 115.46 1.652 . . . . 1.0 115.46 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB3' ' CE2' ' A' ' 114' ' ' PHE . . . -73.1 -37.37 66.74 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.603 1.547 . . . . 1.0 111.596 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.567 HG22 ' HG2' ' A' ' 156' ' ' ARG . 84.3 mt -55.46 -44.01 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 157' ' ' ALA . 1.2 tt0 -59.87 -55.47 33.71 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 123.51 0.506 . . . . 1.0 111.917 -177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' A' ' 154' ' ' GLU . 10.7 pt-20 -64.01 -38.67 91.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 118.067 0.394 . . . . 1.0 111.629 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -73.1 -48.62 34.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.401 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.567 ' HG2' HG22 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -76.54 -28.73 56.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.309 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 153' ' ' GLU . . . -52.5 -50.6 62.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.532 -0.867 . . . . 1.0 108.911 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.39 -23.82 4.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.9 19.21 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.653 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -120.31 60.03 0.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.17 -5.15 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 1.0 110.559 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' H ' ' C ' ' A' ' -1' ' ' GLY . 0.3 OUTLIER -75.35 149.56 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.54 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -93.89 117.95 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.58 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 4' ' ' ASN . 9.9 tt0 -87.3 -23.99 24.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.562 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 3' ' ' GLN . 4.8 t-20 58.64 115.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.572 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 p -129.92 -168.87 2.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.495 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -94.59 125.22 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.536 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -121.24 157.44 55.77 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.44 141.16 38.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.533 2.155 . . . . 1.0 112.179 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 9' ' ' VAL . 23.0 m -91.51 47.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . -43.17 167.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.757 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.64 -66.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.162 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.37 -55.82 2.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -104.69 153.94 20.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 17' ' ' GLU . 4.3 m -121.74 156.36 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 1.0 111.676 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.19 -32.8 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.61 58.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.777 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' THR . 27.6 tp10 -82.2 -40.41 21.75 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.741 HG23 HD22 ' A' ' 23' ' ' LEU . 28.7 m -59.63 159.39 18.23 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.465 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.9 Cg_exo -66.8 133.12 30.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.128 1.219 . . . . 1.0 109.961 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.551 ' HA ' HD21 ' A' ' 23' ' ' LEU . 18.6 tt0 -49.46 -38.01 28.13 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 123.749 0.656 . . . . 1.0 112.125 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.408 ' CE1' ' HB2' ' A' ' 19' ' ' PRO . 6.5 p80 -74.19 -23.25 59.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -75.89 -50.37 23.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 CA-C-N 119.805 1.184 . . . . 1.0 111.629 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.013 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.9 pt? -73.0 -26.02 61.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.648 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.95 -21.04 42.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.57 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.28 39.88 2.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.846 -0.692 . . . . 1.0 111.597 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.581 ' O ' ' O ' ' A' ' 27' ' ' PRO . 25.8 mt -85.17 153.52 59.65 Favored Pre-proline 0 N--CA 1.445 -0.702 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.229 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -34.6 -117.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 124.085 3.19 . . . . 1.0 114.166 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.694 ' HG2' ' HZ3' ' A' ' 48' ' ' LYS . 2.2 pp20? -72.98 -54.91 7.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 116.691 -2.004 . . . . 1.0 106.543 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 5.5 tt0 -174.64 57.75 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.275 1.036 . . . . 1.0 108.441 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.7 t -67.85 173.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.913 -1.04 . . . . 1.0 108.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.548 HH12 ' CG ' ' A' ' 29' ' ' GLU . 17.3 mtt85 -141.03 158.62 43.67 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.249 0.547 . . . . 1.0 110.013 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 32' ' ' LEU . 3.3 mm? -87.53 147.43 25.35 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.92 101.74 3.65 Favored Pre-proline 0 C--N 1.314 -0.953 0 C-N-CA 119.672 -0.811 . . . . 1.0 112.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 44.5 Cg_endo -83.69 149.71 12.75 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 123.272 2.648 . . . . 1.0 111.95 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 4.2 t 99.75 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.183 0.927 . . . . 1.0 111.927 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.33 -53.65 27.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.921 -175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 ' H ' ' A' ' 38' ' ' ASP . 2.4 p -102.07 -52.89 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.281 -0.567 . . . . 1.0 112.189 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -90.62 82.5 5.8 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 38' ' ' ASP . 7.7 mmpt? -28.28 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.343 -1.299 . . . . 1.0 110.07 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.597 ' N ' ' O ' ' A' ' 38' ' ' ASP . 16.4 p -143.22 54.09 1.36 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.2 168.21 8.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -92.27 131.24 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.824 -179.067 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.91 144.92 17.12 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.868 -1.693 . . . . 1.0 108.868 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.622 HG21 ' CE3' ' A' ' 98' ' ' TRP . 12.1 p -97.48 134.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.709 ' O ' HG13 ' A' ' 30' ' ' VAL . 10.6 m95 -129.04 147.65 50.92 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.146 -0.934 . . . . 1.0 110.83 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.973 ' HB3' ' CD ' ' A' ' 134' ' ' GLU . . . -73.32 123.71 24.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.13 -1.028 . . . . 1.0 110.344 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.0 p -93.41 -15.42 25.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.687 0.756 . . . . 1.0 110.947 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.694 ' HZ3' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -107.49 170.72 5.3 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.247 -1.342 . . . . 1.0 111.133 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 4.2 Cg_endo -81.68 131.88 7.46 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.232 1.955 . . . . 1.0 108.145 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 46' ' ' ALA . 4.3 mp -109.62 129.31 64.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 122.429 1.109 . . . . 1.0 111.908 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.053 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.83 147.96 22.83 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.515 -2.13 . . . . 1.0 107.755 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.053 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -59.65 123.72 17.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.38 2.48 47.57 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.626 -1.273 . . . . 1.0 113.253 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' THR . 9.7 ttmt -78.7 139.06 38.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 119.455 -0.898 . . . . 1.0 109.729 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.52 140.61 45.98 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 119.359 -0.936 . . . . 1.0 109.563 178.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.647 ' CE2' HG21 ' A' ' 126' ' ' THR . 37.2 m-85 -116.09 123.33 47.64 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.174 -1.83 . . . . 1.0 106.753 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . -176.53 -164.33 30.36 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 113.778 -1.556 . . . . 1.0 110.201 -176.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CB ' ' CE1' ' A' ' 123' ' ' TYR . 56.4 Cg_endo -98.22 137.66 3.4 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 CA-C-N 118.699 1.249 . . . . 1.0 111.638 -1.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 39.2 t80 -56.8 114.11 1.94 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.736 HG13 ' N ' ' A' ' 61' ' ' GLY . 9.7 p -44.69 -48.39 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.928 0.394 . . . . 1.0 111.109 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.736 ' N ' HG13 ' A' ' 60' ' ' VAL . . . 67.12 114.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 115.374 0.91 . . . . 1.0 115.374 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -99.75 134.43 42.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 175.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -92.2 112.11 23.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.162 1.171 . . . . 1.0 114.162 -176.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -145.07 166.31 25.74 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.983 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.586 ' HZ3' ' HB2' ' A' ' 65' ' ' LYS . 2.7 mtmp? -76.86 133.82 39.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.606 0.717 . . . . 1.0 112.266 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.725 ' O ' ' N ' ' A' ' 68' ' ' GLN . 10.2 ttt180 -57.47 -21.37 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.846 -0.615 . . . . 1.0 112.643 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 t -52.89 55.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.725 ' N ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER 161.62 -126.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER 16.84 77.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.224 0.61 . . . . 1.0 111.969 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' VAL . 8.0 mttt 26.66 -137.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.446 -0.797 . . . . 1.0 112.599 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -162.69 28.03 0.1 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.535 ' HB2' ' HE1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -123.11 -76.64 0.59 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.855 178.113 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.473 ' HB ' ' CE2' ' A' ' 104' ' ' TRP . 1.1 t -118.25 -30.95 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CE1' ' CZ2' ' A' ' 104' ' ' TRP . 40.4 m-85 -39.92 -31.81 0.13 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.554 0.692 . . . . 1.0 111.312 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.533 ' HE3' ' H ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -147.77 166.23 28.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.886 -176.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.824 ' CE3' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -141.43 134.67 29.43 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.038 -1.437 . . . . 1.0 110.108 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 86' ' ' MET . 8.7 tp10 -97.75 122.64 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.597 . . . . 1.0 111.099 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' MET . 2.8 t -142.44 132.25 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.942 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -87.22 123.92 32.75 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.417 -0.913 . . . . 1.0 111.833 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.681 ' C ' ' H ' ' A' ' 82' ' ' ASN . 3.0 m-85 -76.3 113.72 31.13 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.12 29.62 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.172 1.914 . . . . 1.0 110.566 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.681 ' H ' ' C ' ' A' ' 80' ' ' TYR . 62.0 m-80 -135.1 -90.7 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.294 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.0 -41.77 73.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.85 -174.99 26.48 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 119.743 -1.218 . . . . 1.0 110.614 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 11.9 m95 -55.11 121.14 8.12 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.823 -0.81 . . . . 1.0 112.177 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.506 ' O ' ' O ' ' A' ' 78' ' ' VAL . 33.7 tpp -128.63 160.72 31.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.289 0.477 . . . . 1.0 112.289 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -125.08 147.53 48.95 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.729 0.776 . . . . 1.0 109.199 175.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 120' ' ' ARG . 6.3 mt -99.61 155.93 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 114.513 -1.221 . . . . 1.0 107.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.63 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.48 136.65 54.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.243 0.928 . . . . 1.0 113.155 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . . . -134.95 136.22 42.09 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.771 ' H ' ' CG ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 169.88 -37.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.674 1.125 . . . . 1.0 111.401 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.981 ' H ' ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -120.76 146.31 43.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.787 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 59.0 Cg_endo -68.53 -36.79 14.23 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 123.246 2.631 . . . . 1.0 112.6 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -56.94 -10.68 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -89.54 -11.12 43.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.706 ' O ' ' ND2' ' A' ' 97' ' ' ASN . . . 96.56 160.84 32.25 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.733 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 65.59 128.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.622 ' CE3' HG21 ' A' ' 44' ' ' VAL . 47.0 p-90 -73.83 -21.31 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.133 -1.394 . . . . 1.0 109.63 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.563 HD12 ' CE2' ' A' ' 98' ' ' TRP . 1.2 mp -50.12 -26.98 5.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.981 ' HE ' ' H ' ' A' ' 92' ' ' ASP . 6.5 ttt180 -74.68 -36.9 62.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.481 -1.69 . . . . 1.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.4 OUTLIER -68.05 -16.13 63.9 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.462 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.733 HG11 HG23 ' A' ' 138' ' ' VAL . 43.1 t -63.49 124.31 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.882 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -84.42 -174.69 5.41 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.55 -0.86 . . . . 1.0 109.06 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.535 ' HE1' ' HB2' ' A' ' 72' ' ' ASN . 1.2 m-90 -94.79 154.62 17.19 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.39 0.614 . . . . 1.0 112.03 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.842 ' HB2' ' O ' ' A' ' 139' ' ' TRP . . . -31.34 -72.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.039 175.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 51.7 t 120.18 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.248 -2.13 . . . . 1.0 105.248 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 107' ' ' SER . 2.6 t 178.32 29.16 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.33 -1.305 . . . . 1.0 111.934 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.756 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . 67.11 -10.81 0.77 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.132 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 107' ' ' SER . 10.3 mm-40 -74.32 -23.26 59.03 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.636 ' O ' ' O ' ' A' ' 111' ' ' GLN . 6.6 pt-20 -119.12 -0.32 11.1 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.636 ' O ' ' O ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -43.64 -150.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.706 ' C ' HD12 ' A' ' 113' ' ' LEU . 12.5 p30 144.03 27.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.271 -1.331 . . . . 1.0 112.293 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 112' ' ' ASN . 7.3 mp -149.13 174.63 12.13 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.945 -0.472 . . . . 1.0 109.813 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CD2' ' OE2' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -141.44 122.48 8.81 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.105 -0.638 . . . . 1.0 112.252 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.03 80.47 0.15 Allowed 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 121.456 1.438 . . . . 1.0 114.546 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.544 HD23 ' CD1' ' A' ' 118' ' ' ILE . 12.7 tp -90.23 133.66 34.78 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.245 -0.284 . . . . 1.0 110.731 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 tm-20 -108.68 120.39 42.34 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.799 0.687 . . . . 1.0 111.898 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.661 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -136.5 135.04 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.166 -0.924 . . . . 1.0 111.634 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' ILE . 2.6 m-80 35.24 57.28 0.82 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.642 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 8.2 mtp180 57.88 21.13 7.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.3 0.572 . . . . 1.0 111.664 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -125.0 149.81 47.35 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.824 HG21 ' CE3' ' A' ' 76' ' ' TRP . 41.4 mm -118.93 100.84 10.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.068 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.661 ' CG ' HD11 ' A' ' 118' ' ' ILE . 8.3 m-30 -97.33 158.9 15.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 121.762 0.791 . . . . 1.0 110.849 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.693 ' HB3' HD23 ' A' ' 113' ' ' LEU . 13.7 m-30 -106.28 129.11 54.37 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.933 -1.485 . . . . 1.0 108.668 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -117.53 136.62 53.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 113.407 -1.724 . . . . 1.0 109.026 -177.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.647 HG21 ' CE2' ' A' ' 56' ' ' PHE . 29.8 p -104.18 106.37 16.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.362 -0.935 . . . . 1.0 110.629 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.781 HD13 ' HB3' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -73.57 -7.98 54.1 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 112.829 -1.987 . . . . 1.0 111.449 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.632 ' HE2' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -133.63 148.74 69.82 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.803 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -74.15 140.97 28.72 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 105.983 -2.353 . . . . 1.0 105.983 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.422 HG22 ' HG3' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -127.76 138.55 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 118.852 0.751 . . . . 1.0 112.255 -175.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.573 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -75.35 134.54 73.41 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.31 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.53 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . 46.2 Cg_exo -54.41 116.43 3.07 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 122.155 1.904 . . . . 1.0 113.02 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . 121.61 4.21 9.84 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 1.052 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -83.02 147.97 27.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.498 -1.351 . . . . 1.0 114.5 -178.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.655 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 2.0 pm0 -75.5 108.09 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.823 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 137' ' ' LEU . 21.7 mt -71.73 114.87 10.28 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 136' ' ' LEU . 2.2 mp -135.11 160.8 37.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.733 HG23 HG11 ' A' ' 102' ' ' VAL . 26.3 t -118.29 152.52 20.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 O-C-N 123.69 0.618 . . . . 1.0 111.984 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.842 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 0.0 OUTLIER 69.52 137.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.959 1.412 . . . . 1.0 113.059 176.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.562 ' CE1' ' O ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER -87.02 171.49 10.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.775 -1.102 . . . . 1.0 112.16 -178.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.49 ' C ' ' O ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.248 -1.541 . . . . 1.0 109.248 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.87 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 64.7 mt-10 61.71 37.11 16.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.235 -0.982 . . . . 1.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.65 -2.53 54.27 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.407 0.521 . . . . 1.0 112.407 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.447 ' CG ' ' HD2' ' A' ' 146' ' ' PRO . 1.3 t-20 -68.03 151.71 96.99 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.513 -1.291 . . . . 1.0 107.513 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 145' ' ' ASN . 8.1 Cg_exo -41.32 -85.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.851 1.701 . . . . 1.0 116.442 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.781 ' HB3' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -57.03 -45.82 82.83 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.685 0.755 . . . . 1.0 109.049 -177.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.5 OUTLIER -47.49 -50.43 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.688 -175.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.87 ' HB2' ' O ' ' A' ' 143' ' ' GLU . . . -68.45 -49.12 62.22 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.253 -1.379 . . . . 1.0 107.824 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.3 -57.29 13.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.028 -1.896 . . . . 1.0 114.34 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -68.17 -36.29 79.38 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 120.189 1.359 . . . . 1.0 110.827 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.606 HD13 ' CD ' ' A' ' 143' ' ' GLU . 32.2 mt -52.78 -41.92 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.159 -1.423 . . . . 1.0 107.159 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.766 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 1.2 mt-10 -61.82 -52.5 63.92 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.077 -0.965 . . . . 1.0 109.955 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -58.67 -50.4 74.0 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 120.848 0.356 . . . . 1.0 110.684 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.7 OUTLIER -70.97 -50.66 31.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.033 -179.143 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -78.72 -53.25 7.34 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.086 -1.046 . . . . 1.0 110.563 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -70.38 -50.27 40.54 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.936 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 154' ' ' GLU . 0.1 OUTLIER 31.84 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.841 0.713 . . . . 1.0 111.409 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.604 ' N ' ' O ' ' A' ' 157' ' ' ALA . . . -100.65 -120.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.595 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.545 ' N ' ' CD ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER 31.29 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.231 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 159' ' ' ALA . 1.8 m . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.536 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.57 -1.412 . . . . 1.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.3 t -162.49 -167.12 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 1.0 110.568 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mtm -99.8 54.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.563 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -140.41 112.86 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.579 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.15 -41.84 10.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.533 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t30 54.37 -161.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -160.81 48.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.497 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.4 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 19.8 m -148.93 -64.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 6' ' ' THR . 2.6 mp0 47.75 86.27 0.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.798 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.85 178.41 3.22 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.955 2.436 . . . . 1.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ALA . 33.1 m -53.63 171.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . . . 50.6 104.7 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.436 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.631 ' H ' ' CG ' ' A' ' 34' ' ' PRO . . . -68.35 -43.91 76.43 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.678 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -177.57 -25.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.6 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -72.37 0.36 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 119.195 -1.002 . . . . 1.0 113.271 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.498 ' OG1' ' CG ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -142.01 -179.69 6.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.253 -1.794 . . . . 1.0 110.102 174.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 15' ' ' LEU . 2.4 tt -73.66 -62.79 1.37 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 172.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 42' ' ' ILE . . . -89.64 -58.45 2.52 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.749 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 1.1 tm-20 89.57 -155.08 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.098 -2.186 . . . . 1.0 105.098 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.749 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER 51.34 152.39 0.04 OUTLIER Pre-proline 0 C--N 1.268 -2.947 0 O-C-N 125.766 1.916 . . . . 1.0 111.021 -178.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.54 140.16 12.35 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.895 2.396 . . . . 1.0 111.477 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -50.5 -53.05 32.93 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.156 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -60.83 -22.55 64.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 97' ' ' ASN . 2.2 t -79.28 -49.13 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.329 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 1.0 111.769 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.436 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -63.42 -16.89 61.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.68 28.17 15.55 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.012 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 27' ' ' PRO . 39.8 mt -76.96 156.03 82.53 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 112.364 0.505 . . . . 1.0 112.364 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -32.93 -123.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 125.087 3.858 . . . . 1.0 114.033 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' CD ' ' N ' ' A' ' 29' ' ' GLU . 2.2 pp20? -72.76 -51.43 19.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.425 -1.694 . . . . 1.0 106.425 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 tt0 -175.69 60.72 0.02 OUTLIER 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.638 0.733 . . . . 1.0 109.507 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 45' ' ' TRP . 3.4 t -74.15 176.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 8.5 mtt180 -141.91 162.33 35.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.437 0.637 . . . . 1.0 110.881 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -96.81 121.84 39.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -119.76 109.53 37.82 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.87 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.631 ' CG ' ' H ' ' A' ' 11' ' ' ALA . 11.7 Cg_endo -84.5 150.32 11.66 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.529 2.819 . . . . 1.0 114.714 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 9.3 p 95.03 -50.87 0.01 OUTLIER 'General case' 0 C--N 1.344 0.333 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.721 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -48.08 -54.74 12.15 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.631 -0.713 . . . . 1.0 112.704 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.571 HG22 ' H ' ' A' ' 39' ' ' LYS . 2.5 p -90.74 -40.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.76 1.164 . . . . 1.0 110.824 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 67.43 9.94 7.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 178.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' H ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.79 -27.84 0.37 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 177.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.477 ' N ' ' C ' ' A' ' 38' ' ' ASP . 8.7 m -170.27 -58.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.584 -1.189 . . . . 1.0 111.451 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.37 -96.74 0.09 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 16' ' ' ALA . 2.9 tt -98.34 140.9 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 113.795 1.035 . . . . 1.0 113.795 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -120.17 165.23 13.66 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.37 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.758 HG21 ' CE3' ' A' ' 98' ' ' TRP . 12.6 p -103.31 123.74 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.212 0.529 . . . . 1.0 110.313 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 20.9 m95 -127.9 149.04 50.48 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.116 -0.947 . . . . 1.0 112.231 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.757 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -63.37 126.04 26.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.644 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -102.21 -22.22 14.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.504 1.145 . . . . 1.0 108.136 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HZ1' ' HZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -105.74 172.49 3.94 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.231 -2.259 . . . . 1.0 112.458 -175.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -87.74 125.53 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.897 2.398 . . . . 1.0 109.525 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.686 HD13 ' HB ' ' A' ' 130' ' ' ILE . 3.6 mp -98.84 145.94 9.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.481 0.657 . . . . 1.0 110.383 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.064 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.14 148.01 33.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.181 -1.372 . . . . 1.0 108.561 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.064 ' N ' HD22 ' A' ' 51' ' ' LEU . 5.0 ttpt -60.05 126.55 27.97 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.136 0.421 . . . . 1.0 112.136 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.16 4.9 47.29 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 119.32 -1.419 . . . . 1.0 114.133 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 126' ' ' THR . 2.3 ttmt -89.16 142.47 27.62 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.45 -0.9 . . . . 1.0 113.289 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -103.81 138.01 41.02 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.876 -0.787 . . . . 1.0 108.876 175.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 126' ' ' THR . 36.2 m-85 -119.47 125.34 48.67 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.787 1.28 . . . . 1.0 111.443 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.443 ' CA ' HD11 ' A' ' 99' ' ' LEU . . . 127.09 -110.98 1.28 Allowed Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 111.905 -2.407 . . . . 1.0 109.182 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HB3' ' CE1' ' A' ' 123' ' ' TYR . 83.6 Cg_endo -72.95 177.22 37.53 Favored 'Cis proline' 0 N--CA 1.503 2.08 0 CA-C-N 119.76 1.78 . . . . 1.0 112.107 -0.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.915 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 19.4 t80 -68.61 112.2 5.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.716 0.77 . . . . 1.0 111.234 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.672 HG13 ' H ' ' A' ' 61' ' ' GLY . 1.3 p -33.18 -54.84 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.934 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.672 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 75.64 108.97 0.11 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-O 121.389 0.438 . . . . 1.0 113.933 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -99.54 131.09 45.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.422 -2.066 . . . . 1.0 105.422 175.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.549 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -93.47 112.85 24.85 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.86 1.43 . . . . 1.0 114.86 -175.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -148.34 166.34 28.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.3 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.752 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 1.4 mtmp? -77.26 135.44 38.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.227 0.537 . . . . 1.0 111.531 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -57.62 -23.37 50.75 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.657 0.614 . . . . 1.0 112.657 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.419 ' C ' ' OE1' ' A' ' 68' ' ' GLN . 5.0 p -59.63 38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -173.87 7.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.86 135.93 29.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 18.2 pttp -150.31 -141.98 0.12 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.201 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 70' ' ' LYS . 9.3 t30 76.98 -138.91 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -101.95 -83.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.298 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 1.1 t -102.92 104.96 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 119.891 -0.724 . . . . 1.0 111.715 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 12.1 m-85 -162.95 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.824 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.549 ' C ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -143.51 162.39 35.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.649 0.738 . . . . 1.0 111.884 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.73 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -147.75 140.55 24.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.628 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.4 124.59 47.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.365 0.603 . . . . 1.0 111.762 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 120' ' ' ARG . 2.2 t -144.75 130.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -88.28 124.88 34.32 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.659 ' CZ ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 m-85 -77.55 113.19 29.7 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.632 -1.622 . . . . 1.0 112.856 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -53.68 -2.46 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.014 1.809 . . . . 1.0 110.326 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 80' ' ' TYR . 53.2 m-80 -102.98 -96.08 0.3 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.976 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 84' ' ' GLY . 0.8 OUTLIER -65.84 -40.22 91.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.88 1.437 . . . . 1.0 114.88 -176.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' N ' ' HG ' ' A' ' 83' ' ' LEU . . . 147.71 -173.54 27.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 119.772 -1.204 . . . . 1.0 110.32 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 12.0 m95 -55.16 122.14 10.37 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.88 -0.777 . . . . 1.0 111.454 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.497 ' O ' ' O ' ' A' ' 78' ' ' VAL . 5.8 tpp -127.61 157.2 40.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.354 0.501 . . . . 1.0 112.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -120.12 145.36 46.98 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.962 0.887 . . . . 1.0 110.179 176.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' O ' ' A' ' 120' ' ' ARG . 19.7 mt -97.07 156.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.847 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.93 134.02 46.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.915 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . . . -132.83 138.17 46.98 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.082 -2.192 . . . . 1.0 105.082 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 164.88 -31.43 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.868 1.213 . . . . 1.0 111.383 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.29 148.05 59.59 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.537 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 31.5 Cg_exo -55.28 -44.61 47.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.368 1.379 . . . . 1.0 112.481 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.69 -9.32 58.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.746 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -12.59 56.5 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' CA ' HG11 ' A' ' 60' ' ' VAL . . . -178.05 -107.54 0.22 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 119.507 -1.33 . . . . 1.0 113.217 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.691 ' HA ' HG22 ' A' ' 22' ' ' VAL . 44.3 p30 -150.23 -156.1 0.69 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.447 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.758 ' CE3' HG21 ' A' ' 44' ' ' VAL . 23.2 p-90 -70.91 -25.57 62.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.62 HD23 ' CD2' ' A' ' 124' ' ' TYR . 0.3 OUTLIER -53.46 -27.41 24.81 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.487 ' NE ' ' C ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.39 -30.67 53.74 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.554 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.2 m-85 -66.97 -18.54 65.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.32 0.581 . . . . 1.0 109.774 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 136' ' ' LEU . 6.3 t -63.92 116.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.08 -0.964 . . . . 1.0 110.396 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.67 140.79 46.33 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.131 -2.174 . . . . 1.0 105.131 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.637 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 15.8 p90 -92.07 118.73 31.08 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.937 -1.105 . . . . 1.0 110.696 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 12.61 78.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 113.953 -1.476 . . . . 1.0 114.81 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.498 ' C ' ' O ' ' A' ' 105' ' ' ALA . 0.1 OUTLIER -19.5 -40.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 125.197 1.56 . . . . 1.0 110.031 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -168.38 7.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.739 176.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.96 22.48 23.01 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.717 -0.953 . . . . 1.0 110.717 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.425 ' CD ' ' SG ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -77.79 -37.8 48.04 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.297 -0.561 . . . . 1.0 110.118 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.538 ' HG3' HD22 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -119.41 -31.91 4.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.981 1.104 . . . . 1.0 113.981 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.534 ' C ' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 14.25 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 123.416 0.448 . . . . 1.0 111.609 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.849 HD22 HG21 ' A' ' 130' ' ' ILE . 34.0 p-10 -128.06 32.97 4.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER -152.96 172.49 16.73 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.579 ' HB3' HD21 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -148.26 124.15 5.26 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 119.351 -0.94 . . . . 1.0 112.702 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.8 Cg_endo -74.71 109.82 2.99 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 120.64 0.893 . . . . 1.0 113.313 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 23.2 tp -117.42 140.8 49.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.698 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.97 121.34 45.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.794 0.664 . . . . 1.0 112.794 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -135.54 135.66 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.875 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 118' ' ' ILE . 8.0 m-80 35.94 62.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.373 0.509 . . . . 1.0 112.373 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.659 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 7.2 mtp180 55.93 11.89 0.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.984 0.365 . . . . 1.0 111.984 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -122.92 146.16 47.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 59' ' ' PHE . 4.0 mm -107.41 117.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 121.112 0.482 . . . . 1.0 110.566 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.61 ' HB2' HD11 ' A' ' 118' ' ' ILE . 3.0 m-85 -101.14 143.44 31.24 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.62 ' CD2' HD23 ' A' ' 99' ' ' LEU . 15.6 m-30 -102.03 114.72 29.08 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 104.139 -2.541 . . . . 1.0 104.139 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 7.7 ttmt -105.51 141.2 37.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.379 1.05 . . . . 1.0 109.344 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.509 HG21 ' CE2' ' A' ' 56' ' ' PHE . 18.6 p -106.87 110.88 23.16 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.401 0.62 . . . . 1.0 110.068 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -72.41 -4.66 31.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.67 -1.604 . . . . 1.0 111.239 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -145.72 161.14 41.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 120.234 -0.586 . . . . 1.0 112.311 -177.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -75.5 144.42 28.64 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 N-CA-C 105.911 -2.38 . . . . 1.0 105.911 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.849 HG21 HD22 ' A' ' 112' ' ' ASN . 5.2 mt -126.19 135.71 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.719 0.691 . . . . 1.0 110.532 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.53 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.7 134.26 95.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.224 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -59.87 117.98 4.8 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 CA-C-N 120.006 1.038 . . . . 1.0 110.415 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.757 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.28 5.82 14.27 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.824 -1.311 . . . . 1.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.574 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -89.21 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.3 pm0 -78.59 118.84 21.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.268 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 137' ' ' LEU . 2.8 mt -80.3 116.8 20.57 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 105' ' ' ALA . 1.7 mp -129.3 156.17 44.43 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 108.688 -0.856 . . . . 1.0 108.688 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.637 ' H ' ' HA ' ' A' ' 104' ' ' TRP . 5.0 t -122.09 157.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.963 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.578 ' CZ2' ' C ' ' A' ' 141' ' ' IAS . 0.0 OUTLIER 63.03 150.69 0.03 OUTLIER 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 114.985 1.476 . . . . 1.0 114.985 176.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 139' ' ' TRP . 31.4 t80 -108.61 -172.5 2.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.37 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.578 ' C ' ' CZ2' ' A' ' 139' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.262 0 N-CA-C 110.653 -0.979 . . . . 1.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.615 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 0.1 OUTLIER -145.93 -100.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.723 178.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.615 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 4.9 t70 72.04 -37.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.533 ' OD1' HD12 ' A' ' 127' ' ' LEU . 2.0 t-20 -71.77 150.66 93.2 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 145' ' ' ASN . 14.9 Cg_exo -42.7 -84.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.204 0 N-CA-C 117.15 1.942 . . . . 1.0 117.15 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.569 ' HB3' HD13 ' A' ' 127' ' ' LEU . 8.5 tp10 -58.36 -46.78 85.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.391 0.615 . . . . 1.0 109.692 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.563 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.3 OUTLIER -46.12 -53.25 2.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.534 -1.212 . . . . 1.0 109.883 -173.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.563 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -56.34 -52.43 64.6 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 117.615 -1.634 . . . . 1.0 108.213 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.76 -62.32 1.82 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.775 -1.557 . . . . 1.0 113.4 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.505 ' N ' ' OE1' ' A' ' 147' ' ' GLU . . . -63.55 -36.58 84.27 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.12 1.327 . . . . 1.0 111.652 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 156' ' ' ARG . 64.2 mt -53.45 -47.54 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 157' ' ' ALA . 1.8 tt0 -60.76 -53.05 62.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.2 -0.909 . . . . 1.0 110.206 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -57.2 -52.71 64.21 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.027 0.441 . . . . 1.0 111.324 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 3.1 tm-20 -70.17 -49.41 50.67 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.839 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -74.65 -27.27 60.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.108 -0.637 . . . . 1.0 111.029 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 153' ' ' GLU . . . -49.41 -34.6 16.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 118.871 -1.131 . . . . 1.0 108.217 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.82 -27.71 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.845 -1.071 . . . . 1.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.4 ' CA ' ' HE ' ' A' ' 160' ' ' ARG . . . -156.55 119.26 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.626 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -137.39 117.38 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.907 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.616 179.839 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.521 -1.432 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 29.7 m -150.44 7.7 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 1.0 110.554 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 61.74 117.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.499 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -50.14 124.78 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.598 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 7.1 tt0 -75.26 -63.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.614 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 3' ' ' GLN . 0.7 OUTLIER 176.71 -178.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.578 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.73 147.69 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.422 ' N ' ' OE2' ' A' ' 7' ' ' GLU . 6.2 m 55.03 98.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.342 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.422 ' OE2' ' N ' ' A' ' 6' ' ' THR . 4.1 mp0 -126.11 85.98 58.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.98 -175.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.483 2.122 . . . . 1.0 111.798 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -49.6 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.221 0.534 . . . . 1.0 110.891 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . . . -57.95 145.24 36.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.711 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' H ' ' CG ' ' A' ' 34' ' ' PRO . . . -82.75 -44.12 15.97 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m 178.22 -27.65 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.354 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.38 -73.63 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.712 0.767 . . . . 1.0 112.412 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.459 ' CB ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.36 175.81 9.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.135 -1.393 . . . . 1.0 110.632 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 15' ' ' LEU . 3.0 tt -77.19 -62.88 1.51 Allowed 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 172.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 42' ' ' ILE . . . -86.34 -59.39 2.3 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.77 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 9.1 tt0 92.48 -171.48 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 105.415 -2.069 . . . . 1.0 105.415 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.77 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 58.49 151.83 0.08 OUTLIER Pre-proline 0 C--N 1.245 -3.97 0 CA-C-N 112.034 -2.348 . . . . 1.0 108.792 -178.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.92 138.87 6.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 123.429 2.752 . . . . 1.0 111.886 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 27.9 tt0 -50.27 -51.82 41.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-N 114.932 -1.031 . . . . 1.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -63.2 -24.36 67.84 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 97' ' ' ASN . 3.4 t -76.36 -50.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 118.631 -1.228 . . . . 1.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.95 -29.28 65.25 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.132 -0.485 . . . . 1.0 112.245 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.89 -15.98 15.29 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.235 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.42 20.81 31.88 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.936 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 30' ' ' VAL 0.251 17.9 mt -69.19 139.63 90.13 Favored Pre-proline 0 CA--C 1.489 -1.381 0 CA-C-N 118.384 1.092 . . . . 1.0 109.99 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 29' ' ' GLU . 5.9 Cg_exo -61.11 148.43 92.88 Favored 'Trans proline' 0 C--N 1.281 -3.026 0 N-CA-C 107.159 -1.9 . . . . 1.0 107.159 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -49.17 -15.27 0.11 Allowed 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.567 1.175 . . . . 1.0 110.275 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -91.15 19.47 5.8 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 112.596 -2.093 . . . . 1.0 112.707 -178.211 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 26' ' ' LEU . 1.8 t -145.38 151.73 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 118.655 -1.218 . . . . 1.0 112.483 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -147.39 159.09 44.09 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.863 -1.971 . . . . 1.0 106.737 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.807 HD21 ' OH ' ' A' ' 101' ' ' TYR . 1.6 mm? -105.92 140.81 38.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m-85 -148.47 115.35 3.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.641 0.608 . . . . 1.0 112.641 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.9 Cg_endo -85.98 127.62 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.319 2.012 . . . . 1.0 111.123 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 152.55 -71.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.739 0.65 . . . . 1.0 110.831 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.667 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -51.18 -53.25 36.59 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.771 -0.772 . . . . 1.0 113.025 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -53.24 -52.17 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.369 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 40' ' ' THR . 6.4 p-10 -171.34 55.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? 53.82 -9.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.589 ' H ' ' C ' ' A' ' 38' ' ' ASP . 12.3 p -135.42 -90.4 0.31 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.301 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 40' ' ' THR . 4.5 mtt85 -29.43 133.27 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.641 0.588 . . . . 1.0 111.09 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -78.84 133.86 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.94 153.41 17.16 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.3 -1.12 . . . . 1.0 110.3 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -104.14 127.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.621 0.724 . . . . 1.0 109.212 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.667 ' CZ2' ' HB3' ' A' ' 36' ' ' ALA . 4.8 m95 -130.88 149.92 52.28 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 114.469 -1.241 . . . . 1.0 111.507 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.32 138.24 51.31 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.572 -1.251 . . . . 1.0 111.03 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.439 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -112.62 -28.25 7.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.364 -178.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.559 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -116.14 159.71 38.45 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 119.167 -1.013 . . . . 1.0 111.32 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 Cg_endo -57.21 132.27 50.16 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.812 2.341 . . . . 1.0 111.469 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 48' ' ' LYS . 3.4 mp -111.15 144.22 19.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.047 -0.979 . . . . 1.0 108.613 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.051 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.59 149.23 34.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.051 ' N ' HD22 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -64.69 135.47 55.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.757 0.789 . . . . 1.0 111.951 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.7 2.93 49.83 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 119.356 -1.402 . . . . 1.0 113.078 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.651 ' HE3' HD12 ' A' ' 51' ' ' LEU . 3.1 ttmt -96.19 139.73 31.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.162 -1.015 . . . . 1.0 113.475 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.99 139.89 35.01 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 120.16 -0.616 . . . . 1.0 109.534 176.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 126' ' ' THR . 37.1 m-85 -121.89 127.81 50.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 122.852 1.31 . . . . 1.0 110.917 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' CA ' HD11 ' A' ' 99' ' ' LEU . . . 135.11 -106.55 0.59 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 111.526 -2.579 . . . . 1.0 110.251 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 88.8 Cg_endo -83.52 170.46 53.19 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 CA-C-N 119.507 1.654 . . . . 1.0 111.994 -0.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.567 ' CE1' ' NH2' ' A' ' 100' ' ' ARG . 27.7 t80 -59.14 109.75 0.92 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.957 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG13 ' H ' ' A' ' 61' ' ' GLY . 3.0 p -45.99 -50.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.719 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.606 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 72.31 111.18 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.359 -0.448 . . . . 1.0 114.038 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t0 -99.7 132.54 44.98 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -91.22 110.21 21.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 -177.091 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -146.47 166.91 24.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.641 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.555 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 2.1 mtmp? -80.38 132.85 35.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.597 0.713 . . . . 1.0 112.08 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 67' ' ' SER . 2.7 ptm180 -50.19 -24.68 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 1.0 111.28 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.509 ' C ' ' O ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -18.75 -51.24 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.981 0.801 . . . . 1.0 111.907 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.532 ' O ' ' C ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -103.64 -115.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 68' ' ' GLN . 3.2 m 16.05 76.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.448 0 O-C-N 123.713 0.633 . . . . 1.0 111.438 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -114.02 113.34 24.64 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.279 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -174.36 -128.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.559 -0.746 . . . . 1.0 109.172 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.34 -57.57 2.13 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.075 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -105.42 1.4 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.054 0.454 . . . . 1.0 111.358 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.3 m-85 -53.61 -34.75 59.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.502 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -148.16 165.85 29.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.006 1.113 . . . . 1.0 114.006 -175.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.747 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -138.7 125.35 20.78 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.735 -1.575 . . . . 1.0 109.815 -177.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -97.37 123.25 41.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.448 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.0 139.43 22.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.224 -1.353 . . . . 1.0 109.297 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -83.62 129.28 34.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.65 ' CE2' ' NE ' ' A' ' 120' ' ' ARG . 15.5 m-85 -103.52 117.23 60.5 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.693 -1.14 . . . . 1.0 113.74 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -69.9 4.11 2.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.541 1.494 . . . . 1.0 109.774 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 80' ' ' TYR . 15.7 m120 -102.11 -2.84 28.58 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.911 -1.04 . . . . 1.0 111.112 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.9 0.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 80' ' ' TYR . . . 99.19 -164.46 20.36 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 18.8 m95 -60.86 120.18 9.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.759 -0.776 . . . . 1.0 111.019 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 1.4 tpp -130.82 165.62 22.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.185 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.605 ' N ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -120.72 144.48 48.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.045 0.926 . . . . 1.0 110.477 176.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 120' ' ' ARG . 61.1 mt -97.7 156.01 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.44 136.57 54.68 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.273 0.942 . . . . 1.0 112.765 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' HE1' ' A' ' 76' ' ' TRP . . . -134.32 139.82 45.93 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.636 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 167.16 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 120.086 1.312 . . . . 1.0 111.269 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.62 152.37 62.92 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.692 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.443 ' HB2' HG21 ' A' ' 22' ' ' VAL . 51.7 Cg_endo -66.85 -37.67 19.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.543 2.162 . . . . 1.0 111.086 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.16 -14.17 62.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HB3' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.67 -10.78 50.3 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.452 ' HA3' HG11 ' A' ' 60' ' ' VAL . . . 174.92 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 119.761 -1.209 . . . . 1.0 113.854 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -148.26 -163.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.942 0.401 . . . . 1.0 111.783 -177.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.587 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 30.0 p-90 -71.3 -26.8 63.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.645 HD23 ' CD2' ' A' ' 124' ' ' TYR . 2.1 mp -55.03 -28.14 49.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.98 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.611 ' CB ' ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -77.09 -45.27 27.57 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.684 -0.806 . . . . 1.0 111.989 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.807 ' OH ' HD21 ' A' ' 32' ' ' LEU . 11.7 p90 -77.54 1.83 18.26 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 118.335 -1.346 . . . . 1.0 110.82 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.82 119.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 129.28 39.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.52 -1.289 . . . . 1.0 107.52 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.565 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 22.4 p90 -93.42 123.53 36.79 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.883 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.695 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 22.49 76.92 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.065 -1.425 . . . . 1.0 114.094 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.549 ' C ' ' O ' ' A' ' 105' ' ' ALA . 2.2 t -23.99 -38.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.787 1.304 . . . . 1.0 108.165 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -177.98 15.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.3 -1.318 . . . . 1.0 109.716 174.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 107' ' ' SER . . . 89.17 36.28 7.69 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 114.891 -1.049 . . . . 1.0 110.658 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -78.91 -44.41 22.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.047 -0.661 . . . . 1.0 109.891 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.547 ' HG3' HD22 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -120.46 -28.33 5.0 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.601 -0.714 . . . . 1.0 112.337 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' OE1' ' C ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER 22.66 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.937 0.773 . . . . 1.0 110.188 -178.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.531 HD21 ' HA ' ' A' ' 136' ' ' LEU . 41.1 p-10 -128.28 37.89 4.08 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 138' ' ' VAL . 1.0 OUTLIER -154.34 173.44 16.18 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -178.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.564 ' HB3' HD21 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -147.09 123.02 5.46 Favored Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 119.598 -0.841 . . . . 1.0 111.623 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HD3' ' H ' ' A' ' 139' ' ' TRP . 8.7 Cg_endo -67.23 92.52 0.34 Allowed 'Trans proline' 0 N--CA 1.482 0.798 0 CA-C-N 119.276 0.777 . . . . 1.0 112.281 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.576 HD22 ' HE3' ' A' ' 125' ' ' LYS . 31.4 tp -93.07 130.29 38.74 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.98 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.49 116.23 31.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 1.0 110.726 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.961 HD11 ' CG ' ' A' ' 123' ' ' TYR . 2.0 pt -138.39 135.89 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.481 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' ILE . 60.0 m-20 40.35 56.85 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.236 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.65 ' NE ' ' CE2' ' A' ' 80' ' ' TYR . 5.8 mtp180 58.12 12.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 111.84 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -117.25 150.25 39.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.673 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.723 HG21 ' CZ3' ' A' ' 76' ' ' TRP . 26.3 mm -110.52 104.18 16.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.418 0 C-N-CA 120.5 -0.48 . . . . 1.0 109.877 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.961 ' CG ' HD11 ' A' ' 118' ' ' ILE . 3.5 m-85 -92.77 149.96 20.96 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 120.799 -1.188 . . . . 1.0 110.36 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.645 ' CD2' HD23 ' A' ' 99' ' ' LEU . 15.5 m-30 -102.12 111.34 23.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 104.817 -2.29 . . . . 1.0 104.817 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.576 ' HE3' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -106.22 139.33 40.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 124.691 1.245 . . . . 1.0 109.095 -178.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.57 HG21 ' CE2' ' A' ' 56' ' ' PHE . 6.4 p -107.24 111.26 23.57 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.684 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -77.27 0.89 20.37 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.681 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.606 ' NZ ' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -144.02 140.84 17.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.943 -176.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 23.6 Cg_exo -65.98 140.77 61.68 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 N-CA-C 105.589 -2.504 . . . . 1.0 105.589 174.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.556 ' HB ' HD13 ' A' ' 50' ' ' ILE . 24.2 mt -118.89 134.7 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.89 0.768 . . . . 1.0 112.249 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.437 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -72.82 120.81 82.86 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.08 122.45 6.33 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.934 1.756 . . . . 1.0 112.233 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 130.59 -2.92 5.74 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.576 -0.821 . . . . 1.0 114.06 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.781 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -103.81 167.17 9.95 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.111 0.958 . . . . 1.0 112.76 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.3 pm0 -80.5 139.24 36.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.778 -1.555 . . . . 1.0 111.027 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.531 ' HA ' HD21 ' A' ' 112' ' ' ASN . 9.2 mt -88.55 118.14 28.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 105' ' ' ALA . 2.1 mp -121.57 150.68 41.32 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.047 0.451 . . . . 1.0 110.292 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.651 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 17.5 t -118.94 153.27 21.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.166 -0.925 . . . . 1.0 110.12 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.651 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER 59.33 168.29 0.06 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.429 1.081 . . . . 1.0 113.634 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.516 ' CG ' ' N ' ' A' ' 141' ' ' IAS . 55.1 t80 -114.51 168.33 9.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.678 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.53 ' OXT' ' CE2' ' A' ' 139' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 143' ' ' GLU . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.473 ' N ' ' HB3' ' A' ' 140' ' ' TYR . 10.3 pt-20 38.01 103.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 1.0 112.377 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.401 ' CB ' ' CD2' ' A' ' 140' ' ' TYR . 11.0 t70 -139.38 -33.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.061 -0.972 . . . . 1.0 112.063 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.703 ' OD1' HD12 ' A' ' 127' ' ' LEU . 1.4 t-20 -67.91 151.33 97.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 145' ' ' ASN . 5.4 Cg_exo -40.69 -85.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.151 0 N-CA-C 117.496 2.075 . . . . 1.0 117.496 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.615 ' OE1' ' HB2' ' A' ' 151' ' ' ALA . 5.6 tp10 -58.12 -42.26 85.36 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.647 HG13 HD11 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -45.91 -50.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.943 -1.481 . . . . 1.0 109.455 -174.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.548 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -71.62 -47.21 56.11 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.388 -1.325 . . . . 1.0 109.097 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 147' ' ' GLU . . . -53.99 -57.06 12.4 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.629 -1.623 . . . . 1.0 113.235 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.615 ' HB2' ' OE1' ' A' ' 147' ' ' GLU . . . -72.5 -35.21 68.08 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 120.298 1.408 . . . . 1.0 111.94 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 148' ' ' ILE . 55.5 mt -51.95 -48.3 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 106.813 -1.551 . . . . 1.0 106.813 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 157' ' ' ALA . 2.3 mt-10 -60.92 -52.91 63.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.469 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -56.86 -53.24 60.22 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.976 -0.289 . . . . 1.0 111.7 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.539 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -74.12 -48.67 27.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.81 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -70.84 -28.04 64.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.953 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 153' ' ' GLU . . . -49.92 -44.59 50.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.74 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.48 -35.71 30.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.83 -154.91 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.488 ' HE ' ' HE ' ' A' ' 156' ' ' ARG . 13.4 mmt180 57.8 50.93 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.607 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.668 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.8 t 43.54 32.25 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 1.0 110.57 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmt 52.77 173.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 4' ' ' ASN . 1.7 p30 -154.04 22.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -78.11 19.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.506 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -80.03 -14.44 58.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.637 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.84 138.36 15.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.7 m -50.97 117.98 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.56 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -75.15 153.59 86.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.202 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.18 169.69 18.84 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.269 1.979 . . . . 1.0 112.061 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.46 110.15 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.679 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.77 131.66 31.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.247 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.11 -172.35 2.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.01 0.433 . . . . 1.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.426 HG21 ' C ' ' A' ' 40' ' ' THR . 11.4 m -124.2 -78.29 0.6 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.55 -151.56 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.489 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -125.49 155.33 40.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.937 0.875 . . . . 1.0 112.269 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.657 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -51.55 -32.39 28.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.085 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.52 -15.71 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.36 -0.836 . . . . 1.0 112.608 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 14' ' ' THR . 2.8 mt-10 -91.48 -25.36 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.677 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.588 HG22 ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -50.75 141.53 17.77 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.364 -178.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.637 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 22.5 Cg_exo -51.0 141.85 35.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.61 2.206 . . . . 1.0 112.558 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.627 ' HA ' HD21 ' A' ' 23' ' ' LEU . 47.8 tt0 -63.45 -31.73 72.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 113.43 0.9 . . . . 1.0 113.43 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 93' ' ' PRO . 4.6 p-80 -74.56 -26.54 60.01 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.789 1.403 . . . . 1.0 114.789 -176.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.659 HG12 ' C ' ' A' ' 97' ' ' ASN . 4.4 m -78.87 -47.27 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.47 1.032 . . . . 1.0 111.953 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.029 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.17 -22.02 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 122.676 1.227 . . . . 1.0 109.392 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HE ' ' CG ' ' A' ' 20' ' ' GLU . 1.2 mpt_? -63.74 -43.63 95.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.952 -1.931 . . . . 1.0 113.066 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.21 33.95 6.11 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.502 -0.856 . . . . 1.0 112.933 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.651 HD22 ' HB ' ' A' ' 30' ' ' VAL . 35.8 mt -68.49 153.52 95.6 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.668 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.545 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 71.9 Cg_exo -47.37 -106.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 124.287 3.324 . . . . 1.0 115.653 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -74.16 -58.89 3.0 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER -174.76 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 177.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.651 ' HB ' HD22 ' A' ' 26' ' ' LEU . 50.5 t -48.04 178.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.65 -1.159 . . . . 1.0 108.588 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HB3' HG21 ' A' ' 47' ' ' THR . 0.7 OUTLIER -147.88 159.04 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.7 mm? -94.96 121.04 36.16 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.1 -0.64 . . . . 1.0 110.683 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -132.48 139.84 36.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.003 -0.999 . . . . 1.0 111.057 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.2 Cg_endo -80.41 153.18 20.83 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.957 2.438 . . . . 1.0 112.484 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.861 ' H ' HG12 ' A' ' 37' ' ' VAL . 44.2 t 124.16 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.69 1.196 . . . . 1.0 110.958 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.79 12.83 16.01 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.892 1.329 . . . . 1.0 108.057 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 41' ' ' ARG . 3.6 p -93.1 -52.41 9.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 113.306 -1.77 . . . . 1.0 115.062 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.834 ' O ' HG23 ' A' ' 40' ' ' THR . 26.6 t0 126.26 46.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.862 ' H ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 31.86 40.91 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.543 179.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 38' ' ' ASP . 18.4 p -133.56 -16.95 2.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.925 -1.034 . . . . 1.0 111.467 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.915 ' O ' HG11 ' A' ' 37' ' ' VAL . 9.1 ttm-85 179.81 -166.03 0.07 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.784 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -78.02 155.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.887 0.375 . . . . 1.0 110.817 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -114.66 166.14 12.13 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 136' ' ' LEU . 10.0 p -105.41 126.61 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.752 0.776 . . . . 1.0 111.313 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.629 ' O ' HG13 ' A' ' 30' ' ' VAL . 16.1 m95 -126.9 142.38 51.56 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.376 -0.829 . . . . 1.0 113.226 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -69.19 133.51 48.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.305 -1.316 . . . . 1.0 110.304 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.595 HG21 ' HB3' ' A' ' 31' ' ' ARG . 56.0 p -130.34 12.68 5.52 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.868 -1.531 . . . . 1.0 106.868 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.938 ' NZ ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -133.09 170.32 11.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 112.593 -2.094 . . . . 1.0 110.908 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -89.59 141.99 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.289 2.659 . . . . 1.0 111.338 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.938 HD11 ' NZ ' ' A' ' 48' ' ' LYS . 45.2 mt -134.3 146.94 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 114.871 -1.059 . . . . 1.0 112.046 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.718 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.03 168.69 9.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.0 177.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.553 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -65.79 122.83 18.21 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.48 -0.488 . . . . 1.0 111.589 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.926 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.09 7.74 49.24 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.066 -1.064 . . . . 1.0 113.803 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.5 ttmt -75.51 133.16 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 116.787 -1.965 . . . . 1.0 113.852 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -85.8 121.21 28.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 1.0 113.397 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 27' ' ' PRO . 20.9 m-85 -121.17 142.77 49.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.309 1.226 . . . . 1.0 114.309 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.29 -100.49 1.65 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.013 -1.903 . . . . 1.0 110.59 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 95.5 Cg_endo -76.25 167.9 78.8 Favored 'Cis proline' 0 N--CA 1.499 1.814 0 CA-C-N 119.342 1.571 . . . . 1.0 112.049 -0.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.46 ' CZ ' ' O ' ' A' ' 74' ' ' TYR . 19.4 t80 -54.85 108.99 0.45 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.901 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 3.7 p -37.05 -53.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.663 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 52.74 119.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.883 -0.675 . . . . 1.0 113.917 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.85 143.28 33.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -89.08 111.47 22.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.388 0.613 . . . . 1.0 110.921 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CD ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.92 178.84 6.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 1.0 111.79 -176.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -50.88 167.76 0.07 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.084 -0.962 . . . . 1.0 111.703 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.21 -51.55 24.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.67 123.05 48.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.277 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB3' ' HZ2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER 176.94 -20.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.675 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.732 HG11 ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -109.12 -61.71 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.514 0.197 . . . . 1.0 111.404 -178.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 72' ' ' ASN . 44.5 mttp 62.67 -123.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.581 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.426 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 1.6 t30 -42.12 89.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 39.9 t-20 -171.63 -169.21 0.67 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.036 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.681 ' CG1' ' HE1' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -137.95 -56.8 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.529 -0.468 . . . . 1.0 112.064 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' N ' HG22 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -60.68 37.39 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.291 0.37 . . . . 1.0 111.625 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.732 ' SD ' HG11 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -135.19 141.56 45.9 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.671 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -163.95 163.61 23.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.777 -0.769 . . . . 1.0 113.034 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 5.4 pt-20 -100.97 123.24 44.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.093 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.2 124.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.411 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 4.1 t80 -78.06 124.15 27.69 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.632 ' C ' ' H ' ' A' ' 82' ' ' ASN . 23.2 m-85 -103.5 101.65 24.83 Favored Pre-proline 0 N--CA 1.448 -0.571 0 O-C-N 124.522 1.138 . . . . 1.0 112.889 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -65.35 22.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 121.423 1.415 . . . . 1.0 110.611 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.745 ' C ' HD13 ' A' ' 83' ' ' LEU . 83.0 m-20 -118.38 -2.3 11.12 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.837 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -178.1 6.48 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 102.91 174.94 26.71 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 113.844 0.298 . . . . 1.0 113.844 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.518 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.1 m95 -59.1 120.31 8.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.816 0.447 . . . . 1.0 111.656 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.518 ' SD ' ' C ' ' A' ' 85' ' ' TRP . 26.7 mmm -125.46 167.86 14.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.039 1.125 . . . . 1.0 114.039 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.419 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -114.67 138.23 50.94 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 105.604 -1.999 . . . . 1.0 105.604 172.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 78' ' ' VAL . 72.2 mt -103.79 101.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -128.96 127.96 42.75 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.268 0.556 . . . . 1.0 111.283 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -139.75 92.5 2.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.476 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.13 -5.97 21.51 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.419 -0.912 . . . . 1.0 112.811 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.645 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -86.79 120.55 71.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.605 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 52.6 Cg_exo -47.83 -26.98 7.75 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.114 1.876 . . . . 1.0 113.934 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.6 -44.24 82.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.638 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.724 ' O ' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.82 3.26 15.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.619 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . -97.54 -2.94 58.63 Favored Glycine 0 C--O 1.219 -0.795 0 CA-C-N 115.39 -0.823 . . . . 1.0 113.019 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.901 ' ND2' ' H ' ' A' ' 60' ' ' VAL . 28.9 p30 42.57 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.19 0.495 . . . . 1.0 110.109 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.466 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 67.6 p-90 -70.58 -24.55 62.79 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 99' ' ' LEU . 5.2 mp -55.36 -23.6 25.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.078 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -68.26 -13.81 62.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 176.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.3 m-85 -96.93 -10.62 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.475 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 99' ' ' LEU . 70.7 t -66.95 118.5 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.872 -0.731 . . . . 1.0 110.03 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.818 ' ND2' ' H ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -80.57 -164.39 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.55 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.681 ' HE1' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -121.9 154.6 36.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.505 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.936 ' HB3' ' NE2' ' A' ' 111' ' ' GLN . . . -134.89 -176.72 4.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.421 0.629 . . . . 1.0 112.016 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -105.43 -54.15 2.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.596 -178.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -103.16 175.22 5.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 111.379 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.1 -36.88 34.08 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -54.59 -25.39 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 1.0 110.401 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 105' ' ' ALA . 8.3 pt-20 -107.64 -24.01 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.435 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.936 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -103.09 103.82 13.92 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.22 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.731 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -114.45 34.25 4.84 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -177.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 137' ' ' LEU . 5.3 mp -144.42 149.25 35.76 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.606 -0.838 . . . . 1.0 111.77 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.697 ' CD1' HG23 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -150.67 127.16 5.21 Favored Pre-proline 0 N--CA 1.47 0.528 0 C-N-CA 120.287 -0.565 . . . . 1.0 112.395 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 51.6 Cg_exo -60.5 133.55 49.53 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.087 1.858 . . . . 1.0 113.797 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -134.98 136.16 41.98 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.35 120.87 41.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.07 0.462 . . . . 1.0 111.757 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.862 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.1 OUTLIER -129.61 114.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 56.7 42.67 26.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.592 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 65.89 15.1 9.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.974 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -106.75 124.64 49.91 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.66 120.74 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.597 0.713 . . . . 1.0 112.238 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.862 ' CG ' HD11 ' A' ' 118' ' ' ILE . 7.7 m-85 -112.07 153.68 26.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.796 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -112.86 126.51 55.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.45 152.69 43.02 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.558 -0.857 . . . . 1.0 112.525 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.926 ' O ' ' N ' ' A' ' 53' ' ' GLY . 7.3 p -106.68 106.24 16.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.082 -1.417 . . . . 1.0 109.83 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -69.89 -0.46 7.35 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.927 0.767 . . . . 1.0 111.594 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 1.007 ' H ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -148.28 126.95 6.1 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.173 -176.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.63 148.48 2.34 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.951 2.434 . . . . 1.0 112.547 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -114.89 135.87 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.882 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -78.27 115.29 49.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -40.78 117.87 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.458 2.105 . . . . 1.0 113.282 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.62 6.19 13.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.522 -0.599 . . . . 1.0 112.566 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.882 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.4 pt-20 -104.92 166.98 10.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.938 0.869 . . . . 1.0 112.269 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' OE1' ' HB1' ' A' ' 36' ' ' ALA . 5.4 pt-20 -81.09 136.59 35.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.306 -1.315 . . . . 1.0 111.74 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 137' ' ' LEU . 1.2 mp -86.48 128.05 34.92 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.919 -1.037 . . . . 1.0 109.955 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.669 HD21 ' OD1' ' A' ' 103' ' ' ASN . 4.9 mp -142.65 157.98 44.12 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.993 0.517 . . . . 1.0 111.71 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.605 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.66 146.26 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 178.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.872 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 0.3 OUTLIER 23.41 -123.88 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.973 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.647 ' CD1' ' O ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -163.56 -14.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.618 ' OD1' ' C ' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.993 ' O ' ' N ' ' A' ' 145' ' ' ASN . 2.0 tm-20 -62.86 -74.54 0.09 Allowed 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.251 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -36.16 52.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.211 0.944 . . . . 1.0 111.86 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.993 ' N ' ' O ' ' A' ' 143' ' ' GLU . 16.4 t30 -117.57 164.14 20.77 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 114.616 -1.174 . . . . 1.0 109.659 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 63.6 Cg_endo -96.38 -24.83 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.235 1.957 . . . . 1.0 112.203 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.629 ' OE1' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.941 HG22 HD11 ' A' ' 152' ' ' ILE . 93.3 mt -65.5 -53.18 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.222 0.534 . . . . 1.0 111.968 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 152' ' ' ILE . . . -51.54 -33.03 30.32 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.647 -0.706 . . . . 1.0 112.523 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.19 45.44 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.23 -0.588 . . . . 1.0 111.537 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . -78.53 -39.98 36.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.89 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.941 HD11 HG22 ' A' ' 148' ' ' ILE . 20.1 mt -53.33 -52.61 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 106.445 -1.687 . . . . 1.0 106.445 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 60.9 mt-10 -56.39 -28.04 58.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.056 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.518 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.6 OUTLIER -70.47 -49.4 48.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.006 -1.078 . . . . 1.0 111.345 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.546 ' HB2' ' HZ2' ' A' ' 125' ' ' LYS . 10.7 tp10 -79.39 -50.14 11.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.738 ' HG2' HG22 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -64.07 -39.71 94.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . -63.57 -23.27 67.31 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 m -92.81 34.41 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.276 -0.875 . . . . 1.0 110.201 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -143.15 40.15 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.986 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -115.42 -38.98 3.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.464 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.623 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.0 m -52.04 -75.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 1.0 110.575 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.92 171.9 13.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.592 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 44.26 51.64 7.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.502 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER -97.49 55.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.586 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 45.32 18.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 3' ' ' GLN . 3.8 m -92.07 90.04 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.539 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.5 m 58.74 114.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.596 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -131.71 85.46 51.68 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -50.59 174.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.432 2.088 . . . . 1.0 112.052 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.4 141.06 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.324 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 54.52 172.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.416 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.74 -137.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.33 0.586 . . . . 1.0 110.804 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -140.49 -58.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.2 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.06 160.06 0.53 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -123.06 151.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.737 0.779 . . . . 1.0 112.748 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.71 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -55.56 -36.87 67.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.985 -1.007 . . . . 1.0 109.487 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -15.79 60.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.754 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -23.3 33.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.997 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.596 HG21 ' HG ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -60.66 144.59 89.08 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.644 ' O ' HD22 ' A' ' 23' ' ' LEU . 32.2 Cg_exo -48.15 148.64 6.9 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.101 2.534 . . . . 1.0 113.228 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' HD23 ' A' ' 23' ' ' LEU . 30.0 tt0 -60.72 -42.03 96.46 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.617 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 7.8 p-80 -73.4 -29.32 62.52 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.258 1.577 . . . . 1.0 115.258 -176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG12 ' C ' ' A' ' 97' ' ' ASN . 21.5 m -75.36 -47.16 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 119.909 1.231 . . . . 1.0 110.652 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 19' ' ' PRO . 1.6 pt? -67.5 -25.33 65.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.815 0.817 . . . . 1.0 110.321 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HE ' ' HG2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -71.07 -36.04 72.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.078 -1.419 . . . . 1.0 112.813 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.1 31.24 7.11 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.74 -0.743 . . . . 1.0 111.617 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 30' ' ' VAL . 10.3 mt -72.68 120.89 83.21 Favored Pre-proline 0 CA--C 1.5 -0.952 0 C-N-CA 119.651 -0.82 . . . . 1.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.85 168.39 7.21 Favored 'Trans proline' 0 C--N 1.296 -2.227 0 CA-C-N 120.085 1.066 . . . . 1.0 109.438 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 48' ' ' LYS . 3.7 pt-20 -59.02 -8.89 1.59 Allowed 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 112.491 -2.141 . . . . 1.0 115.386 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.822 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -112.51 11.95 19.87 Favored 'General case' 0 CA--C 1.458 -2.586 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.973 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.855 ' O ' HD13 ' A' ' 26' ' ' LEU . 2.3 t -137.1 117.06 16.22 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 C-N-CA 117.38 -1.728 . . . . 1.0 113.95 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' NE ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.67 142.02 49.85 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.144 -1.428 . . . . 1.0 107.144 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 26' ' ' LEU . 4.2 mm? -90.07 116.93 28.47 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.175 1.352 . . . . 1.0 111.548 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -139.73 141.34 27.53 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.725 -1.125 . . . . 1.0 110.942 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 35' ' ' SER . 53.2 Cg_endo -76.16 159.04 37.46 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.863 3.042 . . . . 1.0 113.804 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.75 ' C ' ' H ' ' A' ' 37' ' ' VAL . 13.4 m 110.4 -85.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.814 1.246 . . . . 1.0 108.575 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' ASN . . . -55.54 12.17 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.896 0.855 . . . . 1.0 111.822 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.75 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -95.51 -53.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.864 -1.517 . . . . 1.0 112.555 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.1 m-20 143.65 42.14 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.323 1.014 . . . . 1.0 109.187 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.0 23.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.309 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 38' ' ' ASP . 9.7 t -122.76 -4.48 8.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.064 0.764 . . . . 1.0 113.064 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.603 ' O ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.33 -162.95 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.568 HG21 ' HB3' ' A' ' 32' ' ' LEU . 1.4 mm -79.08 156.21 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.956 0.408 . . . . 1.0 110.904 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -124.88 165.12 18.14 Favored Glycine 0 C--O 1.196 -2.26 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -105.99 135.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 117.605 0.702 . . . . 1.0 110.937 -178.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 15.6 m95 -130.65 149.96 52.06 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.993 -1.003 . . . . 1.0 113.69 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.15 128.98 38.15 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.345 -1.298 . . . . 1.0 113.428 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 28' ' ' GLU . 81.5 p -115.8 -20.91 9.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.058 -0.974 . . . . 1.0 111.085 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' CD ' ' C ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.57 168.22 10.58 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.298 178.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.14 121.99 6.87 Favored 'Trans proline' 0 CA--C 1.498 -1.314 0 C-N-CA 121.915 1.743 . . . . 1.0 111.666 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.733 HD12 HG21 ' A' ' 130' ' ' ILE . 72.6 mt -100.61 143.02 14.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 112.858 -1.974 . . . . 1.0 109.581 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 51' ' ' LEU . 4.0 pp -109.01 164.27 12.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.79 -1.096 . . . . 1.0 109.294 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.613 ' C ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.34 122.74 21.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.01 0.91 . . . . 1.0 111.111 177.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.896 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.13 10.07 40.47 Favored Glycine 0 C--N 1.303 -1.304 0 C-N-CA 120.022 -1.085 . . . . 1.0 114.029 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -89.19 130.85 35.54 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.328 -1.749 . . . . 1.0 114.624 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 4.4 mtmm -85.9 124.54 32.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.857 -1.52 . . . . 1.0 111.473 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CD2' ' OE1' ' A' ' 29' ' ' GLU . 47.5 m-85 -121.65 149.71 42.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.9 -102.37 1.56 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.215 -1.357 . . . . 1.0 111.507 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 50.7 Cg_endo -84.15 165.14 64.22 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 119.753 1.776 . . . . 1.0 113.036 0.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 20.4 t80 -54.39 110.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.849 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.628 HG11 ' HE ' ' A' ' 100' ' ' ARG . 2.9 p -35.42 -56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.446 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 51.28 116.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.558 -0.829 . . . . 1.0 114.799 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 21.4 t0 -103.49 146.69 28.14 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.676 ' HB3' ' HZ3' ' A' ' 63' ' ' LYS . 3.2 mtmp? -89.29 113.64 24.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.443 -0.903 . . . . 1.0 112.202 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.628 ' CE ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -136.04 166.29 23.7 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.328 -0.851 . . . . 1.0 111.345 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.628 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -81.25 131.24 35.28 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.517 0.562 . . . . 1.0 112.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -40.64 -24.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 65' ' ' LYS . 27.5 m -76.92 60.97 1.87 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.461 -0.895 . . . . 1.0 108.714 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HB3' ' HZ2' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -167.0 -7.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.163 1.171 . . . . 1.0 114.163 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.515 HG22 ' HZ3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -110.51 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 119.063 0.847 . . . . 1.0 111.36 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.507 ' H ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER 88.76 -80.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.833 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -102.94 92.83 4.73 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 18.8 t-20 -170.59 172.56 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.107 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.664 ' C ' ' H ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -122.43 -52.31 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 114.38 1.252 . . . . 1.0 114.38 -178.012 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.823 ' C ' ' SD ' ' A' ' 75' ' ' MET . 0.2 OUTLIER -63.54 34.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 -176.493 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.823 ' SD ' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -126.45 139.32 53.34 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -177.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.641 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -164.49 164.23 21.9 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.493 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.73 122.78 41.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.17 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.42 119.45 13.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.445 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 3.0 t80 -78.19 125.03 28.76 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 113.41 0.893 . . . . 1.0 113.41 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ASN . 25.0 m-85 -103.22 97.8 10.71 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 114.698 -1.137 . . . . 1.0 112.172 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 79' ' ' TYR . 51.9 Cg_exo -51.31 -11.33 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.247 1.298 . . . . 1.0 109.785 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' TYR . 77.3 m-20 -76.53 -3.42 37.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.424 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 84' ' ' GLY . 2.5 pp -178.29 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.589 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 146.82 173.24 17.87 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.132 -1.032 . . . . 1.0 112.523 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.502 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.9 m95 -58.53 120.25 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.646 -0.277 . . . . 1.0 111.547 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.505 ' SD ' ' CD1' ' A' ' 83' ' ' LEU . 20.3 mmm -127.25 163.87 22.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.996 1.109 . . . . 1.0 113.996 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.432 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.24 139.78 46.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.354 -2.091 . . . . 1.0 105.354 172.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 75' ' ' MET . 66.4 mt -107.58 103.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 118.219 -0.895 . . . . 1.0 109.7 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -130.29 130.77 44.94 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.207 0.912 . . . . 1.0 112.362 -178.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.782 ' HB1' ' CZ ' ' A' ' 100' ' ' ARG . . . -142.72 113.04 7.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.201 -0.909 . . . . 1.0 109.72 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' HD21 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -132.68 26.93 4.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.979 0.809 . . . . 1.0 110.139 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.729 ' N ' HH11 ' A' ' 100' ' ' ARG . 2.6 m-20 -117.15 81.62 13.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.818 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.617 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 58.6 Cg_exo -48.48 -12.67 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.084 2.523 . . . . 1.0 112.629 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HA ' ' HE2' ' A' ' 21' ' ' HIS . 2.7 mt-10 -79.1 -28.52 43.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.365 0.602 . . . . 1.0 109.691 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 17.89 15.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 1.0 112.779 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -141.02 -121.65 1.79 Allowed Glycine 0 N--CA 1.461 0.336 0 C-N-CA 119.422 -1.371 . . . . 1.0 114.78 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.569 ' C ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -139.18 -177.96 5.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.533 -0.834 . . . . 1.0 110.489 -178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.637 ' CE3' HG11 ' A' ' 30' ' ' VAL . 70.1 p-90 -68.31 -21.66 64.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.462 HD12 ' H ' ' A' ' 99' ' ' LEU . 4.4 mp -56.88 -28.41 61.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.782 ' CZ ' ' HB1' ' A' ' 90' ' ' ALA . 32.0 mtt180 -62.57 -12.52 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.355 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -104.77 -3.35 23.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.643 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.407 ' O ' ' CZ3' ' A' ' 104' ' ' TRP . 18.5 t -66.14 135.03 29.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.893 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.583 ' CG ' ' H ' ' A' ' 104' ' ' TRP . 62.5 t30 -102.63 -174.13 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 120.696 -0.402 . . . . 1.0 110.204 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.586 ' CH2' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -124.53 157.06 36.25 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.763 ' HB2' HD22 ' A' ' 137' ' ' LEU . . . -118.99 -158.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.513 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.53 -22.98 11.38 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.518 -1.219 . . . . 1.0 111.934 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -171.68 137.38 1.02 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 111' ' ' GLN . . . -31.74 -32.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.735 -0.666 . . . . 1.0 113.717 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' SER . 2.1 mt-10 -53.92 -26.76 26.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 117.816 0.808 . . . . 1.0 110.337 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.513 ' OE2' ' SG ' ' A' ' 106' ' ' CYS . 11.0 pt-20 -116.94 -24.34 7.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.07 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 105' ' ' ALA . 2.5 tm0? -93.76 143.98 25.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.11 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.649 ' O ' HG22 ' A' ' 126' ' ' THR . 0.1 OUTLIER -153.9 40.32 0.49 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.845 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.663 HD21 HD23 ' A' ' 136' ' ' LEU . 4.8 mp -143.79 143.21 31.25 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.08 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.695 ' CD1' HG23 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -148.73 128.76 6.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.349 -179.04 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.5 Cg_exo -63.19 121.73 9.67 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.385 2.057 . . . . 1.0 112.284 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 123' ' ' TYR . 9.2 tp -117.14 128.74 55.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -98.02 116.64 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.684 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.3 118.95 51.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.51 31.98 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 80' ' ' TYR . 11.3 mmp_? 67.67 18.22 9.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.53 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.39 125.35 50.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 76' ' ' TRP . 5.6 mm -85.33 120.79 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.009 -0.677 . . . . 1.0 112.659 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 116' ' ' LEU . 8.7 m-85 -112.89 162.32 15.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.909 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.1 m-30 -112.28 118.2 34.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 114' ' ' PHE . 1.9 mttt -110.81 145.91 37.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.695 0.998 . . . . 1.0 113.695 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 53' ' ' GLY . 3.1 p -106.64 111.33 23.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.701 -1.591 . . . . 1.0 109.448 176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.675 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.94 -4.35 46.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.951 0.782 . . . . 1.0 110.076 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.574 ' HZ1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -139.45 147.36 52.15 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.371 177.377 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.83 146.08 77.0 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.288 1.325 . . . . 1.0 111.833 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.733 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -113.7 136.44 50.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.336 -179.011 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.878 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -79.58 121.06 82.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.16 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -41.98 112.28 0.23 Allowed 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 123.111 2.541 . . . . 1.0 115.044 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 119.16 8.03 9.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.001 -0.619 . . . . 1.0 112.768 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.878 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.6 pt-20 -105.35 165.99 10.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 117.507 0.653 . . . . 1.0 111.115 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.493 ' OE1' HD11 ' A' ' 137' ' ' LEU . 4.6 pt-20 -80.01 133.91 36.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.769 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.88 ' C ' HD12 ' A' ' 137' ' ' LEU . 6.4 mp -86.27 132.49 33.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.913 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.88 HD12 ' C ' ' A' ' 136' ' ' LEU . 4.7 mp -140.2 159.59 41.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.703 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -108.56 140.16 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.759 ' CD1' ' N ' ' A' ' 140' ' ' TYR . 29.6 p90 33.96 -63.05 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 O-C-N 124.957 1.41 . . . . 1.0 114.322 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.759 ' N ' ' CD1' ' A' ' 139' ' ' TRP . 44.4 p90 155.5 -64.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.875 1.67 . . . . 1.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.71 ' N ' ' CD2' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 N-CA-C 111.453 -0.659 . . . . 1.0 111.453 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 1.066 ' O ' ' N ' ' A' ' 145' ' ' ASN . 4.2 tm-20 -66.61 -80.91 0.04 OUTLIER 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 0.8 OUTLIER -29.88 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.772 0.796 . . . . 1.0 111.506 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 1.066 ' N ' ' O ' ' A' ' 143' ' ' GLU . 1.6 t-20 -111.15 162.85 19.07 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 114.32 -1.309 . . . . 1.0 108.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.462 ' HD3' ' ND2' ' A' ' 145' ' ' ASN . 73.3 Cg_endo -94.62 -20.27 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.767 1.644 . . . . 1.0 112.063 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.428 ' H ' ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -74.14 -37.45 64.06 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.562 -1.273 . . . . 1.0 107.562 178.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.695 HG23 ' CD1' ' A' ' 114' ' ' PHE . 63.9 mt -75.02 -56.25 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.245 0.545 . . . . 1.0 110.527 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 152' ' ' ILE . . . -56.14 -30.96 62.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.237 -0.892 . . . . 1.0 112.275 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.48 -33.54 48.17 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.507 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -75.55 -42.56 52.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 1.0 111.464 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.719 HG22 ' HG2' ' A' ' 156' ' ' ARG . 60.2 mt -54.24 -51.69 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.466 -1.309 . . . . 1.0 107.466 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 32.6 mt-10 -59.84 -29.71 68.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.783 0.677 . . . . 1.0 111.338 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.4 OUTLIER -71.08 -48.77 50.6 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.402 -0.919 . . . . 1.0 110.763 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.482 ' N ' ' HG2' ' A' ' 154' ' ' GLU . 15.9 tp10 -78.94 -49.83 12.15 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.719 ' HG2' HG22 ' A' ' 152' ' ' ILE . 5.4 ppt_? -66.61 -40.53 88.85 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.836 0.68 . . . . 1.0 112.836 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -64.66 -22.96 67.11 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.0 m -93.9 19.04 9.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.522 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.43 32.44 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.337 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -110.7 -65.32 1.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.522 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.938 -1.029 . . . . 1.0 110.55 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.1 m 42.33 71.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 1.0 110.555 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mmt -101.77 135.21 43.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.566 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -156.66 52.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.27 -46.45 27.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.578 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -42.5 132.22 3.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.497 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 m -89.91 99.93 12.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.531 HG23 ' N ' ' A' ' 7' ' ' GLU . 3.1 t -70.03 -122.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.453 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' N ' HG23 ' A' ' 6' ' ' THR . 7.7 mt-10 -138.78 83.55 19.15 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -83.42 -172.91 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.978 2.452 . . . . 1.0 112.395 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -69.85 -179.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.822 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 53.88 169.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.295 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.56 -144.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.962 0.411 . . . . 1.0 110.967 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -139.13 -76.71 0.35 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.622 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -43.96 160.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.811 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -125.88 150.77 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.62 -0.718 . . . . 1.0 111.062 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -60.74 -27.75 68.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.357 0.599 . . . . 1.0 109.575 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.65 -23.38 63.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' O ' ' O ' ' A' ' 18' ' ' VAL . 1.6 mm-40 -88.84 -117.06 0.05 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.11 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.609 HG23 HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER 51.49 142.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 114.123 -1.399 . . . . 1.0 110.76 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 18' ' ' VAL . 4.3 Cg_exo -55.64 134.64 65.19 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.14 1.226 . . . . 1.0 111.766 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HA ' HD21 ' A' ' 23' ' ' LEU . 38.2 tt0 -53.23 -38.63 63.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.847 1.055 . . . . 1.0 113.847 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.684 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 10.1 p-80 -74.67 -34.25 62.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.467 1.654 . . . . 1.0 115.467 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.669 HG12 ' C ' ' A' ' 97' ' ' ASN . 5.2 m -71.65 -47.83 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.279 0.945 . . . . 1.0 111.181 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 19' ' ' PRO . 1.7 pt? -68.15 -22.32 64.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.67 0.748 . . . . 1.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.49 -29.99 64.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.2 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.46 41.6 2.11 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 30' ' ' VAL . 46.7 mt -85.41 116.59 66.19 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 119.956 -0.698 . . . . 1.0 112.542 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 29' ' ' GLU . 18.7 Cg_endo -68.31 -139.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.682 0 C-N-CA 121.638 1.559 . . . . 1.0 112.856 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.821 ' HB2' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -30.52 -4.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 126.761 2.024 . . . . 1.0 115.648 -173.236 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' A' ' 27' ' ' PRO . 10.9 mt-10 129.55 5.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 126.437 1.895 . . . . 1.0 113.903 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.875 ' O ' HD22 ' A' ' 26' ' ' LEU . 55.5 t -41.99 127.15 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.793 -1.094 . . . . 1.0 108.503 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' NE ' ' CG2' ' A' ' 47' ' ' THR . 0.1 OUTLIER -127.35 155.33 43.76 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.237 0.828 . . . . 1.0 113.237 -177.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 32' ' ' LEU . 1.7 mm? -92.15 116.31 28.83 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.614 0.721 . . . . 1.0 111.863 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -129.87 141.4 41.73 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.601 -1.182 . . . . 1.0 110.907 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . 71.4 Cg_endo -72.58 155.56 54.59 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.742 2.294 . . . . 1.0 114.655 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.708 ' C ' ' H ' ' A' ' 37' ' ' VAL . 11.4 m 109.22 -76.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.324 -1.307 . . . . 1.0 108.179 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.531 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -51.81 7.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.966 -1.016 . . . . 1.0 111.991 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.708 ' H ' ' C ' ' A' ' 35' ' ' SER . 2.1 p -103.44 -50.26 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.772 ' O ' HG22 ' A' ' 40' ' ' THR . 1.9 p30 158.86 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' C ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER 36.58 76.0 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.698 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 38' ' ' ASP . 1.4 t 152.04 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.475 1.11 . . . . 1.0 112.207 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.708 ' O ' HG11 ' A' ' 37' ' ' VAL . 3.3 tpt180 -172.21 -168.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.765 -0.774 . . . . 1.0 111.558 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.609 HG13 HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -95.28 152.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 O-C-N 123.443 0.464 . . . . 1.0 109.933 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -130.87 165.85 22.8 Favored Glycine 0 C--O 1.209 -1.43 0 N-CA-C 108.162 -1.975 . . . . 1.0 108.162 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.848 HG21 ' CE3' ' A' ' 98' ' ' TRP . 13.6 p -101.05 139.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 117.97 0.885 . . . . 1.0 111.276 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.531 ' CZ2' ' HB2' ' A' ' 36' ' ' ALA . 6.0 m95 -134.46 154.0 51.63 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.993 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HB1' ' HZ3' ' A' ' 48' ' ' LYS . . . -92.0 122.54 34.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.887 -1.506 . . . . 1.0 108.581 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.461 ' CG2' ' NE ' ' A' ' 31' ' ' ARG . 62.7 p -109.07 3.77 22.38 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.431 0.634 . . . . 1.0 110.644 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.974 ' NZ ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -128.96 170.9 9.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.696 -1.138 . . . . 1.0 111.826 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' N ' ' HG3' ' A' ' 132' ' ' PRO . 5.3 Cg_endo -85.38 129.66 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.589 2.193 . . . . 1.0 111.921 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.974 HD11 ' NZ ' ' A' ' 48' ' ' LYS . 93.2 mt -120.32 147.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.853 -1.067 . . . . 1.0 111.667 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.816 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -107.01 163.23 13.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.567 -1.197 . . . . 1.0 110.871 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 127.68 33.84 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.017 0.913 . . . . 1.0 112.607 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.857 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.14 8.29 39.11 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 114.535 -1.211 . . . . 1.0 113.944 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.6 ttmm -93.32 131.04 38.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.671 -1.611 . . . . 1.0 115.115 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -96.18 133.73 40.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.415 -1.266 . . . . 1.0 113.532 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.94 149.72 41.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.404 -0.816 . . . . 1.0 112.416 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.67 -100.77 1.55 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.385 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 66.8 Cg_endo -77.26 166.63 81.64 Favored 'Cis proline' 0 N--CA 1.504 2.116 0 CA-C-N 119.195 1.498 . . . . 1.0 112.546 0.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CA ' HD22 ' A' ' 99' ' ' LEU . 17.6 t80 -55.7 107.49 0.34 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.221 -0.592 . . . . 1.0 110.51 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.755 HG13 ' H ' ' A' ' 61' ' ' GLY . 3.5 p -30.85 -61.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 123.774 0.671 . . . . 1.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.755 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 49.16 117.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.302 -0.475 . . . . 1.0 113.678 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 51.6 t0 -101.79 148.38 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.658 ' NZ ' HD21 ' A' ' 83' ' ' LEU . 4.9 mtmt -89.14 112.91 24.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.521 0.677 . . . . 1.0 110.994 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HE3' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -132.73 166.33 22.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.738 -1.119 . . . . 1.0 111.444 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.614 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -84.81 130.99 34.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.321 0.489 . . . . 1.0 112.321 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 68' ' ' GLN . 14.2 ptt180 -43.31 -23.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.002 0.741 . . . . 1.0 113.002 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.12 -13.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.024 -0.671 . . . . 1.0 110.326 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' O ' ' A' ' 69' ' ' VAL . 19.5 mm100 -100.57 -152.77 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.998 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.597 HG22 ' NZ ' ' A' ' 64' ' ' LYS . 23.9 m 31.68 -167.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mttm 174.74 -58.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.189 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 72' ' ' ASN . 25.1 t-20 -111.31 -88.37 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.579 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER 36.61 -160.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.237 0.335 . . . . 1.0 111.009 178.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.606 ' O ' ' CZ3' ' A' ' 76' ' ' TRP . 0.2 OUTLIER -146.45 -50.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 120.115 -0.634 . . . . 1.0 111.186 -179.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -69.78 41.99 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.619 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.551 ' H ' ' C ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -128.31 139.06 52.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.843 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -165.73 164.34 18.92 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.076 -1.05 . . . . 1.0 112.641 175.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.63 122.14 45.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.898 0.856 . . . . 1.0 110.982 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.59 121.96 51.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 106.076 -1.824 . . . . 1.0 106.076 178.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -81.34 123.53 28.61 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.02 -1.072 . . . . 1.0 112.001 -177.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 82' ' ' ASN . 9.9 m-85 -86.56 111.03 36.62 Favored Pre-proline 0 N--CA 1.438 -1.045 0 O-C-N 124.866 1.354 . . . . 1.0 112.531 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.62 -12.13 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.762 1.642 . . . . 1.0 109.518 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 80' ' ' TYR . 73.9 m-80 -85.62 -116.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.208 -1.36 . . . . 1.0 110.47 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.948 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -47.99 -34.92 10.02 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 139.43 -175.14 21.87 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.334 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 16.3 m95 -58.03 120.54 8.74 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.39 0.595 . . . . 1.0 111.704 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 7.2 mmm -130.46 169.25 15.77 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.417 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -119.99 140.77 50.45 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 113.991 -1.459 . . . . 1.0 107.784 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -106.1 103.01 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.195 -0.911 . . . . 1.0 108.598 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.81 129.32 36.37 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.962 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.501 ' HB1' ' HZ3' ' A' ' 95' ' ' LYS . . . -141.41 91.7 2.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.953 -0.699 . . . . 1.0 112.159 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.565 ' HA ' HH11 ' A' ' 100' ' ' ARG . 0.1 OUTLIER -103.31 14.0 32.53 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.456 -0.897 . . . . 1.0 109.873 178.024 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.17 113.27 62.87 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.245 -0.889 . . . . 1.0 108.936 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.684 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 24.6 Cg_endo -69.58 -22.62 32.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.26 1.973 . . . . 1.0 112.097 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -56.6 -42.44 78.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.372 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HZ3' ' HB1' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -114.0 -5.51 13.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.854 0.359 . . . . 1.0 110.77 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.7 ' HA2' HG11 ' A' ' 60' ' ' VAL . . . -89.0 -144.28 10.33 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.516 -1.325 . . . . 1.0 113.432 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.669 ' C ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -146.66 -173.38 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.833 -0.684 . . . . 1.0 109.616 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.848 ' CE3' HG21 ' A' ' 44' ' ' VAL . 65.0 p-90 -68.58 -19.29 64.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.885 -0.143 . . . . 1.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 124' ' ' TYR . 6.3 mp -57.12 -30.31 64.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.728 -0.789 . . . . 1.0 108.958 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.569 ' O ' ' CZ ' ' A' ' 74' ' ' TYR . 3.2 mtp85 -58.76 -11.26 2.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.85 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.5 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 10.7 m-85 -100.96 6.77 43.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.209 0.528 . . . . 1.0 110.405 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 99' ' ' LEU . 44.8 t -81.11 129.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.642 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.666 ' ND2' ' H ' ' A' ' 104' ' ' TRP . 3.1 p-10 -102.42 -137.85 0.34 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.13 -0.941 . . . . 1.0 111.22 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.666 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -132.41 160.39 36.53 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.396 -0.19 . . . . 1.0 110.78 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB3' ' NE2' ' A' ' 111' ' ' GLN . . . -95.0 -120.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.135 1.532 . . . . 1.0 115.135 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.2 t -174.68 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.419 -1.719 . . . . 1.0 107.678 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' GLY . 13.6 t -139.66 -179.02 5.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.84 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . . . -89.26 -5.69 72.35 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 121.325 -0.465 . . . . 1.0 112.682 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.66 -20.29 43.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 10.3 pt-20 -113.78 -19.93 11.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.764 0.793 . . . . 1.0 110.124 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 1.15 ' NE2' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -81.75 157.17 24.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.213 -1.358 . . . . 1.0 108.457 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.891 ' O ' HG22 ' A' ' 126' ' ' THR . 0.3 OUTLIER -173.22 37.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.903 0.859 . . . . 1.0 111.755 -176.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.533 ' O ' ' CE1' ' A' ' 140' ' ' TYR . 5.0 mp -141.13 141.5 34.17 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -144.04 123.3 7.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.142 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.507 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 50.5 Cg_exo -55.28 104.07 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.903 1.735 . . . . 1.0 110.709 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 123' ' ' TYR . 10.0 tp -109.49 118.44 36.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' OE1' ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -94.47 117.76 30.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.31 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.938 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -127.41 118.22 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.372 -1.344 . . . . 1.0 107.372 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.01 31.73 20.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.41 -1.33 . . . . 1.0 107.41 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.744 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 72.2 18.83 4.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.887 -1.051 . . . . 1.0 110.941 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.417 -0.81 . . . . 1.0 108.903 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.69 120.26 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.9 0.857 . . . . 1.0 112.282 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.938 ' CG ' HD11 ' A' ' 118' ' ' ILE . 6.0 m-85 -113.62 157.03 22.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.664 -1.607 . . . . 1.0 108.79 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.653 ' CD2' HD23 ' A' ' 99' ' ' LEU . 4.6 m-30 -115.72 104.84 12.08 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.687 -0.805 . . . . 1.0 111.237 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 114' ' ' PHE . 5.4 ttmm -102.63 150.77 23.1 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 114.331 1.234 . . . . 1.0 114.331 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 112' ' ' ASN . 4.8 p -103.12 107.88 18.85 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.89 -1.959 . . . . 1.0 109.883 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.618 ' HB2' ' HZ3' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -73.69 0.29 13.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 177.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.618 ' HZ3' ' HB2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -150.52 152.07 32.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.055 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.47 143.74 43.56 Favored 'Trans proline' 0 N--CA 1.516 2.803 0 C-N-CA 123.163 2.575 . . . . 1.0 114.379 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.851 HD11 ' OD1' ' A' ' 112' ' ' ASN . 0.8 OUTLIER -110.04 135.59 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.888 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.689 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -77.02 133.45 69.24 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HG3' ' N ' ' A' ' 49' ' ' PRO . 86.9 Cg_exo -50.24 103.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 122.868 2.378 . . . . 1.0 116.513 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 129.15 12.06 2.68 Favored Glycine 0 N--CA 1.468 0.81 0 C-N-CA 120.372 -0.918 . . . . 1.0 113.789 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.689 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.9 pt-20 -109.41 166.47 10.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.881 0.841 . . . . 1.0 111.614 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HB3' ' CE3' ' A' ' 45' ' ' TRP . 7.7 pt-20 -79.06 136.04 37.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.567 -1.197 . . . . 1.0 112.566 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.441 ' C ' HD13 ' A' ' 137' ' ' LEU . 1.3 mt -82.84 116.03 21.98 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.147 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -124.16 159.25 30.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 122.95 0.5 . . . . 1.0 111.658 -178.366 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.483 ' C ' ' OE1' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -122.91 148.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 178.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.829 ' C ' ' CD1' ' A' ' 140' ' ' TYR . 2.7 m95 140.37 -74.52 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.018 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 1.15 ' H ' ' NE2' ' A' ' 111' ' ' GLN . 15.9 p90 44.75 31.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 123.882 0.738 . . . . 1.0 111.75 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.584 ' OD1' ' C ' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.492 ' O ' ' C ' ' A' ' 143' ' ' GLU . . . . . . . . 0 CA--C 1.532 1.141 0 N-CA-C 111.607 -0.597 . . . . 1.0 111.607 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -9.5 122.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.778 0.831 . . . . 1.0 112.546 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 143' ' ' GLU . 6.2 t0 89.33 -1.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.948 -1.478 . . . . 1.0 108.079 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.762 HD21 ' HB2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -71.71 144.68 88.73 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.347 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.416 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 28.3 Cg_endo -62.18 -20.33 69.61 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.13 1.887 . . . . 1.0 112.72 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.762 ' HB2' HD21 ' A' ' 145' ' ' ASN . 0.3 OUTLIER -77.2 -34.4 56.18 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 177.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.638 HD11 ' OH ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -75.23 -54.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 113.933 -1.485 . . . . 1.0 110.874 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.54 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -54.38 -54.19 43.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.2 -31.35 52.76 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.0 -1.0 . . . . 1.0 109.012 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.591 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . -80.34 -45.16 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.833 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.685 HG22 ' HG2' ' A' ' 156' ' ' ARG . 30.2 mt -56.51 -49.37 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.587 -1.634 . . . . 1.0 106.587 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 74.2 mt-10 -60.82 -27.65 68.21 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.061 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -69.48 -50.71 42.82 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.094 -1.042 . . . . 1.0 111.192 -179.206 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.501 ' N ' ' HG2' ' A' ' 154' ' ' GLU . 8.6 tp10 -80.19 -50.52 10.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.685 ' HG2' HG22 ' A' ' 152' ' ' ILE . 4.4 ppt_? -63.24 -41.12 99.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -64.12 -23.0 67.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.528 -0.916 . . . . 1.0 108.528 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.421 ' HA ' HH21 ' A' ' 160' ' ' ARG . 11.0 m -89.67 15.04 10.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.199 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -136.32 39.85 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.16 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.53 ' CD ' ' H ' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -48.61 138.51 10.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.469 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.568 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.566 -1.414 . . . . 1.0 109.566 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.3 p 44.6 -90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.791 0.329 . . . . 1.0 110.565 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' -1' ' ' GLY . 0.1 OUTLIER -167.98 91.36 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.595 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -139.05 114.1 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.628 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -99.33 108.36 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.507 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -149.72 -66.68 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.594 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -145.4 -166.64 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.692 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.2 m -154.1 121.73 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.495 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -95.12 153.33 39.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.0 124.36 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.277 1.985 . . . . 1.0 112.002 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.45 ' H ' HG12 ' A' ' 9' ' ' VAL . 1.2 p -84.17 107.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.634 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.05 60.72 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.509 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 38.18 -148.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -128.7 -73.01 0.59 Allowed 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -44.51 154.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.345 -0.983 . . . . 1.0 108.345 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 151.4 41.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.437 0.637 . . . . 1.0 111.575 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.664 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -51.99 -32.67 34.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.137 -0.938 . . . . 1.0 109.03 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.59 60.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.728 -1.123 . . . . 1.0 111.948 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -24.94 22.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.511 -0.476 . . . . 1.0 112.146 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.552 ' CG1' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.73 144.85 64.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.8 Cg_exo -57.59 132.42 50.3 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.039 1.826 . . . . 1.0 113.077 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.668 ' HA ' HD21 ' A' ' 23' ' ' LEU . 34.3 tt0 -49.04 -31.79 8.32 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.842 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -74.18 -34.32 63.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.544 HG12 ' C ' ' A' ' 97' ' ' ASN . 14.5 m -75.88 -46.08 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.774 -177.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.973 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.01 -21.01 65.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.515 -0.874 . . . . 1.0 109.646 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HE ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.0 -38.91 69.55 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.294 -1.321 . . . . 1.0 111.947 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.57 36.43 4.35 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.681 -0.771 . . . . 1.0 112.318 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.849 HD13 ' O ' ' A' ' 30' ' ' VAL . 18.5 mt -90.09 129.3 46.42 Favored Pre-proline 0 CA--C 1.503 -0.861 0 C-N-CA 119.728 -0.789 . . . . 1.0 111.823 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.02 167.48 15.9 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 N-CA-C 108.63 -1.334 . . . . 1.0 108.63 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' C ' ' HG3' ' A' ' 48' ' ' LYS . 2.7 pt-20 -57.09 -10.2 1.11 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.94 -1.482 . . . . 1.0 114.521 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.957 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -109.23 18.67 20.27 Favored 'General case' 0 CA--C 1.449 -2.907 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.283 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.849 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -138.47 123.35 22.51 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 C-N-CA 117.268 -1.773 . . . . 1.0 114.115 -175.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' HB2' HG21 ' A' ' 47' ' ' THR . 3.3 ttp180 -130.47 151.79 50.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.228 -1.805 . . . . 1.0 107.685 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 26' ' ' LEU . 2.8 mm? -98.11 124.87 42.86 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.175 -0.61 . . . . 1.0 109.881 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.44 133.48 9.57 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.353 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 35' ' ' SER . 5.9 Cg_endo -85.21 149.86 10.58 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.168 1.912 . . . . 1.0 108.389 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.4 m 152.33 -73.31 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.459 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.82 -61.29 2.3 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.575 -1.25 . . . . 1.0 108.895 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 38' ' ' ASP . 4.8 p -60.94 -51.75 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.94 -0.392 . . . . 1.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.56 ' N ' HG13 ' A' ' 37' ' ' VAL . 0.8 OUTLIER 59.52 -40.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.592 0.96 . . . . 1.0 113.592 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' C ' HG22 ' A' ' 40' ' ' THR . 25.6 mttm -30.4 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.172 0.295 . . . . 1.0 111.663 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.598 HG22 ' C ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER 153.41 22.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.038 0.836 . . . . 1.0 111.654 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 17.0 mtp180 -140.54 163.0 34.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.796 -0.762 . . . . 1.0 111.932 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 149.15 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.397 0.618 . . . . 1.0 110.88 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.78 13.63 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.694 HG23 ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -104.87 127.25 59.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.459 ' CZ2' ' HB2' ' A' ' 36' ' ' ALA . 22.5 m95 -126.65 144.69 50.83 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.957 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.72 134.31 49.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.997 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 31' ' ' ARG . 68.4 p -119.11 -21.71 7.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.08 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.657 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -117.84 165.99 14.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.439 179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -77.79 125.31 7.34 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 123.04 2.493 . . . . 1.0 111.772 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.604 HD11 ' HB2' ' A' ' 29' ' ' GLU . 64.0 mt -113.1 149.58 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 113.394 -1.73 . . . . 1.0 112.801 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.833 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.87 164.64 12.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.828 -1.533 . . . . 1.0 110.261 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.695 ' H ' ' CE ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -68.71 128.03 35.18 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.103 178.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 1.003 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.57 8.22 38.03 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 119.066 -0.852 . . . . 1.0 114.455 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 1.9 ttmt -82.24 130.87 35.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 117.278 -1.769 . . . . 1.0 115.308 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -88.98 120.18 30.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.682 -1.599 . . . . 1.0 113.13 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.606 ' CG ' ' OE2' ' A' ' 29' ' ' GLU . 55.0 m-85 -119.75 150.02 41.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.483 0.658 . . . . 1.0 112.714 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.25 -102.29 2.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 113.706 -1.588 . . . . 1.0 110.151 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HB3' ' CE1' ' A' ' 123' ' ' TYR . 96.3 Cg_endo -78.79 170.45 69.42 Favored 'Cis proline' 0 N--CA 1.499 1.816 0 CA-C-N 119.355 1.578 . . . . 1.0 112.414 -1.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.628 ' CD1' ' NH2' ' A' ' 100' ' ' ARG . 38.5 t80 -54.46 107.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.785 -0.766 . . . . 1.0 109.056 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.732 HG12 ' NH2' ' A' ' 100' ' ' ARG . 5.6 p -42.74 -49.51 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.967 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 60' ' ' VAL . . . 45.0 121.32 0.0 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.621 0.608 . . . . 1.0 114.621 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.87 145.93 28.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' NZ ' HD11 ' A' ' 83' ' ' LEU . 1.1 mtmp? -89.51 113.92 25.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.056 0.455 . . . . 1.0 111.679 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HZ2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -142.76 169.88 16.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.631 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -80.65 133.61 35.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.374 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' O ' ' N ' ' A' ' 68' ' ' GLN . 30.8 ttp85 -45.53 -21.34 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.783 1.031 . . . . 1.0 113.783 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -35.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.969 0.414 . . . . 1.0 110.939 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 66' ' ' ARG . 59.5 mm-40 -95.7 -140.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.363 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.524 HG13 ' HZ2' ' A' ' 64' ' ' LYS . 15.7 m 38.87 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 121.521 0.676 . . . . 1.0 111.587 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -114.41 -29.5 6.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.707 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.69 31.7 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.214 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.506 ' CB ' ' SD ' ' A' ' 75' ' ' MET . 30.4 m120 -89.69 -179.37 5.75 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.678 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -119.1 -55.58 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -177.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -66.36 46.84 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.259 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.727 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -129.78 139.58 51.24 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -162.79 163.85 26.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 118.999 -1.08 . . . . 1.0 113.091 175.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -103.37 122.73 45.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.89 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -137.17 122.67 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.932 -1.507 . . . . 1.0 106.932 179.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.5 t80 -80.67 125.66 30.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.653 ' OH ' HD11 ' A' ' 88' ' ' ILE . 20.2 m-85 -103.05 104.2 38.72 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 114.897 -1.047 . . . . 1.0 113.059 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -62.87 10.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.388 1.392 . . . . 1.0 110.811 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 80' ' ' TYR . 76.3 m-20 -97.39 2.41 50.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.094 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.721 ' N ' HD23 ' A' ' 83' ' ' LEU . 1.1 pt? -178.23 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.015 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 150.09 179.67 26.09 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.439 ' C ' ' SD ' ' A' ' 86' ' ' MET . 18.2 m95 -58.15 122.37 12.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 19.1 mmm -127.28 167.39 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -117.75 138.04 52.3 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.265 -1.754 . . . . 1.0 106.265 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.653 HD11 ' OH ' ' A' ' 80' ' ' TYR . 64.3 mt -104.67 102.28 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -131.18 128.18 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.119 0.485 . . . . 1.0 111.33 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HA ' ' HZ3' ' A' ' 95' ' ' LYS . . . -139.73 92.47 2.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.219 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -111.1 13.31 21.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.366 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.84 99.6 35.43 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.938 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.426 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 50.6 Cg_exo -51.2 -14.78 1.74 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.628 2.218 . . . . 1.0 111.45 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.92 -43.84 94.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.646 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.737 ' HZ3' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -116.28 -8.48 11.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.785 -179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.716 ' HA2' HG11 ' A' ' 60' ' ' VAL . . . -95.48 -143.1 13.77 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.125 -1.036 . . . . 1.0 113.05 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.619 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 24.6 m-20 -137.18 -166.21 1.88 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.999 0.428 . . . . 1.0 110.475 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.547 ' CZ3' HG21 ' A' ' 44' ' ' VAL . 58.6 p-90 -70.4 -22.13 62.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.797 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.581 HD12 ' H ' ' A' ' 99' ' ' LEU . 5.9 mp -54.13 -24.22 17.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.835 ' H ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -61.7 -10.28 8.26 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 12.8 m-85 -107.24 -11.81 15.5 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.232 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.517 ' CG1' HG23 ' A' ' 138' ' ' VAL . 55.3 t -62.88 117.66 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.101 -1.04 . . . . 1.0 109.878 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -152.02 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CE3' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -124.5 165.25 18.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.372 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HA ' HD23 ' A' ' 137' ' ' LEU . . . -108.84 -131.83 0.32 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.44 -31.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.47 ' H ' ' CG ' ' A' ' 110' ' ' GLU . 4.0 m -143.78 175.7 9.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.695 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.95 -23.25 76.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 -22.37 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.47 ' CG ' ' H ' ' A' ' 107' ' ' SER . 4.0 pt-20 -109.15 -25.86 10.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.127 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.6 OUTLIER -86.93 102.21 14.14 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.703 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -104.09 0.32 29.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -140.51 144.75 36.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -142.82 132.51 12.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.736 1.754 . . . . 1.0 115.736 -176.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.6 122.36 3.93 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.122 3.215 . . . . 1.0 114.722 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.745 HD13 ' HD2' ' A' ' 125' ' ' LYS . 1.9 tp -132.2 128.05 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -97.49 118.73 34.63 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.947 -0.701 . . . . 1.0 110.856 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.878 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -129.36 114.95 33.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.088 -1.078 . . . . 1.0 108.088 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 58.4 39.21 25.52 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.649 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 67.05 17.56 10.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.004 -0.998 . . . . 1.0 110.658 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -108.69 123.82 49.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.394 -0.821 . . . . 1.0 108.974 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -82.25 126.98 40.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.878 ' CG ' HD11 ' A' ' 118' ' ' ILE . 6.0 m-85 -122.01 155.13 36.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.799 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -111.68 124.22 51.88 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.745 ' HD2' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -128.76 152.82 48.01 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 1.003 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.8 p -102.04 139.73 37.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.111 -1.858 . . . . 1.0 110.789 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.783 ' H ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -107.18 -4.44 18.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.182 -1.372 . . . . 1.0 109.024 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.975 ' H ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.45 131.83 11.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 114.937 -1.028 . . . . 1.0 110.435 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 145.64 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.601 1.534 . . . . 1.0 111.51 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.73 HG23 ' CG ' ' A' ' 134' ' ' GLU . 1.8 mt -108.39 134.48 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.703 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -77.15 115.77 51.67 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -38.68 113.12 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 123.004 2.469 . . . . 1.0 114.243 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 118.32 6.43 12.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.915 -0.659 . . . . 1.0 113.251 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.73 ' CG ' HG23 ' A' ' 130' ' ' ILE . 4.5 pt-20 -100.41 164.43 11.92 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.419 1.11 . . . . 1.0 111.429 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 45' ' ' TRP . 5.9 pt-20 -78.62 133.24 37.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.075 -0.966 . . . . 1.0 111.345 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.882 HD21 ' OE1' ' A' ' 29' ' ' GLU . 5.9 mp -86.36 122.4 30.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.326 -0.852 . . . . 1.0 108.941 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.754 HD12 ' C ' ' A' ' 136' ' ' LEU . 6.6 mp -130.71 158.16 40.83 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 139' ' ' TRP . 4.1 t -114.83 146.13 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.765 ' HZ2' ' N ' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -15.32 -118.12 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 O-C-N 125.83 1.956 . . . . 1.0 113.228 177.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.742 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -124.87 18.63 8.56 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.36 1.615 . . . . 1.0 115.36 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.653 ' OD1' ' C ' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.765 ' N ' ' HZ2' ' A' ' 139' ' ' TRP . . . . . . . . 0 CA--C 1.543 1.802 0 N-CA-C 111.826 -0.51 . . . . 1.0 111.826 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.916 ' O ' ' N ' ' A' ' 145' ' ' ASN . 1.7 tm-20 -177.77 -49.07 0.01 OUTLIER 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -18.97 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.033 1.494 . . . . 1.0 115.033 -178.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.916 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -119.48 166.94 13.2 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.159 0.584 . . . . 1.0 112.029 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.564 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 89.3 Cg_endo -98.56 -15.93 0.22 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 122.402 2.068 . . . . 1.0 112.934 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.799 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 0.6 OUTLIER -75.91 -36.97 59.23 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.466 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 1.4 mt -75.32 -55.97 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.758 -1.11 . . . . 1.0 109.757 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' A' ' 152' ' ' ILE . . . -61.51 -52.17 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.077 -0.965 . . . . 1.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.39 -34.27 47.24 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.78 -33.19 52.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 1.0 111.206 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 149' ' ' ALA . 58.8 mt -52.92 -50.35 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 107.6 -1.259 . . . . 1.0 107.6 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 31.7 mt-10 -59.89 -36.62 77.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.427 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.6 OUTLIER -58.41 -46.48 86.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 119.528 -0.869 . . . . 1.0 111.566 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.512 ' N ' ' HG2' ' A' ' 154' ' ' GLU . 1.8 tp10 -79.15 -50.89 10.28 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 4.7 ppt_? -76.54 -46.8 24.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.955 0.724 . . . . 1.0 112.955 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -61.76 -23.83 66.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.082 0.468 . . . . 1.0 109.944 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.441 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 4.9 m -97.08 27.21 4.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.043 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -141.21 34.02 1.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.719 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -52.82 163.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.399 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.589 -1.405 . . . . 1.0 109.589 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.53 139.28 25.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.358 . . . . 1.0 110.579 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.68 105.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.588 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.94 90.48 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.596 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -46.96 131.68 12.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.15 177.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.489 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 5' ' ' THR . 25.5 m -155.31 57.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.542 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 m -88.56 104.88 17.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.511 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.16 154.85 94.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.296 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -39.32 159.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.396 2.064 . . . . 1.0 111.951 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -86.16 132.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.288 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB1' ' HG2' ' A' ' 34' ' ' PRO . . . 56.39 160.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.496 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . . . -85.6 -35.83 20.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 20.5 m -175.27 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.202 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' PRO . 2.9 mm-40 -57.8 166.23 1.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 1.0 111.453 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -127.42 148.88 50.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.038 -0.983 . . . . 1.0 110.593 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.946 HD12 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.39 -36.2 73.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.9 -18.73 55.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.271 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HB3' ' H ' ' A' ' 14' ' ' THR . 4.6 tp10 -80.28 -46.65 15.82 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.626 -0.716 . . . . 1.0 112.383 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -41.17 158.36 0.18 Allowed Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 120.173 -0.611 . . . . 1.0 109.574 -178.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' HD22 ' A' ' 23' ' ' LEU . 7.4 Cg_endo -48.38 118.75 3.49 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.505 2.136 . . . . 1.0 112.093 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 3.5 tt0 -51.43 -43.24 61.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.459 1.281 . . . . 1.0 114.459 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.629 ' CD2' HG23 ' A' ' 22' ' ' VAL . 8.9 p-80 -62.1 -29.41 70.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.095 0.474 . . . . 1.0 111.302 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.629 HG23 ' CD2' ' A' ' 21' ' ' HIS . 73.2 t -72.93 -48.72 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.305 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.899 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.69 -25.88 62.28 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.175 0.988 . . . . 1.0 110.779 176.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -53.77 -34.36 58.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.433 -1.712 . . . . 1.0 109.612 -176.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.84 17.62 17.59 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.194 -0.762 . . . . 1.0 111.194 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.789 HD12 ' HD2' ' A' ' 27' ' ' PRO . 45.2 tp -79.41 122.98 84.57 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 117.081 0.441 . . . . 1.0 110.735 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.789 ' HD2' HD12 ' A' ' 26' ' ' LEU . 35.4 Cg_exo -35.23 137.26 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.286 1.324 . . . . 1.0 110.954 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.543 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 18.5 pt-20 -53.32 -31.91 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.777 -1.556 . . . . 1.0 109.373 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.5 pm0 -85.4 18.26 2.78 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 113.538 -1.664 . . . . 1.0 112.496 -176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.768 ' CG1' HD11 ' A' ' 26' ' ' LEU . 87.0 t -136.15 143.64 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 C-N-CA 118.726 -1.189 . . . . 1.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -144.0 155.36 43.99 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.192 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.946 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -102.68 148.02 26.11 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.673 0.749 . . . . 1.0 111.753 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.75 119.78 2.24 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 113.86 -1.518 . . . . 1.0 111.834 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 19.0 Cg_endo -80.69 152.02 19.53 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.899 1.732 . . . . 1.0 111.062 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.584 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 4.3 p 87.76 -27.04 0.07 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.964 0.888 . . . . 1.0 108.799 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.713 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -53.89 -62.53 1.59 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.89 -52.32 62.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.563 -0.29 . . . . 1.0 111.586 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 2.2 m-20 162.12 63.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.621 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.0 OUTLIER 30.63 36.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.917 -1.038 . . . . 1.0 109.365 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 91.1 m -91.96 -24.3 19.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.558 -1.655 . . . . 1.0 110.094 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 161.55 -157.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.229 -1.397 . . . . 1.0 107.229 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.19 137.55 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.863 -1.532 . . . . 1.0 106.863 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.57 155.35 19.5 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 109.032 -1.627 . . . . 1.0 109.032 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 2.0 m -100.91 136.5 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.166 0.984 . . . . 1.0 110.52 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.713 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 18.9 m95 -129.97 154.25 47.56 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.477 -1.692 . . . . 1.0 110.37 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.642 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -70.88 144.18 50.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.242 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.65 -26.54 2.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.389 -0.525 . . . . 1.0 110.381 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -120.44 158.77 50.38 Favored Pre-proline 0 C--N 1.341 0.215 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.96 124.73 16.62 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.424 2.083 . . . . 1.0 112.379 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 130' ' ' ILE . 3.9 mt -112.18 131.27 64.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.584 -1.189 . . . . 1.0 108.425 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.944 ' H ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.42 146.11 36.44 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 122.26 1.029 . . . . 1.0 111.314 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -50.69 133.63 25.59 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 113.324 -1.762 . . . . 1.0 107.532 177.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.77 2.06 52.57 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.612 -1.28 . . . . 1.0 115.447 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 26.6 ttpt -96.29 140.72 30.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.913 1.357 . . . . 1.0 112.594 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.21 135.59 40.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.947 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 34.3 m-85 -115.72 126.67 54.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.216 0.531 . . . . 1.0 112.093 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.69 -132.04 7.32 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 119.362 -0.688 . . . . 1.0 112.983 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 37.3 Cg_endo -80.62 171.97 58.26 Favored 'Cis proline' 0 N--CA 1.511 2.551 0 CA-C-N 120.03 1.915 . . . . 1.0 114.305 3.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.759 ' CD2' ' ND2' ' A' ' 97' ' ' ASN . 1.6 t80 -72.44 122.15 20.78 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.672 0.748 . . . . 1.0 109.531 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.793 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 63.8 t -102.9 138.65 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.169 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.39 -171.23 26.03 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -100.48 138.83 37.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.907 0.384 . . . . 1.0 110.499 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.84 117.28 29.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.636 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -140.4 164.81 29.11 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.297 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.19 145.16 33.8 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.653 0.264 . . . . 1.0 110.764 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -50.27 -44.5 53.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 110.161 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 p -70.26 70.39 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.432 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -165.0 -36.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.789 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.596 HG11 ' HE2' ' A' ' 75' ' ' MET . 13.1 m -96.52 154.48 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.104 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -132.92 -90.62 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.48 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -69.94 48.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.253 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.614 HD21 ' CG2' ' A' ' 91' ' ' THR . 0.7 OUTLIER -118.25 -175.18 2.81 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.628 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 73' ' ' VAL . 4.3 p -174.64 -9.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.56 . . . . 1.0 111.92 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 4.9 m-85 -92.37 43.18 1.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -118.03 156.47 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.826 -178.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.66 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -135.3 166.89 22.09 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.446 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -126.43 128.03 46.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.764 0.316 . . . . 1.0 110.744 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.56 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -141.77 141.51 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.294 0.568 . . . . 1.0 112.405 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 15.9 t80 -91.19 125.29 35.92 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.855 0.687 . . . . 1.0 112.855 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CD2' HD23 ' A' ' 83' ' ' LEU . 7.1 m-85 -102.22 145.56 30.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.841 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.62 3.22 5.59 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.72 1.614 . . . . 1.0 109.706 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -125.41 -68.77 0.82 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.412 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.832 HD22 ' H ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -74.41 -23.38 58.94 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.102 -178.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.39 -152.65 25.58 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 108.78 -1.728 . . . . 1.0 108.78 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -63.42 119.22 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.39 -0.924 . . . . 1.0 110.119 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.7 ppp? -129.46 169.15 15.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.838 -1.073 . . . . 1.0 108.951 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' LYS . 26.2 m -121.02 144.79 48.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.36 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 mt -98.58 146.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 106.8 -1.555 . . . . 1.0 106.8 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.79 139.5 50.22 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.078 0.77 . . . . 1.0 113.078 -177.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.619 ' HB1' ' HD3' ' A' ' 100' ' ' ARG . . . -130.66 140.62 50.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.615 -1.624 . . . . 1.0 106.615 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.614 ' CG2' HD21 ' A' ' 72' ' ' ASN . 3.4 p -151.63 15.7 0.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.987 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.26 141.83 0.13 Allowed Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.815 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.488 ' O ' HG21 ' A' ' 22' ' ' VAL . 55.2 Cg_endo -70.81 -18.18 32.25 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.263 1.975 . . . . 1.0 112.597 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -78.04 -6.19 53.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.826 0.822 . . . . 1.0 109.277 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 9.77 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.375 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 97' ' ' ASN . . . 94.26 156.16 32.13 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.793 ' CG ' ' H ' ' A' ' 60' ' ' VAL . 17.2 t30 84.07 110.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.6 ' N ' HG13 ' A' ' 22' ' ' VAL . 70.0 p-90 -71.31 -25.53 62.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.187 0.518 . . . . 1.0 109.759 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 102' ' ' VAL . 1.7 mt -60.08 -24.46 64.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.636 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.619 ' HD3' ' HB1' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -68.29 -11.1 58.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 119.107 -0.473 . . . . 1.0 111.234 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 98' ' ' TRP . 0.1 OUTLIER -120.14 5.87 10.79 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.613 -0.835 . . . . 1.0 113.173 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 99' ' ' LEU . 8.8 p -78.65 119.0 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.291 -0.564 . . . . 1.0 110.825 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -80.98 114.75 20.07 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.62 ' HB2' ' H ' ' A' ' 138' ' ' VAL . 4.9 p90 -88.03 159.09 18.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 104' ' ' TRP . . . -38.72 159.55 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 113.772 -1.558 . . . . 1.0 113.45 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.27 -4.4 21.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.134 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.64 -30.6 0.09 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.561 -0.456 . . . . 1.0 111.974 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.67 -29.37 6.64 Favored Glycine 0 C--N 1.321 -0.28 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.24 -19.46 5.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.513 ' HG3' HD23 ' A' ' 137' ' ' LEU . 20.2 pt-20 -112.76 -24.37 9.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.483 -0.78 . . . . 1.0 111.389 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.645 ' CD ' ' O ' ' A' ' 139' ' ' TRP . 1.1 tp-100 -48.2 139.12 8.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.101 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.712 ' C ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -124.98 6.73 7.97 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 119.154 -0.451 . . . . 1.0 112.106 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.987 HD12 ' N ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -154.96 174.56 14.99 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 118.263 0.483 . . . . 1.0 110.084 176.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.987 ' N ' HD12 ' A' ' 113' ' ' LEU . 1.6 p90 -139.62 145.6 44.15 Favored Pre-proline 0 C--N 1.346 0.425 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 139' ' ' TRP . 70.5 Cg_endo -82.38 138.2 9.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.754 2.303 . . . . 1.0 113.892 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -139.52 134.5 32.32 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.894 179.157 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.766 ' N ' HD23 ' A' ' 116' ' ' LEU . 40.4 mt-10 -89.25 123.71 33.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.223 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 121' ' ' ALA . 15.3 mt -139.6 129.49 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 46.14 43.01 10.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.114 -0.634 . . . . 1.0 110.012 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? 62.87 17.51 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.904 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -121.99 128.71 51.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.445 HD13 ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -88.93 116.46 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.692 -0.803 . . . . 1.0 112.676 -177.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.52 ' HB2' ' HZ3' ' A' ' 125' ' ' LYS . 13.7 m-85 -108.06 156.67 19.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.157 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.591 ' HB3' HD13 ' A' ' 113' ' ' LEU . 5.4 m-30 -112.89 125.78 54.75 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 107.575 -1.268 . . . . 1.0 107.575 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' A' ' 114' ' ' PHE . 2.0 mptt -116.53 139.23 50.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -131.82 125.59 32.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.676 -0.678 . . . . 1.0 112.453 178.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.924 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -98.96 21.42 11.65 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 119.911 -0.716 . . . . 1.0 109.592 175.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.712 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -124.53 119.51 25.99 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.23 97.78 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.963 0 CA-C-N 120.628 1.26 . . . . 1.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.695 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -69.62 136.42 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.447 -176.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.54 132.8 51.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.302 0.852 . . . . 1.0 113.302 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.04 103.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.163 1.908 . . . . 1.0 111.675 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 124.82 -7.22 8.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.062 -0.589 . . . . 1.0 113.164 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 135' ' ' GLU . 1.4 pp20? -87.7 154.14 20.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.942 0.871 . . . . 1.0 111.026 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.454 ' O ' ' OE2' ' A' ' 134' ' ' GLU . 1.6 pm0 -73.71 125.08 27.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.233 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 137' ' ' LEU . 10.9 mp -78.39 124.85 28.57 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 4.2 mp -123.56 146.1 48.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-O 118.982 -0.532 . . . . 1.0 112.18 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.62 ' H ' ' HB2' ' A' ' 104' ' ' TRP . 9.4 t -104.46 132.96 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.645 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 92.36 142.27 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 125.19 1.396 . . . . 1.0 110.869 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 141' ' ' IAS . 8.1 t80 -118.62 163.37 16.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.825 1.417 . . . . 1.0 114.825 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.605 ' N ' ' CD1' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 140' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.396 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 143' ' ' GLU . 2.6 mp0 53.82 88.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.853 -0.174 . . . . 1.0 110.946 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.495 ' N ' HG21 ' A' ' 148' ' ' ILE . 55.4 t0 -103.29 -41.44 6.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.663 2.098 . . . . 1.0 116.663 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.817 HD21 ' HD2' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -66.07 156.28 84.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 119.933 -0.707 . . . . 1.0 112.817 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.817 ' HD2' HD21 ' A' ' 145' ' ' ASN . 8.9 Cg_endo -48.13 -71.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.55 2.167 . . . . 1.0 110.131 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.777 ' HG2' HD22 ' A' ' 145' ' ' ASN . 0.5 OUTLIER -55.52 -20.7 13.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.229 0.537 . . . . 1.0 110.169 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.804 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -74.44 -56.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 119.31 -0.956 . . . . 1.0 108.92 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -74.09 -34.82 64.1 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.548 -0.861 . . . . 1.0 109.744 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 146' ' ' PRO . . . -80.25 -66.6 0.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.603 -0.839 . . . . 1.0 110.765 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 147' ' ' GLU . . . -51.75 -29.54 19.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 117.834 -1.546 . . . . 1.0 110.868 -174.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.804 HD12 ' O ' ' A' ' 148' ' ' ILE . 55.9 mt -66.4 -53.12 39.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.405 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.744 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 0.7 OUTLIER -68.09 -37.6 81.4 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.188 -0.915 . . . . 1.0 113.126 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.546 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 7.2 pt-20 -57.64 -50.12 74.2 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.889 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.546 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 26.8 tp10 -76.29 -50.1 15.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.382 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.737 ' NH2' ' HB2' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -77.57 -49.78 13.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.783 -179.543 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -63.84 -23.61 67.42 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.115 -0.634 . . . . 1.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.41 -35.18 0.25 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.243 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -129.45 136.07 49.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.954 0.407 . . . . 1.0 111.134 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -142.83 -49.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.577 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.593 -179.884 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 71.9 p -140.21 11.64 2.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.72 0.295 . . . . 1.0 110.544 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mmt -133.35 40.63 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.477 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -103.66 169.85 8.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.484 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.65 36.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -169.36 -62.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.502 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 m 43.72 85.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -104.43 102.4 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.547 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.06 153.51 88.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.21 169.4 19.57 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.246 1.964 . . . . 1.0 112.248 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 9' ' ' VAL . 47.7 t -144.7 50.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.56 176.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.498 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . . . -80.99 -45.83 16.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.949 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 88.1 m -169.93 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 34' ' ' PRO . 1.7 mt-10 -50.93 165.54 0.11 Allowed 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.539 0.685 . . . . 1.0 110.735 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.696 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -126.72 153.81 44.98 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.913 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.776 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -52.31 -31.89 35.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.95 -17.77 56.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.073 -1.422 . . . . 1.0 110.131 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.696 ' CB ' ' H ' ' A' ' 14' ' ' THR . 12.8 tp10 -77.97 -47.92 17.45 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.292 0.849 . . . . 1.0 113.292 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.68 HG23 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -48.85 147.8 4.3 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.68 ' HD2' HG23 ' A' ' 18' ' ' VAL . 5.2 Cg_exo -52.39 130.52 36.38 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.199 1.266 . . . . 1.0 111.898 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 4.4 tt0 -52.15 -34.94 46.99 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 114.564 -1.198 . . . . 1.0 113.011 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.734 ' CD2' ' O ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -79.27 -35.26 41.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.573 0.953 . . . . 1.0 113.573 -177.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.826 HG21 ' O ' ' A' ' 93' ' ' PRO . 1.6 t -79.52 -31.2 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.64 HD13 HG13 ' A' ' 18' ' ' VAL . 15.6 tp -71.81 -41.57 68.08 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.753 -2.021 . . . . 1.0 110.831 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -81.54 -20.02 40.89 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.164 0.585 . . . . 1.0 112.279 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.75 -26.98 36.31 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 110.148 -1.181 . . . . 1.0 110.148 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.689 ' HB3' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -63.76 144.13 97.97 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 117.907 -1.517 . . . . 1.0 111.564 -178.544 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 56' ' ' PHE . 50.8 Cg_exo -50.04 151.68 8.5 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 120.988 1.125 . . . . 1.0 111.871 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt-20 -52.84 -31.08 37.24 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.985 -1.461 . . . . 1.0 110.407 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.648 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -87.93 20.53 3.06 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 115.017 -0.992 . . . . 1.0 111.181 -178.366 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.643 HG12 HD22 ' A' ' 26' ' ' LEU . 21.4 t -135.29 137.03 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 C-N-CA 119.52 -0.872 . . . . 1.0 110.879 -177.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.544 ' NH1' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER -146.26 159.45 43.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.795 ' N ' HD22 ' A' ' 32' ' ' LEU . 1.1 mm? -104.57 141.08 37.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -152.16 120.82 3.31 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.772 -0.632 . . . . 1.0 111.654 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.564 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 9.8 Cg_endo -82.1 151.69 16.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.693 1.596 . . . . 1.0 111.689 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB3' ' N ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 78.06 15.6 1.43 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.46 -1.682 . . . . 1.0 106.46 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.654 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.55 -64.53 1.13 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.62 -29.77 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 78.44 -11.79 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.18 -0.918 . . . . 1.0 112.636 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 40' ' ' THR . 1.3 pttp -49.92 -12.19 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 4.9 m 98.84 64.41 0.0 OUTLIER 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.77 1.294 . . . . 1.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.418 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER 171.99 -165.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.196 -0.911 . . . . 1.0 108.951 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.531 HG13 ' N ' ' A' ' 34' ' ' PRO . 2.4 tt -101.62 144.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.58 163.02 22.78 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 109.316 -1.513 . . . . 1.0 109.316 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.565 HG23 HG13 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -99.66 136.24 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 CA-C-O 121.263 0.554 . . . . 1.0 109.724 -178.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 28.6 m95 -129.29 151.84 49.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.881 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.57 144.67 54.47 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.085 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.544 ' CG2' ' NH1' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -126.44 -29.64 2.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.538 -178.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -124.5 159.99 55.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.13 123.95 13.73 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.195 1.93 . . . . 1.0 112.937 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.564 ' C ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -111.04 131.52 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.145 -1.389 . . . . 1.0 107.544 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.003 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -109.72 155.24 21.8 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.925 0.869 . . . . 1.0 111.034 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -63.42 133.76 54.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.03 -1.441 . . . . 1.0 109.027 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.72 1.94 55.26 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.503 -1.332 . . . . 1.0 115.107 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 15.3 ttpt -90.1 134.34 34.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.167 -1.013 . . . . 1.0 112.485 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.08 130.43 36.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.14 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 5.5 m-85 -115.36 127.37 55.36 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.728 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.594 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 146.17 -146.97 17.59 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 5.1 Cg_endo -79.87 166.51 77.01 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 CA-C-N 119.583 1.692 . . . . 1.0 115.118 0.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.744 ' HA ' HD12 ' A' ' 99' ' ' LEU . 25.5 t80 -83.17 111.83 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.246 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.821 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.8 t -43.24 -61.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.401 -2.181 . . . . 1.0 114.079 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.52 ' N ' HG12 ' A' ' 60' ' ' VAL . . . 32.35 106.34 0.0 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-O 121.469 0.483 . . . . 1.0 112.931 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -72.81 143.13 47.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 1.7 mptp? -92.62 117.67 30.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.587 0.708 . . . . 1.0 112.79 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.695 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -141.91 167.89 21.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.677 -1.147 . . . . 1.0 111.213 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -78.95 135.86 37.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.1 0.476 . . . . 1.0 110.435 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -48.07 -24.39 1.08 Allowed 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.964 -0.46 . . . . 1.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.68 -6.29 58.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.342 . . . . 1.0 111.403 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -70.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.674 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.825 HG23 ' H ' ' A' ' 70' ' ' LYS . 3.9 m -36.57 -93.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.825 ' H ' HG23 ' A' ' 69' ' ' VAL . 4.6 tttm 84.82 -4.75 0.96 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.866 0.365 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.85 52.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.104 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.645 ' OD1' HG21 ' A' ' 91' ' ' THR . 0.1 OUTLIER -154.66 -164.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.61 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 73' ' ' VAL . 7.5 p -169.54 -8.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.486 -0.886 . . . . 1.0 112.939 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.8 m-85 -94.54 62.85 2.87 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.723 ' SD ' HG11 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -120.73 150.38 41.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.504 -177.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.678 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -128.58 165.35 20.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.845 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.88 132.04 53.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.749 0.277 . . . . 1.0 111.749 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.567 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -146.73 141.33 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.512 0.672 . . . . 1.0 112.798 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -83.51 124.94 31.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.286 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.531 ' CE1' ' HG3' ' A' ' 120' ' ' ARG . 4.4 m-85 -102.95 120.09 53.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.28 -12.86 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 N-CA-C 109.208 -1.112 . . . . 1.0 109.208 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' N ' ' C ' ' A' ' 80' ' ' TYR . 1.1 m-80 -101.16 -86.96 0.4 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.78 -1.1 . . . . 1.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.913 HD22 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 119.794 -0.762 . . . . 1.0 110.842 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . 89.46 -139.77 15.32 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.905 -1.678 . . . . 1.0 108.905 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.1 118.58 12.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.47 -0.892 . . . . 1.0 110.378 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.567 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -128.9 170.15 13.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.139 178.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.9 m -115.01 142.47 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.439 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.513 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 16.9 mt -96.22 152.08 3.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.58 ' CB ' ' HZ3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -129.39 136.16 49.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.312 0.577 . . . . 1.0 112.312 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.612 ' C ' HG22 ' A' ' 91' ' ' THR . . . -133.39 142.23 48.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.645 HG21 ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER 161.28 7.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 96' ' ' GLY . 5.4 p30 -117.07 62.79 3.08 Favored Pre-proline 0 C--O 1.22 -0.499 0 CA-C-N 114.565 -1.198 . . . . 1.0 109.433 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.826 ' O ' HG21 ' A' ' 22' ' ' VAL . 6.0 Cg_exo -45.68 -13.86 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.566 2.178 . . . . 1.0 112.143 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.734 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -78.2 -42.93 29.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.094 0.949 . . . . 1.0 110.065 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -11.71 12.67 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.134 -1.393 . . . . 1.0 110.143 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.821 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -63.29 -62.36 5.46 Favored Glycine 0 C--O 1.18 -3.269 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.768 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.609 HD22 ' C ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 138.09 150.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.638 0.775 . . . . 1.0 109.621 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.689 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 56.0 p-90 -56.68 -22.72 36.8 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 59' ' ' PHE . 41.7 mt -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.491 -0.884 . . . . 1.0 109.524 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.602 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -75.91 -9.93 59.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 177.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 98' ' ' TRP . 12.3 m-85 -90.33 -9.76 46.59 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.6 131.16 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 114.651 -1.159 . . . . 1.0 111.438 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -97.01 -158.86 0.7 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.109 -1.405 . . . . 1.0 110.033 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 24.5 p90 -136.72 164.26 28.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.524 -1.216 . . . . 1.0 112.058 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.969 ' HB3' ' HE1' ' A' ' 139' ' ' TRP . . . -87.2 140.24 29.74 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.261 0.837 . . . . 1.0 113.261 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -76.0 -13.29 60.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 177.115 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -142.66 132.04 23.56 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.707 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -46.97 -17.17 0.27 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' C ' ' A' ' 107' ' ' SER . 10.7 mm-40 -77.41 -32.88 55.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.861 0.362 . . . . 1.0 110.44 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 137' ' ' LEU . 25.4 tp10 -88.69 -22.88 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.321 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.734 HE21 ' CB ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -59.42 142.47 52.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.51 0.671 . . . . 1.0 109.392 177.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.599 ' HA ' ' HZ2' ' A' ' 128' ' ' LYS . 33.2 p30 -144.3 14.19 1.62 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.6 -1.182 . . . . 1.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -148.54 166.88 26.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.444 -0.503 . . . . 1.0 110.243 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -152.45 130.76 6.27 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 119.093 -1.043 . . . . 1.0 112.552 178.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.44 139.59 20.82 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.241 1.96 . . . . 1.0 113.96 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -142.4 138.76 31.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.517 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.713 ' H ' HD23 ' A' ' 116' ' ' LEU . 3.7 tm-20 -92.16 119.26 31.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 123' ' ' TYR . 23.4 mt -138.11 130.05 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 120.629 -0.428 . . . . 1.0 111.162 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.2 50.63 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.311 0.577 . . . . 1.0 111.473 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.531 ' HG3' ' CE1' ' A' ' 80' ' ' TYR . 1.3 tpp180 65.55 1.64 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.51 -0.476 . . . . 1.0 112.034 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.4 158.06 27.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.276 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -107.69 110.78 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 C-N-CA 119.785 -0.766 . . . . 1.0 112.011 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.3 m-85 -101.53 152.58 20.61 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.976 -1.011 . . . . 1.0 108.761 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.595 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 10.6 m-30 -113.86 127.26 55.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.616 ' NZ ' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -118.14 142.62 47.24 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 1.0 112.103 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.41 ' C ' HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -130.22 120.21 24.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.346 -1.297 . . . . 1.0 111.605 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.985 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -96.41 27.92 3.56 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.523 177.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HZ2' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -129.0 123.36 21.8 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.04 94.99 0.41 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 CA-C-N 120.736 1.299 . . . . 1.0 109.14 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 112' ' ' ASN . 1.3 mt -71.45 136.05 26.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.465 0.65 . . . . 1.0 109.311 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.83 132.67 63.67 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.995 -1.002 . . . . 1.0 113.282 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.53 104.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.923 1.749 . . . . 1.0 111.781 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.06 -7.81 8.1 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.6 150.95 23.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.559 . . . . 1.0 111.485 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 0.6 OUTLIER -79.73 136.96 36.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.773 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.4 mp -89.53 136.66 32.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.734 ' CB ' HE21 ' A' ' 111' ' ' GLN . 1.9 mm? -123.44 135.39 54.07 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.529 0.937 . . . . 1.0 113.529 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 139' ' ' TRP . 1.7 t -104.79 131.81 52.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.03 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.969 ' HE1' ' HB3' ' A' ' 105' ' ' ALA . 6.8 p-90 142.27 -126.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.502 1.521 . . . . 1.0 109.886 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.683 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 0.1 OUTLIER 100.25 26.82 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.416 1.486 . . . . 1.0 109.681 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.517 ' OD1' ' C ' ' A' ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.471 1.025 0 N-CA-C 111.771 -0.532 . . . . 1.0 111.771 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 3.7 tt0 32.77 52.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.264 0.554 . . . . 1.0 111.464 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -87.56 -35.3 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.296 -0.865 . . . . 1.0 111.596 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.688 ' HB3' ' HB ' ' A' ' 148' ' ' ILE . 9.5 t30 -66.83 172.1 3.77 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 114.054 -1.43 . . . . 1.0 110.279 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 150' ' ' ALA . 93.2 Cg_endo -93.2 -62.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.792 2.328 . . . . 1.0 110.092 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 151' ' ' ALA . 24.7 mt-10 -55.07 -22.56 16.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.724 0.774 . . . . 1.0 110.1 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -78.48 -55.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.454 178.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.558 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -75.87 -49.61 17.41 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.292 1.044 . . . . 1.0 109.431 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 146' ' ' PRO . . . -55.04 -65.74 0.53 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.11 -1.859 . . . . 1.0 109.055 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 147' ' ' GLU . . . -53.72 -36.47 62.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 118.103 -1.439 . . . . 1.0 111.209 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 63.8 mt -57.96 -53.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 117.576 -1.65 . . . . 1.0 108.601 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.78 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -66.87 -29.93 69.97 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.815 0.697 . . . . 1.0 111.893 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.508 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 2.8 pt-20 -67.42 -53.23 30.93 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.137 -1.025 . . . . 1.0 111.399 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.8 OUTLIER -82.28 -50.2 9.22 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.205 0.817 . . . . 1.0 113.205 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.572 ' HE ' ' C ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.07 -42.21 97.07 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 120.428 -0.509 . . . . 1.0 112.348 -178.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -75.53 -23.37 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.245 -0.582 . . . . 1.0 111.233 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 46.7 t -37.08 121.9 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.885 0.374 . . . . 1.0 110.976 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . 66.69 88.35 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.72 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -139.08 92.49 2.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.479 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.578 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 6.1 t -158.28 71.22 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.21 105.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -143.71 -16.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.577 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.3 105.8 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.27 139.69 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.587 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.42 94.34 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.513 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.2 m -166.04 124.19 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.742 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 1.7 mp0 -121.59 99.71 44.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.207 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ALA . 2.9 Cg_exo -59.14 -177.65 0.12 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 121.524 1.483 . . . . 1.0 111.712 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -50.61 86.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.319 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . 173.17 154.35 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.505 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -75.07 -67.49 0.64 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.742 HG22 ' N ' ' A' ' 13' ' ' GLU . 81.6 m -174.83 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.742 ' N ' HG22 ' A' ' 12' ' ' THR . 4.6 mm-40 53.8 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.672 ' HB ' ' H ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -140.2 176.32 8.86 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.0 174.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 16' ' ' ALA . 2.5 tt -58.12 -56.73 18.25 Favored 'General case' 0 CA--C 1.47 -2.128 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 175.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.691 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -80.87 -54.55 5.49 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 111.853 -2.431 . . . . 1.0 106.911 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.882 ' HG2' HG13 ' A' ' 18' ' ' VAL . 1.1 tt0 160.24 -21.37 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 115.777 1.769 . . . . 1.0 115.777 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.882 HG13 ' HG2' ' A' ' 17' ' ' GLU 0.279 1.1 m -145.17 -178.66 0.81 Allowed Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 120.457 1.481 . . . . 1.0 111.709 -175.072 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 4.2 Cg_exo -38.4 151.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.362 2.708 . . . . 1.0 111.113 173.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.704 ' HA ' HD11 ' A' ' 23' ' ' LEU . 13.7 tt0 -67.75 -34.26 76.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 115.778 1.77 . . . . 1.0 115.778 -176.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -73.63 -25.22 60.2 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -68.6 -51.37 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.769 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.84 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.05 -24.76 66.02 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.08 0.943 . . . . 1.0 110.617 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.727 -1.579 . . . . 1.0 108.801 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.41 3.98 47.3 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.951 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 32' ' ' LEU . 11.6 mt -62.6 158.51 49.88 Favored Pre-proline 0 CA--C 1.491 -1.309 0 CA-C-N 118.311 1.055 . . . . 1.0 110.256 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.66 145.36 51.73 Favored 'Trans proline' 0 C--N 1.29 -2.552 0 N-CA-C 107.338 -1.832 . . . . 1.0 107.338 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.434 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 19.7 pt-20 -49.01 -30.23 5.86 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.333 1.063 . . . . 1.0 110.944 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 1.4 pm0 -87.39 25.63 1.38 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.002 -1.454 . . . . 1.0 112.463 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 26' ' ' LEU . 11.2 t -143.33 148.91 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.977 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.922 ' C ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -158.34 155.36 28.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.007 -1.906 . . . . 1.0 106.407 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.042 ' H ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -128.73 151.05 49.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.439 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -156.93 142.57 12.69 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 124.209 0.943 . . . . 1.0 113.481 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 45.8 Cg_endo -86.83 150.16 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.699 2.266 . . . . 1.0 109.634 174.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.2 m 85.76 15.75 0.14 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.264 -1.384 . . . . 1.0 107.264 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.53 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -90.84 -61.11 1.74 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.69 -1.967 . . . . 1.0 105.69 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -67.46 -51.55 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.263 -1.335 . . . . 1.0 112.946 -178.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 40' ' ' THR . 27.8 t70 179.56 46.76 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER 30.11 39.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.17 0.986 . . . . 1.0 110.187 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.6 m -127.11 -56.23 1.34 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.714 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 37' ' ' VAL . 6.7 mtm180 -120.08 157.53 28.75 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.228 -2.26 . . . . 1.0 107.324 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.673 HG12 ' OE1' ' A' ' 17' ' ' GLU . 10.3 tt -103.64 146.39 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 118.706 -0.664 . . . . 1.0 109.934 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 17' ' ' GLU . . . -140.46 173.04 23.27 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 119.275 -1.44 . . . . 1.0 114.08 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.697 ' HB ' HD12 ' A' ' 32' ' ' LEU . 1.5 m -101.75 131.39 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.53 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 27.0 m95 -125.88 146.91 49.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -71.4 144.0 49.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.538 -0.756 . . . . 1.0 112.201 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.488 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 45.1 p -119.76 -30.0 4.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.103 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -119.19 158.66 47.84 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.39 123.05 12.86 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 121.873 1.715 . . . . 1.0 111.593 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.406 ' C ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -104.19 133.43 48.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.984 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.9 157.35 19.96 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.29 1.043 . . . . 1.0 111.757 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.77 130.05 42.06 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.464 -1.698 . . . . 1.0 108.938 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.78 3.39 49.37 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 119.607 -1.282 . . . . 1.0 115.797 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 24.7 ttpt -92.48 143.7 26.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 1.267 . . . . 1.0 113.063 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.6 41.77 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.751 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 20.9 m-85 -115.78 129.11 56.32 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.884 -1.053 . . . . 1.0 108.206 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.745 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 132.95 -149.42 19.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.19 -1.005 . . . . 1.0 112.461 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 70.0 Cg_endo -89.17 153.03 30.93 Favored 'Cis proline' 0 N--CA 1.51 2.497 0 CA-C-N 119.214 1.507 . . . . 1.0 115.206 0.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.808 ' CA ' HD12 ' A' ' 99' ' ' LEU . 3.9 t80 -58.01 112.88 1.65 Allowed 'General case' 0 CA--C 1.495 -1.142 0 CA-C-O 122.08 0.943 . . . . 1.0 111.905 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.759 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -86.25 134.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.781 -1.554 . . . . 1.0 108.033 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.52 147.84 17.25 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.84 -1.704 . . . . 1.0 108.84 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -69.15 142.12 54.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.456 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.4 mptt -92.38 115.75 28.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.31 0.576 . . . . 1.0 111.883 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -142.59 167.56 21.81 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.649 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.657 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.98 149.04 34.16 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.28 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -61.26 -48.56 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 1.0 110.73 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 t -67.14 63.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.322 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 66' ' ' ARG . 1.9 mm-40 -157.51 -48.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.482 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -68.7 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.774 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' VAL . 16.5 tttm 83.29 157.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.055 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.74 17.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.98 0.419 . . . . 1.0 110.226 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.5 ' OD1' ' SD ' ' A' ' 75' ' ' MET . 0.4 OUTLIER -110.65 -165.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.023 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' A' ' 75' ' ' MET . 2.0 p -173.58 -23.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 119.469 -0.892 . . . . 1.0 111.835 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' C ' ' SD ' ' A' ' 75' ' ' MET . 6.1 m-85 -76.38 35.96 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.705 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -117.35 152.6 34.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.119 -177.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.616 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -134.02 166.79 21.92 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.165 -0.679 . . . . 1.0 109.165 -178.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -133.48 125.58 29.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.186 0.517 . . . . 1.0 110.576 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.54 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.39 139.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.544 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.548 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 49.7 t80 -87.15 129.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.644 0.735 . . . . 1.0 111.228 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.523 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 4.7 m-85 -105.73 140.42 21.18 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.956 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.56 17.04 0.98 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.849 1.7 . . . . 1.0 110.83 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.516 ' C ' ' ND2' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -149.07 -31.46 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.92 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.523 ' H ' ' HB3' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -106.09 -16.61 14.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.962 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.31 -165.3 53.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -62.84 121.28 13.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.549 -0.86 . . . . 1.0 109.881 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.3 ppp? -130.96 168.66 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.14 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' LYS . 54.4 m -123.84 144.64 49.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.933 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 59' ' ' PHE . 82.8 mt -99.93 146.14 9.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 7.4 p-10 -133.61 119.29 19.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.349 0.977 . . . . 1.0 112.012 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.408 ' HB3' ' HE ' ' A' ' 100' ' ' ARG . . . -143.0 90.99 2.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.71 0.85 28.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.618 1.099 . . . . 1.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -128.89 131.55 23.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.819 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 96' ' ' GLY . 65.9 Cg_exo -48.97 -28.78 14.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.845 1.697 . . . . 1.0 113.728 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.22 -18.69 45.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.313 1.054 . . . . 1.0 108.428 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -88.63 18.19 4.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.123 -1.853 . . . . 1.0 109.473 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' PRO . . . -174.36 166.09 37.89 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.96 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.773 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -71.6 175.3 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.293 -1.002 . . . . 1.0 108.293 177.291 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.656 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 25.9 p-90 -56.44 -22.01 29.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.908 -0.717 . . . . 1.0 112.732 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.808 HD12 ' CA ' ' A' ' 59' ' ' PHE . 19.2 mt -53.71 -28.05 31.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 177.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' NH2' ' HE1' ' A' ' 76' ' ' TRP . 13.6 tpp180 -74.88 -12.9 60.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.949 -0.569 . . . . 1.0 112.006 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.882 ' CD2' HG11 ' A' ' 18' ' ' VAL . 15.9 p90 -123.56 4.15 8.97 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 119.696 -0.802 . . . . 1.0 110.694 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 102' ' ' VAL . 2.7 p -71.71 116.45 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.517 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 1.7 m-20 -85.22 143.36 28.8 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.311 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.521 ' C ' HD23 ' A' ' 137' ' ' LEU . 33.7 p90 -111.58 162.9 14.66 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.835 0.826 . . . . 1.0 112.945 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.955 ' N ' HD23 ' A' ' 137' ' ' LEU . . . -50.9 -179.15 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.132 -1.395 . . . . 1.0 112.336 -177.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -75.09 -20.4 59.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.669 178.423 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 106' ' ' CYS . 1.5 p 151.91 71.17 0.0 OUTLIER 'General case' 0 C--N 1.347 0.464 0 O-C-N 123.857 0.723 . . . . 1.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.41 ' N ' ' OE1' ' A' ' 111' ' ' GLN . . . 72.72 13.96 78.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.559 -0.616 . . . . 1.0 111.559 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.57 -44.08 19.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.012 -0.675 . . . . 1.0 111.36 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.65 ' OE2' HD13 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -120.19 -30.59 4.6 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.605 -0.438 . . . . 1.0 111.863 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.8 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 3.4 mt-30 -24.92 139.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.889 0.876 . . . . 1.0 113.083 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.602 ' ND2' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -140.15 19.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 1.0 110.134 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.84 HD12 ' H ' ' A' ' 114' ' ' PHE . 2.1 tp -153.12 149.3 27.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.69 -0.672 . . . . 1.0 109.698 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.84 ' H ' HD12 ' A' ' 113' ' ' LEU . 3.9 p90 -126.31 150.12 69.18 Favored Pre-proline 0 C--N 1.366 1.305 0 N-CA-C 114.616 1.339 . . . . 1.0 114.616 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -88.68 141.37 4.56 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 123.007 2.472 . . . . 1.0 114.073 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.723 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -141.81 139.74 32.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.847 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.723 ' H ' HD23 ' A' ' 116' ' ' LEU . 7.5 mt-10 -98.41 120.43 38.82 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.567 -0.288 . . . . 1.0 110.677 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -136.75 126.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 120.827 0.346 . . . . 1.0 110.637 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 121' ' ' ALA . 3.5 m-20 52.64 47.92 23.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.177 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.586 ' H ' ' NH1' ' A' ' 120' ' ' ARG . 1.8 mmt-85 62.97 5.96 2.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.126 0.489 . . . . 1.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -107.07 156.8 18.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 1.0 108.785 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -115.82 103.97 16.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.911 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 116' ' ' LEU . 13.4 m-85 -100.1 148.82 24.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.747 ' HB3' HD11 ' A' ' 113' ' ' LEU . 13.5 m-30 -113.16 114.08 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.573 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -107.13 142.57 36.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.124 1.157 . . . . 1.0 114.124 -178.065 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.623 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -129.84 132.43 46.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.423 -1.262 . . . . 1.0 112.491 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -106.38 26.04 10.35 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.7 0.682 . . . . 1.0 109.536 175.216 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.601 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -127.66 117.01 21.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.03 97.87 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 CA-C-N 120.465 1.202 . . . . 1.0 110.635 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.54 HG23 ' CG ' ' A' ' 134' ' ' GLU . 1.6 mt -70.36 136.8 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.27 1.033 . . . . 1.0 109.561 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.13 132.67 76.33 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 113.96 -1.473 . . . . 1.0 114.188 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -50.13 97.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.67 1.58 . . . . 1.0 110.737 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.68 -4.28 8.06 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.786 -0.525 . . . . 1.0 111.786 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.602 ' OE2' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -87.48 151.65 22.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.4 pm0 -77.21 129.08 35.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.919 0.39 . . . . 1.0 110.085 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.863 ' C ' HD12 ' A' ' 137' ' ' LEU . 5.5 mp -81.33 142.21 33.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.955 HD23 ' N ' ' A' ' 105' ' ' ALA . 6.8 mp -139.86 155.25 47.31 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.52 HG21 ' CE2' ' A' ' 124' ' ' TYR . 2.4 t -110.59 131.81 60.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 CA-C-N 114.93 -1.032 . . . . 1.0 113.228 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.672 ' CD1' ' NE2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 173.4 -167.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.5 0.667 . . . . 1.0 112.662 177.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.485 ' O ' ' C ' ' A' ' 141' ' ' IAS . 87.3 m-85 91.5 76.49 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 112.882 -1.963 . . . . 1.0 111.038 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.485 ' C ' ' O ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.468 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 110.802 -0.919 . . . . 1.0 110.802 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 58.96 104.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.26 0.552 . . . . 1.0 111.767 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.651 ' H ' HG21 ' A' ' 148' ' ' ILE . 25.1 t70 -124.55 -54.32 1.67 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.455 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.539 ' OD1' HD23 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -70.64 154.13 94.54 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 122.158 -0.339 . . . . 1.0 111.435 -178.211 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.522 ' HD2' ' ND2' ' A' ' 145' ' ' ASN . 11.5 Cg_endo -49.38 -75.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 123.229 2.619 . . . . 1.0 111.977 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 151' ' ' ALA . 0.3 OUTLIER -54.9 -18.65 5.19 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.831 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -65.69 -54.33 28.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.874 -1.528 . . . . 1.0 106.874 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.537 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -73.87 -35.77 64.76 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.952 -0.699 . . . . 1.0 110.203 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 147' ' ' GLU . . . -78.03 -66.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.046 -1.061 . . . . 1.0 110.233 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 147' ' ' GLU . . . -48.5 -29.75 4.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.129 -1.028 . . . . 1.0 110.153 -175.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.724 HD12 ' O ' ' A' ' 148' ' ' ILE . 50.3 mt -65.04 -51.65 63.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 118.459 -1.296 . . . . 1.0 108.351 176.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.749 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -71.31 -37.52 71.8 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 114.94 -1.027 . . . . 1.0 113.1 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -57.27 -48.58 78.53 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.894 -177.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -74.06 -51.72 14.91 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.681 -0.407 . . . . 1.0 111.824 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.716 ' HE ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -76.84 -47.82 20.25 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.666 -0.814 . . . . 1.0 110.448 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -78.42 -51.26 10.3 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.444 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER 39.38 -163.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.03 0.443 . . . . 1.0 110.949 179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.532 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . 42.99 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 158' ' ' SER . 15.0 mmt-85 42.26 32.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.25 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.683 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.7 p -143.81 -125.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.761 0.315 . . . . 1.0 110.6 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -168.26 97.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.54 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -156.86 98.97 1.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.499 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -101.38 106.16 17.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.621 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -172.31 -168.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.575 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 t -46.82 141.16 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.399 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 175.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.521 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -140.01 153.1 69.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.132 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.78 -173.1 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.073 1.849 . . . . 1.0 111.775 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ALA . 2.2 t -96.33 25.4 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 1.0 110.547 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 44.79 -174.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.003 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 13' ' ' GLU . . . -46.39 -35.44 5.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 14' ' ' THR . 0.4 OUTLIER 73.44 -39.8 0.45 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.579 179.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 42' ' ' ILE . 1.4 mm-40 28.23 -87.09 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -136.78 172.18 13.4 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.663 174.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 15' ' ' LEU . 6.3 tt -73.04 -59.91 2.48 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.823 -1.151 . . . . 1.0 108.336 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -78.35 -59.57 2.73 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-N 113.216 -1.811 . . . . 1.0 108.407 -176.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.734 ' HG3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -145.77 -102.58 0.1 Allowed 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 118.565 -1.254 . . . . 1.0 114.289 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.745 HG13 ' HD3' ' A' ' 19' ' ' PRO 0.284 0.2 OUTLIER 179.38 -80.42 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 116.974 -1.489 . . . . 1.0 111.601 -177.456 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.745 ' HD3' HG13 ' A' ' 18' ' ' VAL . 4.4 Cg_exo -74.19 147.01 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 CA-C-N 124.875 2.777 . . . . 1.0 111.404 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.509 ' CD ' HH12 ' A' ' 24' ' ' ARG . 37.4 tt0 -67.73 -50.26 58.29 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.338 1.066 . . . . 1.0 110.404 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.569 ' NE2' ' O ' ' A' ' 94' ' ' GLU . 28.7 p80 -56.36 -24.85 46.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.884 -1.053 . . . . 1.0 113.408 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.795 HG23 HD12 ' A' ' 23' ' ' LEU . 2.0 m -64.09 -45.0 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 121.284 1.857 . . . . 1.0 106.362 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.795 HD12 HG23 ' A' ' 22' ' ' VAL . 6.5 mp -54.71 -28.67 49.7 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.596 0.712 . . . . 1.0 110.405 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.509 HH12 ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.05 -20.84 60.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.519 -1.219 . . . . 1.0 108.616 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . -114.7 -12.68 10.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.309 -1.314 . . . . 1.0 113.063 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.644 HD13 ' C ' ' A' ' 30' ' ' VAL . 16.8 mt -60.19 150.21 72.31 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-N 118.988 1.394 . . . . 1.0 110.589 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 26' ' ' LEU . 75.9 Cg_exo -42.56 -128.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.666 2.911 . . . . 1.0 113.184 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 48' ' ' LYS . 4.2 mt-10 -68.77 -50.75 47.85 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.776 -1.57 . . . . 1.0 106.796 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' H ' ' HE2' ' A' ' 48' ' ' LYS . 12.5 tt0 -126.18 -77.71 0.59 Allowed 'General case' 0 C--N 1.363 1.17 0 C-N-CA 120.157 -0.617 . . . . 1.0 111.489 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.644 ' C ' HD13 ' A' ' 26' ' ' LEU 0.365 4.9 t 59.43 152.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 C-N-CA 127.881 2.472 . . . . 1.0 116.265 -176.112 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' C ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.79 160.61 42.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.173 -2.285 . . . . 1.0 110.948 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 31' ' ' ARG . 3.5 mm? -117.75 120.41 37.88 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 174.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.54 ' C ' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -129.43 122.56 20.94 Favored Pre-proline 0 N--CA 1.485 1.299 0 O-C-N 121.193 -0.942 . . . . 1.0 112.633 -176.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 4.3 Cg_exo -79.22 130.4 9.2 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.804 2.336 . . . . 1.0 112.897 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.3 t 87.8 30.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.667 -2.06 . . . . 1.0 107.286 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -94.57 -54.12 3.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 38' ' ' ASP . 7.5 p -59.4 -49.85 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 113.614 -1.63 . . . . 1.0 111.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.558 ' N ' HG13 ' A' ' 37' ' ' VAL . 0.6 OUTLIER 169.28 -50.91 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.3 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.548 -1.205 . . . . 1.0 107.909 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.554 ' HB ' HG11 ' A' ' 37' ' ' VAL . 20.7 m -102.83 -34.73 8.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 40' ' ' THR . 7.7 mtm-85 155.06 -159.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.7 -1.593 . . . . 1.0 106.7 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 13' ' ' GLU . 9.5 tt -84.07 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 118.915 0.779 . . . . 1.0 111.315 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.558 ' C ' HD13 ' A' ' 32' ' ' LEU . . . -106.75 166.72 13.66 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -103.28 120.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 118.134 0.967 . . . . 1.0 111.426 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.651 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 4.9 m95 -127.51 143.79 51.14 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.258 -0.883 . . . . 1.0 110.173 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -84.7 123.84 30.83 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.2 -1.0 . . . . 1.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -21.76 19.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.37 0.605 . . . . 1.0 109.409 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.61 ' HZ2' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -107.87 167.89 8.68 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 114.728 -1.124 . . . . 1.0 110.963 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 5.9 Cg_exo -76.09 144.34 26.69 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.65 2.233 . . . . 1.0 111.158 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.61 HG12 ' HZ2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -118.73 144.09 27.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.91 -178.44 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.98 146.31 39.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.92 0.866 . . . . 1.0 110.742 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.65 140.14 58.47 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.323 -1.308 . . . . 1.0 111.822 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.79 3.92 58.07 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 119.409 -1.377 . . . . 1.0 115.302 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' CG ' ' N ' ' A' ' 55' ' ' LYS . 30.0 ttpt -106.22 146.27 30.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 118.92 -1.112 . . . . 1.0 113.968 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -97.39 140.71 31.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.791 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 126' ' ' THR . 3.0 m-85 -118.59 131.03 56.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.052 -1.462 . . . . 1.0 107.052 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.64 -150.45 21.11 Favored Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 21.6 Cg_endo -84.83 170.7 46.88 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 119.671 1.735 . . . . 1.0 113.457 0.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.823 ' HB2' HD12 ' A' ' 99' ' ' LEU . 36.9 t80 -73.72 122.31 22.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.622 0.725 . . . . 1.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -44.37 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.886 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 37.12 109.14 0.0 OUTLIER Glycine 0 C--N 1.333 0.399 0 CA-C-O 121.711 0.617 . . . . 1.0 113.244 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t70 -85.78 134.96 33.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 63' ' ' LYS . 1.5 mptt -90.59 116.33 28.41 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.517 0.675 . . . . 1.0 112.124 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HZ3' ' HB3' ' A' ' 87' ' ' CYS . 0.1 OUTLIER -124.05 158.08 33.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.626 -1.17 . . . . 1.0 110.98 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -83.63 135.53 34.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 177.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -53.27 -31.04 41.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.783 -0.573 . . . . 1.0 110.394 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -91.53 27.22 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.838 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 -68.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.743 0.782 . . . . 1.0 110.255 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.709 HG13 HD22 ' A' ' 72' ' ' ASN . 0.4 OUTLIER -73.85 170.44 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 114.402 -1.272 . . . . 1.0 111.259 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 7.1 tttp -110.27 -128.71 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.108 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.464 ' H ' ' CG ' ' A' ' 70' ' ' LYS . 12.9 t-20 -36.87 -80.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.732 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.709 HD22 HG13 ' A' ' 69' ' ' VAL . 2.3 p30 49.28 -177.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.578 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 73' ' ' VAL . 7.4 p -172.58 -13.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.03 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 3.0 m-85 -98.88 53.31 0.99 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.59 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -125.57 147.05 49.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.653 0.74 . . . . 1.0 112.584 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -123.11 164.28 18.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.525 -1.216 . . . . 1.0 110.512 -178.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -122.69 122.21 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.181 0.515 . . . . 1.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.96 139.93 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.406 -0.816 . . . . 1.0 111.83 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.516 ' O ' ' CZ ' ' A' ' 120' ' ' ARG . 4.4 t80 -92.67 135.84 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.875 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.61 ' CD1' HD11 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -117.12 146.05 37.17 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -70.19 44.46 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 N-CA-C 108.225 -1.49 . . . . 1.0 108.225 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.575 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 1.5 t30 -148.21 -85.77 0.1 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.212 -1.358 . . . . 1.0 110.297 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 84' ' ' GLY . 0.8 OUTLIER -80.48 -8.99 59.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.33 -1.305 . . . . 1.0 112.322 -176.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.74 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 81.65 -145.81 25.31 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -78.68 118.13 20.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.721 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -129.96 173.38 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.744 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.586 ' N ' ' SD ' ' A' ' 86' ' ' MET . 67.8 m -117.96 141.41 48.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.152 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.4 150.66 3.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 N-CA-C 108.05 -1.093 . . . . 1.0 108.05 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -133.66 136.69 44.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.827 1.047 . . . . 1.0 113.827 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 91' ' ' THR . . . -133.23 139.93 47.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 90' ' ' ALA . 30.2 p -158.61 -13.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.487 0.585 . . . . 1.0 110.033 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.03 106.31 3.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.75 -22.09 9.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.132 1.888 . . . . 1.0 114.353 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.569 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 5.9 pt-20 -83.18 -8.39 59.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.904 0.859 . . . . 1.0 110.215 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 11.65 35.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.343 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.442 ' O ' ' ND1' ' A' ' 21' ' ' HIS . . . -165.44 -95.07 0.1 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 119.073 -1.537 . . . . 1.0 114.012 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.672 ' ND2' ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -146.18 173.35 12.29 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 101' ' ' TYR . 30.6 p-90 -70.86 -19.95 62.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.823 HD12 ' HB2' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -50.18 -24.11 2.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.775 HH22 HD21 ' A' ' 103' ' ' ASN . 3.1 tpm_? -84.57 -23.16 29.78 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 120.146 -0.621 . . . . 1.0 110.749 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -72.57 -7.35 49.69 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.299 1.047 . . . . 1.0 109.479 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.718 HG22 ' CZ2' ' A' ' 104' ' ' TRP . 3.4 t -82.48 119.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.249 -1.796 . . . . 1.0 111.041 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.775 HD21 HH22 ' A' ' 100' ' ' ARG . 38.4 m-20 -156.15 71.68 0.73 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.661 0.664 . . . . 1.0 111.464 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.818 ' HE1' ' N ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -141.88 176.69 8.73 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.089 0.956 . . . . 1.0 111.497 -177.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.601 ' C ' ' N ' ' A' ' 107' ' ' SER . . . 26.53 52.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.43 1.081 . . . . 1.0 109.995 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -48.56 -14.53 0.06 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.601 ' N ' ' C ' ' A' ' 105' ' ' ALA . 20.0 p -174.98 18.06 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.35 -1.295 . . . . 1.0 110.561 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.704 ' N ' ' HE1' ' A' ' 139' ' ' TRP . . . -85.2 131.26 10.33 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.06 -12.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 4.3 pt-20 -74.26 5.52 4.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 113.698 0.999 . . . . 1.0 113.698 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.696 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.4 pp0? -54.48 140.23 35.04 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.673 1.36 . . . . 1.0 114.673 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.983 ' ND2' ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -117.58 -5.22 11.19 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.333 -1.758 . . . . 1.0 111.663 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 114' ' ' PHE . 0.3 OUTLIER -155.8 165.47 36.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 119.441 -0.314 . . . . 1.0 110.931 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 1.079 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -133.11 138.03 30.77 Favored Pre-proline 0 C--N 1.357 0.933 0 N-CA-C 113.869 1.062 . . . . 1.0 113.869 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.78 146.02 10.37 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.422 2.748 . . . . 1.0 113.648 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.822 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -144.66 146.54 32.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.293 178.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.822 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.2 tt0 -97.38 119.06 35.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 123' ' ' TYR . 7.7 mt -137.39 132.21 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.929 -177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 121' ' ' ALA . 30.2 m-20 50.14 57.95 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.485 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.516 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 9.8 mmp_? 57.21 -0.8 0.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.494 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 58' ' ' PRO . . . -123.21 155.62 36.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.248 -0.278 . . . . 1.0 110.248 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CE2' ' A' ' 76' ' ' TRP . 1.0 OUTLIER -103.8 113.94 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.602 ' HB2' HD12 ' A' ' 118' ' ' ILE . 5.0 m-85 -101.35 149.32 24.16 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.737 ' CE2' HG21 ' A' ' 138' ' ' VAL . 3.1 m-30 -112.97 126.93 56.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.338 -1.356 . . . . 1.0 107.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.946 ' H ' ' HZ2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -122.5 140.43 52.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.006 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.642 ' C ' HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -128.73 134.47 48.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 1.0 109.708 178.376 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.887 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -105.87 16.78 24.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.103 176.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.593 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -125.16 127.01 25.13 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.22 98.79 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 121.33 1.511 . . . . 1.0 111.068 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.531 HD13 ' OD1' ' A' ' 112' ' ' ASN . 55.6 mt -67.81 134.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.273 1.035 . . . . 1.0 109.594 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.663 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.01 139.32 97.75 Favored Pre-proline 0 C--O 1.212 -0.872 0 CA-C-N 113.929 -1.487 . . . . 1.0 114.086 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.52 115.44 4.29 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.556 2.171 . . . . 1.0 111.692 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 109.65 0.95 30.73 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.914 -0.474 . . . . 1.0 111.914 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.702 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -97.75 173.27 7.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.84 0.829 . . . . 1.0 112.353 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' CG ' ' CD1' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -85.81 141.42 29.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.211 -1.358 . . . . 1.0 108.359 176.369 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.711 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.4 mp -89.9 136.88 32.78 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.218 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.983 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 6.8 mp -121.6 142.84 49.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.757 0.789 . . . . 1.0 112.104 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.818 ' N ' ' HE1' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -119.97 137.12 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 114.034 -1.439 . . . . 1.0 110.014 -176.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.704 ' HE1' ' N ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -137.65 134.82 35.9 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 -177.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 141' ' ' IAS . 0.1 OUTLIER -154.6 29.41 0.43 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.706 -1.588 . . . . 1.0 108.719 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.501 ' OD1' ' C ' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.401 0 N-CA-C 112.282 -0.327 . . . . 1.0 112.282 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.642 ' CD ' ' HB2' ' A' ' 149' ' ' ALA . 0.9 OUTLIER -166.53 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.264 -0.574 . . . . 1.0 111.511 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.625 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 12.2 t0 94.21 -43.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.83 0.706 . . . . 1.0 111.651 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.794 ' ND2' HD23 ' A' ' 127' ' ' LEU . 2.0 t-20 -78.82 149.66 74.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.177 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -55.61 -63.75 0.17 Allowed 'Trans proline' 0 N--CA 1.512 2.57 0 C-N-CA 123.141 2.561 . . . . 1.0 115.493 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.69 ' O ' ' N ' ' A' ' 151' ' ' ALA . 14.0 mm-40 -58.6 -49.07 78.82 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 120.973 0.416 . . . . 1.0 110.468 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.596 ' O ' HD12 ' A' ' 152' ' ' ILE . 2.0 mt -47.48 -52.81 5.06 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 N-CA-C 106.388 -1.708 . . . . 1.0 106.388 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.642 ' HB2' ' CD ' ' A' ' 143' ' ' GLU . . . -71.05 -50.4 34.35 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.123 -1.831 . . . . 1.0 109.191 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.87 -65.59 0.68 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.285 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.69 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -55.87 -34.22 65.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.846 1.657 . . . . 1.0 112.374 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 148' ' ' ILE . 48.5 mt -54.16 -47.26 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.198 -1.801 . . . . 1.0 108.24 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.749 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -71.8 -38.57 70.22 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 124.057 0.848 . . . . 1.0 112.694 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.502 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 5.6 pt-20 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.597 -0.841 . . . . 1.0 112.978 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 4.7 tp10 -79.22 -51.51 9.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.757 ' NH2' ' HB2' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -72.6 -50.34 26.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.225 -0.99 . . . . 1.0 112.201 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.757 ' HB2' ' NH2' ' A' ' 156' ' ' ARG . . . -53.79 -23.85 13.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 119.149 -1.02 . . . . 1.0 108.975 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 4.2 t -79.41 137.26 37.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.705 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . 70.04 14.73 7.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.948 0.404 . . . . 1.0 110.209 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 161' ' ' SER . 2.2 tpt180 -85.99 103.62 14.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.509 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 160' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.499 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.28 -88.57 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 3' ' ' GLN . 4.7 tpp -142.72 126.02 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.598 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 4' ' ' ASN . 39.1 m-20 -65.91 72.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.574 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 1' ' ' MET . 3.2 tp-100 -71.77 12.18 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.599 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 2' ' ' ASP . 3.5 t30 -141.27 114.18 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.56 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.0 116.08 5.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m -41.68 104.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.557 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 1.9 pm0 -89.53 155.23 48.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.473 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.02 -166.73 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.714 2.276 . . . . 1.0 112.35 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.653 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 32.0 m -54.58 -171.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.499 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . 79.31 168.42 0.19 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.44 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.696 ' HB2' ' OG ' ' A' ' 35' ' ' SER . . . -87.81 -79.05 0.3 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.191 0.52 . . . . 1.0 110.192 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.3 m 149.54 -68.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.251 -1.341 . . . . 1.0 108.212 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.502 ' N ' HG22 ' A' ' 12' ' ' THR . 5.9 mm-40 -45.8 138.71 4.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.556 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -121.37 153.45 37.78 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 121.554 0.692 . . . . 1.0 112.321 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.982 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -47.39 -36.0 9.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.465 -178.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.96 44.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.581 -1.191 . . . . 1.0 109.802 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -97.47 -38.1 9.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.034 -0.984 . . . . 1.0 113.617 -177.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -63.49 147.11 95.87 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.688 -1.967 . . . . 1.0 105.688 178.232 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 18' ' ' VAL . 2.8 Cg_exo -48.1 118.61 3.28 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.621 1.548 . . . . 1.0 112.042 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.15 -42.39 60.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.973 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.425 ' CD2' ' H ' ' A' ' 21' ' ' HIS . 12.9 p80 -64.08 -23.65 67.4 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.949 -0.7 . . . . 1.0 111.703 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 97' ' ' ASN . 14.9 t -80.17 -45.33 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 119.009 0.822 . . . . 1.0 111.247 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.624 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -67.04 -25.7 66.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.951 0.881 . . . . 1.0 108.993 178.337 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -61.27 -19.18 61.43 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.592 -1.186 . . . . 1.0 111.913 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.8 39.67 2.82 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.246 -0.502 . . . . 1.0 112.054 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.661 HD22 ' CG1' ' A' ' 30' ' ' VAL . 32.7 mt -80.04 154.48 75.09 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG2' HG21 ' A' ' 30' ' ' VAL . 86.0 Cg_exo -44.23 -120.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.966 3.111 . . . . 1.0 114.138 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 7.8 mm-40 -69.18 -55.11 11.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.65 -2.352 . . . . 1.0 104.65 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 30' ' ' VAL . 7.6 tp10 -133.95 -72.59 0.49 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.661 ' CG1' HD22 ' A' ' 26' ' ' LEU . 96.4 t 52.28 163.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.989 0.9 . . . . 1.0 110.953 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB2' HG21 ' A' ' 47' ' ' THR . 3.2 ttt85 -161.44 163.16 30.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.92 -1.491 . . . . 1.0 107.006 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.654 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.1 mm? -94.45 155.07 17.13 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.544 -1.262 . . . . 1.0 110.098 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.72 111.67 2.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 35' ' ' SER . 13.0 Cg_endo -88.31 154.18 6.71 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.691 2.927 . . . . 1.0 111.926 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.696 ' OG ' ' HB2' ' A' ' 11' ' ' ALA . 1.8 p 50.84 40.3 24.42 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -95.98 -46.4 6.53 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.282 -2.235 . . . . 1.0 106.899 175.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -96.3 -4.06 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 114.16 -1.382 . . . . 1.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t70 98.24 -11.32 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.982 0.802 . . . . 1.0 111.54 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.726 ' HZ3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.24 -35.84 66.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.874 -0.73 . . . . 1.0 109.326 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 92.11 -11.22 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.526 0.936 . . . . 1.0 113.526 177.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.726 ' CB ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -77.22 162.45 27.37 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 32' ' ' LEU . 4.2 mm -74.48 124.73 32.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 120.485 1.493 . . . . 1.0 112.097 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.77 174.19 16.86 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.698 -1.761 . . . . 1.0 108.698 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG21 ' HE3' ' A' ' 98' ' ' TRP . 8.3 p -121.83 125.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.94 0.4 . . . . 1.0 109.94 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.661 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 30.2 m95 -126.92 149.43 49.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.618 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.55 133.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.959 -1.019 . . . . 1.0 108.859 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 31' ' ' ARG . 80.8 p -115.93 -15.73 11.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.241 -1.392 . . . . 1.0 107.241 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.595 ' CD ' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -116.2 171.69 4.47 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 112.847 -1.979 . . . . 1.0 109.59 -178.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.46 153.71 13.84 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 123.264 2.643 . . . . 1.0 111.982 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.495 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 4.1 mp -132.11 150.84 34.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.728 -1.124 . . . . 1.0 111.354 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.734 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.55 165.09 15.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 1.0 111.71 178.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.55 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.9 129.62 40.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.093 177.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.33 -0.71 60.13 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 119.854 -1.165 . . . . 1.0 113.375 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.671 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.7 tptt -57.09 157.96 5.51 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.732 -1.187 . . . . 1.0 110.284 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.7 ttmt -123.76 109.3 13.5 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.46 -1.245 . . . . 1.0 108.403 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 11.6 m-30 -119.58 125.12 48.04 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 58' ' ' PRO . . . 155.02 -153.49 24.83 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.08 -1.418 . . . . 1.0 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 10.2 Cg_endo -82.66 150.83 71.6 Favored 'Cis proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.35 1.575 . . . . 1.0 113.604 0.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 17.6 t80 -62.94 118.92 8.46 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.759 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -27.03 -65.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.345 -1.752 . . . . 1.0 111.495 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 53.89 104.55 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.827 -0.701 . . . . 1.0 113.482 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.01 149.8 20.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 176.412 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.541 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -93.53 116.36 28.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.719 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -146.87 167.22 24.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.016 -178.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.732 ' NZ ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -65.94 153.05 43.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.652 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 6.2 ttm-85 -66.09 -45.33 81.6 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.499 -0.751 . . . . 1.0 111.932 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.7 p -65.87 46.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.008 0.432 . . . . 1.0 110.151 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 66' ' ' ARG . 14.2 mm-40 -129.87 -28.97 2.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.333 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.14 158.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.882 0.372 . . . . 1.0 111.119 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 5.6 tttm -140.98 131.63 25.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 45.83 76.0 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.54 -169.24 1.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.992 -1.003 . . . . 1.0 113.394 -175.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 75' ' ' MET . 25.0 t -150.48 -68.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.698 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.58 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -63.09 41.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.285 -178.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.7 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -149.49 148.23 29.15 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.788 0.804 . . . . 1.0 111.732 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.918 ' CE2' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -160.59 162.3 32.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.244 -1.344 . . . . 1.0 112.618 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 1.3 pm0 -100.93 121.88 42.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.959 0.885 . . . . 1.0 111.355 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.623 ' CG1' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.24 135.85 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 114.747 -1.115 . . . . 1.0 108.986 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.9 t80 -87.0 124.37 33.12 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.511 -0.875 . . . . 1.0 111.329 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.543 ' C ' ' H ' ' A' ' 82' ' ' ASN . 5.0 m-85 -92.19 135.53 26.89 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 114.195 -1.366 . . . . 1.0 110.466 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.34 7.69 1.74 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.771 1.647 . . . . 1.0 108.869 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 80' ' ' TYR . 70.5 m-80 -110.27 -90.72 0.47 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.256 -1.338 . . . . 1.0 111.48 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.031 HD23 ' H ' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -79.64 -7.08 58.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.36 -157.32 15.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 120.393 -0.908 . . . . 1.0 112.717 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.4 m95 -66.08 121.16 14.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.609 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.525 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 38.1 mmm -124.85 150.8 46.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.377 0.88 . . . . 1.0 113.377 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.652 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -106.97 131.36 54.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 88' ' ' ILE . 17.0 mt -106.16 105.34 18.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.719 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 23.5 t0 -130.83 127.57 38.88 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.287 0.949 . . . . 1.0 112.085 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -132.82 96.45 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.192 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.628 HG23 ' OD1' ' A' ' 89' ' ' ASP . 29.3 p -129.55 75.42 1.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.726 0.694 . . . . 1.0 110.617 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.727 ' N ' ' HE ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -162.85 160.82 19.36 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.338 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -67.26 -38.93 14.14 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.15 1.9 . . . . 1.0 112.418 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -77.87 -44.46 27.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -11.42 16.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 1.0 112.076 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . -110.77 111.46 3.02 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.487 -0.863 . . . . 1.0 112.04 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.682 ' HA ' HG22 ' A' ' 22' ' ' VAL . 52.2 p30 -61.95 -157.92 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.919 0.39 . . . . 1.0 110.466 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.563 ' HE3' HG21 ' A' ' 44' ' ' VAL . 43.0 p-90 -72.75 -35.49 67.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.318 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -54.8 -26.5 35.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.365 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.727 ' HE ' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -72.29 -20.5 61.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.917 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.87 -10.68 57.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.758 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 99' ' ' LEU . 3.2 t -64.49 141.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.561 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -101.22 -155.18 0.5 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.088 -0.645 . . . . 1.0 112.234 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.492 ' NE1' ' CG2' ' A' ' 73' ' ' VAL . 2.6 m-90 -112.79 144.12 42.87 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.466 -0.788 . . . . 1.0 111.813 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 139' ' ' TRP . . . -79.06 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER 159.23 -16.05 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.768 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -136.54 -81.56 0.39 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.197 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 163.69 -52.0 0.3 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -24.62 65.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.677 ' O ' ' O ' ' A' ' 111' ' ' GLN . 2.5 pt-20 -92.13 -22.98 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.995 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.688 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -51.24 -134.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.631 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 1.027 HD21 HD22 ' A' ' 137' ' ' LEU . 0.8 OUTLIER 158.51 -33.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.572 -0.705 . . . . 1.0 109.488 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 112' ' ' ASN . 4.2 mm? -129.55 148.26 51.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.807 -0.757 . . . . 1.0 112.055 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -134.06 130.63 20.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 115.105 -0.952 . . . . 1.0 112.498 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 76' ' ' TRP . 78.6 Cg_exo -51.23 130.22 31.53 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 123.894 3.063 . . . . 1.0 115.899 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.692 HD13 HG12 ' A' ' 152' ' ' ILE . 56.2 tp -142.17 137.24 30.7 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 4.7 mm-40 -108.06 114.95 29.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.403 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.577 HD11 ' CD1' ' A' ' 123' ' ' TYR . 4.9 pt -139.09 127.82 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.536 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.59 47.5 23.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 1.0 110.909 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HE ' ' CG1' ' A' ' 78' ' ' VAL . 1.9 mmp_? 54.43 30.56 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -136.82 148.98 47.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.026 -1.101 . . . . 1.0 108.026 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.918 HG21 ' CE2' ' A' ' 76' ' ' TRP . 1.6 mm -110.42 114.24 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.745 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.577 ' CD1' HD11 ' A' ' 118' ' ' ILE . 4.6 m-85 -102.22 157.53 16.83 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.175 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.811 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.5 m-30 -116.66 130.73 56.91 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 105.522 -2.029 . . . . 1.0 105.522 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.594 ' HZ1' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -125.95 153.96 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.967 -177.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.689 ' O ' ' N ' ' A' ' 53' ' ' GLY . 27.7 p -100.76 118.51 37.01 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.231 -0.588 . . . . 1.0 112.471 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.67 HD23 ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -82.77 -21.38 34.66 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 124.224 0.953 . . . . 1.0 109.559 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.893 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -139.8 137.97 19.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.724 0.268 . . . . 1.0 111.724 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.88 144.2 45.58 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.628 1.552 . . . . 1.0 110.732 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.495 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -122.13 137.06 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.524 ' HB3' ' CG ' ' A' ' 134' ' ' GLU . . . -75.08 134.18 74.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.15 -0.477 . . . . 1.0 112.112 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.06 108.99 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 CA-C-N 119.808 0.967 . . . . 1.0 110.534 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 122.03 7.65 7.73 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 2.3 mm-40 -105.53 117.61 34.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.137 0.494 . . . . 1.0 111.187 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.661 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -46.06 146.71 1.21 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.772 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 137' ' ' LEU . 7.2 mp -91.08 132.67 35.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.096 -0.956 . . . . 1.0 108.488 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.027 HD22 HD21 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -136.62 161.81 34.86 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.751 0.786 . . . . 1.0 112.071 -178.28 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.811 HG11 ' CE2' ' A' ' 124' ' ' TYR . 3.1 m -146.13 170.87 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.778 -1.101 . . . . 1.0 111.337 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.655 ' CD1' ' NE2' ' A' ' 111' ' ' GLN . 44.5 p-90 170.77 -161.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.585 -1.643 . . . . 1.0 108.41 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.641 ' CD1' ' ND2' ' A' ' 145' ' ' ASN . 47.5 m-85 104.71 42.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.288 1.618 . . . . 1.0 107.657 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.561 ' OD1' ' N ' ' A' ' 143' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.559 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.561 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 53.6 mt-10 -31.37 -90.2 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 123.861 0.389 . . . . 1.0 110.124 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -108.29 56.49 0.63 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.879 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' ND2' ' CD1' ' A' ' 140' ' ' TYR . 3.1 p30 -68.96 167.08 22.03 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 7.9 Cg_endo -81.04 -14.83 10.73 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.578 1.519 . . . . 1.0 111.311 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 1.1 mp0 -66.76 -32.68 74.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.745 -1.946 . . . . 1.0 105.745 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.608 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mm -79.04 -53.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.224 -1.353 . . . . 1.0 110.662 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 -48.83 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 146' ' ' PRO . . . -55.66 -48.71 74.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 1.0 111.968 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.67 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . -70.49 -28.89 65.33 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 119.48 -0.888 . . . . 1.0 111.451 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.692 HG12 HD13 ' A' ' 116' ' ' LEU . 60.1 mt -66.88 -48.11 80.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 1.0 108.914 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 2.5 mt-10 -52.31 -51.91 55.99 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.67 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 1.2 pm0 -57.35 -38.97 74.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.057 -1.057 . . . . 1.0 112.268 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -77.83 -59.74 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 118.804 -1.158 . . . . 1.0 112.209 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' NH2' HG21 ' A' ' 118' ' ' ILE . 12.4 mmm180 -70.76 -41.0 72.34 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.174 0.805 . . . . 1.0 113.174 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -65.65 -36.52 83.92 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 118.437 -1.305 . . . . 1.0 110.436 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.5 m -77.93 -14.37 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.655 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.87 35.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.563 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -102.27 -73.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.685 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.94 -41.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 1.0 110.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.73 -165.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -160.0 53.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 1.3 mp0 -41.22 128.81 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.644 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -4.49 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.503 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.3 p -65.6 147.18 53.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.547 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 m -152.38 132.37 13.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -41.77 153.24 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.282 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.5 166.41 15.43 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.487 2.125 . . . . 1.0 111.981 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.44 -159.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.837 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.98 120.3 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.152 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . -161.12 -77.79 0.05 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.307 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 89.9 m 122.36 103.62 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 125.204 1.565 . . . . 1.0 107.623 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.511 ' HG3' HG22 ' A' ' 12' ' ' THR . 0.4 OUTLIER 66.25 161.07 0.14 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.106 -1.406 . . . . 1.0 108.824 -177.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.547 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -121.29 156.17 33.1 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 120.458 0.171 . . . . 1.0 111.074 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.738 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -43.9 -30.21 0.66 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.219 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.41 59.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.61 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -73.14 -44.65 59.84 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.787 1.032 . . . . 1.0 113.787 -176.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -56.2 149.77 34.83 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.973 -1.862 . . . . 1.0 105.973 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 18' ' ' VAL . 27.8 Cg_exo -47.37 143.23 11.52 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 120.884 1.056 . . . . 1.0 110.874 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 14.8 tt0 -60.81 -49.9 75.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.511 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.553 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 8.2 p80 -61.76 -26.07 67.85 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.624 HG13 ' C ' ' A' ' 97' ' ' ASN . 22.6 t -79.78 -49.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 118.656 0.662 . . . . 1.0 111.656 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.543 HD23 HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -67.89 -25.5 65.54 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.795 0.807 . . . . 1.0 109.449 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 8.6 mmm180 -59.74 -19.23 48.89 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.181 -1.372 . . . . 1.0 112.019 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.84 35.88 4.38 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.149 -0.548 . . . . 1.0 111.979 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 30' ' ' VAL . 16.4 mt -82.03 123.12 80.08 Favored Pre-proline 0 CA--C 1.514 -0.419 0 CA-C-O 119.477 -0.297 . . . . 1.0 111.11 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.509 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 14.2 Cg_exo -55.41 156.72 16.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 119.748 0.946 . . . . 1.0 110.236 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.423 ' C ' ' HG3' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -47.18 -13.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 115.172 1.545 . . . . 1.0 115.172 -174.266 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 6.2 pm0 -114.19 15.73 18.14 Favored 'General case' 0 CA--C 1.463 -2.386 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.16 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.714 HG12 HG22 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -126.82 125.78 67.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 114.605 1.335 . . . . 1.0 114.605 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.546 ' HB2' HG21 ' A' ' 47' ' ' THR . 6.6 tpm_? -141.6 153.44 44.79 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 113.36 -1.745 . . . . 1.0 107.17 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 15' ' ' LEU . 4.1 mm? -91.82 143.69 26.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 118.84 -1.144 . . . . 1.0 109.958 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.47 110.06 3.64 Favored Pre-proline 0 N--CA 1.444 -0.732 0 N-CA-C 113.253 0.834 . . . . 1.0 113.253 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . 15.5 Cg_endo -84.87 152.58 11.31 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.883 2.389 . . . . 1.0 111.24 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.9 p 86.46 -38.49 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -49.3 -57.88 6.05 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.516 -1.22 . . . . 1.0 107.847 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 3.9 m -57.27 -50.05 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.869 -0.732 . . . . 1.0 110.232 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 1.7 m-20 156.9 70.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.448 0.468 . . . . 1.0 110.591 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.1 OUTLIER 35.67 29.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.387 0.613 . . . . 1.0 109.811 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 m -90.88 -33.56 15.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.086 -0.961 . . . . 1.0 112.62 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 42' ' ' ILE . 4.7 ptm180 162.61 -163.98 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 HD12 ' A' ' 32' ' ' LEU . 2.7 mm -84.37 135.56 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 118.156 0.434 . . . . 1.0 110.386 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.73 155.14 18.92 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.545 -1.022 . . . . 1.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -102.41 131.53 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.51 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 12.0 m95 -132.26 155.21 48.72 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 -176.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.06 120.41 14.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.579 ' H ' ' C ' ' A' ' 29' ' ' GLU . 1.4 p -102.83 -20.81 14.16 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' CD ' ' C ' ' A' ' 48' ' ' LYS 0.252 0.0 OUTLIER -129.29 170.71 10.19 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.827 178.056 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -80.42 125.35 5.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.123 1.882 . . . . 1.0 114.097 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.652 HD11 ' HG3' ' A' ' 29' ' ' GLU . 3.7 mp -99.66 150.78 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.809 -1.541 . . . . 1.0 110.659 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.753 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.17 164.03 13.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.674 177.015 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -66.61 124.18 22.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.813 -0.554 . . . . 1.0 110.385 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 99.75 1.28 56.34 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 119.924 -1.132 . . . . 1.0 113.087 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 2.2 tptt -52.32 159.47 0.97 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 117.625 -1.63 . . . . 1.0 108.356 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.759 ' HG2' ' HZ2' ' A' ' 125' ' ' LYS . 8.8 ttmt -121.48 103.16 8.73 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.315 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.587 ' CE2' ' OE2' ' A' ' 29' ' ' GLU . 13.4 m-85 -116.36 126.44 53.49 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 106.473 -1.677 . . . . 1.0 106.473 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.17 -164.75 35.63 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 109.876 -1.289 . . . . 1.0 109.876 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 7.0 Cg_endo -89.68 138.44 13.22 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 CA-C-N 119.094 1.447 . . . . 1.0 112.884 -0.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.7 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 10.2 t80 -59.13 114.82 2.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.675 0.75 . . . . 1.0 110.509 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -21.51 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.209 -1.814 . . . . 1.0 111.393 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.615 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 45.76 105.49 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.586 -0.734 . . . . 1.0 113.349 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ASP . 13.7 t70 -93.52 147.28 23.12 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -92.8 115.08 27.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.122 0.963 . . . . 1.0 113.149 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -139.85 170.3 16.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.619 -1.628 . . . . 1.0 110.708 -177.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.698 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.48 145.91 31.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 121.126 -0.23 . . . . 1.0 111.384 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -50.85 -23.9 3.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.782 -0.574 . . . . 1.0 111.986 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 66' ' ' ARG . 29.0 t -37.69 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.234 0.54 . . . . 1.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 66' ' ' ARG . 5.7 mt-30 -97.4 -142.07 0.29 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.534 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.585 HG13 ' HG3' ' A' ' 75' ' ' MET . 57.5 t 59.95 -95.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 117.858 0.299 . . . . 1.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 8.2 tptm 73.62 51.77 0.12 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.926 0.393 . . . . 1.0 110.609 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 70' ' ' LYS . 4.0 t30 78.01 113.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.377 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.25 -149.71 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.328 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.661 ' C ' ' H ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -137.87 -60.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-N 118.662 0.665 . . . . 1.0 111.519 -178.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.608 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -63.5 29.46 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.362 -0.835 . . . . 1.0 110.653 -178.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.661 ' H ' ' C ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -139.7 141.06 36.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.75 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.56 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -157.13 162.81 39.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.031 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.27 122.98 44.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.08 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.552 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -134.56 136.59 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.139 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 t80 -85.41 124.56 32.15 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.512 0.672 . . . . 1.0 112.182 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.805 ' OH ' HD11 ' A' ' 88' ' ' ILE . 27.3 m-85 -100.69 125.37 39.07 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.637 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.71 8.57 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 108.305 -1.46 . . . . 1.0 108.305 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 80' ' ' TYR . 74.5 m-20 -109.44 -10.14 14.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.0 -1.455 . . . . 1.0 111.27 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -168.65 1.85 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.709 1.374 . . . . 1.0 114.709 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.59 -160.78 14.27 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 120.608 -0.806 . . . . 1.0 112.912 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.553 ' O ' ' SD ' ' A' ' 86' ' ' MET . 27.5 m95 -76.5 121.06 22.59 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.553 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.8 mmm -127.54 163.63 23.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.131 1.53 . . . . 1.0 115.131 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.03 134.07 53.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.157 -1.383 . . . . 1.0 108.175 177.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.805 HD11 ' OH ' ' A' ' 80' ' ' TYR . 9.2 mt -106.61 111.5 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 118.481 -0.771 . . . . 1.0 109.816 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -134.42 130.94 37.56 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -139.04 104.8 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.79 49.3 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.994 -0.682 . . . . 1.0 109.202 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.62 162.39 36.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.094 -0.957 . . . . 1.0 109.955 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.62 -38.73 7.7 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.307 2.005 . . . . 1.0 112.688 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -78.16 -42.38 31.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 -11.26 20.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.661 0.267 . . . . 1.0 111.529 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 90' ' ' ALA . . . -102.35 -166.76 26.63 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.624 ' C ' HG13 ' A' ' 22' ' ' VAL . 44.1 p-10 -145.36 -153.8 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.239 0.542 . . . . 1.0 111.072 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.503 ' N ' HG13 ' A' ' 22' ' ' VAL . 14.4 p-90 -72.34 -29.61 63.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.949 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.721 HD23 ' CD2' ' A' ' 124' ' ' TYR . 0.3 OUTLIER -66.31 -30.85 71.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.457 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.581 ' NH2' ' OH ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 119.926 -0.71 . . . . 1.0 109.937 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.581 ' OH ' ' NH2' ' A' ' 100' ' ' ARG . 7.8 m-85 -92.96 0.44 57.4 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.69 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 99' ' ' LEU . 23.3 t -68.99 126.11 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -72.7 -157.48 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.605 0.595 . . . . 1.0 112.605 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.607 ' CZ2' ' CG2' ' A' ' 73' ' ' VAL . 4.1 m-90 -112.41 158.72 19.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.468 -0.787 . . . . 1.0 111.046 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.653 ' O ' ' N ' ' A' ' 107' ' ' SER . . . -100.56 -14.62 18.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 116.086 1.884 . . . . 1.0 116.086 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 107' ' ' SER . 49.7 t 32.62 23.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.406 0.548 . . . . 1.0 112.422 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.3 OUTLIER 159.4 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.641 0.258 . . . . 1.0 110.663 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' O ' ' OE1' ' A' ' 111' ' ' GLN . . . -85.25 2.21 88.26 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.197 -0.525 . . . . 1.0 111.907 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -86.59 -22.85 26.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.003 0.371 . . . . 1.0 112.003 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 111' ' ' GLN . 8.4 pt-20 -115.93 -27.55 6.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.401 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.775 HE21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -44.13 110.13 0.19 Allowed 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.762 ' OD1' ' N ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -88.28 -5.31 58.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.753 ' HB2' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -140.55 172.1 13.2 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 124.014 0.821 . . . . 1.0 112.723 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.593 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -148.71 132.07 8.28 Favored Pre-proline 0 N--CA 1.433 -1.287 0 C-N-CA 119.488 -0.885 . . . . 1.0 111.029 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 139' ' ' TRP . 80.6 Cg_exo -55.55 116.39 3.12 Favored 'Trans proline' 0 N--CA 1.509 2.406 0 C-N-CA 123.4 2.733 . . . . 1.0 113.99 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 HG12 ' A' ' 152' ' ' ILE . 30.6 tp -120.39 121.74 39.23 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.048 0.452 . . . . 1.0 111.914 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -102.84 114.26 28.38 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.505 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.557 HD11 ' CG ' ' A' ' 123' ' ' TYR . 2.3 pt -139.61 134.41 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.437 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.64 38.69 30.39 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.039 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.533 ' HE ' HG12 ' A' ' 78' ' ' VAL . 1.2 mmp_? 58.33 32.34 21.96 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.179 0.514 . . . . 1.0 110.452 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.37 155.22 50.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.434 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.52 HG21 ' NE1' ' A' ' 76' ' ' TRP . 15.0 mm -96.22 125.85 48.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.989 0.423 . . . . 1.0 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.557 ' CG ' HD11 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -124.05 150.64 44.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.277 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.817 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.8 m-30 -118.64 118.76 32.53 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.761 0.315 . . . . 1.0 110.486 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.764 ' NZ ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -115.33 155.29 27.59 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.319 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' GLY . 10.7 p -106.69 109.86 21.89 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.843 1.339 . . . . 1.0 110.487 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.775 HD13 HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER -76.18 -8.38 56.9 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.33 1.019 . . . . 1.0 112.091 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.836 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -151.02 135.73 9.94 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 119.923 -0.711 . . . . 1.0 110.929 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.19 129.02 31.42 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.497 1.465 . . . . 1.0 111.65 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.495 ' HB ' HD13 ' A' ' 50' ' ' ILE . 1.7 mt -106.5 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.054 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.521 ' HB3' ' OE2' ' A' ' 134' ' ' GLU . . . -84.18 132.92 46.32 Favored Pre-proline 0 C--O 1.219 -0.541 0 C-N-CA 120.162 -0.615 . . . . 1.0 109.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -45.42 104.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.907 1.738 . . . . 1.0 114.032 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 139.57 0.5 2.05 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 120.254 -0.974 . . . . 1.0 113.382 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -102.71 138.74 39.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.306 0.574 . . . . 1.0 110.145 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.51 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -61.29 130.97 48.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.763 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 11.0 mp -75.6 129.54 37.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.721 -0.791 . . . . 1.0 109.134 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.762 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -141.97 159.4 42.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.817 HG11 ' CE2' ' A' ' 124' ' ' TYR . 2.5 m -128.44 172.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.399 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.626 ' HE1' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -101.3 -174.56 2.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.961 0.886 . . . . 1.0 111.036 178.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -87.38 -142.71 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.759 -1.564 . . . . 1.0 109.948 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.6 ' OD1' ' N ' ' A' ' 144' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 28.4 mt-10 57.35 20.54 5.98 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 1.5 m-20 89.35 69.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.847 -1.07 . . . . 1.0 109.852 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.55 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 0.1 OUTLIER -77.06 163.0 67.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.924 -1.035 . . . . 1.0 109.712 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.38 -20.82 69.89 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.604 1.536 . . . . 1.0 114.234 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.703 ' O ' HD23 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -68.94 -37.67 79.01 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.538 -2.023 . . . . 1.0 105.538 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.558 HG22 HD11 ' A' ' 152' ' ' ILE . 3.8 mm -74.55 -53.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.06 -1.427 . . . . 1.0 109.787 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.41 70.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.79 -38.25 90.34 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.438 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.564 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . -72.29 -35.27 68.64 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.184 -0.607 . . . . 1.0 110.631 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.558 HD11 HG22 ' A' ' 148' ' ' ILE . 37.4 mt -61.21 -42.51 93.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 O-C-N 123.402 0.439 . . . . 1.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 3.3 tt0 -61.99 -55.67 26.95 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.793 -0.763 . . . . 1.0 111.967 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.61 -40.87 84.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.506 0.558 . . . . 1.0 112.506 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' A' ' 156' ' ' ARG . 1.7 pp20? -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.203 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -64.8 -40.59 95.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.318 . . . . 1.0 110.65 178.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -55.1 -49.68 71.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 160' ' ' ARG . 2.9 m -62.8 -32.15 73.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.844 -1.071 . . . . 1.0 111.03 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.561 ' HB2' ' NZ ' ' A' ' 55' ' ' LYS . . . -57.49 -5.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.256 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 158' ' ' SER . 9.3 mtm180 -107.43 -39.17 5.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.983 0.421 . . . . 1.0 110.48 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.566 179.93 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.6 m -71.21 -106.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 1.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.7 135.06 36.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.549 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -144.97 173.33 11.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.603 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.19 36.24 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' N ' ' OD2' ' A' ' 2' ' ' ASP . 0.8 OUTLIER 66.63 -176.19 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.558 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 m -139.45 69.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.569 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -150.67 104.09 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.589 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 2.0 pm0 -90.35 157.75 44.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.394 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.61 -171.58 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.71 2.274 . . . . 1.0 112.222 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 33.2 m -65.02 -174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.541 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . 68.11 171.19 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.401 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.555 ' C ' HG22 ' A' ' 12' ' ' THR . . . -101.46 -85.22 0.43 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.699 0.761 . . . . 1.0 110.379 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER 171.67 -53.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.979 -1.464 . . . . 1.0 109.198 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -126.44 162.1 26.38 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -119.61 161.46 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.614 0.721 . . . . 1.0 111.416 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.16 -39.49 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.614 -178.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.21 -9.4 58.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.391 0.615 . . . . 1.0 110.696 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.798 ' CB ' ' H ' ' A' ' 14' ' ' THR . 17.3 tp10 -89.32 -45.24 9.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.667 HG13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.26 149.88 2.47 Favored Pre-proline 0 C--N 1.342 0.242 0 N-CA-C 105.168 -2.16 . . . . 1.0 105.168 177.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.636 ' HD2' HG23 ' A' ' 18' ' ' VAL . 14.5 Cg_exo -46.77 137.41 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 CA-C-N 120.371 1.168 . . . . 1.0 111.531 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 3.2 tt0 -59.27 -52.01 67.51 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.021 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.516 ' ND1' HG23 ' A' ' 22' ' ' VAL . 6.7 p80 -57.13 -28.89 63.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.991 0.737 . . . . 1.0 112.991 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.763 HG22 ' HA ' ' A' ' 97' ' ' ASN . 23.7 t -79.28 -49.65 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.368 0.531 . . . . 1.0 110.379 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.667 ' CD2' HG13 ' A' ' 18' ' ' VAL . 1.1 pp -72.01 -26.92 62.41 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.364 0.602 . . . . 1.0 111.253 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 10.6 mmm180 -57.87 -25.51 60.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.124 -0.944 . . . . 1.0 112.372 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.25 48.27 0.95 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.878 HD22 HG11 ' A' ' 30' ' ' VAL . 11.7 mt -96.83 131.24 28.33 Favored Pre-proline 0 CA--C 1.511 -0.529 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 29' ' ' GLU . 2.9 Cg_exo -61.86 143.61 95.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 N-CA-C 109.912 -0.842 . . . . 1.0 109.912 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -52.43 -10.04 0.13 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.947 -177.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.908 ' N ' ' HZ2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -84.33 12.14 7.22 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 178.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.878 HG11 HD22 ' A' ' 26' ' ' LEU . 10.8 t -140.1 131.78 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.492 0 N-CA-C 118.227 2.677 . . . . 1.0 118.227 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -134.99 141.37 46.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 110.95 -2.841 . . . . 1.0 103.567 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.755 ' N ' HD22 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -91.28 153.1 20.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 117.759 -1.576 . . . . 1.0 109.856 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 1.3 m-85 -154.53 110.41 2.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HB3' HD13 ' A' ' 42' ' ' ILE . 12.5 Cg_endo -87.89 151.25 7.21 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.104 2.536 . . . . 1.0 112.105 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.436 ' N ' ' HA ' ' A' ' 40' ' ' THR . 2.3 p 55.46 44.11 27.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.19 -43.9 8.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.11 -1.404 . . . . 1.0 107.218 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.578 ' CG2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -104.19 -0.65 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 113.938 -1.483 . . . . 1.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 7.0 t70 96.7 3.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.154 0.909 . . . . 1.0 110.693 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HG2' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.42 -37.27 44.25 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER 84.12 -9.96 0.93 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.741 0.651 . . . . 1.0 112.714 177.315 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.759 ' H ' ' HG2' ' A' ' 39' ' ' LYS . 18.9 ttm180 -77.59 157.03 30.48 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 176.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 34' ' ' PRO . 5.0 mm -77.66 127.1 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 120.599 1.545 . . . . 1.0 109.482 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.36 -176.35 19.38 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.777 HG23 HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.53 130.04 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 178.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.652 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 52.5 m95 -130.57 151.16 51.34 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -66.05 132.0 47.52 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.684 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -26.07 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.908 ' HZ2' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.58 156.25 41.71 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 177.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' CD ' ' HG2' ' A' ' 48' ' ' LYS . 8.1 Cg_exo -73.97 128.35 12.24 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 CA-C-N 121.975 1.741 . . . . 1.0 112.885 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 48' ' ' LYS . 3.4 mp -99.01 146.47 8.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.77 -1.559 . . . . 1.0 112.821 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.76 151.96 32.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.019 -1.901 . . . . 1.0 110.23 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.622 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.25 125.8 25.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.018 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.29 -0.87 53.98 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.451 -1.059 . . . . 1.0 110.451 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.9 tptt -54.42 152.29 6.72 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.817 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 2.9 ttmt -122.51 108.56 13.3 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.857 0.723 . . . . 1.0 109.738 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' ' CD ' ' A' ' 29' ' ' GLU . 18.9 m-85 -116.93 123.11 46.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.865 -1.531 . . . . 1.0 106.865 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 155.82 -157.15 27.57 Favored Glycine 0 C--N 1.31 -0.911 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 10.5 Cg_endo -86.21 150.37 44.9 Favored 'Cis proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.356 1.578 . . . . 1.0 113.201 0.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.626 ' HA ' HD13 ' A' ' 99' ' ' LEU . 7.2 t80 -64.04 120.35 11.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.404 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -27.05 -65.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.829 -1.532 . . . . 1.0 111.432 178.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.675 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 48.78 107.64 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.572 -0.74 . . . . 1.0 113.162 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -94.4 149.46 21.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 176.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -90.52 114.1 26.22 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.177 -1.009 . . . . 1.0 112.165 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HZ2' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -148.28 171.08 16.54 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.628 -1.169 . . . . 1.0 110.672 -176.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 135.1 37.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.102 0.477 . . . . 1.0 111.48 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.672 ' C ' ' H ' ' A' ' 68' ' ' GLN . 9.7 ptt85 -57.95 -24.15 56.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.275 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.51 21.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.756 -0.377 . . . . 1.0 111.188 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.672 ' H ' ' C ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.09 7.31 2.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.723 0.297 . . . . 1.0 111.676 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.422 HG22 ' OD2' ' A' ' 89' ' ' ASP . 37.5 t -99.26 161.08 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 1.6 tttp -177.97 124.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.518 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.4 t30 42.96 55.82 4.28 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' SD ' ' A' ' 75' ' ' MET . 5.4 t-20 -131.44 -178.37 4.82 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.493 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.81 HG22 ' CZ2' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -138.36 -49.74 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 118.817 0.735 . . . . 1.0 111.411 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.615 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -62.69 36.45 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.503 -177.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -144.82 141.59 29.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.543 0.687 . . . . 1.0 111.657 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.881 ' NE1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -159.73 163.4 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.91 -1.041 . . . . 1.0 111.962 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 3.6 pt-20 -98.02 122.49 41.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.894 0.854 . . . . 1.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.731 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -126.78 131.01 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 115.219 -0.9 . . . . 1.0 109.194 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -89.79 121.69 32.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.848 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 82' ' ' ASN . 13.7 m-85 -86.48 108.05 16.21 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 114.607 -1.179 . . . . 1.0 110.047 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.29 48.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.206 1.937 . . . . 1.0 109.955 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.652 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -151.85 -84.0 0.08 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.237 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.779 HD12 ' N ' ' A' ' 84' ' ' GLY . 4.1 pp -78.05 -42.33 32.66 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.779 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 151.22 -170.8 30.88 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.563 -1.303 . . . . 1.0 112.356 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.573 ' O ' ' SD ' ' A' ' 86' ' ' MET . 11.8 m95 -70.43 122.5 19.74 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 117.155 0.478 . . . . 1.0 110.322 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.729 ' CG ' HD11 ' A' ' 83' ' ' LEU . 42.1 mmm -126.91 160.2 31.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -113.35 134.2 54.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.563 -1.199 . . . . 1.0 108.144 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.731 HD12 HG21 ' A' ' 78' ' ' VAL . 7.0 mt -107.64 108.52 25.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 118.668 -0.682 . . . . 1.0 111.943 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.66 ' N ' ' HZ2' ' A' ' 64' ' ' LYS . 28.9 t0 -133.78 131.93 39.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.619 1.1 . . . . 1.0 113.521 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -136.22 91.47 2.68 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.579 HG22 ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -114.91 49.63 1.03 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.862 0.839 . . . . 1.0 110.122 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.467 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -144.15 152.26 54.01 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.987 177.671 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.36 -44.33 4.88 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.282 1.321 . . . . 1.0 112.72 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.48 -45.09 69.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.732 -1.122 . . . . 1.0 113.562 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -11.3 33.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.832 0.349 . . . . 1.0 110.65 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA2' HG21 ' A' ' 60' ' ' VAL . . . -110.68 -158.42 15.97 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.763 ' HA ' HG22 ' A' ' 22' ' ' VAL . 37.9 p30 -145.01 -153.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 1.0 110.007 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.61 ' N ' HG13 ' A' ' 22' ' ' VAL . 45.6 p-90 -74.59 -34.89 62.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.855 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.626 HD13 ' HA ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -54.9 -29.22 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.056 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' O ' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -66.27 -15.08 62.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 0.9 OUTLIER -94.86 0.58 54.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.831 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 99' ' ' LEU . 16.8 t -70.46 132.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 119.936 -0.706 . . . . 1.0 110.174 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -79.26 -153.84 0.08 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.209 -0.596 . . . . 1.0 111.878 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.81 ' CZ2' HG22 ' A' ' 73' ' ' VAL . 6.0 m-90 -126.27 159.35 33.34 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.714 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.657 ' HB2' ' HB2' ' A' ' 137' ' ' LEU . . . -139.27 174.73 10.21 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.427 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -47.87 2.87 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.784 ' O ' ' N ' ' A' ' 109' ' ' GLU . 20.3 m -148.9 132.0 16.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.68 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' C ' ' OE1' ' A' ' 111' ' ' GLN . . . -19.52 -4.29 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 118.456 2.142 . . . . 1.0 118.456 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.784 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.5 mt-10 -82.03 -24.43 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 119.236 1.518 . . . . 1.0 113.693 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 111' ' ' GLN . 13.4 pt-20 -124.18 -17.14 6.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.846 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 6.5 mp0 -45.7 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.954 1.408 . . . . 1.0 109.886 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.783 HD21 HD12 ' A' ' 137' ' ' LEU . 0.3 OUTLIER 163.21 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.961 -1.018 . . . . 1.0 111.852 177.212 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mp -137.92 164.19 29.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.205 -0.998 . . . . 1.0 112.177 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -143.7 130.32 10.34 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 119.013 -1.075 . . . . 1.0 113.566 -178.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' A' ' 140' ' ' TYR . 81.9 Cg_exo -50.42 131.04 31.1 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.676 2.917 . . . . 1.0 113.625 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.714 HD13 HG12 ' A' ' 152' ' ' ILE . 34.2 tp -141.34 130.66 23.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.127 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 78' ' ' VAL . 6.2 mm-40 -102.83 114.85 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.436 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 123' ' ' TYR . 3.2 pt -139.16 123.76 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.851 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.2 42.41 25.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.354 0.597 . . . . 1.0 110.668 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.594 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 5.2 mmt-85 56.74 32.46 21.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -133.49 144.04 49.18 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.881 HG21 ' NE1' ' A' ' 76' ' ' TRP . 4.1 mm -103.07 116.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.567 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.647 ' CD1' HD11 ' A' ' 118' ' ' ILE . 3.5 m-85 -109.04 158.25 17.91 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.4 m-30 -116.85 132.14 56.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -127.64 146.33 50.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.488 -177.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 112' ' ' ASN . 13.1 p -100.72 111.45 23.68 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.935 0.772 . . . . 1.0 111.483 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.702 HD12 ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.96 -5.58 59.2 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 123.926 0.766 . . . . 1.0 111.88 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.89 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.74 122.62 7.23 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.458 0.572 . . . . 1.0 109.986 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -44.17 138.59 6.76 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.521 1.481 . . . . 1.0 111.21 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.416 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -114.13 134.61 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.96 132.59 60.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.02 -0.672 . . . . 1.0 109.931 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.07 104.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.21 1.273 . . . . 1.0 111.906 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 131.87 2.91 4.19 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.035 -0.602 . . . . 1.0 112.834 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -105.56 115.54 30.42 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.218 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.652 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -47.18 139.73 5.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.889 0.852 . . . . 1.0 111.359 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.684 HD21 ' OE2' ' A' ' 29' ' ' GLU . 8.6 mp -78.34 128.79 34.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.708 -1.133 . . . . 1.0 109.072 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.783 HD12 HD21 ' A' ' 112' ' ' ASN . 0.0 OUTLIER -142.58 161.34 38.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.569 0.699 . . . . 1.0 110.706 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.508 HG11 ' CE2' ' A' ' 124' ' ' TYR . 27.9 m -146.31 177.38 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.885 . . . . 1.0 111.968 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.712 ' HE1' ' CG ' ' A' ' 111' ' ' GLN . 9.2 p-90 -158.09 -86.95 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 119.806 -0.758 . . . . 1.0 113.034 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.841 ' CB ' HD11 ' A' ' 148' ' ' ILE . 0.1 OUTLIER 24.47 59.14 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.141 0.901 . . . . 1.0 112.005 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' IAS . . . . . 0.576 ' OD1' ' N ' ' A' ' 143' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.516 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.469 0.874 0 CA-C-O 119.873 -0.404 . . . . 1.0 112.113 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.576 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 28.6 mt-10 -32.5 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -130.03 54.96 1.82 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.404 ' ND2' HG12 ' A' ' 148' ' ' ILE . 0.1 OUTLIER -68.47 163.45 53.43 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.081 -0.963 . . . . 1.0 108.748 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.496 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 10.5 Cg_exo -62.55 -20.2 69.99 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 120.929 1.086 . . . . 1.0 113.672 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.524 ' HG3' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -73.77 -34.08 64.53 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.726 -1.953 . . . . 1.0 105.726 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.841 HD11 ' CB ' ' A' ' 140' ' ' TYR . 1.5 mm -77.75 -50.63 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 113.866 -1.515 . . . . 1.0 109.699 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.83 -52.15 33.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 146' ' ' PRO . . . -56.58 -41.7 77.42 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.817 -176.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.674 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . -73.91 -31.19 62.98 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.674 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 116' ' ' LEU . 22.7 mt -62.47 -48.43 88.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.699 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 3.7 mt-10 -55.72 -52.28 64.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.345 -0.843 . . . . 1.0 113.071 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -56.52 -49.64 74.15 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.75 -1.18 . . . . 1.0 112.543 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.512 ' CD ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -81.92 -58.71 2.86 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.457 -0.897 . . . . 1.0 112.171 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 152' ' ' ILE . 1.0 OUTLIER -55.65 -51.63 66.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.494 -0.775 . . . . 1.0 112.22 -179.175 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -58.78 -23.72 60.63 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.9 m -96.26 0.01 50.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.346 -1.297 . . . . 1.0 110.509 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.04 38.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.494 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -125.95 -65.69 0.98 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.544 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.354 0 CA-C-O 121.177 0.513 . . . . 1.0 110.112 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.2 m 151.52 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.465 -1.243 . . . . 1.0 107.845 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.38 157.44 17.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.234 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 150.54 43.95 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 121.644 0.735 . . . . 1.0 112.587 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.813 ' N ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.12 -35.47 25.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.08 -0.963 . . . . 1.0 110.204 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.29 -9.79 58.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.931 -1.031 . . . . 1.0 111.382 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -31.76 22.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.62 0.97 . . . . 1.0 113.62 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 15' ' ' LEU . 1.5 p -56.15 142.91 65.48 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 18' ' ' VAL . 35.3 Cg_exo -48.44 122.78 8.23 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.431 1.421 . . . . 1.0 110.677 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.772 ' HA ' HD21 ' A' ' 23' ' ' LEU . 37.7 tt0 -48.35 -25.42 1.58 Allowed 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 113.303 0.853 . . . . 1.0 113.303 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.818 ' CD2' ' H ' ' A' ' 21' ' ' HIS . 0.2 OUTLIER -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.164 0.802 . . . . 1.0 113.164 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.756 HG22 ' HA ' ' A' ' 97' ' ' ASN . 6.8 t -76.97 -49.7 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.135 HD23 ' H ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -71.23 -19.58 62.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.711 0.767 . . . . 1.0 109.934 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.83 -27.37 68.83 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 -176.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.33 42.58 1.91 Allowed Glycine 0 N--CA 1.47 0.942 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' PRO . 18.5 mt -76.77 155.47 83.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' O ' ' O ' ' A' ' 26' ' ' LEU . 23.9 Cg_exo -36.25 -112.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 124.537 3.491 . . . . 1.0 113.516 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.92 -57.61 3.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.755 -1.578 . . . . 1.0 107.6 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 12.0 pt-20 -172.89 37.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 2.4 t -45.69 171.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 113.412 -1.722 . . . . 1.0 107.785 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.753 ' CB ' HG21 ' A' ' 47' ' ' THR . 0.0 OUTLIER -141.67 154.1 45.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -91.83 134.67 34.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 118.894 -1.122 . . . . 1.0 109.874 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.7 m-85 -133.95 144.56 52.15 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.866 ' HA ' ' HA ' ' A' ' 42' ' ' ILE . 3.1 Cg_exo -48.32 142.46 16.85 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 CA-C-N 119.715 0.934 . . . . 1.0 114.031 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.637 ' C ' ' H ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -61.69 52.43 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-O 123.087 1.423 . . . . 1.0 110.892 -178.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 34' ' ' PRO . . . -56.84 -5.36 0.23 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.017 -1.901 . . . . 1.0 108.272 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -82.55 -50.37 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 113.689 -1.596 . . . . 1.0 111.83 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 40' ' ' THR . 44.8 t0 -156.04 -66.72 0.11 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.536 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 41' ' ' ARG . 8.1 mmpp? -58.72 3.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.22 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER 35.73 14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 35' ' ' SER . 49.2 mtp85 -107.3 -116.46 0.26 Allowed 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 105.356 -2.09 . . . . 1.0 105.356 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.866 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 9.5 mm -102.19 134.03 44.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 120.09 1.314 . . . . 1.0 111.318 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.23 159.79 23.19 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.617 HG21 ' CE3' ' A' ' 98' ' ' TRP . 6.4 p -102.84 131.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.234 0.54 . . . . 1.0 111.627 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 13.5 m95 -130.33 154.46 47.62 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.711 1.004 . . . . 1.0 113.711 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.83 131.39 45.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.456 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.753 HG21 ' CB ' ' A' ' 31' ' ' ARG . 76.3 p -124.96 -15.19 6.47 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.769 1.271 . . . . 1.0 108.57 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.65 168.89 9.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.843 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.07 152.38 27.86 Favored 'Trans proline' 0 C--N 1.293 -2.356 0 C-N-CA 122.425 2.083 . . . . 1.0 112.415 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.481 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 3.3 mp -134.85 144.28 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.871 -1.059 . . . . 1.0 111.229 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.4 154.37 30.4 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.925 -1.488 . . . . 1.0 110.828 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.649 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.97 125.76 25.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.8 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.28 0.76 55.78 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -53.25 152.54 4.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 119.382 -0.927 . . . . 1.0 109.218 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.591 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.64 107.61 12.59 Favored 'General case' 0 N--CA 1.424 -1.757 0 O-C-N 124.714 1.259 . . . . 1.0 109.198 176.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 10.9 m-30 -119.78 124.46 46.22 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.302 1.048 . . . . 1.0 109.323 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.69 -148.84 20.74 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.223 -1.808 . . . . 1.0 109.753 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 9.5 Cg_endo -80.41 152.57 83.53 Favored 'Cis proline' 0 N--CA 1.49 1.304 0 CA-C-N 119.821 1.811 . . . . 1.0 112.681 0.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 60' ' ' VAL . 9.2 t80 -65.12 115.89 5.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.513 -1.221 . . . . 1.0 111.733 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.725 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -21.68 -63.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.565 178.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.725 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 51.29 104.82 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.354 -0.839 . . . . 1.0 112.945 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -94.18 144.11 25.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.529 -1.656 . . . . 1.0 106.529 177.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -92.02 114.6 27.18 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.949 -1.1 . . . . 1.0 113.025 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -142.99 169.94 16.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.139 -1.391 . . . . 1.0 109.056 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.91 152.98 27.81 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.123 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 4.1 ttm180 -56.31 -24.49 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.756 -0.59 . . . . 1.0 110.706 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.218 0.532 . . . . 1.0 110.055 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.71 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 120.98 0.419 . . . . 1.0 111.731 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.889 ' CE2' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -161.18 163.58 31.08 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.454 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -100.62 125.32 47.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.148 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.12 139.06 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.85 -0.613 . . . . 1.0 112.152 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 11.5 t80 -79.46 126.13 30.45 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.573 0.701 . . . . 1.0 111.601 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 82' ' ' ASN . 7.0 m-85 -99.3 131.36 25.25 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.523 -1.217 . . . . 1.0 112.032 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.19 13.86 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.01 1.807 . . . . 1.0 109.367 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 80' ' ' TYR . 46.2 m-80 -124.35 -9.78 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.681 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.69 -1.16 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.57 -158.89 15.64 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 120.481 -0.866 . . . . 1.0 113.074 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 67.4 m95 -71.34 120.44 16.93 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.0 mmm -125.96 164.68 20.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.328 0.862 . . . . 1.0 113.328 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -111.5 132.81 54.23 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 78' ' ' VAL . 5.5 mt -107.42 109.76 29.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 118.734 -0.651 . . . . 1.0 111.43 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.665 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 21.4 t0 -133.14 130.97 39.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.269 0.94 . . . . 1.0 112.818 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -136.09 97.58 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.628 HG22 ' OD1' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -130.78 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.734 -0.786 . . . . 1.0 110.756 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.423 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -153.84 159.05 32.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.096 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.49 -38.91 13.49 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.567 1.511 . . . . 1.0 111.234 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -77.08 -42.58 37.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.561 -1.199 . . . . 1.0 113.896 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -9.91 16.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.123 -0.231 . . . . 1.0 110.915 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.423 ' CA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.48 123.63 6.11 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.756 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -71.88 -151.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.163 0.506 . . . . 1.0 110.774 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.635 ' N ' HG13 ' A' ' 22' ' ' VAL . 44.0 p-90 -76.06 -31.16 58.65 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.644 -0.707 . . . . 1.0 111.655 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.642 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -57.0 -27.85 61.91 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.602 ' NE ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -67.18 -15.44 63.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.573 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -93.92 2.91 56.04 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 99' ' ' LEU . 6.3 t -78.27 128.61 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.213 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.724 HD21 HD23 ' A' ' 137' ' ' LEU . 15.9 p-10 -87.42 -143.75 0.12 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.909 -0.716 . . . . 1.0 111.495 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.42 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 6.6 m-90 -127.05 160.3 31.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.498 0.555 . . . . 1.0 112.498 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.706 ' HB3' ' CD1' ' A' ' 139' ' ' TRP . . . -101.78 -134.62 0.31 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.639 1.348 . . . . 1.0 114.639 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 t -154.21 -51.81 0.09 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.706 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.595 ' C ' ' H ' ' A' ' 109' ' ' GLU . 38.9 m -165.26 65.4 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.231 0.826 . . . . 1.0 113.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.09 -12.62 0.01 OUTLIER Glycine 0 CA--C 1.534 1.224 0 N-CA-C 114.324 0.49 . . . . 1.0 114.324 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 107' ' ' SER . 12.6 pt-20 -81.19 -26.59 35.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.494 0.647 . . . . 1.0 111.592 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 137' ' ' LEU . 6.0 pt-20 -122.21 -24.39 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.783 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.922 HE21 ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -53.81 132.34 41.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 177.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.78 ' C ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.68 -21.02 11.45 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.317 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.78 HD22 ' C ' ' A' ' 112' ' ' ASN . 4.2 mm? -125.61 143.49 51.0 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.859 -0.737 . . . . 1.0 110.661 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -128.7 131.32 23.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 119.463 -0.895 . . . . 1.0 112.191 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.11 128.34 22.11 Favored 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 124.058 3.172 . . . . 1.0 115.017 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 56.5 tp -140.43 132.74 28.29 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.817 -0.552 . . . . 1.0 110.103 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.446 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 6.8 mm-40 -105.58 115.58 30.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.907 -0.717 . . . . 1.0 110.029 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 123' ' ' TYR . 4.8 pt -139.9 129.61 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.066 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 49.4 46.52 23.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.255 0.55 . . . . 1.0 110.489 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 56.11 32.92 21.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.208 -0.597 . . . . 1.0 109.904 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -137.06 141.73 42.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.321 -0.854 . . . . 1.0 109.006 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.889 HG21 ' CE2' ' A' ' 76' ' ' TRP . 0.8 OUTLIER -102.53 113.0 37.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.079 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.803 ' CD1' HD11 ' A' ' 118' ' ' ILE . 3.1 m-85 -101.04 155.62 17.88 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.874 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 1.4 m-30 -119.02 125.24 48.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.623 -2.362 . . . . 1.0 104.623 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.874 ' HZ2' ' C ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -125.81 155.58 40.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.091 -175.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 53' ' ' GLY . 15.1 p -105.71 117.1 33.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.3 OUTLIER -81.35 -9.43 59.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.844 0.715 . . . . 1.0 109.952 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.702 ' HZ2' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -150.42 141.48 14.8 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 120.452 -0.499 . . . . 1.0 111.947 -178.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -55.75 140.38 84.56 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.133 1.889 . . . . 1.0 111.733 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -121.52 136.33 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.8 37.88 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.3 105.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.35 2.034 . . . . 1.0 113.048 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 133.53 0.18 4.11 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 109.977 -1.249 . . . . 1.0 109.977 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.14 137.81 35.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.63 -0.785 . . . . 1.0 109.21 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.711 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.2 pm0 -73.02 138.77 46.17 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.903 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.463 ' O ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 mp -79.35 127.01 31.55 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.262 -1.384 . . . . 1.0 107.262 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.724 HD23 HD21 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -141.04 159.07 43.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.603 -176.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.735 HG11 ' CE2' ' A' ' 124' ' ' TYR . 26.8 m -143.03 172.5 7.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 113.611 0.967 . . . . 1.0 113.611 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.706 ' CD1' ' HB3' ' A' ' 105' ' ' ALA . 36.3 p-90 . . . . . 0 C--O 1.212 -0.884 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.924 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.4 mm . . . . . 0 N--CA 1.423 -1.803 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.34 -48.97 59.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.13 81.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.468 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--O 1.206 -1.216 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.272 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 111.61 0.226 . . . . 1.0 111.61 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -120.4 -41.8 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.096 0.474 . . . . 1.0 110.057 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.29 161.49 23.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 1.0 108.811 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.581 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -122.16 155.11 36.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 1.0 111.851 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.56 -34.7 18.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.52 -15.88 59.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.604 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.581 ' CB ' ' H ' ' A' ' 14' ' ' THR . 20.8 tp10 -79.16 -41.39 28.58 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.74 HG23 HD22 ' A' ' 23' ' ' LEU . 27.7 m -60.78 154.15 59.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 119.43 -0.908 . . . . 1.0 108.904 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.585 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 24.6 Cg_exo -56.14 130.39 39.95 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 120.982 1.121 . . . . 1.0 109.56 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.535 ' HA ' HD21 ' A' ' 23' ' ' LEU . 24.5 tt0 -50.86 -35.46 32.73 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.585 ' CE1' HG23 ' A' ' 22' ' ' VAL . 19.3 p80 -75.63 -22.68 56.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 97' ' ' ASN . 2.2 t -76.36 -51.81 18.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 CA-C-N 119.966 1.257 . . . . 1.0 112.087 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.979 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.6 pt? -70.9 -24.82 62.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.293 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.418 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -61.49 -19.56 62.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.509 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.63 33.64 6.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.875 -0.679 . . . . 1.0 112.338 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.591 HD23 ' CG ' ' A' ' 98' ' ' TRP . 36.3 mt -77.41 154.29 81.76 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 117.68 0.74 . . . . 1.0 110.609 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' A' ' 26' ' ' LEU . 10.7 Cg_exo -34.0 -109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.383 2.722 . . . . 1.0 114.003 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.73 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -74.55 -58.82 3.05 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.624 177.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.73 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 5.1 pt-20 -170.24 47.36 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 45' ' ' TRP . 54.2 t -57.95 162.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 114.787 -1.097 . . . . 1.0 108.268 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -134.1 158.25 44.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.247 0.546 . . . . 1.0 110.616 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 32' ' ' LEU . 3.6 mm? -88.44 144.64 26.24 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.4 101.75 3.77 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.083 -0.647 . . . . 1.0 112.436 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 35' ' ' SER . 63.1 Cg_endo -82.69 150.01 14.45 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.23 2.62 . . . . 1.0 111.613 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 24.2 p 102.72 -60.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.168 0.918 . . . . 1.0 111.882 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.585 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.77 -54.63 21.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.629 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.519 HG13 ' CG ' ' A' ' 38' ' ' ASP . 1.9 p -101.09 -51.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 118.739 0.699 . . . . 1.0 111.434 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -89.39 82.0 6.53 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.292 0.568 . . . . 1.0 109.591 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -32.38 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.457 -1.247 . . . . 1.0 109.423 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.2 t -143.28 55.38 1.36 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.76 179.1 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.503 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -99.45 128.68 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.221 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.36 152.5 17.02 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.224 -1.551 . . . . 1.0 109.224 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.739 HG21 ' CE3' ' A' ' 98' ' ' TRP . 13.1 p -105.71 127.24 60.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.754 ' O ' HG13 ' A' ' 30' ' ' VAL . 21.7 m95 -126.59 146.55 50.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.281 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB1' HD11 ' A' ' 50' ' ' ILE . . . -65.57 146.64 54.59 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.51 ' CA ' ' O ' ' A' ' 132' ' ' PRO . 34.6 p -117.76 -15.56 10.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.66 0.663 . . . . 1.0 109.662 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.722 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -119.33 158.42 48.76 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.321 -178.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.505 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 7.8 Cg_endo -62.08 124.52 14.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.377 2.052 . . . . 1.0 110.216 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.748 HD11 ' HB1' ' A' ' 46' ' ' ALA . 3.4 mp -99.5 147.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.744 0.783 . . . . 1.0 110.282 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.07 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.61 148.03 34.19 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.829 -1.532 . . . . 1.0 109.471 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.07 ' N ' HD22 ' A' ' 51' ' ' LEU . 4.1 ttpt -59.51 126.49 27.83 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.18 4.53 47.42 Favored Glycine 0 N--CA 1.467 0.747 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.668 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 126' ' ' THR . 19.7 ttmt -89.48 139.58 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -106.53 145.7 31.53 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 175.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.62 ' CE2' HG21 ' A' ' 126' ' ' THR . 46.8 m-85 -120.5 124.83 46.35 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.545 -1.207 . . . . 1.0 109.735 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.29 -133.83 4.16 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 113.23 -1.805 . . . . 1.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 123' ' ' TYR . 78.6 Cg_endo -74.64 148.25 91.35 Favored 'Cis proline' 0 N--CA 1.502 1.991 0 CA-C-N 120.027 1.914 . . . . 1.0 113.308 0.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' O ' ' C ' ' A' ' 60' ' ' VAL . 68.5 t80 -56.26 116.75 3.23 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.934 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -16.38 -67.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 124.024 0.827 . . . . 1.0 112.622 178.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.622 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 97.83 62.01 0.9 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.271 -1.132 . . . . 1.0 110.271 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' ASP . 19.7 t0 -88.45 133.55 34.09 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 106.181 -1.785 . . . . 1.0 106.181 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -104.25 113.19 26.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -176.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' CYS . 1.7 ptpt -133.03 166.91 21.3 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.316 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.588 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -76.9 139.36 40.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 176.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.93 -23.63 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.736 0.303 . . . . 1.0 111.204 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.109 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.505 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.705 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -138.99 144.6 38.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.35 -1.75 . . . . 1.0 109.786 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.75 123.03 47.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.076 -0.65 . . . . 1.0 111.717 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -143.18 133.8 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.79 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 2.3 t80 -89.8 126.38 35.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ASN . 6.8 m-85 -92.31 105.7 15.15 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 113.516 -1.675 . . . . 1.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.77 -14.24 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.009 1.806 . . . . 1.0 109.604 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' TYR . 71.2 m-80 -81.72 -99.12 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.138 -1.392 . . . . 1.0 110.361 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -66.43 -41.93 88.47 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.374 1.25 . . . . 1.0 114.374 -176.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.1 23.99 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 120.03 -1.081 . . . . 1.0 110.485 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.429 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 14.5 m95 -54.27 120.62 6.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.779 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 78' ' ' VAL . 51.4 tpp -129.37 160.92 31.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.399 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -117.85 145.42 44.6 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.934 0.873 . . . . 1.0 109.656 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.484 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 52.1 mt -93.09 159.1 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.892 -1.504 . . . . 1.0 108.492 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.688 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -128.99 123.99 33.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.425 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.656 ' C ' HG22 ' A' ' 91' ' ' THR . . . -133.54 136.36 44.95 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 105.251 -2.129 . . . . 1.0 105.251 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.656 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 166.52 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 120.573 1.533 . . . . 1.0 111.112 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.579 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -126.23 148.89 65.25 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.454 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HB2' HG21 ' A' ' 22' ' ' VAL . 62.8 Cg_endo -66.11 -34.68 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.757 2.305 . . . . 1.0 111.849 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -71.91 -10.23 59.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.223 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.801 ' CB ' HH12 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.88 -16.01 35.14 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.695 ' N ' ' NH1' ' A' ' 100' ' ' ARG . . . -173.81 -92.49 0.08 OUTLIER Glycine 0 C--N 1.348 1.201 0 C-N-CA 120.136 -1.031 . . . . 1.0 114.05 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.739 ' HA ' HG22 ' A' ' 22' ' ' VAL . 5.2 p30 -146.58 -149.34 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.48 0.657 . . . . 1.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.739 ' CE3' HG21 ' A' ' 44' ' ' VAL . 35.2 p-90 -80.39 -24.5 39.68 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 115.163 1.542 . . . . 1.0 115.163 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.615 HD23 ' CE2' ' A' ' 124' ' ' TYR . 3.0 mp -53.5 -27.59 26.23 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.592 -0.843 . . . . 1.0 111.181 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.801 HH12 ' CB ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.65 -30.33 52.07 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 177.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.503 ' CE1' ' CG2' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -64.58 -17.57 64.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.427 HG22 HG11 ' A' ' 44' ' ' VAL . 98.1 t -63.16 117.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.041 -0.982 . . . . 1.0 110.786 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.579 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 14.5 m-20 -77.5 138.69 39.36 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 105.883 -1.895 . . . . 1.0 105.883 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.604 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 16.2 p90 -94.68 122.56 37.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.825 0.822 . . . . 1.0 111.955 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 26.96 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.04 -1.436 . . . . 1.0 114.77 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 105' ' ' ALA . 52.5 t -29.54 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER 174.01 11.29 0.0 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-N 114.721 -1.127 . . . . 1.0 111.03 174.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.58 19.69 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.83 -42.18 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.035 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -118.32 -33.11 4.46 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.038 1.125 . . . . 1.0 114.038 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 110' ' ' GLU . 4.9 mt-30 16.18 101.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.472 0.545 . . . . 1.0 112.472 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.794 HD22 HD13 ' A' ' 130' ' ' ILE . 18.0 p-10 -128.12 37.5 4.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.812 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 1.4 tp -153.32 173.63 15.36 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.152 -0.619 . . . . 1.0 110.698 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.735 ' CE2' ' HB3' ' A' ' 151' ' ' ALA . 9.3 t80 -132.23 147.67 66.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 119.553 -0.26 . . . . 1.0 111.638 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.495 ' N ' ' CD1' ' A' ' 114' ' ' PHE . 23.2 Cg_endo -100.04 96.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.502 2.134 . . . . 1.0 113.483 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 123' ' ' TYR . 8.1 tp -117.41 135.93 53.54 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -109.24 117.19 33.45 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.977 0.798 . . . . 1.0 111.128 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.954 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.8 OUTLIER -137.43 136.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.087 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 49.73 38.41 15.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.432 0.634 . . . . 1.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 63.4 13.3 6.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.019 179.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -110.0 154.89 22.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.082 -1.417 . . . . 1.0 107.86 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 31.5 mm -109.8 115.2 49.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 121.802 0.81 . . . . 1.0 111.888 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.954 ' CG ' HD11 ' A' ' 118' ' ' ILE . 3.6 m-85 -100.44 141.08 33.79 Favored 'General case' 0 CA--C 1.481 -1.694 0 O-C-N 121.234 -0.916 . . . . 1.0 109.27 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.615 ' CE2' HD23 ' A' ' 99' ' ' LEU . 18.3 m-30 -102.73 117.25 34.23 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.29 -2.115 . . . . 1.0 105.29 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -104.37 135.44 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.687 1.242 . . . . 1.0 110.636 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.62 HG21 ' CE2' ' A' ' 56' ' ' PHE . 33.0 p -106.4 112.98 26.23 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.131 0.491 . . . . 1.0 110.696 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -76.64 -6.11 50.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.546 -1.206 . . . . 1.0 111.996 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.59 ' HZ2' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -143.2 158.29 58.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.097 -0.641 . . . . 1.0 112.598 -175.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -72.25 145.3 43.38 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 N-CA-C 104.722 -2.838 . . . . 1.0 104.722 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.796 HG23 ' OE2' ' A' ' 134' ' ' GLU . 59.7 mt -123.5 142.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -174.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.56 128.49 88.37 Favored Pre-proline 0 C--N 1.34 0.193 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.798 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.5 Cg_exo -35.1 -27.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.655 2.236 . . . . 1.0 116.684 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.71 ' HA2' ' O ' ' A' ' 46' ' ' ALA . . . -125.6 37.04 2.61 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 120.308 1.413 . . . . 1.0 110.511 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.796 ' OE2' HG23 ' A' ' 130' ' ' ILE . 4.6 tt0 -95.23 162.38 13.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.907 0.385 . . . . 1.0 111.371 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.492 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 1.6 pm0 -80.85 140.3 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.358 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.535 ' HA ' HD21 ' A' ' 112' ' ' ASN . 4.9 mt -95.17 121.77 37.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.603 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -128.01 153.13 47.11 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.634 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 15.7 t -124.12 159.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.257 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.634 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 116.16 1.911 . . . . 1.0 116.16 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.838 0 CA-C-O 119.777 -0.154 . . . . 1.0 110.855 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -65.06 -46.84 79.56 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 116.457 -2.097 . . . . 1.0 108.244 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.15 25.8 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 115.46 1.652 . . . . 1.0 115.46 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB3' ' CE2' ' A' ' 114' ' ' PHE . . . . . . . . 0 C--N 1.34 0.174 0 CA-C-N 120.603 1.547 . . . . 1.0 111.596 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.774 0.321 . . . . 1.0 111.162 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.37 -55.82 2.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -104.69 153.94 20.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 17' ' ' GLU . 4.3 m -121.74 156.36 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 1.0 111.676 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.19 -32.8 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.61 58.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.777 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' THR . 27.6 tp10 -82.2 -40.41 21.75 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.741 HG23 HD22 ' A' ' 23' ' ' LEU . 28.7 m -59.63 159.39 18.23 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.465 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.9 Cg_exo -66.8 133.12 30.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.128 1.219 . . . . 1.0 109.961 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.551 ' HA ' HD21 ' A' ' 23' ' ' LEU . 18.6 tt0 -49.46 -38.01 28.13 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 123.749 0.656 . . . . 1.0 112.125 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 22' ' ' VAL . 4.4 p-80 -74.19 -23.25 59.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.457 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 1.5 t -75.89 -50.37 23.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 CA-C-N 119.805 1.184 . . . . 1.0 111.629 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.013 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.9 pt? -73.0 -26.02 61.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.648 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.95 -21.04 42.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.57 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.28 39.88 2.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.846 -0.692 . . . . 1.0 111.597 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.581 ' O ' ' O ' ' A' ' 27' ' ' PRO . 25.8 mt -85.17 153.52 59.65 Favored Pre-proline 0 N--CA 1.445 -0.702 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.229 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -34.6 -117.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 124.085 3.19 . . . . 1.0 114.166 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.694 ' HG2' ' HZ3' ' A' ' 48' ' ' LYS . 2.2 pp20? -72.98 -54.91 7.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 116.691 -2.004 . . . . 1.0 106.543 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 5.5 tt0 -174.64 57.75 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.275 1.036 . . . . 1.0 108.441 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.7 t -67.85 173.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.913 -1.04 . . . . 1.0 108.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.548 HH12 ' CG ' ' A' ' 29' ' ' GLU . 17.3 mtt85 -141.03 158.62 43.67 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.249 0.547 . . . . 1.0 110.013 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 32' ' ' LEU . 3.3 mm? -87.53 147.43 25.35 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.92 101.74 3.65 Favored Pre-proline 0 C--N 1.314 -0.953 0 C-N-CA 119.672 -0.811 . . . . 1.0 112.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 44.5 Cg_endo -83.69 149.71 12.75 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 123.272 2.648 . . . . 1.0 111.95 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 4.2 t 99.75 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.183 0.927 . . . . 1.0 111.927 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.33 -53.65 27.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.921 -175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 ' H ' ' A' ' 38' ' ' ASP . 2.4 p -102.07 -52.89 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.281 -0.567 . . . . 1.0 112.189 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -90.62 82.5 5.8 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 38' ' ' ASP . 7.7 mmpt? -28.28 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.343 -1.299 . . . . 1.0 110.07 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.597 ' N ' ' O ' ' A' ' 38' ' ' ASP . 16.4 p -143.22 54.09 1.36 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.2 168.21 8.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -92.27 131.24 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.824 -179.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.91 144.92 17.12 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.868 -1.693 . . . . 1.0 108.868 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.622 HG21 ' CE3' ' A' ' 98' ' ' TRP . 12.1 p -97.48 134.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.709 ' O ' HG13 ' A' ' 30' ' ' VAL . 10.6 m95 -129.04 147.65 50.92 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.146 -0.934 . . . . 1.0 110.83 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.973 ' HB3' ' CD ' ' A' ' 134' ' ' GLU . . . -73.32 123.71 24.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.13 -1.028 . . . . 1.0 110.344 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.0 p -93.41 -15.42 25.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.687 0.756 . . . . 1.0 110.947 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.694 ' HZ3' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -107.49 170.72 5.3 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.247 -1.342 . . . . 1.0 111.133 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.444 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 4.2 Cg_endo -81.68 131.88 7.46 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.232 1.955 . . . . 1.0 108.145 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 46' ' ' ALA . 4.3 mp -109.62 129.31 64.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 122.429 1.109 . . . . 1.0 111.908 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.053 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.83 147.96 22.83 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.515 -2.13 . . . . 1.0 107.755 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.053 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -59.65 123.72 17.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.38 2.48 47.57 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.626 -1.273 . . . . 1.0 113.253 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' THR . 9.7 ttmt -78.7 139.06 38.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 119.455 -0.898 . . . . 1.0 109.729 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.52 140.61 45.98 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 119.359 -0.936 . . . . 1.0 109.563 178.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.647 ' CE2' HG21 ' A' ' 126' ' ' THR . 37.2 m-85 -116.09 123.33 47.64 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.174 -1.83 . . . . 1.0 106.753 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . -176.53 -164.33 30.36 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 113.778 -1.556 . . . . 1.0 110.201 -176.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CB ' ' CE1' ' A' ' 123' ' ' TYR . 56.4 Cg_endo -98.22 137.66 3.4 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 CA-C-N 118.699 1.249 . . . . 1.0 111.638 -1.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 39.2 t80 -56.8 114.11 1.94 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.736 HG13 ' N ' ' A' ' 61' ' ' GLY . 9.7 p -44.69 -48.39 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.928 0.394 . . . . 1.0 111.109 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.736 ' N ' HG13 ' A' ' 60' ' ' VAL . . . 67.12 114.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 115.374 0.91 . . . . 1.0 115.374 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -99.75 134.43 42.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 175.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -92.2 112.11 23.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.162 1.171 . . . . 1.0 114.162 -176.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -145.07 166.31 25.74 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.983 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.586 ' HZ3' ' HB2' ' A' ' 65' ' ' LYS . 2.7 mtmp? -76.86 133.82 39.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.606 0.717 . . . . 1.0 112.266 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -57.47 -21.37 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.846 -0.615 . . . . 1.0 112.643 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.029 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.507 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 CA-C-O 121.887 0.851 . . . . 1.0 112.886 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.824 ' CE3' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -141.43 134.67 29.43 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.038 -1.437 . . . . 1.0 110.108 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 86' ' ' MET . 8.7 tp10 -97.75 122.64 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.597 . . . . 1.0 111.099 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' MET . 2.8 t -142.44 132.25 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.942 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -87.22 123.92 32.75 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.417 -0.913 . . . . 1.0 111.833 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.681 ' C ' ' H ' ' A' ' 82' ' ' ASN . 3.0 m-85 -76.3 113.72 31.13 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.12 29.62 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.172 1.914 . . . . 1.0 110.566 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.681 ' H ' ' C ' ' A' ' 80' ' ' TYR . 62.0 m-80 -135.1 -90.7 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.294 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.0 -41.77 73.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.85 -174.99 26.48 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 119.743 -1.218 . . . . 1.0 110.614 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 11.9 m95 -55.11 121.14 8.12 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.823 -0.81 . . . . 1.0 112.177 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.506 ' O ' ' O ' ' A' ' 78' ' ' VAL . 33.7 tpp -128.63 160.72 31.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.289 0.477 . . . . 1.0 112.289 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -125.08 147.53 48.95 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.729 0.776 . . . . 1.0 109.199 175.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 120' ' ' ARG . 6.3 mt -99.61 155.93 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 114.513 -1.221 . . . . 1.0 107.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.63 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.48 136.65 54.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.243 0.928 . . . . 1.0 113.155 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . . . -134.95 136.22 42.09 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.771 ' H ' ' CG ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 169.88 -37.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.674 1.125 . . . . 1.0 111.401 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.981 ' H ' ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -120.76 146.31 43.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.787 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 59.0 Cg_endo -68.53 -36.79 14.23 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 123.246 2.631 . . . . 1.0 112.6 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -56.94 -10.68 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -89.54 -11.12 43.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' O ' ' OD1' ' A' ' 97' ' ' ASN . . . 96.56 160.84 32.25 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.883 HD21 ' N ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER 65.59 128.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.622 ' CE3' HG21 ' A' ' 44' ' ' VAL . 47.0 p-90 -73.83 -21.31 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.133 -1.394 . . . . 1.0 109.63 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.794 ' N ' HD22 ' A' ' 97' ' ' ASN . 1.2 mp -50.12 -26.98 5.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.981 ' HE ' ' H ' ' A' ' 92' ' ' ASP . 6.5 ttt180 -74.68 -36.9 62.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.481 -1.69 . . . . 1.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.4 OUTLIER -68.05 -16.13 63.9 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.462 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.733 HG11 HG23 ' A' ' 138' ' ' VAL . 43.1 t -63.49 124.31 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.882 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.42 -174.69 5.41 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.55 -0.86 . . . . 1.0 109.06 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.407 ' HE3' ' N ' ' A' ' 104' ' ' TRP . 1.2 m-90 -94.79 154.62 17.19 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.39 0.614 . . . . 1.0 112.03 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.842 ' HB2' ' O ' ' A' ' 139' ' ' TRP . . . -31.34 -72.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.039 175.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 51.7 t 120.18 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.248 -2.13 . . . . 1.0 105.248 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 107' ' ' SER . 2.6 t 178.32 29.16 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.33 -1.305 . . . . 1.0 111.934 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.756 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . 67.11 -10.81 0.77 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.132 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 107' ' ' SER . 10.3 mm-40 -74.32 -23.26 59.03 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.636 ' O ' ' O ' ' A' ' 111' ' ' GLN . 6.6 pt-20 -119.12 -0.32 11.1 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.636 ' O ' ' O ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -43.64 -150.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.706 ' C ' HD12 ' A' ' 113' ' ' LEU . 12.5 p30 144.03 27.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.271 -1.331 . . . . 1.0 112.293 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 112' ' ' ASN . 7.3 mp -149.13 174.63 12.13 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.945 -0.472 . . . . 1.0 109.813 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.504 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -141.44 122.48 8.81 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.105 -0.638 . . . . 1.0 112.252 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.03 80.47 0.15 Allowed 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 121.456 1.438 . . . . 1.0 114.546 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.544 HD23 ' CD1' ' A' ' 118' ' ' ILE . 12.7 tp -90.23 133.66 34.78 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.245 -0.284 . . . . 1.0 110.731 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 tm-20 -108.68 120.39 42.34 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.799 0.687 . . . . 1.0 111.898 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.661 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -136.5 135.04 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.166 -0.924 . . . . 1.0 111.634 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' ILE . 2.6 m-80 35.24 57.28 0.82 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.642 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 8.2 mtp180 57.88 21.13 7.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.3 0.572 . . . . 1.0 111.664 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -125.0 149.81 47.35 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.824 HG21 ' CE3' ' A' ' 76' ' ' TRP . 41.4 mm -118.93 100.84 10.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.068 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.661 ' CG ' HD11 ' A' ' 118' ' ' ILE . 8.3 m-30 -97.33 158.9 15.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 121.762 0.791 . . . . 1.0 110.849 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.693 ' HB3' HD23 ' A' ' 113' ' ' LEU . 13.7 m-30 -106.28 129.11 54.37 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.933 -1.485 . . . . 1.0 108.668 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -117.53 136.62 53.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 113.407 -1.724 . . . . 1.0 109.026 -177.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.647 HG21 ' CE2' ' A' ' 56' ' ' PHE . 29.8 p -104.18 106.37 16.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.362 -0.935 . . . . 1.0 110.629 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -73.57 -7.98 54.1 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 112.829 -1.987 . . . . 1.0 111.449 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.632 ' HE2' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -133.63 148.74 69.82 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.803 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -74.15 140.97 28.72 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 105.983 -2.353 . . . . 1.0 105.983 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.422 HG22 ' HG3' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -127.76 138.55 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 118.852 0.751 . . . . 1.0 112.255 -175.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.573 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -75.35 134.54 73.41 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.31 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.53 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . 46.2 Cg_exo -54.41 116.43 3.07 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 122.155 1.904 . . . . 1.0 113.02 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . 121.61 4.21 9.84 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 1.052 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -83.02 147.97 27.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.498 -1.351 . . . . 1.0 114.5 -178.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.655 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 2.0 pm0 -75.5 108.09 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.823 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 137' ' ' LEU . 21.7 mt -71.73 114.87 10.28 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 136' ' ' LEU . 2.2 mp -135.11 160.8 37.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.733 HG23 HG11 ' A' ' 102' ' ' VAL . 26.3 t -118.29 152.52 20.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 O-C-N 123.69 0.618 . . . . 1.0 111.984 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.842 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.542 0 O-C-N 124.959 1.412 . . . . 1.0 113.059 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.65 0 N-CA-C 111.688 0.255 . . . . 1.0 111.688 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.513 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -68.45 -49.12 62.22 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.253 -1.379 . . . . 1.0 107.824 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.3 -57.29 13.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.028 -1.896 . . . . 1.0 114.34 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.455 0 CA-C-N 120.189 1.359 . . . . 1.0 110.827 -178.741 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -177.57 -25.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.6 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -72.37 0.36 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 119.195 -1.002 . . . . 1.0 113.271 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.498 ' OG1' ' CG ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -142.01 -179.69 6.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.253 -1.794 . . . . 1.0 110.102 174.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 15' ' ' LEU . 2.4 tt -73.66 -62.79 1.37 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 172.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 42' ' ' ILE . . . -89.64 -58.45 2.52 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.749 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 1.1 tm-20 89.57 -155.08 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.098 -2.186 . . . . 1.0 105.098 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.749 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER 51.34 152.39 0.04 OUTLIER Pre-proline 0 C--N 1.268 -2.947 0 O-C-N 125.766 1.916 . . . . 1.0 111.021 -178.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.54 140.16 12.35 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.895 2.396 . . . . 1.0 111.477 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -50.5 -53.05 32.93 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.156 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -60.83 -22.55 64.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 97' ' ' ASN . 2.2 t -79.28 -49.13 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.329 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 1.0 111.769 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -63.42 -16.89 61.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.68 28.17 15.55 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.012 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 27' ' ' PRO . 39.8 mt -76.96 156.03 82.53 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 112.364 0.505 . . . . 1.0 112.364 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -32.93 -123.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 125.087 3.858 . . . . 1.0 114.033 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' CD ' ' N ' ' A' ' 29' ' ' GLU . 2.2 pp20? -72.76 -51.43 19.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.425 -1.694 . . . . 1.0 106.425 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 tt0 -175.69 60.72 0.02 OUTLIER 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.638 0.733 . . . . 1.0 109.507 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 45' ' ' TRP . 3.4 t -74.15 176.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 8.5 mtt180 -141.91 162.33 35.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.437 0.637 . . . . 1.0 110.881 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -96.81 121.84 39.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -119.76 109.53 37.82 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.87 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 35' ' ' SER . 11.7 Cg_endo -84.5 150.32 11.66 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.529 2.819 . . . . 1.0 114.714 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 9.3 p 95.03 -50.87 0.01 OUTLIER 'General case' 0 C--N 1.344 0.333 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.721 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -48.08 -54.74 12.15 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.631 -0.713 . . . . 1.0 112.704 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.571 HG22 ' H ' ' A' ' 39' ' ' LYS . 2.5 p -90.74 -40.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.76 1.164 . . . . 1.0 110.824 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 67.43 9.94 7.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 178.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' H ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.79 -27.84 0.37 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 177.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.477 ' N ' ' C ' ' A' ' 38' ' ' ASP . 8.7 m -170.27 -58.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.584 -1.189 . . . . 1.0 111.451 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.37 -96.74 0.09 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 16' ' ' ALA . 2.9 tt -98.34 140.9 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 113.795 1.035 . . . . 1.0 113.795 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -120.17 165.23 13.66 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.37 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.758 HG21 ' CE3' ' A' ' 98' ' ' TRP . 12.6 p -103.31 123.74 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.212 0.529 . . . . 1.0 110.313 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 20.9 m95 -127.9 149.04 50.48 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.116 -0.947 . . . . 1.0 112.231 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.757 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -63.37 126.04 26.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.644 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -102.21 -22.22 14.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.504 1.145 . . . . 1.0 108.136 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HZ1' ' HZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -105.74 172.49 3.94 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.231 -2.259 . . . . 1.0 112.458 -175.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -87.74 125.53 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.897 2.398 . . . . 1.0 109.525 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.686 HD13 ' HB ' ' A' ' 130' ' ' ILE . 3.6 mp -98.84 145.94 9.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.481 0.657 . . . . 1.0 110.383 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.064 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.14 148.01 33.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.181 -1.372 . . . . 1.0 108.561 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.064 ' N ' HD22 ' A' ' 51' ' ' LEU . 5.0 ttpt -60.05 126.55 27.97 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.136 0.421 . . . . 1.0 112.136 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.16 4.9 47.29 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 119.32 -1.419 . . . . 1.0 114.133 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 126' ' ' THR . 2.3 ttmt -89.16 142.47 27.62 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.45 -0.9 . . . . 1.0 113.289 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -103.81 138.01 41.02 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.876 -0.787 . . . . 1.0 108.876 175.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 126' ' ' THR . 36.2 m-85 -119.47 125.34 48.67 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.787 1.28 . . . . 1.0 111.443 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.443 ' CA ' HD11 ' A' ' 99' ' ' LEU . . . 127.09 -110.98 1.28 Allowed Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 111.905 -2.407 . . . . 1.0 109.182 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HB3' ' CE1' ' A' ' 123' ' ' TYR . 83.6 Cg_endo -72.95 177.22 37.53 Favored 'Cis proline' 0 N--CA 1.503 2.08 0 CA-C-N 119.76 1.78 . . . . 1.0 112.107 -0.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.915 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 19.4 t80 -68.61 112.2 5.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.716 0.77 . . . . 1.0 111.234 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.672 HG13 ' H ' ' A' ' 61' ' ' GLY . 1.3 p -33.18 -54.84 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.934 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.672 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 75.64 108.97 0.11 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-O 121.389 0.438 . . . . 1.0 113.933 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -99.54 131.09 45.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.422 -2.066 . . . . 1.0 105.422 175.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.549 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -93.47 112.85 24.85 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.86 1.43 . . . . 1.0 114.86 -175.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -148.34 166.34 28.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.3 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.841 ' HZ2' ' H ' ' A' ' 65' ' ' LYS . 1.4 mtmp? -77.26 135.44 38.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.227 0.537 . . . . 1.0 111.531 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.443 HH11 ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.62 -23.37 50.75 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.657 0.614 . . . . 1.0 112.657 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.887 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.549 ' C ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.022 0 CA-C-O 121.649 0.738 . . . . 1.0 111.884 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.73 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -147.75 140.55 24.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.628 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.4 124.59 47.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.365 0.603 . . . . 1.0 111.762 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 120' ' ' ARG . 2.2 t -144.75 130.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -88.28 124.88 34.32 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.659 ' CZ ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 m-85 -77.55 113.19 29.7 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.632 -1.622 . . . . 1.0 112.856 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -53.68 -2.46 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.014 1.809 . . . . 1.0 110.326 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 80' ' ' TYR . 53.2 m-80 -102.98 -96.08 0.3 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.976 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 84' ' ' GLY . 0.8 OUTLIER -65.84 -40.22 91.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.88 1.437 . . . . 1.0 114.88 -176.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.4 ' N ' ' HG ' ' A' ' 83' ' ' LEU . . . 147.71 -173.54 27.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 119.772 -1.204 . . . . 1.0 110.32 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 12.0 m95 -55.16 122.14 10.37 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.88 -0.777 . . . . 1.0 111.454 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.497 ' O ' ' O ' ' A' ' 78' ' ' VAL . 5.8 tpp -127.61 157.2 40.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.354 0.501 . . . . 1.0 112.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -120.12 145.36 46.98 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.962 0.887 . . . . 1.0 110.179 176.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' O ' ' A' ' 120' ' ' ARG . 19.7 mt -97.07 156.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.847 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.93 134.02 46.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.915 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . . . -132.83 138.17 46.98 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.082 -2.192 . . . . 1.0 105.082 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 164.88 -31.43 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.868 1.213 . . . . 1.0 111.383 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.29 148.05 59.59 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.537 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 31.5 Cg_exo -55.28 -44.61 47.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.368 1.379 . . . . 1.0 112.481 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.69 -9.32 58.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.746 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -12.59 56.5 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' CA ' HG11 ' A' ' 60' ' ' VAL . . . -178.05 -107.54 0.22 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 119.507 -1.33 . . . . 1.0 113.217 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.691 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -150.23 -156.1 0.69 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.447 -178.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.758 ' CE3' HG21 ' A' ' 44' ' ' VAL . 23.2 p-90 -70.91 -25.57 62.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.62 HD23 ' CD2' ' A' ' 124' ' ' TYR . 0.3 OUTLIER -53.46 -27.41 24.81 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.487 ' C ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.39 -30.67 53.74 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.554 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.2 m-85 -66.97 -18.54 65.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.32 0.581 . . . . 1.0 109.774 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 136' ' ' LEU . 6.3 t -63.92 116.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.08 -0.964 . . . . 1.0 110.396 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.67 140.79 46.33 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.131 -2.174 . . . . 1.0 105.131 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.637 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 15.8 p90 -92.07 118.73 31.08 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.937 -1.105 . . . . 1.0 110.696 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 12.61 78.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 113.953 -1.476 . . . . 1.0 114.81 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.498 ' C ' ' O ' ' A' ' 105' ' ' ALA . 0.1 OUTLIER -19.5 -40.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 125.197 1.56 . . . . 1.0 110.031 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -168.38 7.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.739 176.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.96 22.48 23.01 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.717 -0.953 . . . . 1.0 110.717 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.425 ' CD ' ' SG ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -77.79 -37.8 48.04 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.297 -0.561 . . . . 1.0 110.118 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.538 ' HG3' HD22 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -119.41 -31.91 4.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.981 1.104 . . . . 1.0 113.981 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.534 ' C ' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 14.25 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 123.416 0.448 . . . . 1.0 111.609 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.849 HD22 HG21 ' A' ' 130' ' ' ILE . 34.0 p-10 -128.06 32.97 4.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER -152.96 172.49 16.73 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.579 ' HB3' HD21 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -148.26 124.15 5.26 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 119.351 -0.94 . . . . 1.0 112.702 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.451 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.8 Cg_endo -74.71 109.82 2.99 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 120.64 0.893 . . . . 1.0 113.313 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 23.2 tp -117.42 140.8 49.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.698 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.97 121.34 45.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.794 0.664 . . . . 1.0 112.794 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -135.54 135.66 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.875 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 118' ' ' ILE . 8.0 m-80 35.94 62.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.373 0.509 . . . . 1.0 112.373 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.659 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 7.2 mtp180 55.93 11.89 0.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.984 0.365 . . . . 1.0 111.984 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -122.92 146.16 47.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 59' ' ' PHE . 4.0 mm -107.41 117.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 121.112 0.482 . . . . 1.0 110.566 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.61 ' HB2' HD11 ' A' ' 118' ' ' ILE . 3.0 m-85 -101.14 143.44 31.24 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.62 ' CD2' HD23 ' A' ' 99' ' ' LEU . 15.6 m-30 -102.03 114.72 29.08 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 104.139 -2.541 . . . . 1.0 104.139 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 7.7 ttmt -105.51 141.2 37.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.379 1.05 . . . . 1.0 109.344 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.509 HG21 ' CE2' ' A' ' 56' ' ' PHE . 18.6 p -106.87 110.88 23.16 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.401 0.62 . . . . 1.0 110.068 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -72.41 -4.66 31.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.67 -1.604 . . . . 1.0 111.239 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -145.72 161.14 41.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 120.234 -0.586 . . . . 1.0 112.311 -177.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -75.5 144.42 28.64 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 N-CA-C 105.911 -2.38 . . . . 1.0 105.911 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.849 HG21 HD22 ' A' ' 112' ' ' ASN . 5.2 mt -126.19 135.71 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.719 0.691 . . . . 1.0 110.532 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.53 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.7 134.26 95.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.224 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -59.87 117.98 4.8 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 CA-C-N 120.006 1.038 . . . . 1.0 110.415 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.757 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.28 5.82 14.27 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.824 -1.311 . . . . 1.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.574 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -89.21 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.3 pm0 -78.59 118.84 21.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.268 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 137' ' ' LEU . 2.8 mt -80.3 116.8 20.57 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 105' ' ' ALA . 1.7 mp -129.3 156.17 44.43 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 108.688 -0.856 . . . . 1.0 108.688 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.637 ' H ' ' HA ' ' A' ' 104' ' ' TRP . 5.0 t -122.09 157.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.963 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.543 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.204 -1.339 0 N-CA-C 114.985 1.476 . . . . 1.0 114.985 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.563 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.563 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -56.34 -52.43 64.6 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 117.615 -1.634 . . . . 1.0 108.213 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.76 -62.32 1.82 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.775 -1.557 . . . . 1.0 113.4 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.311 0 CA-C-N 120.12 1.327 . . . . 1.0 111.652 -177.761 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' N ' ' HG2' ' A' ' 34' ' ' PRO . . . . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m 178.22 -27.65 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.354 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.38 -73.63 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.712 0.767 . . . . 1.0 112.412 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.459 ' CB ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.36 175.81 9.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.135 -1.393 . . . . 1.0 110.632 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 15' ' ' LEU . 3.0 tt -77.19 -62.88 1.51 Allowed 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 172.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 42' ' ' ILE . . . -86.34 -59.39 2.3 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.77 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 9.1 tt0 92.48 -171.48 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 105.415 -2.069 . . . . 1.0 105.415 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.77 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 58.49 151.83 0.08 OUTLIER Pre-proline 0 C--N 1.245 -3.97 0 CA-C-N 112.034 -2.348 . . . . 1.0 108.792 -178.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.92 138.87 6.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 123.429 2.752 . . . . 1.0 111.886 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 27.9 tt0 -50.27 -51.82 41.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-N 114.932 -1.031 . . . . 1.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -63.2 -24.36 67.84 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 97' ' ' ASN . 3.4 t -76.36 -50.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 118.631 -1.228 . . . . 1.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.95 -29.28 65.25 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.132 -0.485 . . . . 1.0 112.245 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.89 -15.98 15.29 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.235 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.42 20.81 31.88 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.936 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 30' ' ' VAL 0.251 17.9 mt -69.19 139.63 90.13 Favored Pre-proline 0 CA--C 1.489 -1.381 0 CA-C-N 118.384 1.092 . . . . 1.0 109.99 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 29' ' ' GLU . 5.9 Cg_exo -61.11 148.43 92.88 Favored 'Trans proline' 0 C--N 1.281 -3.026 0 N-CA-C 107.159 -1.9 . . . . 1.0 107.159 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -49.17 -15.27 0.11 Allowed 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.567 1.175 . . . . 1.0 110.275 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -91.15 19.47 5.8 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 112.596 -2.093 . . . . 1.0 112.707 -178.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 26' ' ' LEU . 1.8 t -145.38 151.73 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 118.655 -1.218 . . . . 1.0 112.483 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -147.39 159.09 44.09 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.863 -1.971 . . . . 1.0 106.737 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.807 HD21 ' OH ' ' A' ' 101' ' ' TYR . 1.6 mm? -105.92 140.81 38.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m-85 -148.47 115.35 3.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.641 0.608 . . . . 1.0 112.641 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.9 Cg_endo -85.98 127.62 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.319 2.012 . . . . 1.0 111.123 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 152.55 -71.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.739 0.65 . . . . 1.0 110.831 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.667 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -51.18 -53.25 36.59 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.771 -0.772 . . . . 1.0 113.025 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -53.24 -52.17 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.369 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 40' ' ' THR . 6.4 p-10 -171.34 55.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? 53.82 -9.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.589 ' H ' ' C ' ' A' ' 38' ' ' ASP . 12.3 p -135.42 -90.4 0.31 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.301 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 40' ' ' THR . 4.5 mtt85 -29.43 133.27 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.641 0.588 . . . . 1.0 111.09 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -78.84 133.86 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.94 153.41 17.16 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.3 -1.12 . . . . 1.0 110.3 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -104.14 127.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.621 0.724 . . . . 1.0 109.212 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.667 ' CZ2' ' HB3' ' A' ' 36' ' ' ALA . 4.8 m95 -130.88 149.92 52.28 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 114.469 -1.241 . . . . 1.0 111.507 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.32 138.24 51.31 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.572 -1.251 . . . . 1.0 111.03 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.439 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -112.62 -28.25 7.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.364 -178.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.559 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -116.14 159.71 38.45 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 119.167 -1.013 . . . . 1.0 111.32 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 Cg_endo -57.21 132.27 50.16 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.812 2.341 . . . . 1.0 111.469 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 48' ' ' LYS . 3.4 mp -111.15 144.22 19.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.047 -0.979 . . . . 1.0 108.613 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.051 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.59 149.23 34.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.051 ' N ' HD22 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -64.69 135.47 55.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.757 0.789 . . . . 1.0 111.951 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.7 2.93 49.83 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 119.356 -1.402 . . . . 1.0 113.078 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.651 ' HE3' HD12 ' A' ' 51' ' ' LEU . 3.1 ttmt -96.19 139.73 31.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.162 -1.015 . . . . 1.0 113.475 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.99 139.89 35.01 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 120.16 -0.616 . . . . 1.0 109.534 176.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 126' ' ' THR . 37.1 m-85 -121.89 127.81 50.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 122.852 1.31 . . . . 1.0 110.917 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.409 ' CA ' HD11 ' A' ' 99' ' ' LEU . . . 135.11 -106.55 0.59 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 111.526 -2.579 . . . . 1.0 110.251 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 88.8 Cg_endo -83.52 170.46 53.19 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 CA-C-N 119.507 1.654 . . . . 1.0 111.994 -0.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.567 ' CE1' ' NH2' ' A' ' 100' ' ' ARG . 27.7 t80 -59.14 109.75 0.92 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.957 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG13 ' H ' ' A' ' 61' ' ' GLY . 3.0 p -45.99 -50.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.719 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.606 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 72.31 111.18 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.359 -0.448 . . . . 1.0 114.038 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t0 -99.7 132.54 44.98 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -91.22 110.21 21.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 -177.091 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -146.47 166.91 24.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.641 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.555 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 2.1 mtmp? -80.38 132.85 35.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.597 0.713 . . . . 1.0 112.08 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 67' ' ' SER . 2.7 ptm180 -50.19 -24.68 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 1.0 111.28 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.509 ' C ' ' O ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.638 0 O-C-N 123.981 0.801 . . . . 1.0 111.907 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.502 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.506 -0.728 0 N-CA-C 114.006 1.113 . . . . 1.0 114.006 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.747 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -138.7 125.35 20.78 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.735 -1.575 . . . . 1.0 109.815 -177.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -97.37 123.25 41.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.448 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.0 139.43 22.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.224 -1.353 . . . . 1.0 109.297 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -83.62 129.28 34.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.65 ' CE2' ' NE ' ' A' ' 120' ' ' ARG . 15.5 m-85 -103.52 117.23 60.5 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.693 -1.14 . . . . 1.0 113.74 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -69.9 4.11 2.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.541 1.494 . . . . 1.0 109.774 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.745 ' ND2' HH12 ' A' ' 120' ' ' ARG . 62.8 m-20 -102.11 -2.84 28.58 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.911 -1.04 . . . . 1.0 111.112 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.9 0.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 80' ' ' TYR . . . 99.19 -164.46 20.36 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 18.8 m95 -60.86 120.18 9.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.759 -0.776 . . . . 1.0 111.019 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 1.4 tpp -130.82 165.62 22.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.185 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.605 ' N ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -120.72 144.48 48.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.045 0.926 . . . . 1.0 110.477 176.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 120' ' ' ARG . 61.1 mt -97.7 156.01 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.44 136.57 54.68 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.273 0.942 . . . . 1.0 112.765 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' HE1' ' A' ' 76' ' ' TRP . . . -134.32 139.82 45.93 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.636 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 167.16 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 120.086 1.312 . . . . 1.0 111.269 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.62 152.37 62.92 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.692 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.443 ' HB2' HG21 ' A' ' 22' ' ' VAL . 51.7 Cg_endo -66.85 -37.67 19.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.543 2.162 . . . . 1.0 111.086 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.16 -14.17 62.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HB3' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.67 -10.78 50.3 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.452 ' HA3' HG11 ' A' ' 60' ' ' VAL . . . 174.92 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 119.761 -1.209 . . . . 1.0 113.854 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -148.26 -163.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.942 0.401 . . . . 1.0 111.783 -177.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.587 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 30.0 p-90 -71.3 -26.8 63.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.645 HD23 ' CD2' ' A' ' 124' ' ' TYR . 2.1 mp -55.03 -28.14 49.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.98 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.611 ' CB ' ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -77.09 -45.27 27.57 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.684 -0.806 . . . . 1.0 111.989 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.807 ' OH ' HD21 ' A' ' 32' ' ' LEU . 11.7 p90 -77.54 1.83 18.26 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 118.335 -1.346 . . . . 1.0 110.82 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.82 119.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 129.28 39.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.52 -1.289 . . . . 1.0 107.52 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.565 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 22.4 p90 -93.42 123.53 36.79 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.883 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.695 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 22.49 76.92 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.065 -1.425 . . . . 1.0 114.094 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.549 ' C ' ' O ' ' A' ' 105' ' ' ALA . 2.2 t -23.99 -38.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.787 1.304 . . . . 1.0 108.165 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -177.98 15.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.3 -1.318 . . . . 1.0 109.716 174.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 107' ' ' SER . . . 89.17 36.28 7.69 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 114.891 -1.049 . . . . 1.0 110.658 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -78.91 -44.41 22.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.047 -0.661 . . . . 1.0 109.891 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.547 ' HG3' HD22 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -120.46 -28.33 5.0 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.601 -0.714 . . . . 1.0 112.337 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.53 ' OE1' ' C ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER 22.66 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.937 0.773 . . . . 1.0 110.188 -178.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.531 HD21 ' HA ' ' A' ' 136' ' ' LEU . 41.1 p-10 -128.28 37.89 4.08 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 138' ' ' VAL . 1.0 OUTLIER -154.34 173.44 16.18 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -178.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.564 ' HB3' HD21 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -147.09 123.02 5.46 Favored Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 119.598 -0.841 . . . . 1.0 111.623 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HD3' ' H ' ' A' ' 139' ' ' TRP . 8.7 Cg_endo -67.23 92.52 0.34 Allowed 'Trans proline' 0 N--CA 1.482 0.798 0 CA-C-N 119.276 0.777 . . . . 1.0 112.281 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.576 HD22 ' HE3' ' A' ' 125' ' ' LYS . 31.4 tp -93.07 130.29 38.74 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.98 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.49 116.23 31.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 1.0 110.726 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.961 HD11 ' CG ' ' A' ' 123' ' ' TYR . 2.0 pt -138.39 135.89 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.481 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' ILE . 60.0 m-20 40.35 56.85 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.236 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.745 HH12 ' ND2' ' A' ' 82' ' ' ASN . 5.8 mtp180 58.12 12.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 111.84 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -117.25 150.25 39.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.673 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.723 HG21 ' CZ3' ' A' ' 76' ' ' TRP . 26.3 mm -110.52 104.18 16.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.418 0 C-N-CA 120.5 -0.48 . . . . 1.0 109.877 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.961 ' CG ' HD11 ' A' ' 118' ' ' ILE . 3.5 m-85 -92.77 149.96 20.96 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 120.799 -1.188 . . . . 1.0 110.36 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.645 ' CD2' HD23 ' A' ' 99' ' ' LEU . 15.5 m-30 -102.12 111.34 23.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 104.817 -2.29 . . . . 1.0 104.817 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.576 ' HE3' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -106.22 139.33 40.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 124.691 1.245 . . . . 1.0 109.095 -178.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.57 HG21 ' CE2' ' A' ' 56' ' ' PHE . 6.4 p -107.24 111.26 23.57 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.684 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -77.27 0.89 20.37 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.681 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.606 ' NZ ' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -144.02 140.84 17.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.943 -176.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 23.6 Cg_exo -65.98 140.77 61.68 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 N-CA-C 105.589 -2.504 . . . . 1.0 105.589 174.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.556 ' HB ' HD13 ' A' ' 50' ' ' ILE . 24.2 mt -118.89 134.7 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.89 0.768 . . . . 1.0 112.249 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.437 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -72.82 120.81 82.86 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.08 122.45 6.33 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.934 1.756 . . . . 1.0 112.233 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 130.59 -2.92 5.74 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.576 -0.821 . . . . 1.0 114.06 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.781 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -103.81 167.17 9.95 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.111 0.958 . . . . 1.0 112.76 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.3 pm0 -80.5 139.24 36.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.778 -1.555 . . . . 1.0 111.027 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.531 ' HA ' HD21 ' A' ' 112' ' ' ASN . 9.2 mt -88.55 118.14 28.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 105' ' ' ALA . 2.1 mp -121.57 150.68 41.32 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.047 0.451 . . . . 1.0 110.292 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.651 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 17.5 t -118.94 153.27 21.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.166 -0.925 . . . . 1.0 110.12 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.651 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 O-C-N 124.429 1.081 . . . . 1.0 113.634 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.647 HG13 HD11 ' A' ' 127' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.175 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.548 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -71.62 -47.21 56.11 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.388 -1.325 . . . . 1.0 109.097 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -53.99 -57.06 12.4 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.629 -1.623 . . . . 1.0 113.235 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.344 0 CA-C-N 120.298 1.408 . . . . 1.0 111.94 -178.413 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.278 0 CA-C-O 121.01 0.433 . . . . 1.0 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.426 HG21 ' C ' ' A' ' 40' ' ' THR . 11.4 m -124.2 -78.29 0.6 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.55 -151.56 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.489 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -125.49 155.33 40.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.937 0.875 . . . . 1.0 112.269 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.657 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -51.55 -32.39 28.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.085 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.52 -15.71 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.36 -0.836 . . . . 1.0 112.608 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 14' ' ' THR . 2.8 mt-10 -91.48 -25.36 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.677 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.588 HG22 ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -50.75 141.53 17.77 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.364 -178.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.637 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 22.5 Cg_exo -51.0 141.85 35.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.61 2.206 . . . . 1.0 112.558 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.627 ' HA ' HD21 ' A' ' 23' ' ' LEU . 47.8 tt0 -63.45 -31.73 72.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 113.43 0.9 . . . . 1.0 113.43 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 93' ' ' PRO . 4.6 p-80 -74.56 -26.54 60.01 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.789 1.403 . . . . 1.0 114.789 -176.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.659 HG12 ' C ' ' A' ' 97' ' ' ASN . 4.4 m -78.87 -47.27 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.47 1.032 . . . . 1.0 111.953 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.029 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.17 -22.02 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 122.676 1.227 . . . . 1.0 109.392 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HE ' ' CG ' ' A' ' 20' ' ' GLU . 1.2 mpt_? -63.74 -43.63 95.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.952 -1.931 . . . . 1.0 113.066 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.21 33.95 6.11 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.502 -0.856 . . . . 1.0 112.933 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.651 HD22 ' HB ' ' A' ' 30' ' ' VAL . 35.8 mt -68.49 153.52 95.6 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.668 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.545 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 71.9 Cg_exo -47.37 -106.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 124.287 3.324 . . . . 1.0 115.653 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -74.16 -58.89 3.0 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER -174.76 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 177.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.651 ' HB ' HD22 ' A' ' 26' ' ' LEU . 50.5 t -48.04 178.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.65 -1.159 . . . . 1.0 108.588 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HB3' HG21 ' A' ' 47' ' ' THR . 0.7 OUTLIER -147.88 159.04 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.7 mm? -94.96 121.04 36.16 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.1 -0.64 . . . . 1.0 110.683 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -132.48 139.84 36.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.003 -0.999 . . . . 1.0 111.057 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.2 Cg_endo -80.41 153.18 20.83 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.957 2.438 . . . . 1.0 112.484 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.861 ' H ' HG12 ' A' ' 37' ' ' VAL . 44.2 t 124.16 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.69 1.196 . . . . 1.0 110.958 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.79 12.83 16.01 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.892 1.329 . . . . 1.0 108.057 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 41' ' ' ARG . 3.6 p -93.1 -52.41 9.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 113.306 -1.77 . . . . 1.0 115.062 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.834 ' O ' HG23 ' A' ' 40' ' ' THR . 26.6 t0 126.26 46.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.862 ' H ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 31.86 40.91 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.543 179.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 38' ' ' ASP . 18.4 p -133.56 -16.95 2.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.925 -1.034 . . . . 1.0 111.467 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.915 ' O ' HG11 ' A' ' 37' ' ' VAL . 9.1 ttm-85 179.81 -166.03 0.07 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.784 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -78.02 155.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.887 0.375 . . . . 1.0 110.817 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -114.66 166.14 12.13 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 136' ' ' LEU . 10.0 p -105.41 126.61 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.752 0.776 . . . . 1.0 111.313 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.629 ' O ' HG13 ' A' ' 30' ' ' VAL . 16.1 m95 -126.9 142.38 51.56 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.376 -0.829 . . . . 1.0 113.226 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -69.19 133.51 48.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.305 -1.316 . . . . 1.0 110.304 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.595 HG21 ' HB3' ' A' ' 31' ' ' ARG . 56.0 p -130.34 12.68 5.52 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.868 -1.531 . . . . 1.0 106.868 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.938 ' NZ ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -133.09 170.32 11.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 112.593 -2.094 . . . . 1.0 110.908 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -89.59 141.99 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.289 2.659 . . . . 1.0 111.338 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.938 HD11 ' NZ ' ' A' ' 48' ' ' LYS . 45.2 mt -134.3 146.94 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 114.871 -1.059 . . . . 1.0 112.046 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.718 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.03 168.69 9.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.0 177.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.553 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -65.79 122.83 18.21 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.48 -0.488 . . . . 1.0 111.589 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.926 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.09 7.74 49.24 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.066 -1.064 . . . . 1.0 113.803 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.5 ttmt -75.51 133.16 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 116.787 -1.965 . . . . 1.0 113.852 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -85.8 121.21 28.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 1.0 113.397 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 27' ' ' PRO . 20.9 m-85 -121.17 142.77 49.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.309 1.226 . . . . 1.0 114.309 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.29 -100.49 1.65 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.013 -1.903 . . . . 1.0 110.59 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 95.5 Cg_endo -76.25 167.9 78.8 Favored 'Cis proline' 0 N--CA 1.499 1.814 0 CA-C-N 119.342 1.571 . . . . 1.0 112.049 -0.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 19.4 t80 -54.85 108.99 0.45 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 95' ' ' LYS . 3.7 p -37.05 -53.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.663 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 52.74 119.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.883 -0.675 . . . . 1.0 113.917 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.85 143.28 33.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -89.08 111.47 22.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.388 0.613 . . . . 1.0 110.921 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CD ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.92 178.84 6.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 1.0 111.79 -176.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -50.88 167.76 0.07 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.084 -0.962 . . . . 1.0 111.703 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.21 -51.55 24.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.266 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.277 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.531 ' O ' ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -163.95 163.61 23.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.777 -0.769 . . . . 1.0 113.034 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 5.4 pt-20 -100.97 123.24 44.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.093 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.2 124.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.411 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 4.1 t80 -78.06 124.15 27.69 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.632 ' C ' ' H ' ' A' ' 82' ' ' ASN . 23.2 m-85 -103.5 101.65 24.83 Favored Pre-proline 0 N--CA 1.448 -0.571 0 O-C-N 124.522 1.138 . . . . 1.0 112.889 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -65.35 22.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 121.423 1.415 . . . . 1.0 110.611 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.745 ' C ' HD13 ' A' ' 83' ' ' LEU . 83.0 m-20 -118.38 -2.3 11.12 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.837 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -178.1 6.48 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 102.91 174.94 26.71 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 113.844 0.298 . . . . 1.0 113.844 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.518 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.1 m95 -59.1 120.31 8.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.816 0.447 . . . . 1.0 111.656 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.518 ' SD ' ' C ' ' A' ' 85' ' ' TRP . 26.7 mmm -125.46 167.86 14.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.039 1.125 . . . . 1.0 114.039 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.419 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -114.67 138.23 50.94 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 105.604 -1.999 . . . . 1.0 105.604 172.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 78' ' ' VAL . 72.2 mt -103.79 101.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -128.96 127.96 42.75 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.268 0.556 . . . . 1.0 111.283 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -139.75 92.5 2.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.476 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.13 -5.97 21.51 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.419 -0.912 . . . . 1.0 112.811 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.645 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -86.79 120.55 71.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.605 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 52.6 Cg_exo -47.83 -26.98 7.75 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.114 1.876 . . . . 1.0 113.934 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.6 -44.24 82.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.638 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.724 ' O ' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.82 3.26 15.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.619 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.789 ' O ' ' ND2' ' A' ' 97' ' ' ASN . . . -97.54 -2.94 58.63 Favored Glycine 0 C--O 1.219 -0.795 0 CA-C-N 115.39 -0.823 . . . . 1.0 113.019 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.789 ' ND2' ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER 42.57 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.19 0.495 . . . . 1.0 110.109 -177.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.466 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 67.6 p-90 -70.58 -24.55 62.79 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 97' ' ' ASN . 5.2 mp -55.36 -23.6 25.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.078 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.48 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -68.26 -13.81 62.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 176.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.3 m-85 -96.93 -10.62 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.475 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 99' ' ' LEU . 70.7 t -66.95 118.5 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.872 -0.731 . . . . 1.0 110.03 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.818 ' ND2' ' H ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -80.57 -164.39 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.55 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.615 ' O ' HD23 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -121.9 154.6 36.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.505 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.936 ' HB3' ' NE2' ' A' ' 111' ' ' GLN . . . -134.89 -176.72 4.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.421 0.629 . . . . 1.0 112.016 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.505 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -105.43 -54.15 2.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.596 -178.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -103.16 175.22 5.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 111.379 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.1 -36.88 34.08 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -54.59 -25.39 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 1.0 110.401 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 105' ' ' ALA . 8.3 pt-20 -107.64 -24.01 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.435 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.936 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -103.09 103.82 13.92 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.22 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.731 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -114.45 34.25 4.84 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -177.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 137' ' ' LEU . 5.3 mp -144.42 149.25 35.76 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.606 -0.838 . . . . 1.0 111.77 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.697 ' CD1' HG23 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -150.67 127.16 5.21 Favored Pre-proline 0 N--CA 1.47 0.528 0 C-N-CA 120.287 -0.565 . . . . 1.0 112.395 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 51.6 Cg_exo -60.5 133.55 49.53 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.087 1.858 . . . . 1.0 113.797 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -134.98 136.16 41.98 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.35 120.87 41.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.07 0.462 . . . . 1.0 111.757 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.862 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.1 OUTLIER -129.61 114.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 56.7 42.67 26.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.592 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 65.89 15.1 9.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.974 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -106.75 124.64 49.91 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.66 120.74 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.597 0.713 . . . . 1.0 112.238 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.862 ' CG ' HD11 ' A' ' 118' ' ' ILE . 7.7 m-85 -112.07 153.68 26.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.796 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -112.86 126.51 55.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.45 152.69 43.02 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.558 -0.857 . . . . 1.0 112.525 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.926 ' O ' ' N ' ' A' ' 53' ' ' GLY . 7.3 p -106.68 106.24 16.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.082 -1.417 . . . . 1.0 109.83 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -69.89 -0.46 7.35 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.927 0.767 . . . . 1.0 111.594 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 1.007 ' H ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -148.28 126.95 6.1 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.173 -176.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.63 148.48 2.34 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.951 2.434 . . . . 1.0 112.547 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -114.89 135.87 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.882 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -78.27 115.29 49.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -40.78 117.87 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.458 2.105 . . . . 1.0 113.282 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.62 6.19 13.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.522 -0.599 . . . . 1.0 112.566 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.882 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.4 pt-20 -104.92 166.98 10.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.938 0.869 . . . . 1.0 112.269 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' OE1' ' HB1' ' A' ' 36' ' ' ALA . 5.4 pt-20 -81.09 136.59 35.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.306 -1.315 . . . . 1.0 111.74 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 137' ' ' LEU . 1.2 mp -86.48 128.05 34.92 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.919 -1.037 . . . . 1.0 109.955 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.669 HD21 ' OD1' ' A' ' 103' ' ' ASN . 4.9 mp -142.65 157.98 44.12 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.993 0.517 . . . . 1.0 111.71 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.605 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.66 146.26 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 178.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.872 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.192 -1.973 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.697 HG23 ' CD1' ' A' ' 114' ' ' PHE . 93.3 mt . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 121.222 0.534 . . . . 1.0 111.968 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -51.54 -33.03 30.32 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.647 -0.706 . . . . 1.0 112.523 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.19 45.44 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.23 -0.588 . . . . 1.0 111.537 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.89 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.33 0.586 . . . . 1.0 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -140.49 -58.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.2 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.06 160.06 0.53 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -123.06 151.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.737 0.779 . . . . 1.0 112.748 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.71 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -55.56 -36.87 67.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.985 -1.007 . . . . 1.0 109.487 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -15.79 60.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.754 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -23.3 33.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.997 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.596 HG21 ' HG ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -60.66 144.59 89.08 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.644 ' O ' HD22 ' A' ' 23' ' ' LEU . 32.2 Cg_exo -48.15 148.64 6.9 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.101 2.534 . . . . 1.0 113.228 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' HD23 ' A' ' 23' ' ' LEU . 30.0 tt0 -60.72 -42.03 96.46 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.617 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 7.8 p-80 -73.4 -29.32 62.52 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.258 1.577 . . . . 1.0 115.258 -176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG12 ' C ' ' A' ' 97' ' ' ASN . 21.5 m -75.36 -47.16 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 119.909 1.231 . . . . 1.0 110.652 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 19' ' ' PRO . 1.6 pt? -67.5 -25.33 65.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.815 0.817 . . . . 1.0 110.321 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HE ' ' HG2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -71.07 -36.04 72.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.078 -1.419 . . . . 1.0 112.813 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.1 31.24 7.11 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.74 -0.743 . . . . 1.0 111.617 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 30' ' ' VAL . 10.3 mt -72.68 120.89 83.21 Favored Pre-proline 0 CA--C 1.5 -0.952 0 C-N-CA 119.651 -0.82 . . . . 1.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.85 168.39 7.21 Favored 'Trans proline' 0 C--N 1.296 -2.227 0 CA-C-N 120.085 1.066 . . . . 1.0 109.438 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 48' ' ' LYS . 3.7 pt-20 -59.02 -8.89 1.59 Allowed 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 112.491 -2.141 . . . . 1.0 115.386 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.822 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -112.51 11.95 19.87 Favored 'General case' 0 CA--C 1.458 -2.586 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.973 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.855 ' O ' HD13 ' A' ' 26' ' ' LEU . 2.3 t -137.1 117.06 16.22 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 C-N-CA 117.38 -1.728 . . . . 1.0 113.95 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' NE ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.67 142.02 49.85 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.144 -1.428 . . . . 1.0 107.144 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 26' ' ' LEU . 4.2 mm? -90.07 116.93 28.47 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.175 1.352 . . . . 1.0 111.548 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -139.73 141.34 27.53 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.725 -1.125 . . . . 1.0 110.942 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 35' ' ' SER . 53.2 Cg_endo -76.16 159.04 37.46 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.863 3.042 . . . . 1.0 113.804 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.75 ' C ' ' H ' ' A' ' 37' ' ' VAL . 13.4 m 110.4 -85.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.814 1.246 . . . . 1.0 108.575 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' ASN . . . -55.54 12.17 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.896 0.855 . . . . 1.0 111.822 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.75 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -95.51 -53.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.864 -1.517 . . . . 1.0 112.555 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.1 m-20 143.65 42.14 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.323 1.014 . . . . 1.0 109.187 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.0 23.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.309 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 38' ' ' ASP . 9.7 t -122.76 -4.48 8.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.064 0.764 . . . . 1.0 113.064 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.603 ' O ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.33 -162.95 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 HG21 ' HB3' ' A' ' 32' ' ' LEU . 1.4 mm -79.08 156.21 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.956 0.408 . . . . 1.0 110.904 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -124.88 165.12 18.14 Favored Glycine 0 C--O 1.196 -2.26 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -105.99 135.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 117.605 0.702 . . . . 1.0 110.937 -178.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 15.6 m95 -130.65 149.96 52.06 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.993 -1.003 . . . . 1.0 113.69 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.15 128.98 38.15 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.345 -1.298 . . . . 1.0 113.428 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 28' ' ' GLU . 81.5 p -115.8 -20.91 9.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.058 -0.974 . . . . 1.0 111.085 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' C ' ' CD ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.57 168.22 10.58 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.298 178.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.14 121.99 6.87 Favored 'Trans proline' 0 CA--C 1.498 -1.314 0 C-N-CA 121.915 1.743 . . . . 1.0 111.666 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.733 HD12 HG21 ' A' ' 130' ' ' ILE . 72.6 mt -100.61 143.02 14.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 112.858 -1.974 . . . . 1.0 109.581 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.791 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.0 pp -109.01 164.27 12.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.79 -1.096 . . . . 1.0 109.294 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.613 ' C ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.34 122.74 21.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.01 0.91 . . . . 1.0 111.111 177.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.896 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.13 10.07 40.47 Favored Glycine 0 C--N 1.303 -1.304 0 C-N-CA 120.022 -1.085 . . . . 1.0 114.029 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -89.19 130.85 35.54 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.328 -1.749 . . . . 1.0 114.624 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 4.4 mtmm -85.9 124.54 32.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.857 -1.52 . . . . 1.0 111.473 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CD2' ' OE1' ' A' ' 29' ' ' GLU . 47.5 m-85 -121.65 149.71 42.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.9 -102.37 1.56 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.215 -1.357 . . . . 1.0 111.507 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 50.7 Cg_endo -84.15 165.14 64.22 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 119.753 1.776 . . . . 1.0 113.036 0.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 20.4 t80 -54.39 110.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.849 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.628 HG11 ' HE ' ' A' ' 100' ' ' ARG . 2.9 p -35.42 -56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.446 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 51.28 116.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.558 -0.829 . . . . 1.0 114.799 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 21.4 t0 -103.49 146.69 28.14 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 63' ' ' LYS . 3.2 mtmp? -89.29 113.64 24.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.443 -0.903 . . . . 1.0 112.202 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.628 ' CE ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -136.04 166.29 23.7 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.328 -0.851 . . . . 1.0 111.345 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.628 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -81.25 131.24 35.28 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.517 0.562 . . . . 1.0 112.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -40.64 -24.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 65' ' ' LYS . 27.5 m . . . . . 0 C--N 1.317 -0.822 0 C-N-CA 119.461 -0.895 . . . . 1.0 108.714 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.471 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -164.49 164.23 21.9 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.493 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.73 122.78 41.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.17 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.42 119.45 13.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.445 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 3.0 t80 -78.19 125.03 28.76 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 113.41 0.893 . . . . 1.0 113.41 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ASN . 25.0 m-85 -103.22 97.8 10.71 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 114.698 -1.137 . . . . 1.0 112.172 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 79' ' ' TYR . 51.9 Cg_exo -51.31 -11.33 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.247 1.298 . . . . 1.0 109.785 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' TYR . 77.3 m-20 -76.53 -3.42 37.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.424 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 84' ' ' GLY . 2.5 pp -178.29 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.589 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 146.82 173.24 17.87 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.132 -1.032 . . . . 1.0 112.523 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.502 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.9 m95 -58.53 120.25 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.646 -0.277 . . . . 1.0 111.547 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.505 ' SD ' ' CD1' ' A' ' 83' ' ' LEU . 20.3 mmm -127.25 163.87 22.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.996 1.109 . . . . 1.0 113.996 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.432 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.24 139.78 46.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.354 -2.091 . . . . 1.0 105.354 172.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 75' ' ' MET . 66.4 mt -107.58 103.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 118.219 -0.895 . . . . 1.0 109.7 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -130.29 130.77 44.94 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.207 0.912 . . . . 1.0 112.362 -178.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.782 ' HB1' ' CZ ' ' A' ' 100' ' ' ARG . . . -142.72 113.04 7.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.201 -0.909 . . . . 1.0 109.72 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.496 ' O ' ' OG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -132.68 26.93 4.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.979 0.809 . . . . 1.0 110.139 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.729 ' N ' HH11 ' A' ' 100' ' ' ARG . 2.6 m-20 -117.15 81.62 13.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.818 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.617 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 58.6 Cg_exo -48.48 -12.67 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.084 2.523 . . . . 1.0 112.629 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HA ' ' HE2' ' A' ' 21' ' ' HIS . 2.7 mt-10 -79.1 -28.52 43.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.365 0.602 . . . . 1.0 109.691 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 17.89 15.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 1.0 112.779 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -141.02 -121.65 1.79 Allowed Glycine 0 N--CA 1.461 0.336 0 C-N-CA 119.422 -1.371 . . . . 1.0 114.78 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.569 ' C ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -139.18 -177.96 5.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.533 -0.834 . . . . 1.0 110.489 -178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.637 ' CE3' HG11 ' A' ' 30' ' ' VAL . 70.1 p-90 -68.31 -21.66 64.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 99' ' ' LEU . 4.4 mp -56.88 -28.41 61.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.782 ' CZ ' ' HB1' ' A' ' 90' ' ' ALA . 32.0 mtt180 -62.57 -12.52 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.355 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -104.77 -3.35 23.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.643 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.407 ' O ' ' CZ3' ' A' ' 104' ' ' TRP . 18.5 t -66.14 135.03 29.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.893 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.661 ' ND2' ' H ' ' A' ' 104' ' ' TRP . 4.0 t-20 -102.63 -174.13 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 120.696 -0.402 . . . . 1.0 110.204 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.661 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.53 157.06 36.25 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.763 ' HB2' HD22 ' A' ' 137' ' ' LEU . . . -118.99 -158.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.513 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.53 -22.98 11.38 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.518 -1.219 . . . . 1.0 111.934 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -171.68 137.38 1.02 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 111' ' ' GLN . . . -31.74 -32.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.735 -0.666 . . . . 1.0 113.717 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' SER . 2.1 mt-10 -53.92 -26.76 26.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 117.816 0.808 . . . . 1.0 110.337 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.513 ' OE2' ' SG ' ' A' ' 106' ' ' CYS . 11.0 pt-20 -116.94 -24.34 7.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.07 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 105' ' ' ALA . 2.5 tm0? -93.76 143.98 25.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.11 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.649 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -153.9 40.32 0.49 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.845 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.663 HD21 HD23 ' A' ' 136' ' ' LEU . 4.8 mp -143.79 143.21 31.25 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.08 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.695 ' CD1' HG23 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -148.73 128.76 6.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.349 -179.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.475 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.5 Cg_exo -63.19 121.73 9.67 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.385 2.057 . . . . 1.0 112.284 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 123' ' ' TYR . 9.2 tp -117.14 128.74 55.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -98.02 116.64 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.684 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.3 118.95 51.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.51 31.98 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 80' ' ' TYR . 11.3 mmp_? 67.67 18.22 9.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.53 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.39 125.35 50.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 76' ' ' TRP . 5.6 mm -85.33 120.79 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.009 -0.677 . . . . 1.0 112.659 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 116' ' ' LEU . 8.7 m-85 -112.89 162.32 15.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.909 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.1 m-30 -112.28 118.2 34.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 114' ' ' PHE . 1.9 mttt -110.81 145.91 37.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.695 0.998 . . . . 1.0 113.695 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 53' ' ' GLY . 3.1 p -106.64 111.33 23.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.701 -1.591 . . . . 1.0 109.448 176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.675 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.94 -4.35 46.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.951 0.782 . . . . 1.0 110.076 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.574 ' HZ1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -139.45 147.36 52.15 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.371 177.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.83 146.08 77.0 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.288 1.325 . . . . 1.0 111.833 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.733 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -113.7 136.44 50.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.336 -179.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.878 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -79.58 121.06 82.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.16 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -41.98 112.28 0.23 Allowed 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 123.111 2.541 . . . . 1.0 115.044 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 119.16 8.03 9.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.001 -0.619 . . . . 1.0 112.768 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.878 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.6 pt-20 -105.35 165.99 10.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 117.507 0.653 . . . . 1.0 111.115 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.493 ' OE1' HD11 ' A' ' 137' ' ' LEU . 4.6 pt-20 -80.01 133.91 36.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.769 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.88 ' C ' HD12 ' A' ' 137' ' ' LEU . 6.4 mp -86.27 132.49 33.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.913 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.88 HD12 ' C ' ' A' ' 136' ' ' LEU . 4.7 mp -140.2 159.59 41.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.434 ' C ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -108.56 140.16 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.501 ' N ' ' HG3' ' A' ' 111' ' ' GLN . 29.6 p90 . . . . . 0 CA--C 1.549 0.934 0 O-C-N 124.957 1.41 . . . . 1.0 114.322 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.695 HG23 ' CD1' ' A' ' 114' ' ' PHE . 63.9 mt . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.245 0.545 . . . . 1.0 110.527 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.14 -30.96 62.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.237 -0.892 . . . . 1.0 112.275 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.48 -33.54 48.17 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.507 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 1.0 111.464 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.962 0.411 . . . . 1.0 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -139.13 -76.71 0.35 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.622 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -43.96 160.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.811 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -125.88 150.77 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.62 -0.718 . . . . 1.0 111.062 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -60.74 -27.75 68.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.357 0.599 . . . . 1.0 109.575 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.65 -23.38 63.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' O ' ' O ' ' A' ' 18' ' ' VAL . 1.6 mm-40 -88.84 -117.06 0.05 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.11 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.609 HG23 HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER 51.49 142.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 114.123 -1.399 . . . . 1.0 110.76 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 18' ' ' VAL . 4.3 Cg_exo -55.64 134.64 65.19 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.14 1.226 . . . . 1.0 111.766 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HA ' HD21 ' A' ' 23' ' ' LEU . 38.2 tt0 -53.23 -38.63 63.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.847 1.055 . . . . 1.0 113.847 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.684 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 10.1 p-80 -74.67 -34.25 62.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.467 1.654 . . . . 1.0 115.467 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.669 HG12 ' C ' ' A' ' 97' ' ' ASN . 5.2 m -71.65 -47.83 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.279 0.945 . . . . 1.0 111.181 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 19' ' ' PRO . 1.7 pt? -68.15 -22.32 64.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.67 0.748 . . . . 1.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.49 -29.99 64.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.2 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.46 41.6 2.11 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 30' ' ' VAL . 46.7 mt -85.41 116.59 66.19 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 119.956 -0.698 . . . . 1.0 112.542 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 29' ' ' GLU . 18.7 Cg_endo -68.31 -139.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.682 0 C-N-CA 121.638 1.559 . . . . 1.0 112.856 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.821 ' HB2' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -30.52 -4.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 126.761 2.024 . . . . 1.0 115.648 -173.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' A' ' 27' ' ' PRO . 10.9 mt-10 129.55 5.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 126.437 1.895 . . . . 1.0 113.903 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.875 ' O ' HD22 ' A' ' 26' ' ' LEU . 55.5 t -41.99 127.15 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.793 -1.094 . . . . 1.0 108.503 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' NE ' ' CG2' ' A' ' 47' ' ' THR . 0.1 OUTLIER -127.35 155.33 43.76 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.237 0.828 . . . . 1.0 113.237 -177.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 32' ' ' LEU . 1.7 mm? -92.15 116.31 28.83 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.614 0.721 . . . . 1.0 111.863 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -129.87 141.4 41.73 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.601 -1.182 . . . . 1.0 110.907 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . 71.4 Cg_endo -72.58 155.56 54.59 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.742 2.294 . . . . 1.0 114.655 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.708 ' C ' ' H ' ' A' ' 37' ' ' VAL . 11.4 m 109.22 -76.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.324 -1.307 . . . . 1.0 108.179 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.531 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -51.81 7.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.966 -1.016 . . . . 1.0 111.991 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.708 ' H ' ' C ' ' A' ' 35' ' ' SER . 2.1 p -103.44 -50.26 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.772 ' O ' HG22 ' A' ' 40' ' ' THR . 1.9 p30 158.86 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' C ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER 36.58 76.0 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.698 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 38' ' ' ASP . 1.4 t 152.04 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.475 1.11 . . . . 1.0 112.207 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.708 ' O ' HG11 ' A' ' 37' ' ' VAL . 3.3 tpt180 -172.21 -168.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.765 -0.774 . . . . 1.0 111.558 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.609 HG13 HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -95.28 152.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 O-C-N 123.443 0.464 . . . . 1.0 109.933 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -130.87 165.85 22.8 Favored Glycine 0 C--O 1.209 -1.43 0 N-CA-C 108.162 -1.975 . . . . 1.0 108.162 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.848 HG21 ' CE3' ' A' ' 98' ' ' TRP . 13.6 p -101.05 139.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 117.97 0.885 . . . . 1.0 111.276 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.531 ' CZ2' ' HB2' ' A' ' 36' ' ' ALA . 6.0 m95 -134.46 154.0 51.63 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.993 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HB1' ' HZ3' ' A' ' 48' ' ' LYS . . . -92.0 122.54 34.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.887 -1.506 . . . . 1.0 108.581 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.461 ' CG2' ' NE ' ' A' ' 31' ' ' ARG . 62.7 p -109.07 3.77 22.38 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.431 0.634 . . . . 1.0 110.644 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.974 ' NZ ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -128.96 170.9 9.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.696 -1.138 . . . . 1.0 111.826 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' N ' ' HG3' ' A' ' 132' ' ' PRO . 5.3 Cg_endo -85.38 129.66 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.589 2.193 . . . . 1.0 111.921 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.974 HD11 ' NZ ' ' A' ' 48' ' ' LYS . 93.2 mt -120.32 147.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.853 -1.067 . . . . 1.0 111.667 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.816 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -107.01 163.23 13.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.567 -1.197 . . . . 1.0 110.871 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 127.68 33.84 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.017 0.913 . . . . 1.0 112.607 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.857 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.14 8.29 39.11 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 114.535 -1.211 . . . . 1.0 113.944 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.6 ttmm -93.32 131.04 38.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.671 -1.611 . . . . 1.0 115.115 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -96.18 133.73 40.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.415 -1.266 . . . . 1.0 113.532 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.94 149.72 41.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.404 -0.816 . . . . 1.0 112.416 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.67 -100.77 1.55 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.385 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 66.8 Cg_endo -77.26 166.63 81.64 Favored 'Cis proline' 0 N--CA 1.504 2.116 0 CA-C-N 119.195 1.498 . . . . 1.0 112.546 0.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CA ' HD22 ' A' ' 99' ' ' LEU . 17.6 t80 -55.7 107.49 0.34 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.221 -0.592 . . . . 1.0 110.51 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.755 HG13 ' H ' ' A' ' 61' ' ' GLY . 3.5 p -30.85 -61.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 123.774 0.671 . . . . 1.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.755 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 49.16 117.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.302 -0.475 . . . . 1.0 113.678 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 51.6 t0 -101.79 148.38 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.658 ' NZ ' HD21 ' A' ' 83' ' ' LEU . 4.9 mtmt -89.14 112.91 24.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.521 0.677 . . . . 1.0 110.994 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HE3' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -132.73 166.33 22.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.738 -1.119 . . . . 1.0 111.444 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.614 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -84.81 130.99 34.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.321 0.489 . . . . 1.0 112.321 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . 14.2 ptt180 -43.31 -23.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.002 0.741 . . . . 1.0 113.002 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.542 0 C-N-CA 120.024 -0.671 . . . . 1.0 110.326 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.514 ' O ' ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 111.843 0.312 . . . . 1.0 111.843 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.514 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -165.73 164.34 18.92 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.076 -1.05 . . . . 1.0 112.641 175.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.63 122.14 45.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.898 0.856 . . . . 1.0 110.982 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.59 121.96 51.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 106.076 -1.824 . . . . 1.0 106.076 178.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -81.34 123.53 28.61 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.02 -1.072 . . . . 1.0 112.001 -177.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 82' ' ' ASN . 9.9 m-85 -86.56 111.03 36.62 Favored Pre-proline 0 N--CA 1.438 -1.045 0 O-C-N 124.866 1.354 . . . . 1.0 112.531 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.62 -12.13 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.762 1.642 . . . . 1.0 109.518 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 80' ' ' TYR . 73.9 m-80 -85.62 -116.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.208 -1.36 . . . . 1.0 110.47 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.948 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -47.99 -34.92 10.02 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 139.43 -175.14 21.87 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.334 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 16.3 m95 -58.03 120.54 8.74 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.39 0.595 . . . . 1.0 111.704 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 7.2 mmm -130.46 169.25 15.77 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.417 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -119.99 140.77 50.45 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 113.991 -1.459 . . . . 1.0 107.784 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -106.1 103.01 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.195 -0.911 . . . . 1.0 108.598 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.81 129.32 36.37 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.962 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.501 ' HB1' ' HZ3' ' A' ' 95' ' ' LYS . . . -141.41 91.7 2.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.953 -0.699 . . . . 1.0 112.159 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.565 ' HA ' HH11 ' A' ' 100' ' ' ARG . 0.1 OUTLIER -103.31 14.0 32.53 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.456 -0.897 . . . . 1.0 109.873 178.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.17 113.27 62.87 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.245 -0.889 . . . . 1.0 108.936 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.684 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 24.6 Cg_endo -69.58 -22.62 32.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.26 1.973 . . . . 1.0 112.097 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -56.6 -42.44 78.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.372 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HZ3' ' HB1' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -114.0 -5.51 13.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.854 0.359 . . . . 1.0 110.77 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.7 ' HA2' HG11 ' A' ' 60' ' ' VAL . . . -89.0 -144.28 10.33 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.516 -1.325 . . . . 1.0 113.432 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.669 ' C ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -146.66 -173.38 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.833 -0.684 . . . . 1.0 109.616 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.848 ' CE3' HG21 ' A' ' 44' ' ' VAL . 65.0 p-90 -68.58 -19.29 64.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.885 -0.143 . . . . 1.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 124' ' ' TYR . 6.3 mp -57.12 -30.31 64.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.728 -0.789 . . . . 1.0 108.958 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.565 HH11 ' HA ' ' A' ' 91' ' ' THR . 3.2 mtp85 -58.76 -11.26 2.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.85 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.5 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 10.7 m-85 -100.96 6.77 43.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.209 0.528 . . . . 1.0 110.405 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 99' ' ' LEU . 44.8 t -81.11 129.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.642 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.644 HD21 ' CD1' ' A' ' 137' ' ' LEU . 0.5 OUTLIER -102.42 -137.85 0.34 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.13 -0.941 . . . . 1.0 111.22 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.539 ' N ' ' CG ' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -132.41 160.39 36.53 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.396 -0.19 . . . . 1.0 110.78 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.53 ' H ' HE22 ' A' ' 111' ' ' GLN . . . -95.0 -120.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.135 1.532 . . . . 1.0 115.135 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.2 t -174.68 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.419 -1.719 . . . . 1.0 107.678 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' GLY . 13.6 t -139.66 -179.02 5.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.84 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . . . -89.26 -5.69 72.35 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 121.325 -0.465 . . . . 1.0 112.682 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.66 -20.29 43.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 10.3 pt-20 -113.78 -19.93 11.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.764 0.793 . . . . 1.0 110.124 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.628 ' NE2' ' C ' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -81.75 157.17 24.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.213 -1.358 . . . . 1.0 108.457 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.891 ' O ' HG22 ' A' ' 126' ' ' THR . 0.3 OUTLIER -173.22 37.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.903 0.859 . . . . 1.0 111.755 -176.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 137' ' ' LEU . 5.0 mp -141.13 141.5 34.17 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -144.04 123.3 7.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.142 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.507 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 50.5 Cg_exo -55.28 104.07 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.903 1.735 . . . . 1.0 110.709 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 123' ' ' TYR . 10.0 tp -109.49 118.44 36.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' OE1' ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -94.47 117.76 30.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.31 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.938 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -127.41 118.22 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.372 -1.344 . . . . 1.0 107.372 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.01 31.73 20.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.41 -1.33 . . . . 1.0 107.41 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.744 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 72.2 18.83 4.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.887 -1.051 . . . . 1.0 110.941 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.417 -0.81 . . . . 1.0 108.903 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.69 120.26 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.9 0.857 . . . . 1.0 112.282 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.938 ' CG ' HD11 ' A' ' 118' ' ' ILE . 6.0 m-85 -113.62 157.03 22.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.664 -1.607 . . . . 1.0 108.79 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.653 ' CD2' HD23 ' A' ' 99' ' ' LEU . 4.6 m-30 -115.72 104.84 12.08 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.687 -0.805 . . . . 1.0 111.237 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 114' ' ' PHE . 5.4 ttmm -102.63 150.77 23.1 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 114.331 1.234 . . . . 1.0 114.331 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 112' ' ' ASN . 4.8 p -103.12 107.88 18.85 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.89 -1.959 . . . . 1.0 109.883 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.767 ' HB2' ' HZ3' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -73.69 0.29 13.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 177.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.767 ' HZ3' ' HB2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -150.52 152.07 32.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.055 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.47 143.74 43.56 Favored 'Trans proline' 0 N--CA 1.516 2.803 0 C-N-CA 123.163 2.575 . . . . 1.0 114.379 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.851 HD11 ' OD1' ' A' ' 112' ' ' ASN . 0.8 OUTLIER -110.04 135.59 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.888 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.689 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -77.02 133.45 69.24 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HG3' ' N ' ' A' ' 49' ' ' PRO . 86.9 Cg_exo -50.24 103.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 122.868 2.378 . . . . 1.0 116.513 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 129.15 12.06 2.68 Favored Glycine 0 N--CA 1.468 0.81 0 C-N-CA 120.372 -0.918 . . . . 1.0 113.789 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.689 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.9 pt-20 -109.41 166.47 10.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.881 0.841 . . . . 1.0 111.614 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HB3' ' CE3' ' A' ' 45' ' ' TRP . 7.7 pt-20 -79.06 136.04 37.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.567 -1.197 . . . . 1.0 112.566 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.441 ' C ' HD13 ' A' ' 137' ' ' LEU . 1.3 mt -82.84 116.03 21.98 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.147 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.644 ' CD1' HD21 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.16 159.25 30.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 122.95 0.5 . . . . 1.0 111.658 -178.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.628 ' C ' ' NE2' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -122.91 148.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 178.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.433 ' CE3' ' HA ' ' A' ' 139' ' ' TRP . 2.7 m95 . . . . . 0 CA--C 1.478 -1.813 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.018 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 110.874 -0.047 . . . . 1.0 110.874 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.54 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -54.38 -54.19 43.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.2 -31.35 52.76 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.0 -1.0 . . . . 1.0 109.012 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.591 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.833 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.873 0.368 . . . . 1.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -128.7 -73.01 0.59 Allowed 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -44.51 154.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.345 -0.983 . . . . 1.0 108.345 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 151.4 41.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.437 0.637 . . . . 1.0 111.575 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.664 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -51.99 -32.67 34.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.137 -0.938 . . . . 1.0 109.03 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.59 60.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.728 -1.123 . . . . 1.0 111.948 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -24.94 22.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.511 -0.476 . . . . 1.0 112.146 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.552 ' CG1' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.73 144.85 64.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.8 Cg_exo -57.59 132.42 50.3 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.039 1.826 . . . . 1.0 113.077 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.668 ' HA ' HD21 ' A' ' 23' ' ' LEU . 34.3 tt0 -49.04 -31.79 8.32 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.842 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -74.18 -34.32 63.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.544 HG12 ' C ' ' A' ' 97' ' ' ASN . 14.5 m -75.88 -46.08 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.774 -177.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.973 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.01 -21.01 65.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.515 -0.874 . . . . 1.0 109.646 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HE ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.0 -38.91 69.55 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.294 -1.321 . . . . 1.0 111.947 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.57 36.43 4.35 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.681 -0.771 . . . . 1.0 112.318 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.849 HD13 ' O ' ' A' ' 30' ' ' VAL . 18.5 mt -90.09 129.3 46.42 Favored Pre-proline 0 CA--C 1.503 -0.861 0 C-N-CA 119.728 -0.789 . . . . 1.0 111.823 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.02 167.48 15.9 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 N-CA-C 108.63 -1.334 . . . . 1.0 108.63 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' C ' ' HG3' ' A' ' 48' ' ' LYS . 2.7 pt-20 -57.09 -10.2 1.11 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.94 -1.482 . . . . 1.0 114.521 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.957 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -109.23 18.67 20.27 Favored 'General case' 0 CA--C 1.449 -2.907 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.283 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.849 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -138.47 123.35 22.51 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 C-N-CA 117.268 -1.773 . . . . 1.0 114.115 -175.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' HB2' HG21 ' A' ' 47' ' ' THR . 3.3 ttp180 -130.47 151.79 50.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.228 -1.805 . . . . 1.0 107.685 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 26' ' ' LEU . 2.8 mm? -98.11 124.87 42.86 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.175 -0.61 . . . . 1.0 109.881 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.44 133.48 9.57 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.353 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 35' ' ' SER . 5.9 Cg_endo -85.21 149.86 10.58 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.168 1.912 . . . . 1.0 108.389 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.4 m 152.33 -73.31 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.459 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.82 -61.29 2.3 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.575 -1.25 . . . . 1.0 108.895 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 38' ' ' ASP . 4.8 p -60.94 -51.75 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.94 -0.392 . . . . 1.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.56 ' N ' HG13 ' A' ' 37' ' ' VAL . 0.8 OUTLIER 59.52 -40.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.592 0.96 . . . . 1.0 113.592 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.598 ' C ' HG22 ' A' ' 40' ' ' THR . 25.6 mttm -30.4 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.172 0.295 . . . . 1.0 111.663 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.598 HG22 ' C ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER 153.41 22.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.038 0.836 . . . . 1.0 111.654 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.402 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 17.0 mtp180 -140.54 163.0 34.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.796 -0.762 . . . . 1.0 111.932 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 149.15 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.397 0.618 . . . . 1.0 110.88 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.78 13.63 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.694 HG23 ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -104.87 127.25 59.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.459 ' CZ2' ' HB2' ' A' ' 36' ' ' ALA . 22.5 m95 -126.65 144.69 50.83 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.957 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.72 134.31 49.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.997 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 31' ' ' ARG . 68.4 p -119.11 -21.71 7.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.08 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.657 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -117.84 165.99 14.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.439 179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -77.79 125.31 7.34 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 123.04 2.493 . . . . 1.0 111.772 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.604 HD11 ' HB2' ' A' ' 29' ' ' GLU . 64.0 mt -113.1 149.58 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 113.394 -1.73 . . . . 1.0 112.801 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.833 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.87 164.64 12.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.828 -1.533 . . . . 1.0 110.261 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.695 ' H ' ' CE ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -68.71 128.03 35.18 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.103 178.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 1.003 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.57 8.22 38.03 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 119.066 -0.852 . . . . 1.0 114.455 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 1.9 ttmt -82.24 130.87 35.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 117.278 -1.769 . . . . 1.0 115.308 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -88.98 120.18 30.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.682 -1.599 . . . . 1.0 113.13 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.606 ' CG ' ' OE2' ' A' ' 29' ' ' GLU . 55.0 m-85 -119.75 150.02 41.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.483 0.658 . . . . 1.0 112.714 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.25 -102.29 2.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 113.706 -1.588 . . . . 1.0 110.151 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HB3' ' CE1' ' A' ' 123' ' ' TYR . 96.3 Cg_endo -78.79 170.45 69.42 Favored 'Cis proline' 0 N--CA 1.499 1.816 0 CA-C-N 119.355 1.578 . . . . 1.0 112.414 -1.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.628 ' CD1' ' NH2' ' A' ' 100' ' ' ARG . 38.5 t80 -54.46 107.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.785 -0.766 . . . . 1.0 109.056 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.732 HG12 ' NH2' ' A' ' 100' ' ' ARG . 5.6 p -42.74 -49.51 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.967 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 60' ' ' VAL . . . 45.0 121.32 0.0 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.621 0.608 . . . . 1.0 114.621 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.87 145.93 28.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' NZ ' HD11 ' A' ' 83' ' ' LEU . 1.1 mtmp? -89.51 113.92 25.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.056 0.455 . . . . 1.0 111.679 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.5 ' HG3' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -142.76 169.88 16.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.631 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -80.65 133.61 35.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.374 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 67' ' ' SER . 30.8 ttp85 -45.53 -21.34 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.783 1.031 . . . . 1.0 113.783 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.969 0.414 . . . . 1.0 110.939 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.727 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -162.79 163.85 26.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 118.999 -1.08 . . . . 1.0 113.091 175.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -103.37 122.73 45.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.89 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -137.17 122.67 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.932 -1.507 . . . . 1.0 106.932 179.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.5 t80 -80.67 125.66 30.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.653 ' OH ' HD11 ' A' ' 88' ' ' ILE . 20.2 m-85 -103.05 104.2 38.72 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 114.897 -1.047 . . . . 1.0 113.059 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -62.87 10.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.388 1.392 . . . . 1.0 110.811 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 80' ' ' TYR . 76.3 m-20 -97.39 2.41 50.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.094 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.721 ' N ' HD23 ' A' ' 83' ' ' LEU . 1.1 pt? -178.23 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.015 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 150.09 179.67 26.09 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.439 ' C ' ' SD ' ' A' ' 86' ' ' MET . 18.2 m95 -58.15 122.37 12.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 19.1 mmm -127.28 167.39 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -117.75 138.04 52.3 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.265 -1.754 . . . . 1.0 106.265 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.653 HD11 ' OH ' ' A' ' 80' ' ' TYR . 64.3 mt -104.67 102.28 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -131.18 128.18 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.119 0.485 . . . . 1.0 111.33 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HA ' ' HZ3' ' A' ' 95' ' ' LYS . . . -139.73 92.47 2.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.219 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -111.1 13.31 21.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.366 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.84 99.6 35.43 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.938 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.426 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 50.6 Cg_exo -51.2 -14.78 1.74 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.628 2.218 . . . . 1.0 111.45 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.92 -43.84 94.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.646 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.737 ' HZ3' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -116.28 -8.48 11.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.785 -179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.716 ' HA2' HG11 ' A' ' 60' ' ' VAL . . . -95.48 -143.1 13.77 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.125 -1.036 . . . . 1.0 113.05 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.619 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 24.6 m-20 -137.18 -166.21 1.88 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.999 0.428 . . . . 1.0 110.475 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.547 ' CZ3' HG21 ' A' ' 44' ' ' VAL . 58.6 p-90 -70.4 -22.13 62.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.797 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.581 HD12 ' H ' ' A' ' 99' ' ' LEU . 5.9 mp -54.13 -24.22 17.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.835 ' H ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -61.7 -10.28 8.26 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 12.8 m-85 -107.24 -11.81 15.5 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.232 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.517 ' CG1' HG23 ' A' ' 138' ' ' VAL . 55.3 t -62.88 117.66 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.101 -1.04 . . . . 1.0 109.878 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -152.02 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CE3' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -124.5 165.25 18.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.372 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HA ' HD23 ' A' ' 137' ' ' LEU . . . -108.84 -131.83 0.32 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.44 -31.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.47 ' H ' ' CG ' ' A' ' 110' ' ' GLU . 4.0 m -143.78 175.7 9.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.695 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.95 -23.25 76.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 -22.37 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.47 ' CG ' ' H ' ' A' ' 107' ' ' SER . 4.0 pt-20 -109.15 -25.86 10.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.127 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.6 OUTLIER -86.93 102.21 14.14 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.703 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -104.09 0.32 29.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -140.51 144.75 36.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -142.82 132.51 12.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.736 1.754 . . . . 1.0 115.736 -176.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.6 122.36 3.93 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.122 3.215 . . . . 1.0 114.722 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.745 HD13 ' HD2' ' A' ' 125' ' ' LYS . 1.9 tp -132.2 128.05 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -97.49 118.73 34.63 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.947 -0.701 . . . . 1.0 110.856 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.878 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -129.36 114.95 33.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.088 -1.078 . . . . 1.0 108.088 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.4 39.21 25.52 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.649 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 67.05 17.56 10.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.004 -0.998 . . . . 1.0 110.658 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -108.69 123.82 49.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.394 -0.821 . . . . 1.0 108.974 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -82.25 126.98 40.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.878 ' CG ' HD11 ' A' ' 118' ' ' ILE . 6.0 m-85 -122.01 155.13 36.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.799 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -111.68 124.22 51.88 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.745 ' HD2' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -128.76 152.82 48.01 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 1.003 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.8 p -102.04 139.73 37.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.111 -1.858 . . . . 1.0 110.789 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.783 ' H ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -107.18 -4.44 18.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.182 -1.372 . . . . 1.0 109.024 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.975 ' H ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.45 131.83 11.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 114.937 -1.028 . . . . 1.0 110.435 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 145.64 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.601 1.534 . . . . 1.0 111.51 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.73 HG23 ' CG ' ' A' ' 134' ' ' GLU . 1.8 mt -108.39 134.48 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.703 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -77.15 115.77 51.67 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -38.68 113.12 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 123.004 2.469 . . . . 1.0 114.243 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 118.32 6.43 12.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.915 -0.659 . . . . 1.0 113.251 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.73 ' CG ' HG23 ' A' ' 130' ' ' ILE . 4.5 pt-20 -100.41 164.43 11.92 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.419 1.11 . . . . 1.0 111.429 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 45' ' ' TRP . 5.9 pt-20 -78.62 133.24 37.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.075 -0.966 . . . . 1.0 111.345 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.882 HD21 ' OE1' ' A' ' 29' ' ' GLU . 5.9 mp -86.36 122.4 30.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.326 -0.852 . . . . 1.0 108.941 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.754 HD12 ' C ' ' A' ' 136' ' ' LEU . 6.6 mp -130.71 158.16 40.83 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 139' ' ' TRP . 4.1 t -114.83 146.13 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.586 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.294 -1.817 0 O-C-N 125.83 1.956 . . . . 1.0 113.228 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 149' ' ' ALA . 1.4 mt . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -61.51 -52.17 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.077 -0.965 . . . . 1.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.39 -34.27 47.24 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 1.0 111.206 177.439 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . . . . . . . . 0 CA--C 1.519 -0.233 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 20.5 m -175.27 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.202 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' PRO . 2.9 mm-40 -57.8 166.23 1.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 1.0 111.453 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -127.42 148.88 50.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.038 -0.983 . . . . 1.0 110.593 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.946 HD12 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.39 -36.2 73.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.9 -18.73 55.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.271 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HB3' ' H ' ' A' ' 14' ' ' THR . 4.6 tp10 -80.28 -46.65 15.82 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.626 -0.716 . . . . 1.0 112.383 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -41.17 158.36 0.18 Allowed Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 120.173 -0.611 . . . . 1.0 109.574 -178.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' HD22 ' A' ' 23' ' ' LEU . 7.4 Cg_endo -48.38 118.75 3.49 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.505 2.136 . . . . 1.0 112.093 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 3.5 tt0 -51.43 -43.24 61.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.459 1.281 . . . . 1.0 114.459 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.694 ' CD2' ' H ' ' A' ' 21' ' ' HIS . 4.7 p80 -62.1 -29.41 70.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.095 0.474 . . . . 1.0 111.302 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.6 HG13 ' N ' ' A' ' 98' ' ' TRP . 73.2 t -72.93 -48.72 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.305 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.899 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.69 -25.88 62.28 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.175 0.988 . . . . 1.0 110.779 176.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -53.77 -34.36 58.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.433 -1.712 . . . . 1.0 109.612 -176.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.84 17.62 17.59 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.194 -0.762 . . . . 1.0 111.194 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.789 HD12 ' HD2' ' A' ' 27' ' ' PRO . 45.2 tp -79.41 122.98 84.57 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 117.081 0.441 . . . . 1.0 110.735 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.789 ' HD2' HD12 ' A' ' 26' ' ' LEU . 35.4 Cg_exo -35.23 137.26 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.286 1.324 . . . . 1.0 110.954 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.543 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 18.5 pt-20 -53.32 -31.91 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.777 -1.556 . . . . 1.0 109.373 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.5 pm0 -85.4 18.26 2.78 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 113.538 -1.664 . . . . 1.0 112.496 -176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.768 ' CG1' HD11 ' A' ' 26' ' ' LEU . 87.0 t -136.15 143.64 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 C-N-CA 118.726 -1.189 . . . . 1.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -144.0 155.36 43.99 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.192 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.946 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -102.68 148.02 26.11 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.673 0.749 . . . . 1.0 111.753 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.75 119.78 2.24 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 113.86 -1.518 . . . . 1.0 111.834 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 19.0 Cg_endo -80.69 152.02 19.53 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.899 1.732 . . . . 1.0 111.062 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.584 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 4.3 p 87.76 -27.04 0.07 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.964 0.888 . . . . 1.0 108.799 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.713 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -53.89 -62.53 1.59 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.89 -52.32 62.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.563 -0.29 . . . . 1.0 111.586 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 2.2 m-20 162.12 63.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.621 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.0 OUTLIER 30.63 36.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.917 -1.038 . . . . 1.0 109.365 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 91.1 m -91.96 -24.3 19.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.558 -1.655 . . . . 1.0 110.094 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 161.55 -157.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.229 -1.397 . . . . 1.0 107.229 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.19 137.55 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.863 -1.532 . . . . 1.0 106.863 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.57 155.35 19.5 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 109.032 -1.627 . . . . 1.0 109.032 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 2.0 m -100.91 136.5 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.166 0.984 . . . . 1.0 110.52 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.713 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 18.9 m95 -129.97 154.25 47.56 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.477 -1.692 . . . . 1.0 110.37 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.642 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -70.88 144.18 50.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.242 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.65 -26.54 2.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.389 -0.525 . . . . 1.0 110.381 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -120.44 158.77 50.38 Favored Pre-proline 0 C--N 1.341 0.215 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.96 124.73 16.62 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.424 2.083 . . . . 1.0 112.379 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 130' ' ' ILE . 3.9 mt -112.18 131.27 64.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.584 -1.189 . . . . 1.0 108.425 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.944 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.42 146.11 36.44 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 122.26 1.029 . . . . 1.0 111.314 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -50.69 133.63 25.59 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 113.324 -1.762 . . . . 1.0 107.532 177.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.77 2.06 52.57 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.612 -1.28 . . . . 1.0 115.447 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 26.6 ttpt -96.29 140.72 30.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.913 1.357 . . . . 1.0 112.594 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.21 135.59 40.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.947 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 34.3 m-85 -115.72 126.67 54.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.216 0.531 . . . . 1.0 112.093 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.69 -132.04 7.32 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 119.362 -0.688 . . . . 1.0 112.983 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 37.3 Cg_endo -80.62 171.97 58.26 Favored 'Cis proline' 0 N--CA 1.511 2.551 0 CA-C-N 120.03 1.915 . . . . 1.0 114.305 3.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.759 ' CD2' ' ND2' ' A' ' 97' ' ' ASN . 1.6 t80 -72.44 122.15 20.78 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.672 0.748 . . . . 1.0 109.531 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.793 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 63.8 t -102.9 138.65 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.169 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.39 -171.23 26.03 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -100.48 138.83 37.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.907 0.384 . . . . 1.0 110.499 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.84 117.28 29.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.636 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -140.4 164.81 29.11 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.297 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.19 145.16 33.8 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.653 0.264 . . . . 1.0 110.764 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -50.27 -44.5 53.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 110.161 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.432 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.646 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.955 0.407 . . . . 1.0 110.826 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.66 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -135.3 166.89 22.09 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.446 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -126.43 128.03 46.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.764 0.316 . . . . 1.0 110.744 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.56 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -141.77 141.51 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.294 0.568 . . . . 1.0 112.405 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 15.9 t80 -91.19 125.29 35.92 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.855 0.687 . . . . 1.0 112.855 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CD2' HD23 ' A' ' 83' ' ' LEU . 7.1 m-85 -102.22 145.56 30.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.841 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.62 3.22 5.59 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.72 1.614 . . . . 1.0 109.706 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -125.41 -68.77 0.82 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.412 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.832 HD22 ' H ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -74.41 -23.38 58.94 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.102 -178.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.39 -152.65 25.58 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 108.78 -1.728 . . . . 1.0 108.78 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -63.42 119.22 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.39 -0.924 . . . . 1.0 110.119 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.7 ppp? -129.46 169.15 15.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.838 -1.073 . . . . 1.0 108.951 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' LYS . 26.2 m -121.02 144.79 48.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.36 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 mt -98.58 146.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 106.8 -1.555 . . . . 1.0 106.8 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.79 139.5 50.22 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.078 0.77 . . . . 1.0 113.078 -177.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.619 ' HB1' ' HD3' ' A' ' 100' ' ' ARG . . . -130.66 140.62 50.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.615 -1.624 . . . . 1.0 106.615 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 p -151.63 15.7 0.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.987 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.26 141.83 0.13 Allowed Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.815 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.488 ' O ' HG21 ' A' ' 22' ' ' VAL . 55.2 Cg_endo -70.81 -18.18 32.25 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.263 1.975 . . . . 1.0 112.597 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -78.04 -6.19 53.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.826 0.822 . . . . 1.0 109.277 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 9.77 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.375 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 97' ' ' ASN . . . 94.26 156.16 32.13 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.793 ' CG ' ' H ' ' A' ' 60' ' ' VAL . 17.2 t30 84.07 110.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.6 ' N ' HG13 ' A' ' 22' ' ' VAL . 70.0 p-90 -71.31 -25.53 62.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.187 0.518 . . . . 1.0 109.759 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 102' ' ' VAL . 1.7 mt -60.08 -24.46 64.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.636 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.619 ' HD3' ' HB1' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -68.29 -11.1 58.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 119.107 -0.473 . . . . 1.0 111.234 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 98' ' ' TRP . 0.1 OUTLIER -120.14 5.87 10.79 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.613 -0.835 . . . . 1.0 113.173 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 99' ' ' LEU . 8.8 p -78.65 119.0 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.291 -0.564 . . . . 1.0 110.825 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -80.98 114.75 20.07 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.62 ' HB2' ' H ' ' A' ' 138' ' ' VAL . 4.9 p90 -88.03 159.09 18.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 104' ' ' TRP . . . -38.72 159.55 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 113.772 -1.558 . . . . 1.0 113.45 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.27 -4.4 21.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.134 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.64 -30.6 0.09 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.561 -0.456 . . . . 1.0 111.974 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.67 -29.37 6.64 Favored Glycine 0 C--N 1.321 -0.28 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.24 -19.46 5.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.513 ' HG3' HD23 ' A' ' 137' ' ' LEU . 20.2 pt-20 -112.76 -24.37 9.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.483 -0.78 . . . . 1.0 111.389 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.645 ' CD ' ' O ' ' A' ' 139' ' ' TRP . 1.1 tp-100 -48.2 139.12 8.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.101 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.712 ' C ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -124.98 6.73 7.97 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 119.154 -0.451 . . . . 1.0 112.106 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.987 HD12 ' N ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -154.96 174.56 14.99 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 118.263 0.483 . . . . 1.0 110.084 176.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.987 ' N ' HD12 ' A' ' 113' ' ' LEU . 1.6 p90 -139.62 145.6 44.15 Favored Pre-proline 0 C--N 1.346 0.425 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 139' ' ' TRP . 70.5 Cg_endo -82.38 138.2 9.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.754 2.303 . . . . 1.0 113.892 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -139.52 134.5 32.32 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.894 179.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.766 ' N ' HD23 ' A' ' 116' ' ' LEU . 40.4 mt-10 -89.25 123.71 33.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.223 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 121' ' ' ALA . 15.3 mt -139.6 129.49 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 46.14 43.01 10.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.114 -0.634 . . . . 1.0 110.012 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? 62.87 17.51 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.904 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -121.99 128.71 51.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.445 HD13 ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -88.93 116.46 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.692 -0.803 . . . . 1.0 112.676 -177.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.52 ' HB2' ' HZ3' ' A' ' 125' ' ' LYS . 13.7 m-85 -108.06 156.67 19.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.157 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.591 ' HB3' HD13 ' A' ' 113' ' ' LEU . 5.4 m-30 -112.89 125.78 54.75 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 107.575 -1.268 . . . . 1.0 107.575 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' A' ' 114' ' ' PHE . 2.0 mptt -116.53 139.23 50.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -131.82 125.59 32.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.676 -0.678 . . . . 1.0 112.453 178.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.924 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -98.96 21.42 11.65 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 119.911 -0.716 . . . . 1.0 109.592 175.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.712 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -124.53 119.51 25.99 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.23 97.78 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.963 0 CA-C-N 120.628 1.26 . . . . 1.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.695 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -69.62 136.42 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.447 -176.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.54 132.8 51.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.302 0.852 . . . . 1.0 113.302 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.04 103.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.163 1.908 . . . . 1.0 111.675 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 124.82 -7.22 8.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.062 -0.589 . . . . 1.0 113.164 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 135' ' ' GLU . 1.4 pp20? -87.7 154.14 20.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.942 0.871 . . . . 1.0 111.026 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.454 ' O ' ' OE2' ' A' ' 134' ' ' GLU . 1.6 pm0 -73.71 125.08 27.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.233 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 137' ' ' LEU . 10.9 mp -78.39 124.85 28.57 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 4.2 mp -123.56 146.1 48.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-O 118.982 -0.532 . . . . 1.0 112.18 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.62 ' H ' ' HB2' ' A' ' 104' ' ' TRP . 9.4 t -104.46 132.96 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.645 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.394 0 C-N-CA 125.19 1.396 . . . . 1.0 110.869 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.676 HG12 HD21 ' A' ' 127' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.485 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.53 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -74.09 -34.82 64.1 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.548 -0.861 . . . . 1.0 109.744 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.25 -66.6 0.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.603 -0.839 . . . . 1.0 110.765 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 117.834 -1.546 . . . . 1.0 110.868 -174.714 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . . . . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 120.97 0.415 . . . . 1.0 109.949 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 88.1 m -169.93 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 34' ' ' PRO . 1.7 mt-10 -50.93 165.54 0.11 Allowed 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.539 0.685 . . . . 1.0 110.735 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.696 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -126.72 153.81 44.98 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.913 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.776 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -52.31 -31.89 35.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.95 -17.77 56.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.073 -1.422 . . . . 1.0 110.131 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.696 ' CB ' ' H ' ' A' ' 14' ' ' THR . 12.8 tp10 -77.97 -47.92 17.45 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.292 0.849 . . . . 1.0 113.292 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.68 HG23 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -48.85 147.8 4.3 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.68 ' HD2' HG23 ' A' ' 18' ' ' VAL . 5.2 Cg_exo -52.39 130.52 36.38 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.199 1.266 . . . . 1.0 111.898 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 4.4 tt0 -52.15 -34.94 46.99 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 114.564 -1.198 . . . . 1.0 113.011 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.814 ' CD2' ' H ' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -79.27 -35.26 41.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.573 0.953 . . . . 1.0 113.573 -177.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.826 HG21 ' O ' ' A' ' 93' ' ' PRO . 1.6 t -79.52 -31.2 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.64 HD13 HG13 ' A' ' 18' ' ' VAL . 15.6 tp -71.81 -41.57 68.08 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.753 -2.021 . . . . 1.0 110.831 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -81.54 -20.02 40.89 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.164 0.585 . . . . 1.0 112.279 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.75 -26.98 36.31 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 110.148 -1.181 . . . . 1.0 110.148 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.689 ' HB3' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -63.76 144.13 97.97 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 117.907 -1.517 . . . . 1.0 111.564 -178.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 56' ' ' PHE . 50.8 Cg_exo -50.04 151.68 8.5 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 120.988 1.125 . . . . 1.0 111.871 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt-20 -52.84 -31.08 37.24 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.985 -1.461 . . . . 1.0 110.407 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.648 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -87.93 20.53 3.06 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 115.017 -0.992 . . . . 1.0 111.181 -178.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.643 HG12 HD22 ' A' ' 26' ' ' LEU . 21.4 t -135.29 137.03 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 C-N-CA 119.52 -0.872 . . . . 1.0 110.879 -177.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.544 ' NH1' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER -146.26 159.45 43.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.795 HD22 ' N ' ' A' ' 32' ' ' LEU . 1.1 mm? -104.57 141.08 37.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -152.16 120.82 3.31 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.772 -0.632 . . . . 1.0 111.654 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.564 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 9.8 Cg_endo -82.1 151.69 16.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.693 1.596 . . . . 1.0 111.689 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB3' ' N ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 78.06 15.6 1.43 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.46 -1.682 . . . . 1.0 106.46 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.654 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.55 -64.53 1.13 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.62 -29.77 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 78.44 -11.79 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.18 -0.918 . . . . 1.0 112.636 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 40' ' ' THR . 1.3 pttp -49.92 -12.19 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 4.9 m 98.84 64.41 0.0 OUTLIER 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.77 1.294 . . . . 1.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.418 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER 171.99 -165.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.196 -0.911 . . . . 1.0 108.951 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.531 HG13 ' N ' ' A' ' 34' ' ' PRO . 2.4 tt -101.62 144.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.58 163.02 22.78 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 109.316 -1.513 . . . . 1.0 109.316 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.565 HG23 HG13 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -99.66 136.24 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 CA-C-O 121.263 0.554 . . . . 1.0 109.724 -178.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 28.6 m95 -129.29 151.84 49.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.881 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.57 144.67 54.47 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.085 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.544 ' CG2' ' NH1' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -126.44 -29.64 2.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.538 -178.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -124.5 159.99 55.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.13 123.95 13.73 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.195 1.93 . . . . 1.0 112.937 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.564 ' C ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -111.04 131.52 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.145 -1.389 . . . . 1.0 107.544 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.003 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -109.72 155.24 21.8 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.925 0.869 . . . . 1.0 111.034 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -63.42 133.76 54.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.03 -1.441 . . . . 1.0 109.027 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.72 1.94 55.26 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.503 -1.332 . . . . 1.0 115.107 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 15.3 ttpt -90.1 134.34 34.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.167 -1.013 . . . . 1.0 112.485 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.08 130.43 36.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.14 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 5.5 m-85 -115.36 127.37 55.36 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.728 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.594 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 146.17 -146.97 17.59 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 5.1 Cg_endo -79.87 166.51 77.01 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 CA-C-N 119.583 1.692 . . . . 1.0 115.118 0.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.744 ' HA ' HD12 ' A' ' 99' ' ' LEU . 25.5 t80 -83.17 111.83 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.246 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.821 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.8 t -43.24 -61.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.401 -2.181 . . . . 1.0 114.079 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.52 ' N ' HG12 ' A' ' 60' ' ' VAL . . . 32.35 106.34 0.0 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-O 121.469 0.483 . . . . 1.0 112.931 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -72.81 143.13 47.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 1.7 mptp? -92.62 117.67 30.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.587 0.708 . . . . 1.0 112.79 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HZ3' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -141.91 167.89 21.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.677 -1.147 . . . . 1.0 111.213 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -78.95 135.86 37.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.1 0.476 . . . . 1.0 110.435 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -48.07 -24.39 1.08 Allowed 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.964 -0.46 . . . . 1.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.342 . . . . 1.0 111.403 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.405 ' HB3' ' HZ1' ' A' ' 64' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.997 0.427 . . . . 1.0 111.504 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.678 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -128.58 165.35 20.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.845 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.88 132.04 53.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.749 0.277 . . . . 1.0 111.749 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.567 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -146.73 141.33 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.512 0.672 . . . . 1.0 112.798 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -83.51 124.94 31.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.286 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.531 ' CE1' ' HG3' ' A' ' 120' ' ' ARG . 4.4 m-85 -102.95 120.09 53.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.28 -12.86 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 N-CA-C 109.208 -1.112 . . . . 1.0 109.208 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.529 ' N ' ' C ' ' A' ' 80' ' ' TYR . 1.1 m-80 -101.16 -86.96 0.4 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.78 -1.1 . . . . 1.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.913 HD22 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 119.794 -0.762 . . . . 1.0 110.842 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . 89.46 -139.77 15.32 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.905 -1.678 . . . . 1.0 108.905 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.1 118.58 12.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.47 -0.892 . . . . 1.0 110.378 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.567 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -128.9 170.15 13.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.139 178.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.9 m -115.01 142.47 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.439 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.513 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 16.9 mt -96.22 152.08 3.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.58 ' CB ' ' HZ3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -129.39 136.16 49.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.312 0.577 . . . . 1.0 112.312 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.612 ' C ' HG22 ' A' ' 91' ' ' THR . . . -133.39 142.23 48.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 161.28 7.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 96' ' ' GLY . 5.4 p30 -117.07 62.79 3.08 Favored Pre-proline 0 C--O 1.22 -0.499 0 CA-C-N 114.565 -1.198 . . . . 1.0 109.433 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.826 ' O ' HG21 ' A' ' 22' ' ' VAL . 6.0 Cg_exo -45.68 -13.86 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.566 2.178 . . . . 1.0 112.143 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.535 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -78.2 -42.93 29.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.094 0.949 . . . . 1.0 110.065 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -11.71 12.67 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.134 -1.393 . . . . 1.0 110.143 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.821 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -63.29 -62.36 5.46 Favored Glycine 0 C--O 1.18 -3.269 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.768 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.609 HD22 ' C ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 138.09 150.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.638 0.775 . . . . 1.0 109.621 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.689 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 56.0 p-90 -56.68 -22.72 36.8 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 59' ' ' PHE . 41.7 mt -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.491 -0.884 . . . . 1.0 109.524 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.602 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -75.91 -9.93 59.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 177.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 98' ' ' TRP . 12.3 m-85 -90.33 -9.76 46.59 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.6 131.16 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 114.651 -1.159 . . . . 1.0 111.438 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -97.01 -158.86 0.7 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.109 -1.405 . . . . 1.0 110.033 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 24.5 p90 -136.72 164.26 28.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.524 -1.216 . . . . 1.0 112.058 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.969 ' HB3' ' HE1' ' A' ' 139' ' ' TRP . . . -87.2 140.24 29.74 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.261 0.837 . . . . 1.0 113.261 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -76.0 -13.29 60.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 177.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -142.66 132.04 23.56 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.707 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -46.97 -17.17 0.27 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' C ' ' A' ' 107' ' ' SER . 10.7 mm-40 -77.41 -32.88 55.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.861 0.362 . . . . 1.0 110.44 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 137' ' ' LEU . 25.4 tp10 -88.69 -22.88 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.321 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.935 HE22 ' N ' ' A' ' 139' ' ' TRP . 3.8 tp60 -59.42 142.47 52.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.51 0.671 . . . . 1.0 109.392 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.599 ' HA ' ' HZ2' ' A' ' 128' ' ' LYS . 33.2 p30 -144.3 14.19 1.62 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.6 -1.182 . . . . 1.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -148.54 166.88 26.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.444 -0.503 . . . . 1.0 110.243 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -152.45 130.76 6.27 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 119.093 -1.043 . . . . 1.0 112.552 178.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.44 139.59 20.82 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.241 1.96 . . . . 1.0 113.96 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -142.4 138.76 31.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.517 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.713 ' H ' HD23 ' A' ' 116' ' ' LEU . 3.7 tm-20 -92.16 119.26 31.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 123' ' ' TYR . 23.4 mt -138.11 130.05 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 120.629 -0.428 . . . . 1.0 111.162 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.2 50.63 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.311 0.577 . . . . 1.0 111.473 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.531 ' HG3' ' CE1' ' A' ' 80' ' ' TYR . 1.3 tpp180 65.55 1.64 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.51 -0.476 . . . . 1.0 112.034 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.4 158.06 27.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.276 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -107.69 110.78 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 C-N-CA 119.785 -0.766 . . . . 1.0 112.011 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.3 m-85 -101.53 152.58 20.61 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.976 -1.011 . . . . 1.0 108.761 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.595 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 10.6 m-30 -113.86 127.26 55.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.616 ' N ' ' NZ ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -118.14 142.62 47.24 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 1.0 112.103 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.41 ' C ' HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -130.22 120.21 24.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.346 -1.297 . . . . 1.0 111.605 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.985 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -96.41 27.92 3.56 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.523 177.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HZ2' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -129.0 123.36 21.8 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.04 94.99 0.41 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 CA-C-N 120.736 1.299 . . . . 1.0 109.14 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 112' ' ' ASN . 1.3 mt -71.45 136.05 26.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.465 0.65 . . . . 1.0 109.311 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.83 132.67 63.67 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.995 -1.002 . . . . 1.0 113.282 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.53 104.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.923 1.749 . . . . 1.0 111.781 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.06 -7.81 8.1 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.6 150.95 23.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.559 . . . . 1.0 111.485 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 0.6 OUTLIER -79.73 136.96 36.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.773 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.4 mp -89.53 136.66 32.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 105' ' ' ALA . 1.9 mm? -123.44 135.39 54.07 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.529 0.937 . . . . 1.0 113.529 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 139' ' ' TRP . 1.7 t -104.79 131.81 52.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.03 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.969 ' HE1' ' HB3' ' A' ' 105' ' ' ALA . 6.8 p-90 . . . . . 0 N--CA 1.499 1.996 0 C-N-CA 125.502 1.521 . . . . 1.0 109.886 176.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.562 HG12 HD21 ' A' ' 127' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.213 -0.858 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.558 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -75.87 -49.61 17.41 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.292 1.044 . . . . 1.0 109.431 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.04 -65.74 0.53 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.11 -1.859 . . . . 1.0 109.055 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.702 0 C-N-CA 118.103 -1.439 . . . . 1.0 111.209 -175.627 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.742 HG22 ' N ' ' A' ' 13' ' ' GLU . 81.6 m -174.83 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.742 ' N ' HG22 ' A' ' 12' ' ' THR . 4.6 mm-40 53.8 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.672 ' HB ' ' H ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -140.2 176.32 8.86 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.0 174.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 16' ' ' ALA . 2.5 tt -58.12 -56.73 18.25 Favored 'General case' 0 CA--C 1.47 -2.128 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 175.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.691 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -80.87 -54.55 5.49 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 111.853 -2.431 . . . . 1.0 106.911 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.882 ' HG2' HG13 ' A' ' 18' ' ' VAL . 1.1 tt0 160.24 -21.37 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 115.777 1.769 . . . . 1.0 115.777 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.882 HG13 ' HG2' ' A' ' 17' ' ' GLU 0.279 1.1 m -145.17 -178.66 0.81 Allowed Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 120.457 1.481 . . . . 1.0 111.709 -175.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 4.2 Cg_exo -38.4 151.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.362 2.708 . . . . 1.0 111.113 173.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.704 ' HA ' HD11 ' A' ' 23' ' ' LEU . 13.7 tt0 -67.75 -34.26 76.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 115.778 1.77 . . . . 1.0 115.778 -176.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -73.63 -25.22 60.2 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -68.6 -51.37 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.769 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.84 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.05 -24.76 66.02 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.08 0.943 . . . . 1.0 110.617 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.727 -1.579 . . . . 1.0 108.801 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.41 3.98 47.3 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.951 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 32' ' ' LEU . 11.6 mt -62.6 158.51 49.88 Favored Pre-proline 0 CA--C 1.491 -1.309 0 CA-C-N 118.311 1.055 . . . . 1.0 110.256 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.66 145.36 51.73 Favored 'Trans proline' 0 C--N 1.29 -2.552 0 N-CA-C 107.338 -1.832 . . . . 1.0 107.338 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.434 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 19.7 pt-20 -49.01 -30.23 5.86 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.333 1.063 . . . . 1.0 110.944 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 1.4 pm0 -87.39 25.63 1.38 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.002 -1.454 . . . . 1.0 112.463 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 26' ' ' LEU . 11.2 t -143.33 148.91 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.977 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.922 ' C ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -158.34 155.36 28.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.007 -1.906 . . . . 1.0 106.407 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.042 ' H ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -128.73 151.05 49.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.439 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -156.93 142.57 12.69 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 124.209 0.943 . . . . 1.0 113.481 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 45.8 Cg_endo -86.83 150.16 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.699 2.266 . . . . 1.0 109.634 174.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.2 m 85.76 15.75 0.14 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.264 -1.384 . . . . 1.0 107.264 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.53 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -90.84 -61.11 1.74 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.69 -1.967 . . . . 1.0 105.69 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -67.46 -51.55 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.263 -1.335 . . . . 1.0 112.946 -178.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 40' ' ' THR . 27.8 t70 179.56 46.76 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER 30.11 39.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.17 0.986 . . . . 1.0 110.187 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.6 m -127.11 -56.23 1.34 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.714 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 37' ' ' VAL . 6.7 mtm180 -120.08 157.53 28.75 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.228 -2.26 . . . . 1.0 107.324 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.673 HG12 ' OE1' ' A' ' 17' ' ' GLU . 10.3 tt -103.64 146.39 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 118.706 -0.664 . . . . 1.0 109.934 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 17' ' ' GLU . . . -140.46 173.04 23.27 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 119.275 -1.44 . . . . 1.0 114.08 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.697 ' HB ' HD12 ' A' ' 32' ' ' LEU . 1.5 m -101.75 131.39 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.53 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 27.0 m95 -125.88 146.91 49.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -71.4 144.0 49.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.538 -0.756 . . . . 1.0 112.201 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.488 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 45.1 p -119.76 -30.0 4.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.103 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -119.19 158.66 47.84 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.39 123.05 12.86 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 121.873 1.715 . . . . 1.0 111.593 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.406 ' C ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -104.19 133.43 48.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.984 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.9 157.35 19.96 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.29 1.043 . . . . 1.0 111.757 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.77 130.05 42.06 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.464 -1.698 . . . . 1.0 108.938 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.78 3.39 49.37 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 119.607 -1.282 . . . . 1.0 115.797 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 24.7 ttpt -92.48 143.7 26.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 1.267 . . . . 1.0 113.063 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.6 41.77 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.751 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 20.9 m-85 -115.78 129.11 56.32 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.884 -1.053 . . . . 1.0 108.206 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.745 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 132.95 -149.42 19.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.19 -1.005 . . . . 1.0 112.461 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 70.0 Cg_endo -89.17 153.03 30.93 Favored 'Cis proline' 0 N--CA 1.51 2.497 0 CA-C-N 119.214 1.507 . . . . 1.0 115.206 0.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.808 ' CA ' HD12 ' A' ' 99' ' ' LEU . 3.9 t80 -58.01 112.88 1.65 Allowed 'General case' 0 CA--C 1.495 -1.142 0 CA-C-O 122.08 0.943 . . . . 1.0 111.905 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.759 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -86.25 134.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.781 -1.554 . . . . 1.0 108.033 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.52 147.84 17.25 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.84 -1.704 . . . . 1.0 108.84 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -69.15 142.12 54.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.456 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.4 mptt -92.38 115.75 28.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.31 0.576 . . . . 1.0 111.883 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -142.59 167.56 21.81 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.649 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.657 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.98 149.04 34.16 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.28 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -48.56 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 1.0 110.73 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.322 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.705 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.868 0.366 . . . . 1.0 110.119 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.616 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -134.02 166.79 21.92 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.165 -0.679 . . . . 1.0 109.165 -178.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -133.48 125.58 29.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.186 0.517 . . . . 1.0 110.576 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.54 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.39 139.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.544 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.548 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 49.7 t80 -87.15 129.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.644 0.735 . . . . 1.0 111.228 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.523 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 4.7 m-85 -105.73 140.42 21.18 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.956 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.56 17.04 0.98 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.849 1.7 . . . . 1.0 110.83 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.65 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -149.07 -31.46 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.92 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.65 HD12 ' ND2' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -106.09 -16.61 14.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.962 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.31 -165.3 53.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -62.84 121.28 13.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.549 -0.86 . . . . 1.0 109.881 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.3 ppp? -130.96 168.66 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.14 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' LYS . 54.4 m -123.84 144.64 49.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.933 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 59' ' ' PHE . 82.8 mt -99.93 146.14 9.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 7.4 p-10 -133.61 119.29 19.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.349 0.977 . . . . 1.0 112.012 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.408 ' HB3' ' HE ' ' A' ' 100' ' ' ARG . . . -143.0 90.99 2.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.71 0.85 28.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.618 1.099 . . . . 1.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -128.89 131.55 23.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.819 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 96' ' ' GLY . 65.9 Cg_exo -48.97 -28.78 14.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.845 1.697 . . . . 1.0 113.728 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.22 -18.69 45.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.313 1.054 . . . . 1.0 108.428 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -88.63 18.19 4.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.123 -1.853 . . . . 1.0 109.473 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' PRO . . . -174.36 166.09 37.89 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.96 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.773 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -71.6 175.3 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.293 -1.002 . . . . 1.0 108.293 177.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.656 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 25.9 p-90 -56.44 -22.01 29.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.908 -0.717 . . . . 1.0 112.732 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.808 HD12 ' CA ' ' A' ' 59' ' ' PHE . 19.2 mt -53.71 -28.05 31.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 177.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' NH2' ' HE1' ' A' ' 76' ' ' TRP . 13.6 tpp180 -74.88 -12.9 60.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.949 -0.569 . . . . 1.0 112.006 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.882 ' CD2' HG11 ' A' ' 18' ' ' VAL . 15.9 p90 -123.56 4.15 8.97 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 119.696 -0.802 . . . . 1.0 110.694 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 102' ' ' VAL . 2.7 p -71.71 116.45 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.517 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 1.7 m-20 -85.22 143.36 28.8 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.311 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.521 ' C ' HD23 ' A' ' 137' ' ' LEU . 33.7 p90 -111.58 162.9 14.66 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.835 0.826 . . . . 1.0 112.945 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.955 ' N ' HD23 ' A' ' 137' ' ' LEU . . . -50.9 -179.15 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.132 -1.395 . . . . 1.0 112.336 -177.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -75.09 -20.4 59.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.669 178.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 106' ' ' CYS . 1.5 p 151.91 71.17 0.0 OUTLIER 'General case' 0 C--N 1.347 0.464 0 O-C-N 123.857 0.723 . . . . 1.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.849 ' H ' ' NE2' ' A' ' 111' ' ' GLN . . . 72.72 13.96 78.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.559 -0.616 . . . . 1.0 111.559 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.57 -44.08 19.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.012 -0.675 . . . . 1.0 111.36 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.65 ' OE2' HD13 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -120.19 -30.59 4.6 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.605 -0.438 . . . . 1.0 111.863 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.849 ' NE2' ' H ' ' A' ' 108' ' ' GLY . 1.5 mt-30 -24.92 139.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.889 0.876 . . . . 1.0 113.083 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.601 ' C ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.15 19.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 1.0 110.134 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.84 HD12 ' H ' ' A' ' 114' ' ' PHE . 2.1 tp -153.12 149.3 27.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.69 -0.672 . . . . 1.0 109.698 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.84 ' H ' HD12 ' A' ' 113' ' ' LEU . 3.9 p90 -126.31 150.12 69.18 Favored Pre-proline 0 C--N 1.366 1.305 0 N-CA-C 114.616 1.339 . . . . 1.0 114.616 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -88.68 141.37 4.56 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 123.007 2.472 . . . . 1.0 114.073 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.723 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -141.81 139.74 32.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.847 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.723 ' H ' HD23 ' A' ' 116' ' ' LEU . 7.5 mt-10 -98.41 120.43 38.82 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.567 -0.288 . . . . 1.0 110.677 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -136.75 126.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 120.827 0.346 . . . . 1.0 110.637 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 121' ' ' ALA . 1.1 m-80 52.64 47.92 23.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.177 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.586 ' H ' ' NH1' ' A' ' 120' ' ' ARG . 1.8 mmt-85 62.97 5.96 2.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.126 0.489 . . . . 1.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -107.07 156.8 18.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 1.0 108.785 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -115.82 103.97 16.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.911 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 116' ' ' LEU . 13.4 m-85 -100.1 148.82 24.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.747 ' HB3' HD11 ' A' ' 113' ' ' LEU . 13.5 m-30 -113.16 114.08 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.573 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -107.13 142.57 36.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.124 1.157 . . . . 1.0 114.124 -178.065 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.623 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -129.84 132.43 46.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.423 -1.262 . . . . 1.0 112.491 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -106.38 26.04 10.35 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.7 0.682 . . . . 1.0 109.536 175.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.601 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -127.66 117.01 21.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.03 97.87 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 CA-C-N 120.465 1.202 . . . . 1.0 110.635 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.54 HG23 ' CG ' ' A' ' 134' ' ' GLU . 1.6 mt -70.36 136.8 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.27 1.033 . . . . 1.0 109.561 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.13 132.67 76.33 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 113.96 -1.473 . . . . 1.0 114.188 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -50.13 97.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.67 1.58 . . . . 1.0 110.737 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.68 -4.28 8.06 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.786 -0.525 . . . . 1.0 111.786 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -87.48 151.65 22.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.4 pm0 -77.21 129.08 35.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.919 0.39 . . . . 1.0 110.085 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.863 ' C ' HD12 ' A' ' 137' ' ' LEU . 5.5 mp -81.33 142.21 33.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.955 HD23 ' N ' ' A' ' 105' ' ' ALA . 6.8 mp -139.86 155.25 47.31 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.52 HG21 ' CE2' ' A' ' 124' ' ' TYR . 2.4 t -110.59 131.81 60.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 CA-C-N 114.93 -1.032 . . . . 1.0 113.228 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.707 ' CG ' ' NE2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.5 0.667 . . . . 1.0 112.662 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.057 0 N-CA-C 106.874 -1.528 . . . . 1.0 106.874 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.537 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -73.87 -35.77 64.76 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.952 -0.699 . . . . 1.0 110.203 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.03 -66.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.046 -1.061 . . . . 1.0 110.233 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 119.129 -1.028 . . . . 1.0 110.153 -175.234 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 13' ' ' GLU . . . . . . . . 0 CA--C 1.522 -0.113 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 14' ' ' THR . 0.4 OUTLIER 73.44 -39.8 0.45 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.579 179.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 42' ' ' ILE . 1.4 mm-40 28.23 -87.09 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -136.78 172.18 13.4 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.663 174.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 15' ' ' LEU . 6.3 tt -73.04 -59.91 2.48 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.823 -1.151 . . . . 1.0 108.336 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -78.35 -59.57 2.73 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-N 113.216 -1.811 . . . . 1.0 108.407 -176.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.734 ' HG3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -145.77 -102.58 0.1 Allowed 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 118.565 -1.254 . . . . 1.0 114.289 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.745 HG13 ' HD3' ' A' ' 19' ' ' PRO 0.284 0.2 OUTLIER 179.38 -80.42 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 116.974 -1.489 . . . . 1.0 111.601 -177.456 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.745 ' HD3' HG13 ' A' ' 18' ' ' VAL . 4.4 Cg_exo -74.19 147.01 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 CA-C-N 124.875 2.777 . . . . 1.0 111.404 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.509 ' CD ' HH12 ' A' ' 24' ' ' ARG . 37.4 tt0 -67.73 -50.26 58.29 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.338 1.066 . . . . 1.0 110.404 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.569 ' NE2' ' O ' ' A' ' 94' ' ' GLU . 28.7 p80 -56.36 -24.85 46.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.884 -1.053 . . . . 1.0 113.408 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.795 HG23 HD12 ' A' ' 23' ' ' LEU . 2.0 m -64.09 -45.0 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 121.284 1.857 . . . . 1.0 106.362 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.795 HD12 HG23 ' A' ' 22' ' ' VAL . 6.5 mp -54.71 -28.67 49.7 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.596 0.712 . . . . 1.0 110.405 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.509 HH12 ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.05 -20.84 60.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.519 -1.219 . . . . 1.0 108.616 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . -114.7 -12.68 10.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.309 -1.314 . . . . 1.0 113.063 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.644 HD13 ' C ' ' A' ' 30' ' ' VAL . 16.8 mt -60.19 150.21 72.31 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-N 118.988 1.394 . . . . 1.0 110.589 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 26' ' ' LEU . 75.9 Cg_exo -42.56 -128.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.666 2.911 . . . . 1.0 113.184 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 48' ' ' LYS . 4.2 mt-10 -68.77 -50.75 47.85 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.776 -1.57 . . . . 1.0 106.796 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' H ' ' HE2' ' A' ' 48' ' ' LYS . 12.5 tt0 -126.18 -77.71 0.59 Allowed 'General case' 0 C--N 1.363 1.17 0 C-N-CA 120.157 -0.617 . . . . 1.0 111.489 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.644 ' C ' HD13 ' A' ' 26' ' ' LEU 0.365 4.9 t 59.43 152.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 C-N-CA 127.881 2.472 . . . . 1.0 116.265 -176.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' C ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.79 160.61 42.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.173 -2.285 . . . . 1.0 110.948 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 31' ' ' ARG . 3.5 mm? -117.75 120.41 37.88 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 174.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.54 ' C ' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -129.43 122.56 20.94 Favored Pre-proline 0 N--CA 1.485 1.299 0 O-C-N 121.193 -0.942 . . . . 1.0 112.633 -176.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 4.3 Cg_exo -79.22 130.4 9.2 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.804 2.336 . . . . 1.0 112.897 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.3 t 87.8 30.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.667 -2.06 . . . . 1.0 107.286 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -94.57 -54.12 3.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 38' ' ' ASP . 7.5 p -59.4 -49.85 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 113.614 -1.63 . . . . 1.0 111.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.558 ' N ' HG13 ' A' ' 37' ' ' VAL . 0.6 OUTLIER 169.28 -50.91 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.3 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.548 -1.205 . . . . 1.0 107.909 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.554 ' HB ' HG11 ' A' ' 37' ' ' VAL . 20.7 m -102.83 -34.73 8.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 40' ' ' THR . 7.7 mtm-85 155.06 -159.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.7 -1.593 . . . . 1.0 106.7 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 13' ' ' GLU . 9.5 tt -84.07 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 118.915 0.779 . . . . 1.0 111.315 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.558 ' C ' HD13 ' A' ' 32' ' ' LEU . . . -106.75 166.72 13.66 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -103.28 120.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 118.134 0.967 . . . . 1.0 111.426 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.651 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 4.9 m95 -127.51 143.79 51.14 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.258 -0.883 . . . . 1.0 110.173 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -84.7 123.84 30.83 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.2 -1.0 . . . . 1.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -21.76 19.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.37 0.605 . . . . 1.0 109.409 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.61 ' HZ2' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -107.87 167.89 8.68 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 114.728 -1.124 . . . . 1.0 110.963 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 5.9 Cg_exo -76.09 144.34 26.69 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.65 2.233 . . . . 1.0 111.158 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.61 HG12 ' HZ2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -118.73 144.09 27.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.91 -178.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.98 146.31 39.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.92 0.866 . . . . 1.0 110.742 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.65 140.14 58.47 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.323 -1.308 . . . . 1.0 111.822 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.79 3.92 58.07 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 119.409 -1.377 . . . . 1.0 115.302 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' CG ' ' N ' ' A' ' 55' ' ' LYS . 30.0 ttpt -106.22 146.27 30.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 118.92 -1.112 . . . . 1.0 113.968 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -97.39 140.71 31.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.791 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 126' ' ' THR . 3.0 m-85 -118.59 131.03 56.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.052 -1.462 . . . . 1.0 107.052 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.64 -150.45 21.11 Favored Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 21.6 Cg_endo -84.83 170.7 46.88 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 119.671 1.735 . . . . 1.0 113.457 0.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.823 ' HB2' HD12 ' A' ' 99' ' ' LEU . 36.9 t80 -73.72 122.31 22.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.622 0.725 . . . . 1.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.608 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -44.37 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.886 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 37.12 109.14 0.0 OUTLIER Glycine 0 C--N 1.333 0.399 0 CA-C-O 121.711 0.617 . . . . 1.0 113.244 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t70 -85.78 134.96 33.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 63' ' ' LYS . 1.5 mptt -90.59 116.33 28.41 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.517 0.675 . . . . 1.0 112.124 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HZ3' ' HB3' ' A' ' 87' ' ' CYS . 0.1 OUTLIER -124.05 158.08 33.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.626 -1.17 . . . . 1.0 110.98 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -83.63 135.53 34.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 177.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -53.27 -31.04 41.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.783 -0.573 . . . . 1.0 110.394 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.838 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.653 0.74 . . . . 1.0 112.584 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -123.11 164.28 18.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.525 -1.216 . . . . 1.0 110.512 -178.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -122.69 122.21 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.181 0.515 . . . . 1.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.96 139.93 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.406 -0.816 . . . . 1.0 111.83 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.516 ' O ' ' CZ ' ' A' ' 120' ' ' ARG . 4.4 t80 -92.67 135.84 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.875 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.61 ' CD1' HD11 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -117.12 146.05 37.17 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -70.19 44.46 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 N-CA-C 108.225 -1.49 . . . . 1.0 108.225 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.575 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 1.5 t30 -148.21 -85.77 0.1 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.212 -1.358 . . . . 1.0 110.297 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 84' ' ' GLY . 0.8 OUTLIER -80.48 -8.99 59.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.33 -1.305 . . . . 1.0 112.322 -176.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.74 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 81.65 -145.81 25.31 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -78.68 118.13 20.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.721 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -129.96 173.38 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.744 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.586 ' N ' ' SD ' ' A' ' 86' ' ' MET . 67.8 m -117.96 141.41 48.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.152 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.4 150.66 3.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 N-CA-C 108.05 -1.093 . . . . 1.0 108.05 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -133.66 136.69 44.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.827 1.047 . . . . 1.0 113.827 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 91' ' ' THR . . . -133.23 139.93 47.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 90' ' ' ALA . 30.2 p -158.61 -13.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.487 0.585 . . . . 1.0 110.033 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.03 106.31 3.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.75 -22.09 9.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.132 1.888 . . . . 1.0 114.353 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.569 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 5.9 pt-20 -83.18 -8.39 59.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.904 0.859 . . . . 1.0 110.215 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 11.65 35.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.343 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.442 ' O ' ' ND1' ' A' ' 21' ' ' HIS . . . -165.44 -95.07 0.1 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 119.073 -1.537 . . . . 1.0 114.012 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.672 ' ND2' ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -146.18 173.35 12.29 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 101' ' ' TYR . 30.6 p-90 -70.86 -19.95 62.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.823 HD12 ' HB2' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -50.18 -24.11 2.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.775 HH22 HD21 ' A' ' 103' ' ' ASN . 3.1 tpm_? -84.57 -23.16 29.78 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 120.146 -0.621 . . . . 1.0 110.749 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -72.57 -7.35 49.69 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.299 1.047 . . . . 1.0 109.479 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.718 HG22 ' CZ2' ' A' ' 104' ' ' TRP . 3.4 t -82.48 119.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.249 -1.796 . . . . 1.0 111.041 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.775 HD21 HH22 ' A' ' 100' ' ' ARG . 38.4 m-20 -156.15 71.68 0.73 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.661 0.664 . . . . 1.0 111.464 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.818 ' HE1' ' N ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -141.88 176.69 8.73 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.089 0.956 . . . . 1.0 111.497 -177.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.601 ' C ' ' N ' ' A' ' 107' ' ' SER . . . 26.53 52.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.43 1.081 . . . . 1.0 109.995 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -48.56 -14.53 0.06 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.601 ' N ' ' C ' ' A' ' 105' ' ' ALA . 20.0 p -174.98 18.06 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.35 -1.295 . . . . 1.0 110.561 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.704 ' N ' ' HE1' ' A' ' 139' ' ' TRP . . . -85.2 131.26 10.33 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.06 -12.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 4.3 pt-20 -74.26 5.52 4.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 113.698 0.999 . . . . 1.0 113.698 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.696 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.4 pp0? -54.48 140.23 35.04 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.673 1.36 . . . . 1.0 114.673 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.983 ' ND2' ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -117.58 -5.22 11.19 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.333 -1.758 . . . . 1.0 111.663 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 114' ' ' PHE . 0.3 OUTLIER -155.8 165.47 36.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 119.441 -0.314 . . . . 1.0 110.931 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 1.079 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -133.11 138.03 30.77 Favored Pre-proline 0 C--N 1.357 0.933 0 N-CA-C 113.869 1.062 . . . . 1.0 113.869 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.78 146.02 10.37 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.422 2.748 . . . . 1.0 113.648 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.822 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -144.66 146.54 32.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.293 178.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.822 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.2 tt0 -97.38 119.06 35.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 123' ' ' TYR . 7.7 mt -137.39 132.21 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.929 -177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 121' ' ' ALA . 30.2 m-20 50.14 57.95 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.485 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.516 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 9.8 mmp_? 57.21 -0.8 0.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.494 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 58' ' ' PRO . . . -123.21 155.62 36.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.248 -0.278 . . . . 1.0 110.248 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CE2' ' A' ' 76' ' ' TRP . 1.0 OUTLIER -103.8 113.94 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.602 ' HB2' HD12 ' A' ' 118' ' ' ILE . 5.0 m-85 -101.35 149.32 24.16 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.737 ' CE2' HG21 ' A' ' 138' ' ' VAL . 3.1 m-30 -112.97 126.93 56.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.338 -1.356 . . . . 1.0 107.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.946 ' H ' ' HZ2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -122.5 140.43 52.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.642 ' C ' HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -128.73 134.47 48.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 1.0 109.708 178.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.887 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -105.87 16.78 24.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.103 176.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.593 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -125.16 127.01 25.13 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.22 98.79 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 121.33 1.511 . . . . 1.0 111.068 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.531 HD13 ' OD1' ' A' ' 112' ' ' ASN . 55.6 mt -67.81 134.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.273 1.035 . . . . 1.0 109.594 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.663 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.01 139.32 97.75 Favored Pre-proline 0 C--O 1.212 -0.872 0 CA-C-N 113.929 -1.487 . . . . 1.0 114.086 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.52 115.44 4.29 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.556 2.171 . . . . 1.0 111.692 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 109.65 0.95 30.73 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.914 -0.474 . . . . 1.0 111.914 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.702 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -97.75 173.27 7.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.84 0.829 . . . . 1.0 112.353 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' CG ' ' CD1' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -85.81 141.42 29.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.211 -1.358 . . . . 1.0 108.359 176.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.711 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.4 mp -89.9 136.88 32.78 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.218 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.983 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 6.8 mp -121.6 142.84 49.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.757 0.789 . . . . 1.0 112.104 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.818 ' N ' ' HE1' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -119.97 137.12 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 114.034 -1.439 . . . . 1.0 110.014 -176.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.704 ' HE1' ' N ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--O 1.204 -1.295 0 N-CA-C 106.388 -1.708 . . . . 1.0 106.388 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.05 -50.4 34.35 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.123 -1.831 . . . . 1.0 109.191 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.87 -65.59 0.68 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.285 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.296 0 CA-C-N 120.846 1.657 . . . . 1.0 112.374 -176.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.696 ' HB2' ' OG ' ' A' ' 35' ' ' SER . . . . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.191 0.52 . . . . 1.0 110.192 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.3 m 149.54 -68.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.251 -1.341 . . . . 1.0 108.212 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.502 ' N ' HG22 ' A' ' 12' ' ' THR . 5.9 mm-40 -45.8 138.71 4.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.556 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -121.37 153.45 37.78 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 121.554 0.692 . . . . 1.0 112.321 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.982 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -47.39 -36.0 9.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.465 -178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.96 44.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.581 -1.191 . . . . 1.0 109.802 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -97.47 -38.1 9.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.034 -0.984 . . . . 1.0 113.617 -177.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -63.49 147.11 95.87 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.688 -1.967 . . . . 1.0 105.688 178.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 18' ' ' VAL . 2.8 Cg_exo -48.1 118.61 3.28 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.621 1.548 . . . . 1.0 112.042 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.15 -42.39 60.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.973 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.425 ' CD2' ' H ' ' A' ' 21' ' ' HIS . 12.9 p80 -64.08 -23.65 67.4 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.949 -0.7 . . . . 1.0 111.703 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 97' ' ' ASN . 14.9 t -80.17 -45.33 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 119.009 0.822 . . . . 1.0 111.247 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.624 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -67.04 -25.7 66.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.951 0.881 . . . . 1.0 108.993 178.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -61.27 -19.18 61.43 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.592 -1.186 . . . . 1.0 111.913 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.8 39.67 2.82 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.246 -0.502 . . . . 1.0 112.054 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.661 HD22 ' CG1' ' A' ' 30' ' ' VAL . 32.7 mt -80.04 154.48 75.09 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG2' HG21 ' A' ' 30' ' ' VAL . 86.0 Cg_exo -44.23 -120.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.966 3.111 . . . . 1.0 114.138 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 7.8 mm-40 -69.18 -55.11 11.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.65 -2.352 . . . . 1.0 104.65 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 30' ' ' VAL . 7.6 tp10 -133.95 -72.59 0.49 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.661 ' CG1' HD22 ' A' ' 26' ' ' LEU . 96.4 t 52.28 163.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.989 0.9 . . . . 1.0 110.953 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB2' HG21 ' A' ' 47' ' ' THR . 3.2 ttt85 -161.44 163.16 30.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.92 -1.491 . . . . 1.0 107.006 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.654 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.1 mm? -94.45 155.07 17.13 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.544 -1.262 . . . . 1.0 110.098 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.72 111.67 2.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 35' ' ' SER . 13.0 Cg_endo -88.31 154.18 6.71 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.691 2.927 . . . . 1.0 111.926 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.696 ' OG ' ' HB2' ' A' ' 11' ' ' ALA . 1.8 p 50.84 40.3 24.42 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -95.98 -46.4 6.53 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.282 -2.235 . . . . 1.0 106.899 175.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -96.3 -4.06 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 114.16 -1.382 . . . . 1.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t70 98.24 -11.32 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.982 0.802 . . . . 1.0 111.54 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.726 ' HZ3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.24 -35.84 66.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.874 -0.73 . . . . 1.0 109.326 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 92.11 -11.22 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.526 0.936 . . . . 1.0 113.526 177.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.726 ' CB ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -77.22 162.45 27.37 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 32' ' ' LEU . 4.2 mm -74.48 124.73 32.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 120.485 1.493 . . . . 1.0 112.097 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.77 174.19 16.86 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.698 -1.761 . . . . 1.0 108.698 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG21 ' HE3' ' A' ' 98' ' ' TRP . 8.3 p -121.83 125.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.94 0.4 . . . . 1.0 109.94 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.661 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 30.2 m95 -126.92 149.43 49.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.618 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.55 133.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.959 -1.019 . . . . 1.0 108.859 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 31' ' ' ARG . 80.8 p -115.93 -15.73 11.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.241 -1.392 . . . . 1.0 107.241 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.595 ' CD ' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -116.2 171.69 4.47 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 112.847 -1.979 . . . . 1.0 109.59 -178.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.46 153.71 13.84 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 123.264 2.643 . . . . 1.0 111.982 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.495 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 4.1 mp -132.11 150.84 34.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.728 -1.124 . . . . 1.0 111.354 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.734 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.55 165.09 15.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 1.0 111.71 178.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.55 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.9 129.62 40.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.093 177.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.33 -0.71 60.13 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 119.854 -1.165 . . . . 1.0 113.375 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.671 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.7 tptt -57.09 157.96 5.51 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.732 -1.187 . . . . 1.0 110.284 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.7 ttmt -123.76 109.3 13.5 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.46 -1.245 . . . . 1.0 108.403 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 11.6 m-30 -119.58 125.12 48.04 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 58' ' ' PRO . . . 155.02 -153.49 24.83 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.08 -1.418 . . . . 1.0 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 10.2 Cg_endo -82.66 150.83 71.6 Favored 'Cis proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.35 1.575 . . . . 1.0 113.604 0.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.464 ' CE1' HG23 ' A' ' 60' ' ' VAL . 17.6 t80 -62.94 118.92 8.46 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.759 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 HG22 ' ND2' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -27.03 -65.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.345 -1.752 . . . . 1.0 111.495 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 53.89 104.55 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.827 -0.701 . . . . 1.0 113.482 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.01 149.8 20.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 176.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.541 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -93.53 116.36 28.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.719 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -146.87 167.22 24.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.016 -178.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.732 ' NZ ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -65.94 153.05 43.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.652 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 6.2 ttm-85 -66.09 -45.33 81.6 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.499 -0.751 . . . . 1.0 111.932 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 121.008 0.432 . . . . 1.0 110.151 -179.588 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.7 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.599 0 CA-C-O 121.788 0.804 . . . . 1.0 111.732 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.918 ' CE2' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -160.59 162.3 32.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.244 -1.344 . . . . 1.0 112.618 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 1.3 pm0 -100.93 121.88 42.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.959 0.885 . . . . 1.0 111.355 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.623 ' CG1' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.24 135.85 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 114.747 -1.115 . . . . 1.0 108.986 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.9 t80 -87.0 124.37 33.12 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.511 -0.875 . . . . 1.0 111.329 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.543 ' C ' ' H ' ' A' ' 82' ' ' ASN . 5.0 m-85 -92.19 135.53 26.89 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 114.195 -1.366 . . . . 1.0 110.466 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.34 7.69 1.74 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.771 1.647 . . . . 1.0 108.869 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 80' ' ' TYR . 70.5 m-80 -110.27 -90.72 0.47 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.256 -1.338 . . . . 1.0 111.48 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.031 HD23 ' H ' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -79.64 -7.08 58.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.36 -157.32 15.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 120.393 -0.908 . . . . 1.0 112.717 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.4 m95 -66.08 121.16 14.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.609 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.525 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 38.1 mmm -124.85 150.8 46.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.377 0.88 . . . . 1.0 113.377 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.652 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -106.97 131.36 54.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 88' ' ' ILE . 17.0 mt -106.16 105.34 18.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.719 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 23.5 t0 -130.83 127.57 38.88 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.287 0.949 . . . . 1.0 112.085 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -132.82 96.45 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.192 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.628 HG23 ' OD1' ' A' ' 89' ' ' ASP . 29.3 p -129.55 75.42 1.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.726 0.694 . . . . 1.0 110.617 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.727 ' N ' ' HE ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -162.85 160.82 19.36 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.338 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -67.26 -38.93 14.14 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.15 1.9 . . . . 1.0 112.418 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -77.87 -44.46 27.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -11.42 16.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 1.0 112.076 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . -110.77 111.46 3.02 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.487 -0.863 . . . . 1.0 112.04 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.682 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -61.95 -157.92 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.919 0.39 . . . . 1.0 110.466 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.563 ' HE3' HG21 ' A' ' 44' ' ' VAL . 43.0 p-90 -72.75 -35.49 67.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.318 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -54.8 -26.5 35.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.365 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.727 ' HE ' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -72.29 -20.5 61.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.917 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.87 -10.68 57.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.758 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 99' ' ' LEU . 3.2 t -64.49 141.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.561 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.627 ' ND2' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -101.22 -155.18 0.5 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.088 -0.645 . . . . 1.0 112.234 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.47 ' C ' ' HB3' ' A' ' 137' ' ' LEU . 2.6 m-90 -112.79 144.12 42.87 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.466 -0.788 . . . . 1.0 111.813 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 139' ' ' TRP . . . -79.06 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER 159.23 -16.05 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.768 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -136.54 -81.56 0.39 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.197 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 163.69 -52.0 0.3 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -24.62 65.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.677 ' O ' ' O ' ' A' ' 111' ' ' GLN . 2.5 pt-20 -92.13 -22.98 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.995 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.688 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -51.24 -134.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 1.027 HD21 HD22 ' A' ' 137' ' ' LEU . 0.8 OUTLIER 158.51 -33.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.572 -0.705 . . . . 1.0 109.488 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 112' ' ' ASN . 4.2 mm? -129.55 148.26 51.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.807 -0.757 . . . . 1.0 112.055 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -134.06 130.63 20.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 115.105 -0.952 . . . . 1.0 112.498 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 76' ' ' TRP . 78.6 Cg_exo -51.23 130.22 31.53 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 123.894 3.063 . . . . 1.0 115.899 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.594 HD23 ' HZ1' ' A' ' 125' ' ' LYS . 56.2 tp -142.17 137.24 30.7 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 4.7 mm-40 -108.06 114.95 29.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.403 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.577 HD11 ' CD1' ' A' ' 123' ' ' TYR . 4.9 pt -139.09 127.82 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.536 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.59 47.5 23.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 1.0 110.909 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HE ' ' CG1' ' A' ' 78' ' ' VAL . 1.9 mmp_? 54.43 30.56 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -136.82 148.98 47.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.026 -1.101 . . . . 1.0 108.026 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.918 HG21 ' CE2' ' A' ' 76' ' ' TRP . 1.6 mm -110.42 114.24 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.745 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.577 ' CD1' HD11 ' A' ' 118' ' ' ILE . 4.6 m-85 -102.22 157.53 16.83 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.175 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.811 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.5 m-30 -116.66 130.73 56.91 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 105.522 -2.029 . . . . 1.0 105.522 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.594 ' HZ1' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -125.95 153.96 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.967 -177.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.689 ' O ' ' N ' ' A' ' 53' ' ' GLY . 27.7 p -100.76 118.51 37.01 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.231 -0.588 . . . . 1.0 112.471 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.67 HD23 ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -82.77 -21.38 34.66 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 124.224 0.953 . . . . 1.0 109.559 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.893 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -139.8 137.97 19.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.724 0.268 . . . . 1.0 111.724 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.88 144.2 45.58 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.628 1.552 . . . . 1.0 110.732 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.495 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -122.13 137.06 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.524 ' HB3' ' CG ' ' A' ' 134' ' ' GLU . . . -75.08 134.18 74.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.15 -0.477 . . . . 1.0 112.112 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.06 108.99 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 CA-C-N 119.808 0.967 . . . . 1.0 110.534 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 122.03 7.65 7.73 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 2.3 mm-40 -105.53 117.61 34.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.137 0.494 . . . . 1.0 111.187 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.661 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -46.06 146.71 1.21 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.772 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 137' ' ' LEU . 7.2 mp -91.08 132.67 35.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.096 -0.956 . . . . 1.0 108.488 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 1.027 HD22 HD21 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -136.62 161.81 34.86 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.751 0.786 . . . . 1.0 112.071 -178.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.811 HG11 ' CE2' ' A' ' 124' ' ' TYR . 3.1 m -146.13 170.87 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.778 -1.101 . . . . 1.0 111.337 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.655 ' CD1' ' NE2' ' A' ' 111' ' ' GLN . 44.5 p-90 . . . . . 0 C--N 1.307 -1.239 0 CA-C-N 113.585 -1.643 . . . . 1.0 108.41 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 N--CA 1.428 -1.546 0 CA-C-O 120.678 0.275 . . . . 1.0 110.662 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 -48.83 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.71 74.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 1.0 111.968 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.67 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--O 1.21 -1.01 0 C-N-CA 119.48 -0.888 . . . . 1.0 111.451 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 89.9 m 122.36 103.62 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 125.204 1.565 . . . . 1.0 107.623 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.511 ' HG3' HG22 ' A' ' 12' ' ' THR . 0.4 OUTLIER 66.25 161.07 0.14 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.106 -1.406 . . . . 1.0 108.824 -177.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.547 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -121.29 156.17 33.1 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 120.458 0.171 . . . . 1.0 111.074 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.738 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -43.9 -30.21 0.66 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.219 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.41 59.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.61 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -73.14 -44.65 59.84 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.787 1.032 . . . . 1.0 113.787 -176.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -56.2 149.77 34.83 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.973 -1.862 . . . . 1.0 105.973 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 18' ' ' VAL . 27.8 Cg_exo -47.37 143.23 11.52 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 120.884 1.056 . . . . 1.0 110.874 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 14.8 tt0 -60.81 -49.9 75.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.511 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.553 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 8.2 p80 -61.76 -26.07 67.85 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.624 HG13 ' C ' ' A' ' 97' ' ' ASN . 22.6 t -79.78 -49.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 118.656 0.662 . . . . 1.0 111.656 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.543 HD23 HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -67.89 -25.5 65.54 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.795 0.807 . . . . 1.0 109.449 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 8.6 mmm180 -59.74 -19.23 48.89 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.181 -1.372 . . . . 1.0 112.019 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.84 35.88 4.38 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.149 -0.548 . . . . 1.0 111.979 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 30' ' ' VAL . 16.4 mt -82.03 123.12 80.08 Favored Pre-proline 0 CA--C 1.514 -0.419 0 CA-C-O 119.477 -0.297 . . . . 1.0 111.11 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.509 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 14.2 Cg_exo -55.41 156.72 16.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 119.748 0.946 . . . . 1.0 110.236 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.423 ' C ' ' HG3' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -47.18 -13.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 115.172 1.545 . . . . 1.0 115.172 -174.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 6.2 pm0 -114.19 15.73 18.14 Favored 'General case' 0 CA--C 1.463 -2.386 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.16 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.714 HG12 HG22 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -126.82 125.78 67.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 114.605 1.335 . . . . 1.0 114.605 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.546 ' HB2' HG21 ' A' ' 47' ' ' THR . 6.6 tpm_? -141.6 153.44 44.79 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 113.36 -1.745 . . . . 1.0 107.17 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 15' ' ' LEU . 4.1 mm? -91.82 143.69 26.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 118.84 -1.144 . . . . 1.0 109.958 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.47 110.06 3.64 Favored Pre-proline 0 N--CA 1.444 -0.732 0 N-CA-C 113.253 0.834 . . . . 1.0 113.253 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . 15.5 Cg_endo -84.87 152.58 11.31 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.883 2.389 . . . . 1.0 111.24 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.9 p 86.46 -38.49 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.437 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -49.3 -57.88 6.05 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.516 -1.22 . . . . 1.0 107.847 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 3.9 m -57.27 -50.05 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.869 -0.732 . . . . 1.0 110.232 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 1.7 m-20 156.9 70.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.448 0.468 . . . . 1.0 110.591 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.1 OUTLIER 35.67 29.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.387 0.613 . . . . 1.0 109.811 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 m -90.88 -33.56 15.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.086 -0.961 . . . . 1.0 112.62 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 42' ' ' ILE . 4.7 ptm180 162.61 -163.98 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 HD12 ' A' ' 32' ' ' LEU . 2.7 mm -84.37 135.56 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 118.156 0.434 . . . . 1.0 110.386 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.73 155.14 18.92 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.545 -1.022 . . . . 1.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -102.41 131.53 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.51 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 12.0 m95 -132.26 155.21 48.72 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 -176.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.06 120.41 14.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.579 ' H ' ' C ' ' A' ' 29' ' ' GLU . 1.4 p -102.83 -20.81 14.16 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' CD ' ' C ' ' A' ' 48' ' ' LYS 0.252 0.0 OUTLIER -129.29 170.71 10.19 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.827 178.056 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -80.42 125.35 5.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.123 1.882 . . . . 1.0 114.097 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.652 HD11 ' HG3' ' A' ' 29' ' ' GLU . 3.7 mp -99.66 150.78 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.809 -1.541 . . . . 1.0 110.659 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.753 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.17 164.03 13.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.674 177.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -66.61 124.18 22.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.813 -0.554 . . . . 1.0 110.385 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 99.75 1.28 56.34 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 119.924 -1.132 . . . . 1.0 113.087 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 2.2 tptt -52.32 159.47 0.97 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 117.625 -1.63 . . . . 1.0 108.356 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.759 ' HG2' ' HZ2' ' A' ' 125' ' ' LYS . 8.8 ttmt -121.48 103.16 8.73 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.315 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.587 ' CE2' ' OE2' ' A' ' 29' ' ' GLU . 13.4 m-85 -116.36 126.44 53.49 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 106.473 -1.677 . . . . 1.0 106.473 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.17 -164.75 35.63 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 109.876 -1.289 . . . . 1.0 109.876 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 7.0 Cg_endo -89.68 138.44 13.22 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 CA-C-N 119.094 1.447 . . . . 1.0 112.884 -0.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.7 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 10.2 t80 -59.13 114.82 2.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.675 0.75 . . . . 1.0 110.509 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -21.51 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.209 -1.814 . . . . 1.0 111.393 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.615 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 45.76 105.49 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.586 -0.734 . . . . 1.0 113.349 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ASP . 13.7 t70 -93.52 147.28 23.12 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -92.8 115.08 27.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.122 0.963 . . . . 1.0 113.149 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -139.85 170.3 16.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.619 -1.628 . . . . 1.0 110.708 -177.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.698 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.48 145.91 31.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 121.126 -0.23 . . . . 1.0 111.384 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -50.85 -23.9 3.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.782 -0.574 . . . . 1.0 111.986 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 66' ' ' ARG . 29.0 t . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.234 0.54 . . . . 1.0 110.136 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.56 ' C ' ' CG ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.513 0 CA-C-O 121.125 0.488 . . . . 1.0 111.75 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.56 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -157.13 162.81 39.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.031 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.27 122.98 44.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.08 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.552 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -134.56 136.59 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.139 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 t80 -85.41 124.56 32.15 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.512 0.672 . . . . 1.0 112.182 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.805 ' OH ' HD11 ' A' ' 88' ' ' ILE . 27.3 m-85 -100.69 125.37 39.07 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.637 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.71 8.57 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 108.305 -1.46 . . . . 1.0 108.305 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 80' ' ' TYR . 74.5 m-20 -109.44 -10.14 14.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.0 -1.455 . . . . 1.0 111.27 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -168.65 1.85 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.709 1.374 . . . . 1.0 114.709 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.59 -160.78 14.27 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 120.608 -0.806 . . . . 1.0 112.912 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.553 ' O ' ' SD ' ' A' ' 86' ' ' MET . 27.5 m95 -76.5 121.06 22.59 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.553 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.8 mmm -127.54 163.63 23.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.131 1.53 . . . . 1.0 115.131 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.03 134.07 53.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.157 -1.383 . . . . 1.0 108.175 177.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.805 HD11 ' OH ' ' A' ' 80' ' ' TYR . 9.2 mt -106.61 111.5 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 118.481 -0.771 . . . . 1.0 109.816 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -134.42 130.94 37.56 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -139.04 104.8 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.79 49.3 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.994 -0.682 . . . . 1.0 109.202 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.62 162.39 36.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.094 -0.957 . . . . 1.0 109.955 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.62 -38.73 7.7 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.307 2.005 . . . . 1.0 112.688 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -78.16 -42.38 31.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 -11.26 20.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.661 0.267 . . . . 1.0 111.529 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 90' ' ' ALA . . . -102.35 -166.76 26.63 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.649 ' H ' HD22 ' A' ' 97' ' ' ASN . 0.0 OUTLIER -145.36 -153.8 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.239 0.542 . . . . 1.0 111.072 178.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.503 ' N ' HG13 ' A' ' 22' ' ' VAL . 14.4 p-90 -72.34 -29.61 63.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.949 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.721 HD23 ' CD2' ' A' ' 124' ' ' TYR . 0.3 OUTLIER -66.31 -30.85 71.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.457 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.581 ' NH2' ' OH ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 119.926 -0.71 . . . . 1.0 109.937 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.581 ' OH ' ' NH2' ' A' ' 100' ' ' ARG . 7.8 m-85 -92.96 0.44 57.4 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.69 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 99' ' ' LEU . 23.3 t -68.99 126.11 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -72.7 -157.48 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.605 0.595 . . . . 1.0 112.605 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.433 ' O ' ' HB3' ' A' ' 137' ' ' LEU . 4.1 m-90 -112.41 158.72 19.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.468 -0.787 . . . . 1.0 111.046 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.653 ' O ' ' N ' ' A' ' 107' ' ' SER . . . -100.56 -14.62 18.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 116.086 1.884 . . . . 1.0 116.086 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 107' ' ' SER . 49.7 t 32.62 23.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.406 0.548 . . . . 1.0 112.422 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.3 OUTLIER 159.4 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.641 0.258 . . . . 1.0 110.663 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.645 ' O ' ' NE2' ' A' ' 111' ' ' GLN . . . -85.25 2.21 88.26 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.197 -0.525 . . . . 1.0 111.907 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -86.59 -22.85 26.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.003 0.371 . . . . 1.0 112.003 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 111' ' ' GLN . 8.4 pt-20 -115.93 -27.55 6.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.401 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.826 ' N ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER -44.13 110.13 0.19 Allowed 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.762 ' OD1' ' N ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -88.28 -5.31 58.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.753 ' HB2' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -140.55 172.1 13.2 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 124.014 0.821 . . . . 1.0 112.723 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.593 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -148.71 132.07 8.28 Favored Pre-proline 0 N--CA 1.433 -1.287 0 C-N-CA 119.488 -0.885 . . . . 1.0 111.029 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 139' ' ' TRP . 80.6 Cg_exo -55.55 116.39 3.12 Favored 'Trans proline' 0 N--CA 1.509 2.406 0 C-N-CA 123.4 2.733 . . . . 1.0 113.99 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.6 tp -120.39 121.74 39.23 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.048 0.452 . . . . 1.0 111.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -102.84 114.26 28.38 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.505 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.557 HD11 ' CG ' ' A' ' 123' ' ' TYR . 2.3 pt -139.61 134.41 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.437 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.64 38.69 30.39 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.039 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.533 ' HE ' HG12 ' A' ' 78' ' ' VAL . 1.2 mmp_? 58.33 32.34 21.96 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.179 0.514 . . . . 1.0 110.452 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.37 155.22 50.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.434 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.52 HG21 ' NE1' ' A' ' 76' ' ' TRP . 15.0 mm -96.22 125.85 48.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.989 0.423 . . . . 1.0 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.557 ' CG ' HD11 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -124.05 150.64 44.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.277 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.817 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.8 m-30 -118.64 118.76 32.53 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.761 0.315 . . . . 1.0 110.486 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.764 ' NZ ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -115.33 155.29 27.59 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.319 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' GLY . 10.7 p -106.69 109.86 21.89 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.843 1.339 . . . . 1.0 110.487 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.606 HD13 ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -76.18 -8.38 56.9 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.33 1.019 . . . . 1.0 112.091 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.836 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -151.02 135.73 9.94 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 119.923 -0.711 . . . . 1.0 110.929 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.19 129.02 31.42 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.497 1.465 . . . . 1.0 111.65 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.495 ' HB ' HD13 ' A' ' 50' ' ' ILE . 1.7 mt -106.5 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.054 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.521 ' HB3' ' OE2' ' A' ' 134' ' ' GLU . . . -84.18 132.92 46.32 Favored Pre-proline 0 C--O 1.219 -0.541 0 C-N-CA 120.162 -0.615 . . . . 1.0 109.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -45.42 104.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.907 1.738 . . . . 1.0 114.032 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 139.57 0.5 2.05 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 120.254 -0.974 . . . . 1.0 113.382 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -102.71 138.74 39.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.306 0.574 . . . . 1.0 110.145 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.51 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -61.29 130.97 48.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.763 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 11.0 mp -75.6 129.54 37.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.721 -0.791 . . . . 1.0 109.134 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.762 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -141.97 159.4 42.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.817 HG11 ' CE2' ' A' ' 124' ' ' TYR . 2.5 m -128.44 172.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.399 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.626 ' HE1' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.624 0 CA-C-O 121.961 0.886 . . . . 1.0 111.036 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.8 mm . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.41 70.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.79 -38.25 90.34 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.438 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.564 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 N--CA 1.443 -0.792 0 C-N-CA 120.184 -0.607 . . . . 1.0 110.631 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.555 ' C ' HG22 ' A' ' 12' ' ' THR . . . . . . . . 0 CA--C 1.508 -0.644 0 CA-C-O 121.699 0.761 . . . . 1.0 110.379 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER 171.67 -53.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.979 -1.464 . . . . 1.0 109.198 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -126.44 162.1 26.38 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -119.61 161.46 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.614 0.721 . . . . 1.0 111.416 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.16 -39.49 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.614 -178.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.21 -9.4 58.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.391 0.615 . . . . 1.0 110.696 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.798 ' CB ' ' H ' ' A' ' 14' ' ' THR . 17.3 tp10 -89.32 -45.24 9.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.667 HG13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.26 149.88 2.47 Favored Pre-proline 0 C--N 1.342 0.242 0 N-CA-C 105.168 -2.16 . . . . 1.0 105.168 177.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.636 ' HD2' HG23 ' A' ' 18' ' ' VAL . 14.5 Cg_exo -46.77 137.41 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 CA-C-N 120.371 1.168 . . . . 1.0 111.531 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 3.2 tt0 -59.27 -52.01 67.51 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.021 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.516 ' ND1' HG23 ' A' ' 22' ' ' VAL . 6.7 p80 -57.13 -28.89 63.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.991 0.737 . . . . 1.0 112.991 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.763 HG22 ' HA ' ' A' ' 97' ' ' ASN . 23.7 t -79.28 -49.65 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.368 0.531 . . . . 1.0 110.379 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.667 ' CD2' HG13 ' A' ' 18' ' ' VAL . 1.1 pp -72.01 -26.92 62.41 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.364 0.602 . . . . 1.0 111.253 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 10.6 mmm180 -57.87 -25.51 60.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.124 -0.944 . . . . 1.0 112.372 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.25 48.27 0.95 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.878 HD22 HG11 ' A' ' 30' ' ' VAL . 11.7 mt -96.83 131.24 28.33 Favored Pre-proline 0 CA--C 1.511 -0.529 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 29' ' ' GLU . 2.9 Cg_exo -61.86 143.61 95.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 N-CA-C 109.912 -0.842 . . . . 1.0 109.912 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -52.43 -10.04 0.13 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.947 -177.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.908 ' N ' ' HZ2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -84.33 12.14 7.22 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 178.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.878 HG11 HD22 ' A' ' 26' ' ' LEU . 10.8 t -140.1 131.78 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.492 0 N-CA-C 118.227 2.677 . . . . 1.0 118.227 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -134.99 141.37 46.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 110.95 -2.841 . . . . 1.0 103.567 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.755 ' N ' HD22 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -91.28 153.1 20.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 117.759 -1.576 . . . . 1.0 109.856 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 1.3 m-85 -154.53 110.41 2.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HB3' HD13 ' A' ' 42' ' ' ILE . 12.5 Cg_endo -87.89 151.25 7.21 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.104 2.536 . . . . 1.0 112.105 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.436 ' N ' ' HA ' ' A' ' 40' ' ' THR . 2.3 p 55.46 44.11 27.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.19 -43.9 8.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.11 -1.404 . . . . 1.0 107.218 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.578 ' CG2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -104.19 -0.65 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 113.938 -1.483 . . . . 1.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 7.0 t70 96.7 3.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.154 0.909 . . . . 1.0 110.693 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HG2' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.42 -37.27 44.25 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER 84.12 -9.96 0.93 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.741 0.651 . . . . 1.0 112.714 177.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.759 ' H ' ' HG2' ' A' ' 39' ' ' LYS . 18.9 ttm180 -77.59 157.03 30.48 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 176.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 34' ' ' PRO . 5.0 mm -77.66 127.1 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 120.599 1.545 . . . . 1.0 109.482 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.36 -176.35 19.38 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.777 HG23 HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.53 130.04 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 178.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.652 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 52.5 m95 -130.57 151.16 51.34 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -66.05 132.0 47.52 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.684 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -26.07 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.908 ' HZ2' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.58 156.25 41.71 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 177.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' CD ' ' HG2' ' A' ' 48' ' ' LYS . 8.1 Cg_exo -73.97 128.35 12.24 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 CA-C-N 121.975 1.741 . . . . 1.0 112.885 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 48' ' ' LYS . 3.4 mp -99.01 146.47 8.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.77 -1.559 . . . . 1.0 112.821 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.76 151.96 32.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.019 -1.901 . . . . 1.0 110.23 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.622 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.25 125.8 25.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.018 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.29 -0.87 53.98 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.451 -1.059 . . . . 1.0 110.451 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.9 tptt -54.42 152.29 6.72 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.817 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 2.9 ttmt -122.51 108.56 13.3 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.857 0.723 . . . . 1.0 109.738 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' ' CD ' ' A' ' 29' ' ' GLU . 18.9 m-85 -116.93 123.11 46.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.865 -1.531 . . . . 1.0 106.865 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 155.82 -157.15 27.57 Favored Glycine 0 C--N 1.31 -0.911 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 10.5 Cg_endo -86.21 150.37 44.9 Favored 'Cis proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.356 1.578 . . . . 1.0 113.201 0.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.626 ' HA ' HD13 ' A' ' 99' ' ' LEU . 7.2 t80 -64.04 120.35 11.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.404 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -27.05 -65.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.829 -1.532 . . . . 1.0 111.432 178.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.675 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 48.78 107.64 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.572 -0.74 . . . . 1.0 113.162 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -94.4 149.46 21.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 176.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -90.52 114.1 26.22 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.177 -1.009 . . . . 1.0 112.165 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HZ2' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -148.28 171.08 16.54 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.628 -1.169 . . . . 1.0 110.672 -176.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 135.1 37.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.102 0.477 . . . . 1.0 111.48 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 9.7 ptt85 -57.95 -24.15 56.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.275 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 C-N-CA 120.756 -0.377 . . . . 1.0 111.188 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 CA-C-O 121.543 0.687 . . . . 1.0 111.657 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.881 ' NE1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -159.73 163.4 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.91 -1.041 . . . . 1.0 111.962 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 3.6 pt-20 -98.02 122.49 41.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.894 0.854 . . . . 1.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.731 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -126.78 131.01 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 115.219 -0.9 . . . . 1.0 109.194 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -89.79 121.69 32.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.848 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 82' ' ' ASN . 13.7 m-85 -86.48 108.05 16.21 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 114.607 -1.179 . . . . 1.0 110.047 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.29 48.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.206 1.937 . . . . 1.0 109.955 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.652 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -151.85 -84.0 0.08 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.237 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.779 HD12 ' N ' ' A' ' 84' ' ' GLY . 4.1 pp -78.05 -42.33 32.66 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.779 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 151.22 -170.8 30.88 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.563 -1.303 . . . . 1.0 112.356 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.573 ' O ' ' SD ' ' A' ' 86' ' ' MET . 11.8 m95 -70.43 122.5 19.74 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 117.155 0.478 . . . . 1.0 110.322 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.729 ' CG ' HD11 ' A' ' 83' ' ' LEU . 42.1 mmm -126.91 160.2 31.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -113.35 134.2 54.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.563 -1.199 . . . . 1.0 108.144 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.731 HD12 HG21 ' A' ' 78' ' ' VAL . 7.0 mt -107.64 108.52 25.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 118.668 -0.682 . . . . 1.0 111.943 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.66 ' N ' ' HZ2' ' A' ' 64' ' ' LYS . 28.9 t0 -133.78 131.93 39.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.619 1.1 . . . . 1.0 113.521 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -136.22 91.47 2.68 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.579 HG22 ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -114.91 49.63 1.03 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.862 0.839 . . . . 1.0 110.122 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.467 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -144.15 152.26 54.01 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.987 177.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.36 -44.33 4.88 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.282 1.321 . . . . 1.0 112.72 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.48 -45.09 69.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.732 -1.122 . . . . 1.0 113.562 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -11.3 33.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.832 0.349 . . . . 1.0 110.65 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA2' HG21 ' A' ' 60' ' ' VAL . . . -110.68 -158.42 15.97 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.763 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -145.01 -153.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 1.0 110.007 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.61 ' N ' HG13 ' A' ' 22' ' ' VAL . 45.6 p-90 -74.59 -34.89 62.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.855 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.626 HD13 ' HA ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -54.9 -29.22 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.056 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.486 ' NH1' ' C ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -66.27 -15.08 62.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 0.9 OUTLIER -94.86 0.58 54.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.831 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 99' ' ' LEU . 16.8 t -70.46 132.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 119.936 -0.706 . . . . 1.0 110.174 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -79.26 -153.84 0.08 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.209 -0.596 . . . . 1.0 111.878 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.27 159.35 33.34 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.714 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.657 ' HB2' ' HB2' ' A' ' 137' ' ' LEU . . . -139.27 174.73 10.21 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.427 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -47.87 2.87 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.784 ' O ' ' N ' ' A' ' 109' ' ' GLU . 20.3 m -148.9 132.0 16.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.68 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' C ' ' OE1' ' A' ' 111' ' ' GLN . . . -19.52 -4.29 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 118.456 2.142 . . . . 1.0 118.456 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.784 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.5 mt-10 -82.03 -24.43 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 119.236 1.518 . . . . 1.0 113.693 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 111' ' ' GLN . 13.4 pt-20 -124.18 -17.14 6.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.846 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 6.5 mp0 -45.7 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.954 1.408 . . . . 1.0 109.886 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.783 HD21 HD12 ' A' ' 137' ' ' LEU . 0.3 OUTLIER 163.21 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.961 -1.018 . . . . 1.0 111.852 177.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mp -137.92 164.19 29.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.205 -0.998 . . . . 1.0 112.177 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -143.7 130.32 10.34 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 119.013 -1.075 . . . . 1.0 113.566 -178.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.42 131.04 31.1 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.676 2.917 . . . . 1.0 113.625 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.538 HD23 ' HZ1' ' A' ' 125' ' ' LYS . 34.2 tp -141.34 130.66 23.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.127 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 78' ' ' VAL . 6.2 mm-40 -102.83 114.85 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.436 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 123' ' ' TYR . 3.2 pt -139.16 123.76 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.851 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.2 42.41 25.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.354 0.597 . . . . 1.0 110.668 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.594 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 5.2 mmt-85 56.74 32.46 21.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -133.49 144.04 49.18 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.881 HG21 ' NE1' ' A' ' 76' ' ' TRP . 4.1 mm -103.07 116.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.567 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.647 ' CD1' HD11 ' A' ' 118' ' ' ILE . 3.5 m-85 -109.04 158.25 17.91 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.4 m-30 -116.85 132.14 56.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -127.64 146.33 50.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.488 -177.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 112' ' ' ASN . 13.1 p -100.72 111.45 23.68 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.935 0.772 . . . . 1.0 111.483 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.702 HD12 ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.96 -5.58 59.2 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 123.926 0.766 . . . . 1.0 111.88 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.89 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.74 122.62 7.23 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.458 0.572 . . . . 1.0 109.986 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -44.17 138.59 6.76 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.521 1.481 . . . . 1.0 111.21 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.416 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -114.13 134.61 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.96 132.59 60.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.02 -0.672 . . . . 1.0 109.931 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.07 104.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.21 1.273 . . . . 1.0 111.906 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 131.87 2.91 4.19 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.035 -0.602 . . . . 1.0 112.834 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -105.56 115.54 30.42 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.218 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.652 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -47.18 139.73 5.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.889 0.852 . . . . 1.0 111.359 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.684 HD21 ' OE2' ' A' ' 29' ' ' GLU . 8.6 mp -78.34 128.79 34.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.708 -1.133 . . . . 1.0 109.072 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.783 HD12 HD21 ' A' ' 112' ' ' ASN . 0.0 OUTLIER -142.58 161.34 38.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.569 0.699 . . . . 1.0 110.706 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.508 HG11 ' CE2' ' A' ' 124' ' ' TYR . 27.9 m -146.31 177.38 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.885 . . . . 1.0 111.968 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.712 ' HE1' ' CG ' ' A' ' 111' ' ' GLN . 9.2 p-90 . . . . . 0 CA--C 1.509 -0.622 0 C-N-CA 119.806 -0.758 . . . . 1.0 113.034 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 N--CA 1.429 -1.49 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.83 -52.15 33.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.7 77.42 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.817 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.674 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . . . . . . 0 C--O 1.204 -1.329 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.674 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.482 ' O ' ' SD ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.543 -1.423 . . . . 1.0 109.543 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' -1' ' ' GLY . 1.2 p 75.39 -46.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.791 0.329 . . . . 1.0 110.553 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.495 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -101.19 82.21 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.596 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.08 -6.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -52.8 179.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.558 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -104.71 151.06 24.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.501 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -74.08 128.74 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.616 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -57.33 140.13 50.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.95 152.9 80.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.358 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.24 155.39 70.09 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.511 2.141 . . . . 1.0 112.133 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -143.43 158.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.642 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . 67.73 106.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . -129.86 -76.54 0.54 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.112 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.2 m 151.52 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.465 -1.243 . . . . 1.0 107.845 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.38 157.44 17.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.234 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 150.54 43.95 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-O 121.644 0.735 . . . . 1.0 112.587 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -50.12 -35.47 25.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.08 -0.963 . . . . 1.0 110.204 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.29 -9.79 58.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.931 -1.031 . . . . 1.0 111.382 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -31.76 22.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.62 0.97 . . . . 1.0 113.62 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 15' ' ' LEU . 1.5 p -56.15 142.91 65.48 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.875 -1.157 . . . . 1.0 107.875 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 18' ' ' VAL . 35.3 Cg_exo -48.44 122.78 8.23 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.431 1.421 . . . . 1.0 110.677 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.772 ' HA ' HD21 ' A' ' 23' ' ' LEU . 37.7 tt0 -48.35 -25.42 1.58 Allowed 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 113.303 0.853 . . . . 1.0 113.303 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.818 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.2 OUTLIER -78.72 -26.03 44.73 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.164 0.802 . . . . 1.0 113.164 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.756 HG22 ' HA ' ' A' ' 97' ' ' ASN . 6.8 t -76.97 -49.7 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.222 0.453 . . . . 1.0 112.222 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.135 HD23 ' H ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -71.23 -19.58 62.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.711 0.767 . . . . 1.0 109.934 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.83 -27.37 68.83 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 -176.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.33 42.58 1.91 Allowed Glycine 0 N--CA 1.47 0.942 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 27' ' ' PRO . 18.5 mt -76.77 155.47 83.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' O ' ' O ' ' A' ' 26' ' ' LEU . 23.9 Cg_exo -36.25 -112.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 124.537 3.491 . . . . 1.0 113.516 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.92 -57.61 3.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.755 -1.578 . . . . 1.0 107.6 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 12.0 pt-20 -172.89 37.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 31' ' ' ARG . 2.4 t -45.69 171.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 113.412 -1.722 . . . . 1.0 107.785 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.753 ' CB ' HG21 ' A' ' 47' ' ' THR . 0.0 OUTLIER -141.67 154.1 45.12 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.557 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.9 mm? -91.83 134.67 34.55 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 118.894 -1.122 . . . . 1.0 109.874 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.7 m-85 -133.95 144.56 52.15 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.866 ' HA ' ' HA ' ' A' ' 42' ' ' ILE . 3.1 Cg_exo -48.32 142.46 16.85 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 CA-C-N 119.715 0.934 . . . . 1.0 114.031 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.637 ' C ' ' H ' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -61.69 52.43 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-O 123.087 1.423 . . . . 1.0 110.892 -178.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 34' ' ' PRO . . . -56.84 -5.36 0.23 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.017 -1.901 . . . . 1.0 108.272 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -82.55 -50.37 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 113.689 -1.596 . . . . 1.0 111.83 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 40' ' ' THR . 44.8 t0 -156.04 -66.72 0.11 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.536 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 41' ' ' ARG . 8.1 mmpp? -58.72 3.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.22 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER 35.73 14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.635 ' O ' ' N ' ' A' ' 35' ' ' SER . 49.2 mtp85 -107.3 -116.46 0.26 Allowed 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 105.356 -2.09 . . . . 1.0 105.356 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.866 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 9.5 mm -102.19 134.03 44.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 CA-C-N 120.09 1.314 . . . . 1.0 111.318 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.23 159.79 23.19 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.617 HG21 ' CE3' ' A' ' 98' ' ' TRP . 6.4 p -102.84 131.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.234 0.54 . . . . 1.0 111.627 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 13.5 m95 -130.33 154.46 47.62 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.711 1.004 . . . . 1.0 113.711 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.83 131.39 45.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.456 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.753 HG21 ' CB ' ' A' ' 31' ' ' ARG . 76.3 p -124.96 -15.19 6.47 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.769 1.271 . . . . 1.0 108.57 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.689 ' H ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.65 168.89 9.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.843 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.07 152.38 27.86 Favored 'Trans proline' 0 C--N 1.293 -2.356 0 C-N-CA 122.425 2.083 . . . . 1.0 112.415 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.481 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 3.3 mp -134.85 144.28 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.871 -1.059 . . . . 1.0 111.229 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.778 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.4 154.37 30.4 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.925 -1.488 . . . . 1.0 110.828 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.649 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.97 125.76 25.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.8 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.28 0.76 55.78 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 110.211 -1.156 . . . . 1.0 110.211 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -53.25 152.54 4.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 119.382 -0.927 . . . . 1.0 109.218 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.591 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -121.64 107.61 12.59 Favored 'General case' 0 N--CA 1.424 -1.757 0 O-C-N 124.714 1.259 . . . . 1.0 109.198 176.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 10.9 m-30 -119.78 124.46 46.22 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.302 1.048 . . . . 1.0 109.323 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.69 -148.84 20.74 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.223 -1.808 . . . . 1.0 109.753 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 9.5 Cg_endo -80.41 152.57 83.53 Favored 'Cis proline' 0 N--CA 1.49 1.304 0 CA-C-N 119.821 1.811 . . . . 1.0 112.681 0.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 9.2 t80 -65.12 115.89 5.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.513 -1.221 . . . . 1.0 111.733 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.725 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -21.68 -63.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.565 178.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.725 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 51.29 104.82 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.354 -0.839 . . . . 1.0 112.945 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -94.18 144.11 25.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.529 -1.656 . . . . 1.0 106.529 177.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -92.02 114.6 27.18 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 118.949 -1.1 . . . . 1.0 113.025 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -142.99 169.94 16.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.139 -1.391 . . . . 1.0 109.056 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.91 152.98 27.81 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.123 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 4.1 ttm180 -56.31 -24.49 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.756 -0.59 . . . . 1.0 110.706 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 t -38.08 -27.4 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.218 0.532 . . . . 1.0 110.055 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' ARG . 11.2 mt-30 -91.29 -150.35 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.276 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.538 HG22 ' OD2' ' A' ' 89' ' ' ASP . 59.1 t 58.72 153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.061 0 CA-C-O 121.1 0.476 . . . . 1.0 111.431 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' N ' HG12 ' A' ' 69' ' ' VAL . 2.0 pttp -179.16 89.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.089 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 66.56 64.11 0.5 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.024 0.44 . . . . 1.0 109.912 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 23.5 t-20 -137.17 -171.7 3.02 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.36 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.85 HG22 ' CZ2' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -134.3 -48.5 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 118.835 0.743 . . . . 1.0 110.915 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -62.09 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.751 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.71 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -140.31 140.66 35.7 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.98 0.419 . . . . 1.0 111.731 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.889 ' CE2' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -161.18 163.58 31.08 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.454 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -100.62 125.32 47.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.148 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.12 139.06 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.85 -0.613 . . . . 1.0 112.152 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 11.5 t80 -79.46 126.13 30.45 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.573 0.701 . . . . 1.0 111.601 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 82' ' ' ASN . 7.0 m-85 -99.3 131.36 25.25 Favored Pre-proline 0 N--CA 1.439 -0.976 0 CA-C-N 114.523 -1.217 . . . . 1.0 112.032 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.19 13.86 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.01 1.807 . . . . 1.0 109.367 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 80' ' ' TYR . 46.2 m-80 -124.35 -9.78 7.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.681 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.69 -1.16 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.57 -158.89 15.64 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 120.481 -0.866 . . . . 1.0 113.074 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 67.4 m95 -71.34 120.44 16.93 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.0 mmm -125.96 164.68 20.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.328 0.862 . . . . 1.0 113.328 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -111.5 132.81 54.23 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 78' ' ' VAL . 5.5 mt -107.42 109.76 29.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 118.734 -0.651 . . . . 1.0 111.43 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.665 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 21.4 t0 -133.14 130.97 39.92 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.269 0.94 . . . . 1.0 112.818 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -136.09 97.58 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.628 HG22 ' OD1' ' A' ' 89' ' ' ASP . 0.1 OUTLIER -130.78 63.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.734 -0.786 . . . . 1.0 110.756 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.423 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -153.84 159.05 32.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.096 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.49 -38.91 13.49 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.567 1.511 . . . . 1.0 111.234 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -77.08 -42.58 37.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.561 -1.199 . . . . 1.0 113.896 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -9.91 16.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 121.123 -0.231 . . . . 1.0 110.915 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.423 ' CA ' ' O ' ' A' ' 92' ' ' ASP . . . -114.48 123.63 6.11 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.497 -1.041 . . . . 1.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.756 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -71.88 -151.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.163 0.506 . . . . 1.0 110.774 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.635 ' N ' HG13 ' A' ' 22' ' ' VAL . 44.0 p-90 -76.06 -31.16 58.65 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.644 -0.707 . . . . 1.0 111.655 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.642 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -57.0 -27.85 61.91 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.602 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -67.18 -15.44 63.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.573 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -93.92 2.91 56.04 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 99' ' ' LEU . 6.3 t -78.27 128.61 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.213 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.724 HD21 HD23 ' A' ' 137' ' ' LEU . 15.9 p-10 -87.42 -143.75 0.12 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.909 -0.716 . . . . 1.0 111.495 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.85 ' CZ2' HG22 ' A' ' 73' ' ' VAL . 6.6 m-90 -127.05 160.3 31.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.498 0.555 . . . . 1.0 112.498 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.706 ' HB3' ' CD1' ' A' ' 139' ' ' TRP . . . -101.78 -134.62 0.31 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.639 1.348 . . . . 1.0 114.639 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.7 t -154.21 -51.81 0.09 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.706 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.595 ' C ' ' H ' ' A' ' 109' ' ' GLU . 38.9 m -165.26 65.4 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.231 0.826 . . . . 1.0 113.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.09 -12.62 0.01 OUTLIER Glycine 0 CA--C 1.534 1.224 0 N-CA-C 114.324 0.49 . . . . 1.0 114.324 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 107' ' ' SER . 12.6 pt-20 -81.19 -26.59 35.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.494 0.647 . . . . 1.0 111.592 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 137' ' ' LEU . 6.0 pt-20 -122.21 -24.39 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.783 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.922 ' C ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER -53.81 132.34 41.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 177.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.78 ' C ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.68 -21.02 11.45 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.182 -0.607 . . . . 1.0 110.317 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.78 HD22 ' C ' ' A' ' 112' ' ' ASN . 4.2 mm? -125.61 143.49 51.0 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.859 -0.737 . . . . 1.0 110.661 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -128.7 131.32 23.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 119.463 -0.895 . . . . 1.0 112.191 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.11 128.34 22.11 Favored 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 124.058 3.172 . . . . 1.0 115.017 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.747 HD13 HG12 ' A' ' 152' ' ' ILE . 56.5 tp -140.43 132.74 28.29 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.817 -0.552 . . . . 1.0 110.103 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.446 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 6.8 mm-40 -105.58 115.58 30.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.907 -0.717 . . . . 1.0 110.029 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 123' ' ' TYR . 4.8 pt -139.9 129.61 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.066 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 49.4 46.52 23.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.255 0.55 . . . . 1.0 110.489 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.49 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 56.11 32.92 21.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.208 -0.597 . . . . 1.0 109.904 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -137.06 141.73 42.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.321 -0.854 . . . . 1.0 109.006 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.889 HG21 ' CE2' ' A' ' 76' ' ' TRP . 0.8 OUTLIER -102.53 113.0 37.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.079 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.803 ' CD1' HD11 ' A' ' 118' ' ' ILE . 3.1 m-85 -101.04 155.62 17.88 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.874 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 1.4 m-30 -119.02 125.24 48.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.623 -2.362 . . . . 1.0 104.623 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.874 ' HZ2' ' C ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -125.81 155.58 40.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.091 -175.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 53' ' ' GLY . 15.1 p -105.71 117.1 33.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.3 OUTLIER -81.35 -9.43 59.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.844 0.715 . . . . 1.0 109.952 177.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.702 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -150.42 141.48 14.8 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 120.452 -0.499 . . . . 1.0 111.947 -178.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -55.75 140.38 84.56 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.133 1.889 . . . . 1.0 111.733 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -121.52 136.33 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.8 37.88 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.3 105.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.35 2.034 . . . . 1.0 113.048 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 133.53 0.18 4.11 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 109.977 -1.249 . . . . 1.0 109.977 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.14 137.81 35.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.63 -0.785 . . . . 1.0 109.21 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.711 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.2 pm0 -73.02 138.77 46.17 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.903 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.463 ' O ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 mp -79.35 127.01 31.55 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.262 -1.384 . . . . 1.0 107.262 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.724 HD23 HD21 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -141.04 159.07 43.0 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.603 -176.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.735 HG11 ' CE2' ' A' ' 124' ' ' TYR . 26.8 m -143.03 172.5 7.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 113.611 0.967 . . . . 1.0 113.611 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.706 ' CD1' ' HB3' ' A' ' 105' ' ' ALA . 36.3 p-90 171.87 -164.7 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 113.95 -1.477 . . . . 1.0 109.924 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.805 ' CD1' ' ND2' ' A' ' 145' ' ' ASN . 52.8 m-85 108.08 48.23 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 O-C-N 125.419 1.7 . . . . 1.0 108.395 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.559 ' OD1' ' C ' ' A' ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.559 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 3.0 mt-10 -33.74 -89.32 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -108.93 56.55 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.052 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.805 ' ND2' ' CD1' ' A' ' 140' ' ' TYR . 3.9 p30 -68.97 167.27 21.12 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 9.6 Cg_endo -82.02 -11.79 10.99 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.79 1.66 . . . . 1.0 112.244 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.603 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -70.15 -31.49 69.01 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.614 -1.995 . . . . 1.0 105.614 175.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.614 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.4 mm -78.47 -54.23 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 114.117 -1.401 . . . . 1.0 109.864 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.34 -48.97 59.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 146' ' ' PRO . . . -58.42 -48.13 81.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.77 0.655 . . . . 1.0 112.77 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 154' ' ' GLU . . . -73.01 -26.87 61.48 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.272 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HD13 ' A' ' 116' ' ' LEU . 35.3 mt -65.0 -44.39 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.542 ' CG ' HH21 ' A' ' 156' ' ' ARG . 1.7 tt0 -53.48 -53.99 43.46 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.913 -0.715 . . . . 1.0 111.442 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 1.5 pm0 -57.11 -37.16 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.414 -0.914 . . . . 1.0 112.788 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -74.16 -56.62 4.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.554 -0.859 . . . . 1.0 110.835 179.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.542 HH21 ' CG ' ' A' ' 153' ' ' GLU . 3.2 ppt_? -67.82 -43.67 79.05 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.361 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -58.26 -41.58 84.58 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.863 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 160' ' ' ARG . 51.1 m -74.29 -24.13 59.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.417 -0.81 . . . . 1.0 111.03 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.81 8.91 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.612 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 158' ' ' SER . 8.4 mmm180 -124.65 -82.96 0.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.495 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.022 -0.989 . . . . 1.0 110.527 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 t -146.57 -63.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 1.0 110.573 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -178.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.603 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.43 91.1 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.569 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -152.04 -165.04 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.567 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.68 69.7 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.56 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 114.04 4.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.637 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 m -73.44 -67.89 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.57 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 41.02 79.22 0.33 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -87.44 -172.59 0.9 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.208 2.605 . . . . 1.0 112.314 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 10' ' ' ALA . 1.3 m -61.11 -174.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.345 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' N ' HG23 ' A' ' 9' ' ' VAL . . . 48.33 96.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.752 -0.379 . . . . 1.0 110.115 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.8 -62.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -120.4 -41.8 2.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.096 0.474 . . . . 1.0 110.057 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.29 161.49 23.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 1.0 108.811 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.581 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -122.16 155.11 36.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.306 0.574 . . . . 1.0 111.851 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.56 -34.7 18.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.52 -15.88 59.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.604 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.581 ' CB ' ' H ' ' A' ' 14' ' ' THR . 20.8 tp10 -79.16 -41.39 28.58 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.74 HG23 HD22 ' A' ' 23' ' ' LEU . 27.7 m -60.78 154.15 59.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 119.43 -0.908 . . . . 1.0 108.904 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.585 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 24.6 Cg_exo -56.14 130.39 39.95 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 120.982 1.121 . . . . 1.0 109.56 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.535 ' HA ' HD21 ' A' ' 23' ' ' LEU . 24.5 tt0 -50.86 -35.46 32.73 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.585 ' CE1' HG23 ' A' ' 22' ' ' VAL . 19.3 p80 -75.63 -22.68 56.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 97' ' ' ASN . 2.2 t -76.36 -51.81 18.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 CA-C-N 119.966 1.257 . . . . 1.0 112.087 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.979 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.6 pt? -70.9 -24.82 62.54 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.293 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -61.49 -19.56 62.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.509 179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.63 33.64 6.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.875 -0.679 . . . . 1.0 112.338 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.591 HD23 ' CG ' ' A' ' 98' ' ' TRP . 36.3 mt -77.41 154.29 81.76 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 117.68 0.74 . . . . 1.0 110.609 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' A' ' 26' ' ' LEU . 10.7 Cg_exo -34.0 -109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.383 2.722 . . . . 1.0 114.003 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.73 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -74.55 -58.82 3.05 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 118.029 -1.468 . . . . 1.0 108.624 177.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.73 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 5.1 pt-20 -170.24 47.36 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 45' ' ' TRP . 54.2 t -57.95 162.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 114.787 -1.097 . . . . 1.0 108.268 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -134.1 158.25 44.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.247 0.546 . . . . 1.0 110.616 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 32' ' ' LEU . 3.6 mm? -88.44 144.64 26.24 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.4 101.75 3.77 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.083 -0.647 . . . . 1.0 112.436 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' O ' ' CB ' ' A' ' 35' ' ' SER . 63.1 Cg_endo -82.69 150.01 14.45 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.23 2.62 . . . . 1.0 111.613 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 24.2 p 102.72 -60.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.168 0.918 . . . . 1.0 111.882 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.585 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.77 -54.63 21.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.213 -0.995 . . . . 1.0 111.629 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.519 HG13 ' CG ' ' A' ' 38' ' ' ASP . 1.9 p -101.09 -51.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 118.739 0.699 . . . . 1.0 111.434 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -89.39 82.0 6.53 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-O 121.292 0.568 . . . . 1.0 109.591 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -32.38 -32.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.457 -1.247 . . . . 1.0 109.423 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.2 t -143.28 55.38 1.36 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.76 179.1 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.503 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -99.45 128.68 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 120.038 -0.665 . . . . 1.0 111.221 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.36 152.5 17.02 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 109.224 -1.551 . . . . 1.0 109.224 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.739 HG21 ' CE3' ' A' ' 98' ' ' TRP . 13.1 p -105.71 127.24 60.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.754 ' O ' HG13 ' A' ' 30' ' ' VAL . 21.7 m95 -126.59 146.55 50.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.251 -0.886 . . . . 1.0 111.281 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB1' HD11 ' A' ' 50' ' ' ILE . . . -65.57 146.64 54.59 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.51 ' CA ' ' O ' ' A' ' 132' ' ' PRO . 34.6 p -117.76 -15.56 10.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.66 0.663 . . . . 1.0 109.662 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.722 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -119.33 158.42 48.76 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.321 -178.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.505 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 7.8 Cg_endo -62.08 124.52 14.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.377 2.052 . . . . 1.0 110.216 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.748 HD11 ' HB1' ' A' ' 46' ' ' ALA . 3.4 mp -99.5 147.68 7.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.744 0.783 . . . . 1.0 110.282 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.07 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.61 148.03 34.19 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.829 -1.532 . . . . 1.0 109.471 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.07 ' N ' HD22 ' A' ' 51' ' ' LEU . 4.1 ttpt -59.51 126.49 27.83 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.18 4.53 47.42 Favored Glycine 0 N--CA 1.467 0.747 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.668 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 126' ' ' THR . 19.7 ttmt -89.48 139.58 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -106.53 145.7 31.53 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 175.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.62 ' CE2' HG21 ' A' ' 126' ' ' THR . 46.8 m-85 -120.5 124.83 46.35 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.545 -1.207 . . . . 1.0 109.735 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.29 -133.83 4.16 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 113.23 -1.805 . . . . 1.0 110.268 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 123' ' ' TYR . 78.6 Cg_endo -74.64 148.25 91.35 Favored 'Cis proline' 0 N--CA 1.502 1.991 0 CA-C-N 120.027 1.914 . . . . 1.0 113.308 0.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' O ' ' C ' ' A' ' 60' ' ' VAL . 68.5 t80 -56.26 116.75 3.23 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.934 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -16.38 -67.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 124.024 0.827 . . . . 1.0 112.622 178.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.622 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 97.83 62.01 0.9 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.271 -1.132 . . . . 1.0 110.271 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' ASP . 19.7 t0 -88.45 133.55 34.09 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 106.181 -1.785 . . . . 1.0 106.181 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.2 OUTLIER -104.25 113.19 26.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -176.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' CYS . 1.7 ptpt -133.03 166.91 21.3 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.316 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.544 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -76.9 139.36 40.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 176.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.9 ptt180 -46.93 -23.63 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.736 0.303 . . . . 1.0 111.204 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' CG ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -78.48 135.93 37.48 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.452 -0.499 . . . . 1.0 110.109 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.531 ' OE1' ' NZ ' ' A' ' 65' ' ' LYS . 2.6 pt20 103.2 -8.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.369 1.043 . . . . 1.0 111.943 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -117.79 117.56 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 121.031 0.444 . . . . 1.0 110.46 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -110.22 -131.22 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.14 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.4 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . 0.2 OUTLIER 53.68 -135.54 1.47 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.002 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.454 ' O ' ' CE ' ' A' ' 75' ' ' MET . 7.8 m120 -128.04 -78.14 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.84 0.681 . . . . 1.0 112.84 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.422 HG22 ' CH2' ' A' ' 76' ' ' TRP . 0.3 OUTLIER -78.09 2.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.441 -0.504 . . . . 1.0 112.237 -177.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' O ' ' O ' ' A' ' 90' ' ' ALA . 2.5 m-85 -48.66 -53.48 18.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.135 0.791 . . . . 1.0 113.135 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.505 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -122.77 162.57 21.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 -174.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.705 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -138.99 144.6 38.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.35 -1.75 . . . . 1.0 109.786 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.75 123.03 47.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.076 -0.65 . . . . 1.0 111.717 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -143.18 133.8 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.79 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 2.3 t80 -89.8 126.38 35.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ASN . 6.8 m-85 -92.31 105.7 15.15 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 113.516 -1.675 . . . . 1.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.77 -14.24 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.009 1.806 . . . . 1.0 109.604 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' TYR . 71.2 m-80 -81.72 -99.12 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.138 -1.392 . . . . 1.0 110.361 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -66.43 -41.93 88.47 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.374 1.25 . . . . 1.0 114.374 -176.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.1 23.99 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 120.03 -1.081 . . . . 1.0 110.485 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.429 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 14.5 m95 -54.27 120.62 6.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.779 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 78' ' ' VAL . 51.4 tpp -129.37 160.92 31.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.399 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -117.85 145.42 44.6 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.934 0.873 . . . . 1.0 109.656 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.484 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 52.1 mt -93.09 159.1 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 CA-C-N 113.892 -1.504 . . . . 1.0 108.492 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.688 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -128.99 123.99 33.85 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.425 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.656 ' C ' HG22 ' A' ' 91' ' ' THR . . . -133.54 136.36 44.95 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 105.251 -2.129 . . . . 1.0 105.251 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.656 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 166.52 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 120.573 1.533 . . . . 1.0 111.112 179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.579 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -126.23 148.89 65.25 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.454 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.6 ' HB2' HG21 ' A' ' 22' ' ' VAL . 62.8 Cg_endo -66.11 -34.68 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.757 2.305 . . . . 1.0 111.849 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -71.91 -10.23 59.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.223 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.801 ' CB ' HH12 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.88 -16.01 35.14 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.695 ' N ' ' NH1' ' A' ' 100' ' ' ARG . . . -173.81 -92.49 0.08 OUTLIER Glycine 0 C--N 1.348 1.201 0 C-N-CA 120.136 -1.031 . . . . 1.0 114.05 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.739 ' HA ' HG22 ' A' ' 22' ' ' VAL . 5.2 p30 -146.58 -149.34 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.48 0.657 . . . . 1.0 110.892 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.739 ' CE3' HG21 ' A' ' 44' ' ' VAL . 35.2 p-90 -80.39 -24.5 39.68 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 115.163 1.542 . . . . 1.0 115.163 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.615 HD23 ' CE2' ' A' ' 124' ' ' TYR . 3.0 mp -53.5 -27.59 26.23 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.592 -0.843 . . . . 1.0 111.181 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.801 HH12 ' CB ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.65 -30.33 52.07 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 177.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.503 ' CE1' ' CG2' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -64.58 -17.57 64.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.427 HG22 HG11 ' A' ' 44' ' ' VAL . 98.1 t -63.16 117.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.041 -0.982 . . . . 1.0 110.786 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.579 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 14.5 m-20 -77.5 138.69 39.36 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 105.883 -1.895 . . . . 1.0 105.883 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.604 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 16.2 p90 -94.68 122.56 37.41 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.825 0.822 . . . . 1.0 111.955 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 26.96 89.55 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.04 -1.436 . . . . 1.0 114.77 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 105' ' ' ALA . 52.5 t -29.54 -35.18 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER 174.01 11.29 0.0 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-N 114.721 -1.127 . . . . 1.0 111.03 174.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.58 19.69 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.83 -42.18 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.035 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -118.32 -33.11 4.46 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.038 1.125 . . . . 1.0 114.038 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 110' ' ' GLU . 4.9 mt-30 16.18 101.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.472 0.545 . . . . 1.0 112.472 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.794 HD22 HD13 ' A' ' 130' ' ' ILE . 18.0 p-10 -128.12 37.5 4.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.812 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 1.4 tp -153.32 173.63 15.36 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.152 -0.619 . . . . 1.0 110.698 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.735 ' CE2' ' HB3' ' A' ' 151' ' ' ALA . 9.3 t80 -132.23 147.67 66.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 119.553 -0.26 . . . . 1.0 111.638 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.495 ' N ' ' CD1' ' A' ' 114' ' ' PHE . 23.2 Cg_endo -100.04 96.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.502 2.134 . . . . 1.0 113.483 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 123' ' ' TYR . 8.1 tp -117.41 135.93 53.54 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -109.24 117.19 33.45 Favored 'General case' 0 C--N 1.342 0.279 0 O-C-N 123.977 0.798 . . . . 1.0 111.128 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.954 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.8 OUTLIER -137.43 136.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.087 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 49.73 38.41 15.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.432 0.634 . . . . 1.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 63.4 13.3 6.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.019 179.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -110.0 154.89 22.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.082 -1.417 . . . . 1.0 107.86 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' PHE . 31.5 mm -109.8 115.2 49.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 121.802 0.81 . . . . 1.0 111.888 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.954 ' CG ' HD11 ' A' ' 118' ' ' ILE . 3.6 m-85 -100.44 141.08 33.79 Favored 'General case' 0 CA--C 1.481 -1.694 0 O-C-N 121.234 -0.916 . . . . 1.0 109.27 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.615 ' CE2' HD23 ' A' ' 99' ' ' LEU . 18.3 m-30 -102.73 117.25 34.23 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.29 -2.115 . . . . 1.0 105.29 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -104.37 135.44 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 124.687 1.242 . . . . 1.0 110.636 -176.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.62 HG21 ' CE2' ' A' ' 56' ' ' PHE . 33.0 p -106.4 112.98 26.23 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.131 0.491 . . . . 1.0 110.696 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.825 HD13 ' HB3' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -76.64 -6.11 50.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.546 -1.206 . . . . 1.0 111.996 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.59 ' HZ2' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -143.2 158.29 58.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.097 -0.641 . . . . 1.0 112.598 -175.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -72.25 145.3 43.38 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 N-CA-C 104.722 -2.838 . . . . 1.0 104.722 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.796 HG23 ' OE2' ' A' ' 134' ' ' GLU . 59.7 mt -123.5 142.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 112.245 0.461 . . . . 1.0 112.245 -174.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.56 128.49 88.37 Favored Pre-proline 0 C--N 1.34 0.193 0 C-N-CA 120.178 -0.609 . . . . 1.0 109.798 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.5 Cg_exo -35.1 -27.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.655 2.236 . . . . 1.0 116.684 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.71 ' HA2' ' O ' ' A' ' 46' ' ' ALA . . . -125.6 37.04 2.61 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 120.308 1.413 . . . . 1.0 110.511 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.796 ' OE2' HG23 ' A' ' 130' ' ' ILE . 4.6 tt0 -95.23 162.38 13.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.907 0.385 . . . . 1.0 111.371 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.492 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 1.6 pm0 -80.85 140.3 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.358 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.535 ' HA ' HD21 ' A' ' 112' ' ' ASN . 4.9 mt -95.17 121.77 37.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.603 ' O ' ' CB ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -128.01 153.13 47.11 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.634 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 15.7 t -124.12 159.61 29.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.257 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.684 ' CG ' ' N ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER 59.37 -176.22 0.09 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.16 1.911 . . . . 1.0 116.16 175.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.684 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 71.3 t80 -153.1 -174.9 5.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.016 -1.447 . . . . 1.0 109.904 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.637 ' N ' ' CD2' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.329 0 N-CA-C 111.647 -0.581 . . . . 1.0 111.647 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.512 ' N ' ' HB3' ' A' ' 140' ' ' TYR . 2.1 pt-20 -171.39 -98.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.179 -0.609 . . . . 1.0 112.226 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.421 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 2.2 t70 72.52 -36.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.165 0.802 . . . . 1.0 113.165 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.753 ' ND2' HD12 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -73.59 147.81 87.31 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 119.721 -0.792 . . . . 1.0 110.098 -179.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.517 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 0.3 OUTLIER -34.05 -89.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.229 2.62 . . . . 1.0 116.527 -178.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.825 ' HB3' HD13 ' A' ' 127' ' ' LEU . 9.8 tp10 -55.52 -48.21 75.03 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 149' ' ' ALA . 0.1 OUTLIER -46.31 -53.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.471 -1.24 . . . . 1.0 110.855 -175.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -65.06 -46.84 79.56 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 116.457 -2.097 . . . . 1.0 108.244 177.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.04 -56.15 25.8 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 115.46 1.652 . . . . 1.0 115.46 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB3' ' CE2' ' A' ' 114' ' ' PHE . . . -73.1 -37.37 66.74 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.603 1.547 . . . . 1.0 111.596 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.567 HG22 ' HG2' ' A' ' 156' ' ' ARG . 84.3 mt -55.46 -44.01 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 157' ' ' ALA . 1.2 tt0 -59.87 -55.47 33.71 Favored 'General case' 0 C--O 1.205 -1.244 0 O-C-N 123.51 0.506 . . . . 1.0 111.917 -177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' A' ' 154' ' ' GLU . 10.7 pt-20 -64.01 -38.67 91.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 118.067 0.394 . . . . 1.0 111.629 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -73.1 -48.62 34.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.401 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.567 ' HG2' HG22 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -76.54 -28.73 56.43 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.309 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 153' ' ' GLU . . . -52.5 -50.6 62.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.532 -0.867 . . . . 1.0 108.911 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.39 -23.82 4.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.9 19.21 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.653 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -120.31 60.03 0.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.17 -5.15 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.328 . . . . 1.0 110.559 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' H ' ' C ' ' A' ' -1' ' ' GLY . 0.3 OUTLIER -75.35 149.56 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.54 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -93.89 117.95 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.58 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 4' ' ' ASN . 9.9 tt0 -87.3 -23.99 24.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.562 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 3' ' ' GLN . 0.2 OUTLIER 58.64 115.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.572 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 78.9 p -129.92 -168.87 2.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.495 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 m -94.59 125.22 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.536 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -121.24 157.44 55.77 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.47 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.44 141.16 38.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.533 2.155 . . . . 1.0 112.179 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 9' ' ' VAL . 23.0 m -91.51 47.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . -43.17 167.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.757 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.64 -66.87 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.162 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -117.37 -55.82 2.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -104.69 153.94 20.62 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 17' ' ' GLU . 4.3 m -121.74 156.36 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 1.0 111.676 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -49.19 -32.8 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.61 58.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.777 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' THR . 27.6 tp10 -82.2 -40.41 21.75 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.741 HG23 HD22 ' A' ' 23' ' ' LEU . 28.7 m -59.63 159.39 18.23 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.465 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.556 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.9 Cg_exo -66.8 133.12 30.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.128 1.219 . . . . 1.0 109.961 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.551 ' HA ' HD21 ' A' ' 23' ' ' LEU . 18.6 tt0 -49.46 -38.01 28.13 Favored 'General case' 0 CA--C 1.496 -1.133 0 O-C-N 123.749 0.656 . . . . 1.0 112.125 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 22' ' ' VAL . 4.4 p-80 -74.19 -23.25 59.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.457 ' N ' ' CD2' ' A' ' 21' ' ' HIS . 1.5 t -75.89 -50.37 23.29 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 CA-C-N 119.805 1.184 . . . . 1.0 111.629 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.013 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.9 pt? -73.0 -26.02 61.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.648 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.95 -21.04 42.26 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.57 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.28 39.88 2.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.846 -0.692 . . . . 1.0 111.597 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.581 ' O ' ' O ' ' A' ' 27' ' ' PRO . 25.8 mt -85.17 153.52 59.65 Favored Pre-proline 0 N--CA 1.445 -0.702 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.229 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -34.6 -117.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 124.085 3.19 . . . . 1.0 114.166 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.694 ' HG2' ' HZ3' ' A' ' 48' ' ' LYS . 2.2 pp20? -72.98 -54.91 7.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 116.691 -2.004 . . . . 1.0 106.543 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 5.5 tt0 -174.64 57.75 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.275 1.036 . . . . 1.0 108.441 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 45' ' ' TRP . 2.7 t -67.85 173.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.913 -1.04 . . . . 1.0 108.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.548 HH12 ' CG ' ' A' ' 29' ' ' GLU . 17.3 mtt85 -141.03 158.62 43.67 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.249 0.547 . . . . 1.0 110.013 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 32' ' ' LEU . 3.3 mm? -87.53 147.43 25.35 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.92 101.74 3.65 Favored Pre-proline 0 C--N 1.314 -0.953 0 C-N-CA 119.672 -0.811 . . . . 1.0 112.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 44.5 Cg_endo -83.69 149.71 12.75 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 123.272 2.648 . . . . 1.0 111.95 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 4.2 t 99.75 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 124.183 0.927 . . . . 1.0 111.927 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.33 -53.65 27.27 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.921 -175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 ' H ' ' A' ' 38' ' ' ASP . 2.4 p -102.07 -52.89 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 120.281 -0.567 . . . . 1.0 112.189 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -90.62 82.5 5.8 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 38' ' ' ASP . 7.7 mmpt? -28.28 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.343 -1.299 . . . . 1.0 110.07 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.597 ' N ' ' O ' ' A' ' 38' ' ' ASP . 16.4 p -143.22 54.09 1.36 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.2 168.21 8.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CG2' ' CE1' ' A' ' 101' ' ' TYR . 0.5 OUTLIER -92.27 131.24 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.824 -179.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.91 144.92 17.12 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.868 -1.693 . . . . 1.0 108.868 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.622 HG21 ' CE3' ' A' ' 98' ' ' TRP . 12.1 p -97.48 134.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.709 ' O ' HG13 ' A' ' 30' ' ' VAL . 10.6 m95 -129.04 147.65 50.92 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.146 -0.934 . . . . 1.0 110.83 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.973 ' HB3' ' CD ' ' A' ' 134' ' ' GLU . . . -73.32 123.71 24.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.13 -1.028 . . . . 1.0 110.344 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.0 p -93.41 -15.42 25.66 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.687 0.756 . . . . 1.0 110.947 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.694 ' HZ3' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -107.49 170.72 5.3 Favored Pre-proline 0 C--N 1.308 -1.235 0 CA-C-N 114.247 -1.342 . . . . 1.0 111.133 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 4.2 Cg_endo -81.68 131.88 7.46 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.232 1.955 . . . . 1.0 108.145 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 46' ' ' ALA . 4.3 mp -109.62 129.31 64.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 122.429 1.109 . . . . 1.0 111.908 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.053 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -90.83 147.96 22.83 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.515 -2.13 . . . . 1.0 107.755 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.053 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -59.65 123.72 17.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.38 2.48 47.57 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 119.626 -1.273 . . . . 1.0 113.253 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 126' ' ' THR . 9.7 ttmt -78.7 139.06 38.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 119.455 -0.898 . . . . 1.0 109.729 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.52 140.61 45.98 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 119.359 -0.936 . . . . 1.0 109.563 178.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.647 ' CE2' HG21 ' A' ' 126' ' ' THR . 37.2 m-85 -116.09 123.33 47.64 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.174 -1.83 . . . . 1.0 106.753 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . -176.53 -164.33 30.36 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 113.778 -1.556 . . . . 1.0 110.201 -176.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' CB ' ' CE1' ' A' ' 123' ' ' TYR . 56.4 Cg_endo -98.22 137.66 3.4 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 CA-C-N 118.699 1.249 . . . . 1.0 111.638 -1.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 39.2 t80 -56.8 114.11 1.94 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.121 -0.696 . . . . 1.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.736 HG13 ' N ' ' A' ' 61' ' ' GLY . 9.7 p -44.69 -48.39 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.928 0.394 . . . . 1.0 111.109 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.736 ' N ' HG13 ' A' ' 60' ' ' VAL . . . 67.12 114.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 115.374 0.91 . . . . 1.0 115.374 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -99.75 134.43 42.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 175.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -92.2 112.11 23.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.162 1.171 . . . . 1.0 114.162 -176.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -145.07 166.31 25.74 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.983 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.586 ' HZ3' ' HB2' ' A' ' 65' ' ' LYS . 2.7 mtmp? -76.86 133.82 39.21 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.606 0.717 . . . . 1.0 112.266 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.725 ' O ' ' N ' ' A' ' 68' ' ' GLN . 10.2 ttt180 -57.47 -21.37 36.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.846 -0.615 . . . . 1.0 112.643 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.2 t -52.89 55.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.725 ' N ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER 161.62 -126.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER 16.84 77.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.224 0.61 . . . . 1.0 111.969 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' VAL . 8.0 mttt 26.66 -137.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.446 -0.797 . . . . 1.0 112.599 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -162.69 28.03 0.1 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.535 ' HB2' ' HE1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -123.11 -76.64 0.59 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.855 178.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.473 ' HB ' ' CE2' ' A' ' 104' ' ' TRP . 1.1 t -118.25 -30.95 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CE1' ' CZ2' ' A' ' 104' ' ' TRP . 40.4 m-85 -39.92 -31.81 0.13 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.554 0.692 . . . . 1.0 111.312 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.533 ' HE3' ' H ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -147.77 166.23 28.15 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.886 -176.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.824 ' CE3' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -141.43 134.67 29.43 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.038 -1.437 . . . . 1.0 110.108 -177.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 86' ' ' MET . 8.7 tp10 -97.75 122.64 41.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.355 0.597 . . . . 1.0 111.099 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' MET . 2.8 t -142.44 132.25 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.942 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -87.22 123.92 32.75 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.417 -0.913 . . . . 1.0 111.833 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.681 ' C ' ' H ' ' A' ' 82' ' ' ASN . 3.0 m-85 -76.3 113.72 31.13 Favored Pre-proline 0 N--CA 1.445 -0.693 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.12 29.62 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.172 1.914 . . . . 1.0 110.566 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.681 ' H ' ' C ' ' A' ' 80' ' ' TYR . 62.0 m-80 -135.1 -90.7 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.294 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 pp -70.0 -41.77 73.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 146.85 -174.99 26.48 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 119.743 -1.218 . . . . 1.0 110.614 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 11.9 m95 -55.11 121.14 8.12 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.823 -0.81 . . . . 1.0 112.177 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.506 ' O ' ' O ' ' A' ' 78' ' ' VAL . 33.7 tpp -128.63 160.72 31.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.289 0.477 . . . . 1.0 112.289 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -125.08 147.53 48.95 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.729 0.776 . . . . 1.0 109.199 175.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 120' ' ' ARG . 6.3 mt -99.61 155.93 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 114.513 -1.221 . . . . 1.0 107.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.63 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -123.48 136.65 54.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.243 0.928 . . . . 1.0 113.155 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . . . -134.95 136.22 42.09 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.771 ' H ' ' CG ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 169.88 -37.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.674 1.125 . . . . 1.0 111.401 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.981 ' H ' ' HE ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -120.76 146.31 43.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.787 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.475 ' HB3' ' CE2' ' A' ' 101' ' ' TYR . 59.0 Cg_endo -68.53 -36.79 14.23 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 123.246 2.631 . . . . 1.0 112.6 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -56.94 -10.68 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -89.54 -11.12 43.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' O ' ' OD1' ' A' ' 97' ' ' ASN . . . 96.56 160.84 32.25 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.484 -0.78 . . . . 1.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.883 HD21 ' N ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER 65.59 128.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 179.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.622 ' CE3' HG21 ' A' ' 44' ' ' VAL . 47.0 p-90 -73.83 -21.31 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.133 -1.394 . . . . 1.0 109.63 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.794 ' N ' HD22 ' A' ' 97' ' ' ASN . 1.2 mp -50.12 -26.98 5.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.738 -1.208 . . . . 1.0 107.738 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.981 ' HE ' ' H ' ' A' ' 92' ' ' ASP . 6.5 ttt180 -74.68 -36.9 62.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.481 -1.69 . . . . 1.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.4 OUTLIER -68.05 -16.13 63.9 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.462 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.733 HG11 HG23 ' A' ' 138' ' ' VAL . 43.1 t -63.49 124.31 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.882 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.42 -174.69 5.41 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.55 -0.86 . . . . 1.0 109.06 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.535 ' HE1' ' HB2' ' A' ' 72' ' ' ASN . 1.2 m-90 -94.79 154.62 17.19 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.39 0.614 . . . . 1.0 112.03 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.842 ' HB2' ' O ' ' A' ' 139' ' ' TRP . . . -31.34 -72.19 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.039 175.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 105' ' ' ALA . 51.7 t 120.18 -33.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.248 -2.13 . . . . 1.0 105.248 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 107' ' ' SER . 2.6 t 178.32 29.16 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.33 -1.305 . . . . 1.0 111.934 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.756 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . 67.11 -10.81 0.77 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.132 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 107' ' ' SER . 10.3 mm-40 -74.32 -23.26 59.03 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.636 ' O ' ' O ' ' A' ' 111' ' ' GLN . 6.6 pt-20 -119.12 -0.32 11.1 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.636 ' O ' ' O ' ' A' ' 110' ' ' GLU . 0.3 OUTLIER -43.64 -150.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 -179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.706 ' C ' HD12 ' A' ' 113' ' ' LEU . 12.5 p30 144.03 27.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.271 -1.331 . . . . 1.0 112.293 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 112' ' ' ASN . 7.3 mp -149.13 174.63 12.13 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.945 -0.472 . . . . 1.0 109.813 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CD2' ' OE2' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -141.44 122.48 8.81 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.105 -0.638 . . . . 1.0 112.252 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.03 80.47 0.15 Allowed 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 121.456 1.438 . . . . 1.0 114.546 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.544 HD23 ' CD1' ' A' ' 118' ' ' ILE . 12.7 tp -90.23 133.66 34.78 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.245 -0.284 . . . . 1.0 110.731 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 122' ' ' ILE . 3.8 tm-20 -108.68 120.39 42.34 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.799 0.687 . . . . 1.0 111.898 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.661 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -136.5 135.04 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.166 -0.924 . . . . 1.0 111.634 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' ILE . 2.6 m-80 35.24 57.28 0.82 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.642 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 8.2 mtp180 57.88 21.13 7.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.3 0.572 . . . . 1.0 111.664 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -125.0 149.81 47.35 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.824 HG21 ' CE3' ' A' ' 76' ' ' TRP . 41.4 mm -118.93 100.84 10.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.068 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.661 ' CG ' HD11 ' A' ' 118' ' ' ILE . 8.3 m-30 -97.33 158.9 15.23 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 121.762 0.791 . . . . 1.0 110.849 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.693 ' HB3' HD23 ' A' ' 113' ' ' LEU . 13.7 m-30 -106.28 129.11 54.37 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.933 -1.485 . . . . 1.0 108.668 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -117.53 136.62 53.12 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 113.407 -1.724 . . . . 1.0 109.026 -177.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.647 HG21 ' CE2' ' A' ' 56' ' ' PHE . 29.8 p -104.18 106.37 16.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.362 -0.935 . . . . 1.0 110.629 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.781 HD13 ' HB3' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -73.57 -7.98 54.1 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 112.829 -1.987 . . . . 1.0 111.449 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.632 ' HE2' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -133.63 148.74 69.82 Favored Pre-proline 0 C--N 1.345 0.396 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.803 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -74.15 140.97 28.72 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 105.983 -2.353 . . . . 1.0 105.983 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.422 HG22 ' HG3' ' A' ' 134' ' ' GLU . 0.4 OUTLIER -127.76 138.55 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 118.852 0.751 . . . . 1.0 112.255 -175.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.573 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -75.35 134.54 73.41 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.31 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.53 ' HA ' ' OE2' ' A' ' 134' ' ' GLU . 46.2 Cg_exo -54.41 116.43 3.07 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 122.155 1.904 . . . . 1.0 113.02 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . 121.61 4.21 9.84 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 1.052 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -83.02 147.97 27.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.498 -1.351 . . . . 1.0 114.5 -178.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.655 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 2.0 pm0 -75.5 108.09 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.823 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 137' ' ' LEU . 21.7 mt -71.73 114.87 10.28 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 136' ' ' LEU . 2.2 mp -135.11 160.8 37.2 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.733 HG23 HG11 ' A' ' 102' ' ' VAL . 26.3 t -118.29 152.52 20.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 O-C-N 123.69 0.618 . . . . 1.0 111.984 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.842 ' O ' ' HB2' ' A' ' 105' ' ' ALA . 0.0 OUTLIER 69.52 137.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.959 1.412 . . . . 1.0 113.059 176.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.562 ' CE1' ' O ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER -87.02 171.49 10.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.775 -1.102 . . . . 1.0 112.16 -178.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.49 ' C ' ' O ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.248 -1.541 . . . . 1.0 109.248 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.87 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 64.7 mt-10 61.71 37.11 16.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.235 -0.982 . . . . 1.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.65 -2.53 54.27 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.407 0.521 . . . . 1.0 112.407 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.55 ' ND2' HD12 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -68.03 151.71 96.99 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.513 -1.291 . . . . 1.0 107.513 179.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.531 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 8.1 Cg_exo -41.32 -85.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 121.851 1.701 . . . . 1.0 116.442 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.781 ' HB3' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -57.03 -45.82 82.83 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 121.685 0.755 . . . . 1.0 109.049 -177.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.5 OUTLIER -47.49 -50.43 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.688 -175.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.87 ' HB2' ' O ' ' A' ' 143' ' ' GLU . . . -68.45 -49.12 62.22 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.253 -1.379 . . . . 1.0 107.824 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.3 -57.29 13.54 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.028 -1.896 . . . . 1.0 114.34 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -68.17 -36.29 79.38 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 120.189 1.359 . . . . 1.0 110.827 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.606 HD13 ' CD ' ' A' ' 143' ' ' GLU . 32.2 mt -52.78 -41.92 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 107.159 -1.423 . . . . 1.0 107.159 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.766 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 1.2 mt-10 -61.82 -52.5 63.92 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.077 -0.965 . . . . 1.0 109.955 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -58.67 -50.4 74.0 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 120.848 0.356 . . . . 1.0 110.684 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.7 OUTLIER -70.97 -50.66 31.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.121 -0.491 . . . . 1.0 112.033 -179.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -78.72 -53.25 7.34 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.086 -1.046 . . . . 1.0 110.563 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -70.38 -50.27 40.54 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.936 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 154' ' ' GLU . 0.1 OUTLIER 31.84 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.841 0.713 . . . . 1.0 111.409 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.604 ' N ' ' O ' ' A' ' 157' ' ' ALA . . . -100.65 -120.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.595 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.545 ' N ' ' CD ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER 31.29 -93.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.231 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 159' ' ' ALA . 1.8 m . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.536 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.57 -1.412 . . . . 1.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.3 t -162.49 -167.12 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 1.0 110.568 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mtm -99.8 54.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.563 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -140.41 112.86 7.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.579 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.15 -41.84 10.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.533 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t30 54.37 -161.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -160.81 48.48 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.497 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.4 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 19.8 m -148.93 -64.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 6' ' ' THR . 2.6 mp0 47.75 86.27 0.15 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.798 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.85 178.41 3.22 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.955 2.436 . . . . 1.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ALA . 33.1 m -53.63 171.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . . . 50.6 104.7 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.436 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.631 ' H ' ' CG ' ' A' ' 34' ' ' PRO . . . -68.35 -43.91 76.43 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.678 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -177.57 -25.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.855 -0.612 . . . . 1.0 111.6 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -72.37 0.36 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 119.195 -1.002 . . . . 1.0 113.271 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.498 ' OG1' ' CG ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -142.01 -179.69 6.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.253 -1.794 . . . . 1.0 110.102 174.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 15' ' ' LEU . 2.4 tt -73.66 -62.79 1.37 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 172.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 42' ' ' ILE . . . -89.64 -58.45 2.52 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.749 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 1.1 tm-20 89.57 -155.08 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.098 -2.186 . . . . 1.0 105.098 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.749 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER 51.34 152.39 0.04 OUTLIER Pre-proline 0 C--N 1.268 -2.947 0 O-C-N 125.766 1.916 . . . . 1.0 111.021 -178.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.54 140.16 12.35 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.895 2.396 . . . . 1.0 111.477 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -50.5 -53.05 32.93 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.18 -0.918 . . . . 1.0 111.156 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -60.83 -22.55 64.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 97' ' ' ASN . 2.2 t -79.28 -49.13 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.329 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 1.0 111.769 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.436 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -63.42 -16.89 61.88 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -97.68 28.17 15.55 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.577 -0.821 . . . . 1.0 112.012 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.628 ' O ' ' O ' ' A' ' 27' ' ' PRO . 39.8 mt -76.96 156.03 82.53 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 112.364 0.505 . . . . 1.0 112.364 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -32.93 -123.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 125.087 3.858 . . . . 1.0 114.033 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' CD ' ' N ' ' A' ' 29' ' ' GLU . 2.2 pp20? -72.76 -51.43 19.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.425 -1.694 . . . . 1.0 106.425 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 tt0 -175.69 60.72 0.02 OUTLIER 'General case' 0 C--N 1.358 0.945 0 CA-C-O 121.638 0.733 . . . . 1.0 109.507 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 45' ' ' TRP . 3.4 t -74.15 176.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' N ' ' CG1' ' A' ' 30' ' ' VAL . 8.5 mtt180 -141.91 162.33 35.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.437 0.637 . . . . 1.0 110.881 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -96.81 121.84 39.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -119.76 109.53 37.82 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.87 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.631 ' CG ' ' H ' ' A' ' 11' ' ' ALA . 11.7 Cg_endo -84.5 150.32 11.66 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.529 2.819 . . . . 1.0 114.714 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 9.3 p 95.03 -50.87 0.01 OUTLIER 'General case' 0 C--N 1.344 0.333 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.721 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -48.08 -54.74 12.15 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.631 -0.713 . . . . 1.0 112.704 -174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.571 HG22 ' H ' ' A' ' 39' ' ' LYS . 2.5 p -90.74 -40.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.76 1.164 . . . . 1.0 110.824 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' N ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 67.43 9.94 7.38 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 178.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' H ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.79 -27.84 0.37 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 177.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.477 ' N ' ' C ' ' A' ' 38' ' ' ASP . 8.7 m -170.27 -58.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.584 -1.189 . . . . 1.0 111.451 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.37 -96.74 0.09 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 16' ' ' ALA . 2.9 tt -98.34 140.9 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 113.795 1.035 . . . . 1.0 113.795 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -120.17 165.23 13.66 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.37 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.758 HG21 ' CE3' ' A' ' 98' ' ' TRP . 12.6 p -103.31 123.74 57.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.212 0.529 . . . . 1.0 110.313 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 20.9 m95 -127.9 149.04 50.48 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-N 115.116 -0.947 . . . . 1.0 112.231 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.757 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -63.37 126.04 26.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.644 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -102.21 -22.22 14.22 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.504 1.145 . . . . 1.0 108.136 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HZ1' ' HZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -105.74 172.49 3.94 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.231 -2.259 . . . . 1.0 112.458 -175.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -87.74 125.53 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.897 2.398 . . . . 1.0 109.525 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.686 HD13 ' HB ' ' A' ' 130' ' ' ILE . 3.6 mp -98.84 145.94 9.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.481 0.657 . . . . 1.0 110.383 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.064 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -111.14 148.01 33.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.181 -1.372 . . . . 1.0 108.561 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.064 ' N ' HD22 ' A' ' 51' ' ' LEU . 5.0 ttpt -60.05 126.55 27.97 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.136 0.421 . . . . 1.0 112.136 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 103.16 4.9 47.29 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 119.32 -1.419 . . . . 1.0 114.133 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 126' ' ' THR . 2.3 ttmt -89.16 142.47 27.62 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.45 -0.9 . . . . 1.0 113.289 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -103.81 138.01 41.02 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.876 -0.787 . . . . 1.0 108.876 175.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 126' ' ' THR . 36.2 m-85 -119.47 125.34 48.67 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 122.787 1.28 . . . . 1.0 111.443 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.443 ' CA ' HD11 ' A' ' 99' ' ' LEU . . . 127.09 -110.98 1.28 Allowed Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 111.905 -2.407 . . . . 1.0 109.182 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HB3' ' CE1' ' A' ' 123' ' ' TYR . 83.6 Cg_endo -72.95 177.22 37.53 Favored 'Cis proline' 0 N--CA 1.503 2.08 0 CA-C-N 119.76 1.78 . . . . 1.0 112.107 -0.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.915 ' CZ ' ' HB2' ' A' ' 90' ' ' ALA . 19.4 t80 -68.61 112.2 5.24 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.716 0.77 . . . . 1.0 111.234 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.672 HG13 ' H ' ' A' ' 61' ' ' GLY . 1.3 p -33.18 -54.84 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.934 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.672 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 75.64 108.97 0.11 Allowed Glycine 0 C--N 1.334 0.42 0 CA-C-O 121.389 0.438 . . . . 1.0 113.933 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -99.54 131.09 45.77 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.422 -2.066 . . . . 1.0 105.422 175.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.549 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -93.47 112.85 24.85 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.86 1.43 . . . . 1.0 114.86 -175.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -148.34 166.34 28.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.3 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.752 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 1.4 mtmp? -77.26 135.44 38.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.227 0.537 . . . . 1.0 111.531 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -57.62 -23.37 50.75 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.657 0.614 . . . . 1.0 112.657 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.419 ' C ' ' OE1' ' A' ' 68' ' ' GLN . 5.0 p -59.63 38.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -173.87 7.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.86 135.93 29.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 18.2 pttp -150.31 -141.98 0.12 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.201 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 70' ' ' LYS . 9.3 t30 76.98 -138.91 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -101.95 -83.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.298 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 1.1 t -102.92 104.96 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 119.891 -0.724 . . . . 1.0 111.715 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 12.1 m-85 -162.95 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.824 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.549 ' C ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -143.51 162.39 35.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.649 0.738 . . . . 1.0 111.884 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.73 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -147.75 140.55 24.79 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.628 -176.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.4 124.59 47.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.365 0.603 . . . . 1.0 111.762 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 120' ' ' ARG . 2.2 t -144.75 130.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -88.28 124.88 34.32 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.141 0.793 . . . . 1.0 113.141 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.659 ' CZ ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 m-85 -77.55 113.19 29.7 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.632 -1.622 . . . . 1.0 112.856 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -53.68 -2.46 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.014 1.809 . . . . 1.0 110.326 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 80' ' ' TYR . 53.2 m-80 -102.98 -96.08 0.3 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.976 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 84' ' ' GLY . 0.8 OUTLIER -65.84 -40.22 91.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.88 1.437 . . . . 1.0 114.88 -176.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' N ' ' HG ' ' A' ' 83' ' ' LEU . . . 147.71 -173.54 27.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 119.772 -1.204 . . . . 1.0 110.32 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 12.0 m95 -55.16 122.14 10.37 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.88 -0.777 . . . . 1.0 111.454 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.497 ' O ' ' O ' ' A' ' 78' ' ' VAL . 5.8 tpp -127.61 157.2 40.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.354 0.501 . . . . 1.0 112.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -120.12 145.36 46.98 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.962 0.887 . . . . 1.0 110.179 176.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' O ' ' A' ' 120' ' ' ARG . 19.7 mt -97.07 156.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.847 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.93 134.02 46.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.188 0.81 . . . . 1.0 113.188 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.915 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . . . -132.83 138.17 46.98 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.082 -2.192 . . . . 1.0 105.082 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER 164.88 -31.43 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.868 1.213 . . . . 1.0 111.383 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.29 148.05 59.59 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.537 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 31.5 Cg_exo -55.28 -44.61 47.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.368 1.379 . . . . 1.0 112.481 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.69 -9.32 58.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.746 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -12.59 56.5 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' CA ' HG11 ' A' ' 60' ' ' VAL . . . -178.05 -107.54 0.22 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 119.507 -1.33 . . . . 1.0 113.217 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.691 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -150.23 -156.1 0.69 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.447 -178.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.758 ' CE3' HG21 ' A' ' 44' ' ' VAL . 23.2 p-90 -70.91 -25.57 62.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.62 HD23 ' CD2' ' A' ' 124' ' ' TYR . 0.3 OUTLIER -53.46 -27.41 24.81 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.487 ' NE ' ' C ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.39 -30.67 53.74 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.554 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.2 m-85 -66.97 -18.54 65.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.32 0.581 . . . . 1.0 109.774 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 136' ' ' LEU . 6.3 t -63.92 116.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.08 -0.964 . . . . 1.0 110.396 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.67 140.79 46.33 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.131 -2.174 . . . . 1.0 105.131 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.637 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 15.8 p90 -92.07 118.73 31.08 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.937 -1.105 . . . . 1.0 110.696 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 12.61 78.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 113.953 -1.476 . . . . 1.0 114.81 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.498 ' C ' ' O ' ' A' ' 105' ' ' ALA . 0.1 OUTLIER -19.5 -40.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 125.197 1.56 . . . . 1.0 110.031 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -168.38 7.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.739 176.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.96 22.48 23.01 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.717 -0.953 . . . . 1.0 110.717 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.425 ' CD ' ' SG ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -77.79 -37.8 48.04 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.297 -0.561 . . . . 1.0 110.118 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.538 ' HG3' HD22 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -119.41 -31.91 4.5 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.981 1.104 . . . . 1.0 113.981 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.534 ' C ' ' O ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 14.25 100.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 123.416 0.448 . . . . 1.0 111.609 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.849 HD22 HG21 ' A' ' 130' ' ' ILE . 34.0 p-10 -128.06 32.97 4.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER -152.96 172.49 16.73 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.579 ' HB3' HD21 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -148.26 124.15 5.26 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 119.351 -0.94 . . . . 1.0 112.702 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.8 Cg_endo -74.71 109.82 2.99 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 120.64 0.893 . . . . 1.0 113.313 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 23.2 tp -117.42 140.8 49.11 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.698 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.97 121.34 45.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.794 0.664 . . . . 1.0 112.794 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -135.54 135.66 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.875 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 118' ' ' ILE . 8.0 m-80 35.94 62.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.373 0.509 . . . . 1.0 112.373 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.659 ' NE ' ' CZ ' ' A' ' 80' ' ' TYR . 7.2 mtp180 55.93 11.89 0.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.984 0.365 . . . . 1.0 111.984 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -122.92 146.16 47.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 59' ' ' PHE . 4.0 mm -107.41 117.26 52.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 CA-C-O 121.112 0.482 . . . . 1.0 110.566 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.61 ' HB2' HD11 ' A' ' 118' ' ' ILE . 3.0 m-85 -101.14 143.44 31.24 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.62 ' CD2' HD23 ' A' ' 99' ' ' LEU . 15.6 m-30 -102.03 114.72 29.08 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 104.139 -2.541 . . . . 1.0 104.139 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 7.7 ttmt -105.51 141.2 37.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.379 1.05 . . . . 1.0 109.344 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.509 HG21 ' CE2' ' A' ' 56' ' ' PHE . 18.6 p -106.87 110.88 23.16 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.401 0.62 . . . . 1.0 110.068 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -72.41 -4.66 31.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.67 -1.604 . . . . 1.0 111.239 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -145.72 161.14 41.82 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 120.234 -0.586 . . . . 1.0 112.311 -177.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -75.5 144.42 28.64 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 N-CA-C 105.911 -2.38 . . . . 1.0 105.911 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.849 HG21 HD22 ' A' ' 112' ' ' ASN . 5.2 mt -126.19 135.71 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.719 0.691 . . . . 1.0 110.532 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.53 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.7 134.26 95.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.0 111.224 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -59.87 117.98 4.8 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 CA-C-N 120.006 1.038 . . . . 1.0 110.415 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.757 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.28 5.82 14.27 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.824 -1.311 . . . . 1.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.574 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -89.21 155.14 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 1.3 pm0 -78.59 118.84 21.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.268 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 137' ' ' LEU . 2.8 mt -80.3 116.8 20.57 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 105' ' ' ALA . 1.7 mp -129.3 156.17 44.43 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 108.688 -0.856 . . . . 1.0 108.688 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.637 ' H ' ' HA ' ' A' ' 104' ' ' TRP . 5.0 t -122.09 157.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.963 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.578 ' CZ2' ' C ' ' A' ' 141' ' ' IAS . 0.0 OUTLIER 63.03 150.69 0.03 OUTLIER 'General case' 0 C--O 1.204 -1.339 0 N-CA-C 114.985 1.476 . . . . 1.0 114.985 176.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 139' ' ' TRP . 31.4 t80 -108.61 -172.5 2.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.37 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.578 ' C ' ' CZ2' ' A' ' 139' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.262 0 N-CA-C 110.653 -0.979 . . . . 1.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.615 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 0.1 OUTLIER -145.93 -100.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.723 178.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.615 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 4.9 t70 72.04 -37.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.785 0.291 . . . . 1.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.683 ' ND2' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -71.77 150.66 93.2 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.541 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 14.9 Cg_exo -42.7 -84.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.204 0 N-CA-C 117.15 1.942 . . . . 1.0 117.15 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.569 ' HB3' HD13 ' A' ' 127' ' ' LEU . 8.5 tp10 -58.36 -46.78 85.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.391 0.615 . . . . 1.0 109.692 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.563 ' CG2' ' N ' ' A' ' 149' ' ' ALA . 0.3 OUTLIER -46.12 -53.25 2.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.534 -1.212 . . . . 1.0 109.883 -173.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.563 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -56.34 -52.43 64.6 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 117.615 -1.634 . . . . 1.0 108.213 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.76 -62.32 1.82 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.775 -1.557 . . . . 1.0 113.4 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.505 ' N ' ' OE1' ' A' ' 147' ' ' GLU . . . -63.55 -36.58 84.27 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.12 1.327 . . . . 1.0 111.652 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 156' ' ' ARG . 64.2 mt -53.45 -47.54 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 157' ' ' ALA . 1.8 tt0 -60.76 -53.05 62.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.2 -0.909 . . . . 1.0 110.206 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -57.2 -52.71 64.21 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.027 0.441 . . . . 1.0 111.324 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 3.1 tm-20 -70.17 -49.41 50.67 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.839 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -74.65 -27.27 60.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.108 -0.637 . . . . 1.0 111.029 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 153' ' ' GLU . . . -49.41 -34.6 16.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 118.871 -1.131 . . . . 1.0 108.217 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.82 -27.71 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.845 -1.071 . . . . 1.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.4 ' CA ' ' HE ' ' A' ' 160' ' ' ARG . . . -156.55 119.26 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.626 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -137.39 117.38 13.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.907 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.616 179.839 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.521 -1.432 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 29.7 m -150.44 7.7 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 1.0 110.554 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 61.74 117.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.499 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -50.14 124.78 10.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.598 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 7.1 tt0 -75.26 -63.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.614 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 3' ' ' GLN . 0.7 OUTLIER 176.71 -178.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.578 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.73 147.69 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.422 ' N ' ' OE2' ' A' ' 7' ' ' GLU . 6.2 m 55.03 98.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.342 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.422 ' OE2' ' N ' ' A' ' 6' ' ' THR . 4.1 mp0 -126.11 85.98 58.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.98 -175.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.483 2.122 . . . . 1.0 111.798 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -49.6 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.221 0.534 . . . . 1.0 110.891 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . . . -57.95 145.24 36.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.711 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' H ' ' CG ' ' A' ' 34' ' ' PRO . . . -82.75 -44.12 15.97 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m 178.22 -27.65 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.354 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.38 -73.63 0.35 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.712 0.767 . . . . 1.0 112.412 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.459 ' CB ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.36 175.81 9.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.135 -1.393 . . . . 1.0 110.632 174.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 15' ' ' LEU . 3.0 tt -77.19 -62.88 1.51 Allowed 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 172.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 42' ' ' ILE . . . -86.34 -59.39 2.3 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.77 ' CG ' ' H ' ' A' ' 18' ' ' VAL . 9.1 tt0 92.48 -171.48 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 105.415 -2.069 . . . . 1.0 105.415 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.77 ' H ' ' CG ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 58.49 151.83 0.08 OUTLIER Pre-proline 0 C--N 1.245 -3.97 0 CA-C-N 112.034 -2.348 . . . . 1.0 108.792 -178.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.92 138.87 6.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 123.429 2.752 . . . . 1.0 111.886 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 27.9 tt0 -50.27 -51.82 41.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-N 114.932 -1.031 . . . . 1.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -63.2 -24.36 67.84 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 97' ' ' ASN . 3.4 t -76.36 -50.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 118.631 -1.228 . . . . 1.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.95 -29.28 65.25 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.132 -0.485 . . . . 1.0 112.245 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -58.89 -15.98 15.29 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.235 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.42 20.81 31.88 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.936 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 30' ' ' VAL 0.251 17.9 mt -69.19 139.63 90.13 Favored Pre-proline 0 CA--C 1.489 -1.381 0 CA-C-N 118.384 1.092 . . . . 1.0 109.99 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 29' ' ' GLU . 5.9 Cg_exo -61.11 148.43 92.88 Favored 'Trans proline' 0 C--N 1.281 -3.026 0 N-CA-C 107.159 -1.9 . . . . 1.0 107.159 172.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 48' ' ' LYS . 1.6 pt-20 -49.17 -15.27 0.11 Allowed 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.567 1.175 . . . . 1.0 110.275 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -91.15 19.47 5.8 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 112.596 -2.093 . . . . 1.0 112.707 -178.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 26' ' ' LEU . 1.8 t -145.38 151.73 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 118.655 -1.218 . . . . 1.0 112.483 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -147.39 159.09 44.09 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.863 -1.971 . . . . 1.0 106.737 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.807 HD21 ' OH ' ' A' ' 101' ' ' TYR . 1.6 mm? -105.92 140.81 38.36 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 14.2 m-85 -148.47 115.35 3.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.641 0.608 . . . . 1.0 112.641 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.9 Cg_endo -85.98 127.62 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.319 2.012 . . . . 1.0 111.123 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 152.55 -71.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.739 0.65 . . . . 1.0 110.831 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.667 ' HB3' ' CZ2' ' A' ' 45' ' ' TRP . . . -51.18 -53.25 36.59 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.771 -0.772 . . . . 1.0 113.025 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -53.24 -52.17 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.369 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 40' ' ' THR . 6.4 p-10 -171.34 55.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.222 0.823 . . . . 1.0 113.222 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? 53.82 -9.21 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.589 ' H ' ' C ' ' A' ' 38' ' ' ASP . 12.3 p -135.42 -90.4 0.31 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.301 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 40' ' ' THR . 4.5 mtt85 -29.43 133.27 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.641 0.588 . . . . 1.0 111.09 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -78.84 133.86 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.94 153.41 17.16 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.3 -1.12 . . . . 1.0 110.3 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.447 HG23 ' CG1' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -104.14 127.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 121.621 0.724 . . . . 1.0 109.212 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.667 ' CZ2' ' HB3' ' A' ' 36' ' ' ALA . 4.8 m95 -130.88 149.92 52.28 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 114.469 -1.241 . . . . 1.0 111.507 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.32 138.24 51.31 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.572 -1.251 . . . . 1.0 111.03 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.439 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -112.62 -28.25 7.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.364 -178.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.559 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -116.14 159.71 38.45 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 119.167 -1.013 . . . . 1.0 111.32 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' N ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 Cg_endo -57.21 132.27 50.16 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.812 2.341 . . . . 1.0 111.469 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 48' ' ' LYS . 3.4 mp -111.15 144.22 19.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.047 -0.979 . . . . 1.0 108.613 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.051 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.59 149.23 34.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.051 ' N ' HD22 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -64.69 135.47 55.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.757 0.789 . . . . 1.0 111.951 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.7 2.93 49.83 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 119.356 -1.402 . . . . 1.0 113.078 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.651 ' HE3' HD12 ' A' ' 51' ' ' LEU . 3.1 ttmt -96.19 139.73 31.91 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.162 -1.015 . . . . 1.0 113.475 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.99 139.89 35.01 Favored 'General case' 0 CA--C 1.477 -1.841 0 C-N-CA 120.16 -0.616 . . . . 1.0 109.534 176.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CE2' HG21 ' A' ' 126' ' ' THR . 37.1 m-85 -121.89 127.81 50.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 122.852 1.31 . . . . 1.0 110.917 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' CA ' HD11 ' A' ' 99' ' ' LEU . . . 135.11 -106.55 0.59 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 111.526 -2.579 . . . . 1.0 110.251 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 88.8 Cg_endo -83.52 170.46 53.19 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 CA-C-N 119.507 1.654 . . . . 1.0 111.994 -0.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.567 ' CE1' ' NH2' ' A' ' 100' ' ' ARG . 27.7 t80 -59.14 109.75 0.92 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.957 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG13 ' H ' ' A' ' 61' ' ' GLY . 3.0 p -45.99 -50.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.719 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.606 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 72.31 111.18 0.05 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.359 -0.448 . . . . 1.0 114.038 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t0 -99.7 132.54 44.98 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -91.22 110.21 21.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 -177.091 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -146.47 166.91 24.99 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.936 -0.574 . . . . 1.0 110.641 -179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.555 ' H ' ' HZ2' ' A' ' 65' ' ' LYS . 2.1 mtmp? -80.38 132.85 35.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.597 0.713 . . . . 1.0 112.08 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 67' ' ' SER . 2.7 ptm180 -50.19 -24.68 2.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 1.0 111.28 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.509 ' C ' ' O ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -18.75 -51.24 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.981 0.801 . . . . 1.0 111.907 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.532 ' O ' ' C ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -103.64 -115.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 68' ' ' GLN . 3.2 m 16.05 76.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.448 0 O-C-N 123.713 0.633 . . . . 1.0 111.438 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -114.02 113.34 24.64 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.279 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.43 HD22 ' H ' ' A' ' 72' ' ' ASN . 11.2 t30 -174.36 -128.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.559 -0.746 . . . . 1.0 109.172 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.43 ' H ' HD22 ' A' ' 71' ' ' ASN . 4.1 m120 -117.34 -57.57 2.13 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.12 -0.632 . . . . 1.0 111.075 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 73' ' ' VAL . 0.3 OUTLIER -105.42 1.4 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.054 0.454 . . . . 1.0 111.358 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.3 m-85 -53.61 -34.75 59.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.502 ' SD ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -148.16 165.85 29.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.006 1.113 . . . . 1.0 114.006 -175.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.747 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -138.7 125.35 20.78 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.735 -1.575 . . . . 1.0 109.815 -177.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -97.37 123.25 41.14 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.448 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.0 139.43 22.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.224 -1.353 . . . . 1.0 109.297 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -83.62 129.28 34.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.65 ' CE2' ' NE ' ' A' ' 120' ' ' ARG . 15.5 m-85 -103.52 117.23 60.5 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.693 -1.14 . . . . 1.0 113.74 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -69.9 4.11 2.45 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.541 1.494 . . . . 1.0 109.774 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.745 ' ND2' HH12 ' A' ' 120' ' ' ARG . 62.8 m-20 -102.11 -2.84 28.58 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.911 -1.04 . . . . 1.0 111.112 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.9 0.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 80' ' ' TYR . . . 99.19 -164.46 20.36 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 18.8 m95 -60.86 120.18 9.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.759 -0.776 . . . . 1.0 111.019 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 1.4 tpp -130.82 165.62 22.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.185 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.605 ' N ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -120.72 144.48 48.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.045 0.926 . . . . 1.0 110.477 176.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 120' ' ' ARG . 61.1 mt -97.7 156.01 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -123.44 136.57 54.68 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.273 0.942 . . . . 1.0 112.765 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB2' ' HE1' ' A' ' 76' ' ' TRP . . . -134.32 139.82 45.93 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.636 HG22 ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 167.16 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 120.086 1.312 . . . . 1.0 111.269 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.62 152.37 62.92 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.692 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.443 ' HB2' HG21 ' A' ' 22' ' ' VAL . 51.7 Cg_endo -66.85 -37.67 19.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.543 2.162 . . . . 1.0 111.086 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.16 -14.17 62.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HB3' HH11 ' A' ' 100' ' ' ARG . 0.0 OUTLIER -87.67 -10.78 50.3 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.452 ' HA3' HG11 ' A' ' 60' ' ' VAL . . . 174.92 -91.13 0.08 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 119.761 -1.209 . . . . 1.0 113.854 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -148.26 -163.09 1.69 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.942 0.401 . . . . 1.0 111.783 -177.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.587 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 30.0 p-90 -71.3 -26.8 63.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.645 HD23 ' CD2' ' A' ' 124' ' ' TYR . 2.1 mp -55.03 -28.14 49.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.98 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.611 ' CB ' ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -77.09 -45.27 27.57 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.684 -0.806 . . . . 1.0 111.989 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.807 ' OH ' HD21 ' A' ' 32' ' ' LEU . 11.7 p90 -77.54 1.83 18.26 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 118.335 -1.346 . . . . 1.0 110.82 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.82 119.73 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 106.976 -1.49 . . . . 1.0 106.976 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 129.28 39.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.52 -1.289 . . . . 1.0 107.52 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.565 ' HA ' ' H ' ' A' ' 138' ' ' VAL . 22.4 p90 -93.42 123.53 36.79 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.473 -0.891 . . . . 1.0 111.883 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.695 ' O ' ' N ' ' A' ' 107' ' ' SER . . . 22.49 76.92 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.065 -1.425 . . . . 1.0 114.094 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.549 ' C ' ' O ' ' A' ' 105' ' ' ALA . 2.2 t -23.99 -38.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.787 1.304 . . . . 1.0 108.165 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -177.98 15.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.3 -1.318 . . . . 1.0 109.716 174.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 107' ' ' SER . . . 89.17 36.28 7.69 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 114.891 -1.049 . . . . 1.0 110.658 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -78.91 -44.41 22.74 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 120.047 -0.661 . . . . 1.0 109.891 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.547 ' HG3' HD22 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -120.46 -28.33 5.0 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.601 -0.714 . . . . 1.0 112.337 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' OE1' ' C ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER 22.66 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.937 0.773 . . . . 1.0 110.188 -178.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.531 HD21 ' HA ' ' A' ' 136' ' ' LEU . 41.1 p-10 -128.28 37.89 4.08 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 138' ' ' VAL . 1.0 OUTLIER -154.34 173.44 16.18 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -178.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.564 ' HB3' HD21 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -147.09 123.02 5.46 Favored Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 119.598 -0.841 . . . . 1.0 111.623 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HD3' ' H ' ' A' ' 139' ' ' TRP . 8.7 Cg_endo -67.23 92.52 0.34 Allowed 'Trans proline' 0 N--CA 1.482 0.798 0 CA-C-N 119.276 0.777 . . . . 1.0 112.281 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.576 HD22 ' HE3' ' A' ' 125' ' ' LYS . 31.4 tp -93.07 130.29 38.74 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.98 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.49 116.23 31.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 1.0 110.726 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.961 HD11 ' CG ' ' A' ' 123' ' ' TYR . 2.0 pt -138.39 135.89 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.481 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 118' ' ' ILE . 60.0 m-20 40.35 56.85 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.236 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.745 HH12 ' ND2' ' A' ' 82' ' ' ASN . 5.8 mtp180 58.12 12.26 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 1.0 111.84 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -117.25 150.25 39.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.673 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.723 HG21 ' CZ3' ' A' ' 76' ' ' TRP . 26.3 mm -110.52 104.18 16.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.418 0 C-N-CA 120.5 -0.48 . . . . 1.0 109.877 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.961 ' CG ' HD11 ' A' ' 118' ' ' ILE . 3.5 m-85 -92.77 149.96 20.96 Favored 'General case' 0 CA--C 1.491 -1.324 0 O-C-N 120.799 -1.188 . . . . 1.0 110.36 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.645 ' CD2' HD23 ' A' ' 99' ' ' LEU . 15.5 m-30 -102.12 111.34 23.59 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 104.817 -2.29 . . . . 1.0 104.817 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.576 ' HE3' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -106.22 139.33 40.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 124.691 1.245 . . . . 1.0 109.095 -178.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.57 HG21 ' CE2' ' A' ' 56' ' ' PHE . 6.4 p -107.24 111.26 23.57 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.088 -0.645 . . . . 1.0 110.684 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.853 HD12 ' ND2' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -77.27 0.89 20.37 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.681 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.606 ' NZ ' ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -144.02 140.84 17.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.943 -176.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 23.6 Cg_exo -65.98 140.77 61.68 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 N-CA-C 105.589 -2.504 . . . . 1.0 105.589 174.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.556 ' HB ' HD13 ' A' ' 50' ' ' ILE . 24.2 mt -118.89 134.7 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.89 0.768 . . . . 1.0 112.249 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.437 ' O ' ' OE2' ' A' ' 134' ' ' GLU . . . -72.82 120.81 82.86 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -47.08 122.45 6.33 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.934 1.756 . . . . 1.0 112.233 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 130.59 -2.92 5.74 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.576 -0.821 . . . . 1.0 114.06 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.781 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -103.81 167.17 9.95 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.111 0.958 . . . . 1.0 112.76 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 1.3 pm0 -80.5 139.24 36.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.778 -1.555 . . . . 1.0 111.027 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.531 ' HA ' HD21 ' A' ' 112' ' ' ASN . 9.2 mt -88.55 118.14 28.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 105' ' ' ALA . 2.1 mp -121.57 150.68 41.32 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.047 0.451 . . . . 1.0 110.292 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.651 ' O ' ' HD1' ' A' ' 139' ' ' TRP . 17.5 t -118.94 153.27 21.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.166 -0.925 . . . . 1.0 110.12 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.651 ' HD1' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER 59.33 168.29 0.06 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.429 1.081 . . . . 1.0 113.634 178.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.516 ' CG ' ' N ' ' A' ' 141' ' ' IAS . 55.1 t80 -114.51 168.33 9.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.491 -0.777 . . . . 1.0 111.678 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.53 ' OXT' ' CE2' ' A' ' 139' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 143' ' ' GLU . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 110.496 -1.042 . . . . 1.0 110.496 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.473 ' N ' ' HB3' ' A' ' 140' ' ' TYR . 10.3 pt-20 38.01 103.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 1.0 112.377 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.401 ' CB ' ' CD2' ' A' ' 140' ' ' TYR . 11.0 t70 -139.38 -33.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.061 -0.972 . . . . 1.0 112.063 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.853 ' ND2' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -67.91 151.33 97.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.501 ' N ' ' ND2' ' A' ' 145' ' ' ASN . 5.4 Cg_exo -40.69 -85.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.151 0 N-CA-C 117.496 2.075 . . . . 1.0 117.496 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.615 ' OE1' ' HB2' ' A' ' 151' ' ' ALA . 5.6 tp10 -58.12 -42.26 85.36 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.647 HG13 HD11 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -45.91 -50.78 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.943 -1.481 . . . . 1.0 109.455 -174.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.548 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -71.62 -47.21 56.11 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.388 -1.325 . . . . 1.0 109.097 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 147' ' ' GLU . . . -53.99 -57.06 12.4 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.629 -1.623 . . . . 1.0 113.235 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.615 ' HB2' ' OE1' ' A' ' 147' ' ' GLU . . . -72.5 -35.21 68.08 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 120.298 1.408 . . . . 1.0 111.94 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 148' ' ' ILE . 55.5 mt -51.95 -48.3 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 106.813 -1.551 . . . . 1.0 106.813 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 157' ' ' ALA . 2.3 mt-10 -60.92 -52.91 63.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.469 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.539 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -56.86 -53.24 60.22 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.976 -0.289 . . . . 1.0 111.7 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.539 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -74.12 -48.67 27.99 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.81 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -70.84 -28.04 64.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.953 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 153' ' ' GLU . . . -49.92 -44.59 50.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.74 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.48 -35.71 30.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.83 -154.91 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.488 ' HE ' ' HE ' ' A' ' 156' ' ' ARG . 13.4 mmt180 57.8 50.93 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.607 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.668 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.8 t 43.54 32.25 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 1.0 110.57 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmt 52.77 173.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.608 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 4' ' ' ASN . 1.7 p30 -154.04 22.87 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -78.11 19.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.506 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -80.03 -14.44 58.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.637 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.84 138.36 15.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.7 m -50.97 117.98 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.56 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -75.15 153.59 86.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.202 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.18 169.69 18.84 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.269 1.979 . . . . 1.0 112.061 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.46 110.15 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.679 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.77 131.66 31.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.247 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.11 -172.35 2.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.01 0.433 . . . . 1.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.426 HG21 ' C ' ' A' ' 40' ' ' THR . 11.4 m -124.2 -78.29 0.6 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.55 -151.56 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.489 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -125.49 155.33 40.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.937 0.875 . . . . 1.0 112.269 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.657 ' H ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -51.55 -32.39 28.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.085 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.52 -15.71 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.36 -0.836 . . . . 1.0 112.608 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 14' ' ' THR . 2.8 mt-10 -91.48 -25.36 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.677 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.588 HG22 ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -50.75 141.53 17.77 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.741 -0.663 . . . . 1.0 111.364 -178.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.637 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 22.5 Cg_exo -51.0 141.85 35.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.61 2.206 . . . . 1.0 112.558 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.627 ' HA ' HD21 ' A' ' 23' ' ' LEU . 47.8 tt0 -63.45 -31.73 72.98 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 113.43 0.9 . . . . 1.0 113.43 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 93' ' ' PRO . 4.6 p-80 -74.56 -26.54 60.01 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.789 1.403 . . . . 1.0 114.789 -176.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.659 HG12 ' C ' ' A' ' 97' ' ' ASN . 4.4 m -78.87 -47.27 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.47 1.032 . . . . 1.0 111.953 -178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.029 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.17 -22.02 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 122.676 1.227 . . . . 1.0 109.392 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HE ' ' CG ' ' A' ' 20' ' ' GLU . 1.2 mpt_? -63.74 -43.63 95.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.952 -1.931 . . . . 1.0 113.066 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -102.21 33.95 6.11 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.502 -0.856 . . . . 1.0 112.933 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.651 HD22 ' HB ' ' A' ' 30' ' ' VAL . 35.8 mt -68.49 153.52 95.6 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.022 -0.671 . . . . 1.0 112.668 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.545 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 71.9 Cg_exo -47.37 -106.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 124.287 3.324 . . . . 1.0 115.653 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -74.16 -58.89 3.0 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 47' ' ' THR . 0.0 OUTLIER -174.76 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 177.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.651 ' HB ' HD22 ' A' ' 26' ' ' LEU . 50.5 t -48.04 178.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.65 -1.159 . . . . 1.0 108.588 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HB3' HG21 ' A' ' 47' ' ' THR . 0.7 OUTLIER -147.88 159.04 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.7 mm? -94.96 121.04 36.16 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.1 -0.64 . . . . 1.0 110.683 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -132.48 139.84 36.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.003 -0.999 . . . . 1.0 111.057 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 35' ' ' SER . 40.2 Cg_endo -80.41 153.18 20.83 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.957 2.438 . . . . 1.0 112.484 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.861 ' H ' HG12 ' A' ' 37' ' ' VAL . 44.2 t 124.16 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.69 1.196 . . . . 1.0 110.958 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.79 12.83 16.01 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.892 1.329 . . . . 1.0 108.057 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 41' ' ' ARG . 3.6 p -93.1 -52.41 9.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 113.306 -1.77 . . . . 1.0 115.062 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.834 ' O ' HG23 ' A' ' 40' ' ' THR . 26.6 t0 126.26 46.31 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.862 ' H ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 31.86 40.91 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.543 179.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 38' ' ' ASP . 18.4 p -133.56 -16.95 2.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.925 -1.034 . . . . 1.0 111.467 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.915 ' O ' HG11 ' A' ' 37' ' ' VAL . 9.1 ttm-85 179.81 -166.03 0.07 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.784 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -78.02 155.28 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.887 0.375 . . . . 1.0 110.817 178.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -114.66 166.14 12.13 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.276 -1.53 . . . . 1.0 109.276 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 136' ' ' LEU . 10.0 p -105.41 126.61 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.752 0.776 . . . . 1.0 111.313 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.629 ' O ' HG13 ' A' ' 30' ' ' VAL . 16.1 m95 -126.9 142.38 51.56 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.376 -0.829 . . . . 1.0 113.226 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -69.19 133.51 48.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.305 -1.316 . . . . 1.0 110.304 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.595 HG21 ' HB3' ' A' ' 31' ' ' ARG . 56.0 p -130.34 12.68 5.52 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.868 -1.531 . . . . 1.0 106.868 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.938 ' NZ ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -133.09 170.32 11.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 112.593 -2.094 . . . . 1.0 110.908 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -89.59 141.99 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 123.289 2.659 . . . . 1.0 111.338 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.938 HD11 ' NZ ' ' A' ' 48' ' ' LYS . 45.2 mt -134.3 146.94 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 114.871 -1.059 . . . . 1.0 112.046 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.718 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.03 168.69 9.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.0 177.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.553 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -65.79 122.83 18.21 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.48 -0.488 . . . . 1.0 111.589 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.926 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.09 7.74 49.24 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.066 -1.064 . . . . 1.0 113.803 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.5 ttmt -75.51 133.16 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 116.787 -1.965 . . . . 1.0 113.852 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -85.8 121.21 28.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 1.0 113.397 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 27' ' ' PRO . 20.9 m-85 -121.17 142.77 49.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 114.309 1.226 . . . . 1.0 114.309 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.29 -100.49 1.65 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.013 -1.903 . . . . 1.0 110.59 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 95.5 Cg_endo -76.25 167.9 78.8 Favored 'Cis proline' 0 N--CA 1.499 1.814 0 CA-C-N 119.342 1.571 . . . . 1.0 112.049 -0.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.46 ' CZ ' ' O ' ' A' ' 74' ' ' TYR . 19.4 t80 -54.85 108.99 0.45 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 95' ' ' LYS . 3.7 p -37.05 -53.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.62 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.663 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 52.74 119.5 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.883 -0.675 . . . . 1.0 113.917 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.85 143.28 33.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -89.08 111.47 22.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.388 0.613 . . . . 1.0 110.921 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CD ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.92 178.84 6.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.024 -0.989 . . . . 1.0 111.79 -176.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -50.88 167.76 0.07 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.084 -0.962 . . . . 1.0 111.703 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.21 -51.55 24.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.67 123.05 48.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.277 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB3' ' HZ2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER 176.94 -20.09 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.675 -178.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.732 HG11 ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -109.12 -61.71 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 120.514 0.197 . . . . 1.0 111.404 -178.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 72' ' ' ASN . 44.5 mttp 62.67 -123.13 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.581 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.426 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 1.6 t30 -42.12 89.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.9 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 39.9 t-20 -171.63 -169.21 0.67 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.036 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.681 ' CG1' ' HE1' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -137.95 -56.8 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 120.529 -0.468 . . . . 1.0 112.064 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' N ' HG22 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -60.68 37.39 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.291 0.37 . . . . 1.0 111.625 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.732 ' SD ' HG11 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -135.19 141.56 45.9 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.671 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -163.95 163.61 23.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.777 -0.769 . . . . 1.0 113.034 176.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 5.4 pt-20 -100.97 123.24 44.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.093 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -135.2 124.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.411 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 4.1 t80 -78.06 124.15 27.69 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.632 ' C ' ' H ' ' A' ' 82' ' ' ASN . 23.2 m-85 -103.5 101.65 24.83 Favored Pre-proline 0 N--CA 1.448 -0.571 0 O-C-N 124.522 1.138 . . . . 1.0 112.889 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -65.35 22.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 121.423 1.415 . . . . 1.0 110.611 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.745 ' C ' HD13 ' A' ' 83' ' ' LEU . 83.0 m-20 -118.38 -2.3 11.12 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.837 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -178.1 6.48 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 102.91 174.94 26.71 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 113.844 0.298 . . . . 1.0 113.844 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.518 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.1 m95 -59.1 120.31 8.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.816 0.447 . . . . 1.0 111.656 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.518 ' SD ' ' C ' ' A' ' 85' ' ' TRP . 26.7 mmm -125.46 167.86 14.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.039 1.125 . . . . 1.0 114.039 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.419 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -114.67 138.23 50.94 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 105.604 -1.999 . . . . 1.0 105.604 172.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 78' ' ' VAL . 72.2 mt -103.79 101.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -128.96 127.96 42.75 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.268 0.556 . . . . 1.0 111.283 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -139.75 92.5 2.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.476 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.13 -5.97 21.51 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 119.419 -0.912 . . . . 1.0 112.811 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.645 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -86.79 120.55 71.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.605 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 52.6 Cg_exo -47.83 -26.98 7.75 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.114 1.876 . . . . 1.0 113.934 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.6 -44.24 82.65 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.638 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.724 ' O ' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -113.82 3.26 15.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.619 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.789 ' O ' ' ND2' ' A' ' 97' ' ' ASN . . . -97.54 -2.94 58.63 Favored Glycine 0 C--O 1.219 -0.795 0 CA-C-N 115.39 -0.823 . . . . 1.0 113.019 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.789 ' ND2' ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER 42.57 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.19 0.495 . . . . 1.0 110.109 -177.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.466 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 67.6 p-90 -70.58 -24.55 62.79 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 97' ' ' ASN . 5.2 mp -55.36 -23.6 25.06 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.59 -0.844 . . . . 1.0 109.078 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -68.26 -13.81 62.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 176.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' TRP . 4.3 m-85 -96.93 -10.62 25.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.475 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 99' ' ' LEU . 70.7 t -66.95 118.5 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 119.872 -0.731 . . . . 1.0 110.03 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.818 ' ND2' ' H ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -80.57 -164.39 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.55 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.681 ' HE1' ' CG1' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -121.9 154.6 36.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.804 -0.635 . . . . 1.0 110.505 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.936 ' HB3' ' NE2' ' A' ' 111' ' ' GLN . . . -134.89 -176.72 4.33 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.421 0.629 . . . . 1.0 112.016 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -105.43 -54.15 2.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.745 -1.116 . . . . 1.0 112.596 -178.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -103.16 175.22 5.55 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 111.379 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.1 -36.88 34.08 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -54.59 -25.39 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 1.0 110.401 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 105' ' ' ALA . 8.3 pt-20 -107.64 -24.01 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.435 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.936 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 0.0 OUTLIER -103.09 103.82 13.92 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.22 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.731 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -114.45 34.25 4.84 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -177.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 137' ' ' LEU . 5.3 mp -144.42 149.25 35.76 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.606 -0.838 . . . . 1.0 111.77 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.697 ' CD1' HG23 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -150.67 127.16 5.21 Favored Pre-proline 0 N--CA 1.47 0.528 0 C-N-CA 120.287 -0.565 . . . . 1.0 112.395 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 51.6 Cg_exo -60.5 133.55 49.53 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.087 1.858 . . . . 1.0 113.797 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -134.98 136.16 41.98 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.35 120.87 41.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.07 0.462 . . . . 1.0 111.757 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.862 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.1 OUTLIER -129.61 114.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 56.7 42.67 26.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.592 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 65.89 15.1 9.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.974 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -106.75 124.64 49.91 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.66 120.74 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.597 0.713 . . . . 1.0 112.238 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.862 ' CG ' HD11 ' A' ' 118' ' ' ILE . 7.7 m-85 -112.07 153.68 26.54 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.441 -1.254 . . . . 1.0 110.796 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -112.86 126.51 55.53 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.45 152.69 43.02 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.558 -0.857 . . . . 1.0 112.525 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.926 ' O ' ' N ' ' A' ' 53' ' ' GLY . 7.3 p -106.68 106.24 16.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.082 -1.417 . . . . 1.0 109.83 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -69.89 -0.46 7.35 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.927 0.767 . . . . 1.0 111.594 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 1.007 ' H ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -148.28 126.95 6.1 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.173 -176.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.63 148.48 2.34 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.951 2.434 . . . . 1.0 112.547 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -114.89 135.87 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.882 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -78.27 115.29 49.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.925 -0.769 . . . . 1.0 108.925 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -40.78 117.87 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.458 2.105 . . . . 1.0 113.282 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 117.62 6.19 13.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.522 -0.599 . . . . 1.0 112.566 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.882 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.4 pt-20 -104.92 166.98 10.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.938 0.869 . . . . 1.0 112.269 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' OE1' ' HB1' ' A' ' 36' ' ' ALA . 5.4 pt-20 -81.09 136.59 35.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.306 -1.315 . . . . 1.0 111.74 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 137' ' ' LEU . 1.2 mp -86.48 128.05 34.92 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.919 -1.037 . . . . 1.0 109.955 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.669 HD21 ' OD1' ' A' ' 103' ' ' ASN . 4.9 mp -142.65 157.98 44.12 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.993 0.517 . . . . 1.0 111.71 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.605 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.66 146.26 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 178.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.872 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 0.3 OUTLIER 23.41 -123.88 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.973 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.647 ' CD1' ' O ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -163.56 -14.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.618 ' OD1' ' C ' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.993 ' O ' ' N ' ' A' ' 145' ' ' ASN . 2.0 tm-20 -62.86 -74.54 0.09 Allowed 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.251 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -36.16 52.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.211 0.944 . . . . 1.0 111.86 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.993 ' N ' ' O ' ' A' ' 143' ' ' GLU . 16.4 t30 -117.57 164.14 20.77 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 114.616 -1.174 . . . . 1.0 109.659 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 63.6 Cg_endo -96.38 -24.83 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.235 1.957 . . . . 1.0 112.203 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.629 ' OE1' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -69.45 -43.79 72.57 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.941 HG22 HD11 ' A' ' 152' ' ' ILE . 93.3 mt -65.5 -53.18 42.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.222 0.534 . . . . 1.0 111.968 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 152' ' ' ILE . . . -51.54 -33.03 30.32 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.647 -0.706 . . . . 1.0 112.523 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.19 45.44 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.23 -0.588 . . . . 1.0 111.537 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . -78.53 -39.98 36.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.89 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.941 HD11 HG22 ' A' ' 148' ' ' ILE . 20.1 mt -53.33 -52.61 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 106.445 -1.687 . . . . 1.0 106.445 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 60.9 mt-10 -56.39 -28.04 58.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.667 -0.697 . . . . 1.0 111.056 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.518 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.6 OUTLIER -70.47 -49.4 48.96 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.006 -1.078 . . . . 1.0 111.345 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.546 ' HB2' ' HZ2' ' A' ' 125' ' ' LYS . 10.7 tp10 -79.39 -50.14 11.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.738 ' HG2' HG22 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -64.07 -39.71 94.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.38 0.511 . . . . 1.0 112.38 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . -63.57 -23.27 67.31 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 m -92.81 34.41 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.276 -0.875 . . . . 1.0 110.201 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -143.15 40.15 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.986 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -115.42 -38.98 3.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.464 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.623 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.0 m -52.04 -75.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.8 0.333 . . . . 1.0 110.575 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.92 171.9 13.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.592 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 44.26 51.64 7.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.502 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 3' ' ' GLN . 1.5 tm0? -97.49 55.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.586 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.67 ' N ' HD22 ' A' ' 4' ' ' ASN . 0.7 OUTLIER 45.32 18.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.549 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 3' ' ' GLN . 3.8 m -92.07 90.04 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.539 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.5 m 58.74 114.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.596 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -131.71 85.46 51.68 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.618 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -50.59 174.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.432 2.088 . . . . 1.0 112.052 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.4 141.06 25.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.324 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 54.52 172.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.416 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.74 -137.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.33 0.586 . . . . 1.0 110.804 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.1 m -140.49 -58.77 0.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.2 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.06 160.06 0.53 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -123.06 151.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.737 0.779 . . . . 1.0 112.748 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.71 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -55.56 -36.87 67.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.985 -1.007 . . . . 1.0 109.487 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -15.79 60.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.754 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -23.3 33.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.997 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.596 HG21 ' HG ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -60.66 144.59 89.08 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.644 ' O ' HD22 ' A' ' 23' ' ' LEU . 32.2 Cg_exo -48.15 148.64 6.9 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.101 2.534 . . . . 1.0 113.228 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' HD23 ' A' ' 23' ' ' LEU . 30.0 tt0 -60.72 -42.03 96.46 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.617 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 7.8 p-80 -73.4 -29.32 62.52 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.258 1.577 . . . . 1.0 115.258 -176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG12 ' C ' ' A' ' 97' ' ' ASN . 21.5 m -75.36 -47.16 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 119.909 1.231 . . . . 1.0 110.652 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 19' ' ' PRO . 1.6 pt? -67.5 -25.33 65.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.815 0.817 . . . . 1.0 110.321 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HE ' ' HG2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -71.07 -36.04 72.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.078 -1.419 . . . . 1.0 112.813 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.1 31.24 7.11 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.74 -0.743 . . . . 1.0 111.617 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.855 HD13 ' O ' ' A' ' 30' ' ' VAL . 10.3 mt -72.68 120.89 83.21 Favored Pre-proline 0 CA--C 1.5 -0.952 0 C-N-CA 119.651 -0.82 . . . . 1.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.85 168.39 7.21 Favored 'Trans proline' 0 C--N 1.296 -2.227 0 CA-C-N 120.085 1.066 . . . . 1.0 109.438 174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 48' ' ' LYS . 3.7 pt-20 -59.02 -8.89 1.59 Allowed 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 112.491 -2.141 . . . . 1.0 115.386 -175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.822 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -112.51 11.95 19.87 Favored 'General case' 0 CA--C 1.458 -2.586 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.973 -178.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.855 ' O ' HD13 ' A' ' 26' ' ' LEU . 2.3 t -137.1 117.06 16.22 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 C-N-CA 117.38 -1.728 . . . . 1.0 113.95 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' NE ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.67 142.02 49.85 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.144 -1.428 . . . . 1.0 107.144 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 26' ' ' LEU . 4.2 mm? -90.07 116.93 28.47 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.175 1.352 . . . . 1.0 111.548 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -139.73 141.34 27.53 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.725 -1.125 . . . . 1.0 110.942 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 35' ' ' SER . 53.2 Cg_endo -76.16 159.04 37.46 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.863 3.042 . . . . 1.0 113.804 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.75 ' C ' ' H ' ' A' ' 37' ' ' VAL . 13.4 m 110.4 -85.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.814 1.246 . . . . 1.0 108.575 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 103' ' ' ASN . . . -55.54 12.17 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.896 0.855 . . . . 1.0 111.822 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.75 ' H ' ' C ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -95.51 -53.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 113.864 -1.517 . . . . 1.0 112.555 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 40' ' ' THR . 5.1 m-20 143.65 42.14 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.323 1.014 . . . . 1.0 109.187 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.0 23.34 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.309 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 38' ' ' ASP . 9.7 t -122.76 -4.48 8.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.064 0.764 . . . . 1.0 113.064 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.603 ' O ' HG11 ' A' ' 37' ' ' VAL . 0.0 OUTLIER 175.33 -162.95 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.413 -0.588 . . . . 1.0 109.413 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 HG21 ' HB3' ' A' ' 32' ' ' LEU . 1.4 mm -79.08 156.21 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.956 0.408 . . . . 1.0 110.904 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -124.88 165.12 18.14 Favored Glycine 0 C--O 1.196 -2.26 0 N-CA-C 109.952 -1.259 . . . . 1.0 109.952 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -105.99 135.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 117.605 0.702 . . . . 1.0 110.937 -178.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 15.6 m95 -130.65 149.96 52.06 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 114.993 -1.003 . . . . 1.0 113.69 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -70.15 128.98 38.15 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 114.345 -1.298 . . . . 1.0 113.428 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 28' ' ' GLU . 81.5 p -115.8 -20.91 9.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.058 -0.974 . . . . 1.0 111.085 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' CD ' ' C ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -119.57 168.22 10.58 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.298 178.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.14 121.99 6.87 Favored 'Trans proline' 0 CA--C 1.498 -1.314 0 C-N-CA 121.915 1.743 . . . . 1.0 111.666 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.733 HD12 HG21 ' A' ' 130' ' ' ILE . 72.6 mt -100.61 143.02 14.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 112.858 -1.974 . . . . 1.0 109.581 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.791 HD12 ' C ' ' A' ' 51' ' ' LEU . 4.0 pp -109.01 164.27 12.56 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.79 -1.096 . . . . 1.0 109.294 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.613 ' C ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.34 122.74 21.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.01 0.91 . . . . 1.0 111.111 177.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.896 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.13 10.07 40.47 Favored Glycine 0 C--N 1.303 -1.304 0 C-N-CA 120.022 -1.085 . . . . 1.0 114.029 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -89.19 130.85 35.54 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.328 -1.749 . . . . 1.0 114.624 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 4.4 mtmm -85.9 124.54 32.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.857 -1.52 . . . . 1.0 111.473 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CD2' ' OE1' ' A' ' 29' ' ' GLU . 47.5 m-85 -121.65 149.71 42.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.9 -102.37 1.56 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.215 -1.357 . . . . 1.0 111.507 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 50.7 Cg_endo -84.15 165.14 64.22 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 119.753 1.776 . . . . 1.0 113.036 0.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 20.4 t80 -54.39 110.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.849 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.628 HG11 ' HE ' ' A' ' 100' ' ' ARG . 2.9 p -35.42 -56.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.446 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 51.28 116.21 0.01 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.558 -0.829 . . . . 1.0 114.799 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 21.4 t0 -103.49 146.69 28.14 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.676 ' HB3' ' HZ3' ' A' ' 63' ' ' LYS . 3.2 mtmp? -89.29 113.64 24.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.443 -0.903 . . . . 1.0 112.202 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.628 ' CE ' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -136.04 166.29 23.7 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.328 -0.851 . . . . 1.0 111.345 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.628 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -81.25 131.24 35.28 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.517 0.562 . . . . 1.0 112.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -40.64 -24.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.507 ' O ' ' NE2' ' A' ' 68' ' ' GLN . 27.5 m -76.92 60.97 1.87 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.461 -0.895 . . . . 1.0 108.714 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 67' ' ' SER . 0.3 OUTLIER -167.0 -7.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.163 1.171 . . . . 1.0 114.163 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.515 HG22 ' HZ3' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -110.51 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 119.063 0.847 . . . . 1.0 111.36 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.507 ' H ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER 88.76 -80.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.833 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -102.94 92.83 4.73 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 73' ' ' VAL . 18.8 t-20 -170.59 172.56 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.107 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.664 ' C ' ' H ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -122.43 -52.31 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 114.38 1.252 . . . . 1.0 114.38 -178.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.823 ' C ' ' SD ' ' A' ' 75' ' ' MET . 0.2 OUTLIER -63.54 34.59 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 -176.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.823 ' SD ' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -126.45 139.32 53.34 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 111.907 0.336 . . . . 1.0 111.907 -177.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.641 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -164.49 164.23 21.9 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.493 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -97.73 122.78 41.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.0 111.17 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -139.42 119.45 13.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.445 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 3.0 t80 -78.19 125.03 28.76 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 113.41 0.893 . . . . 1.0 113.41 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 82' ' ' ASN . 25.0 m-85 -103.22 97.8 10.71 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 114.698 -1.137 . . . . 1.0 112.172 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 79' ' ' TYR . 51.9 Cg_exo -51.31 -11.33 0.58 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 121.247 1.298 . . . . 1.0 109.785 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 80' ' ' TYR . 77.3 m-20 -76.53 -3.42 37.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.424 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 84' ' ' GLY . 2.5 pp -178.29 -33.18 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.589 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 146.82 173.24 17.87 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.132 -1.032 . . . . 1.0 112.523 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.502 ' C ' ' SD ' ' A' ' 86' ' ' MET . 21.9 m95 -58.53 120.25 8.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.646 -0.277 . . . . 1.0 111.547 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.505 ' SD ' ' CD1' ' A' ' 83' ' ' LEU . 20.3 mmm -127.25 163.87 22.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.996 1.109 . . . . 1.0 113.996 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.432 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -111.24 139.78 46.35 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.354 -2.091 . . . . 1.0 105.354 172.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 75' ' ' MET . 66.4 mt -107.58 103.15 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 118.219 -0.895 . . . . 1.0 109.7 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -130.29 130.77 44.94 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.207 0.912 . . . . 1.0 112.362 -178.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.782 ' HB1' ' CZ ' ' A' ' 100' ' ' ARG . . . -142.72 113.04 7.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.201 -0.909 . . . . 1.0 109.72 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' HD21 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -132.68 26.93 4.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.979 0.809 . . . . 1.0 110.139 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.729 ' N ' HH11 ' A' ' 100' ' ' ARG . 2.6 m-20 -117.15 81.62 13.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.818 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.617 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 58.6 Cg_exo -48.48 -12.67 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.084 2.523 . . . . 1.0 112.629 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HA ' ' HE2' ' A' ' 21' ' ' HIS . 2.7 mt-10 -79.1 -28.52 43.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.365 0.602 . . . . 1.0 109.691 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 17.89 15.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 1.0 112.779 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -141.02 -121.65 1.79 Allowed Glycine 0 N--CA 1.461 0.336 0 C-N-CA 119.422 -1.371 . . . . 1.0 114.78 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.569 ' C ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -139.18 -177.96 5.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.533 -0.834 . . . . 1.0 110.489 -178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.637 ' CE3' HG11 ' A' ' 30' ' ' VAL . 70.1 p-90 -68.31 -21.66 64.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.462 HD12 ' H ' ' A' ' 99' ' ' LEU . 4.4 mp -56.88 -28.41 61.81 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.782 ' CZ ' ' HB1' ' A' ' 90' ' ' ALA . 32.0 mtt180 -62.57 -12.52 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.355 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -104.77 -3.35 23.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.643 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.407 ' O ' ' CZ3' ' A' ' 104' ' ' TRP . 18.5 t -66.14 135.03 29.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 C-N-CA 119.217 -0.993 . . . . 1.0 108.893 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.661 ' ND2' ' H ' ' A' ' 104' ' ' TRP . 4.0 t-20 -102.63 -174.13 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 120.696 -0.402 . . . . 1.0 110.204 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.661 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.53 157.06 36.25 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.763 ' HB2' HD22 ' A' ' 137' ' ' LEU . . . -118.99 -158.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.513 ' SG ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -110.53 -22.98 11.38 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.518 -1.219 . . . . 1.0 111.934 -178.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -171.68 137.38 1.02 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 111' ' ' GLN . . . -31.74 -32.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.735 -0.666 . . . . 1.0 113.717 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' SER . 2.1 mt-10 -53.92 -26.76 26.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 117.816 0.808 . . . . 1.0 110.337 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.513 ' OE2' ' SG ' ' A' ' 106' ' ' CYS . 11.0 pt-20 -116.94 -24.34 7.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.07 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 105' ' ' ALA . 2.5 tm0? -93.76 143.98 25.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.11 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.649 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -153.9 40.32 0.49 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.438 -0.505 . . . . 1.0 111.845 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.663 HD21 HD23 ' A' ' 136' ' ' LEU . 4.8 mp -143.79 143.21 31.25 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.08 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.695 ' CD1' HG23 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -148.73 128.76 6.6 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.349 -179.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 32.5 Cg_exo -63.19 121.73 9.67 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.385 2.057 . . . . 1.0 112.284 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 123' ' ' TYR . 9.2 tp -117.14 128.74 55.42 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -98.02 116.64 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.255 -0.578 . . . . 1.0 110.684 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.3 118.95 51.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 58.51 31.98 21.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 80' ' ' TYR . 11.3 mmp_? 67.67 18.22 9.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.53 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.39 125.35 50.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.763 -1.199 . . . . 1.0 107.763 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 76' ' ' TRP . 5.6 mm -85.33 120.79 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.009 -0.677 . . . . 1.0 112.659 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 116' ' ' LEU . 8.7 m-85 -112.89 162.32 15.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.909 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.1 m-30 -112.28 118.2 34.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 114' ' ' PHE . 1.9 mttt -110.81 145.91 37.33 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.695 0.998 . . . . 1.0 113.695 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 53' ' ' GLY . 3.1 p -106.64 111.33 23.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.701 -1.591 . . . . 1.0 109.448 176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.675 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.94 -4.35 46.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.951 0.782 . . . . 1.0 110.076 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.574 ' HZ1' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -139.45 147.36 52.15 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.371 177.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.83 146.08 77.0 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.288 1.325 . . . . 1.0 111.833 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.733 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -113.7 136.44 50.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.336 -179.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.878 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -79.58 121.06 82.16 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.16 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -41.98 112.28 0.23 Allowed 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 123.111 2.541 . . . . 1.0 115.044 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 119.16 8.03 9.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.001 -0.619 . . . . 1.0 112.768 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.878 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.6 pt-20 -105.35 165.99 10.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 117.507 0.653 . . . . 1.0 111.115 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.493 ' OE1' HD11 ' A' ' 137' ' ' LEU . 4.6 pt-20 -80.01 133.91 36.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.792 -1.094 . . . . 1.0 111.769 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.88 ' C ' HD12 ' A' ' 137' ' ' LEU . 6.4 mp -86.27 132.49 33.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.913 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.88 HD12 ' C ' ' A' ' 136' ' ' LEU . 4.7 mp -140.2 159.59 41.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.703 ' O ' ' N ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -108.56 140.16 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.759 ' CD1' ' N ' ' A' ' 140' ' ' TYR . 29.6 p90 33.96 -63.05 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 O-C-N 124.957 1.41 . . . . 1.0 114.322 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.759 ' N ' ' CD1' ' A' ' 139' ' ' TRP . 44.4 p90 155.5 -64.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.875 1.67 . . . . 1.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.71 ' N ' ' CD2' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.431 0 N-CA-C 111.453 -0.659 . . . . 1.0 111.453 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 1.066 ' O ' ' N ' ' A' ' 145' ' ' ASN . 4.2 tm-20 -66.61 -80.91 0.04 OUTLIER 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 0.8 OUTLIER -29.88 55.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.772 0.796 . . . . 1.0 111.506 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 1.066 ' N ' ' O ' ' A' ' 143' ' ' GLU . 30.2 t30 -111.15 162.85 19.07 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 114.32 -1.309 . . . . 1.0 108.753 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 73.3 Cg_endo -94.62 -20.27 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.767 1.644 . . . . 1.0 112.063 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.592 ' CG ' HD22 ' A' ' 145' ' ' ASN . 0.0 OUTLIER -74.14 -37.45 64.06 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.562 -1.273 . . . . 1.0 107.562 178.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.695 HG23 ' CD1' ' A' ' 114' ' ' PHE . 63.9 mt -75.02 -56.25 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.245 0.545 . . . . 1.0 110.527 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 152' ' ' ILE . . . -56.14 -30.96 62.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.237 -0.892 . . . . 1.0 112.275 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.48 -33.54 48.17 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.507 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -75.55 -42.56 52.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.836 -1.075 . . . . 1.0 111.464 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.719 HG22 ' HG2' ' A' ' 156' ' ' ARG . 60.2 mt -54.24 -51.69 45.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.466 -1.309 . . . . 1.0 107.466 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 32.6 mt-10 -59.84 -29.71 68.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.783 0.677 . . . . 1.0 111.338 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.4 OUTLIER -71.08 -48.77 50.6 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.402 -0.919 . . . . 1.0 110.763 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.482 ' N ' ' HG2' ' A' ' 154' ' ' GLU . 15.9 tp10 -78.94 -49.83 12.15 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.719 ' HG2' HG22 ' A' ' 152' ' ' ILE . 5.4 ppt_? -66.61 -40.53 88.85 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.836 0.68 . . . . 1.0 112.836 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -64.66 -22.96 67.11 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.0 m -93.9 19.04 9.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.522 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.43 32.44 3.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.337 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -110.7 -65.32 1.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.522 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.938 -1.029 . . . . 1.0 110.55 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.1 m 42.33 71.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 1.0 110.555 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mmt -101.77 135.21 43.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.566 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -156.66 52.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.27 -46.45 27.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.578 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -42.5 132.22 3.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.497 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 m -89.91 99.93 12.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.531 HG23 ' N ' ' A' ' 7' ' ' GLU . 3.1 t -70.03 -122.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.453 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' N ' HG23 ' A' ' 6' ' ' THR . 7.7 mt-10 -138.78 83.55 19.15 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -83.42 -172.91 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.978 2.452 . . . . 1.0 112.395 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -69.85 -179.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.822 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 53.88 169.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.295 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.56 -144.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.962 0.411 . . . . 1.0 110.967 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.3 m -139.13 -76.71 0.35 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.622 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -43.96 160.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.811 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -125.88 150.77 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.62 -0.718 . . . . 1.0 111.062 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -60.74 -27.75 68.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.357 0.599 . . . . 1.0 109.575 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.65 -23.38 63.0 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.363 -0.977 . . . . 1.0 108.363 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' O ' ' O ' ' A' ' 18' ' ' VAL . 1.6 mm-40 -88.84 -117.06 0.05 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.11 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.609 HG23 HG13 ' A' ' 42' ' ' ILE . 0.4 OUTLIER 51.49 142.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 114.123 -1.399 . . . . 1.0 110.76 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 18' ' ' VAL . 4.3 Cg_exo -55.64 134.64 65.19 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.14 1.226 . . . . 1.0 111.766 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HA ' HD21 ' A' ' 23' ' ' LEU . 38.2 tt0 -53.23 -38.63 63.11 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.847 1.055 . . . . 1.0 113.847 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.684 ' NE2' ' O ' ' A' ' 93' ' ' PRO . 10.1 p-80 -74.67 -34.25 62.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 115.467 1.654 . . . . 1.0 115.467 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.669 HG12 ' C ' ' A' ' 97' ' ' ASN . 5.2 m -71.65 -47.83 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 119.279 0.945 . . . . 1.0 111.181 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 19' ' ' PRO . 1.7 pt? -68.15 -22.32 64.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.67 0.748 . . . . 1.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.49 -29.99 64.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.197 -0.91 . . . . 1.0 112.2 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.46 41.6 2.11 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 30' ' ' VAL . 46.7 mt -85.41 116.59 66.19 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 119.956 -0.698 . . . . 1.0 112.542 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 29' ' ' GLU . 18.7 Cg_endo -68.31 -139.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.682 0 C-N-CA 121.638 1.559 . . . . 1.0 112.856 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.821 ' HB2' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -30.52 -4.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 126.761 2.024 . . . . 1.0 115.648 -173.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' A' ' 27' ' ' PRO . 10.9 mt-10 129.55 5.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 126.437 1.895 . . . . 1.0 113.903 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.875 ' O ' HD22 ' A' ' 26' ' ' LEU . 55.5 t -41.99 127.15 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 114.793 -1.094 . . . . 1.0 108.503 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' NE ' ' CG2' ' A' ' 47' ' ' THR . 0.1 OUTLIER -127.35 155.33 43.76 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.237 0.828 . . . . 1.0 113.237 -177.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 32' ' ' LEU . 1.7 mm? -92.15 116.31 28.83 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.614 0.721 . . . . 1.0 111.863 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.2 OUTLIER -129.87 141.4 41.73 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.601 -1.182 . . . . 1.0 110.907 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . 71.4 Cg_endo -72.58 155.56 54.59 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.742 2.294 . . . . 1.0 114.655 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.708 ' C ' ' H ' ' A' ' 37' ' ' VAL . 11.4 m 109.22 -76.43 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.324 -1.307 . . . . 1.0 108.179 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.531 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -51.81 7.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.966 -1.016 . . . . 1.0 111.991 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.708 ' H ' ' C ' ' A' ' 35' ' ' SER . 2.1 p -103.44 -50.26 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.772 ' O ' HG22 ' A' ' 40' ' ' THR . 1.9 p30 158.86 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' C ' HG22 ' A' ' 40' ' ' THR . 0.0 OUTLIER 36.58 76.0 0.06 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.915 -0.584 . . . . 1.0 111.698 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 38' ' ' ASP . 1.4 t 152.04 19.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.475 1.11 . . . . 1.0 112.207 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.708 ' O ' HG11 ' A' ' 37' ' ' VAL . 3.3 tpt180 -172.21 -168.91 0.58 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.765 -0.774 . . . . 1.0 111.558 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.609 HG13 HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -95.28 152.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 O-C-N 123.443 0.464 . . . . 1.0 109.933 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 33' ' ' PHE . . . -130.87 165.85 22.8 Favored Glycine 0 C--O 1.209 -1.43 0 N-CA-C 108.162 -1.975 . . . . 1.0 108.162 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.848 HG21 ' CE3' ' A' ' 98' ' ' TRP . 13.6 p -101.05 139.55 22.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 117.97 0.885 . . . . 1.0 111.276 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.531 ' CZ2' ' HB2' ' A' ' 36' ' ' ALA . 6.0 m95 -134.46 154.0 51.63 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 114.389 -1.278 . . . . 1.0 111.993 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HB1' ' HZ3' ' A' ' 48' ' ' LYS . . . -92.0 122.54 34.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.887 -1.506 . . . . 1.0 108.581 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.461 ' CG2' ' NE ' ' A' ' 31' ' ' ARG . 62.7 p -109.07 3.77 22.38 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.431 0.634 . . . . 1.0 110.644 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.974 ' NZ ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -128.96 170.9 9.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.696 -1.138 . . . . 1.0 111.826 -178.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' N ' ' HG3' ' A' ' 132' ' ' PRO . 5.3 Cg_endo -85.38 129.66 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.589 2.193 . . . . 1.0 111.921 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.974 HD11 ' NZ ' ' A' ' 48' ' ' LYS . 93.2 mt -120.32 147.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.853 -1.067 . . . . 1.0 111.667 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.816 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -107.01 163.23 13.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.567 -1.197 . . . . 1.0 110.871 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.53 127.68 33.84 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.017 0.913 . . . . 1.0 112.607 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.857 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.14 8.29 39.11 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 114.535 -1.211 . . . . 1.0 113.944 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 2.6 ttmm -93.32 131.04 38.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.671 -1.611 . . . . 1.0 115.115 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -96.18 133.73 40.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.415 -1.266 . . . . 1.0 113.532 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.94 149.72 41.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.404 -0.816 . . . . 1.0 112.416 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.67 -100.77 1.55 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.385 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HB3' ' CD1' ' A' ' 123' ' ' TYR . 66.8 Cg_endo -77.26 166.63 81.64 Favored 'Cis proline' 0 N--CA 1.504 2.116 0 CA-C-N 119.195 1.498 . . . . 1.0 112.546 0.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CA ' HD22 ' A' ' 99' ' ' LEU . 17.6 t80 -55.7 107.49 0.34 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.221 -0.592 . . . . 1.0 110.51 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.755 HG13 ' H ' ' A' ' 61' ' ' GLY . 3.5 p -30.85 -61.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 O-C-N 123.774 0.671 . . . . 1.0 110.891 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.755 ' H ' HG13 ' A' ' 60' ' ' VAL . . . 49.16 117.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.302 -0.475 . . . . 1.0 113.678 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 51.6 t0 -101.79 148.38 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.658 ' NZ ' HD21 ' A' ' 83' ' ' LEU . 4.9 mtmt -89.14 112.91 24.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.521 0.677 . . . . 1.0 110.994 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HE3' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -132.73 166.33 22.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.738 -1.119 . . . . 1.0 111.444 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.614 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -84.81 130.99 34.59 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.321 0.489 . . . . 1.0 112.321 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 68' ' ' GLN . 14.2 ptt180 -43.31 -23.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.002 0.741 . . . . 1.0 113.002 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.12 -13.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.024 -0.671 . . . . 1.0 110.326 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' O ' ' A' ' 69' ' ' VAL . 19.5 mm100 -100.57 -152.77 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.998 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.597 HG22 ' NZ ' ' A' ' 64' ' ' LYS . 23.9 m 31.68 -167.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mttm 174.74 -58.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.189 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 72' ' ' ASN . 25.1 t-20 -111.31 -88.37 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.579 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER 36.61 -160.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.237 0.335 . . . . 1.0 111.009 178.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.606 ' O ' ' CZ3' ' A' ' 76' ' ' TRP . 0.2 OUTLIER -146.45 -50.07 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 120.115 -0.634 . . . . 1.0 111.186 -179.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -69.78 41.99 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.619 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.551 ' H ' ' C ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -128.31 139.06 52.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.843 -178.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -165.73 164.34 18.92 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.076 -1.05 . . . . 1.0 112.641 175.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -104.63 122.14 45.01 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.898 0.856 . . . . 1.0 110.982 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' OE1' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -130.59 121.96 51.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 106.076 -1.824 . . . . 1.0 106.076 178.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -81.34 123.53 28.61 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.02 -1.072 . . . . 1.0 112.001 -177.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 82' ' ' ASN . 9.9 m-85 -86.56 111.03 36.62 Favored Pre-proline 0 N--CA 1.438 -1.045 0 O-C-N 124.866 1.354 . . . . 1.0 112.531 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.62 -12.13 0.51 Allowed 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.762 1.642 . . . . 1.0 109.518 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 80' ' ' TYR . 73.9 m-80 -85.62 -116.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.208 -1.36 . . . . 1.0 110.47 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.948 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -47.99 -34.92 10.02 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.816 1.414 . . . . 1.0 114.816 -178.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.511 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 139.43 -175.14 21.87 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.334 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' A' ' 79' ' ' TYR . 16.3 m95 -58.03 120.54 8.74 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.39 0.595 . . . . 1.0 111.704 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 7.2 mmm -130.46 169.25 15.77 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.417 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -119.99 140.77 50.45 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 113.991 -1.459 . . . . 1.0 107.784 173.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -106.1 103.01 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.195 -0.911 . . . . 1.0 108.598 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -133.81 129.32 36.37 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.962 -179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.501 ' HB1' ' HZ3' ' A' ' 95' ' ' LYS . . . -141.41 91.7 2.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.953 -0.699 . . . . 1.0 112.159 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.565 ' HA ' HH11 ' A' ' 100' ' ' ARG . 0.1 OUTLIER -103.31 14.0 32.53 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.456 -0.897 . . . . 1.0 109.873 178.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.17 113.27 62.87 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.245 -0.889 . . . . 1.0 108.936 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.684 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 24.6 Cg_endo -69.58 -22.62 32.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.26 1.973 . . . . 1.0 112.097 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -56.6 -42.44 78.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.372 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HZ3' ' HB1' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -114.0 -5.51 13.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.854 0.359 . . . . 1.0 110.77 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.7 ' HA2' HG11 ' A' ' 60' ' ' VAL . . . -89.0 -144.28 10.33 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 119.516 -1.325 . . . . 1.0 113.432 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.669 ' C ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -146.66 -173.38 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.833 -0.684 . . . . 1.0 109.616 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.848 ' CE3' HG21 ' A' ' 44' ' ' VAL . 65.0 p-90 -68.58 -19.29 64.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.885 -0.143 . . . . 1.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 124' ' ' TYR . 6.3 mp -57.12 -30.31 64.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.728 -0.789 . . . . 1.0 108.958 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.569 ' O ' ' CZ ' ' A' ' 74' ' ' TYR . 3.2 mtp85 -58.76 -11.26 2.99 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.85 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.5 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 10.7 m-85 -100.96 6.77 43.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.209 0.528 . . . . 1.0 110.405 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 99' ' ' LEU . 44.8 t -81.11 129.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.642 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.644 HD21 ' CD1' ' A' ' 137' ' ' LEU . 0.5 OUTLIER -102.42 -137.85 0.34 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.13 -0.941 . . . . 1.0 111.22 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.539 ' N ' ' CG ' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -132.41 160.39 36.53 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.396 -0.19 . . . . 1.0 110.78 -179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.53 ' H ' HE22 ' A' ' 111' ' ' GLN . . . -95.0 -120.82 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.135 1.532 . . . . 1.0 115.135 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.2 t -174.68 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.419 -1.719 . . . . 1.0 107.678 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' GLY . 13.6 t -139.66 -179.02 5.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.84 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . . . -89.26 -5.69 72.35 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 121.325 -0.465 . . . . 1.0 112.682 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.66 -20.29 43.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.54 0.57 . . . . 1.0 112.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.537 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 10.3 pt-20 -113.78 -19.93 11.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.764 0.793 . . . . 1.0 110.124 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.628 ' NE2' ' C ' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -81.75 157.17 24.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.213 -1.358 . . . . 1.0 108.457 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.891 ' O ' HG22 ' A' ' 126' ' ' THR . 0.3 OUTLIER -173.22 37.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.903 0.859 . . . . 1.0 111.755 -176.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.533 ' O ' ' CE1' ' A' ' 140' ' ' TYR . 5.0 mp -141.13 141.5 34.17 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -144.04 123.3 7.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.142 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.507 ' O ' ' CE1' ' A' ' 114' ' ' PHE . 50.5 Cg_exo -55.28 104.07 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.903 1.735 . . . . 1.0 110.709 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 123' ' ' TYR . 10.0 tp -109.49 118.44 36.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' OE1' ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -94.47 117.76 30.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.31 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.938 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -127.41 118.22 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.372 -1.344 . . . . 1.0 107.372 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 57.01 31.73 20.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.41 -1.33 . . . . 1.0 107.41 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.744 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 72.2 18.83 4.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.887 -1.051 . . . . 1.0 110.941 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.417 -0.81 . . . . 1.0 108.903 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.69 120.26 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.9 0.857 . . . . 1.0 112.282 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.938 ' CG ' HD11 ' A' ' 118' ' ' ILE . 6.0 m-85 -113.62 157.03 22.64 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.664 -1.607 . . . . 1.0 108.79 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.653 ' CD2' HD23 ' A' ' 99' ' ' LEU . 4.6 m-30 -115.72 104.84 12.08 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.687 -0.805 . . . . 1.0 111.237 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 114' ' ' PHE . 5.4 ttmm -102.63 150.77 23.1 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 114.331 1.234 . . . . 1.0 114.331 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 112' ' ' ASN . 4.8 p -103.12 107.88 18.85 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.89 -1.959 . . . . 1.0 109.883 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.618 ' HB2' ' HZ3' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -73.69 0.29 13.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 177.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.618 ' HZ3' ' HB2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -150.52 152.07 32.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.055 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.47 143.74 43.56 Favored 'Trans proline' 0 N--CA 1.516 2.803 0 C-N-CA 123.163 2.575 . . . . 1.0 114.379 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.851 HD11 ' OD1' ' A' ' 112' ' ' ASN . 0.8 OUTLIER -110.04 135.59 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.888 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.689 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -77.02 133.45 69.24 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HG3' ' N ' ' A' ' 49' ' ' PRO . 86.9 Cg_exo -50.24 103.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 122.868 2.378 . . . . 1.0 116.513 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 129.15 12.06 2.68 Favored Glycine 0 N--CA 1.468 0.81 0 C-N-CA 120.372 -0.918 . . . . 1.0 113.789 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.689 ' OE1' ' HB3' ' A' ' 131' ' ' ALA . 2.9 pt-20 -109.41 166.47 10.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.881 0.841 . . . . 1.0 111.614 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HB3' ' CE3' ' A' ' 45' ' ' TRP . 7.7 pt-20 -79.06 136.04 37.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.567 -1.197 . . . . 1.0 112.566 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.441 ' C ' HD13 ' A' ' 137' ' ' LEU . 1.3 mt -82.84 116.03 21.98 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.147 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.644 ' CD1' HD21 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -124.16 159.25 30.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 122.95 0.5 . . . . 1.0 111.658 -178.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.628 ' C ' ' NE2' ' A' ' 111' ' ' GLN . 0.2 OUTLIER -122.91 148.69 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 112.677 0.621 . . . . 1.0 112.677 178.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.829 ' C ' ' CD1' ' A' ' 140' ' ' TYR . 2.7 m95 140.37 -74.52 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.018 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.829 ' CD1' ' C ' ' A' ' 139' ' ' TRP . 15.9 p90 44.75 31.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 123.882 0.738 . . . . 1.0 111.75 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.584 ' OD1' ' C ' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.492 ' O ' ' C ' ' A' ' 143' ' ' GLU . . . . . . . . 0 CA--C 1.532 1.141 0 N-CA-C 111.607 -0.597 . . . . 1.0 111.607 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -9.5 122.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.778 0.831 . . . . 1.0 112.546 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 143' ' ' GLU . 6.2 t0 89.33 -1.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.948 -1.478 . . . . 1.0 108.079 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.762 HD21 ' HB2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -71.71 144.68 88.73 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.347 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.416 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 28.3 Cg_endo -62.18 -20.33 69.61 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.13 1.887 . . . . 1.0 112.72 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.762 ' HB2' HD21 ' A' ' 145' ' ' ASN . 0.3 OUTLIER -77.2 -34.4 56.18 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 177.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.638 HD11 ' OH ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -75.23 -54.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 113.933 -1.485 . . . . 1.0 110.874 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.54 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -54.38 -54.19 43.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.2 -31.35 52.76 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.0 -1.0 . . . . 1.0 109.012 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.591 ' HB2' HD23 ' A' ' 127' ' ' LEU . . . -80.34 -45.16 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.833 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.685 HG22 ' HG2' ' A' ' 156' ' ' ARG . 30.2 mt -56.51 -49.37 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 106.587 -1.634 . . . . 1.0 106.587 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 74.2 mt-10 -60.82 -27.65 68.21 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.061 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -69.48 -50.71 42.82 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.094 -1.042 . . . . 1.0 111.192 -179.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.501 ' N ' ' HG2' ' A' ' 154' ' ' GLU . 8.6 tp10 -80.19 -50.52 10.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.967 0.728 . . . . 1.0 112.967 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.685 ' HG2' HG22 ' A' ' 152' ' ' ILE . 4.4 ppt_? -63.24 -41.12 99.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -64.12 -23.0 67.16 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.528 -0.916 . . . . 1.0 108.528 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.421 ' HA ' HH21 ' A' ' 160' ' ' ARG . 11.0 m -89.67 15.04 10.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.199 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -136.32 39.85 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.16 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.53 ' CD ' ' H ' ' A' ' 160' ' ' ARG . 0.3 OUTLIER -48.61 138.51 10.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.469 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.568 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.566 -1.414 . . . . 1.0 109.566 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.3 p 44.6 -90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.791 0.329 . . . . 1.0 110.565 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' -1' ' ' GLY . 0.1 OUTLIER -167.98 91.36 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.595 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -139.05 114.1 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.628 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -99.33 108.36 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.507 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -149.72 -66.68 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.594 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -145.4 -166.64 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.692 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.2 m -154.1 121.73 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.495 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -95.12 153.33 39.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.0 124.36 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.277 1.985 . . . . 1.0 112.002 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.45 ' H ' HG12 ' A' ' 9' ' ' VAL . 1.2 p -84.17 107.86 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.634 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.05 60.72 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.509 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 38.18 -148.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -128.7 -73.01 0.59 Allowed 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -44.51 154.79 0.11 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.345 -0.983 . . . . 1.0 108.345 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.67 151.4 41.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.437 0.637 . . . . 1.0 111.575 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.664 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -51.99 -32.67 34.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.137 -0.938 . . . . 1.0 109.03 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.59 60.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.728 -1.123 . . . . 1.0 111.948 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.15 -24.94 22.08 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.511 -0.476 . . . . 1.0 112.146 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.552 ' CG1' HD22 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.73 144.85 64.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 10.8 Cg_exo -57.59 132.42 50.3 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.039 1.826 . . . . 1.0 113.077 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.668 ' HA ' HD21 ' A' ' 23' ' ' LEU . 34.3 tt0 -49.04 -31.79 8.32 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 112.856 0.688 . . . . 1.0 112.856 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.842 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -74.18 -34.32 63.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.544 HG12 ' C ' ' A' ' 97' ' ' ASN . 14.5 m -75.88 -46.08 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.774 -177.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.973 HD23 ' H ' ' A' ' 23' ' ' LEU . 1.1 pt? -68.01 -21.01 65.06 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.515 -0.874 . . . . 1.0 109.646 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HE ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -72.0 -38.91 69.55 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.294 -1.321 . . . . 1.0 111.947 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.57 36.43 4.35 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.681 -0.771 . . . . 1.0 112.318 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.849 HD13 ' O ' ' A' ' 30' ' ' VAL . 18.5 mt -90.09 129.3 46.42 Favored Pre-proline 0 CA--C 1.503 -0.861 0 C-N-CA 119.728 -0.789 . . . . 1.0 111.823 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.02 167.48 15.9 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 N-CA-C 108.63 -1.334 . . . . 1.0 108.63 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' C ' ' HG3' ' A' ' 48' ' ' LYS . 2.7 pt-20 -57.09 -10.2 1.11 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.94 -1.482 . . . . 1.0 114.521 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.957 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -109.23 18.67 20.27 Favored 'General case' 0 CA--C 1.449 -2.907 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.283 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.849 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -138.47 123.35 22.51 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 C-N-CA 117.268 -1.773 . . . . 1.0 114.115 -175.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' HB2' HG21 ' A' ' 47' ' ' THR . 3.3 ttp180 -130.47 151.79 50.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.228 -1.805 . . . . 1.0 107.685 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 26' ' ' LEU . 2.8 mm? -98.11 124.87 42.86 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.175 -0.61 . . . . 1.0 109.881 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.44 133.48 9.57 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 115.551 -0.75 . . . . 1.0 112.353 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 35' ' ' SER . 5.9 Cg_endo -85.21 149.86 10.58 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.168 1.912 . . . . 1.0 108.389 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.4 m 152.33 -73.31 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.459 ' HB2' ' CZ2' ' A' ' 45' ' ' TRP . . . -50.82 -61.29 2.3 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 118.575 -1.25 . . . . 1.0 108.895 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 38' ' ' ASP . 4.8 p -60.94 -51.75 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.94 -0.392 . . . . 1.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.56 ' N ' HG13 ' A' ' 37' ' ' VAL . 0.8 OUTLIER 59.52 -40.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.592 0.96 . . . . 1.0 113.592 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' C ' HG22 ' A' ' 40' ' ' THR . 25.6 mttm -30.4 -36.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.172 0.295 . . . . 1.0 111.663 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.598 HG22 ' C ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER 153.41 22.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.038 0.836 . . . . 1.0 111.654 178.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 17.0 mtp180 -140.54 163.0 34.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.796 -0.762 . . . . 1.0 111.932 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 149.15 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.397 0.618 . . . . 1.0 110.88 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.78 13.63 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.694 HG23 ' CG1' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -104.87 127.25 59.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.459 ' CZ2' ' HB2' ' A' ' 36' ' ' ALA . 22.5 m95 -126.65 144.69 50.83 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.957 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.72 134.31 49.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 114.126 -1.397 . . . . 1.0 111.997 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 31' ' ' ARG . 68.4 p -119.11 -21.71 7.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.08 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.657 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -117.84 165.99 14.65 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.439 179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -77.79 125.31 7.34 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 123.04 2.493 . . . . 1.0 111.772 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.604 HD11 ' HB2' ' A' ' 29' ' ' GLU . 64.0 mt -113.1 149.58 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 113.394 -1.73 . . . . 1.0 112.801 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.833 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.87 164.64 12.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.828 -1.533 . . . . 1.0 110.261 178.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.695 ' H ' ' CE ' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -68.71 128.03 35.18 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.103 178.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 1.003 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 104.57 8.22 38.03 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-O 119.066 -0.852 . . . . 1.0 114.455 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 1.9 ttmt -82.24 130.87 35.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 117.278 -1.769 . . . . 1.0 115.308 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -88.98 120.18 30.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.682 -1.599 . . . . 1.0 113.13 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.606 ' CG ' ' OE2' ' A' ' 29' ' ' GLU . 55.0 m-85 -119.75 150.02 41.06 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.483 0.658 . . . . 1.0 112.714 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.25 -102.29 2.19 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 113.706 -1.588 . . . . 1.0 110.151 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HB3' ' CE1' ' A' ' 123' ' ' TYR . 96.3 Cg_endo -78.79 170.45 69.42 Favored 'Cis proline' 0 N--CA 1.499 1.816 0 CA-C-N 119.355 1.578 . . . . 1.0 112.414 -1.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.628 ' CD1' ' NH2' ' A' ' 100' ' ' ARG . 38.5 t80 -54.46 107.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.785 -0.766 . . . . 1.0 109.056 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.732 HG12 ' NH2' ' A' ' 100' ' ' ARG . 5.6 p -42.74 -49.51 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.967 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 60' ' ' VAL . . . 45.0 121.32 0.0 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.621 0.608 . . . . 1.0 114.621 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.87 145.93 28.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' NZ ' HD11 ' A' ' 83' ' ' LEU . 1.1 mtmp? -89.51 113.92 25.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.056 0.455 . . . . 1.0 111.679 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HZ2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -142.76 169.88 16.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.631 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' CE ' ' A' ' 64' ' ' LYS . 1.4 mppt? -80.65 133.61 35.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.374 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' O ' ' N ' ' A' ' 68' ' ' GLN . 30.8 ttp85 -45.53 -21.34 0.1 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.783 1.031 . . . . 1.0 113.783 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -35.07 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.969 0.414 . . . . 1.0 110.939 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 66' ' ' ARG . 59.5 mm-40 -95.7 -140.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.363 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.524 HG13 ' HZ2' ' A' ' 64' ' ' LYS . 15.7 m 38.87 96.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 121.521 0.676 . . . . 1.0 111.587 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -114.41 -29.5 6.86 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.707 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.69 31.7 0.1 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.214 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.506 ' CB ' ' SD ' ' A' ' 75' ' ' MET . 55.8 m-80 -89.69 -179.37 5.75 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.678 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -119.1 -55.58 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -177.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' N ' ' SD ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -66.36 46.84 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.259 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.727 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -129.78 139.58 51.24 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -162.79 163.85 26.48 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 118.999 -1.08 . . . . 1.0 113.091 175.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -103.37 122.73 45.44 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.89 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -137.17 122.67 26.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 106.932 -1.507 . . . . 1.0 106.932 179.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 1.5 t80 -80.67 125.66 30.31 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.653 ' OH ' HD11 ' A' ' 88' ' ' ILE . 20.2 m-85 -103.05 104.2 38.72 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 114.897 -1.047 . . . . 1.0 113.059 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -62.87 10.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.388 1.392 . . . . 1.0 110.811 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 80' ' ' TYR . 76.3 m-20 -97.39 2.41 50.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.745 . . . . 1.0 110.094 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.721 ' N ' HD23 ' A' ' 83' ' ' LEU . 1.1 pt? -178.23 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.015 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 86' ' ' MET . . . 150.09 179.67 26.09 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.823 -0.911 . . . . 1.0 110.823 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.439 ' C ' ' SD ' ' A' ' 86' ' ' MET . 18.2 m95 -58.15 122.37 12.96 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 19.1 mmm -127.28 167.39 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -117.75 138.04 52.3 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.265 -1.754 . . . . 1.0 106.265 173.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.653 HD11 ' OH ' ' A' ' 80' ' ' TYR . 64.3 mt -104.67 102.28 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -131.18 128.18 39.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.119 0.485 . . . . 1.0 111.33 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HA ' ' HZ3' ' A' ' 95' ' ' LYS . . . -139.73 92.47 2.56 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.219 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -111.1 13.31 21.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.366 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -108.84 99.6 35.43 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.751 -0.658 . . . . 1.0 110.938 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.426 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 50.6 Cg_exo -51.2 -14.78 1.74 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.628 2.218 . . . . 1.0 111.45 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.92 -43.84 94.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.646 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.737 ' HZ3' ' HA ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -116.28 -8.48 11.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.785 -179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.716 ' HA2' HG11 ' A' ' 60' ' ' VAL . . . -95.48 -143.1 13.77 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.125 -1.036 . . . . 1.0 113.05 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.619 ' O ' ' NH1' ' A' ' 100' ' ' ARG . 24.6 m-20 -137.18 -166.21 1.88 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.999 0.428 . . . . 1.0 110.475 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.547 ' CZ3' HG21 ' A' ' 44' ' ' VAL . 58.6 p-90 -70.4 -22.13 62.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.797 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.581 HD12 ' H ' ' A' ' 99' ' ' LEU . 5.9 mp -54.13 -24.22 17.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.074 -0.713 . . . . 1.0 109.074 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.835 ' H ' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -61.7 -10.28 8.26 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 177.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' OH ' ' CD ' ' A' ' 19' ' ' PRO . 12.8 m-85 -107.24 -11.81 15.5 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.232 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.517 ' CG1' HG23 ' A' ' 138' ' ' VAL . 55.3 t -62.88 117.66 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 119.101 -1.04 . . . . 1.0 109.878 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -152.02 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.464 ' CE3' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -124.5 165.25 18.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.372 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HA ' HD23 ' A' ' 137' ' ' LEU . . . -108.84 -131.83 0.32 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.44 -31.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.363 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.47 ' H ' ' CG ' ' A' ' 110' ' ' GLU . 4.0 m -143.78 175.7 9.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.06 -0.518 . . . . 1.0 109.695 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.95 -23.25 76.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.238 -0.745 . . . . 1.0 111.238 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 -22.37 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.732 0.301 . . . . 1.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.47 ' CG ' ' H ' ' A' ' 107' ' ' SER . 4.0 pt-20 -109.15 -25.86 10.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.127 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.6 OUTLIER -86.93 102.21 14.14 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.703 ' O ' HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -104.09 0.32 29.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.833 HD13 ' N ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -140.51 144.75 36.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -142.82 132.51 12.01 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 115.736 1.754 . . . . 1.0 115.736 -176.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.6 122.36 3.93 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.122 3.215 . . . . 1.0 114.722 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.745 HD13 ' HD2' ' A' ' 125' ' ' LYS . 1.9 tp -132.2 128.05 37.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -97.49 118.73 34.63 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.947 -0.701 . . . . 1.0 110.856 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.878 HD11 ' CG ' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -129.36 114.95 33.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.088 -1.078 . . . . 1.0 108.088 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.4 39.21 25.52 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.649 ' N ' ' HE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 67.05 17.56 10.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.004 -0.998 . . . . 1.0 110.658 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -108.69 123.82 49.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.394 -0.821 . . . . 1.0 108.974 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.4 mm -82.25 126.98 40.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.878 ' CG ' HD11 ' A' ' 118' ' ' ILE . 6.0 m-85 -122.01 155.13 36.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.167 -0.924 . . . . 1.0 109.799 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -111.68 124.22 51.88 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.745 ' HD2' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -128.76 152.82 48.01 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 1.003 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.8 p -102.04 139.73 37.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 113.111 -1.858 . . . . 1.0 110.789 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.783 ' H ' ' CE ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -107.18 -4.44 18.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.182 -1.372 . . . . 1.0 109.024 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.975 ' H ' ' NZ ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.45 131.83 11.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 114.937 -1.028 . . . . 1.0 110.435 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 145.64 60.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.601 1.534 . . . . 1.0 111.51 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.73 HG23 ' CG ' ' A' ' 134' ' ' GLU . 1.8 mt -108.39 134.48 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.703 ' HB3' ' OE1' ' A' ' 134' ' ' GLU . . . -77.15 115.77 51.67 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -38.68 113.12 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 123.004 2.469 . . . . 1.0 114.243 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 118.32 6.43 12.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.915 -0.659 . . . . 1.0 113.251 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.73 ' CG ' HG23 ' A' ' 130' ' ' ILE . 4.5 pt-20 -100.41 164.43 11.92 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.419 1.11 . . . . 1.0 111.429 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 45' ' ' TRP . 5.9 pt-20 -78.62 133.24 37.28 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.075 -0.966 . . . . 1.0 111.345 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.882 HD21 ' OE1' ' A' ' 29' ' ' GLU . 5.9 mp -86.36 122.4 30.28 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.326 -0.852 . . . . 1.0 108.941 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.754 HD12 ' C ' ' A' ' 136' ' ' LEU . 6.6 mp -130.71 158.16 40.83 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.408 -0.589 . . . . 1.0 109.408 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 139' ' ' TRP . 4.1 t -114.83 146.13 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.827 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.765 ' HZ2' ' N ' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -15.32 -118.12 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 O-C-N 125.83 1.956 . . . . 1.0 113.228 177.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.742 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 0.0 OUTLIER -124.87 18.63 8.56 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.36 1.615 . . . . 1.0 115.36 -177.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.653 ' OD1' ' C ' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.765 ' N ' ' HZ2' ' A' ' 139' ' ' TRP . . . . . . . . 0 CA--C 1.543 1.802 0 N-CA-C 111.826 -0.51 . . . . 1.0 111.826 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.916 ' O ' ' N ' ' A' ' 145' ' ' ASN . 1.7 tm-20 -177.77 -49.07 0.01 OUTLIER 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -18.97 51.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.033 1.494 . . . . 1.0 115.033 -178.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.916 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -119.48 166.94 13.2 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.159 0.584 . . . . 1.0 112.029 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.564 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 89.3 Cg_endo -98.56 -15.93 0.22 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 122.402 2.068 . . . . 1.0 112.934 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.799 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 0.6 OUTLIER -75.91 -36.97 59.23 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.466 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 1.4 mt -75.32 -55.97 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 114.758 -1.11 . . . . 1.0 109.757 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' A' ' 152' ' ' ILE . . . -61.51 -52.17 65.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.077 -0.965 . . . . 1.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -52.39 -34.27 47.24 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.78 -33.19 52.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 1.0 111.206 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 149' ' ' ALA . 58.8 mt -52.92 -50.35 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 107.6 -1.259 . . . . 1.0 107.6 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 31.7 mt-10 -59.89 -36.62 77.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.427 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 155' ' ' GLU . 0.6 OUTLIER -58.41 -46.48 86.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 119.528 -0.869 . . . . 1.0 111.566 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.512 ' N ' ' HG2' ' A' ' 154' ' ' GLU . 1.8 tp10 -79.15 -50.89 10.28 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 4.7 ppt_? -76.54 -46.8 24.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.955 0.724 . . . . 1.0 112.955 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -61.76 -23.83 66.43 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.082 0.468 . . . . 1.0 109.944 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.441 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 4.9 m -97.08 27.21 4.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.043 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -141.21 34.02 1.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.719 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -52.82 163.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.399 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.061 -0.971 . . . . 1.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.589 -1.405 . . . . 1.0 109.589 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.53 139.28 25.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.358 . . . . 1.0 110.579 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.68 105.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.588 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.94 90.48 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.596 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -46.96 131.68 12.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -59.15 177.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.489 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 5' ' ' THR . 25.5 m -155.31 57.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.542 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 m -88.56 104.88 17.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.511 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -70.16 154.85 94.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.296 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -39.32 159.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.396 2.064 . . . . 1.0 111.951 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -86.16 132.16 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.288 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB1' ' HG2' ' A' ' 34' ' ' PRO . . . 56.39 160.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.496 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . . . -85.6 -35.83 20.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 20.5 m -175.27 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.202 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' PRO . 2.9 mm-40 -57.8 166.23 1.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.101 -0.954 . . . . 1.0 111.453 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -127.42 148.88 50.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.038 -0.983 . . . . 1.0 110.593 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.946 HD12 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.39 -36.2 73.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.9 -18.73 55.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.304 -0.862 . . . . 1.0 110.271 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HB3' ' H ' ' A' ' 14' ' ' THR . 4.6 tp10 -80.28 -46.65 15.82 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.626 -0.716 . . . . 1.0 112.383 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -41.17 158.36 0.18 Allowed Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 120.173 -0.611 . . . . 1.0 109.574 -178.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' O ' HD22 ' A' ' 23' ' ' LEU . 7.4 Cg_endo -48.38 118.75 3.49 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.505 2.136 . . . . 1.0 112.093 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 3.5 tt0 -51.43 -43.24 61.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.459 1.281 . . . . 1.0 114.459 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.694 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 4.7 p80 -62.1 -29.41 70.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.095 0.474 . . . . 1.0 111.302 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.6 HG13 ' N ' ' A' ' 98' ' ' TRP . 73.2 t -72.93 -48.72 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.305 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.899 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.69 -25.88 62.28 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.175 0.988 . . . . 1.0 110.779 176.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -53.77 -34.36 58.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.433 -1.712 . . . . 1.0 109.612 -176.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.84 17.62 17.59 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.194 -0.762 . . . . 1.0 111.194 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.789 HD12 ' HD2' ' A' ' 27' ' ' PRO . 45.2 tp -79.41 122.98 84.57 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 117.081 0.441 . . . . 1.0 110.735 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.789 ' HD2' HD12 ' A' ' 26' ' ' LEU . 35.4 Cg_exo -35.23 137.26 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.286 1.324 . . . . 1.0 110.954 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.543 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 18.5 pt-20 -53.32 -31.91 46.48 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.777 -1.556 . . . . 1.0 109.373 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.5 pm0 -85.4 18.26 2.78 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 113.538 -1.664 . . . . 1.0 112.496 -176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.768 ' CG1' HD11 ' A' ' 26' ' ' LEU . 87.0 t -136.15 143.64 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 C-N-CA 118.726 -1.189 . . . . 1.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -144.0 155.36 43.99 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.192 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.946 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -102.68 148.02 26.11 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.673 0.749 . . . . 1.0 111.753 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.75 119.78 2.24 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 113.86 -1.518 . . . . 1.0 111.834 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 19.0 Cg_endo -80.69 152.02 19.53 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.899 1.732 . . . . 1.0 111.062 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.584 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 4.3 p 87.76 -27.04 0.07 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.964 0.888 . . . . 1.0 108.799 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.713 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -53.89 -62.53 1.59 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.89 -52.32 62.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.563 -0.29 . . . . 1.0 111.586 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 2.2 m-20 162.12 63.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.621 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.0 OUTLIER 30.63 36.86 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.917 -1.038 . . . . 1.0 109.365 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 91.1 m -91.96 -24.3 19.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.558 -1.655 . . . . 1.0 110.094 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 161.55 -157.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.229 -1.397 . . . . 1.0 107.229 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.19 137.55 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 106.863 -1.532 . . . . 1.0 106.863 176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.57 155.35 19.5 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 109.032 -1.627 . . . . 1.0 109.032 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 2.0 m -100.91 136.5 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.166 0.984 . . . . 1.0 110.52 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.713 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 18.9 m95 -129.97 154.25 47.56 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.477 -1.692 . . . . 1.0 110.37 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.642 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -70.88 144.18 50.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.242 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.65 -26.54 2.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.389 -0.525 . . . . 1.0 110.381 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -120.44 158.77 50.38 Favored Pre-proline 0 C--N 1.341 0.215 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.96 124.73 16.62 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.424 2.083 . . . . 1.0 112.379 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 130' ' ' ILE . 3.9 mt -112.18 131.27 64.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.584 -1.189 . . . . 1.0 108.425 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.944 ' H ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.42 146.11 36.44 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 122.26 1.029 . . . . 1.0 111.314 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -50.69 133.63 25.59 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 113.324 -1.762 . . . . 1.0 107.532 177.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.77 2.06 52.57 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.612 -1.28 . . . . 1.0 115.447 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 26.6 ttpt -96.29 140.72 30.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.913 1.357 . . . . 1.0 112.594 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -99.21 135.59 40.4 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.947 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 34.3 m-85 -115.72 126.67 54.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.216 0.531 . . . . 1.0 112.093 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.69 -132.04 7.32 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 119.362 -0.688 . . . . 1.0 112.983 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 37.3 Cg_endo -80.62 171.97 58.26 Favored 'Cis proline' 0 N--CA 1.511 2.551 0 CA-C-N 120.03 1.915 . . . . 1.0 114.305 3.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.759 ' CD2' ' ND2' ' A' ' 97' ' ' ASN . 1.6 t80 -72.44 122.15 20.78 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-O 121.672 0.748 . . . . 1.0 109.531 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.793 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 63.8 t -102.9 138.65 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.169 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.39 -171.23 26.03 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 109.334 -1.506 . . . . 1.0 109.334 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -100.48 138.83 37.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.907 0.384 . . . . 1.0 110.499 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -90.84 117.28 29.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.636 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -140.4 164.81 29.11 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.297 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.19 145.16 33.8 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.653 0.264 . . . . 1.0 110.764 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -50.27 -44.5 53.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.858 0.361 . . . . 1.0 110.161 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 p -70.26 70.39 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.432 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.0 -36.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.789 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.596 HG11 ' HE2' ' A' ' 75' ' ' MET . 13.1 m -96.52 154.48 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.104 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -132.92 -90.62 0.39 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.48 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -69.94 48.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.253 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.614 HD21 ' CG2' ' A' ' 91' ' ' THR . 0.7 OUTLIER -118.25 -175.18 2.81 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.628 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 73' ' ' VAL . 4.3 p -174.64 -9.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.56 . . . . 1.0 111.92 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' CB ' ' HB3' ' A' ' 90' ' ' ALA . 4.9 m-85 -92.37 43.18 1.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -118.03 156.47 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.826 -178.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.66 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -135.3 166.89 22.09 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.446 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -126.43 128.03 46.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.764 0.316 . . . . 1.0 110.744 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.56 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -141.77 141.51 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.294 0.568 . . . . 1.0 112.405 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 15.9 t80 -91.19 125.29 35.92 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.855 0.687 . . . . 1.0 112.855 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CD2' HD23 ' A' ' 83' ' ' LEU . 7.1 m-85 -102.22 145.56 30.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.841 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.62 3.22 5.59 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.72 1.614 . . . . 1.0 109.706 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -125.41 -68.77 0.82 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.412 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.832 HD22 ' H ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -74.41 -23.38 58.94 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.102 -178.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.39 -152.65 25.58 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 108.78 -1.728 . . . . 1.0 108.78 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -63.42 119.22 9.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.39 -0.924 . . . . 1.0 110.119 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.56 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.7 ppp? -129.46 169.15 15.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.838 -1.073 . . . . 1.0 108.951 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' LYS . 26.2 m -121.02 144.79 48.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.36 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 mt -98.58 146.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 106.8 -1.555 . . . . 1.0 106.8 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -130.79 139.5 50.22 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.078 0.77 . . . . 1.0 113.078 -177.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.619 ' HB1' ' HD3' ' A' ' 100' ' ' ARG . . . -130.66 140.62 50.39 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.615 -1.624 . . . . 1.0 106.615 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.614 ' CG2' HD21 ' A' ' 72' ' ' ASN . 3.4 p -151.63 15.7 0.68 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.987 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.26 141.83 0.13 Allowed Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 120.272 -0.571 . . . . 1.0 110.815 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.488 ' O ' HG21 ' A' ' 22' ' ' VAL . 55.2 Cg_endo -70.81 -18.18 32.25 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.263 1.975 . . . . 1.0 112.597 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -78.04 -6.19 53.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.826 0.822 . . . . 1.0 109.277 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.39 9.77 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.375 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 97' ' ' ASN . . . 94.26 156.16 32.13 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.456 -1.058 . . . . 1.0 110.456 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.793 ' CG ' ' H ' ' A' ' 60' ' ' VAL . 17.2 t30 84.07 110.01 0.06 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.463 1.283 . . . . 1.0 114.463 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.6 ' N ' HG13 ' A' ' 22' ' ' VAL . 70.0 p-90 -71.31 -25.53 62.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.187 0.518 . . . . 1.0 109.759 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 102' ' ' VAL . 1.7 mt -60.08 -24.46 64.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.636 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.619 ' HD3' ' HB1' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -68.29 -11.1 58.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 119.107 -0.473 . . . . 1.0 111.234 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 98' ' ' TRP . 0.1 OUTLIER -120.14 5.87 10.79 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.613 -0.835 . . . . 1.0 113.173 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 99' ' ' LEU . 8.8 p -78.65 119.0 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.291 -0.564 . . . . 1.0 110.825 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -80.98 114.75 20.07 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.62 ' HB2' ' H ' ' A' ' 138' ' ' VAL . 4.9 p90 -88.03 159.09 18.42 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 114.779 1.4 . . . . 1.0 114.779 -177.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' A' ' 104' ' ' TRP . . . -38.72 159.55 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 113.772 -1.558 . . . . 1.0 113.45 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.27 -4.4 21.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.134 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.64 -30.6 0.09 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.561 -0.456 . . . . 1.0 111.974 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.67 -29.37 6.64 Favored Glycine 0 C--N 1.321 -0.28 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.24 -19.46 5.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.513 ' HG3' HD23 ' A' ' 137' ' ' LEU . 20.2 pt-20 -112.76 -24.37 9.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.483 -0.78 . . . . 1.0 111.389 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.645 ' CD ' ' O ' ' A' ' 139' ' ' TRP . 1.1 tp-100 -48.2 139.12 8.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.101 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.712 ' C ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -124.98 6.73 7.97 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 119.154 -0.451 . . . . 1.0 112.106 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.987 HD12 ' N ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -154.96 174.56 14.99 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 118.263 0.483 . . . . 1.0 110.084 176.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.987 ' N ' HD12 ' A' ' 113' ' ' LEU . 1.6 p90 -139.62 145.6 44.15 Favored Pre-proline 0 C--N 1.346 0.425 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 139' ' ' TRP . 70.5 Cg_endo -82.38 138.2 9.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.754 2.303 . . . . 1.0 113.892 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -139.52 134.5 32.32 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.894 179.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.766 ' N ' HD23 ' A' ' 116' ' ' LEU . 40.4 mt-10 -89.25 123.71 33.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.223 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 121' ' ' ALA . 15.3 mt -139.6 129.49 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 46.14 43.01 10.58 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.114 -0.634 . . . . 1.0 110.012 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? 62.87 17.51 10.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.904 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 118' ' ' ILE . . . -121.99 128.71 51.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.196 -1.038 . . . . 1.0 108.196 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.445 HD13 ' CE3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -88.93 116.46 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.692 -0.803 . . . . 1.0 112.676 -177.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.52 ' HB2' ' HZ3' ' A' ' 125' ' ' LYS . 13.7 m-85 -108.06 156.67 19.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.157 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.591 ' HB3' HD13 ' A' ' 113' ' ' LEU . 5.4 m-30 -112.89 125.78 54.75 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 107.575 -1.268 . . . . 1.0 107.575 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' A' ' 114' ' ' PHE . 2.0 mptt -116.53 139.23 50.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 112.344 0.498 . . . . 1.0 112.344 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -131.82 125.59 32.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 118.676 -0.678 . . . . 1.0 112.453 178.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.924 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -98.96 21.42 11.65 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 119.911 -0.716 . . . . 1.0 109.592 175.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.712 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -124.53 119.51 25.99 Favored Pre-proline 0 C--N 1.332 -0.157 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -61.23 97.78 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.963 0 CA-C-N 120.628 1.26 . . . . 1.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.695 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -69.62 136.42 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.447 -176.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.54 132.8 51.13 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.302 0.852 . . . . 1.0 113.302 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.04 103.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.163 1.908 . . . . 1.0 111.675 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 124.82 -7.22 8.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.062 -0.589 . . . . 1.0 113.164 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 135' ' ' GLU . 1.4 pp20? -87.7 154.14 20.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.942 0.871 . . . . 1.0 111.026 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.454 ' O ' ' OE2' ' A' ' 134' ' ' GLU . 1.6 pm0 -73.71 125.08 27.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.233 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 137' ' ' LEU . 10.9 mp -78.39 124.85 28.57 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 4.2 mp -123.56 146.1 48.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-O 118.982 -0.532 . . . . 1.0 112.18 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.62 ' H ' ' HB2' ' A' ' 104' ' ' TRP . 9.4 t -104.46 132.96 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.645 ' O ' ' CD ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 92.36 142.27 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 125.19 1.396 . . . . 1.0 110.869 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 141' ' ' IAS . 8.1 t80 -118.62 163.37 16.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.825 1.417 . . . . 1.0 114.825 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.605 ' N ' ' CD1' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 140' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.396 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 143' ' ' GLU . 2.6 mp0 53.82 88.9 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.853 -0.174 . . . . 1.0 110.946 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.495 ' N ' HG21 ' A' ' 148' ' ' ILE . 55.4 t0 -103.29 -41.44 6.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 116.663 2.098 . . . . 1.0 116.663 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.667 HD22 ' CG1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -66.07 156.28 84.82 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 119.933 -0.707 . . . . 1.0 112.817 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 150' ' ' ALA . 8.9 Cg_endo -48.13 -71.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.55 2.167 . . . . 1.0 110.131 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.765 ' O ' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -55.52 -20.7 13.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.229 0.537 . . . . 1.0 110.169 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.804 ' O ' HD12 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -74.44 -56.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 119.31 -0.956 . . . . 1.0 108.92 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -74.09 -34.82 64.1 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.548 -0.861 . . . . 1.0 109.744 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 146' ' ' PRO . . . -80.25 -66.6 0.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.603 -0.839 . . . . 1.0 110.765 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 147' ' ' GLU . . . -51.75 -29.54 19.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 117.834 -1.546 . . . . 1.0 110.868 -174.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.804 HD12 ' O ' ' A' ' 148' ' ' ILE . 55.9 mt -66.4 -53.12 39.34 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.405 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.744 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 0.7 OUTLIER -68.09 -37.6 81.4 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.188 -0.915 . . . . 1.0 113.126 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.546 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 7.2 pt-20 -57.64 -50.12 74.2 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.889 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.546 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 26.8 tp10 -76.29 -50.1 15.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.382 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.737 ' NH2' ' HB2' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -77.57 -49.78 13.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.783 -179.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -63.84 -23.61 67.42 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.115 -0.634 . . . . 1.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.41 -35.18 0.25 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.578 . . . . 1.0 111.243 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -129.45 136.07 49.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.954 0.407 . . . . 1.0 111.134 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -142.83 -49.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.577 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.019 -0.991 . . . . 1.0 110.593 -179.884 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 71.9 p -140.21 11.64 2.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.72 0.295 . . . . 1.0 110.544 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mmt -133.35 40.63 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.477 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -103.66 169.85 8.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.484 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.65 36.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 5' ' ' THR . 1.9 p-10 -169.36 -62.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.502 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.659 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 51.3 m 43.72 85.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 m -104.43 102.4 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.547 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.06 153.51 88.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.318 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.21 169.4 19.57 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.246 1.964 . . . . 1.0 112.248 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 9' ' ' VAL . 47.7 t -144.7 50.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.56 176.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.498 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . . . -80.99 -45.83 16.0 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.186 -0.461 . . . . 1.0 109.949 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 11' ' ' ALA . 88.1 m -169.93 -78.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 34' ' ' PRO . 1.7 mt-10 -50.93 165.54 0.11 Allowed 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.539 0.685 . . . . 1.0 110.735 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.696 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -126.72 153.81 44.98 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.648 -0.706 . . . . 1.0 111.913 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.776 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -52.31 -31.89 35.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.95 -17.77 56.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.073 -1.422 . . . . 1.0 110.131 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.696 ' CB ' ' H ' ' A' ' 14' ' ' THR . 12.8 tp10 -77.97 -47.92 17.45 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.292 0.849 . . . . 1.0 113.292 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.68 HG23 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -48.85 147.8 4.3 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 107.218 -1.401 . . . . 1.0 107.218 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.68 ' HD2' HG23 ' A' ' 18' ' ' VAL . 5.2 Cg_exo -52.39 130.52 36.38 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.199 1.266 . . . . 1.0 111.898 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 4.4 tt0 -52.15 -34.94 46.99 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 114.564 -1.198 . . . . 1.0 113.011 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.814 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -79.27 -35.26 41.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.573 0.953 . . . . 1.0 113.573 -177.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.826 HG21 ' O ' ' A' ' 93' ' ' PRO . 1.6 t -79.52 -31.2 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.64 HD13 HG13 ' A' ' 18' ' ' VAL . 15.6 tp -71.81 -41.57 68.08 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.753 -2.021 . . . . 1.0 110.831 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -81.54 -20.02 40.89 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.164 0.585 . . . . 1.0 112.279 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.75 -26.98 36.31 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 110.148 -1.181 . . . . 1.0 110.148 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.689 ' HB3' ' CG ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -63.76 144.13 97.97 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 117.907 -1.517 . . . . 1.0 111.564 -178.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HG2' ' CD1' ' A' ' 56' ' ' PHE . 50.8 Cg_exo -50.04 151.68 8.5 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 120.988 1.125 . . . . 1.0 111.871 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt-20 -52.84 -31.08 37.24 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.985 -1.461 . . . . 1.0 110.407 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.648 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -87.93 20.53 3.06 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 115.017 -0.992 . . . . 1.0 111.181 -178.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.643 HG12 HD22 ' A' ' 26' ' ' LEU . 21.4 t -135.29 137.03 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 C-N-CA 119.52 -0.872 . . . . 1.0 110.879 -177.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.544 ' NH1' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER -146.26 159.45 43.32 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 110.005 -0.368 . . . . 1.0 110.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.795 ' N ' HD22 ' A' ' 32' ' ' LEU . 1.1 mm? -104.57 141.08 37.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -152.16 120.82 3.31 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.772 -0.632 . . . . 1.0 111.654 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.564 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 9.8 Cg_endo -82.1 151.69 16.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 121.693 1.596 . . . . 1.0 111.689 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB3' ' N ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 78.06 15.6 1.43 Allowed 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 106.46 -1.682 . . . . 1.0 106.46 -177.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.654 ' HB1' ' CZ2' ' A' ' 45' ' ' TRP . . . -89.55 -64.53 1.13 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.62 -29.77 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 40' ' ' THR . 0.0 OUTLIER 78.44 -11.79 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.18 -0.918 . . . . 1.0 112.636 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 40' ' ' THR . 1.3 pttp -49.92 -12.19 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 4.9 m 98.84 64.41 0.0 OUTLIER 'General case' 0 C--N 1.347 0.463 0 O-C-N 124.77 1.294 . . . . 1.0 110.485 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.418 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER 171.99 -165.09 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.196 -0.911 . . . . 1.0 108.951 178.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.531 HG13 ' N ' ' A' ' 34' ' ' PRO . 2.4 tt -101.62 144.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.58 163.02 22.78 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 109.316 -1.513 . . . . 1.0 109.316 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.565 HG23 HG13 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -99.66 136.24 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 CA-C-O 121.263 0.554 . . . . 1.0 109.724 -178.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.654 ' CZ2' ' HB1' ' A' ' 36' ' ' ALA . 28.6 m95 -129.29 151.84 49.5 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.881 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.57 144.67 54.47 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.085 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.544 ' CG2' ' NH1' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -126.44 -29.64 2.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.538 -178.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -124.5 159.99 55.21 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.13 123.95 13.73 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.195 1.93 . . . . 1.0 112.937 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.564 ' C ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -111.04 131.52 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.145 -1.389 . . . . 1.0 107.544 179.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.003 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -109.72 155.24 21.8 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.925 0.869 . . . . 1.0 111.034 -178.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -63.42 133.76 54.53 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.03 -1.441 . . . . 1.0 109.027 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 100.72 1.94 55.26 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 119.503 -1.332 . . . . 1.0 115.107 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 15.3 ttpt -90.1 134.34 34.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.167 -1.013 . . . . 1.0 112.485 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.08 130.43 36.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.14 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 5.5 m-85 -115.36 127.37 55.36 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.728 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.594 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 146.17 -146.97 17.59 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 5.1 Cg_endo -79.87 166.51 77.01 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 CA-C-N 119.583 1.692 . . . . 1.0 115.118 0.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.744 ' HA ' HD12 ' A' ' 99' ' ' LEU . 25.5 t80 -83.17 111.83 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.246 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.821 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.8 t -43.24 -61.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.401 -2.181 . . . . 1.0 114.079 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.52 ' N ' HG12 ' A' ' 60' ' ' VAL . . . 32.35 106.34 0.0 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-O 121.469 0.483 . . . . 1.0 112.931 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -72.81 143.13 47.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 80' ' ' TYR . 1.7 mptp? -92.62 117.67 30.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.587 0.708 . . . . 1.0 112.79 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.695 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -141.91 167.89 21.07 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.677 -1.147 . . . . 1.0 111.213 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -78.95 135.86 37.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.1 0.476 . . . . 1.0 110.435 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -48.07 -24.39 1.08 Allowed 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.964 -0.46 . . . . 1.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.68 -6.29 58.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.449 -0.342 . . . . 1.0 111.403 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -70.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.674 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.825 HG23 ' H ' ' A' ' 70' ' ' LYS . 3.9 m -36.57 -93.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.427 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.825 ' H ' HG23 ' A' ' 69' ' ' VAL . 4.6 tttm 84.82 -4.75 0.96 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.866 0.365 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.85 52.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.104 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.819 HD21 HG21 ' A' ' 91' ' ' THR . 0.7 OUTLIER -154.66 -164.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.61 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 73' ' ' VAL . 7.5 p -169.54 -8.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.486 -0.886 . . . . 1.0 112.939 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.8 m-85 -94.54 62.85 2.87 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.723 ' SD ' HG11 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -120.73 150.38 41.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.504 -177.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.678 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -128.58 165.35 20.96 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.802 -0.635 . . . . 1.0 109.845 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -123.88 132.04 53.68 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.749 0.277 . . . . 1.0 111.749 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.567 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -146.73 141.33 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.512 0.672 . . . . 1.0 112.798 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -83.51 124.94 31.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.286 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.531 ' CE1' ' HG3' ' A' ' 120' ' ' ARG . 4.4 m-85 -102.95 120.09 53.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.28 -12.86 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 N-CA-C 109.208 -1.112 . . . . 1.0 109.208 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' N ' ' C ' ' A' ' 80' ' ' TYR . 1.1 m-80 -101.16 -86.96 0.4 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.78 -1.1 . . . . 1.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.913 HD22 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 119.794 -0.762 . . . . 1.0 110.842 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . 89.46 -139.77 15.32 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.905 -1.678 . . . . 1.0 108.905 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.1 118.58 12.18 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.47 -0.892 . . . . 1.0 110.378 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.567 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -128.9 170.15 13.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.139 178.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.9 m -115.01 142.47 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.152 -0.619 . . . . 1.0 111.439 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.513 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 16.9 mt -96.22 152.08 3.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.58 ' CB ' ' HZ3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -129.39 136.16 49.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.312 0.577 . . . . 1.0 112.312 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.612 ' C ' HG22 ' A' ' 91' ' ' THR . . . -133.39 142.23 48.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.819 HG21 HD21 ' A' ' 72' ' ' ASN . 0.0 OUTLIER 161.28 7.98 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 96' ' ' GLY . 5.4 p30 -117.07 62.79 3.08 Favored Pre-proline 0 C--O 1.22 -0.499 0 CA-C-N 114.565 -1.198 . . . . 1.0 109.433 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.826 ' O ' HG21 ' A' ' 22' ' ' VAL . 6.0 Cg_exo -45.68 -13.86 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.566 2.178 . . . . 1.0 112.143 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.535 ' O ' ' ND1' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -78.2 -42.93 29.89 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.094 0.949 . . . . 1.0 110.065 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -11.71 12.67 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.134 -1.393 . . . . 1.0 110.143 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.821 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -63.29 -62.36 5.46 Favored Glycine 0 C--O 1.18 -3.269 0 CA-C-N 114.472 -1.24 . . . . 1.0 112.768 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.609 HD22 ' C ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER 138.09 150.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.638 0.775 . . . . 1.0 109.621 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.689 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 56.0 p-90 -56.68 -22.72 36.8 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 59' ' ' PHE . 41.7 mt -56.22 -33.37 65.31 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.491 -0.884 . . . . 1.0 109.524 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.602 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -75.91 -9.93 59.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 177.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 98' ' ' TRP . 12.3 m-85 -90.33 -9.76 46.59 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.6 131.16 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 114.651 -1.159 . . . . 1.0 111.438 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -97.01 -158.86 0.7 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.109 -1.405 . . . . 1.0 110.033 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 24.5 p90 -136.72 164.26 28.67 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.524 -1.216 . . . . 1.0 112.058 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.969 ' HB3' ' HE1' ' A' ' 139' ' ' TRP . . . -87.2 140.24 29.74 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.261 0.837 . . . . 1.0 113.261 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -76.0 -13.29 60.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 177.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -142.66 132.04 23.56 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.707 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -46.97 -17.17 0.27 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.189 -0.764 . . . . 1.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' C ' ' A' ' 107' ' ' SER . 10.7 mm-40 -77.41 -32.88 55.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.861 0.362 . . . . 1.0 110.44 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 137' ' ' LEU . 25.4 tp10 -88.69 -22.88 23.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.321 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.935 HE22 ' N ' ' A' ' 139' ' ' TRP . 3.8 tp60 -59.42 142.47 52.24 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.51 0.671 . . . . 1.0 109.392 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.599 ' HA ' ' HZ2' ' A' ' 128' ' ' LYS . 33.2 p30 -144.3 14.19 1.62 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.6 -1.182 . . . . 1.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -148.54 166.88 26.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.444 -0.503 . . . . 1.0 110.243 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -152.45 130.76 6.27 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 119.093 -1.043 . . . . 1.0 112.552 178.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.44 139.59 20.82 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.241 1.96 . . . . 1.0 113.96 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -142.4 138.76 31.37 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.517 178.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.713 ' H ' HD23 ' A' ' 116' ' ' LEU . 3.7 tm-20 -92.16 119.26 31.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 123' ' ' TYR . 23.4 mt -138.11 130.05 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 120.629 -0.428 . . . . 1.0 111.162 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 51.2 50.63 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.311 0.577 . . . . 1.0 111.473 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.531 ' HG3' ' CE1' ' A' ' 80' ' ' TYR . 1.3 tpp180 65.55 1.64 1.77 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.51 -0.476 . . . . 1.0 112.034 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.4 158.06 27.97 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.276 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -107.69 110.78 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 C-N-CA 119.785 -0.766 . . . . 1.0 112.011 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.3 m-85 -101.53 152.58 20.61 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.976 -1.011 . . . . 1.0 108.761 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.595 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 10.6 m-30 -113.86 127.26 55.92 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.616 ' NZ ' ' N ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -118.14 142.62 47.24 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 121.5 0.667 . . . . 1.0 112.103 -179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.41 ' C ' HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -130.22 120.21 24.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.346 -1.297 . . . . 1.0 111.605 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.985 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -96.41 27.92 3.56 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 120.265 -0.574 . . . . 1.0 109.523 177.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HZ2' ' HA ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -129.0 123.36 21.8 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -68.04 94.99 0.41 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 CA-C-N 120.736 1.299 . . . . 1.0 109.14 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 112' ' ' ASN . 1.3 mt -71.45 136.05 26.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.465 0.65 . . . . 1.0 109.311 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.83 132.67 63.67 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 114.995 -1.002 . . . . 1.0 113.282 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.53 104.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.923 1.749 . . . . 1.0 111.781 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.06 -7.81 8.1 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.6 150.95 23.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.273 0.559 . . . . 1.0 111.485 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 112' ' ' ASN . 0.6 OUTLIER -79.73 136.96 36.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.773 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.4 mp -89.53 136.66 32.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.697 -0.483 . . . . 1.0 109.697 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 105' ' ' ALA . 1.9 mm? -123.44 135.39 54.07 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.529 0.937 . . . . 1.0 113.529 -176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 139' ' ' TRP . 1.7 t -104.79 131.81 52.98 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.03 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.969 ' HE1' ' HB3' ' A' ' 105' ' ' ALA . 6.8 p-90 142.27 -126.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.502 1.521 . . . . 1.0 109.886 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.683 ' N ' ' CG ' ' A' ' 139' ' ' TRP . 0.1 OUTLIER 100.25 26.82 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.416 1.486 . . . . 1.0 109.681 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.517 ' OD1' ' C ' ' A' ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.471 1.025 0 N-CA-C 111.771 -0.532 . . . . 1.0 111.771 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 3.7 tt0 32.77 52.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.264 0.554 . . . . 1.0 111.464 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -87.56 -35.3 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.296 -0.865 . . . . 1.0 111.596 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.688 ' HB3' ' HB ' ' A' ' 148' ' ' ILE . 9.5 t30 -66.83 172.1 3.77 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 114.054 -1.43 . . . . 1.0 110.279 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 150' ' ' ALA . 93.2 Cg_endo -93.2 -62.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.792 2.328 . . . . 1.0 110.092 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 151' ' ' ALA . 24.7 mt-10 -55.07 -22.56 16.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.724 0.774 . . . . 1.0 110.1 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 145' ' ' ASN . 0.1 OUTLIER -78.48 -55.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.454 178.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.558 ' N ' ' CG2' ' A' ' 148' ' ' ILE . . . -75.87 -49.61 17.41 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.292 1.044 . . . . 1.0 109.431 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 146' ' ' PRO . . . -55.04 -65.74 0.53 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.11 -1.859 . . . . 1.0 109.055 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 147' ' ' GLU . . . -53.72 -36.47 62.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 118.103 -1.439 . . . . 1.0 111.209 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 63.8 mt -57.96 -53.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 C-N-CA 117.576 -1.65 . . . . 1.0 108.601 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.78 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -66.87 -29.93 69.97 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.815 0.697 . . . . 1.0 111.893 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.508 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 2.8 pt-20 -67.42 -53.23 30.93 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.137 -1.025 . . . . 1.0 111.399 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 0.8 OUTLIER -82.28 -50.2 9.22 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 113.205 0.817 . . . . 1.0 113.205 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.572 ' HE ' ' C ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -64.07 -42.21 97.07 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 120.428 -0.509 . . . . 1.0 112.348 -178.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -75.53 -23.37 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.245 -0.582 . . . . 1.0 111.233 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 46.7 t -37.08 121.9 0.82 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.885 0.374 . . . . 1.0 110.976 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . 66.69 88.35 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.72 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -139.08 92.49 2.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.479 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.578 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 6.1 t -158.28 71.22 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.21 105.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -143.71 -16.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.577 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.3 105.8 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.27 139.69 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.587 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.42 94.34 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.513 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.2 m -166.04 124.19 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.742 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 1.7 mp0 -121.59 99.71 44.84 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.207 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ALA . 2.9 Cg_exo -59.14 -177.65 0.12 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 121.524 1.483 . . . . 1.0 111.712 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -50.61 86.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.319 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . 173.17 154.35 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.505 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -75.07 -67.49 0.64 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.742 HG22 ' N ' ' A' ' 13' ' ' GLU . 81.6 m -174.83 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.742 ' N ' HG22 ' A' ' 12' ' ' THR . 4.6 mm-40 53.8 -84.55 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.672 ' HB ' ' H ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -140.2 176.32 8.86 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.0 174.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 16' ' ' ALA . 2.5 tt -58.12 -56.73 18.25 Favored 'General case' 0 CA--C 1.47 -2.128 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 175.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.691 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -80.87 -54.55 5.49 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 111.853 -2.431 . . . . 1.0 106.911 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.882 ' HG2' HG13 ' A' ' 18' ' ' VAL . 1.1 tt0 160.24 -21.37 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 115.777 1.769 . . . . 1.0 115.777 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.882 HG13 ' HG2' ' A' ' 17' ' ' GLU 0.279 1.1 m -145.17 -178.66 0.81 Allowed Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 120.457 1.481 . . . . 1.0 111.709 -175.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 4.2 Cg_exo -38.4 151.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.362 2.708 . . . . 1.0 111.113 173.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.704 ' HA ' HD11 ' A' ' 23' ' ' LEU . 13.7 tt0 -67.75 -34.26 76.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 115.778 1.77 . . . . 1.0 115.778 -176.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -73.63 -25.22 60.2 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -68.6 -51.37 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.769 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.84 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.05 -24.76 66.02 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.08 0.943 . . . . 1.0 110.617 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.727 -1.579 . . . . 1.0 108.801 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.41 3.98 47.3 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.951 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.903 HD11 HD11 ' A' ' 32' ' ' LEU . 11.6 mt -62.6 158.51 49.88 Favored Pre-proline 0 CA--C 1.491 -1.309 0 CA-C-N 118.311 1.055 . . . . 1.0 110.256 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.66 145.36 51.73 Favored 'Trans proline' 0 C--N 1.29 -2.552 0 N-CA-C 107.338 -1.832 . . . . 1.0 107.338 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.434 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 19.7 pt-20 -49.01 -30.23 5.86 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.333 1.063 . . . . 1.0 110.944 -176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 1.4 pm0 -87.39 25.63 1.38 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.002 -1.454 . . . . 1.0 112.463 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 26' ' ' LEU . 11.2 t -143.33 148.91 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 C-N-CA 118.828 -1.149 . . . . 1.0 111.977 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.922 ' C ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -158.34 155.36 28.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.007 -1.906 . . . . 1.0 106.407 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.042 ' H ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -128.73 151.05 49.98 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.439 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -156.93 142.57 12.69 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 124.209 0.943 . . . . 1.0 113.481 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 45.8 Cg_endo -86.83 150.16 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.699 2.266 . . . . 1.0 109.634 174.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.2 m 85.76 15.75 0.14 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 107.264 -1.384 . . . . 1.0 107.264 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.53 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -90.84 -61.11 1.74 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.69 -1.967 . . . . 1.0 105.69 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -67.46 -51.55 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.263 -1.335 . . . . 1.0 112.946 -178.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 40' ' ' THR . 27.8 t70 179.56 46.76 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER 30.11 39.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 122.17 0.986 . . . . 1.0 110.187 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.6 m -127.11 -56.23 1.34 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.714 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 37' ' ' VAL . 6.7 mtm180 -120.08 157.53 28.75 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.228 -2.26 . . . . 1.0 107.324 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.673 HG12 ' OE1' ' A' ' 17' ' ' GLU . 10.3 tt -103.64 146.39 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 CA-C-O 118.706 -0.664 . . . . 1.0 109.934 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 17' ' ' GLU . . . -140.46 173.04 23.27 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 119.275 -1.44 . . . . 1.0 114.08 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.697 ' HB ' HD12 ' A' ' 32' ' ' LEU . 1.5 m -101.75 131.39 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.53 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 27.0 m95 -125.88 146.91 49.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.15 -0.932 . . . . 1.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -71.4 144.0 49.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.538 -0.756 . . . . 1.0 112.201 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.488 ' CG2' ' HB3' ' A' ' 31' ' ' ARG . 45.1 p -119.76 -30.0 4.88 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.103 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' H ' ' HA ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -119.19 158.66 47.84 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.39 123.05 12.86 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 121.873 1.715 . . . . 1.0 111.593 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.406 ' C ' HD13 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -104.19 133.43 48.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.984 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.9 157.35 19.96 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.29 1.043 . . . . 1.0 111.757 -177.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.77 130.05 42.06 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.464 -1.698 . . . . 1.0 108.938 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 102.78 3.39 49.37 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 119.607 -1.282 . . . . 1.0 115.797 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HE3' ' CZ ' ' A' ' 56' ' ' PHE . 24.7 ttpt -92.48 143.7 26.09 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.733 1.267 . . . . 1.0 113.063 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 133.6 41.77 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.751 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' ' HE3' ' A' ' 54' ' ' LYS . 20.9 m-85 -115.78 129.11 56.32 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.884 -1.053 . . . . 1.0 108.206 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.745 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 132.95 -149.42 19.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.19 -1.005 . . . . 1.0 112.461 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 70.0 Cg_endo -89.17 153.03 30.93 Favored 'Cis proline' 0 N--CA 1.51 2.497 0 CA-C-N 119.214 1.507 . . . . 1.0 115.206 0.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.808 ' CA ' HD12 ' A' ' 99' ' ' LEU . 3.9 t80 -58.01 112.88 1.65 Allowed 'General case' 0 CA--C 1.495 -1.142 0 CA-C-O 122.08 0.943 . . . . 1.0 111.905 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.759 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -86.25 134.31 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.781 -1.554 . . . . 1.0 108.033 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.52 147.84 17.25 Favored Glycine 0 C--N 1.316 -0.582 0 N-CA-C 108.84 -1.704 . . . . 1.0 108.84 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -69.15 142.12 54.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.456 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.4 mptt -92.38 115.75 28.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.31 0.576 . . . . 1.0 111.883 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -142.59 167.56 21.81 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.649 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.657 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -77.98 149.04 34.16 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.28 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -61.26 -48.56 80.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 1.0 110.73 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 t -67.14 63.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.322 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 66' ' ' ARG . 1.9 mm-40 -157.51 -48.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.482 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -68.7 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.749 -0.659 . . . . 1.0 111.774 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' VAL . 16.5 tttm 83.29 157.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.055 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.74 17.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.98 0.419 . . . . 1.0 110.226 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.5 ' OD1' ' SD ' ' A' ' 75' ' ' MET . 0.4 OUTLIER -110.65 -165.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.023 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' A' ' 75' ' ' MET . 2.0 p -173.58 -23.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 119.469 -0.892 . . . . 1.0 111.835 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' C ' ' SD ' ' A' ' 75' ' ' MET . 6.1 m-85 -76.38 35.96 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.705 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -117.35 152.6 34.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.119 -177.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.616 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -134.02 166.79 21.92 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.165 -0.679 . . . . 1.0 109.165 -178.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -133.48 125.58 29.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.186 0.517 . . . . 1.0 110.576 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.54 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.39 139.56 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.544 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.548 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 49.7 t80 -87.15 129.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.644 0.735 . . . . 1.0 111.228 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.523 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 4.7 m-85 -105.73 140.42 21.18 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 113.887 -1.506 . . . . 1.0 110.956 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.56 17.04 0.98 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.849 1.7 . . . . 1.0 110.83 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.65 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -149.07 -31.46 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.92 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.65 HD12 ' ND2' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -106.09 -16.61 14.56 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.962 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.31 -165.3 53.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -62.84 121.28 13.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.549 -0.86 . . . . 1.0 109.881 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' A' ' 78' ' ' VAL . 1.3 ppp? -130.96 168.66 16.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.14 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' LYS . 54.4 m -123.84 144.64 49.61 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.933 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 59' ' ' PHE . 82.8 mt -99.93 146.14 9.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 177.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 7.4 p-10 -133.61 119.29 19.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.349 0.977 . . . . 1.0 112.012 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.408 ' HB3' ' HE ' ' A' ' 100' ' ' ARG . . . -143.0 90.99 2.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.71 0.85 28.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 119.618 1.099 . . . . 1.0 110.213 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -128.89 131.55 23.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.819 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 96' ' ' GLY . 65.9 Cg_exo -48.97 -28.78 14.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.845 1.697 . . . . 1.0 113.728 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.22 -18.69 45.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.313 1.054 . . . . 1.0 108.428 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -88.63 18.19 4.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.123 -1.853 . . . . 1.0 109.473 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' PRO . . . -174.36 166.09 37.89 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.96 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.773 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -71.6 175.3 5.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.293 -1.002 . . . . 1.0 108.293 177.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.656 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 25.9 p-90 -56.44 -22.01 29.2 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.908 -0.717 . . . . 1.0 112.732 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.808 HD12 ' CA ' ' A' ' 59' ' ' PHE . 19.2 mt -53.71 -28.05 31.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 177.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' NH2' ' HE1' ' A' ' 76' ' ' TRP . 13.6 tpp180 -74.88 -12.9 60.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.949 -0.569 . . . . 1.0 112.006 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.882 ' CD2' HG11 ' A' ' 18' ' ' VAL . 15.9 p90 -123.56 4.15 8.97 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 119.696 -0.802 . . . . 1.0 110.694 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 102' ' ' VAL . 2.7 p -71.71 116.45 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.517 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 1.7 m-20 -85.22 143.36 28.8 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.311 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.521 ' C ' HD23 ' A' ' 137' ' ' LEU . 33.7 p90 -111.58 162.9 14.66 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.835 0.826 . . . . 1.0 112.945 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.955 ' N ' HD23 ' A' ' 137' ' ' LEU . . . -50.9 -179.15 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.132 -1.395 . . . . 1.0 112.336 -177.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -75.09 -20.4 59.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.112 -0.949 . . . . 1.0 108.669 178.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 106' ' ' CYS . 1.5 p 151.91 71.17 0.0 OUTLIER 'General case' 0 C--N 1.347 0.464 0 O-C-N 123.857 0.723 . . . . 1.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.849 ' H ' ' NE2' ' A' ' 111' ' ' GLN . . . 72.72 13.96 78.16 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.559 -0.616 . . . . 1.0 111.559 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.57 -44.08 19.58 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.012 -0.675 . . . . 1.0 111.36 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.65 ' OE2' HD13 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -120.19 -30.59 4.6 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.605 -0.438 . . . . 1.0 111.863 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.849 ' NE2' ' H ' ' A' ' 108' ' ' GLY . 1.5 mt-30 -24.92 139.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.889 0.876 . . . . 1.0 113.083 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.601 ' C ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.15 19.86 2.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.89 -1.05 . . . . 1.0 110.134 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.84 HD12 ' H ' ' A' ' 114' ' ' PHE . 2.1 tp -153.12 149.3 27.93 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.69 -0.672 . . . . 1.0 109.698 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.84 ' H ' HD12 ' A' ' 113' ' ' LEU . 3.9 p90 -126.31 150.12 69.18 Favored Pre-proline 0 C--N 1.366 1.305 0 N-CA-C 114.616 1.339 . . . . 1.0 114.616 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -88.68 141.37 4.56 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 123.007 2.472 . . . . 1.0 114.073 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.723 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -141.81 139.74 32.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.847 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.723 ' H ' HD23 ' A' ' 116' ' ' LEU . 7.5 mt-10 -98.41 120.43 38.82 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 116.567 -0.288 . . . . 1.0 110.677 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -136.75 126.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 120.827 0.346 . . . . 1.0 110.637 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 121' ' ' ALA . 1.1 m-80 52.64 47.92 23.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.177 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.586 ' H ' ' NH1' ' A' ' 120' ' ' ARG . 1.8 mmt-85 62.97 5.96 2.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.126 0.489 . . . . 1.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -107.07 156.8 18.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 1.0 108.785 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 76' ' ' TRP . 0.1 OUTLIER -115.82 103.97 16.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.911 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 116' ' ' LEU . 13.4 m-85 -100.1 148.82 24.15 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.747 ' HB3' HD11 ' A' ' 113' ' ' LEU . 13.5 m-30 -113.16 114.08 26.28 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.573 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -107.13 142.57 36.62 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.124 1.157 . . . . 1.0 114.124 -178.065 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.623 ' O ' ' N ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -129.84 132.43 46.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.423 -1.262 . . . . 1.0 112.491 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.694 HD23 ' ND2' ' A' ' 145' ' ' ASN . 0.0 OUTLIER -106.38 26.04 10.35 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.7 0.682 . . . . 1.0 109.536 175.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.601 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -127.66 117.01 21.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 -178.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.03 97.87 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 CA-C-N 120.465 1.202 . . . . 1.0 110.635 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.54 HG23 ' CG ' ' A' ' 134' ' ' GLU . 1.6 mt -70.36 136.8 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.27 1.033 . . . . 1.0 109.561 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.13 132.67 76.33 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 113.96 -1.473 . . . . 1.0 114.188 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -50.13 97.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.67 1.58 . . . . 1.0 110.737 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 125.68 -4.28 8.06 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.786 -0.525 . . . . 1.0 111.786 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -87.48 151.65 22.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.4 pm0 -77.21 129.08 35.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.919 0.39 . . . . 1.0 110.085 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.863 ' C ' HD12 ' A' ' 137' ' ' LEU . 5.5 mp -81.33 142.21 33.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.955 HD23 ' N ' ' A' ' 105' ' ' ALA . 6.8 mp -139.86 155.25 47.31 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.52 HG21 ' CE2' ' A' ' 124' ' ' TYR . 2.4 t -110.59 131.81 60.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.134 0 CA-C-N 114.93 -1.032 . . . . 1.0 113.228 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.707 ' CG ' ' NE2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 173.4 -167.79 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.5 0.667 . . . . 1.0 112.662 177.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.485 ' O ' ' C ' ' A' ' 141' ' ' IAS . 87.3 m-85 91.5 76.49 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 112.882 -1.963 . . . . 1.0 111.038 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.485 ' C ' ' O ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.468 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 110.802 -0.919 . . . . 1.0 110.802 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 58.96 104.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.26 0.552 . . . . 1.0 111.767 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.651 ' H ' HG21 ' A' ' 148' ' ' ILE . 25.1 t70 -124.55 -54.32 1.67 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.455 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 148' ' ' ILE . 0.3 OUTLIER -70.64 154.13 94.54 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 122.158 -0.339 . . . . 1.0 111.435 -178.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -49.38 -75.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.506 2.215 0 C-N-CA 123.229 2.619 . . . . 1.0 111.977 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 151' ' ' ALA . 0.3 OUTLIER -54.9 -18.65 5.19 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.831 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.736 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 0.0 OUTLIER -65.69 -54.33 28.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.874 -1.528 . . . . 1.0 106.874 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.537 ' N ' HG22 ' A' ' 148' ' ' ILE . . . -73.87 -35.77 64.76 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.952 -0.699 . . . . 1.0 110.203 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 147' ' ' GLU . . . -78.03 -66.05 0.9 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.046 -1.061 . . . . 1.0 110.233 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 147' ' ' GLU . . . -48.5 -29.75 4.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.129 -1.028 . . . . 1.0 110.153 -175.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.724 HD12 ' O ' ' A' ' 148' ' ' ILE . 50.3 mt -65.04 -51.65 63.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 118.459 -1.296 . . . . 1.0 108.351 176.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.749 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -71.31 -37.52 71.8 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 114.94 -1.027 . . . . 1.0 113.1 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -57.27 -48.58 78.53 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.272 -0.571 . . . . 1.0 111.894 -177.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -74.06 -51.72 14.91 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.681 -0.407 . . . . 1.0 111.824 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.716 ' HE ' ' N ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -76.84 -47.82 20.25 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.666 -0.814 . . . . 1.0 110.448 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -78.42 -51.26 10.3 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.444 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 0.4 OUTLIER 39.38 -163.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.03 0.443 . . . . 1.0 110.949 179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.532 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . 42.99 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 158' ' ' SER . 15.0 mmt-85 42.26 32.88 0.35 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.25 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.683 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 1.0 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 78.7 p -143.81 -125.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.761 0.315 . . . . 1.0 110.6 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -168.26 97.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.54 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -156.86 98.97 1.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.499 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -101.38 106.16 17.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.621 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -172.31 -168.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.575 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 t -46.82 141.16 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.399 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.45 175.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.521 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -140.01 153.1 69.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.132 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.78 -173.1 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.073 1.849 . . . . 1.0 111.775 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ALA . 2.2 t -96.33 25.4 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 1.0 110.547 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 44.79 -174.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.003 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 13' ' ' GLU . . . -46.39 -35.44 5.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 14' ' ' THR . 0.4 OUTLIER 73.44 -39.8 0.45 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.305 -0.861 . . . . 1.0 110.579 179.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 42' ' ' ILE . 1.4 mm-40 28.23 -87.09 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -136.78 172.18 13.4 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.663 174.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 15' ' ' LEU . 6.3 tt -73.04 -59.91 2.48 Favored 'General case' 0 CA--C 1.478 -1.793 0 C-N-CA 118.823 -1.151 . . . . 1.0 108.336 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -78.35 -59.57 2.73 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-N 113.216 -1.811 . . . . 1.0 108.407 -176.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.734 ' HG3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -145.77 -102.58 0.1 Allowed 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 118.565 -1.254 . . . . 1.0 114.289 -175.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.745 HG13 ' HD3' ' A' ' 19' ' ' PRO 0.284 0.2 OUTLIER 179.38 -80.42 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 116.974 -1.489 . . . . 1.0 111.601 -177.456 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.745 ' HD3' HG13 ' A' ' 18' ' ' VAL . 4.4 Cg_exo -74.19 147.01 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 CA-C-N 124.875 2.777 . . . . 1.0 111.404 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.509 ' CD ' HH12 ' A' ' 24' ' ' ARG . 37.4 tt0 -67.73 -50.26 58.29 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.338 1.066 . . . . 1.0 110.404 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.569 ' NE2' ' O ' ' A' ' 94' ' ' GLU . 28.7 p80 -56.36 -24.85 46.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.884 -1.053 . . . . 1.0 113.408 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.795 HG23 HD12 ' A' ' 23' ' ' LEU . 2.0 m -64.09 -45.0 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 121.284 1.857 . . . . 1.0 106.362 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.795 HD12 HG23 ' A' ' 22' ' ' VAL . 6.5 mp -54.71 -28.67 49.7 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.596 0.712 . . . . 1.0 110.405 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.509 HH12 ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -74.05 -20.84 60.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.519 -1.219 . . . . 1.0 108.616 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . -114.7 -12.68 10.13 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.309 -1.314 . . . . 1.0 113.063 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.644 HD13 ' C ' ' A' ' 30' ' ' VAL . 16.8 mt -60.19 150.21 72.31 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-N 118.988 1.394 . . . . 1.0 110.589 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 26' ' ' LEU . 75.9 Cg_exo -42.56 -128.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.666 2.911 . . . . 1.0 113.184 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 48' ' ' LYS . 4.2 mt-10 -68.77 -50.75 47.85 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 117.776 -1.57 . . . . 1.0 106.796 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' H ' ' HE2' ' A' ' 48' ' ' LYS . 12.5 tt0 -126.18 -77.71 0.59 Allowed 'General case' 0 C--N 1.363 1.17 0 C-N-CA 120.157 -0.617 . . . . 1.0 111.489 178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.644 ' C ' HD13 ' A' ' 26' ' ' LEU 0.365 4.9 t 59.43 152.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 C-N-CA 127.881 2.472 . . . . 1.0 116.265 -176.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' C ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.79 160.61 42.55 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 112.173 -2.285 . . . . 1.0 110.948 -177.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 31' ' ' ARG . 3.5 mm? -117.75 120.41 37.88 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 174.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.54 ' C ' HG13 ' A' ' 42' ' ' ILE . 1.1 t80 -129.43 122.56 20.94 Favored Pre-proline 0 N--CA 1.485 1.299 0 O-C-N 121.193 -0.942 . . . . 1.0 112.633 -176.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 4.3 Cg_exo -79.22 130.4 9.2 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.804 2.336 . . . . 1.0 112.897 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 1.3 t 87.8 30.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 112.667 -2.06 . . . . 1.0 107.286 -176.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -94.57 -54.12 3.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.169 -1.419 . . . . 1.0 107.169 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 38' ' ' ASP . 7.5 p -59.4 -49.85 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 113.614 -1.63 . . . . 1.0 111.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.558 ' N ' HG13 ' A' ' 37' ' ' VAL . 0.6 OUTLIER 169.28 -50.91 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.3 38.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.548 -1.205 . . . . 1.0 107.909 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.554 ' HB ' HG11 ' A' ' 37' ' ' VAL . 20.7 m -102.83 -34.73 8.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 40' ' ' THR . 7.7 mtm-85 155.06 -159.79 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 106.7 -1.593 . . . . 1.0 106.7 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 13' ' ' GLU . 9.5 tt -84.07 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 118.915 0.779 . . . . 1.0 111.315 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.558 ' C ' HD13 ' A' ' 32' ' ' LEU . . . -106.75 166.72 13.66 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -103.28 120.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 118.134 0.967 . . . . 1.0 111.426 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.651 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 4.9 m95 -127.51 143.79 51.14 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.258 -0.883 . . . . 1.0 110.173 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -84.7 123.84 30.83 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.2 -1.0 . . . . 1.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -21.76 19.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.37 0.605 . . . . 1.0 109.409 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.61 ' HZ2' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -107.87 167.89 8.68 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-N 114.728 -1.124 . . . . 1.0 110.963 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 5.9 Cg_exo -76.09 144.34 26.69 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.65 2.233 . . . . 1.0 111.158 -176.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.61 HG12 ' HZ2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -118.73 144.09 27.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.91 -178.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.98 146.31 39.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.92 0.866 . . . . 1.0 110.742 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -65.65 140.14 58.47 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.323 -1.308 . . . . 1.0 111.822 179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.79 3.92 58.07 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 119.409 -1.377 . . . . 1.0 115.302 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' CG ' ' N ' ' A' ' 55' ' ' LYS . 30.0 ttpt -106.22 146.27 30.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 118.92 -1.112 . . . . 1.0 113.968 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 124' ' ' TYR . 0.1 OUTLIER -97.39 140.71 31.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.791 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 126' ' ' THR . 3.0 m-85 -118.59 131.03 56.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.052 -1.462 . . . . 1.0 107.052 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.64 -150.45 21.11 Favored Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 21.6 Cg_endo -84.83 170.7 46.88 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 119.671 1.735 . . . . 1.0 113.457 0.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.823 ' HB2' HD12 ' A' ' 99' ' ' LEU . 36.9 t80 -73.72 122.31 22.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.622 0.725 . . . . 1.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.608 ' H ' ' CG ' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -44.37 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.886 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 60' ' ' VAL . . . 37.12 109.14 0.0 OUTLIER Glycine 0 C--N 1.333 0.399 0 CA-C-O 121.711 0.617 . . . . 1.0 113.244 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 89' ' ' ASP . 12.5 t70 -85.78 134.96 33.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 63' ' ' LYS . 1.5 mptt -90.59 116.33 28.41 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.517 0.675 . . . . 1.0 112.124 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HZ3' ' HB3' ' A' ' 87' ' ' CYS . 0.1 OUTLIER -124.05 158.08 33.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.626 -1.17 . . . . 1.0 110.98 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -83.63 135.53 34.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 177.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -53.27 -31.04 41.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.783 -0.573 . . . . 1.0 110.394 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -91.53 27.22 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.838 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 -68.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.743 0.782 . . . . 1.0 110.255 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.709 HG13 HD22 ' A' ' 72' ' ' ASN . 0.4 OUTLIER -73.85 170.44 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 114.402 -1.272 . . . . 1.0 111.259 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 7.1 tttp -110.27 -128.71 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.108 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.464 ' H ' ' CG ' ' A' ' 70' ' ' LYS . 12.9 t-20 -36.87 -80.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.732 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.709 HD22 HG13 ' A' ' 69' ' ' VAL . 2.3 p30 49.28 -177.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.578 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 73' ' ' VAL . 7.4 p -172.58 -13.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.03 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 3.0 m-85 -98.88 53.31 0.99 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.59 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -125.57 147.05 49.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.653 0.74 . . . . 1.0 112.584 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -123.11 164.28 18.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.525 -1.216 . . . . 1.0 110.512 -178.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -122.69 122.21 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.181 0.515 . . . . 1.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.96 139.93 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.406 -0.816 . . . . 1.0 111.83 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.516 ' O ' ' CZ ' ' A' ' 120' ' ' ARG . 4.4 t80 -92.67 135.84 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.875 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.61 ' CD1' HD11 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -117.12 146.05 37.17 Favored Pre-proline 0 C--N 1.338 0.103 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -70.19 44.46 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 N-CA-C 108.225 -1.49 . . . . 1.0 108.225 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.575 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 1.5 t30 -148.21 -85.77 0.1 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.212 -1.358 . . . . 1.0 110.297 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 84' ' ' GLY . 0.8 OUTLIER -80.48 -8.99 59.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.33 -1.305 . . . . 1.0 112.322 -176.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.74 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 81.65 -145.81 25.31 Favored Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -78.68 118.13 20.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.721 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -129.96 173.38 10.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.744 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.586 ' N ' ' SD ' ' A' ' 86' ' ' MET . 67.8 m -117.96 141.41 48.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.152 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.4 150.66 3.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 N-CA-C 108.05 -1.093 . . . . 1.0 108.05 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -133.66 136.69 44.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.827 1.047 . . . . 1.0 113.827 179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 91' ' ' THR . . . -133.23 139.93 47.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 90' ' ' ALA . 30.2 p -158.61 -13.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.487 0.585 . . . . 1.0 110.033 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -148.03 106.31 3.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.284 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.75 -22.09 9.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.132 1.888 . . . . 1.0 114.353 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.569 ' O ' ' NE2' ' A' ' 21' ' ' HIS . 5.9 pt-20 -83.18 -8.39 59.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.904 0.859 . . . . 1.0 110.215 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 11.65 35.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.343 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.442 ' O ' ' ND1' ' A' ' 21' ' ' HIS . . . -165.44 -95.07 0.1 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 119.073 -1.537 . . . . 1.0 114.012 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.672 ' ND2' ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -146.18 173.35 12.29 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 101' ' ' TYR . 30.6 p-90 -70.86 -19.95 62.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.823 HD12 ' HB2' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -50.18 -24.11 2.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.775 HH22 HD21 ' A' ' 103' ' ' ASN . 3.1 tpm_? -84.57 -23.16 29.78 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 120.146 -0.621 . . . . 1.0 110.749 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 98' ' ' TRP . 0.3 OUTLIER -72.57 -7.35 49.69 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.299 1.047 . . . . 1.0 109.479 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.718 HG22 ' CZ2' ' A' ' 104' ' ' TRP . 3.4 t -82.48 119.64 32.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.249 -1.796 . . . . 1.0 111.041 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.775 HD21 HH22 ' A' ' 100' ' ' ARG . 38.4 m-20 -156.15 71.68 0.73 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.661 0.664 . . . . 1.0 111.464 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.818 ' HE1' ' N ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -141.88 176.69 8.73 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.089 0.956 . . . . 1.0 111.497 -177.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.601 ' C ' ' N ' ' A' ' 107' ' ' SER . . . 26.53 52.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.43 1.081 . . . . 1.0 109.995 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -48.56 -14.53 0.06 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.601 ' N ' ' C ' ' A' ' 105' ' ' ALA . 20.0 p -174.98 18.06 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.35 -1.295 . . . . 1.0 110.561 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.704 ' N ' ' HE1' ' A' ' 139' ' ' TRP . . . -85.2 131.26 10.33 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 111.589 -0.604 . . . . 1.0 111.589 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.06 -12.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -177.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 4.3 pt-20 -74.26 5.52 4.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 113.698 0.999 . . . . 1.0 113.698 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.696 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.4 pp0? -54.48 140.23 35.04 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.673 1.36 . . . . 1.0 114.673 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.983 ' ND2' ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -117.58 -5.22 11.19 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.333 -1.758 . . . . 1.0 111.663 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 114' ' ' PHE . 0.3 OUTLIER -155.8 165.47 36.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 119.441 -0.314 . . . . 1.0 110.931 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 1.079 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -133.11 138.03 30.77 Favored Pre-proline 0 C--N 1.357 0.933 0 N-CA-C 113.869 1.062 . . . . 1.0 113.869 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.78 146.02 10.37 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 123.422 2.748 . . . . 1.0 113.648 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.822 HD23 ' H ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -144.66 146.54 32.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.293 178.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.822 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.2 tt0 -97.38 119.06 35.22 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 123' ' ' TYR . 7.7 mt -137.39 132.21 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.929 -177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 121' ' ' ALA . 30.2 m-20 50.14 57.95 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.485 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.516 ' CZ ' ' O ' ' A' ' 79' ' ' TYR . 9.8 mmp_? 57.21 -0.8 0.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.494 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 58' ' ' PRO . . . -123.21 155.62 36.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.248 -0.278 . . . . 1.0 110.248 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CE2' ' A' ' 76' ' ' TRP . 1.0 OUTLIER -103.8 113.94 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.602 ' HB2' HD12 ' A' ' 118' ' ' ILE . 5.0 m-85 -101.35 149.32 24.16 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.737 ' CE2' HG21 ' A' ' 138' ' ' VAL . 3.1 m-30 -112.97 126.93 56.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.338 -1.356 . . . . 1.0 107.338 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.946 ' H ' ' HZ2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -122.5 140.43 52.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.782 0.66 . . . . 1.0 112.782 -178.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.642 ' C ' HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -128.73 134.47 48.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 1.0 109.708 178.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.887 ' H ' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -105.87 16.78 24.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.228 -0.589 . . . . 1.0 110.103 176.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.593 ' HZ2' ' C ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -125.16 127.01 25.13 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -178.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.22 98.79 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 CA-C-N 121.33 1.511 . . . . 1.0 111.068 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.531 HD13 ' OD1' ' A' ' 112' ' ' ASN . 55.6 mt -67.81 134.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.273 1.035 . . . . 1.0 109.594 -176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.663 ' O ' ' OE1' ' A' ' 134' ' ' GLU . . . -65.01 139.32 97.75 Favored Pre-proline 0 C--O 1.212 -0.872 0 CA-C-N 113.929 -1.487 . . . . 1.0 114.086 -174.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.52 115.44 4.29 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.556 2.171 . . . . 1.0 111.692 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 109.65 0.95 30.73 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.914 -0.474 . . . . 1.0 111.914 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.702 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -97.75 173.27 7.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.84 0.829 . . . . 1.0 112.353 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' CG ' ' CD1' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -85.81 141.42 29.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.211 -1.358 . . . . 1.0 108.359 176.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.711 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.4 mp -89.9 136.88 32.78 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.218 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.983 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 6.8 mp -121.6 142.84 49.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.757 0.789 . . . . 1.0 112.104 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.818 ' N ' ' HE1' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -119.97 137.12 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 114.034 -1.439 . . . . 1.0 110.014 -176.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.704 ' HE1' ' N ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -137.65 134.82 35.9 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 -177.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 141' ' ' IAS . 0.1 OUTLIER -154.6 29.41 0.43 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.706 -1.588 . . . . 1.0 108.719 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.501 ' OD1' ' C ' ' A' ' 141' ' ' IAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.401 0 N-CA-C 112.282 -0.327 . . . . 1.0 112.282 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.642 ' CD ' ' HB2' ' A' ' 149' ' ' ALA . 0.9 OUTLIER -166.53 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.264 -0.574 . . . . 1.0 111.511 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.625 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 12.2 t0 94.21 -43.28 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.83 0.706 . . . . 1.0 111.651 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.812 ' ND2' ' H ' ' A' ' 148' ' ' ILE . 0.3 OUTLIER -78.82 149.66 74.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.92 -0.582 . . . . 1.0 112.177 -177.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -55.61 -63.75 0.17 Allowed 'Trans proline' 0 N--CA 1.512 2.57 0 C-N-CA 123.141 2.561 . . . . 1.0 115.493 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.69 ' O ' ' N ' ' A' ' 151' ' ' ALA . 14.0 mm-40 -58.6 -49.07 78.82 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 120.973 0.416 . . . . 1.0 110.468 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.812 ' H ' ' ND2' ' A' ' 145' ' ' ASN . 2.0 mt -47.48 -52.81 5.06 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 N-CA-C 106.388 -1.708 . . . . 1.0 106.388 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.642 ' HB2' ' CD ' ' A' ' 143' ' ' GLU . . . -71.05 -50.4 34.35 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.123 -1.831 . . . . 1.0 109.191 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -68.87 -65.59 0.68 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.285 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.69 ' N ' ' O ' ' A' ' 147' ' ' GLU . . . -55.87 -34.22 65.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.846 1.657 . . . . 1.0 112.374 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 148' ' ' ILE . 48.5 mt -54.16 -47.26 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.198 -1.801 . . . . 1.0 108.24 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.749 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -71.8 -38.57 70.22 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 124.057 0.848 . . . . 1.0 112.694 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.502 ' CG ' ' N ' ' A' ' 155' ' ' GLU . 5.6 pt-20 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.597 -0.841 . . . . 1.0 112.978 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 154' ' ' GLU . 4.7 tp10 -79.22 -51.51 9.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.757 ' NH2' ' HB2' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -72.6 -50.34 26.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.225 -0.99 . . . . 1.0 112.201 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.757 ' HB2' ' NH2' ' A' ' 156' ' ' ARG . . . -53.79 -23.85 13.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 119.149 -1.02 . . . . 1.0 108.975 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 4.2 t -79.41 137.26 37.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.705 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . 70.04 14.73 7.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.948 0.404 . . . . 1.0 110.209 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 161' ' ' SER . 2.2 tpt180 -85.99 103.62 14.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.509 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 160' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.499 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.28 -88.57 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 1.0 110.616 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 3' ' ' GLN . 4.7 tpp -142.72 126.02 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.598 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 4' ' ' ASN . 39.1 m-20 -65.91 72.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.574 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 1' ' ' MET . 3.2 tp-100 -71.77 12.18 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.599 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 2' ' ' ASP . 3.5 t30 -141.27 114.18 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.56 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.0 116.08 5.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m -41.68 104.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.557 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 1.9 pm0 -89.53 155.23 48.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.473 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.02 -166.73 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.714 2.276 . . . . 1.0 112.35 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.653 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 32.0 m -54.58 -171.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.499 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . 79.31 168.42 0.19 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.44 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.696 ' HB2' ' OG ' ' A' ' 35' ' ' SER . . . -87.81 -79.05 0.3 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.191 0.52 . . . . 1.0 110.192 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.3 m 149.54 -68.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.251 -1.341 . . . . 1.0 108.212 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.502 ' N ' HG22 ' A' ' 12' ' ' THR . 5.9 mm-40 -45.8 138.71 4.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.556 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -121.37 153.45 37.78 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 121.554 0.692 . . . . 1.0 112.321 -178.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.982 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -47.39 -36.0 9.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.465 -178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.96 44.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.581 -1.191 . . . . 1.0 109.802 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.637 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -97.47 -38.1 9.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.034 -0.984 . . . . 1.0 113.617 -177.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -63.49 147.11 95.87 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.688 -1.967 . . . . 1.0 105.688 178.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 18' ' ' VAL . 2.8 Cg_exo -48.1 118.61 3.28 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.621 1.548 . . . . 1.0 112.042 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.15 -42.39 60.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.973 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.425 ' CD2' ' H ' ' A' ' 21' ' ' HIS . 12.9 p80 -64.08 -23.65 67.4 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.949 -0.7 . . . . 1.0 111.703 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 97' ' ' ASN . 14.9 t -80.17 -45.33 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 119.009 0.822 . . . . 1.0 111.247 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.624 ' CD2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -67.04 -25.7 66.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.951 0.881 . . . . 1.0 108.993 178.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -61.27 -19.18 61.43 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 114.592 -1.186 . . . . 1.0 111.913 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.8 39.67 2.82 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.246 -0.502 . . . . 1.0 112.054 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.661 HD22 ' CG1' ' A' ' 30' ' ' VAL . 32.7 mt -80.04 154.48 75.09 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.366 0.506 . . . . 1.0 112.366 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG2' HG21 ' A' ' 30' ' ' VAL . 86.0 Cg_exo -44.23 -120.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.966 3.111 . . . . 1.0 114.138 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 28' ' ' GLU . 7.8 mm-40 -69.18 -55.11 11.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.65 -2.352 . . . . 1.0 104.65 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 30' ' ' VAL . 7.6 tp10 -133.95 -72.59 0.49 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.661 ' CG1' HD22 ' A' ' 26' ' ' LEU . 96.4 t 52.28 163.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-O 121.989 0.9 . . . . 1.0 110.953 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB2' HG21 ' A' ' 47' ' ' THR . 3.2 ttt85 -161.44 163.16 30.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.92 -1.491 . . . . 1.0 107.006 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.654 ' N ' HD22 ' A' ' 32' ' ' LEU . 3.1 mm? -94.45 155.07 17.13 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.544 -1.262 . . . . 1.0 110.098 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.72 111.67 2.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.719 1.377 . . . . 1.0 114.719 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 35' ' ' SER . 13.0 Cg_endo -88.31 154.18 6.71 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 123.691 2.927 . . . . 1.0 111.926 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.696 ' OG ' ' HB2' ' A' ' 11' ' ' ALA . 1.8 p 50.84 40.3 24.42 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB1' ' CE2' ' A' ' 45' ' ' TRP . . . -95.98 -46.4 6.53 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.282 -2.235 . . . . 1.0 106.899 175.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -96.3 -4.06 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 114.16 -1.382 . . . . 1.0 110.933 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 14.8 t70 98.24 -11.32 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.982 0.802 . . . . 1.0 111.54 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.726 ' HZ3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.24 -35.84 66.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.874 -0.73 . . . . 1.0 109.326 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 92.11 -11.22 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.526 0.936 . . . . 1.0 113.526 177.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.726 ' CB ' ' HZ3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -77.22 162.45 27.37 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 177.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 32' ' ' LEU . 4.2 mm -74.48 124.73 32.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 120.485 1.493 . . . . 1.0 112.097 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.77 174.19 16.86 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.698 -1.761 . . . . 1.0 108.698 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG21 ' HE3' ' A' ' 98' ' ' TRP . 8.3 p -121.83 125.7 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 120.94 0.4 . . . . 1.0 109.94 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.661 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 30.2 m95 -126.92 149.43 49.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.968 1.099 . . . . 1.0 113.968 -177.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.618 ' O ' ' N ' ' A' ' 133' ' ' GLY . . . -67.55 133.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.959 -1.019 . . . . 1.0 108.859 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 31' ' ' ARG . 80.8 p -115.93 -15.73 11.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.241 -1.392 . . . . 1.0 107.241 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.595 ' CD ' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -116.2 171.69 4.47 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 112.847 -1.979 . . . . 1.0 109.59 -178.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.46 153.71 13.84 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 123.264 2.643 . . . . 1.0 111.982 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.495 ' HB ' ' H ' ' A' ' 130' ' ' ILE . 4.1 mp -132.11 150.84 34.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.728 -1.124 . . . . 1.0 111.354 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.734 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.55 165.09 15.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 1.0 111.71 178.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.55 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -69.9 129.62 40.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.093 177.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 97.33 -0.71 60.13 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 119.854 -1.165 . . . . 1.0 113.375 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.671 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.7 tptt -57.09 157.96 5.51 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.732 -1.187 . . . . 1.0 110.284 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.7 ttmt -123.76 109.3 13.5 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.46 -1.245 . . . . 1.0 108.403 175.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 54' ' ' LYS . 11.6 m-30 -119.58 125.12 48.04 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 58' ' ' PRO . . . 155.02 -153.49 24.83 Favored Glycine 0 C--N 1.308 -0.99 0 CA-C-N 114.08 -1.418 . . . . 1.0 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 57' ' ' GLY . 10.2 Cg_endo -82.66 150.83 71.6 Favored 'Cis proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.35 1.575 . . . . 1.0 113.604 0.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.58 ' CE2' ' O ' ' A' ' 74' ' ' TYR . 17.6 t80 -62.94 118.92 8.46 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.759 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 HG22 ' ND2' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -27.03 -65.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.345 -1.752 . . . . 1.0 111.495 178.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 53.89 104.55 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.827 -0.701 . . . . 1.0 113.482 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -95.01 149.8 20.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.58 -1.637 . . . . 1.0 106.58 176.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.541 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -93.53 116.36 28.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.719 ' HZ2' ' CB ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -146.87 167.22 24.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.016 -178.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.732 ' NZ ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -65.94 153.05 43.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.652 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 6.2 ttm-85 -66.09 -45.33 81.6 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 121.499 -0.751 . . . . 1.0 111.932 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 95.7 p -65.87 46.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.008 0.432 . . . . 1.0 110.151 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 66' ' ' ARG . 9.4 mm100 -129.87 -28.97 2.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 1.0 111.333 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.14 158.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.882 0.372 . . . . 1.0 111.119 -178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 5.6 tttm -140.98 131.63 25.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 45.83 76.0 0.1 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -122.54 -169.24 1.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.992 -1.003 . . . . 1.0 113.394 -175.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 75' ' ' MET . 25.0 t -150.48 -68.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.698 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.58 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -63.09 41.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.285 -178.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.7 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -149.49 148.23 29.15 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.788 0.804 . . . . 1.0 111.732 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.918 ' CE2' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -160.59 162.3 32.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.244 -1.344 . . . . 1.0 112.618 -178.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 1.3 pm0 -100.93 121.88 42.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.959 0.885 . . . . 1.0 111.355 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.623 ' CG1' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.24 135.85 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 114.747 -1.115 . . . . 1.0 108.986 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.9 t80 -87.0 124.37 33.12 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.511 -0.875 . . . . 1.0 111.329 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.543 ' C ' ' H ' ' A' ' 82' ' ' ASN . 5.0 m-85 -92.19 135.53 26.89 Favored Pre-proline 0 N--CA 1.427 -1.581 0 CA-C-N 114.195 -1.366 . . . . 1.0 110.466 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.34 7.69 1.74 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.771 1.647 . . . . 1.0 108.869 177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 80' ' ' TYR . 70.5 m-80 -110.27 -90.72 0.47 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.256 -1.338 . . . . 1.0 111.48 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.031 HD23 ' H ' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -79.64 -7.08 58.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.652 0.982 . . . . 1.0 113.652 -177.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.36 -157.32 15.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 120.393 -0.908 . . . . 1.0 112.717 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' TYR . 25.4 m95 -66.08 121.16 14.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.609 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.525 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 38.1 mmm -124.85 150.8 46.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 113.377 0.88 . . . . 1.0 113.377 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.652 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -106.97 131.36 54.13 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 88' ' ' ILE . 17.0 mt -106.16 105.34 18.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.442 0.904 . . . . 1.0 113.442 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.719 ' CB ' ' HZ2' ' A' ' 64' ' ' LYS . 23.5 t0 -130.83 127.57 38.88 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.287 0.949 . . . . 1.0 112.085 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -132.82 96.45 3.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.192 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.628 HG23 ' OD1' ' A' ' 89' ' ' ASP . 29.3 p -129.55 75.42 1.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.726 0.694 . . . . 1.0 110.617 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.727 ' N ' ' HE ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -162.85 160.82 19.36 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 120.405 -0.518 . . . . 1.0 111.338 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -67.26 -38.93 14.14 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.15 1.9 . . . . 1.0 112.418 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -77.87 -44.46 27.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 -11.42 16.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 1.0 112.076 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . -110.77 111.46 3.02 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.487 -0.863 . . . . 1.0 112.04 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.682 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -61.95 -157.92 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.919 0.39 . . . . 1.0 110.466 179.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.563 ' HE3' HG21 ' A' ' 44' ' ' VAL . 43.0 p-90 -72.75 -35.49 67.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.318 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -54.8 -26.5 35.13 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.365 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.727 ' HE ' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -72.29 -20.5 61.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.917 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -83.87 -10.68 57.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.758 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 99' ' ' LEU . 3.2 t -64.49 141.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.561 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.627 ' ND2' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -101.22 -155.18 0.5 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.088 -0.645 . . . . 1.0 112.234 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.492 ' NE1' ' CG2' ' A' ' 73' ' ' VAL . 2.6 m-90 -112.79 144.12 42.87 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.466 -0.788 . . . . 1.0 111.813 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 139' ' ' TRP . . . -79.06 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER 159.23 -16.05 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.768 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -136.54 -81.56 0.39 Allowed 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.197 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 163.69 -52.0 0.3 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -24.62 65.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.677 ' O ' ' O ' ' A' ' 111' ' ' GLN . 2.5 pt-20 -92.13 -22.98 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.995 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.688 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -51.24 -134.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 178.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 1.027 HD21 HD22 ' A' ' 137' ' ' LEU . 0.8 OUTLIER 158.51 -33.47 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.572 -0.705 . . . . 1.0 109.488 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 112' ' ' ASN . 4.2 mm? -129.55 148.26 51.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.807 -0.757 . . . . 1.0 112.055 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -134.06 130.63 20.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 115.105 -0.952 . . . . 1.0 112.498 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 76' ' ' TRP . 78.6 Cg_exo -51.23 130.22 31.53 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 123.894 3.063 . . . . 1.0 115.899 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.692 HD13 HG12 ' A' ' 152' ' ' ILE . 56.2 tp -142.17 137.24 30.7 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CD ' ' CD1' ' A' ' 122' ' ' ILE . 4.7 mm-40 -108.06 114.95 29.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.403 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.577 HD11 ' CD1' ' A' ' 123' ' ' TYR . 4.9 pt -139.09 127.82 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.536 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.59 47.5 23.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 1.0 110.909 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HE ' ' CG1' ' A' ' 78' ' ' VAL . 1.9 mmp_? 54.43 30.56 13.02 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -136.82 148.98 47.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.026 -1.101 . . . . 1.0 108.026 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.918 HG21 ' CE2' ' A' ' 76' ' ' TRP . 1.6 mm -110.42 114.24 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.745 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.577 ' CD1' HD11 ' A' ' 118' ' ' ILE . 4.6 m-85 -102.22 157.53 16.83 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.175 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.811 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.5 m-30 -116.66 130.73 56.91 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 105.522 -2.029 . . . . 1.0 105.522 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.594 ' HZ1' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -125.95 153.96 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.967 -177.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.689 ' O ' ' N ' ' A' ' 53' ' ' GLY . 27.7 p -100.76 118.51 37.01 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.231 -0.588 . . . . 1.0 112.471 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.67 HD23 ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -82.77 -21.38 34.66 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 124.224 0.953 . . . . 1.0 109.559 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.893 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -139.8 137.97 19.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.724 0.268 . . . . 1.0 111.724 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.88 144.2 45.58 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.628 1.552 . . . . 1.0 110.732 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.495 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -122.13 137.06 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.524 ' HB3' ' CG ' ' A' ' 134' ' ' GLU . . . -75.08 134.18 74.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.15 -0.477 . . . . 1.0 112.112 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.06 108.99 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 CA-C-N 119.808 0.967 . . . . 1.0 110.534 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 122.03 7.65 7.73 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 2.3 mm-40 -105.53 117.61 34.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.137 0.494 . . . . 1.0 111.187 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.661 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -46.06 146.71 1.21 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.614 -0.721 . . . . 1.0 109.772 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 137' ' ' LEU . 7.2 mp -91.08 132.67 35.89 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.096 -0.956 . . . . 1.0 108.488 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.027 HD22 HD21 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -136.62 161.81 34.86 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.751 0.786 . . . . 1.0 112.071 -178.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.811 HG11 ' CE2' ' A' ' 124' ' ' TYR . 3.1 m -146.13 170.87 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.778 -1.101 . . . . 1.0 111.337 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.655 ' CD1' ' NE2' ' A' ' 111' ' ' GLN . 44.5 p-90 170.77 -161.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 113.585 -1.643 . . . . 1.0 108.41 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.641 ' CD1' ' ND2' ' A' ' 145' ' ' ASN . 47.5 m-85 104.71 42.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.288 1.618 . . . . 1.0 107.657 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.561 ' OD1' ' N ' ' A' ' 143' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.559 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.468 0.829 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.561 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 53.6 mt-10 -31.37 -90.2 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 123.861 0.389 . . . . 1.0 110.124 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -108.29 56.49 0.63 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.435 -0.802 . . . . 1.0 109.879 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' ND2' ' CD1' ' A' ' 140' ' ' TYR . 3.1 p30 -68.96 167.08 22.03 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 7.9 Cg_endo -81.04 -14.83 10.73 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.578 1.519 . . . . 1.0 111.311 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 1.1 mp0 -66.76 -32.68 74.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 105.745 -1.946 . . . . 1.0 105.745 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.608 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mm -79.04 -53.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-N 114.224 -1.353 . . . . 1.0 110.662 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 -48.83 61.97 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 146' ' ' PRO . . . -55.66 -48.71 74.57 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.356 -0.538 . . . . 1.0 111.968 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.67 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . -70.49 -28.89 65.33 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 119.48 -0.888 . . . . 1.0 111.451 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.692 HG12 HD13 ' A' ' 116' ' ' LEU . 60.1 mt -66.88 -48.11 80.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.137 0.97 . . . . 1.0 108.914 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 2.5 mt-10 -52.31 -51.91 55.99 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.67 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 1.2 pm0 -57.35 -38.97 74.97 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.057 -1.057 . . . . 1.0 112.268 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -77.83 -59.74 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 118.804 -1.158 . . . . 1.0 112.209 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' NH2' HG21 ' A' ' 118' ' ' ILE . 12.4 mmm180 -70.76 -41.0 72.34 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.174 0.805 . . . . 1.0 113.174 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -65.65 -36.52 83.92 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 118.437 -1.305 . . . . 1.0 110.436 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.5 m -77.93 -14.37 59.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.896 -0.593 . . . . 1.0 110.655 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.87 35.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.563 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -102.27 -73.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.685 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.552 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.94 -41.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.776 0.322 . . . . 1.0 110.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.73 -165.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -160.0 53.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 3' ' ' GLN . 1.3 mp0 -41.22 128.81 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.644 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -100.24 -4.49 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.503 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.3 p -65.6 147.18 53.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.547 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 m -152.38 132.37 13.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -41.77 153.24 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.282 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.5 166.41 15.43 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.487 2.125 . . . . 1.0 111.981 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.44 -159.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.837 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.98 120.3 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.152 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' O ' ' CB ' ' A' ' 12' ' ' THR . . . -161.12 -77.79 0.05 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.307 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.547 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 89.9 m 122.36 103.62 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 125.204 1.565 . . . . 1.0 107.623 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.511 ' HG3' HG22 ' A' ' 12' ' ' THR . 0.4 OUTLIER 66.25 161.07 0.14 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.106 -1.406 . . . . 1.0 108.824 -177.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.547 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -121.29 156.17 33.1 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 120.458 0.171 . . . . 1.0 111.074 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.738 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -43.9 -30.21 0.66 Allowed 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.219 -178.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.41 59.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.61 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -73.14 -44.65 59.84 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.787 1.032 . . . . 1.0 113.787 -176.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -56.2 149.77 34.83 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.973 -1.862 . . . . 1.0 105.973 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 18' ' ' VAL . 27.8 Cg_exo -47.37 143.23 11.52 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 120.884 1.056 . . . . 1.0 110.874 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 14.8 tt0 -60.81 -49.9 75.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.511 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.553 ' H ' ' CD2' ' A' ' 21' ' ' HIS . 8.2 p80 -61.76 -26.07 67.85 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.624 HG13 ' C ' ' A' ' 97' ' ' ASN . 22.6 t -79.78 -49.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 118.656 0.662 . . . . 1.0 111.656 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.543 HD23 HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -67.89 -25.5 65.54 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.795 0.807 . . . . 1.0 109.449 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 8.6 mmm180 -59.74 -19.23 48.89 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 114.181 -1.372 . . . . 1.0 112.019 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.84 35.88 4.38 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.149 -0.548 . . . . 1.0 111.979 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 30' ' ' VAL . 16.4 mt -82.03 123.12 80.08 Favored Pre-proline 0 CA--C 1.514 -0.419 0 CA-C-O 119.477 -0.297 . . . . 1.0 111.11 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.509 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 14.2 Cg_exo -55.41 156.72 16.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 119.748 0.946 . . . . 1.0 110.236 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.423 ' C ' ' HG3' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -47.18 -13.72 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 115.172 1.545 . . . . 1.0 115.172 -174.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 6.2 pm0 -114.19 15.73 18.14 Favored 'General case' 0 CA--C 1.463 -2.386 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.16 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.714 HG12 HG22 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -126.82 125.78 67.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 114.605 1.335 . . . . 1.0 114.605 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.546 ' HB2' HG21 ' A' ' 47' ' ' THR . 6.6 tpm_? -141.6 153.44 44.79 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 113.36 -1.745 . . . . 1.0 107.17 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 15' ' ' LEU . 4.1 mm? -91.82 143.69 26.26 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 118.84 -1.144 . . . . 1.0 109.958 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.47 110.06 3.64 Favored Pre-proline 0 N--CA 1.444 -0.732 0 N-CA-C 113.253 0.834 . . . . 1.0 113.253 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . 15.5 Cg_endo -84.87 152.58 11.31 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.883 2.389 . . . . 1.0 111.24 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.9 p 86.46 -38.49 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' CB ' ' CZ2' ' A' ' 45' ' ' TRP . . . -49.3 -57.88 6.05 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.516 -1.22 . . . . 1.0 107.847 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 3.9 m -57.27 -50.05 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.869 -0.732 . . . . 1.0 110.232 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' THR . 1.7 m-20 156.9 70.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.448 0.468 . . . . 1.0 110.591 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' H ' ' HA ' ' A' ' 35' ' ' SER . 0.1 OUTLIER 35.67 29.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.387 0.613 . . . . 1.0 109.811 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 m -90.88 -33.56 15.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.086 -0.961 . . . . 1.0 112.62 -177.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 42' ' ' ILE . 4.7 ptm180 162.61 -163.98 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 HD12 ' A' ' 32' ' ' LEU . 2.7 mm -84.37 135.56 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 118.156 0.434 . . . . 1.0 110.386 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.73 155.14 18.92 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.545 -1.022 . . . . 1.0 110.545 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -102.41 131.53 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.51 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 12.0 m95 -132.26 155.21 48.72 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 -176.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -68.06 120.41 14.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.579 ' H ' ' C ' ' A' ' 29' ' ' GLU . 1.4 p -102.83 -20.81 14.16 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' CD ' ' C ' ' A' ' 48' ' ' LYS 0.252 0.0 OUTLIER -129.29 170.71 10.19 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.574 . . . . 1.0 109.827 178.056 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -80.42 125.35 5.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.123 1.882 . . . . 1.0 114.097 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.652 HD11 ' HG3' ' A' ' 29' ' ' GLU . 3.7 mp -99.66 150.78 5.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 113.809 -1.541 . . . . 1.0 110.659 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.753 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -112.17 164.03 13.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.674 177.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' C ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -66.61 124.18 22.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.813 -0.554 . . . . 1.0 110.385 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 99.75 1.28 56.34 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 119.924 -1.132 . . . . 1.0 113.087 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 2.2 tptt -52.32 159.47 0.97 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 117.625 -1.63 . . . . 1.0 108.356 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.759 ' HG2' ' HZ2' ' A' ' 125' ' ' LYS . 8.8 ttmt -121.48 103.16 8.73 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.315 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.587 ' CE2' ' OE2' ' A' ' 29' ' ' GLU . 13.4 m-85 -116.36 126.44 53.49 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 106.473 -1.677 . . . . 1.0 106.473 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.17 -164.75 35.63 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 109.876 -1.289 . . . . 1.0 109.876 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HG3' ' CE2' ' A' ' 123' ' ' TYR . 7.0 Cg_endo -89.68 138.44 13.22 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 CA-C-N 119.094 1.447 . . . . 1.0 112.884 -0.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.7 ' CZ ' ' HB3' ' A' ' 90' ' ' ALA . 10.2 t80 -59.13 114.82 2.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.675 0.75 . . . . 1.0 110.509 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -21.51 -64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 113.209 -1.814 . . . . 1.0 111.393 179.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.615 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 45.76 105.49 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.586 -0.734 . . . . 1.0 113.349 178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' ASP . 13.7 t70 -93.52 147.28 23.12 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 106.417 -1.697 . . . . 1.0 106.417 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -92.8 115.08 27.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.122 0.963 . . . . 1.0 113.149 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -139.85 170.3 16.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.619 -1.628 . . . . 1.0 110.708 -177.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.698 ' CD ' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -80.48 145.91 31.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 121.126 -0.23 . . . . 1.0 111.384 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 0.0 OUTLIER -50.85 -23.9 3.14 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.782 -0.574 . . . . 1.0 111.986 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 66' ' ' ARG . 29.0 t -37.69 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.234 0.54 . . . . 1.0 110.136 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 66' ' ' ARG . 1.4 mt-30 -97.4 -142.07 0.29 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.297 -0.865 . . . . 1.0 109.534 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.585 HG13 ' HG3' ' A' ' 75' ' ' MET . 57.5 t 59.95 -95.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 117.858 0.299 . . . . 1.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 8.2 tptm 73.62 51.77 0.12 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.926 0.393 . . . . 1.0 110.609 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 70' ' ' LYS . 4.0 t30 78.01 113.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.377 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.25 -149.71 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.328 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.661 ' C ' ' H ' ' A' ' 75' ' ' MET . 0.1 OUTLIER -137.87 -60.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-N 118.662 0.665 . . . . 1.0 111.519 -178.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.608 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -63.5 29.46 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.362 -0.835 . . . . 1.0 110.653 -178.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.661 ' H ' ' C ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -139.7 141.06 36.97 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.75 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.56 ' CG ' ' C ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -157.13 162.81 39.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.031 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -101.27 122.98 44.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.08 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.552 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -134.56 136.59 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.139 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 t80 -85.41 124.56 32.15 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.512 0.672 . . . . 1.0 112.182 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.805 ' OH ' HD11 ' A' ' 88' ' ' ILE . 27.3 m-85 -100.69 125.37 39.07 Favored Pre-proline 0 N--CA 1.442 -0.845 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.637 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.71 8.57 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 108.305 -1.46 . . . . 1.0 108.305 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 80' ' ' TYR . 74.5 m-20 -109.44 -10.14 14.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.0 -1.455 . . . . 1.0 111.27 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -168.65 1.85 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.709 1.374 . . . . 1.0 114.709 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.59 -160.78 14.27 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 120.608 -0.806 . . . . 1.0 112.912 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.553 ' O ' ' SD ' ' A' ' 86' ' ' MET . 27.5 m95 -76.5 121.06 22.59 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.553 ' SD ' ' O ' ' A' ' 85' ' ' TRP . 41.8 mmm -127.54 163.63 23.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.131 1.53 . . . . 1.0 115.131 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.03 134.07 53.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.157 -1.383 . . . . 1.0 108.175 177.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.805 HD11 ' OH ' ' A' ' 80' ' ' TYR . 9.2 mt -106.61 111.5 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 118.481 -0.771 . . . . 1.0 109.816 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -134.42 130.94 37.56 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -177.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . . . -139.04 104.8 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.79 49.3 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.994 -0.682 . . . . 1.0 109.202 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.62 162.39 36.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.094 -0.957 . . . . 1.0 109.955 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.62 -38.73 7.7 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.307 2.005 . . . . 1.0 112.688 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -78.16 -42.38 31.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 -11.26 20.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.661 0.267 . . . . 1.0 111.529 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA2' ' HB1' ' A' ' 90' ' ' ALA . . . -102.35 -166.76 26.63 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.649 ' H ' HD22 ' A' ' 97' ' ' ASN . 0.0 OUTLIER -145.36 -153.8 0.5 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.239 0.542 . . . . 1.0 111.072 178.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.503 ' N ' HG13 ' A' ' 22' ' ' VAL . 14.4 p-90 -72.34 -29.61 63.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.949 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.721 HD23 ' CD2' ' A' ' 124' ' ' TYR . 0.3 OUTLIER -66.31 -30.85 71.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.457 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.581 ' NH2' ' OH ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -58.94 -14.97 10.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 119.926 -0.71 . . . . 1.0 109.937 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.581 ' OH ' ' NH2' ' A' ' 100' ' ' ARG . 7.8 m-85 -92.96 0.44 57.4 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.69 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 99' ' ' LEU . 23.3 t -68.99 126.11 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.142 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -72.7 -157.48 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.605 0.595 . . . . 1.0 112.605 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.607 ' CZ2' ' CG2' ' A' ' 73' ' ' VAL . 4.1 m-90 -112.41 158.72 19.49 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.468 -0.787 . . . . 1.0 111.046 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.653 ' O ' ' N ' ' A' ' 107' ' ' SER . . . -100.56 -14.62 18.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 116.086 1.884 . . . . 1.0 116.086 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 107' ' ' SER . 49.7 t 32.62 23.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.406 0.548 . . . . 1.0 112.422 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' ALA . 0.3 OUTLIER 159.4 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.641 0.258 . . . . 1.0 110.663 -178.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.645 ' O ' ' NE2' ' A' ' 111' ' ' GLN . . . -85.25 2.21 88.26 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.197 -0.525 . . . . 1.0 111.907 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -86.59 -22.85 26.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.003 0.371 . . . . 1.0 112.003 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 111' ' ' GLN . 8.4 pt-20 -115.93 -27.55 6.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.401 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.826 ' N ' HE21 ' A' ' 111' ' ' GLN . 0.0 OUTLIER -44.13 110.13 0.19 Allowed 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.762 ' OD1' ' N ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -88.28 -5.31 58.42 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.753 ' HB2' HG12 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -140.55 172.1 13.2 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 124.014 0.821 . . . . 1.0 112.723 -177.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.593 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -148.71 132.07 8.28 Favored Pre-proline 0 N--CA 1.433 -1.287 0 C-N-CA 119.488 -0.885 . . . . 1.0 111.029 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 139' ' ' TRP . 80.6 Cg_exo -55.55 116.39 3.12 Favored 'Trans proline' 0 N--CA 1.509 2.406 0 C-N-CA 123.4 2.733 . . . . 1.0 113.99 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 HG12 ' A' ' 152' ' ' ILE . 30.6 tp -120.39 121.74 39.23 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.048 0.452 . . . . 1.0 111.914 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -102.84 114.26 28.38 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.505 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.557 HD11 ' CG ' ' A' ' 123' ' ' TYR . 2.3 pt -139.61 134.41 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.437 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.64 38.69 30.39 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.039 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.533 ' HE ' HG12 ' A' ' 78' ' ' VAL . 1.2 mmp_? 58.33 32.34 21.96 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.179 0.514 . . . . 1.0 110.452 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.37 155.22 50.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.434 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.52 HG21 ' NE1' ' A' ' 76' ' ' TRP . 15.0 mm -96.22 125.85 48.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.989 0.423 . . . . 1.0 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.557 ' CG ' HD11 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -124.05 150.64 44.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.277 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.817 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.8 m-30 -118.64 118.76 32.53 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.761 0.315 . . . . 1.0 110.486 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.764 ' NZ ' ' O ' ' A' ' 124' ' ' TYR . 0.0 OUTLIER -115.33 155.29 27.59 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.319 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' GLY . 10.7 p -106.69 109.86 21.89 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.843 1.339 . . . . 1.0 110.487 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -76.18 -8.38 56.9 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.33 1.019 . . . . 1.0 112.091 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.836 ' H ' ' HZ2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -151.02 135.73 9.94 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 119.923 -0.711 . . . . 1.0 110.929 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -53.19 129.02 31.42 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.497 1.465 . . . . 1.0 111.65 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.495 ' HB ' HD13 ' A' ' 50' ' ' ILE . 1.7 mt -106.5 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.054 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.521 ' HB3' ' OE2' ' A' ' 134' ' ' GLU . . . -84.18 132.92 46.32 Favored Pre-proline 0 C--O 1.219 -0.541 0 C-N-CA 120.162 -0.615 . . . . 1.0 109.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -45.42 104.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.907 1.738 . . . . 1.0 114.032 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 139.57 0.5 2.05 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 120.254 -0.974 . . . . 1.0 113.382 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -102.71 138.74 39.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.306 0.574 . . . . 1.0 110.145 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.51 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -61.29 130.97 48.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.763 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' ALA . 11.0 mp -75.6 129.54 37.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 119.721 -0.791 . . . . 1.0 109.134 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.762 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -141.97 159.4 42.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.817 HG11 ' CE2' ' A' ' 124' ' ' TYR . 2.5 m -128.44 172.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.436 -0.506 . . . . 1.0 111.399 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.626 ' HE1' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -101.3 -174.56 2.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.961 0.886 . . . . 1.0 111.036 178.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -87.38 -142.71 0.12 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.759 -1.564 . . . . 1.0 109.948 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.6 ' OD1' ' N ' ' A' ' 144' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 28.4 mt-10 57.35 20.54 5.98 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 1.5 m-20 89.35 69.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.847 -1.07 . . . . 1.0 109.852 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.55 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 0.1 OUTLIER -77.06 163.0 67.83 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.924 -1.035 . . . . 1.0 109.712 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.38 -20.82 69.89 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.604 1.536 . . . . 1.0 114.234 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.703 ' O ' HD23 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -68.94 -37.67 79.01 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.538 -2.023 . . . . 1.0 105.538 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.558 HG22 HD11 ' A' ' 152' ' ' ILE . 3.8 mm -74.55 -53.3 17.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.06 -1.427 . . . . 1.0 109.787 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.41 70.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.79 -38.25 90.34 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.438 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.564 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . -72.29 -35.27 68.64 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.184 -0.607 . . . . 1.0 110.631 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.558 HD11 HG22 ' A' ' 148' ' ' ILE . 37.4 mt -61.21 -42.51 93.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 O-C-N 123.402 0.439 . . . . 1.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 157' ' ' ALA . 3.3 tt0 -61.99 -55.67 26.95 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.793 -0.763 . . . . 1.0 111.967 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.61 -40.87 84.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.506 0.558 . . . . 1.0 112.506 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' A' ' 156' ' ' ARG . 1.7 pp20? -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.203 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -64.8 -40.59 95.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.318 . . . . 1.0 110.65 178.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 153' ' ' GLU . . . -55.1 -49.68 71.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 160' ' ' ARG . 2.9 m -62.8 -32.15 73.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.844 -1.071 . . . . 1.0 111.03 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.561 ' HB2' ' NZ ' ' A' ' 55' ' ' LYS . . . -57.49 -5.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.256 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 158' ' ' SER . 9.3 mtm180 -107.43 -39.17 5.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.983 0.421 . . . . 1.0 110.48 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.566 179.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 19.6 m -71.21 -106.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 1.0 110.542 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.7 135.06 36.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.549 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -144.97 173.33 11.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.603 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.19 36.24 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.505 HD22 ' H ' ' A' ' 5' ' ' THR . 0.6 OUTLIER 66.63 -176.19 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.558 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.505 ' H ' HD22 ' A' ' 4' ' ' ASN . 7.1 m -139.45 69.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.569 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -150.67 104.09 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.589 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 2.0 pm0 -90.35 157.75 44.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.394 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.61 -171.58 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.71 2.274 . . . . 1.0 112.222 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 33.2 m -65.02 -174.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.541 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . 68.11 171.19 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.401 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.555 ' C ' HG22 ' A' ' 12' ' ' THR . . . -101.46 -85.22 0.43 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.699 0.761 . . . . 1.0 110.379 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER 171.67 -53.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.979 -1.464 . . . . 1.0 109.198 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -126.44 162.1 26.38 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.798 ' H ' ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -119.61 161.46 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.614 0.721 . . . . 1.0 111.416 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.16 -39.49 9.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.614 -178.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.21 -9.4 58.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.391 0.615 . . . . 1.0 110.696 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.798 ' CB ' ' H ' ' A' ' 14' ' ' THR . 17.3 tp10 -89.32 -45.24 9.65 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.667 HG13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.26 149.88 2.47 Favored Pre-proline 0 C--N 1.342 0.242 0 N-CA-C 105.168 -2.16 . . . . 1.0 105.168 177.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.636 ' HD2' HG23 ' A' ' 18' ' ' VAL . 14.5 Cg_exo -46.77 137.41 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 CA-C-N 120.371 1.168 . . . . 1.0 111.531 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 3.2 tt0 -59.27 -52.01 67.51 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.021 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.516 ' ND1' HG23 ' A' ' 22' ' ' VAL . 6.7 p80 -57.13 -28.89 63.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.991 0.737 . . . . 1.0 112.991 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.763 HG22 ' HA ' ' A' ' 97' ' ' ASN . 23.7 t -79.28 -49.65 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.368 0.531 . . . . 1.0 110.379 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.667 ' CD2' HG13 ' A' ' 18' ' ' VAL . 1.1 pp -72.01 -26.92 62.41 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.364 0.602 . . . . 1.0 111.253 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 20' ' ' GLU . 10.6 mmm180 -57.87 -25.51 60.85 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.124 -0.944 . . . . 1.0 112.372 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.25 48.27 0.95 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.878 HD22 HG11 ' A' ' 30' ' ' VAL . 11.7 mt -96.83 131.24 28.33 Favored Pre-proline 0 CA--C 1.511 -0.529 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 29' ' ' GLU . 2.9 Cg_exo -61.86 143.61 95.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 N-CA-C 109.912 -0.842 . . . . 1.0 109.912 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -52.43 -10.04 0.13 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.947 -177.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.908 ' N ' ' HZ2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -84.33 12.14 7.22 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 178.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.878 HG11 HD22 ' A' ' 26' ' ' LEU . 10.8 t -140.1 131.78 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.492 0 N-CA-C 118.227 2.677 . . . . 1.0 118.227 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -134.99 141.37 46.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 110.95 -2.841 . . . . 1.0 103.567 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.755 ' N ' HD22 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -91.28 153.1 20.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 117.759 -1.576 . . . . 1.0 109.856 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 45' ' ' TRP . 1.3 m-85 -154.53 110.41 2.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.335 1.235 . . . . 1.0 114.335 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.581 ' HB3' HD13 ' A' ' 42' ' ' ILE . 12.5 Cg_endo -87.89 151.25 7.21 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.104 2.536 . . . . 1.0 112.105 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.436 ' N ' ' HA ' ' A' ' 40' ' ' THR . 2.3 p 55.46 44.11 27.53 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.19 -43.9 8.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.11 -1.404 . . . . 1.0 107.218 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.578 ' CG2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -104.19 -0.65 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 113.938 -1.483 . . . . 1.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 37' ' ' VAL . 7.0 t70 96.7 3.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.154 0.909 . . . . 1.0 110.693 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.759 ' HG2' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -78.42 -37.27 44.25 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER 84.12 -9.96 0.93 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.741 0.651 . . . . 1.0 112.714 177.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.759 ' H ' ' HG2' ' A' ' 39' ' ' LYS . 18.9 ttm180 -77.59 157.03 30.48 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 176.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 34' ' ' PRO . 5.0 mm -77.66 127.1 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 120.599 1.545 . . . . 1.0 109.482 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.36 -176.35 19.38 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 109.137 -1.585 . . . . 1.0 109.137 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.777 HG23 HG13 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -125.53 130.04 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 107.601 -1.259 . . . . 1.0 107.601 178.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.652 ' CE3' ' N ' ' A' ' 135' ' ' GLU . 52.5 m95 -130.57 151.16 51.34 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' GLU . . . -66.05 132.0 47.52 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.684 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -26.07 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.806 -0.813 . . . . 1.0 108.806 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.908 ' HZ2' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.58 156.25 41.71 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 177.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' CD ' ' HG2' ' A' ' 48' ' ' LYS . 8.1 Cg_exo -73.97 128.35 12.24 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 CA-C-N 121.975 1.741 . . . . 1.0 112.885 -177.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 48' ' ' LYS . 3.4 mp -99.01 146.47 8.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.77 -1.559 . . . . 1.0 112.821 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.763 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -114.76 151.96 32.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.019 -1.901 . . . . 1.0 110.23 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.622 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.25 125.8 25.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.018 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 126' ' ' THR . . . 101.29 -0.87 53.98 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.451 -1.059 . . . . 1.0 110.451 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 1.9 tptt -54.42 152.29 6.72 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.817 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 2.9 ttmt -122.51 108.56 13.3 Favored 'General case' 0 N--CA 1.425 -1.676 0 O-C-N 123.857 0.723 . . . . 1.0 109.738 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.586 ' CE2' ' CD ' ' A' ' 29' ' ' GLU . 18.9 m-85 -116.93 123.11 46.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.865 -1.531 . . . . 1.0 106.865 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' HD11 ' A' ' 99' ' ' LEU . . . 155.82 -157.15 27.57 Favored Glycine 0 C--N 1.31 -0.911 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HG3' ' CE1' ' A' ' 123' ' ' TYR . 10.5 Cg_endo -86.21 150.37 44.9 Favored 'Cis proline' 0 N--CA 1.494 1.553 0 CA-C-N 119.356 1.578 . . . . 1.0 113.201 0.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.626 ' HA ' HD13 ' A' ' 99' ' ' LEU . 7.2 t80 -64.04 120.35 11.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.404 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -27.05 -65.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.829 -1.532 . . . . 1.0 111.432 178.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.675 ' H ' HG23 ' A' ' 60' ' ' VAL . . . 48.78 107.64 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.572 -0.74 . . . . 1.0 113.162 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -94.4 149.46 21.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 176.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -90.52 114.1 26.22 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.177 -1.009 . . . . 1.0 112.165 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HZ2' ' N ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -148.28 171.08 16.54 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.628 -1.169 . . . . 1.0 110.672 -176.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.1 135.1 37.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.102 0.477 . . . . 1.0 111.48 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.672 ' C ' ' H ' ' A' ' 68' ' ' GLN . 9.7 ptt85 -57.95 -24.15 56.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.275 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.51 21.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.756 -0.377 . . . . 1.0 111.188 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.672 ' H ' ' C ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.09 7.31 2.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.723 0.297 . . . . 1.0 111.676 -179.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.422 HG22 ' OD2' ' A' ' 89' ' ' ASP . 37.5 t -99.26 161.08 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' N ' ' CG1' ' A' ' 69' ' ' VAL . 1.6 tttp -177.97 124.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.518 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 42.96 55.82 4.28 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' OD1' ' SD ' ' A' ' 75' ' ' MET . 5.4 t-20 -131.44 -178.37 4.82 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.493 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.81 HG22 ' CZ2' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -138.36 -49.74 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 118.817 0.735 . . . . 1.0 111.411 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.615 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -62.69 36.45 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.503 -177.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -144.82 141.59 29.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.543 0.687 . . . . 1.0 111.657 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.881 ' NE1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -159.73 163.4 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.91 -1.041 . . . . 1.0 111.962 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 77' ' ' GLU . 3.6 pt-20 -98.02 122.49 41.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.894 0.854 . . . . 1.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.731 HG21 HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -126.78 131.01 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-N 115.219 -0.9 . . . . 1.0 109.194 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -89.79 121.69 32.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.848 -179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.584 ' O ' ' N ' ' A' ' 82' ' ' ASN . 13.7 m-85 -86.48 108.05 16.21 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 114.607 -1.179 . . . . 1.0 110.047 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.29 48.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.206 1.937 . . . . 1.0 109.955 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.652 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -151.85 -84.0 0.08 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.237 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.779 HD12 ' N ' ' A' ' 84' ' ' GLY . 4.1 pp -78.05 -42.33 32.66 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.779 ' N ' HD12 ' A' ' 83' ' ' LEU . . . 151.22 -170.8 30.88 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.563 -1.303 . . . . 1.0 112.356 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.573 ' O ' ' SD ' ' A' ' 86' ' ' MET . 11.8 m95 -70.43 122.5 19.74 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 117.155 0.478 . . . . 1.0 110.322 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.729 ' CG ' HD11 ' A' ' 83' ' ' LEU . 42.1 mmm -126.91 160.2 31.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -113.35 134.2 54.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.563 -1.199 . . . . 1.0 108.144 177.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.731 HD12 HG21 ' A' ' 78' ' ' VAL . 7.0 mt -107.64 108.52 25.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 118.668 -0.682 . . . . 1.0 111.943 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.66 ' N ' ' HZ2' ' A' ' 64' ' ' LYS . 28.9 t0 -133.78 131.93 39.89 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.619 1.1 . . . . 1.0 113.521 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -136.22 91.47 2.68 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.579 HG22 ' OD1' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -114.91 49.63 1.03 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.862 0.839 . . . . 1.0 110.122 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.467 ' N ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -144.15 152.26 54.01 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.987 177.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.36 -44.33 4.88 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.282 1.321 . . . . 1.0 112.72 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.48 -45.09 69.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.732 -1.122 . . . . 1.0 113.562 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 -11.3 33.93 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.832 0.349 . . . . 1.0 110.65 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA2' HG21 ' A' ' 60' ' ' VAL . . . -110.68 -158.42 15.97 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.763 ' HA ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -145.01 -153.08 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 1.0 110.007 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.61 ' N ' HG13 ' A' ' 22' ' ' VAL . 45.6 p-90 -74.59 -34.89 62.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.855 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.626 HD13 ' HA ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -54.9 -29.22 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.602 -0.727 . . . . 1.0 109.056 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' O ' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -66.27 -15.08 62.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 101' ' ' TYR . 0.9 OUTLIER -94.86 0.58 54.94 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.831 -178.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 99' ' ' LEU . 16.8 t -70.46 132.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 119.936 -0.706 . . . . 1.0 110.174 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -79.26 -153.84 0.08 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.209 -0.596 . . . . 1.0 111.878 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.81 ' CZ2' HG22 ' A' ' 73' ' ' VAL . 6.0 m-90 -126.27 159.35 33.34 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.714 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.657 ' HB2' ' HB2' ' A' ' 137' ' ' LEU . . . -139.27 174.73 10.21 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.427 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 -47.87 2.87 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.784 ' O ' ' N ' ' A' ' 109' ' ' GLU . 20.3 m -148.9 132.0 16.32 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.68 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' C ' ' OE1' ' A' ' 111' ' ' GLN . . . -19.52 -4.29 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 118.456 2.142 . . . . 1.0 118.456 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.784 ' N ' ' O ' ' A' ' 107' ' ' SER . 1.5 mt-10 -82.03 -24.43 35.34 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 119.236 1.518 . . . . 1.0 113.693 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.646 ' O ' ' O ' ' A' ' 111' ' ' GLN . 13.4 pt-20 -124.18 -17.14 6.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.846 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 6.5 mp0 -45.7 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.954 1.408 . . . . 1.0 109.886 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.783 HD21 HD12 ' A' ' 137' ' ' LEU . 0.3 OUTLIER 163.21 -28.32 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.961 -1.018 . . . . 1.0 111.852 177.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mp -137.92 164.19 29.62 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.205 -0.998 . . . . 1.0 112.177 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -143.7 130.32 10.34 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 119.013 -1.075 . . . . 1.0 113.566 -178.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' A' ' 140' ' ' TYR . 81.9 Cg_exo -50.42 131.04 31.1 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.676 2.917 . . . . 1.0 113.625 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.714 HD13 HG12 ' A' ' 152' ' ' ILE . 34.2 tp -141.34 130.66 23.63 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.127 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 78' ' ' VAL . 6.2 mm-40 -102.83 114.85 29.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.908 -0.717 . . . . 1.0 110.436 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 123' ' ' TYR . 3.2 pt -139.16 123.76 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.0 110.851 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.2 42.41 25.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.354 0.597 . . . . 1.0 110.668 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.594 ' NE ' ' O ' ' A' ' 79' ' ' TYR . 5.2 mmt-85 56.74 32.46 21.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 118' ' ' ILE . . . -133.49 144.04 49.18 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.881 HG21 ' NE1' ' A' ' 76' ' ' TRP . 4.1 mm -103.07 116.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.567 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.647 ' CD1' HD11 ' A' ' 118' ' ' ILE . 3.5 m-85 -109.04 158.25 17.91 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CE2' HG11 ' A' ' 138' ' ' VAL . 1.4 m-30 -116.85 132.14 56.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -127.64 146.33 50.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.488 -177.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 112' ' ' ASN . 13.1 p -100.72 111.45 23.68 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.935 0.772 . . . . 1.0 111.483 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.702 HD12 ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.96 -5.58 59.2 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 123.926 0.766 . . . . 1.0 111.88 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.89 ' NZ ' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.74 122.62 7.23 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.458 0.572 . . . . 1.0 109.986 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -44.17 138.59 6.76 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.521 1.481 . . . . 1.0 111.21 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.416 ' H ' ' HB ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -114.13 134.61 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.462 -0.57 . . . . 1.0 109.462 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.96 132.59 60.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.02 -0.672 . . . . 1.0 109.931 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.07 104.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.21 1.273 . . . . 1.0 111.906 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 46' ' ' ALA . . . 131.87 2.91 4.19 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.035 -0.602 . . . . 1.0 112.834 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -105.56 115.54 30.42 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.218 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.652 ' N ' ' CE3' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -47.18 139.73 5.81 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.889 0.852 . . . . 1.0 111.359 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.684 HD21 ' OE2' ' A' ' 29' ' ' GLU . 8.6 mp -78.34 128.79 34.18 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.708 -1.133 . . . . 1.0 109.072 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.783 HD12 HD21 ' A' ' 112' ' ' ASN . 0.0 OUTLIER -142.58 161.34 38.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.569 0.699 . . . . 1.0 110.706 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.508 HG11 ' CE2' ' A' ' 124' ' ' TYR . 27.9 m -146.31 177.38 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.254 -0.885 . . . . 1.0 111.968 -178.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.712 ' HE1' ' CG ' ' A' ' 111' ' ' GLN . 9.2 p-90 -158.09 -86.95 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 119.806 -0.758 . . . . 1.0 113.034 178.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.841 ' CB ' HD11 ' A' ' 148' ' ' ILE . 0.1 OUTLIER 24.47 59.14 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 124.141 0.901 . . . . 1.0 112.005 179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' IAS . . . . . 0.576 ' OD1' ' N ' ' A' ' 143' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.516 ' C ' ' OD1' ' A' ' 141' ' ' IAS . . . . . . . . 0 N--CA 1.469 0.874 0 CA-C-O 119.873 -0.404 . . . . 1.0 112.113 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.576 ' N ' ' OD1' ' A' ' 141' ' ' IAS . 28.6 mt-10 -32.5 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.532 -0.544 . . . . 1.0 109.532 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -130.03 54.96 1.82 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.404 ' ND2' HG12 ' A' ' 148' ' ' ILE . 0.1 OUTLIER -68.47 163.45 53.43 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.081 -0.963 . . . . 1.0 108.748 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.496 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 10.5 Cg_exo -62.55 -20.2 69.99 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 120.929 1.086 . . . . 1.0 113.672 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.524 ' HG3' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -73.77 -34.08 64.53 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.726 -1.953 . . . . 1.0 105.726 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.841 HD11 ' CB ' ' A' ' 140' ' ' TYR . 1.5 mm -77.75 -50.63 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 113.866 -1.515 . . . . 1.0 109.699 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.83 -52.15 33.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 146' ' ' PRO . . . -56.58 -41.7 77.42 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.817 -176.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.674 ' CB ' HD23 ' A' ' 127' ' ' LEU . . . -73.91 -31.19 62.98 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.674 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 116' ' ' LEU . 22.7 mt -62.47 -48.43 88.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.921 -0.712 . . . . 1.0 109.783 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.699 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 3.7 mt-10 -55.72 -52.28 64.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.345 -0.843 . . . . 1.0 113.071 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -56.52 -49.64 74.15 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 118.75 -1.18 . . . . 1.0 112.543 -178.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.512 ' CD ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -81.92 -58.71 2.86 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.457 -0.897 . . . . 1.0 112.171 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 152' ' ' ILE . 1.0 OUTLIER -55.65 -51.63 66.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.494 -0.775 . . . . 1.0 112.22 -179.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 153' ' ' GLU . . . -58.78 -23.72 60.63 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.9 m -96.26 0.01 50.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.346 -1.297 . . . . 1.0 110.509 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.04 38.09 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.494 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -125.95 -65.69 0.98 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 117.949 -1.024 . . . . 1.0 110.544 -179.95 . . . . . . . . 0 0 . 1 stop_ save_